Psyllid ID: psy14740
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 362 | 2.2.26 [Sep-21-2011] | |||||||
| Q03043 | 1088 | cGMP-dependent protein ki | no | N/A | 0.745 | 0.248 | 0.654 | 1e-116 | |
| P32023 | 934 | cGMP-dependent protein ki | no | N/A | 0.745 | 0.289 | 0.654 | 1e-116 | |
| P0C605 | 671 | cGMP-dependent protein ki | yes | N/A | 0.740 | 0.399 | 0.504 | 7e-84 | |
| P00516 | 671 | cGMP-dependent protein ki | yes | N/A | 0.740 | 0.399 | 0.504 | 8e-84 | |
| Q13976 | 671 | cGMP-dependent protein ki | yes | N/A | 0.740 | 0.399 | 0.504 | 1e-83 | |
| O77676 | 671 | cGMP-dependent protein ki | yes | N/A | 0.740 | 0.399 | 0.501 | 3e-82 | |
| O76360 | 780 | cGMP-dependent protein ki | yes | N/A | 0.754 | 0.35 | 0.443 | 1e-77 | |
| Q64595 | 762 | cGMP-dependent protein ki | no | N/A | 0.732 | 0.347 | 0.436 | 5e-74 | |
| Q61410 | 762 | cGMP-dependent protein ki | no | N/A | 0.732 | 0.347 | 0.433 | 1e-73 | |
| Q13237 | 762 | cGMP-dependent protein ki | no | N/A | 0.732 | 0.347 | 0.428 | 7e-73 |
| >sp|Q03043|KGP24_DROME cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B OS=Drosophila melanogaster GN=for PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 214/327 (65%), Positives = 242/327 (74%), Gaps = 57/327 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ GDYI+RQGARGDTFFIISKGKV+VT+KQ ++ EEK+IR L KGDFFGEKALQGD
Sbjct: 656 ETHYQRGDYIVRQGARGDTFFIISKGKVRVTIKQQDTQEEKFIRMLGKGDFFGEKALQGD 715
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS-ERRRLNEEFRSLRLS 149
DLRTANI+ +GVSCLVID+ETFNQLIS+LDEI+ +Y DE + ERR++NEEFR + L+
Sbjct: 716 DLRTANIICESADGVSCLVIDRETFNQLISNLDEIKHRYDDEGAMERRKINEEFRDINLT 775
Query: 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSC 209
DLRVI TLGVGGFGRVELVQ GD SRSFALKQMKKSQ++
Sbjct: 776 DLRVIATLGVGGFGRVELVQTNGDSSRSFALKQMKKSQIV-------------------- 815
Query: 210 LVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIV 269
E R+ I+ ++ IMGEANC FIV
Sbjct: 816 ---------------------------ETRQQQHIMSEKE---------IMGEANCQFIV 839
Query: 270 KLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329
KL+KTFKDKKYLYMLMESCLGGELWTILRDKGNFDD+TTRFYTACVVEAFDYLHSRNIIY
Sbjct: 840 KLFKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDSTTRFYTACVVEAFDYLHSRNIIY 899
Query: 330 RDLKPENLLLSTSGYVKLVDFGFAKKL 356
RDLKPENLLL+ GYVKLVDFGFAKKL
Sbjct: 900 RDLKPENLLLNERGYVKLVDFGFAKKL 926
|
Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 2 |
| >sp|P32023|KGP25_DROME cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 OS=Drosophila melanogaster GN=for PE=2 SV=3 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 214/327 (65%), Positives = 242/327 (74%), Gaps = 57/327 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ GDYI+RQGARGDTFFIISKGKV+VT+KQ ++ EEK+IR L KGDFFGEKALQGD
Sbjct: 502 ETHYQRGDYIVRQGARGDTFFIISKGKVRVTIKQQDTQEEKFIRMLGKGDFFGEKALQGD 561
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS-ERRRLNEEFRSLRLS 149
DLRTANI+ +GVSCLVID+ETFNQLIS+LDEI+ +Y DE + ERR++NEEFR + L+
Sbjct: 562 DLRTANIICESADGVSCLVIDRETFNQLISNLDEIKHRYDDEGAMERRKINEEFRDINLT 621
Query: 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSC 209
DLRVI TLGVGGFGRVELVQ GD SRSFALKQMKKSQ++
Sbjct: 622 DLRVIATLGVGGFGRVELVQTNGDSSRSFALKQMKKSQIV-------------------- 661
Query: 210 LVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIV 269
E R+ I+ ++ IMGEANC FIV
Sbjct: 662 ---------------------------ETRQQQHIMSEKE---------IMGEANCQFIV 685
Query: 270 KLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329
KL+KTFKDKKYLYMLMESCLGGELWTILRDKGNFDD+TTRFYTACVVEAFDYLHSRNIIY
Sbjct: 686 KLFKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDSTTRFYTACVVEAFDYLHSRNIIY 745
Query: 330 RDLKPENLLLSTSGYVKLVDFGFAKKL 356
RDLKPENLLL+ GYVKLVDFGFAKKL
Sbjct: 746 RDLKPENLLLNERGYVKLVDFGFAKKL 772
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus GN=Prkg1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 166/329 (50%), Positives = 215/329 (65%), Gaps = 61/329 (18%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ G+YIIRQGARGDTFFIISKG+V VT + S + ++RTL KGD+FGEKALQG+
Sbjct: 239 ETHYENGEYIIRQGARGDTFFIISKGQVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGE 298
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE---FRSLR 147
D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + + E F +L+
Sbjct: 299 DVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFANLK 356
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
LSD +I TLGVGGFGRVELVQ+ + S++FA+K +KK +++
Sbjct: 357 LSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDT---------------- 400
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
R+ I R ++ IM A+ DF
Sbjct: 401 -------------------------------RQQEHI---RSEKQIMQ------GAHSDF 420
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F+D+TTRFYTACVVEAF YLHS+ I
Sbjct: 421 IVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGI 480
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
IYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 481 IYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus GN=PRKG1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 8e-84, Method: Compositional matrix adjust.
Identities = 166/329 (50%), Positives = 215/329 (65%), Gaps = 61/329 (18%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ G+YIIRQGARGDTFFIISKGKV VT + + + ++RTL KGD+FGEKALQG+
Sbjct: 239 ETHYENGEYIIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDWFGEKALQGE 298
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE---FRSLR 147
D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + + E F +L+
Sbjct: 299 DVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFANLK 356
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
LSD +I TLGVGGFGRVELVQ+ + S++FA+K +KK +++
Sbjct: 357 LSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDT---------------- 400
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
R+ I R ++ IM A+ DF
Sbjct: 401 -------------------------------RQQEHI---RSEKQIMQ------GAHSDF 420
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F+D+TTRFYTACVVEAF YLHS+ I
Sbjct: 421 IVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGI 480
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
IYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 481 IYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q13976|KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens GN=PRKG1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 166/329 (50%), Positives = 214/329 (65%), Gaps = 61/329 (18%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ G+YIIRQGARGDTFFIISKG V VT + S + ++RTL KGD+FGEKALQG+
Sbjct: 239 ETHYENGEYIIRQGARGDTFFIISKGTVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGE 298
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE---FRSLR 147
D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + + E F +L+
Sbjct: 299 DVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFANLK 356
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
LSD +I TLGVGGFGRVELVQ+ + S++FA+K +KK +++
Sbjct: 357 LSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDT---------------- 400
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
R+ I R ++ IM A+ DF
Sbjct: 401 -------------------------------RQQEHI---RSEKQIMQ------GAHSDF 420
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F+D+TTRFYTACVVEAF YLHS+ I
Sbjct: 421 IVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGI 480
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
IYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 481 IYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|O77676|KGP1_RABIT cGMP-dependent protein kinase 1 OS=Oryctolagus cuniculus GN=PRKG1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 165/329 (50%), Positives = 213/329 (64%), Gaps = 61/329 (18%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ +Y IRQGARGDTFFIISKGKV VT + S + ++RTL KGD+FGEKALQG+
Sbjct: 239 ETHYENEEYSIRQGARGDTFFIISKGKVNVTREDSPSEDPIFLRTLGKGDWFGEKALQGE 298
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE---FRSLR 147
D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + + E F +L+
Sbjct: 299 DVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFANLK 356
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
LSD +I TLGVGGFGRVELVQ+ + S++FA+K +KK +++
Sbjct: 357 LSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDT---------------- 400
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
R+ I R ++ IM A+ DF
Sbjct: 401 -------------------------------RQQEHI---RSEKQIMQ------GAHSDF 420
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F+D+TTRFYTACVVEAF YLHS+ I
Sbjct: 421 IVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGI 480
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
IYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 481 IYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|O76360|EGL4_CAEEL cGMP-dependent protein kinase egl-4 OS=Caenorhabditis elegans GN=egl-4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 152/343 (44%), Positives = 207/343 (60%), Gaps = 70/343 (20%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
Q +Y G YIIRQG +GD FF+I+ G+VKVT + TE + IR L +GDFFGE+AL G+
Sbjct: 337 QDYYDGGHYIIRQGEKGDAFFVINSGQVKVTQQIEGETEPREIRVLNQGDFFGERALLGE 396
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR------------- 137
++RTANI+A P GV L +D+E+F +LI L+ ++ Y D+ +
Sbjct: 397 EVRTANIIAQAP-GVEVLTLDRESFGKLIGDLESLKKDYGDKERLAQVVREPPSPVKIVD 455
Query: 138 RLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTA 197
EEF + L +++ + TLGVGGFGRVELV + GD +++F
Sbjct: 456 DFREEFAQVTLKNVKRLATLGVGGFGRVELVCVNGDKAKTF------------------- 496
Query: 198 NIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEK 257
+L ++ K+ IV+TRQQ+HI +E+
Sbjct: 497 -------------------------ALKALKKKH------------IVDTRQQEHIFAER 519
Query: 258 EIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVE 317
IM E + D+IVKLYKTF+D+K++YML+E CLGGELWT LRD+G+FDD T RFY ACV+E
Sbjct: 520 NIMMETSTDWIVKLYKTFRDQKFVYMLLEVCLGGELWTTLRDRGHFDDYTARFYVACVLE 579
Query: 318 AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
+YLH +NI+YRDLKPEN LL+ +GY+KLVDFGFAKKL R
Sbjct: 580 GLEYLHRKNIVYRDLKPENCLLANTGYLKLVDFGFAKKLASGR 622
|
Promotes chemoreceptor gene expression in response to increased cGMP levels by antagonizing the gene repression functions of the class II HDAC hda-4 and the mef-2 transcription factor. Represses body size and lifespan through the dbl-1 and insulin pathways, respectively. May also signal through daf-3 and/or daf-5. Role in egg-laying and dauer formation. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q64595|KGP2_RAT cGMP-dependent protein kinase 2 OS=Rattus norvegicus GN=Prkg2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 155/355 (43%), Positives = 205/355 (57%), Gaps = 90/355 (25%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
+Y +GDYIIR+G G TFFI++KGKVKVT + + I+TL KG++FGEKAL DD+
Sbjct: 306 YYDKGDYIIREGEEGSTFFILAKGKVKVTQSTEGHDQPQLIKTLQKGEYFGEKALISDDV 365
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV-------DETSERRRLNEEFRS 145
R+ANI+A + + V+CLVID+ETFNQ + + DE++ KY+ + E+R S
Sbjct: 366 RSANIIAEEND-VACLVIDRETFNQTVGTFDELQ-KYLEGYVATLNRDDEKRHAKRSMSS 423
Query: 146 LRLS------------------------DLRVITTLGVGGFGRVELVQIAGDPSRSFALK 181
+LS +L +I TLGVGGFGRVELV++
Sbjct: 424 WKLSKALSLEMIQLKEKVARFSSTSPFQNLEIIATLGVGGFGRVELVKV----------- 472
Query: 182 QMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRA 241
+ NI A + C+ R
Sbjct: 473 -------------KNENIAFA----MKCI-----------------------------RK 486
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
IV+T+QQ+H+ SEK I+ E FIVKLY+TFKD KY+YML+E+CLGGELW+ILRD+G
Sbjct: 487 KHIVDTKQQEHVYSEKRILEELCSPFIVKLYRTFKDNKYVYMLLEACLGGELWSILRDRG 546
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+FD+ T++F ACV EAFDYLH IIYRDLKPENL+L GY+KLVDFGFAKK+
Sbjct: 547 SFDEPTSKFCVACVTEAFDYLHRLGIIYRDLKPENLILDADGYLKLVDFGFAKKI 601
|
Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q61410|KGP2_MOUSE cGMP-dependent protein kinase 2 OS=Mus musculus GN=Prkg2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 154/355 (43%), Positives = 205/355 (57%), Gaps = 90/355 (25%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
+Y +GDYIIR+G G TFFI++KGKVKVT + + I+TL KG++FGEKAL DD+
Sbjct: 306 YYDKGDYIIREGEEGSTFFILAKGKVKVTQSTEGHDQPQLIKTLQKGEYFGEKALISDDV 365
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV-------DETSERRRLNEEFRS 145
R+ANI+A + + V+CLVID+ETFNQ + + DE++ KY+ + E+R S
Sbjct: 366 RSANIIAEEND-VACLVIDRETFNQTVGTFDELQ-KYLEGYVATLNRDDEKRHAKRSMSS 423
Query: 146 LRLS------------------------DLRVITTLGVGGFGRVELVQIAGDPSRSFALK 181
+LS +L +I TLGVGGFGRVELV++
Sbjct: 424 WKLSKALSLEMIQLKEKVARFSSTSPFQNLEIIATLGVGGFGRVELVKV----------- 472
Query: 182 QMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRA 241
+ N+ A + C+ R
Sbjct: 473 -------------KNENVAFA----MKCI-----------------------------RK 486
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
IV+T+QQ+H+ SEK I+ E FIVKLY+TFKD KY+YML+E+CLGGELW+ILRD+G
Sbjct: 487 KHIVDTKQQEHVYSEKRILEELCSPFIVKLYRTFKDNKYVYMLLEACLGGELWSILRDRG 546
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+FD+ T++F ACV EAFDYLH IIYRDLKPENL+L GY+KLVDFGFAKK+
Sbjct: 547 SFDEPTSKFCVACVTEAFDYLHLLGIIYRDLKPENLILDADGYLKLVDFGFAKKI 601
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q13237|KGP2_HUMAN cGMP-dependent protein kinase 2 OS=Homo sapiens GN=PRKG2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 152/355 (42%), Positives = 205/355 (57%), Gaps = 90/355 (25%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
+Y +GDYIIR+G G TFFI++KGKVKVT + + I+TL KG++FGEKAL DD+
Sbjct: 306 YYDKGDYIIREGEEGSTFFILAKGKVKVTQSTEGHDQPQLIKTLQKGEYFGEKALISDDV 365
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV-------DETSERRRLNEEFRS 145
R+ANI+A + + V+CLVID+ETFNQ + + +E++ KY+ + E+R +
Sbjct: 366 RSANIIAEEND-VACLVIDRETFNQTVGTFEELQ-KYLEGYVANLNRDDEKRHAKRSMSN 423
Query: 146 LRLS------------------------DLRVITTLGVGGFGRVELVQIAGDPSRSFALK 181
+LS +L +I TLGVGGFGRVELV++
Sbjct: 424 WKLSKALSLEMIQLKEKVARFSSSSPFQNLEIIATLGVGGFGRVELVKV----------- 472
Query: 182 QMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRA 241
+ N+ A + C+ R
Sbjct: 473 -------------KNENVAFA----MKCI-----------------------------RK 486
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
IV+T+QQ+H+ SEK I+ E FIVKLY+TFKD KY+YML+E+CLGGELW+ILRD+G
Sbjct: 487 KHIVDTKQQEHVYSEKRILEELCSPFIVKLYRTFKDNKYVYMLLEACLGGELWSILRDRG 546
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+FD+ T++F ACV EAFDYLH IIYRDLKPENL+L GY+KLVDFGFAKK+
Sbjct: 547 SFDEPTSKFCVACVTEAFDYLHRLGIIYRDLKPENLILDAEGYLKLVDFGFAKKI 601
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 362 | ||||||
| 402502111 | 634 | cGMP-dependent protein kinase, partial [ | 0.745 | 0.425 | 0.702 | 1e-126 | |
| 340723955 | 722 | PREDICTED: cGMP-dependent protein kinase | 0.745 | 0.373 | 0.677 | 1e-121 | |
| 225618775 | 668 | cGMP dependent protein kinase [Bombus ig | 0.745 | 0.404 | 0.677 | 1e-121 | |
| 350422649 | 668 | PREDICTED: cGMP-dependent protein kinase | 0.745 | 0.404 | 0.677 | 1e-121 | |
| 239946290 | 668 | cGMP-dependent protein kinase foraging [ | 0.745 | 0.404 | 0.677 | 1e-121 | |
| 158147011 | 674 | cGMP-dependent protein kinase 1 foraging | 0.745 | 0.400 | 0.677 | 1e-120 | |
| 242009000 | 542 | cAMP-dependent protein kinase catalytic | 0.745 | 0.498 | 0.665 | 1e-120 | |
| 383857827 | 721 | PREDICTED: cGMP-dependent protein kinase | 0.745 | 0.374 | 0.677 | 1e-120 | |
| 307211418 | 470 | cGMP-dependent protein kinase, isozyme 2 | 0.745 | 0.574 | 0.668 | 1e-120 | |
| 380021437 | 674 | PREDICTED: cGMP-dependent protein kinase | 0.745 | 0.400 | 0.677 | 1e-120 |
| >gi|402502111|gb|ADP94162.2| cGMP-dependent protein kinase, partial [Schistocerca gregaria] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1176), Expect = e-126, Method: Compositional matrix adjust.
Identities = 229/326 (70%), Positives = 253/326 (77%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T+Y EGDYIIRQGARGDTFFIISKG+VKVTMKQPNS EEKY+RTL+KGDFFGEKALQGD
Sbjct: 203 ETYYNEGDYIIRQGARGDTFFIISKGQVKVTMKQPNSLEEKYVRTLHKGDFFGEKALQGD 262
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A+DPEGV+CLVID+ETFNQLISSLDEIRT+Y DE ERRR++EEFR ++LSD
Sbjct: 263 DLRTANIIASDPEGVTCLVIDRETFNQLISSLDEIRTRYKDEGVERRRIDEEFRDVKLSD 322
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LRV+ TLGVGGFGRVELVQIAGDP RSFALKQMKKSQ++
Sbjct: 323 LRVLATLGVGGFGRVELVQIAGDPLRSFALKQMKKSQIV--------------------- 361
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ + EIMGEANC+FIVK
Sbjct: 362 --------------------------ETRQQQHIMSEK---------EIMGEANCNFIVK 386
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
LYKTFKD+KYLYMLMESCLGGELWTILRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 387 LYKTFKDRKYLYMLMESCLGGELWTILRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 446
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL +GYVKLVDFGFAKKL
Sbjct: 447 DLKPENLLLDNAGYVKLVDFGFAKKL 472
|
Source: Schistocerca gregaria Species: Schistocerca gregaria Genus: Schistocerca Family: Acrididae Order: Orthoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340723955|ref|XP_003400352.1| PREDICTED: cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1134), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 247/326 (75%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIISKG+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 291 ETFYNNGDYIIRQGARGDTFFIISKGQVRVTIKQPDTPEEKYIRTLSKGDFFGEKALQGD 350
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 351 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 410
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQI GD SRSFALKQMKK+Q++
Sbjct: 411 LRPLATLGVGGFGRVELVQIVGDSSRSFALKQMKKAQIV--------------------- 449
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IMGEA+CDF+VK
Sbjct: 450 --------------------------ETRQQQHIMSEKR---------IMGEADCDFVVK 474
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 475 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 534
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 535 DLKPENLLLDSQGYVKLVDFGFAKRL 560
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|225618775|dbj|BAH29963.1| cGMP dependent protein kinase [Bombus ignitus] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 247/326 (75%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIISKG+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 237 ETFYNNGDYIIRQGARGDTFFIISKGQVRVTIKQPDTPEEKYIRTLSKGDFFGEKALQGD 296
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 297 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 356
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQI GD SRSFALKQMKK+Q++
Sbjct: 357 LRPLATLGVGGFGRVELVQIVGDSSRSFALKQMKKAQIV--------------------- 395
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IMGEA+CDF+VK
Sbjct: 396 --------------------------ETRQQQHIMSEKR---------IMGEADCDFVVK 420
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 421 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 480
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 481 DLKPENLLLDSQGYVKLVDFGFAKRL 506
|
Source: Bombus ignitus Species: Bombus ignitus Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350422649|ref|XP_003493238.1| PREDICTED: cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 247/326 (75%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIISKG+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 237 ETFYNNGDYIIRQGARGDTFFIISKGQVRVTIKQPDTPEEKYIRTLSKGDFFGEKALQGD 296
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 297 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 356
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQI GD SRSFALKQMKK+Q++
Sbjct: 357 LRPLATLGVGGFGRVELVQIVGDSSRSFALKQMKKAQIV--------------------- 395
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IMGEA+CDF+VK
Sbjct: 396 --------------------------ETRQQQHIMSEKR---------IMGEADCDFVVK 420
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 421 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 480
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 481 DLKPENLLLDSQGYVKLVDFGFAKRL 506
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|239946290|gb|ACS36224.1| cGMP-dependent protein kinase foraging [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 247/326 (75%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIISKG+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 237 ETFYNNGDYIIRQGARGDTFFIISKGQVRVTIKQPDTPEEKYIRTLSKGDFFGEKALQGD 296
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 297 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 356
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQI GD SRSFALKQMKK+Q++
Sbjct: 357 LRPLATLGVGGFGRVELVQIVGDSSRSFALKQMKKAQIV--------------------- 395
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IMGEA+CDF+VK
Sbjct: 396 --------------------------ETRQQQHIMSEKR---------IMGEADCDFVVK 420
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 421 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 480
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 481 DLKPENLLLDSQGYVKLVDFGFAKRL 506
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|158147011|gb|ABW22623.1| cGMP-dependent protein kinase 1 foraging [Pheidole pallidula] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1127), Expect = e-120, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 246/326 (75%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIIS+G+V+VT+KQP++TEEKYIRTL KGDFFGEKALQGD
Sbjct: 243 ETFYNNGDYIIRQGARGDTFFIISRGQVRVTIKQPDTTEEKYIRTLRKGDFFGEKALQGD 302
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR +RL D
Sbjct: 303 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYRDELVERRRLNEEFRDVRLQD 362
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR I TLGVGGFGRVELVQIAGD +RSFALKQMKKSQ++
Sbjct: 363 LRTIATLGVGGFGRVELVQIAGDSTRSFALKQMKKSQIV--------------------- 401
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IM EA+CDF+VK
Sbjct: 402 --------------------------ETRQQQHIMSEKR---------IMSEADCDFVVK 426
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 427 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGYFDDGTTRFYTACVVEAFDYLHSRNIIYR 486
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL GYVKLVDFGFAK+L
Sbjct: 487 DLKPENLLLDNQGYVKLVDFGFAKRL 512
|
Source: Pheidole pallidula Species: Pheidole pallidula Genus: Pheidole Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242009000|ref|XP_002425281.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212509046|gb|EEB12543.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-120, Method: Compositional matrix adjust.
Identities = 225/338 (66%), Positives = 249/338 (73%), Gaps = 68/338 (20%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+ +Y +GDYIIRQGARGDTFFIISKG+VKVT+KQPN++EEKYIRTL KGDFFGEKALQGD
Sbjct: 99 EAYYNQGDYIIRQGARGDTFFIISKGEVKVTIKQPNTSEEKYIRTLGKGDFFGEKALQGD 158
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRR------------ 138
DLRTANI+A DPEGV+CLVID+E+FNQLIS LDEIRTKY DE ERR
Sbjct: 159 DLRTANIIANDPEGVTCLVIDRESFNQLISGLDEIRTKYADEGIERRNVNETRWVRLINV 218
Query: 139 LNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTAN 198
+NEEFR L+LSDLR++ TLGVGGFGRVELVQIAGD +RSFALKQMKKSQ++
Sbjct: 219 VNEEFRDLKLSDLRILATLGVGGFGRVELVQIAGDCTRSFALKQMKKSQIV--------- 269
Query: 199 IVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKE 258
E R+ I+ SEK+
Sbjct: 270 --------------------------------------ETRQQQHIM---------SEKD 282
Query: 259 IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEA 318
IM EANCDFIVKLYKTFKD+KYLYMLMESCLGGELWTILRDKG+FDD+TTRFYTACVV A
Sbjct: 283 IMSEANCDFIVKLYKTFKDRKYLYMLMESCLGGELWTILRDKGHFDDSTTRFYTACVVSA 342
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
FDYLHSRNIIYRDLKPENLLL GYVKLVDFGFAKKL
Sbjct: 343 FDYLHSRNIIYRDLKPENLLLDVQGYVKLVDFGFAKKL 380
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383857827|ref|XP_003704405.1| PREDICTED: cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-120, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 248/326 (76%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIIS+G+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 290 ETFYNNGDYIIRQGARGDTFFIISRGQVRVTIKQPDTPEEKYIRTLGKGDFFGEKALQGD 349
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 350 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 409
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQIAGD +RSFALKQMKK+Q++
Sbjct: 410 LRPLATLGVGGFGRVELVQIAGDGTRSFALKQMKKAQIV--------------------- 448
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IM GEA+CDFIVK
Sbjct: 449 --------------------------ETRQQQHIM---SEKRIM------GEADCDFIVK 473
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 474 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 533
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 534 DLKPENLLLDSQGYVKLVDFGFAKRL 559
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307211418|gb|EFN87545.1| cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1121), Expect = e-120, Method: Compositional matrix adjust.
Identities = 218/326 (66%), Positives = 249/326 (76%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYI+RQGARGDTFFIIS+G+V+VT+KQP++TEEKYIRTL +GDFFGEKALQGD
Sbjct: 39 ETFYNNGDYIVRQGARGDTFFIISRGQVRVTIKQPDTTEEKYIRTLGRGDFFGEKALQGD 98
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 99 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 158
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQI GD +RSFALKQMKK+Q++
Sbjct: 159 LRALATLGVGGFGRVELVQIIGDNTRSFALKQMKKAQIV--------------------- 197
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IMGEA+CDF+VK
Sbjct: 198 --------------------------ETRQQQHIMSEKR---------IMGEADCDFVVK 222
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD+TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 223 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDSTTRFYTACVVEAFDYLHSRNIIYR 282
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 283 DLKPENLLLDSQGYVKLVDFGFAKRL 308
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380021437|ref|XP_003694572.1| PREDICTED: cGMP-dependent protein kinase, isozyme 2 forms cD5/T2-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1121), Expect = e-120, Method: Compositional matrix adjust.
Identities = 221/326 (67%), Positives = 248/326 (76%), Gaps = 56/326 (17%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+TFY GDYIIRQGARGDTFFIIS+G+V+VT+KQP++ EEKYIRTL KGDFFGEKALQGD
Sbjct: 243 ETFYNNGDYIIRQGARGDTFFIISRGQVRVTIKQPDTPEEKYIRTLSKGDFFGEKALQGD 302
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSD 150
DLRTANI+A DPEGVSCLVID+ETFNQLISSLDEIRT+Y DE ERRRLNEEFR LRL D
Sbjct: 303 DLRTANIIADDPEGVSCLVIDRETFNQLISSLDEIRTRYKDELVERRRLNEEFRDLRLQD 362
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
LR + TLGVGGFGRVELVQIAGD SRSFALKQMKK+Q++
Sbjct: 363 LRPLATLGVGGFGRVELVQIAGDSSRSFALKQMKKAQIV--------------------- 401
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E R+ I+ ++ IM GEA+CDF+VK
Sbjct: 402 --------------------------ETRQQQHIM---SEKRIM------GEADCDFVVK 426
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L+KTFKD+KYLYMLME+CLGGELWT+LRDKG+FDD TTRFYTACVVEAFDYLHSRNIIYR
Sbjct: 427 LFKTFKDRKYLYMLMEACLGGELWTVLRDKGHFDDGTTRFYTACVVEAFDYLHSRNIIYR 486
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356
DLKPENLLL + GYVKLVDFGFAK+L
Sbjct: 487 DLKPENLLLDSQGYVKLVDFGFAKRL 512
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 362 | ||||||
| FB|FBgn0000721 | 1088 | for "foraging" [Drosophila mel | 0.439 | 0.146 | 0.743 | 3.6e-116 | |
| RGD|1587390 | 459 | Prkg1 "protein kinase, cGMP-de | 0.312 | 0.246 | 0.778 | 8e-91 | |
| UNIPROTKB|F1SD02 | 459 | PRKG1 "Uncharacterized protein | 0.312 | 0.246 | 0.778 | 1e-90 | |
| UNIPROTKB|P00516 | 671 | PRKG1 "cGMP-dependent protein | 0.312 | 0.168 | 0.778 | 1.7e-90 | |
| UNIPROTKB|F1MY76 | 686 | PRKG1 "cGMP-dependent protein | 0.312 | 0.164 | 0.778 | 1.9e-90 | |
| MGI|MGI:108174 | 671 | Prkg1 "protein kinase, cGMP-de | 0.312 | 0.168 | 0.778 | 2.1e-90 | |
| UNIPROTKB|Q13976 | 671 | PRKG1 "cGMP-dependent protein | 0.312 | 0.168 | 0.778 | 3.4e-90 | |
| UNIPROTKB|Q5SQU3 | 659 | PRKG1 "cGMP-dependent protein | 0.312 | 0.171 | 0.778 | 3.4e-90 | |
| UNIPROTKB|F1NE85 | 685 | F1NE85 "cGMP-dependent protein | 0.312 | 0.164 | 0.778 | 7.1e-90 | |
| UNIPROTKB|J9JHE0 | 489 | PRKG1 "Uncharacterized protein | 0.312 | 0.231 | 0.778 | 7.1e-90 |
| FB|FBgn0000721 for "foraging" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 3.6e-116, Sum P(2) = 3.6e-116
Identities = 119/160 (74%), Positives = 140/160 (87%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+T Y+ GDYI+RQGARGDTFFIISKGKV+VT+KQ ++ EEK+IR L KGDFFGEKALQGD
Sbjct: 656 ETHYQRGDYIVRQGARGDTFFIISKGKVRVTIKQQDTQEEKFIRMLGKGDFFGEKALQGD 715
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS-ERRRLNEEFRSLRLS 149
DLRTANI+ +GVSCLVID+ETFNQLIS+LDEI+ +Y DE + ERR++NEEFR + L+
Sbjct: 716 DLRTANIICESADGVSCLVIDRETFNQLISNLDEIKHRYDDEGAMERRKINEEFRDINLT 775
Query: 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVM 189
DLRVI TLGVGGFGRVELVQ GD SRSFALKQMKKSQ++
Sbjct: 776 DLRVIATLGVGGFGRVELVQTNGDSSRSFALKQMKKSQIV 815
|
|
| RGD|1587390 Prkg1 "protein kinase, cGMP-dependent, type 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 8.0e-91, Sum P(2) = 8.0e-91
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 185 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 244
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 245 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 297
|
|
| UNIPROTKB|F1SD02 PRKG1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.0e-90, Sum P(2) = 1.0e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 185 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 244
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 245 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 297
|
|
| UNIPROTKB|P00516 PRKG1 "cGMP-dependent protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.7e-90, Sum P(2) = 1.7e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 397 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 456
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 457 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
|
| UNIPROTKB|F1MY76 PRKG1 "cGMP-dependent protein kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.9e-90, Sum P(2) = 1.9e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 412 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 471
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 472 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 524
|
|
| MGI|MGI:108174 Prkg1 "protein kinase, cGMP-dependent, type I" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 2.1e-90, Sum P(2) = 2.1e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 397 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 456
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 457 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
|
| UNIPROTKB|Q13976 PRKG1 "cGMP-dependent protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 3.4e-90, Sum P(2) = 3.4e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 397 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 456
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 457 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 509
|
|
| UNIPROTKB|Q5SQU3 PRKG1 "cGMP-dependent protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 3.4e-90, Sum P(2) = 3.4e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 385 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 444
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 445 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 497
|
|
| UNIPROTKB|F1NE85 F1NE85 "cGMP-dependent protein kinase" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 88/113 (77%), Positives = 102/113 (90%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME+CLGGELWTILRD+G+F
Sbjct: 411 IVDTRQQEHIRSEKQIMQSAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSF 470
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 471 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKI 523
|
|
| UNIPROTKB|J9JHE0 PRKG1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 88/113 (77%), Positives = 101/113 (89%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV+TRQQ+HI SEK+IM A+ DFIV+LY+TFKD KYLYMLME CLGGELWTILRD+G+F
Sbjct: 215 IVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEVCLGGELWTILRDRGSF 274
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D+TTRFYTACVVEAF YLHS+ IIYRDLKPENL+L GY KLVDFGFAKK+
Sbjct: 275 EDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYTKLVDFGFAKKI 327
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P00516 | KGP1_BOVIN | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5045 | 0.7403 | 0.3994 | yes | N/A |
| O77676 | KGP1_RABIT | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5015 | 0.7403 | 0.3994 | yes | N/A |
| P0C605 | KGP1_MOUSE | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5045 | 0.7403 | 0.3994 | yes | N/A |
| Q13976 | KGP1_HUMAN | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5045 | 0.7403 | 0.3994 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 362 | |||
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-74 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-57 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-48 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-39 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-36 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-36 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-22 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-20 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-20 | |
| cd00038 | 115 | cd00038, CAP_ED, effector domain of the CAP family | 4e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-18 | |
| pfam00027 | 91 | pfam00027, cNMP_binding, Cyclic nucleotide-binding | 9e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-16 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| smart00100 | 120 | smart00100, cNMP, Cyclic nucleotide-monophosphate | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| COG0664 | 214 | COG0664, Crp, cAMP-binding proteins - catabolite g | 2e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| PLN02868 | 413 | PLN02868, PLN02868, acyl-CoA thioesterase family p | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-05 | |
| PRK11753 | 211 | PRK11753, PRK11753, DNA-binding transcriptional du | 7e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.003 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.003 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 4e-74
Identities = 89/114 (78%), Positives = 99/114 (86%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
IVET QQ+HI SEKEI+ E N FIVKLY+TFKDKKY+YMLME CLGGELWTILRD+G
Sbjct: 30 HIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL 89
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
FD+ T RFY ACVV AF+YLH+R IIYRDLKPENLLL ++GYVKLVDFGFAKKL
Sbjct: 90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 4e-57
Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 57/208 (27%)
Query: 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
D I TLG G FGRV LV+ + +ALK + K+++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRH-KGSGKYYALKILSKAKI-------------------- 39
Query: 209 CLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI 268
++ K Q +H+++EK I+ F+
Sbjct: 40 ------------------VKLK------------------QVEHVLNEKRILQSIRHPFL 63
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328
V LY +F+D LY++ME GGEL++ LR G F + RFY A VV A +YLHS +I+
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV 123
Query: 329 YRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YRDLKPENLLL + GY+K+ DFGFAK++
Sbjct: 124 YRDLKPENLLLDSDGYIKITDFGFAKRV 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 52/114 (45%), Positives = 78/114 (68%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
I++ ++ +H ++E+ I+ N FIVKL+ F+ ++ LY+++E GGEL++ L +G F
Sbjct: 31 IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRF 90
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ RFY A +V A +YLHS IIYRDLKPEN+LL G++KL DFG AK+L
Sbjct: 91 SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS 144
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 75/211 (35%), Positives = 109/211 (51%), Gaps = 61/211 (28%)
Query: 149 SDLRVITTLGVGGFGRVELVQ--IAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEG 206
DL I T+G G FGRV LV+ I+ +ALK VM +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISE---HYYALK------VMAI--------------- 36
Query: 207 VSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD 266
P+++ +Q+QH+ +EK ++ E +
Sbjct: 37 -----------------------------------PEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 267 FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRN 326
FI++L+ T D+++LYMLME GGEL++ LR+ G F ++T FY + +V A +YLHS+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
I+YRDLKPEN+LL G++KL DFGFAKKL
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-41
Identities = 46/111 (41%), Positives = 74/111 (66%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
+ ++ I+ E +I+ + IV+LY F+D+ LY++ME C GG+L+ +L+ +G +
Sbjct: 37 IKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE 96
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
RFY ++ A +YLHS+ I++RDLKPEN+LL G+VKL DFG A++L
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL 147
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 74/216 (34%), Positives = 106/216 (49%), Gaps = 57/216 (26%)
Query: 141 EEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIV 200
+ S +LSD + TLG G FGRV + + G +A+K +KK ++
Sbjct: 10 PDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT-GEYYAIKCLKKREI------------ 56
Query: 201 AADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIM 260
++ K V H+ EK I+
Sbjct: 57 --------------------------LKMKQVQ------------------HVAQEKSIL 72
Query: 261 GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFD 320
E + FIV + +F+D+ +Y L+E +GGEL+T LR G F + +FY A +V AF+
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE 132
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YLHS++IIYRDLKPENLLL G+VK+ DFGFAKK+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 46/107 (42%), Positives = 76/107 (71%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
Q +++E++I+ +A ++VKLY +F+ KK LY++ME GG+L ++L + G+ D+
Sbjct: 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV 94
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
R Y A +V A +YLHS II+RDLKP+N+L+ ++G++KL DFG +K
Sbjct: 95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-37
Identities = 48/113 (42%), Positives = 76/113 (67%), Gaps = 1/113 (0%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCD-FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
Q+++ ++ +++ EKE++ N I+KLY TF+D++ LY ++E GEL +R G
Sbjct: 38 QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG 97
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ D+ TRFY A ++ A +YLHS+ II+RDLKPEN+LL ++K+ DFG AK
Sbjct: 98 SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAK 150
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 57/209 (27%), Positives = 84/209 (40%), Gaps = 58/209 (27%)
Query: 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCL 210
++ LG G FG V + G A+K +KK
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKI-VAVKILKK------------------------- 34
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
E + ++ EIR I+ + IV+
Sbjct: 35 --RSEKSKKDQTARREIR------------------------------ILRRLSHPNIVR 62
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L F+DK +LY++ME C GG+L+ L G + + ++ +YLHS II+R
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
DLKPEN+LL +G VK+ DFG AKKL+
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKS 151
|
Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 46/115 (40%), Positives = 77/115 (66%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+++ Q H+ +E++I+ +A+ +IVKLY +F+D+++LY++ME GG+L +L K
Sbjct: 38 DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV 97
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
F + T RFY A +V A D +H I+RD+KP+N+L+ G++KL DFG KK+
Sbjct: 98 FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 41/113 (36%), Positives = 73/113 (64%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
VE +++++E+ I+ E N F+V L+ +F+D++ +Y++++ LGG+L L K F
Sbjct: 38 CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF 97
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ +F+ +V A +YLHS+ II+RD+KP+N+LL G+V + DF A K+
Sbjct: 98 SEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-31
Identities = 79/238 (33%), Positives = 111/238 (46%), Gaps = 60/238 (25%)
Query: 117 QLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSR 176
Q + +L + K D T E +R N+ ++ D I TLG G FGRV L +
Sbjct: 2 QFLKNLQLHKKKDSDSTKEPKRKNK----MKYEDFNFIRTLGTGSFGRVILATYKNEDFP 57
Query: 177 SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236
A+K+ +KS++ I+ K VD
Sbjct: 58 PVAIKRFEKSKI--------------------------------------IKQKQVD--- 76
Query: 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTI 296
H+ SE++I+ N F V LY +FKD+ YLY+++E +GGE +T
Sbjct: 77 ---------------HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF 121
Query: 297 LRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
LR F + FY A +V F+YL S NI+YRDLKPENLLL G++K+ DFGFAK
Sbjct: 122 LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 57/214 (26%)
Query: 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
D +++T +G GG+G+V L + D ALK+MKK
Sbjct: 1 KDFQILTQVGQGGYGQVFLAK-KKDTGEIVALKRMKK----------------------- 36
Query: 209 CLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI 268
L+ L+E+R H+++E++I+ +++
Sbjct: 37 ----------SLLFKLNEVR-----------------------HVLTERDILTTTKSEWL 63
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328
VKL F+D +YLY+ ME GG+ T+L + G + RFY A + EA D LH I
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123
Query: 329 YRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+RDLKPEN L+ SG++KL DFG +K ++ S
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 49/117 (41%), Positives = 76/117 (64%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R +++E Q H+ +E++I+ EA+ ++VKLY +F+D+ YLY++ME GG++ T+L
Sbjct: 35 RKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
K F + TRFY A + A D +H I+RD+KP+NLLL G++KL DFG L
Sbjct: 95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 59/210 (28%)
Query: 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
+ I LG G GRV LV++ G + FALK
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT-GKLFALK--------------------------- 32
Query: 209 CLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI 268
V+D++ ++++ + + +++E+EI+ + F+
Sbjct: 33 --VLDKK---------------------------EMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTIL--RDKGNFDDATTRFYTACVVEAFDYLHSRN 326
LY +F+ + YL ++M+ C GGEL+ +L + + RFY A V+ A +YLH
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
I+YRDLKPEN+LL SG++ L DF +K+
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQS 153
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 5e-28
Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTF--KDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
+ E I+ IV+ Y + ++K L + +E GG L ++L+ G + R
Sbjct: 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK 105
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YT ++E YLHS I++RD+K N+L+ + G VKL DFG AK+L
Sbjct: 106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 49/133 (36%), Positives = 76/133 (57%), Gaps = 6/133 (4%)
Query: 230 KYVDETSERRRA----PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
D+ + ++ A + + + ++ E EI+ + N IVKLY F+D+ +LY++M
Sbjct: 11 LARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM 70
Query: 286 ESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-STSG 343
E C GG L +L++ G + ++E +YLHS II+RDLKPEN+LL S +G
Sbjct: 71 EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG 130
Query: 344 YVKLVDFGFAKKL 356
VKL DFG +K L
Sbjct: 131 KVKLADFGLSKLL 143
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 48/115 (41%), Positives = 72/115 (62%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R IV + H ++E+ ++ + NC FIV L +F+ + LY+++ GGEL+ L+
Sbjct: 27 RKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR 86
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+G FD + RFYTA ++ A + LH N+IYRDLKPEN+LL G++ L DFG K
Sbjct: 87 EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK 141
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 47/121 (38%), Positives = 67/121 (55%), Gaps = 6/121 (4%)
Query: 244 IVETRQQQHIMSEKEIMGEANCD---FIVKLYKTFKDKKYLYMLMESCLGGEL-WTILRD 299
I+ + + +M EK I AN + F+V L+ F+ + ++ +ME GG+L I D
Sbjct: 37 IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD 96
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + FY ACVV YLH I+YRDLK +NLLL T G+VK+ DFG K+ +G
Sbjct: 97 V--FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154
Query: 360 R 360
Sbjct: 155 G 155
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 48/98 (48%), Positives = 68/98 (69%), Gaps = 5/98 (5%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD--DATTRFYTA 313
E++IM AN ++IV+L+ F+D KYLYM+ME GG+L ++ N+D + RFYTA
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTA 149
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
VV A D +HS I+RD+KP+N+LL SG++KL DFG
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 48/117 (41%), Positives = 74/117 (63%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIM-GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
I++ ++Q+HIM+E+ ++ F+V L+ +F+ LY +++ GGEL+ L+ + +
Sbjct: 33 ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS 92
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + RFY A + A YLHS NIIYRDLKPEN+LL + G+V L DFG K+ I
Sbjct: 93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 45/126 (35%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 244 IVETRQQQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
++ Q ++ +E+ I M + ++ KLY +F+ K YLY++ME GG+ ++++ G
Sbjct: 34 MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG 93
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA------KKL 356
+ + Y A VV + LH R II+RD+KPENLL+ +G++KL DFG + KK
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153
Query: 357 IG-PRY 361
+G P Y
Sbjct: 154 VGTPDY 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 42/108 (38%), Positives = 64/108 (59%), Gaps = 1/108 (0%)
Query: 254 MSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M+EK ++ A F+ +L+ F+ K L+ +ME GG+L ++ G FD+ RFY
Sbjct: 43 MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYA 102
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
A +V +LH R IIYRDLK +N+LL + G++K+ DFG K+ I
Sbjct: 103 AEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 41/112 (36%), Positives = 72/112 (64%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R ++ Q H+ +E++I+ EA+ +++VKLY +F+DK LY +M+ GG++ ++L
Sbjct: 35 RKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
G F++ RFY A + A + +H I+RD+KP+N+L+ G++KL DFG
Sbjct: 95 LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 36/114 (31%), Positives = 67/114 (58%), Gaps = 1/114 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN- 302
+ +++ I++E +I+ + IVK Y ++ K L+++ME C GG L +L+
Sbjct: 35 LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT 94
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++ + +++ +YLHS II+RD+K N+LL++ G VKL+DFG + +L
Sbjct: 95 LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-24
Identities = 43/123 (34%), Positives = 76/123 (61%), Gaps = 3/123 (2%)
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEA--NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTI 296
++A + + + +H +E++++ EA C F+V L+ F+ L+++++ GGEL+T
Sbjct: 37 KKATIVQKAKTAEHTRTERQVL-EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH 95
Query: 297 LRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
L + +F ++ R Y A +V A D+LH IIYRD+K EN+LL + G+V L DFG +K+
Sbjct: 96 LYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155
Query: 357 IGP 359
+
Sbjct: 156 LAE 158
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 49/117 (41%), Positives = 74/117 (63%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIM-GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
I++ ++Q HIM+E+ ++ F+V L+ +F+ + LY +++ GGEL+ L+ +
Sbjct: 33 ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC 92
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + RFY A V A YLHS NIIYRDLKPEN+LL + G+V L DFG K+ + P
Sbjct: 93 FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 48/117 (41%), Positives = 74/117 (63%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R ++E Q HI +E++I+ EA+ ++VK++ +F+DK+ LY++ME GG++ T+L
Sbjct: 35 RKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
K + T+FY A V A D +H I+RD+KP+NLLL G+VKL DFG L
Sbjct: 95 KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 41/105 (39%), Positives = 69/105 (65%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
Q H+ +E++++ E++ ++V LY +F+D +YLY++ME GG+L T+L F + T
Sbjct: 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT 103
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
RFY A V A + +H I+RD+KP+N+L+ G++KL DFG +
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-23
Identities = 48/117 (41%), Positives = 74/117 (63%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R ++E Q HI +E++I+ EA+ ++VK++ +F+DK LY++ME GG++ T+L
Sbjct: 35 RKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
K + T+FY A V A D +H I+RD+KP+NLLL + G+VKL DFG L
Sbjct: 95 KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 39/104 (37%), Positives = 64/104 (61%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
+ +E++ + + FIV LY + + +Y++ME +GG++ ++L G FD+
Sbjct: 49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK 108
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
Y + V A DYLH II+RDLKP+N+L+S G++KL DFG +K
Sbjct: 109 YISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 42/106 (39%), Positives = 69/106 (65%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
Q Q + E++I+ A F+V ++ +F+ K++L M+ME GG+ T+L++ G
Sbjct: 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA 103
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
R Y A V A +YLH+ I++RDLKP+NLL+++ G++KL DFG +K
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 41/114 (35%), Positives = 63/114 (55%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
I+ + H ++E ++ F+ L +F+ L +ME GGEL+ L + F
Sbjct: 33 IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF 92
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ RFY A +V A YLHS +++YRDLK ENL+L G++K+ DFG K+ I
Sbjct: 93 SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 51/150 (34%), Positives = 89/150 (59%), Gaps = 3/150 (2%)
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIM-GEANCDFIV 269
VI + +F +++ + + K+ +++A I++ ++++HIMSE+ ++ F+V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 270 KLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329
L+ +F+ LY +++ GGEL+ L+ + F + RFY A + A YLHS NI+Y
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 330 RDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
RDLKPEN+LL + G++ L DFG K+ I
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEH 149
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 47/113 (41%), Positives = 72/113 (63%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
++ R + E++I+ E N FIVKL+ F+ + LY++++ GG+L+T L + F
Sbjct: 37 LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT 96
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ +FY A + A D+LHS IIYRDLKPEN+LL G++KL DFG +K+ I
Sbjct: 97 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 46/119 (38%), Positives = 68/119 (57%)
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298
++A + + H +E+ I+ FIV L F+ LY+++E GGEL+ L
Sbjct: 33 KKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE 92
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+G F + T FY + + A ++LH + IIYRDLKPEN+LL G+VKL DFG K+ I
Sbjct: 93 REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 58/199 (29%)
Query: 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQET 216
LG G FG+V L ++ G + FA+K +KK V+ DD V C ++
Sbjct: 3 LGKGSFGKVMLAELKGT-NEFFAIKALKKDVVLEDDD-------------VECTMV---- 44
Query: 217 FNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTF 275
E+ ++ A F+ L+ TF
Sbjct: 45 ---------------------------------------ERRVLALAWEHPFLTHLFCTF 65
Query: 276 KDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPE 335
+ K++L+ +ME GG+L ++ G FD+A RFY A ++ +LH + IIYRDLK +
Sbjct: 66 QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLD 125
Query: 336 NLLLSTSGYVKLVDFGFAK 354
N+LL G++K+ DFG K
Sbjct: 126 NVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 46/115 (40%), Positives = 74/115 (64%), Gaps = 1/115 (0%)
Query: 244 IVETRQQQHIMSEKEIM-GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
++ ++Q+HIM+E+ ++ F+V L+ +F+ + LY +++ GGEL+ L+ + +
Sbjct: 33 VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS 92
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
F + RFY A + A YLHS NI+YRDLKPEN+LL + G+V L DFG K+ I
Sbjct: 93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 62/210 (29%)
Query: 150 DLRVITTLGVGGFGRVELV--QIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
D V + +G G FG V++V + GD +A+K MKKS +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGD---IYAMKVMKKSVL------------------- 39
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
L + + +E E++I+ +N +
Sbjct: 40 ----------------LAQETVSFFEE---------------------ERDILSISNSPW 62
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKGNFDDATTRFYTACVVEAFDYLHSRN 326
I +L F+DK LY++ME GG+L ++L R + FD+ +FY A +V A +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++RD+KPEN+L+ +G++KL DFG A +L
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARL 152
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 62/210 (29%)
Query: 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLV 211
+I +G G FG+V LV+ D + + LK++
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSD-GKLYVLKEID--------------------------- 34
Query: 212 IDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKL 271
+S++ E ER A ++E +I+ + N I+K
Sbjct: 35 ---------LSNMSE---------KEREDA------------LNEVKILKKLNHPNIIKY 64
Query: 272 YKTFKDKKYLYMLMESCLGGELWTILRDKGN----FDDATTRFYTACVVEAFDYLHSRNI 327
Y++F++K L ++ME GG+L ++ + F + + + A YLHSR I
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
++RD+KP+N+ L+++G VKL DFG +K L
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 40/113 (35%), Positives = 70/113 (61%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R ++ Q H+ +E++I+ EA+ +++VKLY +F+DK LY +M+ GG++ ++L
Sbjct: 35 RKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGF 352
F + RFY A + A + +H I+RD+KP+N+L+ G++KL DFG
Sbjct: 95 MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 5e-21
Identities = 43/114 (37%), Positives = 68/114 (59%), Gaps = 3/114 (2%)
Query: 244 IVETRQQQHIMSEKEIM---GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300
IV ++ H + E+ I+ FIV L +F+ LY++ + GGEL+ L+ +
Sbjct: 31 IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE 90
Query: 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
G F + +FY A +V A ++LH +I+YRDLKPEN+LL +G++ L DFG +K
Sbjct: 91 GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 47/103 (45%), Positives = 69/103 (66%), Gaps = 5/103 (4%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD--DATTRFYTA 313
E++IM AN ++V+L+ F+D +YLYM+ME GG+L ++ N+D + RFYTA
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTA 149
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
VV A D +HS I+RD+KP+N+LL SG++KL DFG K+
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 40/113 (35%), Positives = 71/113 (62%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R ++ Q H+ +E++I+ EA+ +++V+LY +F+DK LY +M+ GG++ ++L
Sbjct: 35 RKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 94
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGF 352
G F + RFY A + A + +H I+RD+KP+N+L+ G++KL DFG
Sbjct: 95 MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 46/103 (44%), Positives = 69/103 (66%), Gaps = 5/103 (4%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD--DATTRFYTA 313
E++IM AN ++V+L+ F+D KYLYM+ME GG+L ++ N+D + +FYTA
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTA 149
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
VV A D +HS +I+RD+KP+N+LL G++KL DFG K+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|237999 cd00038, CAP_ED, effector domain of the CAP family of transcription factors; members include CAP (or cAMP receptor protein (CRP)), which binds cAMP, FNR (fumarate and nitrate reduction), which uses an iron-sulfur cluster to sense oxygen) and CooA, a heme containing CO sensor | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-20
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
+ G+ IIRQG D+ +I+ G V+V + E+ + L GD FGE AL G+
Sbjct: 21 RFPAGEVIIRQGDPADSLYIVLSGSVEVYKLDEDG-REQIVGFLGPGDLFGELALLGNGP 79
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130
R+A + A LV+ + F +L+ E+ + +
Sbjct: 80 RSATVRALTD--SELLVLPRSDFRRLLQEYPELARRLL 115
|
In all cases binding of the effector leads to conformational changes and the ability to activate transcription. Cyclic nucleotide-binding domain similar to CAP are also present in cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) and vertebrate cyclic nucleotide-gated ion-channels. Cyclic nucleotide-monophosphate binding domain; proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues; the best studied is the prokaryotic catabolite gene activator, CAP, where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure; three conserved glycine residues are thought to be essential for maintenance of the structural integrity of the beta-barrel; CooA is a homodimeric transcription factor that belongs to CAP family; cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) contain two tandem copies of the cyclic nucleotide-binding domain; cAPK's are composed of two different subunits, a catalytic chain and a regulatory chain, which contains both copies of the domain; cGPK's are single chain enzymes that include the two copies of the domain in their N-terminal section; also found in vertebrate cyclic nucleotide-gated ion-channels. Length = 115 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-20
Identities = 36/112 (32%), Positives = 64/112 (57%), Gaps = 3/112 (2%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
E R+Q ++ E + + ++VK Y F + + +++E GG L +L+ G +
Sbjct: 41 EFRKQ--LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE 98
Query: 306 ATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ +++ DYLH+ R+II+RD+KP NLL+++ G VK+ DFG +K L
Sbjct: 99 PVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 38/104 (36%), Positives = 56/104 (53%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
I E +++ +VK Y ++ +Y+ ME C GG L +L D+ R YT
Sbjct: 46 IADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT 105
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++E YLHS I++RD+KP N+ L +G +KL DFG A KL
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308
Q+ I+ E +I+ + N +IV Y F + + + ME GG L IL++ +G +
Sbjct: 43 QKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL 102
Query: 309 RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
V++ YLH II+RD+KP N+L+++ G +KL DFG + +L+
Sbjct: 103 GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 8e-19
Identities = 41/116 (35%), Positives = 65/116 (56%), Gaps = 5/116 (4%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
+ + ++ I++E IM + IV Y ++ L+++ME GG L I+ NF
Sbjct: 53 RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--QNF 110
Query: 304 DDAT-TRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ C V++ +YLHS+N+I+RD+K +N+LLS G VKL DFGFA +L
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-19
Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 2/147 (1%)
Query: 211 VIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
++ + TF ++I ++ KY ++ I+ + H ++E ++ F+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEV--IIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 271 LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
L +F+ K L +ME GGEL+ L + F + TRFY A +V A DYLHS I+YR
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 331 DLKPENLLLSTSGYVKLVDFGFAKKLI 357
DLK ENL+L G++K+ DFG K+ I
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGI 146
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 44/105 (41%), Positives = 62/105 (59%), Gaps = 1/105 (0%)
Query: 254 MSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M+EK I+ A N F+ +LY F+ L+ +ME GG+L ++ FD+A RFY
Sbjct: 43 MTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 102
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
A + A +LH + IIYRDLK +N+LL G+ KL DFG K+ I
Sbjct: 103 AEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 42/118 (35%), Positives = 65/118 (55%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R I+ + H ++E ++ F+ L F+ L +ME GGEL+ L
Sbjct: 29 RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR 88
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ F + RFY A +V A +YLHSR+++YRD+K ENL+L G++K+ DFG K+ I
Sbjct: 89 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 37/120 (30%), Positives = 73/120 (60%), Gaps = 1/120 (0%)
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
++A + + + +H +E+ ++ F+V L+ F+ + L+++++ GGE++T L
Sbjct: 37 QKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL 96
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ NF + RFY+ ++ A ++LH I+YRD+K EN+LL + G+V L DFG +K+ +
Sbjct: 97 YQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 35/108 (32%), Positives = 56/108 (51%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+ IM E +++ IVK + + LY+++E G L I++ G F ++
Sbjct: 42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV 101
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y V++ YLH + +I+RD+K N+L + G VKL DFG A KL
Sbjct: 102 AVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 43/114 (37%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTI---LRDKGNFD 304
Q+ I+ E EI +IVK Y F D+ + + ME C GG L +I ++ +G
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI 102
Query: 305 DATTRFYTA-CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
A V++ YLHSR II+RD+KP N+LL+ G VKL DFG + +L+
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 42/107 (39%), Positives = 60/107 (56%), Gaps = 1/107 (0%)
Query: 254 MSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M+EK I+ A F+ L+ F+ K L+ +ME GG+L ++ FD+ +RFY
Sbjct: 43 MTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYA 102
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
A V A +LH +IYRDLK +N+LL G+ KL DFG K+ I
Sbjct: 103 AEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 39/102 (38%), Positives = 60/102 (58%), Gaps = 2/102 (1%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFY 311
++EK+I+ + + FIV L F+ K L ++M GG+L + + G F +A FY
Sbjct: 41 LNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY 100
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
A ++ ++LH R I+YRDLKPEN+LL G V++ D G A
Sbjct: 101 AAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 35/89 (39%), Positives = 56/89 (62%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+ T +++ LY+ +E GG L +L+ G+F + R YT ++ +YLH RN
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++RD+K N+L+ T+G VKL DFG AK++
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQV 152
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 43/103 (41%), Positives = 64/103 (62%), Gaps = 1/103 (0%)
Query: 254 MSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M EK ++ A F+ LY TF+ K++L+ +ME GG+L ++DKG FD FY
Sbjct: 43 MVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYA 102
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
A +V +LHS+ IIYRDLK +N++L G++K+ DFG K+
Sbjct: 103 AEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215664 pfam00027, cNMP_binding, Cyclic nucleotide-binding domain | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 9e-18
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+K+G+ I R+G D+ +I+ GKVKV + E+ + L GDFFGE AL G + R
Sbjct: 4 FKKGEVIFREGDPADSLYIVLSGKVKVYKLDEDG-REQILAFLGPGDFFGELALLGGEPR 62
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISS 121
+A +VA LVI +E F +L+
Sbjct: 63 SATVVALTD--SELLVIPREDFLELLEQ 88
|
Length = 91 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 44/115 (38%), Positives = 66/115 (57%), Gaps = 1/115 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV + H ++E ++ + F+ L +F+ L +ME GGEL+ L + F
Sbjct: 33 IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF 92
Query: 304 DDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ RFY A +V A DYLHS +N++YRDLK ENL+L G++K+ DFG K+ I
Sbjct: 93 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 6/132 (4%)
Query: 230 KYVDETSERRRAPQIVETRQQQHI---MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLME 286
K + + A +I++ ++ + M E +I+ E IV LY+ + + L++L+E
Sbjct: 23 KAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82
Query: 287 SCLGGELWTILR--DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY 344
C GG L +I+ ++G + R+ ++EA ++LHS +I+RDLK N+LL+ G
Sbjct: 83 FCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD 141
Query: 345 VKLVDFGFAKKL 356
VKL DFG + K
Sbjct: 142 VKLADFGVSAKN 153
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.1 bits (201), Expect = 3e-17
Identities = 48/119 (40%), Positives = 70/119 (58%), Gaps = 5/119 (4%)
Query: 249 QQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR---DKGNFD 304
+ + + E +I+ N IVKLY F+D+ LY++ME GG L +L+ KG
Sbjct: 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLS 99
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-VKLVDFGFAKKLIGPRYS 362
++ F A ++ A +YLHS+ II+RD+KPEN+LL G VKL+DFG AK L P +
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
|
Length = 384 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 41/110 (37%), Positives = 61/110 (55%), Gaps = 4/110 (3%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL----WTILRDKGNFDDA 306
+ M EK I+ + + FIV L F+ K L ++M GG+L + + + F +
Sbjct: 38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP 97
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
FYTA ++ ++LH R IIYRDLKPEN+LL G V++ D G A +L
Sbjct: 98 RACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 37/92 (40%), Positives = 51/92 (55%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV L + F+ K LY++ E L + G R Y +++A Y HS NI
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
I+RD+KPEN+L+S SG +KL DFGFA+ L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRAR 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 41/110 (37%), Positives = 63/110 (57%), Gaps = 8/110 (7%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF----DDATTR 309
M E ++ + + +V L + F+ KK LY++ E T+L D + D++ R
Sbjct: 48 MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVR 103
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
Y ++ ++ HS NII+RD+KPEN+L+S SG VKL DFGFA+ L P
Sbjct: 104 KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 259 IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGE--LWTILRDK-GNFDDATTRFYTACV 315
++ E IVKL ++ LY++ E C + L L + G + +
Sbjct: 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 316 VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ Y HS I++RDLKP+N+L++ G +KL DFG A+
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 1/107 (0%)
Query: 254 MSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M EK ++ F+ +L+ F+ LY +ME GG+L ++ G F + FY
Sbjct: 48 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYA 107
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
A + +LHS+ IIYRDLK +N++L G++K+ DFG K+ I
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 37/105 (35%), Positives = 65/105 (61%), Gaps = 7/105 (6%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA----TTRFY 311
E+ ++ +C +I L+ F+D+ YLY++M+ +GG+L T+L F+D RFY
Sbjct: 51 ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFY 107
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A +V A +H + ++RD+KP+N+LL +G+++L DFG K+
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 1/103 (0%)
Query: 254 MSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M EK ++ A F+ LY TF+ K+ L+ +ME GG+L ++ FD FY
Sbjct: 43 MVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA 102
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
A ++ +LHS+ I+YRDLK +N+LL T G++K+ DFG K+
Sbjct: 103 AEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 256 EKEI--MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATTRFYT 312
KEI + + + +IVK Y ++ L+++ME C G + I++ +
Sbjct: 46 IKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL 105
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
++ +YLHS I+RD+K N+LL+ G KL DFG + +L
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 38/108 (35%), Positives = 66/108 (61%), Gaps = 1/108 (0%)
Query: 253 IMSEKEIMGEANCD-FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
+ +EK + +A+ + F+V L+ F+ L++++E GG+L ++ + + RFY
Sbjct: 42 VQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY 101
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
A + A ++LH R IIYRDLK +N+LL G++KL D+G K+ +GP
Sbjct: 102 AAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 39/108 (36%), Positives = 66/108 (61%), Gaps = 1/108 (0%)
Query: 253 IMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
+ +EK + +A N F+V L+ F+ + L+ ++E GG+L ++ + + RFY
Sbjct: 42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY 101
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+A + A +YLH R IIYRDLK +N+LL + G++KL D+G K+ + P
Sbjct: 102 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 36/105 (34%), Positives = 64/105 (60%), Gaps = 7/105 (6%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD----ATTRFY 311
E++++ + +I L+ F+D+ LY++M+ +GG+L T+L F+D RFY
Sbjct: 51 ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFY 107
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A +V A D +H ++RD+KP+N+LL +G+++L DFG +L
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTIL--RDKGNFDDATTRFYTACVVEAFDYLHSR 325
IVKL + F++ LY + E + G L+ ++ R F ++ R +++ ++H
Sbjct: 60 IVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+RDLKPENLL+S VK+ DFG A+++
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREI 149
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 37/120 (30%), Positives = 71/120 (59%), Gaps = 1/120 (0%)
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
++A + + + +H +E++++ F+V L+ F+ L+++++ GGEL+T L
Sbjct: 37 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL 96
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ F + + Y+ +V A ++LH IIYRD+K EN+LL ++G+V L DFG +K+
Sbjct: 97 SQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 1/104 (0%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
I E + + + +I K Y +F L+++ME C GG +L+ G D+ F
Sbjct: 46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFIL 104
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V+ +YLH I+RD+K N+LLS G VKL DFG + +L
Sbjct: 105 REVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 1/108 (0%)
Query: 253 IMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
+ +EK + A N F+V L+ F+ + L+ ++E GG+L ++ + + RFY
Sbjct: 42 VQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY 101
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+A + A ++LH R IIYRDLK +N+LL G++KL D+G K+ I P
Sbjct: 102 SAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 2/102 (1%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYT 312
+ E + + ++VKL F ++ME L +LRD+ +A + Y
Sbjct: 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYM 105
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++ Y+H+ I++RDLKP NLL+S G +K+ DFG A+
Sbjct: 106 RMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|197516 smart00100, cNMP, Cyclic nucleotide-monophosphate binding domain | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-15
Identities = 39/92 (42%), Positives = 52/92 (56%), Gaps = 1/92 (1%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
Y G+ IIRQG GD+F+II G+V+V K EE+ + TL GDFFGE AL + R
Sbjct: 22 YPAGEVIIRQGDVGDSFYIIVSGEVEVY-KVLEDGEEQIVGTLGPGDFFGELALLTNSRR 80
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEI 125
A+ A E + L ID F QL+ L ++
Sbjct: 81 AASAAAVALELATLLRIDFRDFLQLLPELPQL 112
|
Catabolite gene activator protein (CAP) is a prokaryotic homologue of eukaryotic cNMP-binding domains, present in ion channels, and cNMP-dependent kinases. Length = 120 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTAC 314
E +++ E N I+KL F+ K LY++ E +L+ +++D+ ++ + Y
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+++ + HS I++RDLKPENLL++T G +KL DFG A+ P
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 43/120 (35%), Positives = 68/120 (56%), Gaps = 6/120 (5%)
Query: 241 APQIVETRQQQHI---MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
A +++ET+ ++ + M E EI+ N +IVKL F L++++E C GG + I+
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 298 R--DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
D+G + + ++EA YLHS II+RDLK N+LL+ G +KL DFG + K
Sbjct: 101 LELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 35/89 (39%), Positives = 53/89 (59%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+ Y +D + L + ME GG + L+ G + TR YT ++E +YLHS I
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++RD+K N+L ++G VKL DFG +K+L
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 36/105 (34%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFY 311
++EK+I+ + N F+V L ++ K L +++ GG+L + + GN FD+ FY
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY 107
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A + + LH I+YRDLKPEN+LL G++++ D G A ++
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 36/111 (32%), Positives = 60/111 (54%), Gaps = 2/111 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELW-TILRDKGN-FDD 305
++++ ++E I+ I+ Y F D L + ME GG L+ I+R KG F++
Sbjct: 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+Y +V A Y+H I++RD+K N+ L+ +G +KL DFG +K L
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 40/128 (31%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
Y + E++R I + + + ++EK+I+ + N F+V L ++ K L +++ G
Sbjct: 28 YACKRLEKKR---IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 291 GELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
G+L + + GN F++ FY A ++ + LH N +YRDLKPEN+LL G++++
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRIS 144
Query: 349 DFGFAKKL 356
D G A K+
Sbjct: 145 DLGLAVKI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 34/103 (33%), Positives = 66/103 (64%), Gaps = 1/103 (0%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKGNFDDATTRFYTAC 314
E++++ + +I L+ F+D+ LY++M+ +GG+L T+L + + + RFY A
Sbjct: 51 ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE 110
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+V A D +H + ++RD+KP+N+L+ +G+++L DFG KL+
Sbjct: 111 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 6e-14
Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDA 306
+++ + E IM + + IV+L + LY++ E GG+L LR G
Sbjct: 43 EEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLK 102
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + +YL S+N ++RDL N L++ + VK+ DFG ++ +
Sbjct: 103 DLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDI 152
|
Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 254 MSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M EK ++ F+ +L+ F+ LY +ME GG+L ++ G F + FY
Sbjct: 48 MVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYA 107
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
A + +LHS+ IIYRDLK +N++L + G++K+ DFG K+
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 33/90 (36%), Positives = 52/90 (57%)
Query: 264 NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
+C FIV + F L +++ GG+L L G F +A RFY A ++ +++H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+R ++YRDLKP N+LL G+V++ D G A
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 33/76 (43%), Positives = 48/76 (63%)
Query: 280 YLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL 339
YL + +E GG + + LR G F++ RF+T V+E YLHS+ I++RDLK +NLL+
Sbjct: 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV 141
Query: 340 STSGYVKLVDFGFAKK 355
G K+ DFG +KK
Sbjct: 142 DADGICKISDFGISKK 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 254 MSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
M EK ++ + F+ +L+ F+ LY +ME GG+L ++ G F + FY
Sbjct: 48 MVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 107
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
A + +LH R IIYRDLK +N++L + G++K+ DFG K+
Sbjct: 108 AEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---GNFDDATT 308
+ E + M + N +VK Y +F L+++M GG L I++ G D+A
Sbjct: 45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII 104
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
V++ +YLHS I+RD+K N+LL G VK+ DFG
Sbjct: 105 ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFG 147
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 30/92 (32%), Positives = 53/92 (57%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+V L + F+ K+ L+++ E C L + ++ + + ++A ++ H N
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
I+RD+KPEN+L++ G +KL DFGFA+ L GP
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 245 VETRQQQHIMSEKEIM----GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300
++ +Q + + + IM +C FIV + F L +++ GG+L L
Sbjct: 32 IKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH 91
Query: 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
G F + RFY ++ +++H+R ++YRDLKP N+LL G+V++ D G A
Sbjct: 92 GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 1/109 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
++ I+ E +IM E +IV Y F ++ + M ME G L I + G
Sbjct: 47 RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG 106
Query: 310 FYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
VVE YL++ + I++RD+KP N+L+++ G +KL DFG + +LI
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 38/122 (31%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTIL----RDK 300
+++Q ++SE I+ E IV+ Y D+ + LY++ME C GG+L ++ +++
Sbjct: 40 EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER 99
Query: 301 GNFD-DATTRFYTACVVEAFDYLHSRN-----IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ + R T ++ A H+R+ +++RDLKP N+ L + VKL DFG AK
Sbjct: 100 KYIEEEFIWRILTQ-LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 355 KL 356
L
Sbjct: 159 IL 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 39/128 (30%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
Y + E++R I + + + ++EK I+ + N F+V L ++ K L +++ G
Sbjct: 28 YACKKLEKKR---IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 291 GELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
G+L + + GN FD+ FY A + + L I+YRDLKPEN+LL G++++
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRIS 144
Query: 349 DFGFAKKL 356
D G A ++
Sbjct: 145 DLGLAVQI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 34/113 (30%), Positives = 62/113 (54%), Gaps = 4/113 (3%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL---RDKGNF 303
R+++ + E ++ + + +I++ Y++F DK L ++ME G+L +L R +
Sbjct: 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP 99
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+D RF+ ++ +LHS+ I++RD+K NL L VK+ D G AK L
Sbjct: 100 EDQVWRFFIQILL-GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 38/125 (30%), Positives = 67/125 (53%), Gaps = 5/125 (4%)
Query: 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
Y + E++R I + + + ++EK+I+ + N F+V L ++ K L +++ G
Sbjct: 28 YACKKLEKKR---IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 291 GELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
G+L + G F++ FY A + + LH I+YRDLKPEN+LL G++++
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRIS 144
Query: 349 DFGFA 353
D G A
Sbjct: 145 DLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 4/95 (4%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD--ATTRFYTACVVEAFDYLHS 324
IV+ + + + + ME GG L +LR K G D T FYT ++E YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 325 RNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLIG 358
I++RD+K +N+L++T SG VK+ DFG +K+L G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 8e-13
Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
+Q + + E IM + + IVKL +++ L ++ME GG+L LR +
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL 100
Query: 306 ATTRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + + +YL S+N I+RDL N L+ + VK+ DFG ++ L
Sbjct: 101 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 1/107 (0%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
+ + E +M N I+++ + + + +E GG + +L G F +A
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN 107
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-VKLVDFGFAKKL 356
YT ++ YLH II+RD+K NLL+ ++G +++ DFG A +L
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTAC 314
E +++ E I+ L F K + ++ E + +L +++DK A + Y
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ +YLHS I++RDLKP NLL+++ G +KL DFG A+
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR--FYTA 313
EKEI+ + N FIV L F+ K +L ++M GG+L + + G R Y+A
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ +LHS +I+YRD+KPEN+LL G +L D G A +L
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 35/131 (26%), Positives = 68/131 (51%), Gaps = 6/131 (4%)
Query: 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
++ V +S+ R+ + + E ++ E + IV+ + D +L + +
Sbjct: 32 QVELPSVSASSKDRKRSML------DALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYV 345
E GG + +L + G F++ R + +++ +YLH+R II+RD+K N+L+ G +
Sbjct: 86 EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGI 145
Query: 346 KLVDFGFAKKL 356
K+ DFG +KKL
Sbjct: 146 KISDFGISKKL 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 30/114 (26%), Positives = 59/114 (51%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ ++ + + E +++ IV+ T D + + ME GG + +IL G
Sbjct: 39 VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP 98
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YT +++ YLH+ +++RD+K N++L +G +KL+DFG A++L
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 40/131 (30%), Positives = 69/131 (52%), Gaps = 5/131 (3%)
Query: 230 KYVDETSERRRAPQIVETRQQQH----IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
K +D +++ A +I++ + + I E ++ + + ++ K Y ++ L+++M
Sbjct: 22 KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYV 345
E GG +LR G FD+ +++ DYLHS I+RD+K N+LLS G V
Sbjct: 82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV 140
Query: 346 KLVDFGFAKKL 356
KL DFG A +L
Sbjct: 141 KLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223736 COG0664, Crp, cAMP-binding proteins - catabolite gene activator and regulatory subunit of cAMP-dependent protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 6/127 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+G+ + +G D+ +II G VK+ + E + L GDFFGE AL G D R
Sbjct: 28 LPKGEVLFTEGEEADSLYIILSGIVKLYANTEDG-REIILGFLGPGDFFGELALLGGDPR 86
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
+A+ VA V L I ++ F +L++ ++ + + R R+ E L D+
Sbjct: 87 SASAVALTD--VEVLEIPRKDFLELLAESPKLALALLRLLARRLRQALERLSLLARKDVE 144
Query: 152 -RVITTL 157
R+ L
Sbjct: 145 ERLARFL 151
|
Length = 214 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 1/109 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307
Q + + E IM + + +VKL +++ LY++ME GG+L + LR + +
Sbjct: 44 QIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSD 103
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + +YL S+N I+RDL N L+ + VK+ DFG ++ L
Sbjct: 104 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 152
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 3/118 (2%)
Query: 242 PQIVETRQQQHIMS-EKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILR 298
P+ ET ++ + E +++ + IV+ Y +D+ K L + ME GG + L+
Sbjct: 39 PESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK 98
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
G ++ TR YT ++E YLHS I++RD+K N+L ++G VKL DFG +K+L
Sbjct: 99 AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL---RDKGNFDDATTR 309
I+ E +I+ +A +IV Y F + +YM ME G L + + R
Sbjct: 46 IIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR 105
Query: 310 FYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
T VV+ +L NII+RD+KP N+L++ +G VKL DFG + L+
Sbjct: 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 40/121 (33%), Positives = 68/121 (56%), Gaps = 8/121 (6%)
Query: 241 APQIVETRQQQHI---MSEKEIMGEANCDF--IVKLYKTFKDKKYLYMLMESCLGGELWT 295
A ++++T+ ++ + M E +I+ A+CD IVKL F + L++L+E C GG +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDIL--ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91
Query: 296 ILRD-KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++ + + + R +EA +YLH II+RDLK N+L + G +KL DFG +
Sbjct: 92 VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151
Query: 355 K 355
K
Sbjct: 152 K 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 42/129 (32%), Positives = 77/129 (59%), Gaps = 8/129 (6%)
Query: 233 DETSERRRAPQIVETRQQQH---IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
++ S R+ A ++++ R+QQ + +E IM + +V++YK++ + L++LME
Sbjct: 42 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101
Query: 290 GGELWTILRDKGNFDDATTRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKL 347
GG L I+ ++ + T C V++A YLHS+ +I+RD+K +++LL+ G VKL
Sbjct: 102 GGALTDIVSQTRLNEE---QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKL 158
Query: 348 VDFGFAKKL 356
DFGF ++
Sbjct: 159 SDFGFCAQI 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 37/127 (29%), Positives = 73/127 (57%), Gaps = 4/127 (3%)
Query: 233 DETSERRRAPQIVETRQQQH---IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
D+++ R+ A + ++ R+QQ + +E IM + IV++Y ++ L+++ME
Sbjct: 40 DKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99
Query: 290 GGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
GG L I+ ++ V++A +LH++ +I+RD+K +++LL++ G VKL D
Sbjct: 100 GGALTDIV-THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSD 158
Query: 350 FGFAKKL 356
FGF ++
Sbjct: 159 FGFCAQV 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 35/120 (29%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLY-KTFKDKK-YLYM-LMESCLGGELWTILRD- 299
+ E Q++ +M +M ++C +IVK Y F++ ++ M LM+ L + + + +
Sbjct: 41 VDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLD-KFYKYVYEV 99
Query: 300 -KGNFDDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
K + V+A +YL II+RD+KP N+LL +G +KL DFG + +L+
Sbjct: 100 LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 3/113 (2%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
R Q I+ E +++ E N +IV Y F + + ME GG L +L+ G +
Sbjct: 41 AIRNQ--IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 98
Query: 306 ATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ V+ YL I++RD+KP N+L+++ G +KL DFG + +LI
Sbjct: 99 NILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
I K Y ++ L+++ME GG + T+++ G + V+ A Y+H +
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-AGPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
I+RD+K N+L++ +G VKL DFG A L
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 5/131 (3%)
Query: 230 KYVDETSERRRAPQIVETRQQQH----IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
K +D +++ A +I++ + + I E ++ + + ++ K Y ++ L+++M
Sbjct: 22 KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYV 345
E GG +L + G D+ +++ DYLHS I+RD+K N+LLS G V
Sbjct: 82 EYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 140
Query: 346 KLVDFGFAKKL 356
KL DFG A +L
Sbjct: 141 KLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 1/105 (0%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKGNFDDATTRFY 311
I E ++ E IV + ++ + L+++ME C GG L I +G + +
Sbjct: 47 IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV 106
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++ YLH I+RD+K N+LL+ G VKL DFG + +L
Sbjct: 107 CRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 1/109 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
+ I+ E +++ E N +IV Y F + + ME GG L +L+ G +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 106
Query: 310 FYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ V++ YL ++ I++RD+KP N+L+++ G +KL DFG + +LI
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 2/91 (2%)
Query: 268 IVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
IV+ Y +D ++ L + ME GG + L+ G + TR YT ++E YLHS
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
I++RD+K N+L + G VKL DFG +K+L
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 268 IVKLYK--TFKDKKYLYMLMESC---LGGELWTILRDKGN-FDDATTRFYTACVVEAFDY 321
IV+L + T K K +YM+ E L G +L F ++ + Y ++E Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 322 LHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
LHS I++RD+K N+L++ G +KL DFG A+
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL---WTILRDKGNFDDA 306
Q+ IMSE EI+ + + +I+ Y F + + + E GG L I +
Sbjct: 43 QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP------EHV 96
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
R A VV+ YL S I++RD+KP N+L++T G VKL DFG + +L+
Sbjct: 97 LGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 19/36 (52%), Positives = 29/36 (80%)
Query: 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
D+LHS I++RDLKP+N+L+++ G VK+ DFG A+
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 264 NCDFIVKLYKTFK--DKKYLYM---LMESCLGGELWTILRDKGNFDDATTRFYTACVVEA 318
+ IVKL K + K +Y+ ME+ +L ++R +D R+ +++A
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMET----DLHAVIR-ANILEDVHKRYIMYQLLKA 119
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+HS N+I+RDLKP N+LL++ VKL DFG A+ L
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 31/111 (27%), Positives = 61/111 (54%), Gaps = 3/111 (2%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDA 306
++ +E +++ + I++ Y+ F + K L ++ME GG L ++ + N D+
Sbjct: 42 ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED 101
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356
T + ++ A ++H++ I++RDLK +N+LL VK+ DFG +K L
Sbjct: 102 TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 38/118 (32%), Positives = 65/118 (55%), Gaps = 3/118 (2%)
Query: 242 PQIVETRQQQHIMS-EKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILR 298
P ET ++ + + E +++ D IV+ Y +D +K L + +E GG + L+
Sbjct: 39 PDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK 98
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
G + TR YT +++ YLHS I++RD+K N+L ++G VKL DFG +K++
Sbjct: 99 AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 25/117 (21%), Positives = 54/117 (46%), Gaps = 9/117 (7%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+++ + E +M + +V+L +++ LY+++E GG+L LR +
Sbjct: 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPE 98
Query: 309 R---------FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + + +YL S+ ++RDL N L+ VK+ DFG ++ +
Sbjct: 99 KSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 31/103 (30%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 256 EKEIMGEANCDF--IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
++EI+ +C IV + ++ + L++ ME C GG L I G ++ + +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++ YLHS+ ++RD+K N+LL+ +G+VKL DFG + ++
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
QQ I KE +C+ IV + ++ ++ L++ ME C GG L I G +
Sbjct: 54 QQEIFMVKEC---KHCN-IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA 109
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ ++ YLHS+ ++RD+K N+LL+ +G VKL DFG A K+
Sbjct: 110 YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 211 VIDQETFNQLISSLDEIRTKY--VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI 268
I + +F ++ + + +++ + E + + E +++ I+ K M N I
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAK--MKHPN---I 61
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWT-ILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
V + +F++ L+++ME C GG+L I R +G F + + + ++H R
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 327 IIYRDLKPENLLLSTSGYV-KLVDFGFAKKL 356
I++RD+K +N+ LS +G V KL DFG A++L
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
++ + E EI+ + + IVKL K+ +Y++ME GG L T LR K N T
Sbjct: 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTV 92
Query: 309 RFYTACVVEA---FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ ++A +YL S+N I+RDL N L+ + +K+ DFG +++ G Y+
Sbjct: 93 KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 230 KYVDETSERRRAPQIVETRQQQH----IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
K +D ++ A +I++ + + I E ++ + + +I + Y ++ L+++M
Sbjct: 22 KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYV 345
E GG +L+ G ++ +++ DYLHS I+RD+K N+LLS G V
Sbjct: 82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV 140
Query: 346 KLVDFGFAKKL 356
KL DFG A +L
Sbjct: 141 KLADFGVAGQL 151
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 36/129 (27%), Positives = 75/129 (58%), Gaps = 8/129 (6%)
Query: 233 DETSERRRAPQIVETRQQQH---IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
++ + ++ A + ++ R+QQ + +E IM + + + +V +Y ++ L+++ME
Sbjct: 43 EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102
Query: 290 GGELWTILRDKGNFDDATTRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKL 347
GG L I+ ++ + T C V+ A YLH++ +I+RD+K +++LL++ G +KL
Sbjct: 103 GGALTDIVTHTRMNEE---QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKL 159
Query: 348 VDFGFAKKL 356
DFGF ++
Sbjct: 160 SDFGFCAQV 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 268 IVKLYKTFKDKKYLYMLM---ESCLGGELWTILRDKG-NFDDATTRFYTACVVEAFDYLH 323
IV+ YKTF + LY++M E GE + L++K F + +V A YLH
Sbjct: 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130
Query: 324 -SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ I++RDL P N++L V + DFG AK+
Sbjct: 131 KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 32/109 (29%), Positives = 58/109 (53%), Gaps = 1/109 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
+ I+ E +++ E N +IV Y F + + ME GG L +L++ +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG 106
Query: 310 FYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ V+ YL ++ I++RD+KP N+L+++ G +KL DFG + +LI
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 35/117 (29%), Positives = 65/117 (55%), Gaps = 7/117 (5%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGN- 302
VE +++ ++ K M N IV ++F+ +LY++ME C GG+L ++ +G
Sbjct: 42 VEDSRKEAVLLAK--MKHPN---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL 96
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + T + + ++H + +++RD+K +N+ L+ +G VKL DFG A+ L P
Sbjct: 97 FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 5/102 (4%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLME---SCLGGELWTILRDKGNFDDATTRFYT 312
E ++ E N IV+L + LY++ E L + + D + Y
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG--LDPPLIKSYL 105
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++ Y HS +++RDLKP+NLL+ G +KL DFG A+
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 264 NCDFIVKLYKTF---KDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFD 320
+C +IVK Y F D LM +CL L R +G + T +V+A
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLL---KRIQGPIPEDILGKMTVAIVKALH 128
Query: 321 YLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
YL + +I+RD+KP N+LL SG VKL DFG + +L+
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 6/126 (4%)
Query: 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDF--IVKLYKTFKDKKYLYMLMESCLGGEL 293
E+ A ++ ++Q + E+ A CD IVK + FK L ++ME GG+L
Sbjct: 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL 152
Query: 294 ----WTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
L++ F + +V A D +HSR +++RDLK N+ L +G +KL D
Sbjct: 153 NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGD 212
Query: 350 FGFAKK 355
FGF+K+
Sbjct: 213 FGFSKQ 218
|
Length = 478 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307
Q +I++ KE++ +N D I YM+ME + +L +++ K F +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKI-------------YMVME-YVEHDLKSLMETMKQPFLQSE 107
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ ++ +LH I++RDLK NLLL+ G +K+ DFG A++ P
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 30/115 (26%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 251 QHIMSEKEIMGEANCDFIVKL--------YKTFKDKKYLYM-LMESCLGGELWTILRDKG 301
+ I+ E +++ + I+ L + F D Y+ LME+ +L +++
Sbjct: 44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV-YIVTELMET----DLHKVIKSPQ 98
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D +++ ++ YLHS N+I+RDLKP N+L++++ +K+ DFG A+ +
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 12/115 (10%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWT-ILRDKGNF- 303
E+R++ ++S M N IV+ ++F++ LY++M+ C GG+L+ I +G
Sbjct: 45 ESRKEVAVLSN---MKHPN---IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF 98
Query: 304 --DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D F C+ A ++H R I++RD+K +N+ L+ G +KL DFG A+ L
Sbjct: 99 PEDQILDWFVQICL--ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 20/97 (20%)
Query: 268 IVKLYKTFKDKKYLYMLMESC----------LGGELWTILRDKGNFDDATTRFYTACVVE 317
IV+LY K L ++ E C G++ D + + +++
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI----------DPEIVKSFMFQLLK 110
Query: 318 AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ HS N+++RDLKP+NLL++ +G +KL DFG A+
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 1/108 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+++ I++E +M E IV ++ L+++ME GG L ++ + D+
Sbjct: 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQI 117
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++A ++LHS +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 30/91 (32%), Positives = 50/91 (54%)
Query: 266 DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
+ IV+L + F+ + LY++ E L + R Y +++A + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+I++RD+KPENLL+S + +KL DFGFA+ L
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 268 IVKLYKTF-KDKKY----LYMLMESCLGGELWTI----LRDKGNFDDATTRFYTACVVEA 318
+VK Y F K K L++++E C GG + + L D+A + +
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
+LH+ II+RD+K N+LL+T G VKLVDFG + +L R
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 25/85 (29%), Positives = 46/85 (54%)
Query: 267 FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRN 326
+V L+K + ++++++ GG+LW+ + N + + + A +V A D LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFG 351
I+ RDL P N+LL G+++L F
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 1/108 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+++ I++E +M E IV ++ L+++ME GG L ++ + +
Sbjct: 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 118
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
C+ +A D+LHS +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 119 AVCRECL-QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 26/108 (24%), Positives = 49/108 (45%), Gaps = 1/108 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
++ + E +M + + IV+L K + + ++ME G L L+ + +
Sbjct: 39 GKKEFLREASVMAQLDHPCIVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDL 97
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ V YL S++ ++RDL N+LL K+ DFG ++ L
Sbjct: 98 KELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 36/128 (28%), Positives = 72/128 (56%), Gaps = 8/128 (6%)
Query: 234 ETSERRRAPQIVETRQQQH---IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
++S + A + ++ R+QQ + +E IM + + +V++Y ++ L+++ME G
Sbjct: 42 KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 291 GELWTILRDKGNFDDATTRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
G L I+ ++ + C V++A LH++ +I+RD+K +++LL+ G VKL
Sbjct: 102 GALTDIVTHTRMNEE---QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 349 DFGFAKKL 356
DFGF ++
Sbjct: 159 DFGFCAQV 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 17/119 (14%)
Query: 255 SEKEIMGEANC--DF-----IVKLYKTFKDKKY------LYMLMESCLGG---ELWTILR 298
E+EI E N + I Y F K L+++ME C GG +L LR
Sbjct: 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR 104
Query: 299 DKGN-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
KG + + + YLH +I+RD+K +N+LL+ + VKLVDFG + +L
Sbjct: 105 KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 33/136 (24%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 221 ISSLDEIRTKYVDE--TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK 278
I ++ +IR + +E S R +++ Q +I+ ++++ + + +++ + + K
Sbjct: 27 IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLK 86
Query: 279 KYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLL 338
KY ++S L D + Y +++ + HSR +++RDLKP+NLL
Sbjct: 87 KY----LDS---------LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133
Query: 339 LSTSGYVKLVDFGFAK 354
+ G +KL DFG A+
Sbjct: 134 IDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-09
Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 1/108 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+++ I++E +M E IV +F L+++ME GG L ++ + D+A
Sbjct: 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQI 117
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++A ++LH+ +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 30/83 (36%), Positives = 47/83 (56%), Gaps = 6/83 (7%)
Query: 275 FKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLK 333
FKD Y+ M LMES +L I+ + R++ ++ Y+HS N+I+RDLK
Sbjct: 80 FKDV-YVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLK 134
Query: 334 PENLLLSTSGYVKLVDFGFAKKL 356
P NLL++ +++ DFG A+ L
Sbjct: 135 PSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 27/115 (23%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR----D 299
+++ + + + E +++ + N ++K Y +F + L +++E G+L +++
Sbjct: 40 LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 99
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
K + T Y + A +++HSR +++RD+KP N+ ++ +G VKL D G +
Sbjct: 100 KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 206 GVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQH--IMSEKEIMGEA 263
G+ C + ET N+ ++ + +I + + +R +I R H +++ K+IM
Sbjct: 19 GIVCSAKNSET-NEKVA-IKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP 76
Query: 264 NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
+ + F D +Y LM++ +L I+R D +++ ++ Y+H
Sbjct: 77 HRE-------AFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
S N+++RDLKP NLLL+ + +K+ DFG A+
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 1/117 (0%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R + + +++ I++E +M E IV ++ L+++ME GG L ++ +
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ C+ +A ++LHS +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 111 TCMDEGQIAAVCRECL-QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 280 YLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLL 338
YLY LME+ +L I+R DA + + ++ Y+HS N+++RDLKP NLL
Sbjct: 82 YLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137
Query: 339 LSTSGYVKLVDFGFAK 354
++ +K+ DFG A+
Sbjct: 138 VNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF----- 303
+++ ++E I+ N I+ + F D L ++ME G+L + +
Sbjct: 42 EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIP 101
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ R + ++ LH + I++RDLK N+LL + VK+ D G +K L
Sbjct: 102 EQEIWRIFIQ-LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 37/126 (29%), Positives = 74/126 (58%), Gaps = 9/126 (7%)
Query: 239 RRAPQIVETRQQQHIMSEKEI-MGEANCDFIVKLYKT-FKDKK-YLYM-LMESCLGGELW 294
+R V +++Q+ ++ + +I M +C + V Y F++ ++ M +M++ L + +
Sbjct: 32 KRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLD-KFY 90
Query: 295 TILRDKGNF--DDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFG 351
+ DKG +D + +V+A +YLHS+ ++I+RD+KP N+L++ +G VKL DFG
Sbjct: 91 KKVYDKGLTIPEDILGKI-AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 352 FAKKLI 357
+ L+
Sbjct: 150 ISGYLV 155
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 21/149 (14%)
Query: 232 VDETSERRRAPQIVETRQQQ---HIMSEKEIMGEANCDFIVKLYKTFKDK---------- 278
VD ++R A + + Q H + E +I+ + D IVK+Y+
Sbjct: 25 VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 279 ----KYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKP 334
+Y++ E + +L +L ++G + R + ++ Y+HS N+++RDLKP
Sbjct: 85 LTELNSVYIVQE-YMETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 335 ENLLLSTSGYV-KLVDFGFAKKLIGPRYS 362
N+ ++T V K+ DFG A +++ P YS
Sbjct: 143 ANVFINTEDLVLKIGDFGLA-RIVDPHYS 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 3/109 (2%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFDDAT 307
+ E IM + + +++LY L M+ E G L LR G+F +T
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLIST 98
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y + YL S+ I+RDL N+LL++ VK+ DFG + L
Sbjct: 99 LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 27/117 (23%), Positives = 52/117 (44%), Gaps = 10/117 (8%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-------DK 300
R++ ++E +M E NC +V+L + ++ME G+L + LR +
Sbjct: 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENN 110
Query: 301 GNFDDATT-RFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
T +F + + YL ++ ++RDL N +++ VK+ DFG +
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 2/107 (1%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATT 308
Q ++E +M +V+L LY++ E G L LR +G A
Sbjct: 45 QAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ 104
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ V E +YL +N ++RDL N+L+S K+ DFG AK+
Sbjct: 105 LGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 35/161 (21%)
Query: 206 GVSCLVIDQETFNQL-ISSLDEIRTKYVDETSERR--------RAPQIVETRQQQHIM-- 254
GV C ID T ++ I ++++ D T R R P IVE + HIM
Sbjct: 14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK---HIMLP 70
Query: 255 -SEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
S +E FKD ++ LMES +L +++ + +F+
Sbjct: 71 PSRRE----------------FKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY 110
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++ A Y+H+ N+ +RDLKP+N+L + +K+ DFG A+
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 19/35 (54%), Positives = 26/35 (74%)
Query: 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
Y H R +++RDLKP+NLL+S G +KL DFG A+
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178459 PLN02868, PLN02868, acyl-CoA thioesterase family protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 35/136 (25%), Positives = 63/136 (46%), Gaps = 13/136 (9%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
Y +G+Y++R+G GD + I KG+ +V+ + +++ L + D+FG +
Sbjct: 35 RYGKGEYVVREGEPGDGLYFIWKGEAEVSGPAEEESRPEFL--LKRYDYFGYGLSG--SV 90
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNE---EFRSLRLS 149
+A++VA ++CLV+ E L+S + D+T + L E L +
Sbjct: 91 HSADVVAVSE--LTCLVLPHE-HCHLLSPKSIWDS---DKTPKDCSLVERILHLEPLEVD 144
Query: 150 DLRVITTLGVGGFGRV 165
R IT FG+V
Sbjct: 145 IFRGITLPDAPTFGKV 160
|
Length = 413 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYML-----------MESCLGGELWTILRDKGNFD 304
E ++ E N IVKL + LY++ M++ + L
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL------- 101
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ Y +++ + HS +++RDLKP+NLL++T G +KL DFG A+
Sbjct: 102 ---IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 238 RRRAPQIVETRQQQ-------HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
+ + P V+T ++ +SE I+ + + IVKL ++ +Y++ME G
Sbjct: 17 KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76
Query: 291 GELWTILRDKGNFDDATTRFYTACVVEA---FDYLHSRNIIYRDLKPENLLLSTSGYVKL 347
G+ + LR K D+ T+ ++A YL S+N I+RDL N L+ + +K+
Sbjct: 77 GDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKI 134
Query: 348 VDFGFAKKLIGPRYS 362
DFG +++ YS
Sbjct: 135 SDFGMSRQEDDGIYS 149
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 8/110 (7%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL-WTILRDKGNFDDA 306
R+Q I E EI+ + N +VK + F + +L+E GG L T + D+ D
Sbjct: 116 RRQ--ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV 173
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ ++ YLH R+I++RD+KP NLL++++ VK+ DFG ++ L
Sbjct: 174 ARQ-----ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKGNFDDATTR 309
+ + E IM + + IVKL + ++++ME GEL + L +K + D A+
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLI 110
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+ + A YL S+ ++RD+ N+L+S+ VKL DFG ++ L
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 19/40 (47%), Positives = 32/40 (80%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++ D+LHS +++RDLKP+N+L+++SG +KL DFG A+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 23/58 (39%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 304 DDATTRFYTACV-------VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
D+ T F + V + YLH II+RDLK NLLL+ G +K+ DFG A+
Sbjct: 99 DNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 4/82 (4%)
Query: 281 LYMLMESCLGGELWTILRDKGNFDDATTRF--YTACVVEAFDYLHSRNIIYRDLKPENLL 338
LY++ME G L LR +G + + ++ V E +YL S+ +++RDL N+L
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 339 LSTSGYVKLVDFGFAKKLIGPR 360
+S G K+ DFG A+ +G
Sbjct: 133 VSEDGVAKVSDFGLAR--VGSM 152
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 7e-08
Identities = 28/95 (29%), Positives = 48/95 (50%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV L+ K+ L ++ E + + G + + ++ Y+H R I
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
++RDLKP+NLL+S +G +KL DFG A+ P ++
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 2/101 (1%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGG--ELWTILRDKGNFDDATTRFYTA 313
E +M E + IV+L+ + L ++ E + +G D T + +T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++ + H +++RDLKP+NLL++ G +KL DFG A+
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 254 MSEKEIMGEANCDF------IVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306
MSE++ + EA +V+LY +K LY++ E G L LR + G
Sbjct: 41 MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD 100
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
V E +YL + I+RDL N L+S++G VK+ DFG + ++ Y
Sbjct: 101 MLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 26/116 (22%), Positives = 63/116 (54%), Gaps = 4/116 (3%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR---- 298
++++ + +Q + E +++ + + ++K +F + L +++E G+L +++
Sbjct: 39 EMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK 98
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
K + T Y + A +++HS+ I++RD+KP N+ ++ +G VKL D G +
Sbjct: 99 QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 20/36 (55%), Positives = 29/36 (80%)
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
D+LH+ I++RDLKPEN+L+++ G VKL DFG A+
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 27/116 (23%), Positives = 63/116 (54%), Gaps = 4/116 (3%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL----R 298
++++ + +Q + E +++ + N ++K +F + L +++E G+L ++ +
Sbjct: 39 EMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK 98
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
K + T Y + A +++HSR +++RD+KP N+ ++ +G VKL D G +
Sbjct: 99 QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 268 IVKLYKTF--KDKK---YLYMLMESCLGGELWTI----LRDKGNFDDATTRFYTACVVEA 318
+VK Y + KD K L++++E C GG + + L+ ++ + +
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
+LH I+RD+K N+LL+T G VKLVDFG + +L R
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 27/87 (31%), Positives = 45/87 (51%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV L+ K+ L + E +++ G R + ++ Y+H ++I
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAK 354
++RDLKP+NLL+S G +KL DFG A+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 190 NLDDLRTANIVAADPEGVSCLV--IDQETFNQL-------ISSLDEIRTKYVDETSERRR 240
+LDD+ + + DP G+ LV + T+ Q+ L I+ V E E
Sbjct: 2 SLDDIDLSAL--RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI 59
Query: 241 APQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD- 299
+I ++ H + G FI K D+ L+++ME C G + ++++
Sbjct: 60 KLEINMLKKYSHHRNIATYYGA----FIKKSPPGHDDQ--LWLVMEFCGAGSVTDLVKNT 113
Query: 300 KGN-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
KGN + + ++ +LH+ +I+RD+K +N+LL+ + VKLVDFG + +L
Sbjct: 114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 38/130 (29%), Positives = 55/130 (42%), Gaps = 22/130 (16%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+++ + E +M N IVKL + Y++ME GG+L + LRD
Sbjct: 42 EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-----RVE 96
Query: 309 RFYTA--CVVEAFD----------YLHSRNIIYRDLKPENLLLSTSGY-----VKLVDFG 351
RF + E D YL + I+RDL N L+S GY VK+ DFG
Sbjct: 97 RFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 352 FAKKLIGPRY 361
A+ + Y
Sbjct: 157 LARDIYKSDY 166
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 5/114 (4%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTF---KDKKYLYMLMESCLGGELWTIL-RDKGN 302
+ E EI+ D IVK YK ++ L ++ME G L L + +
Sbjct: 46 AEHLRDFEREIEILKSLQHDNIVK-YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER 104
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D Y + + + +YL S+ ++RDL N+L+ + VK+ DFG K L
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 28/74 (37%), Positives = 40/74 (54%)
Query: 282 YMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
+++ME CLG + K + T ++ YLHS N+I+RD+K N+LL+
Sbjct: 97 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 156
Query: 342 SGYVKLVDFGFAKK 355
G VKL DFG A K
Sbjct: 157 PGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA-TTRFYTACVVEAFDYLHSRN 326
IV L+ +K L ++ E L +L L D GN + + + ++ +Y H R
Sbjct: 66 IVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++ G +KL DFG A+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 25/107 (23%), Positives = 54/107 (50%), Gaps = 1/107 (0%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315
E +IM E + I+ L + + ++ ++M+ + +L ++ K ++ + +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 316 VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ + LH ++RDL P N+ +++ G K+ DFG A++ P YS
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
|
Length = 335 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 27/72 (37%), Positives = 39/72 (54%)
Query: 282 YMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
+++ME CLG + K + T ++ YLHS N+I+RD+K N+LL+
Sbjct: 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160
Query: 342 SGYVKLVDFGFA 353
G VKL DFG A
Sbjct: 161 PGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 25/78 (32%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 281 LYMLMESCLGGELWTILRD-KGN-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLL 338
L+++ME C G + ++++ KGN + + ++ +LH +I+RD+K +N+L
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143
Query: 339 LSTSGYVKLVDFGFAKKL 356
L+ + VKLVDFG + +L
Sbjct: 144 LTENAEVKLVDFGVSAQL 161
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 2/119 (1%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD- 304
+T + + + E +M E +V+L + Y++ E G L LR+ +
Sbjct: 42 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 101
Query: 305 DATTRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+A Y A + A +YL +N I+RDL N L+ + VK+ DFG ++ + G Y+
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 25/72 (34%), Positives = 36/72 (50%)
Query: 282 YMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
+++ME CLG + K + ++ YLHS I+RD+K N+LL+
Sbjct: 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150
Query: 342 SGYVKLVDFGFA 353
G VKL DFG A
Sbjct: 151 PGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 254 MSEKEIMGEANC------DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
MSE E + EA + +V+LY ++ +Y++ E G L LR+ G
Sbjct: 41 MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQP 99
Query: 308 TRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
++ C V E YL S+ I+RDL N L+ G VK+ DFG ++ ++ Y+
Sbjct: 100 SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 21/122 (17%)
Query: 254 MSEKEIM---GEA----NCDF--IVKLYKTF--KDKK------YLYMLMESCLGGELWTI 296
MSE + E NCDF IVK ++ F KD + + ++++ G+L
Sbjct: 70 MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQE 129
Query: 297 LRDKGN----FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGF 352
++ + F + V+ A ++HS+++I+RD+K N+LL ++G VKL DFGF
Sbjct: 130 IKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189
Query: 353 AK 354
+K
Sbjct: 190 SK 191
|
Length = 496 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 2/118 (1%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
T Q + E +M D +V+LY ++ +Y++ E G L L+
Sbjct: 42 TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL 101
Query: 307 TTRF--YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ ++A + E Y+ +N I+RDL+ N+L+S S K+ DFG A+ + Y+
Sbjct: 102 LPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 25/83 (30%), Positives = 52/83 (62%), Gaps = 5/83 (6%)
Query: 272 YKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRD 331
+++F D + LME+ +L+ +++ + + + +++ ++ Y+HS N+++RD
Sbjct: 77 FESFNDVYIVQELMET----DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSANVLHRD 131
Query: 332 LKPENLLLSTSGYVKLVDFGFAK 354
LKP NLLL+T+ +K+ DFG A+
Sbjct: 132 LKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328
+KLY + K ++M+ G+L+ +L+ +G +A + +VEA + LH NII
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 329 YRDLKPENLLLSTS-GYVKLVDFGFAK 354
+ D+K EN+L + + L D+G K
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA-TTRFYTACVVEAFDYLHSRN 326
IV L+ K L ++ E L +L + D GN + + ++ Y H R
Sbjct: 66 IVTLHDIVHTDKSLTLVFEY-LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++ G +KL DFG A+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 7/111 (6%)
Query: 249 QQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----NF 303
+++ +MSE +IM N + IV L + ++ E C G+L LR K
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+D + ++ V + +L S+N I+RDL N+LL+ VK+ DFG A+
Sbjct: 141 EDLLS--FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA-TTRFYTACVVEAFDYLHSRN 326
IV L+ ++ L ++ E L +L L + GN + + ++ Y H R
Sbjct: 65 IVTLHDIIHTERCLTLVFEY-LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
I++RDLKP+NLL++ G +KL DFG A+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 5/109 (4%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDKGNF---DDA 306
Q ++E +M + +V+L ++K LY++ E G L LR +G D
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+F + V EA +YL + N ++RDL N+L+S K+ DFG K+
Sbjct: 104 LLKF-SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
E + +M E EIM + + +IV++ + + L ++ME GG L L K D
Sbjct: 35 EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGK---KD 90
Query: 306 ATTRFYTACVVE-------AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
T + VVE YL +N ++RDL N+LL Y K+ DFG +K L
Sbjct: 91 EIT---VSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 254 MSEKEIMGEANC------DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
MSE + + EA +V+LY ++ ++++ E G L LR+ KG
Sbjct: 41 MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKL--G 98
Query: 307 TTRFYTAC--VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
T C V EA +YL S I+RDL N L+ VK+ DFG A+ ++ +Y+
Sbjct: 99 TEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 268 IVKLYKTF---KDKKYLYMLMESCLGGE--LWTILRD-----KGNFDDATTRFYTACVVE 317
+V L + F DK +Y+L + E LW I++ + + + + ++
Sbjct: 64 VVSLVEVFLEHADKS-VYLLFDYA---EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 318 AFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIGP 359
YLHS +++RDLKP N+L+ G VK+ D G A+ P
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 28/72 (38%), Positives = 39/72 (54%)
Query: 282 YMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
+++ME CLG + K + T ++ YLHS N+I+RD+K N+LLS
Sbjct: 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150
Query: 342 SGYVKLVDFGFA 353
G VKL DFG A
Sbjct: 151 PGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDK---KYLYMLMESCLGGELWTILRD-KGNFDDATTRFY 311
E EI+ + + IVK YK +K + L ++ME G L L+ + + +
Sbjct: 56 EIEILRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++ + + DYL S+ I+RDL N+L+ + VK+ DFG AK
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 26/79 (32%), Positives = 48/79 (60%), Gaps = 4/79 (5%)
Query: 281 LYMLMESCLGGELWTILRD-KGNF--DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENL 337
LY++M C GG+L+ L++ KG ++ ++ + A YLH ++I++RDLK +N+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNV 133
Query: 338 LLSTSGYVKLVDFGFAKKL 356
L+ + +K+ D G A+ L
Sbjct: 134 FLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 17/35 (48%), Positives = 27/35 (77%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
YLHS I++RD+KP NLL++++ +K+ DFG A+
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 23/55 (41%), Positives = 36/55 (65%), Gaps = 1/55 (1%)
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-VKLVDFGFAKKLIGPRYS 362
+ Y+ + A Y+HS+ I +RDLKP+NLL+ + + +KL DFG AK L+ + S
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227
|
Length = 440 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 254 MSEKEIMGEANC------DFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDA 306
MSE++ + EA +V+LY ++ + ++ E G L LR +G F
Sbjct: 41 MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE 100
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
T V E YL S N+I+RDL N L+ + VK+ DFG + ++ +Y+
Sbjct: 101 TLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 1/110 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
+++ Q+ +E I+ N I++L TF K+ +++ +L+ L K N
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR-YKTDLYCYLAAKRNI 179
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
V+ A YLH II+RD+K EN+ ++ G V L DFG A
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 1/103 (0%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
+ E I+ + + IV+L K+ +Y++ME GG+ T LR +G
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100
Query: 314 CVVEA-FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
A +YL S++ I+RDL N L++ +K+ DFG +++
Sbjct: 101 ENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
E R +H M + ++G + + + F D + LM G +L I++ + DD
Sbjct: 66 ELRLLKH-MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM----GADLNNIVKCQKLTDD 120
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+F ++ Y+HS +II+RDLKP NL ++ +K++DFG A+
Sbjct: 121 HV-QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 25/80 (31%), Positives = 45/80 (56%), Gaps = 2/80 (2%)
Query: 276 KDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKP 334
KDK Y++ E + +L +L +F + + + ++E +Y H +N ++RD+K
Sbjct: 86 KDKGAFYLVFEY-MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144
Query: 335 ENLLLSTSGYVKLVDFGFAK 354
N+LL+ G +KL DFG A+
Sbjct: 145 SNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 18/46 (39%), Positives = 29/46 (63%)
Query: 317 EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
E +YLH +I++RD+K N+L+ G +K+ DFG A+ GP +
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 35/132 (26%), Positives = 64/132 (48%), Gaps = 9/132 (6%)
Query: 236 SERRRAPQI-VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELW 294
ER A ++ +R + +E +G N + I+K+ + + + YM+ + +L+
Sbjct: 192 CERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQK-YDFDLY 250
Query: 295 TILRDKGNFD--DA----TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
+ + D FD D TR ++ A +Y+H + +I+RD+K EN+ L+ G + L
Sbjct: 251 SFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG 309
Query: 349 DFGFAKKLIGPR 360
DFG A R
Sbjct: 310 DFGTAMPFEKER 321
|
Length = 501 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 15/34 (44%), Positives = 24/34 (70%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
Y+H I++RD+K N+L++ G +KL DFG A+
Sbjct: 134 YIHRNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 22/53 (41%), Positives = 31/53 (58%), Gaps = 12/53 (22%)
Query: 322 LHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK------------LIGPRYS 362
LH I++RD+KPENLL++ G VK++DFG A ++ PRYS
Sbjct: 325 LHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377
|
Length = 507 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 255 SEKEIMGEANCDFIVKLYKTFKDKKYLYMLME--SCLGGELWTILRDKGNFDDATTRFYT 312
E +I+ + I+ L ++ K + M+M C +L+T + G
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQ 191
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++EA YLH R II+RD+K EN+ L L DFG A KL
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
|
Length = 392 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF--DDATTRFYTA 313
E ++ E IV+L +K LY++ E L +L + +F + + Y
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-LDLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAK 354
++ Y HS +++RDLKP+NLL+ +KL DFG A+
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 281 LYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS 340
L+ + E G L +L G T V++A H++ I++RDLKP+N+++S
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 341 TSG---YVKLVDFGFAKKLIGPR 360
+G + K++DFG L G R
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVR 136
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDATTRFYTAC 314
E +IM + D +V+LY +++ +Y++ E G L L+ +G A
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 315 -VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ E YL SRN I+RDL N+L+ + K+ DFG A+ +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
E +++ + + IVK + +F ++ ++ E C G +L L +
Sbjct: 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEE---LKHTGKTLS 104
Query: 312 TACVVEAF-------DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
V E F Y+H R I++RDLK +N+ L + +K+ DFG ++ L+G
Sbjct: 105 ENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 24/83 (28%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 274 TFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLK 333
F+D +Y++ +G +L I++ + D +F ++ Y+HS II+RDLK
Sbjct: 91 DFQD---VYLVTH-LMGADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK 145
Query: 334 PENLLLSTSGYVKLVDFGFAKKL 356
P N+ ++ +K++DFG A+
Sbjct: 146 PSNIAVNEDCELKILDFGLARHT 168
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306
+Q+Q +SE IMG+ + I++L K ++ E G L LRD G F
Sbjct: 48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY 107
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL N ++RDL N+L++++ K+ DFG ++ L
Sbjct: 108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 18/45 (40%), Positives = 30/45 (66%), Gaps = 2/45 (4%)
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
F+ C +Y+HS+ +++RDLKP+N+LL G V ++D+G A
Sbjct: 119 FHKIC--ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161
|
Length = 932 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 3/103 (2%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDATTRF-Y 311
++E +M D +VKL+ K+ +Y++ E G L L+ D+G+ +
Sbjct: 49 LAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+A + E ++ RN I+RDL+ N+L+S S K+ DFG A+
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 1/75 (1%)
Query: 283 MLMESCLGGELWTIL-RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
++ME G L L R+K + Y + + DYL SR ++RDL N+L+ +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 342 SGYVKLVDFGFAKKL 356
VK+ DFG K +
Sbjct: 145 EHQVKIGDFGLTKAI 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 35/155 (22%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 200 VAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEI 259
+ + +G+ C D + ++ ++ + ++T +R ++V + H K I
Sbjct: 32 IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNH----KNI 85
Query: 260 MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAF 319
+G N K + F+D +Y++ME + L +++ + + + + Y ++
Sbjct: 86 IGLLNVFTPQKSLEEFQD---VYIVME-LMDANLCQVIQMELDHERMSYLLYQ--MLCGI 139
Query: 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LHS II+RDLKP N+++ + +K++DFG A+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
+++ K I+G N K + F+D +Y++ME I D D +
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQD---VYLVMELMDANLCQVIQMD---LDHERMSYLL 124
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
++ +LHS II+RDLKP N+++ + +K++DFG A+
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 28/76 (36%), Positives = 38/76 (50%), Gaps = 1/76 (1%)
Query: 279 KYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLL 338
K L ++ME G L L K + A + + E YLHS++ I+RDL N+L
Sbjct: 81 KGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVL 139
Query: 339 LSTSGYVKLVDFGFAK 354
L VK+ DFG AK
Sbjct: 140 LDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 27/104 (25%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
++ E +M + + +IV++ + + ++ ++ME G L L+ + +
Sbjct: 43 LLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELV 101
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V YL N ++RDL N+LL T Y K+ DFG +K L
Sbjct: 102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|236969 PRK11753, PRK11753, DNA-binding transcriptional dual regulator Crp; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 8/89 (8%)
Query: 40 IIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDLRTANIV 98
+I G + +T + I KG V V +K +E + L +GDF GE L + R+A +
Sbjct: 31 LIHAGEKAETLYYIVKGSVAVLIKD-EEGKEMILSYLNQGDFIGELGLFEEGQERSAWVR 89
Query: 99 AADPEGVSCLV--IDQETFNQLISSLDEI 125
A C V I + F QLI +I
Sbjct: 90 AKTA----CEVAEISYKKFRQLIQVNPDI 114
|
Length = 211 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 21/74 (28%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 281 LYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS 340
+Y + E LG +L +L + + +++ ++ Y+HS +++RDLKP N+L++
Sbjct: 85 IYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142
Query: 341 TSGYVKLVDFGFAK 354
+ +K+ DFG A+
Sbjct: 143 ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+ V ++L SR I+RDL N+LLS + VK+ DFG A+ +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 16/52 (30%), Positives = 30/52 (57%), Gaps = 1/52 (1%)
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ + Y ++++ D++H I +RD+KPEN+L+ +KL DFG +
Sbjct: 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK-DDILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 2/118 (1%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+QQ E + + ++ L+ + +Y++ E G L LR +G
Sbjct: 43 LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP 102
Query: 306 ATTRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ AC V E YL +N I+RDL N+L+ K+ DFG A+ + Y
Sbjct: 103 VASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 21/72 (29%), Positives = 42/72 (58%), Gaps = 1/72 (1%)
Query: 284 LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG 343
L+ + +G +L I++ + D +F ++ Y+HS II+RDLKP N+ ++
Sbjct: 97 LVTNLMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC 155
Query: 344 YVKLVDFGFAKK 355
++++DFG A++
Sbjct: 156 ELRILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 17/42 (40%), Positives = 27/42 (64%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + +YL R +++RDL N+L+ T +VK+ DFG AK L
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+ V ++L SR I+RDL N+LLS + VK+ DFG A+ +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 13/61 (21%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKL------------IGPRY 361
++ A D LHS I++RD+KP+N++ S SG K++D G A L + PRY
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRY 323
Query: 362 S 362
+
Sbjct: 324 A 324
|
Length = 566 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 34/155 (21%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 200 VAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEI 259
+ + +G+ C D + ++ ++ + ++T +R ++V + H K I
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNH----KNI 78
Query: 260 MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAF 319
+ N K + F+D +Y++ME + L +++ + + + + Y ++
Sbjct: 79 ISLLNVFTPQKSLEEFQD---VYLVME-LMDANLCQVIQMELDHERMSYLLYQ--MLCGI 132
Query: 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LHS II+RDLKP N+++ + +K++DFG A+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/130 (24%), Positives = 57/130 (43%), Gaps = 10/130 (7%)
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
P+ + + + E IM + N IV+L ++ ++L+E GG+L + LR+
Sbjct: 45 PESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENR 104
Query: 302 NFDDATTRF------YTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFG 351
+ + + A V + YL + I+RD+ N LL+ G K+ DFG
Sbjct: 105 PRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 352 FAKKLIGPRY 361
A+ + Y
Sbjct: 165 MARDIYRASY 174
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+ V + ++L SR I+RDL N+LLS + VK+ DFG A+ +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 26/111 (23%), Positives = 52/111 (46%), Gaps = 3/111 (2%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF--Y 311
++E +M + +V+LY ++ +Y++ E G L L+ +
Sbjct: 49 LAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
A + E ++ +N I+RDL+ N+L+S + K+ DFG A+ + Y+
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 35/155 (22%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 200 VAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEI 259
+ + +G+ C D T + ++ ++ + ++T +R ++V + H K I
Sbjct: 29 IGSGAQGIVCAAFD--TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH----KNI 82
Query: 260 MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAF 319
+ N K + F+D +Y++ME + L ++ + + + + Y ++
Sbjct: 83 ISLLNVFTPQKSLEEFQD---VYLVME-LMDANLCQVIHMELDHERMSYLLYQ--MLCGI 136
Query: 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LHS II+RDLKP N+++ + +K++DFG A+
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 4/109 (3%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYM--LMESCLGGELWTILRDKGNFDDAT 307
+ I+ E +M + +V+L + + LM LG L + K N
Sbjct: 53 NKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMP--LGCLLDYVRNHKDNIGSQY 110
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + YL + +++RDL N+L+ T +VK+ DFG AK L
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 291 GELWTILRDKGNFDDATTR---FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKL 347
E+ +L D G + TT +T V ++L S+N ++RDL N+LL+ VK+
Sbjct: 220 SEVKNLLSDDG-SEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 348 VDFGFAKKLI 357
DFG A+ ++
Sbjct: 279 CDFGLARDIM 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 17/36 (47%), Positives = 24/36 (66%)
Query: 318 AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
A DY+H II+RD+K EN+L++ + L DFG A
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 16/41 (39%), Positives = 29/41 (70%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+++ Y+H+ II+RDLKP NL ++ +K++DFG A++
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 16/40 (40%), Positives = 25/40 (62%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
V + D+L S+N I+RD+ N+LL+ K+ DFG A+
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 17/34 (50%), Positives = 25/34 (73%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
Y+HS II+RDLKP NL ++ +K++DFG A+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 3/110 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
T + + E +IM + D +V+LY ++ +Y++ E G L L+D +G
Sbjct: 42 TMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALK 100
Query: 306 ATTRFYTACVVEA-FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
A V A Y+ N I+RDL+ N+L+ K+ DFG A+
Sbjct: 101 LPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 32/139 (23%), Positives = 59/139 (42%), Gaps = 14/139 (10%)
Query: 232 VDETSERRRAPQIV----ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMES 287
V + E R A + V R++ ++E +M E NC +V+L + ++ME
Sbjct: 31 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90
Query: 288 CLGGELWTILRD-----KGNFDDATTRF-----YTACVVEAFDYLHSRNIIYRDLKPENL 337
G+L + LR + N A + + YL++ ++RDL N
Sbjct: 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNC 150
Query: 338 LLSTSGYVKLVDFGFAKKL 356
+++ VK+ DFG + +
Sbjct: 151 MVAEDFTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 17/47 (36%), Positives = 27/47 (57%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
+ +YL S+N I+RDL N +L+ + V + DFG +KK+ Y
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 12/106 (11%)
Query: 265 CDFIVKLY-----KTFKDKKYLYMLMESCLGGEL--WTILRDKGN---FDDATTRFYTAC 314
+IV+L + K LY++ E L +L + +G T + +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIGP 359
+++ + H +++RDLKP+NLL+ G +K+ D G + P
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 27/110 (24%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
T + ++E +IM + +++LY ++ +Y++ E G L L+
Sbjct: 42 TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK 101
Query: 307 TTRF--YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ A V YL ++N I+RDL N+L+ + K+ DFG A+
Sbjct: 102 LPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 15/40 (37%), Positives = 26/40 (65%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++E YLH++ II+RD+K EN+ ++ V + D G A+
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 16/44 (36%), Positives = 27/44 (61%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
+ + YL R +++RDL N+L+ + +VK+ DFG A+ L G
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIGP 359
+++ YLH+ +++RDLKP N+L+ G VK+ D GFA+ P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIGP 359
+++ YLH+ +++RDLKP N+L+ G VK+ D GFA+ P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFDDATTRFYTACVVEAFDYLHSR 325
I+ +F LY++ G +L+ + F V+ A DY+HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
I+R +K ++LLS G V L ++ +I
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDA 306
+Q++ +SE IMG+ + I+ L + + ++ E G L + LR + G F
Sbjct: 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI 106
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL N ++RDL N+L++++ K+ DFG ++ L
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-- 300
++ R++ ++ E +M E IV+ F +K + LY+LME C G+L ++
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 301 --GNFDDATTRFYTACVVEAFDYLHS-------RNIIYRDLKPENLLLST 341
G ++ T ++ A Y H+ +++RDLKP+N+ LST
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 16/42 (38%), Positives = 25/42 (59%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V + +L S+N I+RDL N+LL+ K+ DFG A+ +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 16/90 (17%)
Query: 281 LYMLMESCLGGELWTILRD------KGNFDDA-------TTRFYTAC---VVEAFDYLHS 324
LY+++E G L LR + DD T + + V ++L S
Sbjct: 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150
Query: 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ I+RDL N+L++ +K+ DFG A+
Sbjct: 151 KKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 3/118 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR--DKGNFD 304
T + + E +IM + D +V LY ++ +Y++ E G L L+ D
Sbjct: 42 TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLK 100
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
A + + Y+ N I+RDL+ N+L+ + K+ DFG A+ + Y+
Sbjct: 101 LPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 16/40 (40%), Positives = 24/40 (60%)
Query: 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
V +YL SR I+RDL N+L++ +K+ DFG A+
Sbjct: 143 VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 362 | |||
| KOG0614|consensus | 732 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0575|consensus | 592 | 99.98 | ||
| KOG0581|consensus | 364 | 99.97 | ||
| KOG0611|consensus | 668 | 99.97 | ||
| KOG0593|consensus | 396 | 99.97 | ||
| KOG0661|consensus | 538 | 99.97 | ||
| KOG0600|consensus | 560 | 99.97 | ||
| KOG0659|consensus | 318 | 99.96 | ||
| KOG0583|consensus | 370 | 99.96 | ||
| KOG0585|consensus | 576 | 99.96 | ||
| KOG0591|consensus | 375 | 99.96 | ||
| KOG0610|consensus | 459 | 99.96 | ||
| KOG0694|consensus | 694 | 99.96 | ||
| KOG0663|consensus | 419 | 99.96 | ||
| KOG0580|consensus | 281 | 99.96 | ||
| KOG0597|consensus | 808 | 99.96 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| KOG0198|consensus | 313 | 99.95 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG0588|consensus | 786 | 99.95 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0594|consensus | 323 | 99.95 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| KOG0608|consensus | 1034 | 99.95 | ||
| KOG0192|consensus | 362 | 99.95 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1113|consensus | 368 | 99.95 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0197|consensus | 468 | 99.95 | ||
| KOG0194|consensus | 474 | 99.95 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| KOG0658|consensus | 364 | 99.94 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0582|consensus | 516 | 99.94 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| KOG0660|consensus | 359 | 99.94 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| KOG0662|consensus | 292 | 99.94 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0586|consensus | 596 | 99.94 | ||
| KOG0612|consensus | 1317 | 99.94 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| KOG0032|consensus | 382 | 99.94 | ||
| KOG0589|consensus | 426 | 99.94 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0033|consensus | 355 | 99.93 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| KOG0599|consensus | 411 | 99.93 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| KOG0578|consensus | 550 | 99.93 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0667|consensus | 586 | 99.93 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0690|consensus | 516 | 99.93 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| KOG4250|consensus | 732 | 99.93 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG1187|consensus | 361 | 99.92 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG1989|consensus | 738 | 99.92 | ||
| KOG1152|consensus | 772 | 99.92 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| KOG4236|consensus | 888 | 99.92 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG4717|consensus | 864 | 99.91 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| KOG0574|consensus | 502 | 99.91 | ||
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG0193|consensus | 678 | 99.9 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.9 | |
| KOG0666|consensus | 438 | 99.9 | ||
| KOG0696|consensus | 683 | 99.9 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.9 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.9 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| KOG0986|consensus | 591 | 99.9 | ||
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1035|consensus | 1351 | 99.9 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG0607|consensus | 463 | 99.9 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0579|consensus | 1187 | 99.9 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.9 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| KOG0577|consensus | 948 | 99.9 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG1094|consensus | 807 | 99.9 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0201|consensus | 467 | 99.9 | ||
| KOG1026|consensus | 774 | 99.9 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG2345|consensus | 302 | 99.89 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.89 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.89 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| KOG0614|consensus | 732 | 99.89 | ||
| KOG0695|consensus | 593 | 99.89 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| KOG0604|consensus | 400 | 99.89 | ||
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| KOG1095|consensus | 1025 | 99.89 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| KOG4279|consensus | 1226 | 99.89 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG4645|consensus | 1509 | 99.89 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| KOG0984|consensus | 282 | 99.89 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.88 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.88 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.88 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.88 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.88 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.88 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.88 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.88 | |
| KOG1163|consensus | 341 | 99.88 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| KOG0196|consensus | 996 | 99.88 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0584|consensus | 632 | 99.87 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| KOG4721|consensus | 904 | 99.87 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.87 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG4257|consensus | 974 | 99.87 | ||
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.87 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0587|consensus | 953 | 99.86 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| KOG2052|consensus | 513 | 99.86 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG1151|consensus | 775 | 99.86 | ||
| KOG0668|consensus | 338 | 99.86 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.86 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.86 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.86 | |
| KOG3653|consensus | 534 | 99.86 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0669|consensus | 376 | 99.86 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| KOG4278|consensus | 1157 | 99.85 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.85 | |
| KOG0983|consensus | 391 | 99.85 | ||
| KOG1006|consensus | 361 | 99.85 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.85 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.85 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.85 | |
| KOG0596|consensus | 677 | 99.85 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| KOG0664|consensus | 449 | 99.84 | ||
| KOG0576|consensus | 829 | 99.84 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1345|consensus | 378 | 99.82 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1165|consensus | 449 | 99.82 | ||
| KOG0199|consensus | 1039 | 99.82 | ||
| KOG0671|consensus | 415 | 99.81 | ||
| KOG0603|consensus | 612 | 99.81 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.81 | |
| KOG1164|consensus | 322 | 99.81 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.8 | |
| PRK09392 | 236 | ftrB transcriptional activator FtrB; Provisional | 99.79 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.79 | |
| KOG0670|consensus | 752 | 99.79 | ||
| KOG1027|consensus | 903 | 99.78 | ||
| KOG1025|consensus | 1177 | 99.78 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1167|consensus | 418 | 99.77 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| KOG0665|consensus | 369 | 99.75 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.75 | |
| KOG0200|consensus | 609 | 99.75 | ||
| PRK11753 | 211 | DNA-binding transcriptional dual regulator Crp; Pr | 99.75 | |
| KOG1290|consensus | 590 | 99.74 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| COG0664 | 214 | Crp cAMP-binding proteins - catabolite gene activa | 99.73 | |
| cd00038 | 115 | CAP_ED effector domain of the CAP family of transc | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK10402 | 226 | DNA-binding transcriptional activator YeiL; Provis | 99.7 | |
| PF00027 | 91 | cNMP_binding: Cyclic nucleotide-binding domain; In | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.69 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.68 | |
| PRK11161 | 235 | fumarate/nitrate reduction transcriptional regulat | 99.68 | |
| smart00100 | 120 | cNMP Cyclic nucleotide-monophosphate binding domai | 99.67 | |
| KOG1166|consensus | 974 | 99.66 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PLN02868 | 413 | acyl-CoA thioesterase family protein | 99.6 | |
| TIGR03697 | 193 | NtcA_cyano global nitrogen regulator NtcA, cyanoba | 99.58 | |
| KOG0498|consensus | 727 | 99.58 | ||
| PRK09391 | 230 | fixK transcriptional regulator FixK; Provisional | 99.57 | |
| KOG1113|consensus | 368 | 99.56 | ||
| PRK13918 | 202 | CRP/FNR family transcriptional regulator; Provisio | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0500|consensus | 536 | 99.5 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG0590|consensus | 601 | 99.47 | ||
| COG2905 | 610 | Predicted signal-transduction protein containing c | 99.45 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| KOG1024|consensus | 563 | 99.45 | ||
| KOG0603|consensus | 612 | 99.42 | ||
| KOG0499|consensus | 815 | 99.42 | ||
| KOG4158|consensus | 598 | 99.38 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| KOG3087|consensus | 229 | 99.14 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1240|consensus | 1431 | 99.11 | ||
| KOG0590|consensus | 601 | 99.05 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| KOG0606|consensus | 1205 | 98.93 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| KOG2968|consensus | 1158 | 98.91 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| KOG0601|consensus | 524 | 98.81 | ||
| KOG0601|consensus | 524 | 98.79 | ||
| KOG1243|consensus | 690 | 98.71 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| KOG1023|consensus | 484 | 98.68 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| KOG0501|consensus | 971 | 98.57 | ||
| KOG0195|consensus | 448 | 98.5 | ||
| KOG3741|consensus | 655 | 98.48 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| KOG2968|consensus | 1158 | 98.33 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| KOG1266|consensus | 458 | 98.22 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| KOG1033|consensus | 516 | 98.17 | ||
| KOG1235|consensus | 538 | 98.16 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| PF04831 | 153 | Popeye: Popeye protein conserved region; InterPro: | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| KOG0606|consensus | 1205 | 97.72 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| PRK11832 | 207 | putative DNA-binding transcriptional regulator; Pr | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.36 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.12 | |
| KOG2268|consensus | 465 | 97.04 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| KOG3542|consensus | 1283 | 96.88 |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-55 Score=396.15 Aligned_cols=346 Identities=42% Similarity=0.717 Sum_probs=286.0
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
++....++.+| ++.++.+|..+|..++|++|++|++|||+|+.+|++.+|++.|. ++.+.++.+++|.+|||+
T Consensus 155 Ai~~NdFLknL-d~~Qi~e~v~~Myp~~~~~gs~IIrege~Gs~~yV~aeG~~~V~------~~g~ll~~m~~gtvFGEL 227 (732)
T KOG0614|consen 155 AIQKNDFLKNL-DASQIKELVDCMYPVEYRAGSWIIREGEPGSHLYVSAEGELQVS------REGKLLGKMGAGTVFGEL 227 (732)
T ss_pred HHHhhHHHHhh-hHHHHHHHHHhhCcccccCCcEEEecCCCCceEEEeecceEEEe------eCCeeeeccCCchhhhHH
Confidence 45667888999 99999999999999999999999999999999999999999998 555889999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH----Hhhhhhhhh--------hccccCcEE
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE----RRRLNEEFR--------SLRLSDLRV 153 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~----~~~~~~~~~--------~~~~~~~~~ 153 (362)
|++++++|+|||+|+ +++.+|+|+|+.|++++......+..-+.++.+ +..+++++. ...++.-..
T Consensus 228 AILynctRtAsV~al--t~~~lWaidR~vFq~IM~~tg~~r~~~~~~fLrsv~~~q~l~Ee~L~KiaD~le~~~Yd~g~y 305 (732)
T KOG0614|consen 228 AILYNCTRTASVRAL--TDVRLWAIDREVFQAIMMRTGLERHEQYMNFLRSVPLFQNLPEELLLKIADVLEEEYYDAGEY 305 (732)
T ss_pred HHHhCCcchhhhhhh--hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhccCCHHHHHHHHHHHHHHhhcCCce
Confidence 999999999999999 569999999999999999877766544444433 333333321 111222223
Q ss_pred EEEecc-cc-e-----ecEEEEEecCCCCCceeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 154 ITTLGV-GG-F-----GRVELVQIAGDPSRSFALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 154 ~~~lg~-G~-~-----g~v~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
+-.-|+ |. | |+|...+....+.++..++.++++++|| .++.|+|+++|..| +|.|++|||++|++++
T Consensus 306 Iirqge~G~~ffii~~G~V~vtq~~e~~~q~~~lr~l~kGd~FGE~al~~edvRtAniia~~~-gv~cl~lDresF~~li 384 (732)
T KOG0614|consen 306 IIRQGEKGDTFFIISKGTVKVTQQDEGSTQPQELRTLNKGDYFGERALLGEDVRTANIIAQAP-GVECLTLDRESFKKLI 384 (732)
T ss_pred EEeecCCCCeEEEEecceEEEeecCCCCCchhHHhhccccchhhHHHhhccCccchhhhccCC-CceEEEecHHHHHHhc
Confidence 322332 22 1 6776666555567889999999999998 46899999999876 6999999999999999
Q ss_pred cchHHhhhhccchhhhhc---------------------------------------------------cccccccchhh
Q psy14740 222 SSLDEIRTKYVDETSERR---------------------------------------------------RAPQIVETRQQ 250 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~ 250 (362)
|++.++..+.+.....+- ....+++....
T Consensus 385 G~l~~l~ek~~~D~~r~A~~~~~~~~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQq 464 (732)
T KOG0614|consen 385 GDLEELKEKDYGDEERRASVVIKEDFAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQ 464 (732)
T ss_pred ccHHHhhhhhccchhhhhhhHHHHHHHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHH
Confidence 999999944322221110 00112344456
Q ss_pred hhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEee
Q psy14740 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330 (362)
Q Consensus 251 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHr 330 (362)
+++..|.+||..+..|.|+++|..|.+..++|++||-|-||.|+..+...+.|++..+++++.++++|++|||++|||+|
T Consensus 465 eHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYR 544 (732)
T KOG0614|consen 465 EHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYR 544 (732)
T ss_pred HHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceec
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 331 DLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 331 Dikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
||||+|++++.+|.+||.|||+|+++..++.
T Consensus 545 DLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 545 DLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred cCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999999999999999999877653
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.80 Aligned_cols=156 Identities=33% Similarity=0.567 Sum_probs=140.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+.+|.+...||.|+||.||++++.. ++..+|||.+.+..
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~--------------------------------------- 47 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKK--------------------------------------- 47 (429)
T ss_pred ccccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhc---------------------------------------
Confidence 57899999999999999999999765 46899999987642
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+..|+.+|+.++|||||.++++...++++|+|||||.||+|.+++++.+.+++.
T Consensus 48 ------------------l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~ 109 (429)
T KOG0595|consen 48 ------------------LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEA 109 (429)
T ss_pred ------------------cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHH
Confidence 12334566889999999999999999999999999999999999999999999998899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC------CcEEEEecccceecCCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS------GYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~------~~~kl~DFG~a~~~~~~~ 360 (362)
.++.++.|++.||++||+++||||||||+|||++.. -.+||+|||+||.+.++.
T Consensus 110 t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 110 TARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 999999999999999999999999999999999864 458999999999887543
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=256.39 Aligned_cols=160 Identities=29% Similarity=0.423 Sum_probs=138.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|.+.+.||+|+||.|.++... .+++.||||++.+....+...
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~---------------------------------- 215 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSR---------------------------------- 215 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccc----------------------------------
Confidence 455778889999999999999854 679999999998864322110
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+++|++++|||||+++++|..+++.|+||||++||+|.+.+-.++.+.+..
T Consensus 216 ------------------~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~ 277 (475)
T KOG0615|consen 216 ------------------AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDL 277 (475)
T ss_pred ------------------cccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccch
Confidence 11123347899999999999999999999999999999999999999999999989999999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC---CcEEEEecccceecCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS---GYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~---~~~kl~DFG~a~~~~~~~ 360 (362)
.+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+......
T Consensus 278 ~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s 333 (475)
T KOG0615|consen 278 GKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS 333 (475)
T ss_pred hHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccce
Confidence 99999999999999999999999999999999866 679999999999876543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=253.58 Aligned_cols=156 Identities=40% Similarity=0.727 Sum_probs=144.6
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
....++|++.++||+|+||.|+.++.. ++++.||+|+++|.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~-------------------------------------- 61 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKK-------------------------------------- 61 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhh--------------------------------------
Confidence 346789999999999999999999955 88999999999886
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.+.......+...|..||..++||+||+++..|++++.+|+|+||+.||.|...+++++.++
T Consensus 62 ------------------~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~ 123 (357)
T KOG0598|consen 62 ------------------KIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFS 123 (357)
T ss_pred ------------------HhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcc
Confidence 34444566778999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+++++..|+.||.|||++|||||||||+|||++..|+++|+|||+|+...
T Consensus 124 E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 124 EDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred hhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999999999999999999999999999999999999998543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=245.02 Aligned_cols=159 Identities=47% Similarity=0.825 Sum_probs=146.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|..+..+|.|+||+|.+++.. .++..+|+|++.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~v------------------------------------- 82 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKV------------------------------------- 82 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEc-cCCceeehhhcCHHHH-------------------------------------
Confidence 57899999999999999999999955 5688999999988743
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
+.....++..+|..+|+.+.||+++++++.+.+.+++|+||||++||.|..++++.+++++
T Consensus 83 -------------------VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e 143 (355)
T KOG0616|consen 83 -------------------VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSE 143 (355)
T ss_pred -------------------HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCc
Confidence 3445567789999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
..+++++.||+.||+|||+++|++||+||+|||+|.+|.+||+|||+|+.+.+..|
T Consensus 144 ~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 144 PHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred hhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999999999999999999999999999999999999999999876543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=255.58 Aligned_cols=155 Identities=38% Similarity=0.707 Sum_probs=143.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+.+++|.++..||+|+||.||+++ ..++|+.+|+|+++|...+..
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLar-Kk~Tg~iyAmK~LkKS~M~~~---------------------------------- 182 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLAR-KKDTGEIYAMKILKKSEMLKK---------------------------------- 182 (550)
T ss_pred CCcccchhheeeccccceeEEEEE-EccCCcEEeeecccHHHHHhh----------------------------------
Confidence 467899999999999999999998 668899999999999855433
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
....++..|..+|...++|.||++|.+|++.+++||||||++||++..+|.+.+.|++
T Consensus 183 ----------------------~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e 240 (550)
T KOG0605|consen 183 ----------------------NQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTE 240 (550)
T ss_pred ----------------------hhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCch
Confidence 2345678899999999999999999999999999999999999999999999899999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++++.+++.|++.+|+.|+|||||||+|+|||..|++||+|||+|.-+.
T Consensus 241 ~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 241 DWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred HHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999999999999999999999999999999999999996553
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=255.81 Aligned_cols=157 Identities=36% Similarity=0.628 Sum_probs=143.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...+||...+.||+|+|++|+++.. .++++.||||++.|..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~-~~t~keYAiKVl~K~~-------------------------------------- 110 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLARE-KATGKEYAIKVLDKRY-------------------------------------- 110 (604)
T ss_pred CChhhcchhheeccccceeEEEeee-cCCCceeeHhhhhHHH--------------------------------------
Confidence 3578999999999999999999984 4689999999998862
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
+..+.....+.+|.++|..| +||.|+++|..|+++..+|+|+||+++|+|.++|++.+.|+
T Consensus 111 ------------------Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfd 172 (604)
T KOG0592|consen 111 ------------------IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFD 172 (604)
T ss_pred ------------------HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcch
Confidence 23333445678899999999 89999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+++++.||+.||+|||++|||||||||+|||++.+++++|+|||.|+.+.+.
T Consensus 173 e~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 173 ETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999999999999999999999999999999999999988654
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=251.84 Aligned_cols=154 Identities=31% Similarity=0.504 Sum_probs=142.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|...+.||+|+|+.+|.+... ++++.||+|++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~------------------------------------------ 54 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKK------------------------------------------ 54 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehH------------------------------------------
Confidence 56999999999999999999853 67899999999886
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
..........+.+|++|.+.++|||||++|++|++.+++|||+|+|+.++|..++++.++++|..+
T Consensus 55 --------------~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEa 120 (592)
T KOG0575|consen 55 --------------LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEA 120 (592)
T ss_pred --------------HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHH
Confidence 233445667799999999999999999999999999999999999999999999998899999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+++++||+.||.|||+++|+|||||..|++++.+.++||+|||+|..+..+
T Consensus 121 ry~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 121 RYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred HHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999999999999999999999999999999999999988744
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=239.43 Aligned_cols=154 Identities=33% Similarity=0.512 Sum_probs=138.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++.+....||+|..|.||++.+. .+++.+|+|++.-
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~----------------------------------------- 114 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILL----------------------------------------- 114 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecc-----------------------------------------
Confidence 4567788899999999999999966 5689999999832
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-eEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
..+...++++.+|+++++.++||+||.+|+.|..++ .++|+||||++|||.++++..+++++
T Consensus 115 -----------------~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E 177 (364)
T KOG0581|consen 115 -----------------NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPE 177 (364)
T ss_pred -----------------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCH
Confidence 123456678999999999999999999999999998 59999999999999999998889999
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..+..++.+++.||.|||+ ++||||||||+|||++..|.|||||||.++.+.++
T Consensus 178 ~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 178 PVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred HHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999999999995 99999999999999999999999999999887653
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=241.50 Aligned_cols=153 Identities=31% Similarity=0.581 Sum_probs=140.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+.+.||+|+||.|.++.. ...++.||||.+++.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e-~~sgR~VAiKsIrKd----------------------------------------- 89 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYE-HKSGREVAIKSIRKD----------------------------------------- 89 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhh-ccCCcEeehhhhhhh-----------------------------------------
Confidence 35788889999999999999984 356899999999886
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
++.+....-++.+|++||..++||||+.+|.+|+..+.+.|||||..+|.|++++.+.+.+++..
T Consensus 90 ---------------kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErE 154 (668)
T KOG0611|consen 90 ---------------KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSERE 154 (668)
T ss_pred ---------------hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHH
Confidence 45556667789999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.+++||.+|+.|||.++++|||||.+|||+|.++++||+|||++-.+.
T Consensus 155 aRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 155 ARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred HHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999999999999999999999999999999999986543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=228.19 Aligned_cols=152 Identities=26% Similarity=0.469 Sum_probs=131.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|+....+|+|+||.|++++ .+++|+.||||.+....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCr-nk~TgqIVAIKkF~Ese----------------------------------------- 39 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCR-NKDTGQIVAIKKFVESE----------------------------------------- 39 (396)
T ss_pred cHHhhhhccccCcceEEEEec-cCCcccEEEEEeeccCC-----------------------------------------
Confidence 467788899999999999998 55889999999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
.+....+-.++|+.+|++++|||+|.+..+|.....+++|+|||+. ++.+.+.+ ...+++..
T Consensus 40 ----------------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~ 102 (396)
T KOG0593|consen 40 ----------------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSEL 102 (396)
T ss_pred ----------------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHH
Confidence 1122334578999999999999999999999999999999999954 55555554 45699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
++.++.|++.|+.|||++++|||||||+|||++.+|.+||||||+|+.+..|
T Consensus 103 vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 103 VKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred HHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9999999999999999999999999999999999999999999999988743
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=241.89 Aligned_cols=151 Identities=28% Similarity=0.484 Sum_probs=133.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+++.+|.|+||.||+++.. .+++.||||.+++.-+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~--------------------------------------- 48 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFY--------------------------------------- 48 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhc---------------------------------------
Confidence 568999999999999999999954 6688899999876521
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeeeeccc-eEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
.-...--++|+..|++++ ||||+++++++.+++ .+|+||||+ ..+|+++++.+ +.|+
T Consensus 49 -------------------s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fs 108 (538)
T KOG0661|consen 49 -------------------SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFS 108 (538)
T ss_pred -------------------cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCC
Confidence 112233578999999998 999999999999888 999999999 88999999865 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+||.+.+
T Consensus 109 e~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 109 ESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 999999999999999999999999999999999999888999999999998853
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.57 Aligned_cols=155 Identities=25% Similarity=0.445 Sum_probs=133.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..+.|+.++.||+|+||.||++++. .+++.||+|.+....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~--------------------------------------- 154 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDN--------------------------------------- 154 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeeccc---------------------------------------
Confidence 5567888899999999999999954 679999999886531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcC-CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKG-NF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l 303 (362)
..........+|+.||++++||||+++.+...+. ..+|+|+||+ ..+|.-++...+ .|
T Consensus 155 ------------------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~p~vkf 215 (560)
T KOG0600|consen 155 ------------------EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSSPGVKF 215 (560)
T ss_pred ------------------CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcCCCccc
Confidence 1122334467999999999999999999987665 6899999999 679998887743 69
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
++.+++.+|.|++.||+|||++||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 216 t~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 216 TEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999999999999999999999999999999999999999999999999776543
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=217.33 Aligned_cols=153 Identities=27% Similarity=0.453 Sum_probs=135.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|...+.+|+|.||.||++++. .+++.||||.++.++..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~k--------------------------------------- 41 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAK--------------------------------------- 41 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccc---------------------------------------
Confidence 46777889999999999999955 57899999999876321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~ 307 (362)
........+|+..|+.++||||+.+.++|.+.+.+.+|+||+ ..+|...++... .++..+
T Consensus 42 ------------------dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~ 102 (318)
T KOG0659|consen 42 ------------------DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPAD 102 (318)
T ss_pred ------------------cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHH
Confidence 122344689999999999999999999999999999999999 779999998654 589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
++.++.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.++.
T Consensus 103 iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 103 IKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred HHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99999999999999999999999999999999999999999999999988765
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=232.17 Aligned_cols=156 Identities=32% Similarity=0.563 Sum_probs=137.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.....|.+.+.||+|+||.|+.+.+. .+++.+|+|++.+....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~------------------------------------ 56 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVS------------------------------------ 56 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhccc------------------------------------
Confidence 35789999999999999999999865 45789999977654110
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
... ......+.+|+.+++.+. ||||++++.++.....+|+||||+.||+|.+++.+.++++
T Consensus 57 -----------------~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~ 118 (370)
T KOG0583|consen 57 -----------------SKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLK 118 (370)
T ss_pred -----------------ccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCC
Confidence 001 123345668999999998 9999999999999999999999999999999999988999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~ 356 (362)
+..++.+++|+++|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 119 E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 119 EDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred hHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999999999999999999999 99999999999877
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=230.03 Aligned_cols=166 Identities=28% Similarity=0.466 Sum_probs=135.1
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
....+++|.++..||+|.||.|.++++.. .++.||||++.+..+.........
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~-------------------------- 144 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQ-------------------------- 144 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccc--------------------------
Confidence 34578999999999999999999999664 588999999987633221100000
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+.+|+.+|+++.|||||+++.+..++ +.+|+|+|||..|.+...-. .+
T Consensus 145 -------------------~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~ 204 (576)
T KOG0585|consen 145 -------------------PAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DK 204 (576)
T ss_pred -------------------cccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-Cc
Confidence 011112345789999999999999999999998765 67999999999888765332 34
Q ss_pred C-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 N-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 ~-l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+ +++.+++.|++.++.||+|||.+|||||||||+|+|++.+|++||+|||.+...
T Consensus 205 ~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 205 PELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence 4 899999999999999999999999999999999999999999999999999866
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=223.89 Aligned_cols=155 Identities=28% Similarity=0.473 Sum_probs=133.4
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+.+|++.++||.|+||+||+++.. .++..+|.|.+.-+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~--------------------------------------- 55 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFG--------------------------------------- 55 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchh---------------------------------------
Confidence 45678999999999999999999966 45888999987532
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeee-eeeccce-EEEEEeccCCcchHHHHHhc---
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYK-TFKDKKY-LYMLMESCLGGELWTILRDK--- 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~--- 300 (362)
..+....+.+..|+.+|++++||||+++|+ .+..+.. ++||||+|.+|+|.+.++..
T Consensus 56 ------------------~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~q 117 (375)
T KOG0591|consen 56 ------------------MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQ 117 (375)
T ss_pred ------------------hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhc
Confidence 123445677899999999999999999999 5655554 99999999999999998752
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHS--RN--IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~--~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+.+++..+|.++.|++.||.++|+ .. |+||||||.||+++.+|.+||+|||+++.+.+
T Consensus 118 kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 118 KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 359999999999999999999998 44 99999999999999999999999999998754
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=224.45 Aligned_cols=155 Identities=36% Similarity=0.688 Sum_probs=138.6
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
.+.++.|++++.||.|.-|.||+++..+ ++..+|+|++.+..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~------------------------------------- 114 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKES------------------------------------- 114 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHH-------------------------------------
Confidence 3457788999999999999999999664 56899999998762
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GN 302 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~ 302 (362)
........+...|.+||+.++||.++.+|..|+.+.+.|++||||+||+|..+.+++ +.
T Consensus 115 -------------------l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~ 175 (459)
T KOG0610|consen 115 -------------------LASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKR 175 (459)
T ss_pred -------------------HhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCc
Confidence 222334567888999999999999999999999999999999999999999999875 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++..+++|+..++.||+|||..|||+|||||+|||+..+|++.|+||.++...
T Consensus 176 fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 176 FSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999999999999999999999999999999999999999998765
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=234.69 Aligned_cols=155 Identities=39% Similarity=0.711 Sum_probs=137.5
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.++.+||+|+||.|+++...+ +++.+|||+++|+++..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~---------------------------------- 408 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQ---------------------------------- 408 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceec----------------------------------
Confidence 4578999999999999999999999664 57799999999985543
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
.......+.|..|+... +||.++.++.+|+.++++|+||||+.||++..+.+ .+.|
T Consensus 409 ----------------------~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-~~~F 465 (694)
T KOG0694|consen 409 ----------------------RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH-TDVF 465 (694)
T ss_pred ----------------------cccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe-cccc
Confidence 33445678899998887 59999999999999999999999999999555443 3679
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+++|+..++.||.|||++||||||||.+|||+|.+|++||+|||+|+...
T Consensus 466 ~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 466 SEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999999999999999999999999999999999999999999764
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=218.22 Aligned_cols=155 Identities=23% Similarity=0.344 Sum_probs=133.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.....|++|+||.||++++. .+++.||+|.++...
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmek--------------------------------------- 113 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEK--------------------------------------- 113 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccC-CcceeEEeeeccccc---------------------------------------
Confidence 5678899999999999999999954 568899999987541
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--ccceEEEEEeccCCcchHHHHHhcC-CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--DKKYLYMLMESCLGGELWTILRDKG-NF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~-~l 303 (362)
......-.-++|+.+|.+++|||||.+-.+.. .-+.+|+||||| ..+|..++..-+ +|
T Consensus 114 ------------------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-EhDLksl~d~m~q~F 174 (419)
T KOG0663|consen 114 ------------------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EHDLKSLMETMKQPF 174 (419)
T ss_pred ------------------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-HhhHHHHHHhccCCC
Confidence 01112223578999999999999999998764 446799999999 679999998754 79
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
....++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+||.+++|.
T Consensus 175 ~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 175 LPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred chHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999999999999999999999999999999999999999999999999998773
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=212.22 Aligned_cols=155 Identities=34% Similarity=0.530 Sum_probs=139.7
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-.+++|.+.+.||.|.||.||++... .++..+|+|++.+.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi------------------------------------- 60 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQI------------------------------------- 60 (281)
T ss_pred cchhhccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHH-------------------------------------
Confidence 36889999999999999999999854 5678899999988742
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHH--hcCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR--DKGNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~l 303 (362)
......+++.+|++|.+.++||||.++|++|-+...+|+++||.++|++...+. ...++
T Consensus 61 -------------------~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f 121 (281)
T KOG0580|consen 61 -------------------LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRF 121 (281)
T ss_pred -------------------HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccc
Confidence 223345678999999999999999999999999999999999999999999998 45679
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|+|.+++|||||||+|+|++.++.+|++|||.+..-.
T Consensus 122 ~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 122 DEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred cccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999999999999999999999999999999999999999987653
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=230.96 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=136.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.+|+|+||.||+++++ .+.+.||+|.+.|..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~g----------------------------------------- 39 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSG----------------------------------------- 39 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcC-----------------------------------------
Confidence 57888899999999999999854 568899999987742
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
......+.+.+|++|++.++||||+.++++|+...++|+|+||+.| +|..++...+.++++.+
T Consensus 40 ----------------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v 102 (808)
T KOG0597|consen 40 ----------------RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQV 102 (808)
T ss_pred ----------------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHH
Confidence 1234456789999999999999999999999999999999999955 99999999999999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.+++.||.|||+++|+|||+||.|||+...|.+|+||||+|+-..
T Consensus 103 ~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 103 RAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred HHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 9999999999999999999999999999999999999999999998664
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=227.67 Aligned_cols=152 Identities=39% Similarity=0.680 Sum_probs=135.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADM---------------------------------------- 39 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4588999999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|+.++..++||||+++++.+.+...+|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~ 103 (363)
T cd05628 40 ----------------LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET 103 (363)
T ss_pred ----------------HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHH
Confidence 1122335678899999999999999999999999999999999999999999988888999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+|+.+.
T Consensus 104 ~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 104 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred HHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=224.69 Aligned_cols=158 Identities=43% Similarity=0.792 Sum_probs=139.0
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.+.+.||+|+||.||++.+.......+|+|.+.+...
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~------------------------------------ 69 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI------------------------------------ 69 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh------------------------------------
Confidence 34678999999999999999999986655556899998865311
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||+++++|.+++.+.+.++
T Consensus 70 --------------------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~ 129 (340)
T PTZ00426 70 --------------------IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129 (340)
T ss_pred --------------------hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence 112233457889999999999999999999999999999999999999999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+..
T Consensus 130 ~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999999999999999999999999999999999999987643
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=218.19 Aligned_cols=150 Identities=32% Similarity=0.504 Sum_probs=131.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|...+.||+|+||.||++.+.. +++..|+|.+...+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~---------------------------------------- 54 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELED---------------------------------------- 54 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC-CCcceeeeeeeccc----------------------------------------
Confidence 5668889999999999999999654 47889999875321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--eEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
....+.+.+|+.+|.+++|||||++++...... .++++|||+++|+|.+++.+.+ .++
T Consensus 55 -------------------~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~ 115 (313)
T KOG0198|consen 55 -------------------SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLP 115 (313)
T ss_pred -------------------chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCC
Confidence 001456889999999999999999999754443 6999999999999999999876 799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~ 357 (362)
++.++.+.+|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 116 E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 116 EPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999999999999999999999999 7999999999998776
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=223.56 Aligned_cols=156 Identities=46% Similarity=0.794 Sum_probs=138.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------------------- 56 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREI------------------------------------- 56 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHH-------------------------------------
Confidence 46789999999999999999999865 4578899999865311
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+++.+|++|||+++++|.+.+.+.+.+++
T Consensus 57 -------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 117 (329)
T PTZ00263 57 -------------------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117 (329)
T ss_pred -------------------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCH
Confidence 1122345678899999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999999999999999999999999999999999987654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=227.84 Aligned_cols=151 Identities=36% Similarity=0.705 Sum_probs=134.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+++.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEM---------------------------------------- 39 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4578899998865311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+++++|+||||+++++|.+++...+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~ 103 (377)
T cd05629 40 ----------------FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT 103 (377)
T ss_pred ----------------HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence 1122345678899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 104 ~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999999999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=225.67 Aligned_cols=152 Identities=41% Similarity=0.748 Sum_probs=135.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||.|+||.||++.+. .+++.+|+|++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------------------------------- 39 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEM---------------------------------------- 39 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHh----------------------------------------
Confidence 47999999999999999999965 4578899999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~ 103 (364)
T cd05599 40 ----------------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET 103 (364)
T ss_pred ----------------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHH
Confidence 1112334577899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 104 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 104 RFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=229.28 Aligned_cols=154 Identities=31% Similarity=0.481 Sum_probs=140.7
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..++-|++.+.||.|+-|.|.++++. .+|+.+|||++.+.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~--------------------------------------- 48 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKR--------------------------------------- 48 (786)
T ss_pred ccccceeccccccCCCCceehhhhcc-cccceeEEEeeccc---------------------------------------
Confidence 35788999999999999999999954 67999999999775
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
..........+.+|+.+|+.+.|||++++|++|++..++|+|.||++||.|++++-+.+++++
T Consensus 49 -----------------~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e 111 (786)
T KOG0588|consen 49 -----------------SELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPE 111 (786)
T ss_pred -----------------cccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCC
Confidence 123344556789999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+..+++||+.|+.|||..+|+|||+||+|+|++..+++||+|||+|..-
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 999999999999999999999999999999999999999999999999643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.28 Aligned_cols=151 Identities=36% Similarity=0.653 Sum_probs=134.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+++.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~---------------------------------------- 39 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDV---------------------------------------- 39 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHh----------------------------------------
Confidence 36889999999999999999855 4688999999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~ 103 (381)
T cd05626 40 ----------------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA 103 (381)
T ss_pred ----------------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHH
Confidence 1222345688999999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 104 ~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=225.69 Aligned_cols=151 Identities=36% Similarity=0.690 Sum_probs=134.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~---------------------------------------- 39 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADV---------------------------------------- 39 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHH----------------------------------------
Confidence 47999999999999999999865 4588999999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++.+.+++.+|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~ 103 (376)
T cd05598 40 ----------------LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA 103 (376)
T ss_pred ----------------HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence 1112235577899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+|..+
T Consensus 104 ~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=215.35 Aligned_cols=150 Identities=26% Similarity=0.414 Sum_probs=128.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|..++.+|+|+||.||+++.. .+++.||+|.++-..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~----------------------------------------- 48 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEF----------------------------------------- 48 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccc-----------------------------------------
Confidence 34555667999999999999955 567899999886431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcc-eeeeeeeeeccc------eEEEEEeccCCcchHHHHHhcC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF-IVKLYKTFKDKK------YLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.+........+|+.+++.++|+| |+.+++++.... .+++|+||+ ..+|.+++....
T Consensus 49 ----------------~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~ 111 (323)
T KOG0594|consen 49 ----------------EEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLP 111 (323)
T ss_pred ----------------cccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhcc
Confidence 00123455689999999999999 999999987766 899999999 789999998754
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ----NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ----~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...++.+++|++.||+|||+++|+||||||+|||++++|.+||+|||+|+-+.
T Consensus 112 ~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 112 KKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 47889999999999999999999999999999999999999999999999998664
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=225.44 Aligned_cols=151 Identities=36% Similarity=0.668 Sum_probs=134.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+++.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~---------------------------------------- 39 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDV---------------------------------------- 39 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHh----------------------------------------
Confidence 36889999999999999999855 4578899999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++.+.+++.+|+||||+++|+|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~ 103 (382)
T cd05625 40 ----------------LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA 103 (382)
T ss_pred ----------------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence 1122345678899999999999999999999999999999999999999999988778999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 104 ~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=217.77 Aligned_cols=153 Identities=48% Similarity=0.816 Sum_probs=134.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... .+++.+|+|.+.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEV---------------------------------------- 39 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4578899998864311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+...+|+||||+++++|.+++...+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 103 (291)
T cd05612 40 ----------------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG 103 (291)
T ss_pred ----------------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHH
Confidence 1112335578899999999999999999999999999999999999999999988888999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 104 ~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=222.93 Aligned_cols=150 Identities=35% Similarity=0.683 Sum_probs=136.5
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
-|..++.||-|+||+|-++... |+..-||+|.+.|.|++.++.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~rnQ------------------------------------ 672 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLMRNQ------------------------------------ 672 (1034)
T ss_pred ceEEEeeecccccceeEEEeec-chhhHHHHhhhHHHHHHhhhh------------------------------------
Confidence 3667788999999999999854 678889999999998765432
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
..++..|..||...+++-||++|.+|++.+.+|+||||++||++..++.+.+-|+++.++
T Consensus 673 --------------------vaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LAR 732 (1034)
T KOG0608|consen 673 --------------------VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLAR 732 (1034)
T ss_pred --------------------hhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHH
Confidence 244677999999999999999999999999999999999999999999998999999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++..+..|+++.|..|+|||||||+|||||.+|++||+|||+|.-+
T Consensus 733 FYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 733 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred HHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999999999999999999999999999999999999644
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=220.32 Aligned_cols=150 Identities=25% Similarity=0.416 Sum_probs=130.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.++.+...+|.|+||+||.+.+.+. ..+|+|.+...+.-
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~--------------------------------------- 79 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFD--------------------------------------- 79 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCc--eeEEEEEecchhcC---------------------------------------
Confidence 3444555699999999999997753 23999998765321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-eEEEEEeccCCcchHHHHHh--cCCCCH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRD--KGNFDD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~l~~ 305 (362)
....+.+.+|+.+|..++||||+++++++..+. .+.+||||+++|+|.+++.. ...++.
T Consensus 80 ------------------~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~ 141 (362)
T KOG0192|consen 80 ------------------DESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPL 141 (362)
T ss_pred ------------------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCH
Confidence 111577999999999999999999999998887 79999999999999999987 567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCC-cEeecCCCCcEEecCCC-cEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSG-YVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~-iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~ 357 (362)
..+..++.+|+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus 142 ~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 142 KVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999999999999 99999999999999998 99999999998654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=221.06 Aligned_cols=152 Identities=39% Similarity=0.695 Sum_probs=135.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++... .+++.+|+|.+.+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADM---------------------------------------- 39 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4578899999865321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|+.++..++||||+++++.+.+.+.+|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~ 103 (360)
T cd05627 40 ----------------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT 103 (360)
T ss_pred ----------------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHH
Confidence 1122345678899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 104 ~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1113|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=209.61 Aligned_cols=211 Identities=24% Similarity=0.380 Sum_probs=167.9
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
+++..-||.+| +++++.+++++|..+++++|+.|++|||.|++||||.+|++.|++. ...+..++||..|||+
T Consensus 123 a~r~~~LF~~L-d~eq~~~v~dam~~~~v~~G~~Vi~qGdeGd~fYvI~kGt~dVyv~------~~~v~~~~~g~sFGEl 195 (368)
T KOG1113|consen 123 AFRKNLLFANL-DDEQLSQVLDAMFEKRVKAGETVIKQGDEGDNFYVIDKGTFDVYVN------GTYVTTYSPGGSFGEL 195 (368)
T ss_pred HHHhccccccC-CHHHHHHHHHhhceeeecCCcEEEecCCcCCcEEEEecceEEEEEC------CeEEeeeCCCCchhhh
Confidence 46778899999 9999999999999999999999999999999999999999999965 2569999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhhccccCcEEEEEec-------
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLG------- 158 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg------- 158 (362)
||+++.||.||+.|+ +++.+|.+++..|++++..+....++++.++.....+.+.+.. .++-++...++
T Consensus 196 ALmyn~PRaATv~a~--t~~klWgldr~SFrrIi~~s~~kkrkMy~~~l~s~pil~~l~k--~er~kv~dal~~k~y~~G 271 (368)
T KOG1113|consen 196 ALMYNPPRAATVVAK--SLKKLWGLDRTSFRRIIMKSCIKKRKMYEPFLESVPILESLEK--LERAKVADALGTKSYKDG 271 (368)
T ss_pred HhhhCCCcccceeec--cccceEEEeeceeEEEeeccchhhhhhhhhhhhcchhhHHHHH--HHHHhhhcccceeeccCC
Confidence 999999999999999 5599999999999999999999889998888766665554432 11112222222
Q ss_pred -----ccceecEEEEEecCC-----CCCceeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 159 -----VGGFGRVELVQIAGD-----PSRSFALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 159 -----~G~~g~v~~~~~~~~-----~~~~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
+|.-|..+...-.|. ...-+.+ .+.++++|+ .+.+|.|++.|.++ ++|.++|++.|++++|+
T Consensus 272 ~~Vi~qg~~ge~f~~i~eGEvdv~~~~~~v~v-kl~~~dyfge~al~~~~pr~Atv~a~~~--~kc~~~dk~~ferllgp 348 (368)
T KOG1113|consen 272 ERVIVQGDQGEHFYIIEEGEVDVLKKRDGVEV-KLKKGDYFGELALLKNLPRAATVVAKGR--LKCAKLDKPRFERLLGP 348 (368)
T ss_pred ceEEeccCCcceEEEecccccchhhccCCeEE-EechhhhcchHHHHhhchhhceeeccCC--ceeeeeChHHHHHHhhH
Confidence 222333333322211 0112555 567788888 46899999999876 89999999999999999
Q ss_pred hHHhhhh
Q psy14740 224 LDEIRTK 230 (362)
Q Consensus 224 ~~~~~~~ 230 (362)
-.++.++
T Consensus 349 c~dilkr 355 (368)
T KOG1113|consen 349 CQDILKR 355 (368)
T ss_pred HHHHHHh
Confidence 8877664
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=218.70 Aligned_cols=151 Identities=40% Similarity=0.725 Sum_probs=134.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~---------------------------------------- 39 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLL---------------------------------------- 39 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4578899999865411
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|+.++..++||||+++++++...+..|+||||+++++|.+++...+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~ 103 (333)
T cd05600 40 ----------------FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA 103 (333)
T ss_pred ----------------hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHH
Confidence 1112335678899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 104 RFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 999999999999999999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=219.84 Aligned_cols=153 Identities=37% Similarity=0.653 Sum_probs=134.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~-------------------------------------- 81 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEM-------------------------------------- 81 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHh--------------------------------------
Confidence 4678999999999999999999865 4578899999865311
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||+++++|.+++.. ..+++.
T Consensus 82 ------------------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~ 142 (370)
T cd05621 82 ------------------IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEK 142 (370)
T ss_pred ------------------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHH
Confidence 1112234567899999999999999999999999999999999999999999875 468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 143 ~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 143 WAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred HHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=221.58 Aligned_cols=150 Identities=31% Similarity=0.490 Sum_probs=132.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.+++++.||+|.||.|+++.+.+ ...+|+|.++.+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~--~~~vavk~ik~~~------------------------------------------ 242 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG--STKVAVKTIKEGS------------------------------------------ 242 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC--CCcccceEEeccc------------------------------------------
Confidence 34566789999999999999875 4468999886642
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh--cCCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~ 307 (362)
...+.+.+|+.+|++++|+|||++++++..++.+||||||++.|+|.++++. ...+...+
T Consensus 243 ------------------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~ 304 (468)
T KOG0197|consen 243 ------------------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQ 304 (468)
T ss_pred ------------------cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHH
Confidence 2235577999999999999999999999988899999999999999999987 34589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
...++.||++|++||+++++|||||...|||++.+..+||+|||+||.+.++.|
T Consensus 305 Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 305 LLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred HHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999999999999999999999999999999999999999997666665
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=216.05 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=178.7
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCe---EEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDT---FFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~---~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
.++..++|-++++.++.+.++.. .|+++++.-++.+. .+.|++ |...
T Consensus 45 ~~~~~~~yHG~l~red~~~lL~~-------~GDfLvR~s~~~~~~~~~~~vlS----v~~~------------------- 94 (474)
T KOG0194|consen 45 DLRELPYYHGLLPREDAEKLLKN-------DGDFLVRASEPKEGEKREFVVLS----VKWS------------------- 94 (474)
T ss_pred HhhcCccccccccHhHHHHHhCC-------CCceEEEeecccCCcceeEEEEE----EEee-------------------
Confidence 35667999999899999888876 89999988777542 111221 1110
Q ss_pred ecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhh----hHHhhhhhhhhhccccCcEEEEEec
Q psy14740 83 GEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET----SERRRLNEEFRSLRLSDLRVITTLG 158 (362)
Q Consensus 83 GE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lg 158 (362)
.....+..-+... .+ ..+......|..+..-..........-. -....+..+--++.-++..+.+.||
T Consensus 95 -----~~~~~~h~vi~~~--~~-~~~~~~~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLG 166 (474)
T KOG0194|consen 95 -----VFKKIKHYVIKRN--GN-LFFFEGLRKFPTISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLG 166 (474)
T ss_pred -----cCCceeEEEEEEc--CC-eeEEeccccCCcHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceee
Confidence 0001112233333 22 3344444444433322222211111000 0112222222233445666778999
Q ss_pred ccceecEEEEEecCCCC---CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 159 VGGFGRVELVQIAGDPS---RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 159 ~G~~g~v~~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
+|.||+||.+......+ ..||+|.....
T Consensus 167 eGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~------------------------------------------------- 197 (474)
T KOG0194|consen 167 EGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS------------------------------------------------- 197 (474)
T ss_pred cccccEEEEEEEEecCCceeeeeEEEeeccc-------------------------------------------------
Confidence 99999999998765433 23788876532
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~q 314 (362)
..........+++|+++|++++||||+++|++......+++|||+|+||+|.+++++++. ++..+...++.+
T Consensus 198 -------~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~ 270 (474)
T KOG0194|consen 198 -------SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYD 270 (474)
T ss_pred -------ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHH
Confidence 112234567799999999999999999999999999999999999999999999998764 999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+.||+|||++++|||||-.+|+|++.++.+||+|||+++.-
T Consensus 271 AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 271 AARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred HHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999999999999999999999998753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=215.75 Aligned_cols=144 Identities=35% Similarity=0.631 Sum_probs=127.6
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (323)
T cd05571 2 LLGKGTFGKVILVREK-ATGKYYAMKILKKEVI----------------------------------------------- 33 (323)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4588999999865311
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql 315 (362)
........+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+.+++..++.++.|+
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi 104 (323)
T cd05571 34 ---------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104 (323)
T ss_pred ---------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 11223345678999999999999999999999999999999999999999999888889999999999999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 316 VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 316 ~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 105 VSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred HHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=214.65 Aligned_cols=152 Identities=29% Similarity=0.616 Sum_probs=133.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... .+++.+|+|++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEM---------------------------------------- 39 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999855 4578899999865311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
........+.+|..++..++||||+++++++.+++++|+||||+++++|.+++.+ ...+++..
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~ 103 (331)
T cd05597 40 ----------------LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103 (331)
T ss_pred ----------------hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHH
Confidence 1112334577899999999999999999999999999999999999999999976 35699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred HHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=216.91 Aligned_cols=154 Identities=37% Similarity=0.663 Sum_probs=134.4
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~------------------------------------- 81 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEM------------------------------------- 81 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHh-------------------------------------
Confidence 35689999999999999999999855 5678899999865311
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++.+..++.+|+||||+++++|.+++.. ..+++
T Consensus 82 -------------------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~ 141 (371)
T cd05622 82 -------------------IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPE 141 (371)
T ss_pred -------------------hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCH
Confidence 1112234467899999999999999999999999999999999999999999875 45899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=214.09 Aligned_cols=152 Identities=31% Similarity=0.648 Sum_probs=132.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEM---------------------------------------- 39 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHH----------------------------------------
Confidence 47999999999999999999855 4578899998865311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
........+..|..++..++||||+++++++.++++.|+||||+++++|.+++.+ ...+++..
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~ 103 (331)
T cd05624 40 ----------------LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103 (331)
T ss_pred ----------------HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHH
Confidence 1112234577889999999999999999999999999999999999999999986 45789999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 104 ARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=217.25 Aligned_cols=154 Identities=40% Similarity=0.711 Sum_probs=136.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDM---------------------------------------- 39 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHH----------------------------------------
Confidence 47899999999999999999865 4588999999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|+.++..++||||+++++++.+++++|+||||+++++|.+++.+.+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 103 (350)
T cd05573 40 ----------------IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA 103 (350)
T ss_pred ----------------hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHH
Confidence 1112335578899999999999999999999999999999999999999999988778999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+...
T Consensus 104 ~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=209.25 Aligned_cols=146 Identities=28% Similarity=0.461 Sum_probs=123.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
-.|+-.+.+|.|+||.||.+.... +++++|||...+...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r---------------------------------------- 62 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR---------------------------------------- 62 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCCC----------------------------------------
Confidence 346778899999999999999664 488999998765421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHh----
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRD---- 299 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~---- 299 (362)
---+|..+|+.++|||||++..+|... -+..+||||+ ..+|.+.++.
T Consensus 63 -----------------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~ 118 (364)
T KOG0658|consen 63 -----------------------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRA 118 (364)
T ss_pred -----------------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhc
Confidence 124699999999999999998887532 2567999999 6789998874
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecCCC
Q psy14740 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 300 ~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~~ 359 (362)
+..++...++.++.|++.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+..+
T Consensus 119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 119 NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 4679999999999999999999999999999999999999975 99999999999988654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=217.40 Aligned_cols=154 Identities=39% Similarity=0.671 Sum_probs=134.4
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------------------- 81 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEM------------------------------------- 81 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-------------------------------------
Confidence 35688999999999999999999855 4678899999865311
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+..|+.+++.++||||+++++++.+++.+|+||||+++++|.+++.. ..+++
T Consensus 82 -------------------~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~ 141 (370)
T cd05596 82 -------------------IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPE 141 (370)
T ss_pred -------------------hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCH
Confidence 1112234467899999999999999999999999999999999999999998865 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=213.25 Aligned_cols=153 Identities=35% Similarity=0.589 Sum_probs=134.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+...||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVL---------------------------------------- 39 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHh----------------------------------------
Confidence 46899999999999999999855 4688999999865411
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.+. ..+++..
T Consensus 40 ----------------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~ 103 (330)
T cd05601 40 ----------------LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM 103 (330)
T ss_pred ----------------hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHH
Confidence 11223355778999999999999999999999999999999999999999999876 5799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred HHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=207.52 Aligned_cols=153 Identities=26% Similarity=0.389 Sum_probs=137.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||.|.-+.||+++.. ..++.||||++.-.+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inLEk--------------------------------------- 63 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINLEK--------------------------------------- 63 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeehhh---------------------------------------
Confidence 5688999999999999999999865 557899999986542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
.+.....+.+|+..|+.++||||++++.+|..+..+|+||.|+.+||+.++++.. ..++
T Consensus 64 -------------------c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~ 124 (516)
T KOG0582|consen 64 -------------------CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLE 124 (516)
T ss_pred -------------------hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccccc
Confidence 1223567899999999999999999999999999999999999999999999874 3499
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 125 E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 125 EASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999999999999999999999999999999999999998866543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=214.20 Aligned_cols=144 Identities=35% Similarity=0.648 Sum_probs=127.1
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------------------------------------- 33 (323)
T cd05595 2 LLGKGTFGKVILVREK-ATGRYYAMKILRKEVI----------------------------------------------- 33 (323)
T ss_pred eeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4578899999865311
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql 315 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|..++...+.+++..++.++.|+
T Consensus 34 ---------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi 104 (323)
T cd05595 34 ---------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104 (323)
T ss_pred ---------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH
Confidence 11223345678999999999999999999999999999999999999999999887789999999999999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 316 VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 316 ~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 105 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred HHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=213.54 Aligned_cols=144 Identities=38% Similarity=0.654 Sum_probs=127.4
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~----------------------------------------------- 33 (328)
T cd05593 2 LLGKGTFGKVILVREK-ASGKYYAMKILKKEVI----------------------------------------------- 33 (328)
T ss_pred eeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999854 5588999999865311
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql 315 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|...+...+.+++..+..++.|+
T Consensus 34 ---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi 104 (328)
T cd05593 34 ---------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104 (328)
T ss_pred ---------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH
Confidence 11223356778999999999999999999999999999999999999999999887789999999999999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 316 VEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 316 ~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 105 VSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred HHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=207.15 Aligned_cols=150 Identities=24% Similarity=0.451 Sum_probs=131.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.|..++.+|.|+||.|..+.+. .+++.||||.+...
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~------------------------------------------- 58 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNP------------------------------------------- 58 (359)
T ss_pred eecccccccCcceeeEEEEEEc-CCCCEeehhhhhhh-------------------------------------------
Confidence 4455789999999999999855 56789999987531
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-----cceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-----KKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.......++..+|+.+|+.++|+||+.+++++.. -..+|+|+|++ +.+|.++++.+..++
T Consensus 59 --------------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~ 123 (359)
T KOG0660|consen 59 --------------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLT 123 (359)
T ss_pred --------------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcccc
Confidence 2234455778999999999999999999998865 35699999999 899999999987899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+++++.|++.||.|+|+.+|+|||+||.|++++.++.+||+|||+||...+
T Consensus 124 d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 124 DDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 999999999999999999999999999999999999999999999999998753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=211.66 Aligned_cols=143 Identities=41% Similarity=0.733 Sum_probs=126.7
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~------------------------------------------------- 30 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAH------------------------------------------------- 30 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHH-------------------------------------------------
Confidence 699999999999865 557889999986531
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVV 316 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~ 316 (362)
.........+..|+.+++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+..++.|++
T Consensus 31 -------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~ 103 (312)
T cd05585 31 -------IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL 103 (312)
T ss_pred -------hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 1112234557789999999999999999999999999999999999999999998878899999999999999
Q ss_pred HHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 317 EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 317 ~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 104 ~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 104 CALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred HHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 9999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=211.96 Aligned_cols=152 Identities=31% Similarity=0.643 Sum_probs=132.3
Q ss_pred CcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+|++.+.||+|+||.||++.... .+++.+|+|++.+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------------------------------------- 41 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL--------------------------------------- 41 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH---------------------------------------
Confidence 58899999999999999998643 4578899999865311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+..|+.++..+ +||||+++++++..++.+|++|||+++++|.+++...+.+++.
T Consensus 42 ----------------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 105 (332)
T cd05614 42 ----------------VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED 105 (332)
T ss_pred ----------------hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence 01112334577899999999 5999999999999999999999999999999999887789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 106 ~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred HHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=210.78 Aligned_cols=150 Identities=32% Similarity=0.600 Sum_probs=130.4
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++++.||+|+||.||++... .+++.+|+|++.+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~----------------------------------------- 38 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVI----------------------------------------- 38 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------
Confidence 5889999999999999999855 4578899999865411
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|..++..++| ++|+++++++...+.+|+||||+++++|.+++.....+++..+
T Consensus 39 ---------------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~ 103 (324)
T cd05587 39 ---------------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA 103 (324)
T ss_pred ---------------hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHH
Confidence 112233457788999999876 5688999999999999999999999999999988778999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 104 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=210.36 Aligned_cols=144 Identities=38% Similarity=0.665 Sum_probs=126.4
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~----------------------------------------------- 33 (325)
T cd05594 2 LLGKGTFGKVILVKEK-ATGRYYAMKILKKEVI----------------------------------------------- 33 (325)
T ss_pred eeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4688999999865311
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql 315 (362)
........+..|+.+++.++||||+++++++..++.+|+||||+++++|..++...+.+++..+..++.|+
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi 104 (325)
T cd05594 34 ---------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104 (325)
T ss_pred ---------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 11122345678999999999999999999999999999999999999999999887789999999999999
Q ss_pred HHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 316 VEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 316 ~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred HHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999997 79999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=188.14 Aligned_cols=151 Identities=26% Similarity=0.452 Sum_probs=131.3
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.-.+.||+|+||+|+++++ .++++.+|+|.++-.+
T Consensus 3 ~ydkmekigegtygtvfkarn-~~t~eivalkrvrldd------------------------------------------ 39 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARN-RETHEIVALKRVRLDD------------------------------------------ 39 (292)
T ss_pred chHHHHhhcCCcceeeEeccc-CCccceEEEEEEeccC------------------------------------------
Confidence 344557799999999999984 4678999999876431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~ 308 (362)
.+....+...+|+-+++.++|.||++++++.-.+..+.+|+||| ..+|..+..+ ++.++.+.+
T Consensus 40 ---------------ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~ 103 (292)
T KOG0662|consen 40 ---------------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIV 103 (292)
T ss_pred ---------------CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHH
Confidence 12334456789999999999999999999999999999999999 7789988875 567999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+.++.|++.||.|+|+++++|||+||.|+||+.+|.+||+|||+|+-++-|
T Consensus 104 rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 104 RSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 999999999999999999999999999999999999999999999977543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=205.90 Aligned_cols=151 Identities=25% Similarity=0.373 Sum_probs=130.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.+.+.||.|+||.||++... .+++.+|+|.+....
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 42 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEH--------------------------------------- 42 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccc---------------------------------------
Confidence 4688999999999999999999855 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
.......+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++...+ .+++
T Consensus 43 -------------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~ 102 (288)
T cd07871 43 -------------------EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSM 102 (288)
T ss_pred -------------------cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCH
Confidence 01112346789999999999999999999999999999999996 58998887544 4789
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 103 HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9999999999999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=214.20 Aligned_cols=156 Identities=33% Similarity=0.512 Sum_probs=141.8
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
......|.++..||+|.|+.|.++.+. .++..||||.+.+...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~l------------------------------------ 94 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQL------------------------------------ 94 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhccc------------------------------------
Confidence 346888999999999999999999966 5688999999987532
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
+....+.+.+|+++|+.++||||++++.+...+..+|+||||+.+|.+.+++.+++.+.
T Consensus 95 ---------------------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~ 153 (596)
T KOG0586|consen 95 ---------------------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMK 153 (596)
T ss_pred ---------------------ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccch
Confidence 22334558899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|+.+|++|||+++|+|||||++|||++.+.++||+|||++..+..
T Consensus 154 e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 154 EKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred hhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999999999999999999999999999999999999999988753
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=233.71 Aligned_cols=154 Identities=36% Similarity=0.630 Sum_probs=139.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-++|.++++||.|+||.|.+++.. .+++.||+|+++|-....+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr----------------------------------- 116 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKR----------------------------------- 116 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhc-----------------------------------
Confidence 5688999999999999999999965 5688999999988543221
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
....-|..|..+|...+.+=|++++..|+++.++|+||||++||+|..++.+..++|+.
T Consensus 117 ---------------------~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~ 175 (1317)
T KOG0612|consen 117 ---------------------AETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPED 175 (1317)
T ss_pred ---------------------hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHH
Confidence 12245788999999999999999999999999999999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++++|+..|+.||.-+|+.|+|||||||+|||+|..|++||+|||.|-.+.
T Consensus 176 ~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 176 WARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred HHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999999999999999999999999999999999999997765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=210.65 Aligned_cols=147 Identities=39% Similarity=0.666 Sum_probs=128.1
Q ss_pred EEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 155 TTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
+.||+|+||.||++.... ..++.+|+|.+.+....
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~------------------------------------------- 38 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV------------------------------------------- 38 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-------------------------------------------
Confidence 579999999999998642 45788999998654210
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
........+..|+.+++.++||||+++++++..++.+|++|||+++++|.+++.+.+.+++..+..++
T Consensus 39 ------------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 106 (323)
T cd05584 39 ------------RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL 106 (323)
T ss_pred ------------hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHH
Confidence 11122345678999999999999999999999999999999999999999999888889999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 107 ~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 107 SEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=204.69 Aligned_cols=150 Identities=30% Similarity=0.559 Sum_probs=129.6
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|+..+.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~------------------------------------------ 38 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRI------------------------------------------ 38 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhh------------------------------------------
Confidence 788899999999999999865 4578899998865411
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+.+.++++|||+++++|.+.+... ..+++..+
T Consensus 39 --------------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~ 104 (285)
T cd05631 39 --------------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA 104 (285)
T ss_pred --------------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHH
Confidence 11112345678999999999999999999999999999999999999998877543 35899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 105 ~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 105 IFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred HHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 9999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=209.54 Aligned_cols=151 Identities=30% Similarity=0.625 Sum_probs=131.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... ..++.+|+|.+.+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEM---------------------------------------- 39 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHH----------------------------------------
Confidence 47899999999999999999865 4577899998865311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
........+..|+.++..++||+|+++++.+.+++.+|+||||+++|+|.+++.+ ...+++..
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~ 103 (332)
T cd05623 40 ----------------LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103 (332)
T ss_pred ----------------HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHH
Confidence 1111234467889999999999999999999999999999999999999999976 35689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 104 ~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=211.06 Aligned_cols=154 Identities=32% Similarity=0.525 Sum_probs=135.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-..|.+.+.||.|.||.||.+... .+++.+|+|.+.+...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~-------------------------------------- 73 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKL-------------------------------------- 73 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhc--------------------------------------
Confidence 3456889999999999999999955 5588999999987522
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+|+.+. ||||+.++++|++.+.+|+|||++.||.|.+.+... .+++
T Consensus 74 ------------------~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE 134 (382)
T KOG0032|consen 74 ------------------RGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSE 134 (382)
T ss_pred ------------------cccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCH
Confidence 11124466889999999998 999999999999999999999999999999988775 4999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC----CcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 135 ~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 135 RDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred HHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999999999999999999999999999643 4799999999998866
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=215.23 Aligned_cols=156 Identities=26% Similarity=0.484 Sum_probs=137.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|..++++|.|+||.++++++..+ ...+++|.+.-..
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~-~~~~vlK~I~l~~--------------------------------------- 41 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSD-DKLYVLKKINLEK--------------------------------------- 41 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccC-CceEEEEEEeccc---------------------------------------
Confidence 367899999999999999999997765 5578999876432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccce-EEEEEeccCCcchHHHHHhcC--CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKY-LYMLMESCLGGELWTILRDKG--NF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~--~l 303 (362)
.....+....+|..+++++.||||+.+.+.|..++. ++|||+||+||++.+.+++.+ .+
T Consensus 42 ------------------~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f 103 (426)
T KOG0589|consen 42 ------------------LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLF 103 (426)
T ss_pred ------------------cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccc
Confidence 122233467899999999999999999999998887 999999999999999998754 59
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
+++.+..++.|++.|+.|||+++|+|||||+.||++..++.|+|+|||+|+.+.++.
T Consensus 104 ~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 104 PEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred cHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999999999999999999999999999999999999999999887764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=210.56 Aligned_cols=151 Identities=30% Similarity=0.435 Sum_probs=126.4
Q ss_pred ccCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|++.+.||+|+||.||++.+. ...++.+|+|.+....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------------------------------ 49 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA------------------------------------ 49 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc------------------------------------
Confidence 357999999999999999999753 2345679999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc-ceEEEEEeccCCcchHHHHHhc-
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK-KYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.......+.+|+.++..+ +||||+++++++... +.+|++|||+++|+|.+++...
T Consensus 50 ----------------------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~ 107 (338)
T cd05102 50 ----------------------TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKR 107 (338)
T ss_pred ----------------------chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcc
Confidence 112234588999999999 899999999987654 4689999999999999988642
Q ss_pred -------------------------------------------------------------CCCCHHHHHHHHHHHHHHH
Q psy14740 301 -------------------------------------------------------------GNFDDATTRFYTACVVEAF 319 (362)
Q Consensus 301 -------------------------------------------------------------~~l~~~~~~~~~~ql~~al 319 (362)
.+++...+..++.|++.||
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 187 (338)
T cd05102 108 EFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187 (338)
T ss_pred hhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHH
Confidence 2367788899999999999
Q ss_pred HHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 320 DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 320 ~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 188 ~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 188 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred HHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 9999999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=207.52 Aligned_cols=150 Identities=33% Similarity=0.604 Sum_probs=130.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+...||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~----------------------------------------- 38 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVV----------------------------------------- 38 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------
Confidence 5889999999999999999865 4578899999865411
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
...........|..++..+ .||+|+++++++...+.+|+||||+++++|.+.+...+.+++..+
T Consensus 39 ---------------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~ 103 (323)
T cd05616 39 ---------------IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA 103 (323)
T ss_pred ---------------hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHH
Confidence 1112234456777887776 589999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred HHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=209.43 Aligned_cols=143 Identities=34% Similarity=0.632 Sum_probs=126.2
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~----------------------------------------------- 33 (329)
T cd05588 2 VIGRGSYAKVLLVELK-KTRRIYAMKVIKKELV----------------------------------------------- 33 (329)
T ss_pred eEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4578899999875411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|..++..+ +||||+++++++.+.+.+|+||||+++++|.+++.+.+.+++..++.++.|
T Consensus 34 ---------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~q 104 (329)
T cd05588 34 ---------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE 104 (329)
T ss_pred ---------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 1122334577899999888 799999999999999999999999999999999888788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++.
T Consensus 105 i~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 105 ISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-28 Score=201.51 Aligned_cols=153 Identities=29% Similarity=0.469 Sum_probs=133.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+.+.||+|.|+.|+++. .+.+++.+|+|+++-.
T Consensus 11 d~y~l~e~igkG~FSvVrRc~-~~~tg~~fa~kiin~~------------------------------------------ 47 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTK------------------------------------------ 47 (355)
T ss_pred hhhhHHHHHccCchHHHHHHH-hccchHHHHHHHhhhh------------------------------------------
Confidence 567778889999999999998 5578999999988543
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+.+|+.|.+.++||||+++++.+...++.|+|+|++.|++|..-+-...-+++..+
T Consensus 48 ---------------k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~a 112 (355)
T KOG0033|consen 48 ---------------KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 112 (355)
T ss_pred ---------------hhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHH
Confidence 12233667789999999999999999999999999999999999999999876665556899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~~ 359 (362)
-.+++||++||.|+|.++|+|||+||+|+++.+ ..-+||+|||+|..+.++
T Consensus 113 SH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 113 SHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred HHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999999999999999999999999999999964 345999999999988754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=205.33 Aligned_cols=149 Identities=25% Similarity=0.409 Sum_probs=128.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++... .+++.+|+|.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~---------------------------------------- 42 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQE---------------------------------------- 42 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEecccc----------------------------------------
Confidence 578999999999999999999855 457889999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
.......+.+|+.+++.++||||+++++++.+.+..|+||||+ .++|.+++... +.+++.
T Consensus 43 ------------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~ 103 (303)
T cd07869 43 ------------------EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE 103 (303)
T ss_pred ------------------ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCCCCCCHH
Confidence 0111234678999999999999999999999999999999999 56787777653 468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=208.08 Aligned_cols=144 Identities=37% Similarity=0.684 Sum_probs=123.7
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------------------------------------- 33 (316)
T cd05592 2 VLGKGSFGKVMLAELK-GTNEFFAIKALKKDVV----------------------------------------------- 33 (316)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999865 4578899999865411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
...........|..++.. .+||||+++++++..++.+|+||||+++++|..++...+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~q 104 (316)
T cd05592 34 ---------LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE 104 (316)
T ss_pred ---------hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 111223344566666665 4899999999999999999999999999999999988778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 105 i~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 105 IICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred HHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=208.24 Aligned_cols=146 Identities=41% Similarity=0.681 Sum_probs=127.6
Q ss_pred EEecccceecEEEEEec--CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 155 TTLGVGGFGRVELVQIA--GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
+.||+|+||.||++... ..+++.+|+|++.+...
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------------------------------------------- 37 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-------------------------------------------- 37 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--------------------------------------------
Confidence 56899999999998853 34678899998865310
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
.......+..|+.+++.++||||+++++++..++.+|+||||+++++|.+++.+...+++..++.++
T Consensus 38 -------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 104 (318)
T cd05582 38 -------------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 104 (318)
T ss_pred -------------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHH
Confidence 1112334678999999999999999999999999999999999999999999887789999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 105 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 105 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred HHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=198.92 Aligned_cols=160 Identities=26% Similarity=0.420 Sum_probs=135.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+..|...+.+|.|..+.|..+.+. .+++.+|+|++.-.. ..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~a--------------t~------------------------ 56 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTA--------------TT------------------------ 56 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecc--------------cc------------------------
Confidence 566777888999999999988855 567778888874321 00
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.. ..........-.+|++||+++ .||+|+++.++|+.+.++++|+|.++.|.|.+++.+.-.+++.
T Consensus 57 -----------~~--~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK 123 (411)
T KOG0599|consen 57 -----------ES--GETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEK 123 (411)
T ss_pred -----------cC--CccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHH
Confidence 00 011233445567899999997 8999999999999999999999999999999999987789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..+.+|+|++.|++|||.++|+||||||+|||++++.+++|+|||+|+++..+
T Consensus 124 ~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 124 ETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999998654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=207.26 Aligned_cols=150 Identities=33% Similarity=0.605 Sum_probs=129.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.....||+|+||.||++... .+++.+|+|++.+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------------------------------- 38 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVV----------------------------------------- 38 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------
Confidence 4778899999999999999855 4578899999865311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+..|..++..+. ||+|+++++++...+.+|+||||+++++|.+++...+.+++..+
T Consensus 39 ---------------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~ 103 (323)
T cd05615 39 ---------------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA 103 (323)
T ss_pred ---------------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHH
Confidence 11122345677888888875 57888999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 104 ~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 104 VFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=204.60 Aligned_cols=152 Identities=23% Similarity=0.358 Sum_probs=126.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCC---------------CCCceeeeeeccccccccccccccceeeeCCCCceEEEe
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD---------------PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVI 212 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~---------------~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l 212 (362)
-++|.+.+.||+|+||.||++.+... .+..+|+|.+...
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------------------------- 57 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-------------------------- 57 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--------------------------
Confidence 35789999999999999999975321 2235677765432
Q ss_pred ehhhHHhhccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcc
Q psy14740 213 DQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGE 292 (362)
Q Consensus 213 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 292 (362)
........+.+|+.++..++||||+++++++.+.+..+++|||+++++
T Consensus 58 --------------------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 105 (304)
T cd05096 58 --------------------------------ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105 (304)
T ss_pred --------------------------------CCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCc
Confidence 112234568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 293 LWTILRDKG-------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 293 L~~~l~~~~-------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
|.+++.... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~ 185 (304)
T cd05096 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185 (304)
T ss_pred HHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccc
Confidence 999886531 2566788999999999999999999999999999999999999999999999
Q ss_pred eecC
Q psy14740 354 KKLI 357 (362)
Q Consensus 354 ~~~~ 357 (362)
+.+.
T Consensus 186 ~~~~ 189 (304)
T cd05096 186 RNLY 189 (304)
T ss_pred eecc
Confidence 8653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=207.82 Aligned_cols=144 Identities=34% Similarity=0.629 Sum_probs=125.8
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (329)
T cd05618 2 VIGRGSYAKVLLVRLK-KTERIYAMKVVKKELV----------------------------------------------- 33 (329)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHh-----------------------------------------------
Confidence 5899999999999855 4578899999875411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|+.++..+ +||||+++++++..++.+|+||||+++++|..++...+.+++..++.++.|
T Consensus 34 ---------~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~q 104 (329)
T cd05618 34 ---------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 104 (329)
T ss_pred ---------cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 1122334567888888776 899999999999999999999999999999999888788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 105 i~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 105 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred HHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=207.31 Aligned_cols=144 Identities=36% Similarity=0.628 Sum_probs=125.4
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (321)
T cd05591 2 VLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVI----------------------------------------------- 33 (321)
T ss_pred ccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHh-----------------------------------------------
Confidence 5899999999999855 4578899999865311
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|..++..+ +||||+++++++..++.+|+||||+++++|...+...+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~q 104 (321)
T cd05591 34 ---------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE 104 (321)
T ss_pred ---------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 1112234466788888865 899999999999999999999999999999999988788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 105 i~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 105 VTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred HHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=207.00 Aligned_cols=144 Identities=38% Similarity=0.678 Sum_probs=125.3
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 2 ~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (320)
T cd05590 2 VLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVI----------------------------------------------- 33 (320)
T ss_pred eeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHH-----------------------------------------------
Confidence 5899999999999854 4578899999865411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|..++..+ +||||+++++++...+.+|+||||+++++|.+++.+.+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~q 104 (320)
T cd05590 34 ---------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 104 (320)
T ss_pred ---------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHH
Confidence 1112234566788888776 799999999999999999999999999999999988788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 105 l~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 105 ITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred HHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=211.68 Aligned_cols=151 Identities=25% Similarity=0.434 Sum_probs=134.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|.....+|+|.-|.||.+...+ +++.||+|.+...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~----------------------------------------- 309 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS-TKQEVAIKRMDLR----------------------------------------- 309 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc-CCceEEEEEEEec-----------------------------------------
Confidence 4567888899999999999999664 5778999998653
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.+...+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.+++.. ..+++.+
T Consensus 310 ------------------~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~q 370 (550)
T KOG0578|consen 310 ------------------KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEGQ 370 (550)
T ss_pred ------------------cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-ccccHHH
Confidence 122334578999999999999999999999999999999999999999998876 4599999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+.+.++.||+|||.+||+|||||.+|||++.+|.+||+|||+|.++...
T Consensus 371 IA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 371 IAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred HHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999999999999999999999999999999999999999988654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=210.84 Aligned_cols=143 Identities=24% Similarity=0.320 Sum_probs=128.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. .+++.+|+|....
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~~----------------------------------------- 127 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQR----------------------------------------- 127 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechhh-----------------------------------------
Confidence 4568999999999999999999854 5678899985421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..+.+|+.+++.++||||+++++++..+...+++||++ +++|.+++.....+++.
T Consensus 128 ------------------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~ 182 (391)
T PHA03212 128 ------------------------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAIC 182 (391)
T ss_pred ------------------------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHH
Confidence 23568999999999999999999999999999999999 67899988877789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+|+..
T Consensus 183 ~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 99999999999999999999999999999999999999999999999643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=207.01 Aligned_cols=144 Identities=38% Similarity=0.708 Sum_probs=123.2
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~----------------------------------------------- 33 (323)
T cd05575 2 VIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAI----------------------------------------------- 33 (323)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------------------------------------------
Confidence 5899999999999955 4588999999865421
Q ss_pred hhhccccccccchhhhhhHHHHH-HHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKE-IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|.. +++.++||||+++++.+...+.+|+||||+++++|..++.+.+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~q 104 (323)
T cd05575 34 ---------LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE 104 (323)
T ss_pred ---------hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 01112233455554 45778999999999999999999999999999999999988788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 i~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 105 IASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred HHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=211.72 Aligned_cols=150 Identities=27% Similarity=0.372 Sum_probs=131.5
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||+|+||.|-++.+ ..+++.||||++++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d-~~T~e~VAIKIiKN~------------------------------------------- 222 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYD-HKTGEIVAIKIIKNK------------------------------------------- 222 (586)
T ss_pred EEEEEEEecccccceeEEEEe-cCCCcEEEEEeeccC-------------------------------------------
Confidence 678999999999999999984 467999999999764
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcC-C-----cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-C-----DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.....+...|+.+|..++ | -|+|+++++|...+++|||+|.+ ..+|+++++.++
T Consensus 223 -----------------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~ 284 (586)
T KOG0667|consen 223 -----------------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR 284 (586)
T ss_pred -----------------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC
Confidence 233456678999999986 3 38999999999999999999999 889999999864
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CCcEEEEecccceecCCCCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~~~kl~DFG~a~~~~~~~~ 361 (362)
.++...++.++.||+.||.+||+.+|||+||||+|||+.. ...+|++|||.|+.....-|
T Consensus 285 Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 285 GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 5899999999999999999999999999999999999975 45799999999987665443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=206.83 Aligned_cols=144 Identities=39% Similarity=0.685 Sum_probs=123.0
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (321)
T cd05603 2 VIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTI----------------------------------------------- 33 (321)
T ss_pred eeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHH-----------------------------------------------
Confidence 6899999999999855 4578899999865411
Q ss_pred hhhccccccccchhhhhhHHHHH-HHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKE-IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|.. +++.++||||+++++++.+.+..|+||||+++++|...+.....+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 104 (321)
T cd05603 34 ---------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAE 104 (321)
T ss_pred ---------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 11112233445544 57788999999999999999999999999999999998887778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 105 i~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 105 VASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred HHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=206.87 Aligned_cols=144 Identities=38% Similarity=0.699 Sum_probs=123.2
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (325)
T cd05604 2 VIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIV----------------------------------------------- 33 (325)
T ss_pred ceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4588999999865311
Q ss_pred hhhccccccccchhhhhhHHHHH-HHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKE-IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|.. +++.++||||+++++++...+.+|+||||+++++|...+.+.+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~q 104 (325)
T cd05604 34 ---------LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE 104 (325)
T ss_pred ---------hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 11122234455554 46778999999999999999999999999999999999988788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 105 i~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 105 IASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred HHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=202.05 Aligned_cols=151 Identities=26% Similarity=0.449 Sum_probs=130.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~----------------------------------------- 38 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSE----------------------------------------- 38 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEeccc-----------------------------------------
Confidence 47899999999999999999865 457889999885431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||++++.+..+......+++..+
T Consensus 39 ----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 102 (287)
T cd07848 39 ----------------ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV 102 (287)
T ss_pred ----------------ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHH
Confidence 0112234577899999999999999999999999999999999988777665555557999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+.
T Consensus 103 ~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=206.14 Aligned_cols=148 Identities=36% Similarity=0.697 Sum_probs=125.7
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.||+|+||.||++.+. .+++.+|+|.+.+....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~----------------------------------------- 38 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDII----------------------------------------- 38 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhh-----------------------------------------
Confidence 678999999999999999855 45788999998764211
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHH---hhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIM---GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+.++ +.++||||+++++++...+.+|+||||+++++|...+.. +.+++..
T Consensus 39 ---------------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~ 102 (324)
T cd05589 39 ---------------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPR 102 (324)
T ss_pred ---------------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHH
Confidence 111223455666554 566899999999999999999999999999999988764 5699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 103 AVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-27 Score=203.38 Aligned_cols=153 Identities=37% Similarity=0.655 Sum_probs=138.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|...++||+|+||.|-+++ .+.+++.+|+|++++.-+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~r-EKat~k~YAiKIlkKevi-------------------------------------- 206 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCR-EKATGKLYAIKILKKEVI-------------------------------------- 206 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEe-ecccCceeehhhhhhhhe--------------------------------------
Confidence 56788889999999999999998 667899999999988622
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.......+-+.|-.+|+..+||.+..+-.+|+..+.+++||||..||.|.-.+.+.+.+++.
T Consensus 207 ------------------iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~ 268 (516)
T KOG0690|consen 207 ------------------IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSED 268 (516)
T ss_pred ------------------eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccch
Confidence 22233355678999999999999999999999999999999999999999989888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++++...|++||.|||+++|++||+|.+|+|++.+|++||+|||+|+.-
T Consensus 269 RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 269 RTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred hhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999999999999999999999999999999854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=223.05 Aligned_cols=153 Identities=32% Similarity=0.622 Sum_probs=136.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+++.||.|+||.||++.+. ..++.||+|++.+...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~--------------------------------------- 42 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADM--------------------------------------- 42 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhc---------------------------------------
Confidence 678999999999999999999865 4578999999865421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+..|+.+++.++||||++++.++...+++|+||||+++++|.+++...+.+++..
T Consensus 43 -----------------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~ 105 (669)
T cd05610 43 -----------------INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM 105 (669)
T ss_pred -----------------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHH
Confidence 112234567889999999999999999999999999999999999999999998777899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.++.|++.||.|||.++|+||||||+|||++.++.++|+|||+++...
T Consensus 106 ~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 106 AVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=206.18 Aligned_cols=148 Identities=21% Similarity=0.408 Sum_probs=127.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------------------------------------------ 37 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVF------------------------------------------ 37 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhh------------------------------------------
Confidence 5889999999999999999855 457889999875320
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.......++.+|+.+++.++||||+++++++... ..+|+||||+ +++|.+++.....++
T Consensus 38 ---------------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~ 101 (338)
T cd07859 38 ---------------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLT 101 (338)
T ss_pred ---------------ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCC
Confidence 0111234578899999999999999999987533 3589999999 679999998877899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 102 PEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=203.77 Aligned_cols=152 Identities=28% Similarity=0.470 Sum_probs=134.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++++.||+|+||.||++.+. .++..+|+|.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~---------------------------------------- 41 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLE---------------------------------------- 41 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecc----------------------------------------
Confidence 4578999999999999999999855 45778999987532
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+.+|+++++.++||||+++++++...+.+++||||+++++|.+++.....+++.
T Consensus 42 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 103 (331)
T cd06649 42 ------------------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103 (331)
T ss_pred ------------------cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHH
Confidence 01123456889999999999999999999999999999999999999999999887789999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred HHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999999986 69999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=205.96 Aligned_cols=144 Identities=37% Similarity=0.684 Sum_probs=122.1
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 2 ~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (325)
T cd05602 2 VIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAI----------------------------------------------- 33 (325)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------------------------------------------
Confidence 5899999999999865 4577899999865311
Q ss_pred hhhccccccccchhhhhhHHHH-HHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEK-EIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|. .+++.++||||+++++++...+.+|+||||+++++|.+++...+.+++..++.++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~q 104 (325)
T cd05602 34 ---------LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE 104 (325)
T ss_pred ---------HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 0011122334444 456778999999999999999999999999999999999988778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 105 i~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 105 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=205.07 Aligned_cols=144 Identities=31% Similarity=0.605 Sum_probs=126.5
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... ..++.+|+|++.+..
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~------------------------------------------------ 32 (327)
T cd05617 2 VIGRGSYAKVLLVRLK-KNDQIYAMKVVKKEL------------------------------------------------ 32 (327)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHH------------------------------------------------
Confidence 6899999999999855 457889999986541
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
.........+..|+.++..+ +||||+++++++...+.+|+||||+++++|..++...+.+++..++.++.|
T Consensus 33 --------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~q 104 (327)
T cd05617 33 --------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE 104 (327)
T ss_pred --------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 11122335577899998887 699999999999999999999999999999999988788999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 i~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 105 ICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=213.34 Aligned_cols=151 Identities=27% Similarity=0.357 Sum_probs=130.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|.+.+.+|.|+||.||++....+.++.+++|.+...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----------------------------------------- 104 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----------------------------------------- 104 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----------------------------------------
Confidence 445999999999999999999866554677888865321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l 303 (362)
.......+.+|+.+++.++||||+++++.+..++.+|+||||+++++|.+++.. ..++
T Consensus 105 ------------------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l 166 (478)
T PTZ00267 105 ------------------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF 166 (478)
T ss_pred ------------------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCC
Confidence 112234567899999999999999999999999999999999999999987753 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 167 ~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999999999999999999999999999999999999999998764
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=204.17 Aligned_cols=143 Identities=38% Similarity=0.661 Sum_probs=123.7
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----------------------------------------------- 33 (316)
T cd05620 2 VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVV----------------------------------------------- 33 (316)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 6899999999999865 4678899999865411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
...........|..++.. .+||||+++++++.+.+++|+||||+++++|..++.....+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~q 104 (316)
T cd05620 34 ---------LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE 104 (316)
T ss_pred ---------hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 011122345667777765 4899999999999999999999999999999999988778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++.
T Consensus 105 i~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 105 IVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-25 Score=198.66 Aligned_cols=151 Identities=30% Similarity=0.568 Sum_probs=130.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.|++.+.||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------------------------------- 38 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRI----------------------------------------- 38 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhh-----------------------------------------
Confidence 4788999999999999999854 4578899998865311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++.+..++.+|++|||+++++|.+.+... ..+++..
T Consensus 39 ---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 103 (285)
T cd05605 39 ---------------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEER 103 (285)
T ss_pred ---------------hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHH
Confidence 11112345678999999999999999999999999999999999999999887643 3589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 104 AVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred HHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=205.09 Aligned_cols=143 Identities=37% Similarity=0.675 Sum_probs=121.8
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~------------------------------------------------ 31 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEI------------------------------------------------ 31 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHH------------------------------------------------
Confidence 699999999999854 5688999999865311
Q ss_pred hhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
...........|..++... +||||++++.++...+.+|+||||+++++|..++.+.+.+++..++.++.
T Consensus 32 --------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 103 (330)
T cd05586 32 --------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA 103 (330)
T ss_pred --------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHH
Confidence 0111223345566666654 79999999999999999999999999999999998878899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 104 qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred HHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=213.78 Aligned_cols=152 Identities=30% Similarity=0.411 Sum_probs=129.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.-|...+.||+|+||.||..++. .+|+.+|+|.+++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~----------------------------------------- 50 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKES----------------------------------------- 50 (732)
T ss_pred cceeehhhhcCCccceeeeeccc-ccccchhHHhhhhhc-----------------------------------------
Confidence 45677889999999999999854 679999999987641
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc--
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
..+..+.+.+|+++|++++|||||+++++-+.. +...++||||.||||...+.+.
T Consensus 51 -----------------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN 113 (732)
T KOG4250|consen 51 -----------------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPEN 113 (732)
T ss_pred -----------------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCccc
Confidence 233456688999999999999999999986543 3578999999999999999864
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CC--cEEEEecccceecCCC
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SG--YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~--~~kl~DFG~a~~~~~~ 359 (362)
..+++..+..++..+..||.|||++||+||||||.||++-. +| ..||+|||.||.+.++
T Consensus 114 ~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 114 AYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 35999999999999999999999999999999999999953 34 3799999999988654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=199.73 Aligned_cols=144 Identities=36% Similarity=0.629 Sum_probs=123.6
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~------------------------------------------------ 31 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRL------------------------------------------------ 31 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHH------------------------------------------------
Confidence 699999999999855 4578899998865310
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCCCHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNFDDATTRFYT 312 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~ 312 (362)
........+..|+.+++.++||||+++++++..++.+|++|||+++++|...+.. +..+++..+..++
T Consensus 32 --------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~ 103 (280)
T cd05608 32 --------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYT 103 (280)
T ss_pred --------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHH
Confidence 1112234567899999999999999999999999999999999999999887743 3458999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-25 Score=198.79 Aligned_cols=153 Identities=48% Similarity=0.887 Sum_probs=135.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||.+.+.. .++.+++|.+.+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~---------------------------------------- 39 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKI---------------------------------------- 39 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHh----------------------------------------
Confidence 478999999999999999998654 578899998765311
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+++++.++||||+++++++..++.+|++|||+++++|.+++...+.+++..+
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~ 103 (290)
T cd05580 40 ----------------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA 103 (290)
T ss_pred ----------------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHH
Confidence 1122345678899999999999999999999999999999999999999999988888999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 104 ~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 104 RFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=202.78 Aligned_cols=144 Identities=36% Similarity=0.631 Sum_probs=123.8
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------------------------------------- 33 (316)
T cd05619 2 MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVV----------------------------------------------- 33 (316)
T ss_pred eeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------------------------------------------
Confidence 5899999999999855 4578899999865411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
...........|..++.. .+||||+++++++.+.+.+|+||||+++++|.+++.....+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~q 104 (316)
T cd05619 34 ---------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE 104 (316)
T ss_pred ---------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHH
Confidence 011122345667777776 4999999999999999999999999999999999988778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 105 i~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 105 IICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred HHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=208.30 Aligned_cols=151 Identities=29% Similarity=0.423 Sum_probs=128.6
Q ss_pred cCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
++|++.+.||+|+||.||++.+. .+++..+|+|.+....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~------------------------------------- 77 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA------------------------------------- 77 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-------------------------------------
Confidence 47889999999999999998742 3445679999875421
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+.++..+ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 78 ---------------------~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~ 136 (375)
T cd05104 78 ---------------------HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136 (375)
T ss_pred ---------------------CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccc
Confidence 112234578899999999 89999999999999999999999999999999886421
Q ss_pred -------------------------------------------------------------------------CCCHHHH
Q psy14740 302 -------------------------------------------------------------------------NFDDATT 308 (362)
Q Consensus 302 -------------------------------------------------------------------------~l~~~~~ 308 (362)
.+++..+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 216 (375)
T cd05104 137 FICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDL 216 (375)
T ss_pred cccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHH
Confidence 3677888
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 217 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 9999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=205.98 Aligned_cols=148 Identities=26% Similarity=0.322 Sum_probs=128.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.-...||+|+||.||++.... +..+|||.+....
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~--~~~vAVK~~~~~~----------------------------------------- 111 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD--GTVVAVKRLSSNS----------------------------------------- 111 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC--CCEEEEEEecCCC-----------------------------------------
Confidence 667777889999999999998553 3789999765421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-eEEEEEeccCCcchHHHHHhcC--CCCH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRDKG--NFDD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~l~~ 305 (362)
... ...|.+|++++..++|||++++++++.+.+ ..++|+||+++|+|.+.+.... ++++
T Consensus 112 -----------------~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W 173 (361)
T KOG1187|consen 112 -----------------GQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDW 173 (361)
T ss_pred -----------------Ccc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCH
Confidence 011 344999999999999999999999999888 5999999999999999987654 7899
Q ss_pred HHHHHHHHHHHHHHHHHHHCC---cEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRN---IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~---iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.....|+..++.||+|||... ||||||||+|||+|.+.++||+|||+|+...
T Consensus 174 ~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 174 ETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred HHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 999999999999999999854 9999999999999999999999999996543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=207.10 Aligned_cols=152 Identities=30% Similarity=0.463 Sum_probs=129.1
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|.+.+.||+|+||.||++.... ++...+|+|.+....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~------------------------------------ 80 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA------------------------------------ 80 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC------------------------------------
Confidence 4578999999999999999988532 334579999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.......+.+|+.+++.+ +||||+++++++...+.+|+||||+++|+|.+++...
T Consensus 81 ----------------------~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~ 138 (374)
T cd05106 81 ----------------------HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138 (374)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhh
Confidence 112235678899999999 8999999999999999999999999999999988542
Q ss_pred --------------------------------------------------------------------CCCCHHHHHHHH
Q psy14740 301 --------------------------------------------------------------------GNFDDATTRFYT 312 (362)
Q Consensus 301 --------------------------------------------------------------------~~l~~~~~~~~~ 312 (362)
.+++...+..++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 218 (374)
T cd05106 139 TFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFS 218 (374)
T ss_pred hhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHH
Confidence 136778899999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 219 ~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~ 263 (374)
T cd05106 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263 (374)
T ss_pred HHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence 999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=202.36 Aligned_cols=143 Identities=36% Similarity=0.689 Sum_probs=125.4
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 2 ~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------------- 33 (318)
T cd05570 2 VLGKGSFGKVLLAELK-GTDELYAVKVLKKDVI----------------------------------------------- 33 (318)
T ss_pred eeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------------------------------------------
Confidence 5899999999999865 4577899999875411
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|..+++.+ +||||+++++++...+.+|+||||+++++|...+.+.+.+++..+..++.|
T Consensus 34 ---------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~q 104 (318)
T cd05570 34 ---------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE 104 (318)
T ss_pred ---------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHH
Confidence 1122334567788888877 799999999999999999999999999999999988778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++.
T Consensus 105 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred HHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=202.38 Aligned_cols=151 Identities=28% Similarity=0.468 Sum_probs=132.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .++..+++|.+...
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~---------------------------------------- 41 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLE---------------------------------------- 41 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecc----------------------------------------
Confidence 3578999999999999999999865 45777888876532
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++...+.+++.
T Consensus 42 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 103 (333)
T cd06650 42 ------------------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 103 (333)
T ss_pred ------------------cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHH
Confidence 01122345789999999999999999999999999999999999999999999887789999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..+
T Consensus 104 ~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred HHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999999999999975 7999999999999999999999999998755
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=195.12 Aligned_cols=152 Identities=16% Similarity=0.239 Sum_probs=130.8
Q ss_pred cccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+|++.+.||+|+||.||++.+.. ..+..+|+|.+....
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~------------------------------------- 45 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC------------------------------------- 45 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------------------------------------
Confidence 34678999999999999999987543 335678999875431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
.......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... ..+
T Consensus 46 ---------------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l 104 (266)
T cd05064 46 ---------------------SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL 104 (266)
T ss_pred ---------------------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCC
Confidence 1122345788999999999999999999999999999999999999999998764 468
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+...
T Consensus 105 ~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=206.22 Aligned_cols=148 Identities=23% Similarity=0.380 Sum_probs=128.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++++.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------------------------------------------ 37 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVF------------------------------------------ 37 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccc------------------------------------------
Confidence 4788999999999999999854 457889999874320
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.......++.+|+.+++.++||||+++++++..++ ..|+||||+ +++|.+.+...+.++
T Consensus 38 ---------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~l~ 101 (372)
T cd07853 38 ---------------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLS 101 (372)
T ss_pred ---------------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecc-ccCHHHHHhcCCCCC
Confidence 01112345788999999999999999999998776 799999999 578888887777899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 102 SDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999999999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=213.73 Aligned_cols=147 Identities=31% Similarity=0.398 Sum_probs=126.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.++++.++|.+|||+.||+++..+. +..+|+|.+-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~-~~~~AlKrm~-------------------------------------------- 71 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKG-GKKYALKRMY-------------------------------------------- 71 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCC-Cceeeeeeee--------------------------------------------
Confidence 4568889999999999999997654 4789999763
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeee-eec------cceEEEEEeccCCcchHHHHHhc
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKT-FKD------KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~------~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..+......+.+|+++|+.|. |||||.+++. ... .-.++|+||||.||+|-+++...
T Consensus 72 ---------------~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R 136 (738)
T KOG1989|consen 72 ---------------VNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR 136 (738)
T ss_pred ---------------cCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHH
Confidence 234556677899999999995 9999999993 221 12588999999999999999853
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
..|++.+++.|+.++++|+.+||.+. |||||||.+||||+.+|..||||||.|..
T Consensus 137 lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 137 LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 45999999999999999999999998 99999999999999999999999998864
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=206.06 Aligned_cols=163 Identities=29% Similarity=0.486 Sum_probs=140.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+.+|..+..+|+|+||.|.++.+.. +...|++|.+.|..++-
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~------------------------------------ 601 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILV------------------------------------ 601 (772)
T ss_pred ccccceeeeeccccccceEEEeeecc-cceEEEeeehhhhhhhh------------------------------------
Confidence 56789999999999999999999665 47889999998874431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC---CcceeeeeeeeeccceEEEEEeccC-CcchHHHHHhcCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN---CDFIVKLYKTFKDKKYLYMLMESCL-GGELWTILRDKGN 302 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 302 (362)
|.+ ...+..-.+-.|+.||..++ |+||+++.++|++++++||+||... |-+|.++|.....
T Consensus 602 ------DtW---------vrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~ 666 (772)
T KOG1152|consen 602 ------DTW---------VRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR 666 (772)
T ss_pred ------hhh---------hcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc
Confidence 111 12223344667999999997 9999999999999999999999863 4599999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
+++..+..|++|+..|+++||++||+|||||-+|++++.+|.+||+|||.|....++.|
T Consensus 667 m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf 725 (772)
T KOG1152|consen 667 MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF 725 (772)
T ss_pred cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCCc
Confidence 99999999999999999999999999999999999999999999999999987766654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=193.75 Aligned_cols=148 Identities=36% Similarity=0.620 Sum_probs=130.3
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.||+|+||.||++.+.+ .++.+|+|.+.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~------------------------------------------ 37 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEI------------------------------------------ 37 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTH------------------------------------------
T ss_pred CEEeEEEEeCCCEEEEEEEECC-CCeEEEEEEeccccc------------------------------------------
Confidence 7889999999999999999664 577899999876421
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 310 (362)
.........+|+.+++.++||||+++++++......+++||++++++|.+++...+.+++..+..
T Consensus 38 ---------------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~ 102 (260)
T PF00069_consen 38 ---------------EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILK 102 (260)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHH
T ss_pred ---------------cccccchhhhhhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11112233459999999999999999999999999999999999999999998778899999999
Q ss_pred HHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 311 ~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.|++.||.+||+++++|+||||+||+++.++.++|+|||.+..+
T Consensus 103 ~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 103 IAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp HHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=217.50 Aligned_cols=152 Identities=26% Similarity=0.352 Sum_probs=130.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l---------------------------------------- 39 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDL---------------------------------------- 39 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECccc----------------------------------------
Confidence 468999999999999999999855 457889999885421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-------
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK------- 300 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------- 300 (362)
........++.+|+.+++.++||||+++++++.+++..|++|||++|++|.+++...
T Consensus 40 ----------------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~ 103 (932)
T PRK13184 40 ----------------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS 103 (932)
T ss_pred ----------------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccc
Confidence 111223456889999999999999999999999999999999999999999988641
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 ----GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ----~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 104 e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 104 KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred hhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence 12455677889999999999999999999999999999999999999999999876
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=194.18 Aligned_cols=144 Identities=35% Similarity=0.567 Sum_probs=122.6
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~------------------------------------------------ 31 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRL------------------------------------------------ 31 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHh------------------------------------------------
Confidence 699999999999855 4588999998865311
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTRFYTAC 314 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~q 314 (362)
...........|+++++.++||||+++++.+..+.++|++|||+++++|.+++.... .+++..+..++.|
T Consensus 32 --------~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~q 103 (277)
T cd05607 32 --------KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ 103 (277)
T ss_pred --------hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHH
Confidence 011112335569999999999999999999999999999999999999998876533 4889999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|||+.|++||||||+||+++.++.++|+|||++..+.
T Consensus 104 i~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146 (277)
T ss_pred HHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence 9999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=197.14 Aligned_cols=150 Identities=24% Similarity=0.371 Sum_probs=128.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.+.+.||+|+||.||++... .+++.+|+|.+....
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 43 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEH--------------------------------------- 43 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccc---------------------------------------
Confidence 4678999999999999999999854 457789999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
.......+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++...+ .++.
T Consensus 44 -------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~ 103 (309)
T cd07872 44 -------------------EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSM 103 (309)
T ss_pred -------------------cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCH
Confidence 01112346689999999999999999999999999999999995 58888776543 4889
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 104 ~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=197.05 Aligned_cols=148 Identities=32% Similarity=0.518 Sum_probs=126.4
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
++||+|.||.||-+++. .+|+.||+|++.|-..
T Consensus 570 evLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrF---------------------------------------------- 602 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRF---------------------------------------------- 602 (888)
T ss_pred hhccCCcceeeecceec-ccCceeeeeeeecccC----------------------------------------------
Confidence 67999999999999865 5699999999977421
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHH-Hh-cCCCCHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RD-KGNFDDATTRFYT 312 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~-~~~l~~~~~~~~~ 312 (362)
......++..|+.||+++.||.||.+-..|+..+.+|+|||.+ .|+..+.| .. .+++++...++++
T Consensus 603 -----------p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlv 670 (888)
T KOG4236|consen 603 -----------PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLV 670 (888)
T ss_pred -----------CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHH
Confidence 1122366889999999999999999999999999999999999 55555544 43 4679999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCC---CcEEEEecccceecCCCCC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTS---GYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~---~~~kl~DFG~a~~~~~~~~ 361 (362)
.||+.||.|||.++|+|+||||+|+|+... ..+||||||+||.++...|
T Consensus 671 tQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 671 TQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 999999999999999999999999999754 4699999999999876544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=194.40 Aligned_cols=151 Identities=25% Similarity=0.410 Sum_probs=123.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|++...||+|+||.||++.+....++.+|+|.+....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~----------------------------------------- 39 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT----------------------------------------- 39 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEeccc-----------------------------------------
Confidence 368899999999999999998765557789999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHhc
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..........+|+.+++.+ +||||+++++++. ....++++||++ .++|.+++...
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 102 (290)
T cd07862 40 ----------------GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKV 102 (290)
T ss_pred ----------------CCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccC-CCCHHHHHHhC
Confidence 0011123345677666655 7999999999874 345699999999 46899988753
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 103 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 103 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 348999999999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=204.14 Aligned_cols=148 Identities=30% Similarity=0.428 Sum_probs=126.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|..++.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 111 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNH--------------------------------------- 111 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCC---------------------------------------
Confidence 4567788899999999999999855 457889999874320
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.......+.+|+.+++.++||||+++++++...+.+|+||||+++++|... ...++.
T Consensus 112 -------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~ 168 (353)
T PLN00034 112 -------------------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQ 168 (353)
T ss_pred -------------------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHH
Confidence 112235678999999999999999999999999999999999999998642 345778
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 169 FLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 888999999999999999999999999999999999999999999998653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=203.98 Aligned_cols=145 Identities=26% Similarity=0.357 Sum_probs=127.2
Q ss_pred ccCcEEEEEecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..+|.++..||.|+||.||++...+ ..+..+++|.+...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------------------------------------- 130 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------------------------------------- 130 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------------------------------------
Confidence 3579999999999999999987543 33567888876432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
....+|+.+++.++||||+++++++.....+|++||++ +++|.+++.....+++.
T Consensus 131 ------------------------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~ 185 (392)
T PHA03207 131 ------------------------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLE 185 (392)
T ss_pred ------------------------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHH
Confidence 12357999999999999999999999999999999998 57899988766789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 186 ~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999999999999999999999999999999999999999999997654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=193.29 Aligned_cols=153 Identities=24% Similarity=0.349 Sum_probs=130.1
Q ss_pred cccCcEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.+++|++.+.||+|+||.||++... ...+..+++|.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~------------------------------------- 45 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI------------------------------------- 45 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-------------------------------------
Confidence 4678999999999999999998752 234567888877532
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--- 300 (362)
........+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++...
T Consensus 46 ---------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 104 (283)
T cd05090 46 ---------------------NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPH 104 (283)
T ss_pred ---------------------CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCC
Confidence 11122345788999999999999999999999999999999999999999988532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (283)
T cd05090 105 SDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175 (283)
T ss_pred CccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecccccccccc
Confidence 237788899999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=195.48 Aligned_cols=150 Identities=28% Similarity=0.457 Sum_probs=131.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .++..+++|.+....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~----------------------------------------- 38 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEI----------------------------------------- 38 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEecccc-----------------------------------------
Confidence 46899999999999999999855 457778888765320
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
......++.+|+++++.++||||+++++.+..++.+|++|||+++++|.+++.+.+.+++..+
T Consensus 39 -----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~ 101 (308)
T cd06615 39 -----------------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENIL 101 (308)
T ss_pred -----------------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHH
Confidence 112334578899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++..+.
T Consensus 102 ~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred HHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999999997 699999999999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=192.39 Aligned_cols=151 Identities=28% Similarity=0.429 Sum_probs=133.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.||+|+||.||++... .+++.+++|.+....
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~--------------------------------------- 46 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEP--------------------------------------- 46 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCc---------------------------------------
Confidence 4578999999999999999999864 457789999875320
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+.+++.
T Consensus 47 --------------------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~ 106 (267)
T cd06646 47 --------------------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL 106 (267)
T ss_pred --------------------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHH
Confidence 011234678999999999999999999999999999999999999999999877789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 107 QIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999999999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=190.63 Aligned_cols=153 Identities=33% Similarity=0.495 Sum_probs=133.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.+|+|+||.||.+... .+++.+++|.+.....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~---------------------------------------- 40 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPD---------------------------------------- 40 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeeccc----------------------------------------
Confidence 46889999999999999999854 5578899998754310
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
..........+.+|+.+++.++||||+++++++..++.+|++||++++++|.+++...+.+++..+
T Consensus 41 --------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 106 (263)
T cd06625 41 --------------SPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT 106 (263)
T ss_pred --------------chhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHH
Confidence 001112235678899999999999999999999999999999999999999999988778999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 107 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=196.50 Aligned_cols=152 Identities=26% Similarity=0.456 Sum_probs=128.7
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
+.+.+++|++.+.||+|+||.||++.+.. ++. .+++|.+...
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~----------------------------------- 45 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEY----------------------------------- 45 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEeccc-----------------------------------
Confidence 34568899999999999999999998654 343 3466654321
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.++..+ +||||+++++++...+.+|++|||+++++|.+++.+.
T Consensus 46 -----------------------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 102 (303)
T cd05088 46 -----------------------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 102 (303)
T ss_pred -----------------------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhc
Confidence 1122335678899999999 8999999999999999999999999999999998753
Q ss_pred C----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 301 G----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 301 ~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
+ .+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||+++
T Consensus 103 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~ 172 (303)
T cd05088 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172 (303)
T ss_pred ccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCc
Confidence 2 47889999999999999999999999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=192.46 Aligned_cols=149 Identities=32% Similarity=0.591 Sum_probs=128.5
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|+..+.||+|+||.||++... .+++.+|+|.+.+..
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~------------------------------------------- 37 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKR------------------------------------------- 37 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhh-------------------------------------------
Confidence 677888999999999999865 457889999886531
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~ 308 (362)
.........+.+|+.+++.++||||+.+++.+..++..+++|||+++++|.+.+... ..+++..+
T Consensus 38 -------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 104 (285)
T cd05632 38 -------------IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA 104 (285)
T ss_pred -------------hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHH
Confidence 111122344678999999999999999999999999999999999999999887643 35999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 105 ~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=192.41 Aligned_cols=149 Identities=31% Similarity=0.584 Sum_probs=128.3
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|+..+.||+|+||.||++... .+++.+|+|.+.+..
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~------------------------------------------- 37 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKR------------------------------------------- 37 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhh-------------------------------------------
Confidence 678889999999999999855 457889999876431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~ 308 (362)
.........+..|+.+++.++||+|+.+++.+...+.+|++|||+++++|.+++... ..+++..+
T Consensus 38 -------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~ 104 (285)
T cd05630 38 -------------IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA 104 (285)
T ss_pred -------------ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHH
Confidence 011112244678999999999999999999999999999999999999999988643 35899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 105 ~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 105 VFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred HHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=202.50 Aligned_cols=152 Identities=29% Similarity=0.441 Sum_probs=127.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|.+.+.||+|+||.||.+.+.+. +...+|+|.+.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~------------------------------------ 79 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA------------------------------------ 79 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC------------------------------------
Confidence 45788889999999999999885432 23468999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.....+.+.+|+.+++.++ ||||+++++++...+.+|+||||+++|+|.+++..+
T Consensus 80 ----------------------~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~ 137 (400)
T cd05105 80 ----------------------RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRD 137 (400)
T ss_pred ----------------------ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhh
Confidence 1122356889999999996 999999999999999999999999999999887642
Q ss_pred --------------------------------------------------------------------------------
Q psy14740 301 -------------------------------------------------------------------------------- 300 (362)
Q Consensus 301 -------------------------------------------------------------------------------- 300 (362)
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (400)
T cd05105 138 NFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGS 217 (400)
T ss_pred hhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCc
Confidence
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.+.
T Consensus 218 ~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~ 288 (400)
T cd05105 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288 (400)
T ss_pred chhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecc
Confidence 136777888999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=189.22 Aligned_cols=149 Identities=28% Similarity=0.470 Sum_probs=129.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.+|+|+||.||.+...+ +..+|+|.+....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~~---------------------------------------- 40 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGS---------------------------------------- 40 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC--CCcEEEEEcCCCc----------------------------------------
Confidence 4678999999999999999997543 4458999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
.....+.+|+.+++.++||||+++++++...+.+|++|||+++++|.+++... ..+++.
T Consensus 41 --------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~ 100 (256)
T cd05113 41 --------------------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS 100 (256)
T ss_pred --------------------ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHH
Confidence 01244788999999999999999999999889999999999999999998764 368999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+..
T Consensus 101 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 9999999999999999999999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=194.14 Aligned_cols=150 Identities=35% Similarity=0.626 Sum_probs=132.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.+|+|+||.||++.+. ..++.+++|.+.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~----------------------------------------- 38 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQN----------------------------------------- 38 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhh-----------------------------------------
Confidence 46899999999999999999855 457889999876531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.........+.+|+++++.++||||+++++.+..++++|++|||++|++|.+++...+.+++..+
T Consensus 39 ---------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~ 103 (305)
T cd05609 39 ---------------LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA 103 (305)
T ss_pred ---------------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHH
Confidence 01112334677899999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 104 ~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=196.00 Aligned_cols=153 Identities=23% Similarity=0.378 Sum_probs=128.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCC---CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDP---SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
+...+|++...||+|+||.||++.+.... ...+|+|.+...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~------------------------------------ 47 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA------------------------------------ 47 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc------------------------------------
Confidence 35678999999999999999999854321 224788876432
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG- 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 301 (362)
......+.+.+|+.+++.++||||+++++++... ..+++++|+++|+|.+++....
T Consensus 48 ----------------------~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~ 104 (316)
T cd05108 48 ----------------------TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 104 (316)
T ss_pred ----------------------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc
Confidence 1122345678899999999999999999988764 5789999999999999998643
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 105 ~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 105 NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 58899999999999999999999999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=189.17 Aligned_cols=148 Identities=28% Similarity=0.464 Sum_probs=128.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.... +..+++|.+.+..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~~---------------------------------------- 40 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEGA---------------------------------------- 40 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc--CceEEEEecccCC----------------------------------------
Confidence 3578899999999999999997543 4568999765431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
.....+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... +.+++.
T Consensus 41 --------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~ 100 (256)
T cd05114 41 --------------------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD 100 (256)
T ss_pred --------------------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHH
Confidence 11245788999999999999999999999999999999999999999998753 458999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++...
T Consensus 101 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 101 MLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 999999999999999999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=199.34 Aligned_cols=149 Identities=22% Similarity=0.350 Sum_probs=125.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 58 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPF--------------------------------------- 58 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccc---------------------------------------
Confidence 4688999999999999999999854 457889999886431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ..+|+||||++ ++|.+.+.
T Consensus 59 ------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-- 117 (359)
T cd07876 59 ------------------QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-- 117 (359)
T ss_pred ------------------cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--
Confidence 1122234567899999999999999999988644 35799999995 56766664
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 118 ~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 34889999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=206.25 Aligned_cols=153 Identities=24% Similarity=0.376 Sum_probs=129.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~--------------------------------------- 69 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEG--------------------------------------- 69 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEeccc---------------------------------------
Confidence 4579999999999999999999855 457899999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--------eEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--------YLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~ 298 (362)
........+.+|+.++..++|+||++++..+...+ .+++||||+++|+|.+++.
T Consensus 70 ------------------~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~ 131 (496)
T PTZ00283 70 ------------------MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIK 131 (496)
T ss_pred ------------------CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHH
Confidence 11223345778999999999999999988765332 4789999999999999886
Q ss_pred hc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 299 DK----GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~~----~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.. ..+++..+..++.|++.||.|+|+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 132 ~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~ 194 (496)
T PTZ00283 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194 (496)
T ss_pred HhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence 42 458999999999999999999999999999999999999999999999999998653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=189.67 Aligned_cols=143 Identities=24% Similarity=0.427 Sum_probs=124.4
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+++|.+.+.
T Consensus 2 ~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~------------------------------------------------- 31 (252)
T cd05084 2 RIGRGNFGEVFSGRLR-ADNTPVAVKSCRET------------------------------------------------- 31 (252)
T ss_pred ccCcccCccEEEEEEe-cCCceEEEEecCcc-------------------------------------------------
Confidence 5899999999999864 45778999976432
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~q 314 (362)
........+.+|+++++.++||||+++++++......|+||||+++++|.+++...+ .+++..+..++.|
T Consensus 32 ---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~q 102 (252)
T cd05084 32 ---------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102 (252)
T ss_pred ---------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHH
Confidence 111233567889999999999999999999999999999999999999999987644 5899999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus 103 i~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 103 AAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccc
Confidence 9999999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=189.81 Aligned_cols=152 Identities=24% Similarity=0.358 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+|++.+.||+|+||.||++..... ....+++|.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------------------------------------- 44 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------------------------------------- 44 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--------------------------------------
Confidence 45788999999999999999986432 23368888764320
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
.......+..|+.+++.++||||+++++++..++.+|++|||+++++|.+++... ..++
T Consensus 45 --------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 104 (267)
T cd05066 45 --------------------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT 104 (267)
T ss_pred --------------------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCC
Confidence 1123356788999999999999999999999999999999999999999999764 4589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 105 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=189.22 Aligned_cols=153 Identities=23% Similarity=0.424 Sum_probs=131.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+.+.+|.|+||.||++... .+++.+++|.+....
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~---------------------------------------- 39 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFE---------------------------------------- 39 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccc----------------------------------------
Confidence 367999999999999999999855 457889999775421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l 303 (362)
.........+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++.. ...+
T Consensus 40 ----------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 103 (267)
T cd08228 40 ----------------MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103 (267)
T ss_pred ----------------cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCC
Confidence 11122345678899999999999999999999999999999999999999988753 2348
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+.
T Consensus 104 ~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 899999999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=189.64 Aligned_cols=152 Identities=36% Similarity=0.682 Sum_probs=134.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||.+.+. .+++.+++|.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------ 37 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQK------------------------------------------ 37 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhh------------------------------------------
Confidence 4889999999999999999854 567889999986541
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.........+.+|+++++.++||||+++++.+..+...|+++||+++++|.+++....++++..+.
T Consensus 38 --------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 103 (258)
T cd05578 38 --------------CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVK 103 (258)
T ss_pred --------------hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHH
Confidence 111223466889999999999999999999999999999999999999999999877789999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 104 ~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 104 FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=198.12 Aligned_cols=153 Identities=30% Similarity=0.495 Sum_probs=134.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.-|.+.+.||+|.|+.|.++++.. +|+.||+|++.|...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKl---------------------------------------- 56 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKL---------------------------------------- 56 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc-ccceeEEEEeccccc----------------------------------------
Confidence 346777889999999999999775 588999999987521
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~ 307 (362)
+.....++.+|+..|+.++|||||++|.+......+|+|+|+=++|+|+++|-++ ..+.++.
T Consensus 57 -----------------D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~L 119 (864)
T KOG4717|consen 57 -----------------DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDL 119 (864)
T ss_pred -----------------chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHH
Confidence 2233466889999999999999999999999999999999999999999998764 4699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~~~ 359 (362)
++.|+.||+.|+.|||...++||||||+|+++. +-|.+||+|||++-.+.++
T Consensus 120 a~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 120 AKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred HHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999999999999999999999986 4689999999999877654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=187.70 Aligned_cols=148 Identities=24% Similarity=0.372 Sum_probs=130.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||.|+||.||++.... ++.+++|.+....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~---------------------------------------- 42 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN--TTPVAVKTLKPGT---------------------------------------- 42 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC--CeEEEEEeeCCCc----------------------------------------
Confidence 4578999999999999999998543 4679999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~ 305 (362)
.....+.+|+.+++.++||||+++++++...+..|++||++++++|.+++.... .++.
T Consensus 43 --------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 102 (261)
T cd05068 43 --------------------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL 102 (261)
T ss_pred --------------------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCH
Confidence 112447789999999999999999999999999999999999999999997643 6899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 103 ~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 103 PQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=198.58 Aligned_cols=150 Identities=24% Similarity=0.366 Sum_probs=126.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||.+.+. ..++.+|+|.+.+..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 54 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPF--------------------------------------- 54 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcc---------------------------------------
Confidence 4688999999999999999999854 557889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ..+|++|||++ +++.+.+..
T Consensus 55 ------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~- 114 (355)
T cd07874 55 ------------------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM- 114 (355)
T ss_pred ------------------cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh-
Confidence 1122335577899999999999999999987543 35799999995 567776653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 115 -~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 115 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 48899999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=192.03 Aligned_cols=109 Identities=24% Similarity=0.371 Sum_probs=101.1
Q ss_pred hhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHH
Q psy14740 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-----------NFDDATTRFYTACVVE 317 (362)
Q Consensus 249 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~ql~~ 317 (362)
....+.+|+.+++.++||||+++++++..++..+++||++++++|.+++.... .+++..++.++.|++.
T Consensus 62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999997655 6899999999999999
Q ss_pred HHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 318 AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 318 al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred HHHHHHHcCccccccchhceeecCCCceEEccccceeecc
Confidence 9999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=191.96 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=129.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.+.+.||.|+||.||++... .+++.+|+|.+....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 43 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEH--------------------------------------- 43 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEeccc---------------------------------------
Confidence 5788999999999999999999855 457789999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
.......+.+|+.+++.++||||+++++++..++.+|+||||++ ++|.+++... ..+++
T Consensus 44 -------------------~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~ 103 (301)
T cd07873 44 -------------------EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINM 103 (301)
T ss_pred -------------------ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCH
Confidence 01112345689999999999999999999999999999999995 6888887654 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 104 ~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=191.92 Aligned_cols=150 Identities=26% Similarity=0.458 Sum_probs=131.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||.+.+. .+++.+++|.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~---------------------------------------- 46 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEP---------------------------------------- 46 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCc----------------------------------------
Confidence 356788888999999999999855 457889999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++.+...+.+|++|||+++++|.+++...+.+++..
T Consensus 47 -------------------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 107 (267)
T cd06645 47 -------------------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ 107 (267)
T ss_pred -------------------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHH
Confidence 1112346789999999999999999999999999999999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 108 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=202.04 Aligned_cols=146 Identities=28% Similarity=0.369 Sum_probs=120.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++... .+++.+|+|.+.+..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~--------------------------------------- 103 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP--------------------------------------- 103 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc---------------------------------------
Confidence 3567999999999999999999854 557889999764320
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--------cceEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--------KKYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~ 298 (362)
....+|+.+|+.++||||+++++++.. ..++++||||++ ++|.+++.
T Consensus 104 ------------------------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~ 158 (440)
T PTZ00036 104 ------------------------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMK 158 (440)
T ss_pred ------------------------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHH
Confidence 113469999999999999999887643 235789999995 57776664
Q ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecC
Q psy14740 299 D----KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~----~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~ 357 (362)
. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 159 HYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 2 35689999999999999999999999999999999999998664 69999999998654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=188.98 Aligned_cols=152 Identities=24% Similarity=0.423 Sum_probs=131.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++...+|+|+||.||++... .+++.+++|.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~----------------------------------------- 38 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESE----------------------------------------- 38 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecc-----------------------------------------
Confidence 46899999999999999999855 457889999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
......+.+.+|+.+++.++|||++++++++.....++++|||+++++|..++.....+++..+
T Consensus 39 ----------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 102 (286)
T cd07847 39 ----------------DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI 102 (286)
T ss_pred ----------------cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHH
Confidence 0011223467899999999999999999999999999999999999888888776667999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+..
T Consensus 103 ~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 103 KKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred HHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999999999999999999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=189.19 Aligned_cols=150 Identities=29% Similarity=0.455 Sum_probs=127.8
Q ss_pred cCcEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+|++++.||+|+||.||.+... ...++.+++|.+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------------------------------------- 44 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------------------------------------- 44 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---------------------------------------
Confidence 57899999999999999998742 234678999987532
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
.......+.+|+++++.++||||+++++++.. ...+++||||+++++|.+++.+. ..
T Consensus 45 --------------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 104 (284)
T cd05081 45 --------------------TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER 104 (284)
T ss_pred --------------------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcC
Confidence 11223557889999999999999999987543 35689999999999999998764 45
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 105 l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=198.20 Aligned_cols=151 Identities=21% Similarity=0.386 Sum_probs=127.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+++.||.|+||.||++.+. .+++.+|+|.+.+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 52 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPF--------------------------------------- 52 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchh---------------------------------------
Confidence 3467999999999999999999855 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ...|++|+++ +++|.+++..
T Consensus 53 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~- 112 (343)
T cd07878 53 ------------------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC- 112 (343)
T ss_pred ------------------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-
Confidence 1112234467899999999999999999987533 4579999998 8899888764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 113 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 569999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=187.66 Aligned_cols=152 Identities=24% Similarity=0.360 Sum_probs=131.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+|++.+.+|.|+||.||++....+. ...+++|.+.+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--------------------------------------- 43 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--------------------------------------- 43 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---------------------------------------
Confidence 467899999999999999999865432 236899987542
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
........+..|+.+++.++||||+++++++..+...+++|||+++++|.+++... +.++
T Consensus 44 -------------------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 104 (269)
T cd05065 44 -------------------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT 104 (269)
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCC
Confidence 01223456889999999999999999999999999999999999999999998764 4589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999999999999999999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-25 Score=194.19 Aligned_cols=146 Identities=28% Similarity=0.513 Sum_probs=131.6
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+...||+|+||.|+++.+. .+|+-+|||.+.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV--------------------------------------------- 68 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV--------------------------------------------- 68 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc---------------------------------------------
Confidence 556788999999999999855 6799999997632
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~ 309 (362)
....+.+..|+.||++++.|++|++|++|-....+|+|||||..|++.++++- ++++++..+.
T Consensus 69 ----------------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs 132 (502)
T KOG0574|consen 69 ----------------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEIS 132 (502)
T ss_pred ----------------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHH
Confidence 23557788999999999999999999999988999999999999999999874 5679999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..+.||+|||...-||||||..|||++.+|..||+|||.|.++++
T Consensus 133 ~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 133 AVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred HHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 9999999999999999999999999999999999999999999988753
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=188.09 Aligned_cols=148 Identities=27% Similarity=0.449 Sum_probs=128.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.+|+|+||.||++.+. .+..+++|.+.+...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~--------------------------------------- 41 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAM--------------------------------------- 41 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCC---------------------------------------
Confidence 356888999999999999999854 255789998754310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
....+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++... ..+++.
T Consensus 42 ---------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 100 (256)
T cd05059 42 ---------------------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE 100 (256)
T ss_pred ---------------------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHH
Confidence 1234678999999999999999999999999999999999999999998753 468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 101 ~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 101 WLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence 999999999999999999999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=189.51 Aligned_cols=150 Identities=27% Similarity=0.418 Sum_probs=129.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.+.+.||+|+||.||++... .+++.+++|.+....
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~--------------------------------------- 42 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEH--------------------------------------- 42 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEeccc---------------------------------------
Confidence 4688999999999999999999854 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
.......+.+|+++++.++||||+++++++...+..|+||||++ ++|.+++... ..+++
T Consensus 43 -------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~ 102 (291)
T cd07844 43 -------------------EEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSM 102 (291)
T ss_pred -------------------ccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCH
Confidence 00111235689999999999999999999999999999999996 5899988754 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 103 ~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=184.58 Aligned_cols=151 Identities=28% Similarity=0.493 Sum_probs=132.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.+|+|+||.||++... .+++.+++|.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~------------------------------------------ 37 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSK------------------------------------------ 37 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhh------------------------------------------
Confidence 5788999999999999999865 457889999875421
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++... ..+++..
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 102 (256)
T cd08529 38 ---------------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ 102 (256)
T ss_pred ---------------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHH
Confidence 11223456788999999999999999999999999999999999999999998764 4689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 103 ~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999999999999999999999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-23 Score=186.19 Aligned_cols=154 Identities=33% Similarity=0.500 Sum_probs=130.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|++.+.+|+|+||.||.+.+. ++++.+++|.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~---------------------------------------- 40 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPE---------------------------------------- 40 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcC----------------------------------------
Confidence 47899999999999999999854 5678899998743210
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.++||||+++++++.+. ..++++|||+++++|.+++.+...+++.
T Consensus 41 --------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~ 106 (265)
T cd06652 41 --------------SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN 106 (265)
T ss_pred --------------CcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHH
Confidence 001112335678899999999999999999988663 5789999999999999999877778999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 107 VTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999999999999999999999999999999999999999987543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=190.29 Aligned_cols=151 Identities=25% Similarity=0.402 Sum_probs=129.0
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|.+...+|.|+||.||++.... ..+..+++|.+...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~------------------------------------- 46 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------------------------------------- 46 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-------------------------------------
Confidence 3578899999999999999997422 23445788876432
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+.+++.++||||+++++++...+.+|++|||+++++|.+++...+
T Consensus 47 ----------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~ 104 (288)
T cd05093 47 ----------------------SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPD 104 (288)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCc
Confidence 12234557889999999999999999999999999999999999999999987543
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 -----------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 -----------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 171 (288)
T cd05093 105 AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171 (288)
T ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCcccccc
Confidence 38999999999999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=187.22 Aligned_cols=152 Identities=24% Similarity=0.364 Sum_probs=131.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-++|++.+.||+|+||.||++.+... ....+++|.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--------------------------------------- 43 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--------------------------------------- 43 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---------------------------------------
Confidence 35789999999999999999986532 2457888876532
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
........+..|+.+++.++||||+++++++...+..+++|||+++++|.+++... +.++
T Consensus 44 -------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~ 104 (266)
T cd05033 44 -------------------SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT 104 (266)
T ss_pred -------------------CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCC
Confidence 11123345788999999999999999999999999999999999999999998764 4689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 105 VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=185.70 Aligned_cols=152 Identities=22% Similarity=0.418 Sum_probs=132.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.+|+|+||.||++... .+++.+++|.+....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 39 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFE----------------------------------------- 39 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeeccc-----------------------------------------
Confidence 57999999999999999999865 457889999876431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNFD 304 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~ 304 (362)
.........+.+|+++++.++|||++++++.+...+..+++|||+++++|..++.. ...++
T Consensus 40 ---------------~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 104 (267)
T cd08224 40 ---------------MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred ---------------ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcC
Confidence 11122345688999999999999999999999999999999999999999998864 23489
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 105 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 105 ERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=189.62 Aligned_cols=152 Identities=22% Similarity=0.358 Sum_probs=126.8
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|++.+.||+|+||.||++.... ..+..+|+|.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------------------------------ 48 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA------------------------------------ 48 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC------------------------------------
Confidence 4679999999999999999986432 234578888764321
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++.+.+
T Consensus 49 ----------------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 106 (288)
T cd05061 49 ----------------------SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 106 (288)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccc
Confidence 11122346789999999999999999999999999999999999999999997532
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 --------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 --------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~ 170 (288)
T cd05061 107 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170 (288)
T ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccc
Confidence 24567888999999999999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=191.01 Aligned_cols=108 Identities=25% Similarity=0.382 Sum_probs=98.5
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-----------NFDDATTRFYTACVVEA 318 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~ql~~a 318 (362)
...+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++.... .++...+..++.|++.|
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05095 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG 142 (296)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999987632 25677899999999999
Q ss_pred HHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 319 l~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 143 l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 143 MKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred HHHHHHCCeecccCChheEEEcCCCCEEeccCccccccc
Confidence 999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=188.34 Aligned_cols=148 Identities=30% Similarity=0.401 Sum_probs=125.0
Q ss_pred cEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 151 LRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
|++++.||+|+||.||++... ...+..+|+|.+....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---------------------------------------- 45 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---------------------------------------- 45 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----------------------------------------
Confidence 388999999999999886532 2356789999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.......+.+|+++++.++||||+++++++.. ...+|++|||+++++|.+++.. ..+++
T Consensus 46 ------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~ 106 (283)
T cd05080 46 ------------------GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNL 106 (283)
T ss_pred ------------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCH
Confidence 01123457789999999999999999998754 3468999999999999999876 45999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=183.92 Aligned_cols=150 Identities=27% Similarity=0.482 Sum_probs=130.4
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||++.+. .+++.+++|.+....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~------------------------------------------ 37 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPK------------------------------------------ 37 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCc------------------------------------------
Confidence 5889999999999999999865 457789999875321
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
.......+..|+.+++.++||||+++++.+.+.+.+|++|||+++++|.+++... ..+++..
T Consensus 38 ----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~ 101 (255)
T cd08219 38 ----------------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT 101 (255)
T ss_pred ----------------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHH
Confidence 1122345678999999999999999999999999999999999999999988653 3589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++.+..
T Consensus 102 ~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999999999999999999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=188.16 Aligned_cols=152 Identities=23% Similarity=0.386 Sum_probs=127.5
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|++...+|.|+||.||.+...+ ..+..+|+|.+....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~------------------------------------ 48 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA------------------------------------ 48 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC------------------------------------
Confidence 4679999999999999999987543 234568888764320
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.+..
T Consensus 49 ----------------------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 106 (277)
T cd05062 49 ----------------------SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 106 (277)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcc
Confidence 11123457889999999999999999999999999999999999999999987532
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 --------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 --------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 170 (277)
T cd05062 107 MENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170 (277)
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccC
Confidence 24677889999999999999999999999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=187.91 Aligned_cols=147 Identities=30% Similarity=0.415 Sum_probs=127.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~----------------------------------------- 38 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDI----------------------------------------- 38 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCC-----------------------------------------
Confidence 36788999999999999999855 457889999875420
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+|+.+++.++||||+++++.+...+..+++|||+++++|..+ ..+++..+
T Consensus 39 -----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~ 97 (279)
T cd06619 39 -----------------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVL 97 (279)
T ss_pred -----------------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHH
Confidence 112234578899999999999999999999999999999999999998654 35789999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..+..
T Consensus 98 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 98 GRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred HHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999999999999999999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=185.22 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=132.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.+|.|+||.||.+... .+++.+++|.+....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 40 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEP----------------------------------------- 40 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCc-----------------------------------------
Confidence 57899999999999999999865 346789999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++.+...+.+|++|||+++++|.+++... ..+++..
T Consensus 41 ------------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~ 102 (262)
T cd06613 41 ------------------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ 102 (262)
T ss_pred ------------------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHH
Confidence 113356788999999999999999999999999999999999999999998775 6799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+.
T Consensus 103 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 103 IAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred HHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=189.14 Aligned_cols=153 Identities=31% Similarity=0.624 Sum_probs=132.4
Q ss_pred CcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+|++.+.||.|+||.||.+.... .+++.+|+|.+.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~--------------------------------------- 41 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI--------------------------------------- 41 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh---------------------------------------
Confidence 47889999999999999998643 3578899998865311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+..|+.++..+ +||||+++++++..+..+|+||||+++++|.+++.....+++.
T Consensus 42 ----------------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 105 (290)
T cd05613 42 ----------------VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ 105 (290)
T ss_pred ----------------hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHH
Confidence 11122345577899999999 6999999999999999999999999999999999887789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=187.52 Aligned_cols=152 Identities=20% Similarity=0.369 Sum_probs=127.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCC---ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSR---SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
...+|++++.||+|+||.||++.+..+... .+|+|.+....
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~------------------------------------ 48 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT------------------------------------ 48 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC------------------------------------
Confidence 457899999999999999999986543221 47888775321
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
.......+.+|+.+++.++||||+++++++.. ...+++|+++++|+|.+++..+ +.
T Consensus 49 ----------------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~ 105 (279)
T cd05109 49 ----------------------SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDR 105 (279)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCC
Confidence 11223457789999999999999999998865 4578999999999999998764 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+.
T Consensus 106 ~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 106 IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=188.26 Aligned_cols=107 Identities=21% Similarity=0.245 Sum_probs=97.1
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-----NFDDATTRFYTACVVEAFDYLHS 324 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~ql~~al~~lH~ 324 (362)
...+.+|+.+++.++||||+++++.+.....+|++|||+++++|.+++.... ..++..+..++.|++.||.|||+
T Consensus 39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 3457889999999999999999999999999999999999999999987643 24677889999999999999999
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++|+||||||+||+++.++.+||+|||+++..
T Consensus 119 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cCEecccccHhheEecCCCcEEEecccccccc
Confidence 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=189.59 Aligned_cols=152 Identities=28% Similarity=0.434 Sum_probs=129.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCC----CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDP----SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
.+++|++.+.||+|+||.||.+...... ...+++|.+...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~------------------------------------ 46 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN------------------------------------ 46 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC------------------------------------
Confidence 4568899999999999999999865432 246788876432
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
........+.+|+.++..++||||+++++++......|++|||+++++|.+++...
T Consensus 47 ----------------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~ 104 (283)
T cd05048 47 ----------------------AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSP 104 (283)
T ss_pred ----------------------CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCC
Confidence 11123355788999999999999999999999889999999999999999998764
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 --------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 --------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 105 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~ 174 (283)
T cd05048 105 HSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174 (283)
T ss_pred CcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeec
Confidence 34778899999999999999999999999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=191.06 Aligned_cols=151 Identities=37% Similarity=0.718 Sum_probs=132.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|++.+.||.|+||.||++... .+++.+++|.+.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 39 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEM---------------------------------------- 39 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEecccc----------------------------------------
Confidence 36899999999999999999865 4578899998865411
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~ 306 (362)
........+..|+++++.++||||+++++.+......|++|||+.+++|.+++... ..+++.
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~ 103 (316)
T cd05574 40 ----------------IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE 103 (316)
T ss_pred ----------------chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHH
Confidence 11123456788999999999999999999999999999999999999999998754 468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 104 VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=185.94 Aligned_cols=150 Identities=27% Similarity=0.439 Sum_probs=130.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.+|+|+||.||++... .+..+++|.+....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~--------------------------------------- 42 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT--------------------------------------- 42 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc---------------------------------------
Confidence 4578999999999999999999854 24568999765321
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
...+.+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++... ..++
T Consensus 43 ---------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 101 (261)
T cd05072 43 ---------------------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL 101 (261)
T ss_pred ---------------------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCC
Confidence 11245788999999999999999999999999999999999999999998753 4578
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.+..
T Consensus 102 ~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 102 LPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 889999999999999999999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=183.94 Aligned_cols=151 Identities=26% Similarity=0.463 Sum_probs=131.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.+|.|+||.|+.+... .+++.+++|.+....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~------------------------------------------ 37 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTR------------------------------------------ 37 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecc------------------------------------------
Confidence 5889999999999999999855 457789999875321
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++.+.+.++++|||+++++|.+++.+. ..+++..
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08221 38 ---------------LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM 102 (256)
T ss_pred ---------------cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHH
Confidence 11223355788999999999999999999999999999999999999999999764 3589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||+++....
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999999999999999999999999999999999999999986633
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=195.74 Aligned_cols=150 Identities=24% Similarity=0.360 Sum_probs=125.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||.+.+. ..++.+|+|.+.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 61 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPF--------------------------------------- 61 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccc---------------------------------------
Confidence 3678999999999999999999854 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ..+|+||||++ ++|.+.+..
T Consensus 62 ------------------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~- 121 (364)
T cd07875 62 ------------------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM- 121 (364)
T ss_pred ------------------cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh-
Confidence 1122334577899999999999999999987543 35899999994 577777753
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 122 -~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 48889999999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=189.62 Aligned_cols=153 Identities=26% Similarity=0.399 Sum_probs=131.7
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+++.||.|+||.||++.... +++.+++|.+......
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~---------------------------------------- 39 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERK---------------------------------------- 39 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-CCcEEEEEEEeccccc----------------------------------------
Confidence 47889999999999999998553 4778999998654210
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~ 308 (362)
.........+..|+.+++.++||||+++++++.+.+..|+||||+ +++|.+++.... .+++..+
T Consensus 40 --------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~ 104 (298)
T cd07841 40 --------------EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADI 104 (298)
T ss_pred --------------cccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHH
Confidence 001122345678999999999999999999999999999999999 999999998765 7999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 105 ~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=186.61 Aligned_cols=151 Identities=25% Similarity=0.390 Sum_probs=131.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.+|+|+||.||++... ..++.+++|.+.+..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~---------------------------------------- 43 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT---------------------------------------- 43 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCCc----------------------------------------
Confidence 456889999999999999999865 457789999875321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
.....+.+|+.+++.++||||+++++++...+.++++|||+++++|.+++... ..+++
T Consensus 44 --------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~ 103 (263)
T cd05052 44 --------------------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 103 (263)
T ss_pred --------------------hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCH
Confidence 12245788999999999999999999999999999999999999999998753 35889
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...++
T Consensus 104 ~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 104 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999999999999999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=187.20 Aligned_cols=151 Identities=25% Similarity=0.330 Sum_probs=129.5
Q ss_pred cCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
++|+++..+|.|+||.||++..... ..+.+++|.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------------------------------------- 46 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------------------------------------- 46 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--------------------------------------
Confidence 6788999999999999999986432 2356777765332
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC---
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--- 301 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--- 301 (362)
........+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++....
T Consensus 47 --------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~ 106 (275)
T cd05046 47 --------------------KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD 106 (275)
T ss_pred --------------------cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccc
Confidence 011234568889999999999999999999999899999999999999999998655
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||+++...
T Consensus 107 ~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 107 EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccC
Confidence 68999999999999999999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=190.85 Aligned_cols=152 Identities=26% Similarity=0.391 Sum_probs=128.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCC------CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD------PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
.++|.+.+.||+|+||.||++...+. ....+|+|.+.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----------------------------------- 61 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----------------------------------- 61 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-----------------------------------
Confidence 46799999999999999999985431 2245888877532
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+..|+++++.+ +||||+++++++...+..|++|||+++++|.+++...
T Consensus 62 -----------------------~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~ 118 (307)
T cd05098 62 -----------------------ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 118 (307)
T ss_pred -----------------------CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhc
Confidence 0112235578899999999 7999999999999999999999999999999999753
Q ss_pred C----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 G----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+ .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 119 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 119 RPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191 (307)
T ss_pred CCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccccccc
Confidence 2 37888999999999999999999999999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=200.37 Aligned_cols=146 Identities=28% Similarity=0.413 Sum_probs=130.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++..+...||+|.||+||++.+.|+ ||||+++-.+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd----VAVK~Lnv~~--------------------------------------- 426 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD----VAVKLLNVDD--------------------------------------- 426 (678)
T ss_pred CHHHhhccceeccccccceeecccccc----eEEEEEecCC---------------------------------------
Confidence 456778889999999999999999875 8999986542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
......+.|..|+..+++-+|.||+=+.+++..+.. .||+.+|+|.+|+.+++-. ..|..
T Consensus 427 ------------------pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm 487 (678)
T KOG0193|consen 427 ------------------PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDM 487 (678)
T ss_pred ------------------CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhH
Confidence 122367889999999999999999999999987776 9999999999999999753 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
...+.|+.|++.|+.|||.++|||||||..||++.+++.|||+|||++.
T Consensus 488 ~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 488 NTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred HHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999999999999999999999999999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=195.44 Aligned_cols=141 Identities=23% Similarity=0.325 Sum_probs=124.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+++.||+|+||.||++... ..++.+|+|...+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~----------------------------------------- 102 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG----------------------------------------- 102 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc-----------------------------------------
Confidence 357999999999999999999865 45778999864321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 306 (362)
....|+.+++.++||||+++++++......++|||++ .++|.+++.. ...+++.
T Consensus 103 ------------------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~ 157 (357)
T PHA03209 103 ------------------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPID 157 (357)
T ss_pred ------------------------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHH
Confidence 1245889999999999999999999999999999999 5688887765 3568999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 158 QALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 9999999999999999999999999999999999999999999999974
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=189.03 Aligned_cols=152 Identities=24% Similarity=0.449 Sum_probs=131.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||.|+||.||++... .+++.+++|.+...+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~---------------------------------------- 39 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFD---------------------------------------- 39 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehh----------------------------------------
Confidence 357888999999999999999854 347789999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l 303 (362)
.........+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++.. ...+
T Consensus 40 ----------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 103 (267)
T cd08229 40 ----------------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103 (267)
T ss_pred ----------------hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCC
Confidence 11222345678899999999999999999999999999999999999999998864 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 104 ~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999999999999999999999999999999999999999988755
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=188.93 Aligned_cols=154 Identities=25% Similarity=0.419 Sum_probs=130.1
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.... .....+++|.+....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----------------------------------- 54 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----------------------------------- 54 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-----------------------------------
Confidence 34678999999999999999998653 223568888765320
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.......+.+|+.++..+ +||||+++++++...+.+|++|||+++++|.+++...
T Consensus 55 -----------------------~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~ 111 (293)
T cd05053 55 -----------------------TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR 111 (293)
T ss_pred -----------------------CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcC
Confidence 112234578899999999 8999999999999999999999999999999998642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 ---------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ---------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+..
T Consensus 112 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcccccccccc
Confidence 3478899999999999999999999999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=190.68 Aligned_cols=153 Identities=26% Similarity=0.403 Sum_probs=128.9
Q ss_pred cccCcEEEEEecccceecEEEEEecC------CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG------DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
...+|.+...||+|+||.||.+.... ..+..+++|.+...
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---------------------------------- 58 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---------------------------------- 58 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----------------------------------
Confidence 45778999999999999999997532 12346888876432
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.+ +||||+++++++...+..|++|||+++++|.+++.+
T Consensus 59 ------------------------~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (304)
T cd05101 59 ------------------------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 114 (304)
T ss_pred ------------------------cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHh
Confidence 1122345678899999999 899999999999999999999999999999999876
Q ss_pred cC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KG----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.. .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~ 188 (304)
T cd05101 115 RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188 (304)
T ss_pred cCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecc
Confidence 32 36778889999999999999999999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=187.36 Aligned_cols=149 Identities=26% Similarity=0.396 Sum_probs=127.5
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.||+|+||.||++... .+++.+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------ 37 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLES------------------------------------------ 37 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEecccc------------------------------------------
Confidence 5889999999999999999854 457889999875421
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---CCCCHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---GNFDDA 306 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++..++.+|+||||++ ++|.+++... ..+++.
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~ 101 (285)
T cd07861 38 ---------------EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAE 101 (285)
T ss_pred ---------------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHH
Confidence 011123456789999999999999999999999999999999996 6888887642 458999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 999999999999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=186.08 Aligned_cols=154 Identities=25% Similarity=0.437 Sum_probs=128.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCC---CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPS---RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
+..|+.+..||+|+||.||++...+.+. +.+|||.++...-
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------------------------------------ 66 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------------------------------------ 66 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------------------------------------
Confidence 5678999999999999999996544322 3789998754310
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc---
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK--- 300 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--- 300 (362)
....-....+|+.+++.++|||++.+..+|.. +..+|+++||. ..+|.++|+-.
T Consensus 67 ---------------------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA-EhDL~~II~fHr~~ 124 (438)
T KOG0666|consen 67 ---------------------GTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA-EHDLWHIIKFHRAS 124 (438)
T ss_pred ---------------------CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh-hhhHHHHHHHhccc
Confidence 01112346789999999999999999999877 77899999998 67999998743
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC----CcEEEEecccceecCCC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~~~~~~ 359 (362)
+.++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||+||.+.+|
T Consensus 125 ~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 125 KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP 189 (438)
T ss_pred hhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence 348999999999999999999999999999999999999876 89999999999988665
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=193.10 Aligned_cols=156 Identities=32% Similarity=0.595 Sum_probs=136.3
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
+.+...+|..+.+||+|+||.|.++.+. .+.+.+|||++++.-+...+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdD------------------------------- 391 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDD------------------------------- 391 (683)
T ss_pred cceeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecC-------------------------------
Confidence 4557789999999999999999999955 46788999999886332221
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
..+--+.|..+|+.. +.|.+++++.+|+..+.+|+||||+.||+|.-.++.-+.
T Consensus 392 -------------------------Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk 446 (683)
T KOG0696|consen 392 -------------------------DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK 446 (683)
T ss_pred -------------------------cccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc
Confidence 112235677888877 578999999999999999999999999999999998899
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.+..+.+++..|+-||-|||++|||+||||.+|+|++.+|++||+|||+++.-
T Consensus 447 FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 447 FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999999999999999999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=192.35 Aligned_cols=147 Identities=20% Similarity=0.165 Sum_probs=114.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+...||+|+||.||++.+...+++.+|+|.+.....
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~-------------------------------------- 57 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP-------------------------------------- 57 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc--------------------------------------
Confidence 457899999999999999999987655677789987642100
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceee-eeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK-LYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
..........+.+|+.+|+.++|+|++. ++.. +..|+||||++|++|... . ...
T Consensus 58 ----------------~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~---~~~- 112 (365)
T PRK09188 58 ----------------WWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-R---PHG- 112 (365)
T ss_pred ----------------ccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-C---ccc-
Confidence 0001123456889999999999999885 4442 358999999999999632 1 111
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecC-CCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDL-KPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDi-kp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+.+..
T Consensus 113 --~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 113 --DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred --hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 1467889999999999999999999 99999999999999999999997643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=189.74 Aligned_cols=145 Identities=16% Similarity=0.180 Sum_probs=124.7
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
..+++|++|.||++... ++.+|+|.+.+..
T Consensus 26 ~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~----------------------------------------------- 55 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---NKEVIIRTFKKFH----------------------------------------------- 55 (283)
T ss_pred eEEeeCCceEEEEEEEC---CEEEEEEeccccc-----------------------------------------------
Confidence 46899999999999863 6789999886531
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCCCHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 310 (362)
.......+.+.+|+.+|++++||||+++++++.+ ...++++|||+++|+|.+++.+.+.++......
T Consensus 56 ---------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~ 126 (283)
T PHA02988 56 ---------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLD 126 (283)
T ss_pred ---------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHH
Confidence 1112223567899999999999999999998866 457899999999999999998877899999999
Q ss_pred HHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 311 YTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 311 ~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.+..
T Consensus 127 i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 127 MAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999999998 5999999999999999999999999999986543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=190.46 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=126.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCC-------------CCCceeeeeeccccccccccccccceeeeCCCCceEEEeeh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD-------------PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQ 214 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~-------------~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~ 214 (362)
..+|++.+.||+|+||.||++...+. ....+|+|.+.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---------------------------- 55 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---------------------------- 55 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----------------------------
Confidence 35899999999999999999875421 1123667665432
Q ss_pred hhHHhhccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchH
Q psy14740 215 ETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELW 294 (362)
Q Consensus 215 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 294 (362)
........+.+|+++++.++|||++++++++...+..+++|||+++++|.
T Consensus 56 ------------------------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (295)
T cd05097 56 ------------------------------VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105 (295)
T ss_pred ------------------------------CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHH
Confidence 11123345889999999999999999999999999999999999999999
Q ss_pred HHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 295 TILRDKG------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 295 ~~l~~~~------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++.... .++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 106 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179 (295)
T ss_pred HHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEeccccccccc
Confidence 9886431 3678888999999999999999999999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=188.09 Aligned_cols=149 Identities=28% Similarity=0.405 Sum_probs=127.2
Q ss_pred cEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 151 LRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
|++++.||+|+||.||++... ..++..+++|.+....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---------------------------------------- 45 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---------------------------------------- 45 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----------------------------------------
Confidence 578899999999999999743 3456789999875321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
.......+.+|+.+++.++||||+++++++... ..++++|||+++++|.+++.+.. .++
T Consensus 46 ------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~ 107 (284)
T cd05079 46 ------------------GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107 (284)
T ss_pred ------------------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCC
Confidence 112234578999999999999999999988765 57899999999999999987643 589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|+|++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 108 ~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 108 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=188.40 Aligned_cols=149 Identities=28% Similarity=0.438 Sum_probs=131.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.||+|+||.||++... .+++.+++|.+....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 56 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQ---------------------------------------- 56 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCc----------------------------------------
Confidence 478999999999999999999854 457889999875321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++.+..++..|+||||+++++|.+++.+ ..+++..
T Consensus 57 -------------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~ 116 (297)
T cd06656 57 -------------------QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQ 116 (297)
T ss_pred -------------------cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHH
Confidence 11224477899999999999999999999999999999999999999999865 4689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 117 ~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=186.37 Aligned_cols=151 Identities=25% Similarity=0.320 Sum_probs=125.7
Q ss_pred cEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
|++.+.+|+|+||.||.+....+ .+..+|+|.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~----------------------------------------- 39 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI----------------------------------------- 39 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-----------------------------------------
Confidence 46778899999999999986543 34679999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------eEEEEEeccCCcchHHHHHhc--
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
........+.+|+.+++.++||||+++++++.... ..+++|||+++++|..++...
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~ 103 (273)
T cd05035 40 ----------------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL 103 (273)
T ss_pred ----------------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhc
Confidence 11223456889999999999999999999875544 389999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 ----GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ----~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 165 (273)
T cd05035 104 GGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165 (273)
T ss_pred cCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccc
Confidence 2588999999999999999999999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=187.64 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=121.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||+|+||.||++.+. .+++.+|+|.+.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~----------------------------------------- 38 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTN----------------------------------------- 38 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcC-----------------------------------------
Confidence 4889999999999999999855 5688999998754210
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeeec-----cceEEEEEeccCCcchHHHHHhc-
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFKD-----KKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.........+|+.+++.+ +||||+++++++.. ...++++||+++ ++|.+++...
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 101 (288)
T cd07863 39 ----------------EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP 101 (288)
T ss_pred ----------------CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcC
Confidence 011112345566666654 79999999998754 346899999995 5888888753
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 102 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 348999999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=197.53 Aligned_cols=152 Identities=28% Similarity=0.435 Sum_probs=127.5
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++.+.+ ..+..+|+|.+....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------------------------------- 79 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----------------------------------- 79 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-----------------------------------
Confidence 34567788999999999999998643 234579999885431
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.....+.+.+|+.++..+. ||||+++++++..++..++||||+++|+|.+++..++
T Consensus 80 -----------------------~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~ 136 (401)
T cd05107 80 -----------------------RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNK 136 (401)
T ss_pred -----------------------ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhcc
Confidence 1112245789999999997 9999999999999999999999999999999986431
Q ss_pred --------------------------------------------------------------------------------
Q psy14740 302 -------------------------------------------------------------------------------- 301 (362)
Q Consensus 302 -------------------------------------------------------------------------------- 301 (362)
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (401)
T cd05107 137 HTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQY 216 (401)
T ss_pred ccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhh
Confidence
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 ------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 ------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289 (401)
T ss_pred hcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceec
Confidence 2466678889999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=187.82 Aligned_cols=150 Identities=24% Similarity=0.315 Sum_probs=131.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-.+|++.+.||.|+||.||++.... +..+++|.+....
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~---------------------------------------- 42 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDD---------------------------------------- 42 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccc----------------------------------------
Confidence 3568889999999999999998654 7789999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
......+..|+.+++.++||||+++++++...+.++++|||+++++|.+++.+. ..++.
T Consensus 43 -------------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 103 (261)
T cd05148 43 -------------------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV 103 (261)
T ss_pred -------------------hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCH
Confidence 112345778999999999999999999999999999999999999999999753 35899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+..+..
T Consensus 104 ~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999999999999999999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=185.97 Aligned_cols=157 Identities=27% Similarity=0.424 Sum_probs=133.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+...||.|+||.||.+... ..++.+++|.+.........
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~------------------------------------- 42 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASS------------------------------------- 42 (267)
T ss_pred CccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccch-------------------------------------
Confidence 4677889999999999999855 34778999987653110000
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
..........+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++...+.+++..+.
T Consensus 43 -------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 109 (267)
T cd06628 43 -------------KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR 109 (267)
T ss_pred -------------hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHH
Confidence 0011223356788999999999999999999999999999999999999999999887789999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 110 ~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred HHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999999999999999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=192.28 Aligned_cols=159 Identities=33% Similarity=0.598 Sum_probs=138.2
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.....+.|+.-.+||.|+||+|+-++ ..++++-||.|.+.|....
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acq-vraTGKMYAcKkL~KKRiK---------------------------------- 224 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQ-VRATGKMYACKKLDKKRIK---------------------------------- 224 (591)
T ss_pred hhccccceeeeEEEecccccceeEEE-EecchhhHHHHHHHHHHHH----------------------------------
Confidence 34567889999999999999999988 5578999999988775221
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
...-..-.+.|..+|.+++.|.||.+-..|+..+.+++||..+.||+|.-.|-+.+
T Consensus 225 ----------------------kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~ 282 (591)
T KOG0986|consen 225 ----------------------KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP 282 (591)
T ss_pred ----------------------HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC
Confidence 11122346789999999999999999999999999999999999999987666544
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.|++..+++++.+|+.||++||+.+|++||+||+|||+|+.|++.|+|+|+|..+..+
T Consensus 283 gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 283 GFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred CCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 6999999999999999999999999999999999999999999999999999887654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=186.10 Aligned_cols=154 Identities=24% Similarity=0.385 Sum_probs=131.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.+|+|+||.||.+... .+++.+++|.+......
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~---------------------------------------- 39 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNT---------------------------------------- 39 (268)
T ss_pred CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCC----------------------------------------
Confidence 4777889999999999999854 55788999987543100
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
..........+.+|+.+++.++||||+++++++.+++.++++|||+++++|.+++.+.+++++..+.
T Consensus 40 -------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~ 106 (268)
T cd06630 40 -------------SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII 106 (268)
T ss_pred -------------chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHH
Confidence 0011123466889999999999999999999999999999999999999999999887889999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLI 357 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~ 357 (362)
.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+..+.
T Consensus 107 ~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 107 NYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999999999999999999998765 59999999987664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=186.71 Aligned_cols=149 Identities=25% Similarity=0.347 Sum_probs=126.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.||+|+||.||.+.... +++.+++|.+....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~---------------------------------------- 42 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKT---------------------------------------- 42 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccC----------------------------------------
Confidence 4789999999999999999998553 47789999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 306 (362)
.......+.+|+.+++.++||||+++++++..++..|++|||+. +++.+++.. ...+++.
T Consensus 43 ------------------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 103 (291)
T cd07870 43 ------------------EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPY 103 (291)
T ss_pred ------------------cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHH
Confidence 01112345689999999999999999999999999999999995 677766654 3457888
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus 104 ~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=178.85 Aligned_cols=168 Identities=15% Similarity=0.063 Sum_probs=113.3
Q ss_pred EEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 154 ITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 154 ~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
...||+|+||.||.+... +++.+|+|+++++.....+... .... ...|.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~---~~~~-----------~~~~~~~------------- 52 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDR---YVSG-----------EFRFRHG------------- 52 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHH---hhcC-----------Cchhhcc-------------
Confidence 357999999999999864 5889999999764210000000 0000 0000000
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
................|+.++..+.++++......... ..++||||++|+++........+++...+..++.
T Consensus 53 ------~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~ 124 (190)
T cd05147 53 ------YCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYL 124 (190)
T ss_pred ------ccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHH
Confidence 00000001112234579999999987776544333222 2389999998877765544456799999999999
Q ss_pred HHHHHHHHH-HHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 314 CVVEAFDYL-HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 314 ql~~al~~l-H~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
|++.+|.++ |+.||+||||||+|||++ ++.++|+|||+|.....|
T Consensus 125 qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 125 QVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCCCc
Confidence 999999999 799999999999999998 578999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=214.70 Aligned_cols=149 Identities=30% Similarity=0.505 Sum_probs=127.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+.+|..+..||+|+||.||++++.-| |+.||||.+.-.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlD-Gr~YAIKKIpl~----------------------------------------- 515 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLD-GREYAIKKIPLK----------------------------------------- 515 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeeccc-chhhhhhhccCc-----------------------------------------
Confidence 35677788999999999999997654 889999988532
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------------------------------
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------------------------------ 277 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------------------------------ 277 (362)
.+......+.+|+.++++++|||||++|..|..
T Consensus 516 -----------------~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~ 578 (1351)
T KOG1035|consen 516 -----------------ASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDI 578 (1351)
T ss_pred -----------------hHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCccccee
Confidence 134455778999999999999999999998722
Q ss_pred --------------------------------------------------------------------------------
Q psy14740 278 -------------------------------------------------------------------------------- 277 (362)
Q Consensus 278 -------------------------------------------------------------------------------- 277 (362)
T Consensus 579 ~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~ 658 (1351)
T KOG1035|consen 579 RYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENS 658 (1351)
T ss_pred eeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCc
Confidence
Q ss_pred -c--------ceEEEEEeccCCcchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEE
Q psy14740 278 -K--------KYLYMLMESCLGGELWTILRDKGNF-DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKL 347 (362)
Q Consensus 278 -~--------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl 347 (362)
+ ..+||-||||+..++.+++.++... ....++.+++||++||.|+|++|||||||||.||+++.++.|||
T Consensus 659 ~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKI 738 (1351)
T KOG1035|consen 659 SEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKI 738 (1351)
T ss_pred cccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeee
Confidence 0 2479999999988888888876544 57889999999999999999999999999999999999999999
Q ss_pred Eeccccee
Q psy14740 348 VDFGFAKK 355 (362)
Q Consensus 348 ~DFG~a~~ 355 (362)
+|||+|..
T Consensus 739 GDFGLAt~ 746 (1351)
T KOG1035|consen 739 GDFGLATD 746 (1351)
T ss_pred cccccchh
Confidence 99999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=183.23 Aligned_cols=147 Identities=33% Similarity=0.564 Sum_probs=125.6
Q ss_pred EEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 152 RVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+.+.||.|.||.||.+.+. ...+..+++|.++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~------------------------------------------ 39 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS------------------------------------------ 39 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT------------------------------------------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc------------------------------------------
Confidence 46789999999999999987 233567899887432
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~ 306 (362)
........+.+|++.++.++||||+++++++...+..++||||+++++|.+++... ..++..
T Consensus 40 ----------------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~ 103 (259)
T PF07714_consen 40 ----------------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQ 103 (259)
T ss_dssp ----------------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHH
T ss_pred ----------------cccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11223567889999999999999999999999888899999999999999999886 569999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
....++.|++.||.|||+++++|+||+|+||+++.++.+||+|||+++..
T Consensus 104 ~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 104 QRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999999999877
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=198.13 Aligned_cols=143 Identities=20% Similarity=0.195 Sum_probs=125.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|.+...||+|+||.||++.+.. .++.+++|....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~~------------------------------------------ 204 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGWY------------------------------------------ 204 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-CCCEEEEecccc------------------------------------------
Confidence 4579999999999999999998654 467889885311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
..+.+|+.+++.++||||+++++++..++..+++|+++ .++|..++... ..+++.
T Consensus 205 -----------------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~ 260 (461)
T PHA03211 205 -----------------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLA 260 (461)
T ss_pred -----------------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHH
Confidence 12467999999999999999999999999999999999 57888887654 469999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 261 ~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred HHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999999999999999999999999999999999999999999998653
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=185.63 Aligned_cols=152 Identities=25% Similarity=0.419 Sum_probs=131.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||++.. .+++.+|+|.+......
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~---------------------------------------- 38 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSN---------------------------------------- 38 (265)
T ss_pred CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccc----------------------------------------
Confidence 478889999999999999974 34678999987543100
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
..........+.+|+++++.++||||+++++++.+.+..|++|||+++++|.+++.+..++++..+.
T Consensus 39 -------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 105 (265)
T cd06631 39 -------------VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC 105 (265)
T ss_pred -------------hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHH
Confidence 0011223356889999999999999999999999999999999999999999999887789999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.+
T Consensus 106 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred HHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=187.60 Aligned_cols=152 Identities=26% Similarity=0.404 Sum_probs=128.5
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
...+|.+...||.|+||.||++.... .+...+++|.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~------------------------------------ 46 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------------------------------------ 46 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc------------------------------------
Confidence 35678999999999999999998533 22345677765432
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG- 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 301 (362)
.......+.+|+.+++.++||||+++++++...+..++||||+++++|.+++....
T Consensus 47 -----------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~ 103 (291)
T cd05094 47 -----------------------TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP 103 (291)
T ss_pred -----------------------cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCc
Confidence 11223457889999999999999999999999999999999999999999997532
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ---------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ---------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~ 174 (291)
T cd05094 104 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174 (291)
T ss_pred ccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccC
Confidence 37889999999999999999999999999999999999999999999999997553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=193.86 Aligned_cols=151 Identities=30% Similarity=0.432 Sum_probs=125.5
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|++.+.||.|+||.||++.+.+ .+++.+|+|.+....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~------------------------------------ 49 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------------------------------ 49 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC------------------------------------
Confidence 4579999999999999999997532 346789999875421
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhcC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.++..+ +||||+++++++.. +..++++|||+++++|.+++....
T Consensus 50 ----------------------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~ 107 (343)
T cd05103 50 ----------------------THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKR 107 (343)
T ss_pred ----------------------ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcC
Confidence 112234578899999999 68999999998754 456899999999999999886421
Q ss_pred -------------------------------------------------------------------CCCHHHHHHHHHH
Q psy14740 302 -------------------------------------------------------------------NFDDATTRFYTAC 314 (362)
Q Consensus 302 -------------------------------------------------------------------~l~~~~~~~~~~q 314 (362)
.++...+..++.|
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 187 (343)
T cd05103 108 GEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQ 187 (343)
T ss_pred CccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHH
Confidence 2567788889999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++||+||||||+||+++.++.++|+|||+++.+
T Consensus 188 i~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred HHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 999999999999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=187.94 Aligned_cols=151 Identities=30% Similarity=0.481 Sum_probs=131.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. ..++.+|+|.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~----------------------------------------- 38 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESE----------------------------------------- 38 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhcc-----------------------------------------
Confidence 46889999999999999999865 457889999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+++++.++||||+++++++..++..|++|||+++++|..+......+++..+
T Consensus 39 ----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 102 (286)
T cd07846 39 ----------------DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV 102 (286)
T ss_pred ----------------CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHH
Confidence 0112234577899999999999999999999999999999999999999888776667999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 103 ~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 9999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=189.74 Aligned_cols=152 Identities=27% Similarity=0.409 Sum_probs=127.8
Q ss_pred ccCcEEEEEecccceecEEEEEecC------CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG------DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
-++|.+.+.||+|+||.||++...+ .....+++|.+...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----------------------------------- 55 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----------------------------------- 55 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-----------------------------------
Confidence 4678899999999999999997432 23446788876432
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+..|+.+++.+ +||||+++++++...+.+|++|||+++++|.+++...
T Consensus 56 -----------------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~ 112 (314)
T cd05099 56 -----------------------ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRAR 112 (314)
T ss_pred -----------------------CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhc
Confidence 0112234578899999999 6999999999999999999999999999999999653
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 ----------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ----------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.
T Consensus 113 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 113 RPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185 (314)
T ss_pred CCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccccccc
Confidence 237888899999999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=185.01 Aligned_cols=142 Identities=25% Similarity=0.488 Sum_probs=126.5
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
+.||+|+|+.|--+... .++..||+|++.|.
T Consensus 84 e~LGeGAyasVqtcv~i-~t~~EYAVKiidKq------------------------------------------------ 114 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSI-QTGKEYAVKIIDKQ------------------------------------------------ 114 (463)
T ss_pred HHhcCccceeeeeeeee-ccchhhhhhhhhcC------------------------------------------------
Confidence 56999999999988855 46888999998663
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
....+.++.+|++++..+ .|+||++++++|+++..+|+|||.+.||+|.+.|.+.+.|++..+..+..
T Consensus 115 -----------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvk 183 (463)
T KOG0607|consen 115 -----------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVK 183 (463)
T ss_pred -----------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHH
Confidence 234567899999999998 69999999999999999999999999999999999988999999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceec
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKL 356 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~ 356 (362)
.|+.||.|||.+||.|||+||+|||-...+ -+|||||.++..+
T Consensus 184 dia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 184 DIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999999999999999999996543 4899999887543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=188.34 Aligned_cols=152 Identities=24% Similarity=0.352 Sum_probs=130.5
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
..+|.+.+.+|+|+||.||++.... ..++.+++|.+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~------------------------------------- 46 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET------------------------------------- 46 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-------------------------------------
Confidence 4568888999999999999997542 23567899987542
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
........+.+|+++++.++||||+++++++......|++|||+++++|.+++...+
T Consensus 47 ---------------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~ 105 (280)
T cd05049 47 ---------------------ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD 105 (280)
T ss_pred ---------------------CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCc
Confidence 111234568899999999999999999999999999999999999999999987542
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~ 173 (280)
T cd05049 106 AAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY 173 (280)
T ss_pred hhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecc
Confidence 37888999999999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=188.31 Aligned_cols=149 Identities=26% Similarity=0.462 Sum_probs=127.7
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||.|+||.||++.+. .+++.+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~------------------------------------------ 37 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDD------------------------------------------ 37 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeeccc------------------------------------------
Confidence 4788999999999999999865 457889999875421
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++.+...+|+++||++ ++|.+++.+ .+.+++..+
T Consensus 38 ---------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 101 (284)
T cd07839 38 ---------------DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIV 101 (284)
T ss_pred ---------------ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHH
Confidence 011122446779999999999999999999999999999999995 578887764 456999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 9999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=188.57 Aligned_cols=149 Identities=24% Similarity=0.415 Sum_probs=125.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCC-CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPS-RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
++|++.+.||+|+||.||++....+.. ..+++|.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----------------------------------------- 40 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----------------------------------------- 40 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-----------------------------------------
Confidence 578999999999999999998654322 34677765421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-----
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----- 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----- 301 (362)
......+.+.+|+.++.++ +||||+++++++...+.+|++|||+++++|.+++....
T Consensus 41 -----------------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 103 (297)
T cd05089 41 -----------------ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETD 103 (297)
T ss_pred -----------------CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccc
Confidence 1112235578899999998 79999999999999999999999999999999986532
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 302 -----------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 302 -----------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 168 (297)
T cd05089 104 PAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168 (297)
T ss_pred cccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcc
Confidence 378889999999999999999999999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=186.10 Aligned_cols=153 Identities=24% Similarity=0.404 Sum_probs=129.2
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+...||+|+||.||.+.... ..+..+++|.+....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----------------------------------- 48 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----------------------------------- 48 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-----------------------------------
Confidence 34678999999999999999988643 234678888864321
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG- 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 301 (362)
.......+.+|+.+++.++||||+++++++......|++|||+++++|.+++....
T Consensus 49 -----------------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 105 (277)
T cd05032 49 -----------------------SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRP 105 (277)
T ss_pred -----------------------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhccc
Confidence 11223457789999999999999999999999999999999999999999986532
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ---------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ---------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05032 106 EAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170 (277)
T ss_pred chhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhc
Confidence 36778899999999999999999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=203.77 Aligned_cols=168 Identities=23% Similarity=0.350 Sum_probs=124.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++++.||+|+||.||++......+...+.|.+.....- .... ...+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~---~~~~---------------------------~~~~ 196 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQG---KPKC---------------------------ERLI 196 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhcccccccc---chhh---------------------------hhhH
Confidence 578999999999999999998765444444444422211000 0000 0000
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-----CC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-----GN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~ 302 (362)
.+. ..........+.+|+.+|+.++||||+++++++...+..|++++++ +++|..++... ..
T Consensus 197 -----~k~-------~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~ 263 (501)
T PHA03210 197 -----AKR-------VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDR 263 (501)
T ss_pred -----hHH-------hhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccccccc
Confidence 000 0111223456889999999999999999999999999999999998 66777776542 12
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.....++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 264 ~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 319 (501)
T PHA03210 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319 (501)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCc
Confidence 34567888999999999999999999999999999999999999999999987643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=208.11 Aligned_cols=154 Identities=31% Similarity=0.507 Sum_probs=128.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.++..||.|+||.||++.+. ..++.+++|.+....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~-------------------------------------- 50 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRG-------------------------------------- 50 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccc--------------------------------------
Confidence 35789999999999999999999965 457789999875431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhc---
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDK--- 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--- 300 (362)
........+..|+.+++.++||||++++++|.. ...+|+||||+++++|.+++...
T Consensus 51 -------------------l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~ 111 (1021)
T PTZ00266 51 -------------------LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM 111 (1021)
T ss_pred -------------------cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhc
Confidence 112234567889999999999999999998854 46799999999999999988752
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeecCCCCcEEecC-----------------CCcEEEEeccccee
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHSR-------NIIYRDLKPENLLLST-----------------SGYVKLVDFGFAKK 355 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~~-------~iiHrDikp~NIl~~~-----------------~~~~kl~DFG~a~~ 355 (362)
..+++..++.|+.||+.||.|||+. +|+||||||+|||++. .+.+||+|||+++.
T Consensus 112 ~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~ 191 (1021)
T PTZ00266 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191 (1021)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccc
Confidence 4699999999999999999999985 4999999999999964 23489999999976
Q ss_pred cC
Q psy14740 356 LI 357 (362)
Q Consensus 356 ~~ 357 (362)
+.
T Consensus 192 l~ 193 (1021)
T PTZ00266 192 IG 193 (1021)
T ss_pred cc
Confidence 53
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=183.40 Aligned_cols=147 Identities=29% Similarity=0.415 Sum_probs=130.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.+|.|+||.||.+... ++.+++|.+....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~--------------------------------------- 41 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDS--------------------------------------- 41 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec---CcEEEEEEeccch---------------------------------------
Confidence 3567899999999999999999743 6789999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 304 (362)
....++..|+.+++.++||||+++++++.+.+..|++|||+++++|.+++.... .++
T Consensus 42 ---------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~ 100 (256)
T cd05039 42 ---------------------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT 100 (256)
T ss_pred ---------------------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCC
Confidence 133567889999999999999999999988899999999999999999998654 689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++..
T Consensus 101 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 101 LAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999999999999999999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=190.58 Aligned_cols=141 Identities=25% Similarity=0.471 Sum_probs=116.6
Q ss_pred EEecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 155 TTLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
..||+|+||.||++.... ..++.+|+|.+....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---------------------------------------------- 40 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---------------------------------------------- 40 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC----------------------------------------------
Confidence 579999999999998643 356789999875321
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhc---------CC
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDK---------GN 302 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~ 302 (362)
......+|+.+++.++||||+++++++.. ...+|++|||+ +++|.+++... ..
T Consensus 41 ---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~ 104 (317)
T cd07868 41 ---------------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQ 104 (317)
T ss_pred ---------------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCccc
Confidence 11235689999999999999999998854 46789999998 56888877532 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe----cCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~----~~~~~~kl~DFG~a~~~~ 357 (362)
+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 105 l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 8899999999999999999999999999999999999 456789999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=183.54 Aligned_cols=149 Identities=28% Similarity=0.429 Sum_probs=130.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.+|.|+||.||++...+ ++.+++|.+....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~--~~~~~vK~~~~~~--------------------------------------- 42 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG--TTKVAVKTLKPGT--------------------------------------- 42 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC--CceEEEEEecCCc---------------------------------------
Confidence 35789999999999999999998543 4678999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 304 (362)
.....+.+|+.+++.++||||+++++++......+++|||+++++|.+++.... .++
T Consensus 43 ---------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~ 101 (261)
T cd05034 43 ---------------------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR 101 (261)
T ss_pred ---------------------cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCC
Confidence 112457889999999999999999999998889999999999999999997643 589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 102 LPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999999999999999999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=184.37 Aligned_cols=144 Identities=25% Similarity=0.405 Sum_probs=123.4
Q ss_pred EecccceecEEEEEec-CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 156 TLGVGGFGRVELVQIA-GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
.||+|+||.||++.+. ...+..+|+|++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~----------------------------------------------- 34 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN----------------------------------------------- 34 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-----------------------------------------------
Confidence 4899999999998643 3456789999875431
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
........+..|+.+++.++||||+++++++. .+..+++|||+++++|.+++...+.+++..+..++.|
T Consensus 35 ----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~q 103 (257)
T cd05116 35 ----------NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ 103 (257)
T ss_pred ----------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHH
Confidence 11223456788999999999999999999875 4567999999999999999987778999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|+|++|++||||||.||+++.++.++|+|||+++.+.
T Consensus 104 i~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 104 VSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred HHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 9999999999999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=204.23 Aligned_cols=148 Identities=30% Similarity=0.476 Sum_probs=129.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+-|.++..||.|+||.||++.+. +++-..|-|++..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIet------------------------------------------- 67 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIET------------------------------------------- 67 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcc-------------------------------------------
Confidence 45788999999999999999854 6666666676532
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
.+......++-|++||..++||+|+++++.|..++.+||+.|||.||.+..++-. ...+++.+
T Consensus 68 ----------------kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~Q 131 (1187)
T KOG0579|consen 68 ----------------KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQ 131 (1187)
T ss_pred ----------------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHH
Confidence 3344567788999999999999999999999999999999999999999887765 45699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.+++|++.||.|||++.|||||||..|||+.-+|.++|+|||.+.+.
T Consensus 132 Iqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 132 IQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred HHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 9999999999999999999999999999999999999999999998654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=189.13 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=129.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... ..++.+|+|.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~------------------------------------------ 37 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLE------------------------------------------ 37 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecc------------------------------------------
Confidence 36888999999999999999865 45788999987432
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---CCCCH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---GNFDD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~ 305 (362)
........+.+|+.+++.++||||+++++.+..++.+|++|||+++++|.+++... ..+++
T Consensus 38 ----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 101 (286)
T cd06622 38 ----------------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE 101 (286)
T ss_pred ----------------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCH
Confidence 01122356788999999999999999999999999999999999999999988763 36899
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+
T Consensus 102 ~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999999999999999997 59999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=186.88 Aligned_cols=153 Identities=38% Similarity=0.639 Sum_probs=135.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.||.|+||.||.+... .+++.+++|++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 38 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQ----------------------------------------- 38 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHh-----------------------------------------
Confidence 47899999999999999999865 457889999886531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.........+..|..+++.++ ||||+++++++...+..+++||++++++|.+++.+.+.+++..
T Consensus 39 ---------------~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 103 (280)
T cd05581 39 ---------------LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC 103 (280)
T ss_pred ---------------ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence 111222356788999999998 9999999999999999999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 104 ~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=188.81 Aligned_cols=153 Identities=29% Similarity=0.435 Sum_probs=130.0
Q ss_pred cccCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++... ...+..+|+|.+.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------------------------- 77 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----------------------------------- 77 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-----------------------------------
Confidence 3467899999999999999998742 2334568888765421
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.+++.+ +||||+++++++...+..|++|||+++++|.+++....
T Consensus 78 -----------------------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~ 134 (302)
T cd05055 78 -----------------------HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR 134 (302)
T ss_pred -----------------------ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC
Confidence 112235678899999999 79999999999999999999999999999999997643
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 --NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 --~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++.++..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+.
T Consensus 135 ~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 135 ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 38999999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=188.32 Aligned_cols=149 Identities=32% Similarity=0.490 Sum_probs=131.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||.|+||.||++.... ++..+++|.+...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~----------------------------------------- 41 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIE----------------------------------------- 41 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeC-----------------------------------------
Confidence 4568889999999999999998654 5778999987432
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
.......+..|+.+++.++||||+++++.+..+...|+||||+++++|.+++.+. ..+++.
T Consensus 42 ------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~ 103 (280)
T cd06611 42 ------------------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEP 103 (280)
T ss_pred ------------------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHH
Confidence 1223355788999999999999999999999999999999999999999998764 469999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 104 ~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999999999999999999999999999999999999999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=182.83 Aligned_cols=153 Identities=31% Similarity=0.498 Sum_probs=132.3
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.||.|+||.||++... .+++.+++|.+.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~----------------------------------------- 38 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADD----------------------------------------- 38 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccc-----------------------------------------
Confidence 4677788999999999999855 4578899998754311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
........+.+.+|+.+++.++||||+++++++.....+|++|||+++++|.+++.+...+++..+.
T Consensus 39 -------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 105 (258)
T cd06632 39 -------------GQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR 105 (258)
T ss_pred -------------cccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHH
Confidence 0111223456889999999999999999999999999999999999999999999887779999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=185.71 Aligned_cols=144 Identities=30% Similarity=0.598 Sum_probs=119.1
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+++.+|+|.+.+....
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~---------------------------------------------- 33 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIK---------------------------------------------- 33 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccc----------------------------------------------
Confidence 3799999999999855 45789999988654210
Q ss_pred hhhccccccccchhhhhhHHHHHH---HhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEI---MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
.........+|..+ +...+||||+.+++.+..++..++||||+++++|.+++...+.+++..+..++
T Consensus 34 ----------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~ 103 (279)
T cd05633 34 ----------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA 103 (279)
T ss_pred ----------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHH
Confidence 00111122334333 33457999999999999999999999999999999999887889999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 104 ~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred HHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 99999999999999999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=186.28 Aligned_cols=143 Identities=36% Similarity=0.641 Sum_probs=124.2
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||.+... .+++.+++|.+.+..
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~------------------------------------------------- 30 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKR------------------------------------------------- 30 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhh-------------------------------------------------
Confidence 689999999999854 458889999886531
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTRFYTAC 314 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~q 314 (362)
.........+..|+++++.++||||+++++++...+.+|+||||+++++|.+++.+.. .+++..+..++.|
T Consensus 31 -------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~q 103 (277)
T cd05577 31 -------LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ 103 (277)
T ss_pred -------hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHH
Confidence 1111223456789999999999999999999999999999999999999999987655 6899999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|||++|++|+||+|+||+++.++.++|+|||.+..+
T Consensus 104 l~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 104 IICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999999999999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=187.07 Aligned_cols=149 Identities=23% Similarity=0.391 Sum_probs=125.3
Q ss_pred CcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+|++...||+|+||.||++..... ....+++|.+.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--------------------------------------- 41 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--------------------------------------- 41 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---------------------------------------
Confidence 477889999999999999985432 2245677766432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-----
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----- 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----- 300 (362)
........+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++...
T Consensus 42 -------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 102 (290)
T cd05045 42 -------------------ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGP 102 (290)
T ss_pred -------------------CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccc
Confidence 11122356888999999999999999999999999999999999999999988642
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 -------------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 -------------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++...+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 103 SYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred cccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccc
Confidence 23778899999999999999999999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=184.44 Aligned_cols=157 Identities=30% Similarity=0.456 Sum_probs=132.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||.|+||.||++... .+++.+|+|.+.........
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~------------------------------------- 43 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGR------------------------------------- 43 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcc-------------------------------------
Confidence 4778899999999999999854 45788999987543110000
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.........+.+..|+.+++.++|||++++++++...+..++||||+++++|.+++.+.+.+++..+.
T Consensus 44 ------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 111 (272)
T cd06629 44 ------------HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR 111 (272)
T ss_pred ------------cchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHH
Confidence 00011122356788999999999999999999999999999999999999999999887789999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..
T Consensus 112 ~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred HHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=199.03 Aligned_cols=143 Identities=29% Similarity=0.417 Sum_probs=125.6
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||.|+||.||.+.+. .+.+.||||.+.-.
T Consensus 33 EIGHGSFGAVYfArd~-~n~evVAIKKMsyS------------------------------------------------- 62 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDV-RNSEVVAIKKMSYS------------------------------------------------- 62 (948)
T ss_pred HhcCCccceeEEeecc-Cccceeeeeecccc-------------------------------------------------
Confidence 3899999999999855 56788999988543
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~q 314 (362)
-.++...++.+..|+..|..++|||++.+-++|..+...|+||||| -||-.+++.- .+++.+..+..|..+
T Consensus 63 -------GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~g 134 (948)
T KOG0577|consen 63 -------GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHG 134 (948)
T ss_pred -------ccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHH
Confidence 1233456678999999999999999999999999999999999999 6777887764 357999999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+.||.|||+++.||||||..|||++..|.|||+|||.|...
T Consensus 135 aL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 135 ALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 999999999999999999999999999999999999998643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=182.90 Aligned_cols=152 Identities=26% Similarity=0.350 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCC--CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPS--RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.++|+..+.+|+|+||.||++....+.+ ..+++|.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--------------------------------------- 44 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--------------------------------------- 44 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---------------------------------------
Confidence 4578889999999999999998654322 36888876432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
......+.+..|+.+++.++||||+++++++...+..|++|||+++++|.+++... +.++
T Consensus 45 -------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 105 (268)
T cd05063 45 -------------------YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFS 105 (268)
T ss_pred -------------------CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCC
Confidence 01223355788999999999999999999999999999999999999999998764 4689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 106 ~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999999999999999999999999999999999997663
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=186.57 Aligned_cols=149 Identities=32% Similarity=0.483 Sum_probs=130.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|++.+.+|.|+||.||++... .+++.+++|.+...
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~----------------------------------------- 48 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETK----------------------------------------- 48 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccC-----------------------------------------
Confidence 366899999999999999999855 45778999987542
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 306 (362)
.......+.+|+.+++.++||||+++++.+..+..+|+||||+++++|..++.+ ...+++.
T Consensus 49 ------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~ 110 (292)
T cd06644 49 ------------------SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP 110 (292)
T ss_pred ------------------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHH
Confidence 122345578899999999999999999999999999999999999999887754 3568999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.+|.|||+++++||||||+||+++.++.++|+|||++...
T Consensus 111 ~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred HHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=180.53 Aligned_cols=150 Identities=23% Similarity=0.486 Sum_probs=128.3
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||.+.+.. +++.+++|.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~------------------------------------------ 37 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRN------------------------------------------ 37 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhh------------------------------------------
Confidence 48899999999999999999654 47789999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc--CCCCHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK--GNFDDA 306 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~ 306 (362)
........+.+|+++++.++|||++++++.+.. ...+|++|||+++++|.+++... ..+++.
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~ 102 (257)
T cd08223 38 ---------------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPEN 102 (257)
T ss_pred ---------------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHH
Confidence 111233457889999999999999999998764 45689999999999999988763 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++..+.
T Consensus 103 ~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 999999999999999999999999999999999999999999999997664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=184.38 Aligned_cols=152 Identities=23% Similarity=0.369 Sum_probs=128.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCC---CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDP---SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
...+|++.+.||+|+||.||++...... ...+++|...+..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~------------------------------------ 48 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET------------------------------------ 48 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC------------------------------------
Confidence 4567899999999999999999864322 2257888764421
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
.......+.+|+.+++.++||||+++++++.. ...+++|||+++++|.+++..+ ..
T Consensus 49 ----------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~ 105 (279)
T cd05057 49 ----------------------SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN 105 (279)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCC
Confidence 12233557889999999999999999999876 7899999999999999998764 45
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8999999999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=185.30 Aligned_cols=149 Identities=26% Similarity=0.326 Sum_probs=121.2
Q ss_pred EEEEEecccceecEEEEEecCCCC-CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPS-RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
.+.+.||+|+||.||++.+..... ..+|+|.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-------------------------------------------- 37 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-------------------------------------------- 37 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccC--------------------------------------------
Confidence 456789999999999998654322 25888876542
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHh-----
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRD----- 299 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~----- 299 (362)
.........+..|+.+++.++||||+++++.+.. ....+++|||+++++|.+++..
T Consensus 38 -------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 104 (272)
T cd05075 38 -------------ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104 (272)
T ss_pred -------------cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccC
Confidence 1122334667889999999999999999986532 2357899999999999988742
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 -KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 -~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163 (272)
T ss_pred CcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence 1347899999999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=183.04 Aligned_cols=147 Identities=24% Similarity=0.394 Sum_probs=125.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+.+ ...+++|.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~---------------------------------------- 42 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT---------------------------------------- 42 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC--CceEEEEecccCc----------------------------------------
Confidence 3579999999999999999998643 2458999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
.....+.+|+.+++.++||||+++++.+. .+..|++|||+++++|.+++.+. ..++.
T Consensus 43 --------------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 101 (262)
T cd05071 43 --------------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 101 (262)
T ss_pred --------------------cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCH
Confidence 01235788999999999999999999875 45689999999999999999753 34789
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|+|+.+++|+||||+||+++.++.++|+|||.++.+.
T Consensus 102 ~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999999999999999999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=192.69 Aligned_cols=150 Identities=29% Similarity=0.438 Sum_probs=125.5
Q ss_pred cCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
++|++.+.||.|+||.||.+...+ .+++.+|+|.+....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~------------------------------------- 49 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA------------------------------------- 49 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-------------------------------------
Confidence 478999999999999999997432 235689999875320
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc--
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.......+..|+.++..+ +||||+++++++.. ...++++|||+++++|.+++...
T Consensus 50 ---------------------~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~ 108 (337)
T cd05054 50 ---------------------TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRE 108 (337)
T ss_pred ---------------------CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccc
Confidence 112234577899999999 89999999998754 45689999999999999988542
Q ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q psy14740 301 -----------------------------------------------------------GNFDDATTRFYTACVVEAFDY 321 (362)
Q Consensus 301 -----------------------------------------------------------~~l~~~~~~~~~~ql~~al~~ 321 (362)
.+++...+..++.|++.||.|
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 188 (337)
T cd05054 109 CFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188 (337)
T ss_pred cccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHH
Confidence 257888999999999999999
Q ss_pred HHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 322 LHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 322 lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
||++||+||||||+||+++.++.++|+|||+++.+
T Consensus 189 lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred HHhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 99999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=196.09 Aligned_cols=153 Identities=25% Similarity=0.387 Sum_probs=133.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+...+.++||+|.||+|.+++..+ ...||+|.++..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a----------------------------------------- 574 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDA----------------------------------------- 574 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC--ceEEEEeecCccc-----------------------------------------
Confidence 345677889999999999999665 5679999987652
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC--CCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~ 306 (362)
.......|.+|+.+|.+++||||+.+.+++..++.+++++||+++|+|.+++..+.. ....
T Consensus 575 -----------------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~ 637 (807)
T KOG1094|consen 575 -----------------TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETA 637 (807)
T ss_pred -----------------chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccc
Confidence 122346799999999999999999999999999999999999999999999987632 3556
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
....++.||++|++||.+.+++|||+.+.|+|++.++++||+|||++|.+.++.|
T Consensus 638 ~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 638 PGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 6677999999999999999999999999999999999999999999998887766
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-23 Score=185.01 Aligned_cols=151 Identities=24% Similarity=0.371 Sum_probs=123.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCc----eeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRS----FALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
...+|++.+.||.|+||.||++.+... ++. +++|.+...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~~~~~~~~k~~~~~------------------------------------ 47 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPE-GDSIKIPVAIKTIQDR------------------------------------ 47 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCC-CCceeeEEEEeecccc------------------------------------
Confidence 456889999999999999999986432 433 455544211
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-C
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-G 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 301 (362)
........+..|+.+++.++||||+++++++.. ...++++||+++++|.+++... +
T Consensus 48 ----------------------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~ 104 (279)
T cd05111 48 ----------------------SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRD 104 (279)
T ss_pred ----------------------cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhccc
Confidence 111223456778888899999999999998754 4578899999999999999764 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+.
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 105 SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 68999999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=190.32 Aligned_cols=145 Identities=17% Similarity=0.263 Sum_probs=124.1
Q ss_pred EEEEeccc--ceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 153 VITTLGVG--GFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 153 ~~~~lg~G--~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
+++.||+| +||.||++... .+++.+|+|.+....
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~------------------------------------------- 37 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEA------------------------------------------- 37 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhh-------------------------------------------
Confidence 45678999 78899999855 568899999875431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++... ..+++..+
T Consensus 38 --------------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~ 103 (327)
T cd08227 38 --------------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAI 103 (327)
T ss_pred --------------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHH
Confidence 11223345778999999999999999999999999999999999999999998653 45899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
..++.|++.||.|||+++|+||||||+||+++.++.++++|||.+..
T Consensus 104 ~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 104 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 99999999999999999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-23 Score=186.14 Aligned_cols=148 Identities=27% Similarity=0.441 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.+|.|+||.||++... .+++.+++|.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~---------------------------------------- 57 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQ---------------------------------------- 57 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCC----------------------------------------
Confidence 468999999999999999999854 457789999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++.+..+...|+||||+++++|.+++.. ..+++..
T Consensus 58 -------------------~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~ 117 (296)
T cd06654 58 -------------------QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQ 117 (296)
T ss_pred -------------------cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHH
Confidence 11224577899999999999999999999999999999999999999998865 4689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++..
T Consensus 118 ~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 9999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=195.32 Aligned_cols=152 Identities=28% Similarity=0.455 Sum_probs=135.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|+..+.||.|+||.||++.+ ..+++.+|+|++.-.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le------------------------------------------ 49 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAID-NKTKKVVAIKIIDLE------------------------------------------ 49 (467)
T ss_pred cccccchhccccccceeeeeee-ccccceEEEEEechh------------------------------------------
Confidence 4567779999999999999994 467889999998543
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+++|+.++.++++|||.++|+.|..+..+|++||||.||++.++++....+++..+
T Consensus 50 ----------------~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i 113 (467)
T KOG0201|consen 50 ----------------EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEI 113 (467)
T ss_pred ----------------hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCcccee
Confidence 1223345678999999999999999999999999999999999999999999998777799999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++++++.|+.|+|.++.+|||||+.|||+..+|.+||+|||.+.++...
T Consensus 114 ~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 114 AVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred eeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999999999999999999999999999999999999999887653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=204.86 Aligned_cols=155 Identities=27% Similarity=0.449 Sum_probs=136.0
Q ss_pred cCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
.+....+.||+|.||+||+++-.+ ....-||||.++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-------------------------------------- 527 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-------------------------------------- 527 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--------------------------------------
Confidence 455677789999999999998654 23456889988643
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC---
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--- 301 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--- 301 (362)
.+...+++|.+|++++..++|||||++++++..++.+|+|+||+..|||.+++....
T Consensus 528 --------------------a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a 587 (774)
T KOG1026|consen 528 --------------------AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKA 587 (774)
T ss_pred --------------------ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCcc
Confidence 344567889999999999999999999999999999999999999999999997421
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 302 -----------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 302 -----------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
+++..+...++.||+.|+.||-++.++||||-..|.|++.+-.|||+|||++|.+.+.+|
T Consensus 588 ~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDY 658 (774)
T KOG1026|consen 588 DKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDY 658 (774)
T ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhh
Confidence 277899999999999999999999999999999999999999999999999999888776
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=182.62 Aligned_cols=152 Identities=34% Similarity=0.503 Sum_probs=129.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.+|+|+||.||++... .++..+++|.+.....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~----------------------------------------- 40 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPE----------------------------------------- 40 (266)
T ss_pred CccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcC-----------------------------------------
Confidence 6888999999999999999855 4577899998754311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
..........+.+|+.+++.++||||+++++++.. ...++++|||+++++|.+++...+.+++..
T Consensus 41 -------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~ 107 (266)
T cd06651 41 -------------SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107 (266)
T ss_pred -------------CchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence 01112233567889999999999999999998765 367899999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
...++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+
T Consensus 108 ~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 108 TRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999999999999999999999999999999999998755
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=189.28 Aligned_cols=152 Identities=26% Similarity=0.397 Sum_probs=127.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCC------CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD------PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
..+|++.+.||+|+||.||++.+.+. ....+++|.+...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----------------------------------- 55 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----------------------------------- 55 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-----------------------------------
Confidence 35689999999999999999985431 1235788866431
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.+ +||||+++++++...+..|++|||+++++|.+++.+.
T Consensus 56 -----------------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 112 (334)
T cd05100 56 -----------------------ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR 112 (334)
T ss_pred -----------------------cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhc
Confidence 1122345678899999999 8999999999999999999999999999999998753
Q ss_pred C----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 G----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
. .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 113 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 185 (334)
T cd05100 113 RPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185 (334)
T ss_pred CCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecc
Confidence 2 36678888999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=182.31 Aligned_cols=154 Identities=32% Similarity=0.478 Sum_probs=130.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|++.+.||+|+||.||++.+. .+++.+++|.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~---------------------------------------- 40 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPD---------------------------------------- 40 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcc----------------------------------------
Confidence 46899999999999999999855 4578899998643210
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.++||||+++++.+.+. ..++++|||+++++|.+++.+.+.+++.
T Consensus 41 --------------~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~ 106 (264)
T cd06653 41 --------------SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN 106 (264)
T ss_pred --------------cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHH
Confidence 001122345688999999999999999999988654 5689999999999999999877779999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=188.88 Aligned_cols=153 Identities=22% Similarity=0.360 Sum_probs=128.9
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
.+.+|++.+.||.|+||.||++...+ ..++.+|+|.+....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----------------------------------- 47 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----------------------------------- 47 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-----------------------------------
Confidence 34567788899999999999998643 235678999875320
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.......+..|+.++..++||||+++++++...+..++++||+++++|.+++...
T Consensus 48 -----------------------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~ 104 (283)
T cd05091 48 -----------------------EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSP 104 (283)
T ss_pred -----------------------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCC
Confidence 1123355788999999999999999999999999999999999999999988531
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++...+..++.|++.||.|+|++|++||||||+||+++.++.+||+|||+++.+.
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (283)
T cd05091 105 HSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175 (283)
T ss_pred CccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccc
Confidence 247888899999999999999999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=174.92 Aligned_cols=151 Identities=24% Similarity=0.346 Sum_probs=130.7
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++...+|+|+|+.||+++.. .+++.||+|.+.-.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~--------------------------------------- 57 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCH--------------------------------------- 57 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeeccc-Ccccchhhheeecc---------------------------------------
Confidence 35678999999999999999999955 45788999987432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhc
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
+.......++|++..++++|||++++++....+ ...|++++|+..|+|.+.+...
T Consensus 58 --------------------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~ 117 (302)
T KOG2345|consen 58 --------------------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERL 117 (302)
T ss_pred --------------------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHH
Confidence 244567789999999999999999998875432 4599999999999999988753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 ----GNFDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ----~~l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++.++..++.+++.||++||+.. +.||||||.|||++..+.++|.|||.+.+.
T Consensus 118 k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 118 KIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred hhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 25899999999999999999999998 999999999999999999999999998753
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=185.20 Aligned_cols=146 Identities=31% Similarity=0.502 Sum_probs=127.0
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.||.|+||.||++... ..+..+++|.+...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~-------------------------------------------- 41 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTK-------------------------------------------- 41 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCC--------------------------------------------
Confidence 567788999999999999855 45677888877432
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~ 309 (362)
.......+.+|+++++.++||||+++++.+......|+||||+++++|..++.+ ..++++..+.
T Consensus 42 ---------------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~ 106 (282)
T cd06643 42 ---------------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR 106 (282)
T ss_pred ---------------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHH
Confidence 112234577899999999999999999999999999999999999999887764 4568999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 107 ~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 107 VVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=184.10 Aligned_cols=150 Identities=26% Similarity=0.473 Sum_probs=131.2
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|+|+||.||++.+. .+++.+++|.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~----------------------------------------- 38 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRL----------------------------------------- 38 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccc-----------------------------------------
Confidence 5889999999999999999865 3478899998765311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~ 308 (362)
.......+.+|+.+++.++||||+++++++..+..+|+||||+ +++|.+++.. ...+++..+
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~ 101 (286)
T cd07832 39 ----------------EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQV 101 (286)
T ss_pred ----------------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHH
Confidence 1123356788999999999999999999999999999999999 9999998865 356899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+..
T Consensus 102 ~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 102 KSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99999999999999999999999999999999999999999999887644
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=184.83 Aligned_cols=152 Identities=31% Similarity=0.484 Sum_probs=131.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.+|+|+||.||++.+. .+++.+++|.+....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~----------------------------------------- 38 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESE----------------------------------------- 38 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhc-----------------------------------------
Confidence 36899999999999999999855 457889999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|+.+++.++||||+++++++...+..|++|||++++.+..+..+...+++..+
T Consensus 39 ----------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~ 102 (288)
T cd07833 39 ----------------DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV 102 (288)
T ss_pred ----------------ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHH
Confidence 1122345678899999999999999999999999999999999988777766666667999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+..
T Consensus 103 ~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 103 RSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999999999999999999999999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=182.91 Aligned_cols=145 Identities=74% Similarity=1.217 Sum_probs=127.9
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||.|+||.||++.... .++.+++|.+.+..
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~------------------------------------------------- 30 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRH------------------------------------------------- 30 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhc-------------------------------------------------
Confidence 6899999999999654 57889999886531
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVV 316 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~ 316 (362)
.........+.+|+.+++.++||||+++++.+.++..+|++|||+++++|.+++.+...+++..+..++.|++
T Consensus 31 -------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~ 103 (262)
T cd05572 31 -------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV 103 (262)
T ss_pred -------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 1112234568899999999999999999999999999999999999999999998877799999999999999
Q ss_pred HHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 317 EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 317 ~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.||.|+|+++++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 104 ~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 104 LAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=181.91 Aligned_cols=147 Identities=24% Similarity=0.405 Sum_probs=126.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++++.||+|+||.||++... .++.+|+|.+.+..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~---------------------------------------- 42 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS---------------------------------------- 42 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC----------------------------------------
Confidence 357899999999999999999843 36779999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
.....+.+|+.+++.++||||+++++++. .+.+|++||++++++|.+++... ..++.
T Consensus 43 --------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 101 (260)
T cd05067 43 --------------------MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTI 101 (260)
T ss_pred --------------------CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCH
Confidence 11245788999999999999999999874 45799999999999999988653 35889
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 102 NKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred HHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999999999999999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=183.73 Aligned_cols=150 Identities=26% Similarity=0.440 Sum_probs=127.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++... ..++.+++|.+....
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~--------------------------------------- 55 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH--------------------------------------- 55 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc---------------------------------------
Confidence 4678999999999999999999865 457789999764320
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHh-
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRD- 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~- 299 (362)
.....+..|+.+++.+ +||||+++++++. .+..+|++|||+++++|.+++..
T Consensus 56 ---------------------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 114 (286)
T cd06638 56 ---------------------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF 114 (286)
T ss_pred ---------------------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHh
Confidence 1123467788999998 7999999999873 45679999999999999988753
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 ---KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ---~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.
T Consensus 115 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 115 LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred hccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 2458899999999999999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=181.40 Aligned_cols=142 Identities=30% Similarity=0.442 Sum_probs=120.1
Q ss_pred EecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 156 TLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
.||+|+||.||++.... ..+..+|+|.+...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~------------------------------------------------ 33 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE------------------------------------------------ 33 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc------------------------------------------------
Confidence 38999999999987543 23456889887532
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTRFYTA 313 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ 313 (362)
........+.+|+.+++.++||||+++++++.. +..++||||+++++|.+++.. ...+++..+..++.
T Consensus 34 ----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 102 (257)
T cd05115 34 ----------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH 102 (257)
T ss_pred ----------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHH
Confidence 011233568899999999999999999998754 578999999999999999875 34689999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 103 ~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 103 QVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred HHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=180.61 Aligned_cols=147 Identities=29% Similarity=0.473 Sum_probs=126.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.+|+|+||.||++... +..+++|.+...
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~---------------------------------------- 40 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND---------------------------------------- 40 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC----------------------------------------
Confidence 4568999999999999999998754 567898876432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeee-eccceEEEEEeccCCcchHHHHHhcC--CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDKG--NF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--~l 303 (362)
.....+.+|+.+++.++|||++++++++ ......|++|||+++++|.+++.+.. .+
T Consensus 41 ---------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 99 (256)
T cd05082 41 ---------------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 99 (256)
T ss_pred ---------------------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCC
Confidence 1124578899999999999999999875 45567999999999999999987643 37
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 100 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 100 GGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 889999999999999999999999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=181.10 Aligned_cols=149 Identities=28% Similarity=0.433 Sum_probs=129.4
Q ss_pred EEEEEecccceecEEEEEecCCC---CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDP---SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+.+.+|.|+||.||.+.+.... +..+++|.+....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------------------------------------- 40 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----------------------------------------- 40 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-----------------------------------------
Confidence 46788999999999999976532 4789999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC--CCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~ 306 (362)
.......+..|+.++..++||||+++++++.+.+..|++||++++++|.+++..... +++.
T Consensus 41 -----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~ 103 (258)
T smart00219 41 -----------------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLS 103 (258)
T ss_pred -----------------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHH
Confidence 111345678899999999999999999999999999999999999999999976544 9999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++....
T Consensus 104 ~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 104 DLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred HHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999999999999999999999999999999999999986654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=184.74 Aligned_cols=149 Identities=27% Similarity=0.430 Sum_probs=130.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+...+|.|+||.||.+... .+++.+++|.+...
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~----------------------------------------- 55 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQ----------------------------------------- 55 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecc-----------------------------------------
Confidence 456999999999999999999854 45788999987432
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++++...+.+|+|+||+++++|..++.. ..+++..
T Consensus 56 ------------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~ 116 (296)
T cd06655 56 ------------------KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQ 116 (296)
T ss_pred ------------------cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHH
Confidence 111234577899999999999999999999999999999999999999998875 4689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 117 ~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=185.36 Aligned_cols=152 Identities=26% Similarity=0.408 Sum_probs=129.9
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|++...||.|+||.||++...+ .++..+++|.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~------------------------------------ 47 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------------------------------------ 47 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc------------------------------------
Confidence 4678999999999999999998643 346678888875421
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++....
T Consensus 48 ----------------------~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 105 (288)
T cd05050 48 ----------------------SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPR 105 (288)
T ss_pred ----------------------CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcc
Confidence 11223557889999999999999999999999999999999999999999987432
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 --------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 --------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 106 AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred ccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecc
Confidence 36778889999999999999999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=183.31 Aligned_cols=143 Identities=22% Similarity=0.299 Sum_probs=119.7
Q ss_pred EecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 156 TLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
.||+|+||.||++...+ .+...+++|.+....
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----------------------------------------------- 34 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----------------------------------------------- 34 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-----------------------------------------------
Confidence 58999999999997543 344568888764321
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-----CCCHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-----NFDDATTR 309 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~ 309 (362)
.......+.+|+.+++.++||||+++++++.+...+++||||+++++|.+++.... ..+...+.
T Consensus 35 -----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 103 (269)
T cd05087 35 -----------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ 103 (269)
T ss_pred -----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHH
Confidence 11123457889999999999999999999998899999999999999999987532 35667788
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.|+.|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 104 ~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 104 RMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred HHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence 89999999999999999999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=183.43 Aligned_cols=152 Identities=26% Similarity=0.421 Sum_probs=128.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|.+.+.||+|+||.||++..... ....+++|.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~------------------------------------- 47 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES------------------------------------- 47 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-------------------------------------
Confidence 46789999999999999999986541 3567888866421
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
........+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++...+
T Consensus 48 ---------------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~ 106 (277)
T cd05036 48 ---------------------CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPR 106 (277)
T ss_pred ---------------------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCC
Confidence 111223457889999999999999999999988889999999999999999987643
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceecC
Q psy14740 302 -----NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLI 357 (362)
Q Consensus 302 -----~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||+++.+.
T Consensus 107 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 107 PERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 478899999999999999999999999999999999998654 59999999998653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=184.17 Aligned_cols=150 Identities=25% Similarity=0.386 Sum_probs=127.5
Q ss_pred ccCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
..++.+...+|+|+||.||++... ...+..+++|.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~------------------------------------- 46 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------------------------------------- 46 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-------------------------------------
Confidence 356788999999999999998642 223456777765432
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
.......+.+|+++++.++||||+++++++...+..+++|||+++++|.+++...+
T Consensus 47 ----------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~ 104 (280)
T cd05092 47 ----------------------SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 104 (280)
T ss_pred ----------------------CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcc
Confidence 12234568889999999999999999999999999999999999999999987542
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 -------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 -------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 105 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 172 (280)
T cd05092 105 AKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172 (280)
T ss_pred hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEc
Confidence 3788999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=186.27 Aligned_cols=151 Identities=25% Similarity=0.430 Sum_probs=126.7
Q ss_pred CcEEEEEecccceecEEEEEecCC-CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGD-PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+|.+...||+|+||.||++..... .++.+|+|.+.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~---------------------------------------- 40 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE---------------------------------------- 40 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc----------------------------------------
Confidence 478899999999999999996542 578999999865310
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc-----C
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-----G 301 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~ 301 (362)
........+.+|+.+++.++||||+++++++.+. ..+|+||||++ +++.+++... .
T Consensus 41 ----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~ 103 (316)
T cd07842 41 ----------------QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRV 103 (316)
T ss_pred ----------------cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCc
Confidence 1112234567899999999999999999999888 88999999995 5777766432 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC----CCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~----~~~~kl~DFG~a~~~~ 357 (362)
.+++..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||+++.+.
T Consensus 104 ~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~ 163 (316)
T cd07842 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163 (316)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence 5889999999999999999999999999999999999999 8999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=179.16 Aligned_cols=151 Identities=25% Similarity=0.510 Sum_probs=131.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|+|+||.+|.+... ..++.+++|.+.....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~----------------------------------------- 38 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKM----------------------------------------- 38 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhC-----------------------------------------
Confidence 5889999999999999999865 4578899998754211
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+.+.... .+++..
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~ 102 (256)
T cd08218 39 ----------------SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ 102 (256)
T ss_pred ----------------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHH
Confidence 11223457889999999999999999999999999999999999999999887543 478999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999999999999999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=181.69 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=126.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.+|+|+||.||++... .+..+++|.+....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~---------------------------------------- 42 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGT---------------------------------------- 42 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCC----------------------------------------
Confidence 467899999999999999999754 24568999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
.....+.+|+.+++.++|||++++++++. ....|++|||+++++|.+++... ..+++
T Consensus 43 --------------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 101 (260)
T cd05070 43 --------------------MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKL 101 (260)
T ss_pred --------------------CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCH
Confidence 01234788999999999999999999875 45689999999999999998753 35899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+.
T Consensus 102 ~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 102 PNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999999999999999999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=180.50 Aligned_cols=150 Identities=31% Similarity=0.505 Sum_probs=132.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||+|+||.||.+... .+++.+++|.+....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------ 37 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQD------------------------------------------ 37 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcc------------------------------------------
Confidence 5888999999999999999854 457789999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
........+..|+.+++.++||||+++++.....+.+++++||+++++|.+++.....+++..+.
T Consensus 38 ---------------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (264)
T cd06626 38 ---------------NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR 102 (264)
T ss_pred ---------------cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHH
Confidence 11234466889999999999999999999999999999999999999999999887678999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 103 ~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 103 VYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 999999999999999999999999999999999999999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=186.86 Aligned_cols=151 Identities=31% Similarity=0.473 Sum_probs=132.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. ..++.+++|.+....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~--------------------------------------- 42 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGA--------------------------------------- 42 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecC---------------------------------------
Confidence 4567889999999999999999854 457789999875321
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.......+.+|+++++.++||||+++++.+.....+|+||||+++++|.+++.+.+.+++.
T Consensus 43 -------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 103 (284)
T cd06620 43 -------------------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE 103 (284)
T ss_pred -------------------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHH
Confidence 1122356789999999999999999999999999999999999999999999887789999
Q ss_pred HHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++..+
T Consensus 104 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999999999999997 69999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-24 Score=193.95 Aligned_cols=182 Identities=48% Similarity=0.844 Sum_probs=157.4
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|+++ +++-|..+++++....|.+|++|++||+.|+.||||..|.|+|...+....++..+++++.||+|||
T Consensus 272 ~fLrsv~~~q~l-~Ee~L~KiaD~le~~~Yd~g~yIirqge~G~~ffii~~G~V~vtq~~e~~~q~~~lr~l~kGd~FGE 350 (732)
T KOG0614|consen 272 NFLRSVPLFQNL-PEELLLKIADVLEEEYYDAGEYIIRQGEKGDTFFIISKGTVKVTQQDEGSTQPQELRTLNKGDYFGE 350 (732)
T ss_pred HHHHhhhhhccC-CHHHHHHHHHHHHHHhhcCCceEEeecCCCCeEEEEecceEEEeecCCCCCchhHHhhccccchhhH
Confidence 358999999999 9999999999999999999999999999999999999999999998876678899999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH------HhhhhhhhhhccccCcEEEEEec
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE------RRRLNEEFRSLRLSDLRVITTLG 158 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~lg 158 (362)
-||+....|+|+++|..+ +++|+.|+++.|.+++....++..+.+..... ...+.+.+.+..+++++.+..||
T Consensus 351 ~al~~edvRtAniia~~~-gv~cl~lDresF~~liG~l~~l~ek~~~D~~r~A~~~~~~~~~~e~a~v~l~dl~~iaTLG 429 (732)
T KOG0614|consen 351 RALLGEDVRTANIIAQAP-GVECLTLDRESFKKLIGDLEELKEKDYGDEERRASVVIKEDFAEEFAQVKLSDLKRIATLG 429 (732)
T ss_pred HHhhccCccchhhhccCC-CceEEEecHHHHHHhcccHHHhhhhhccchhhhhhhHHHHHHHhhhcccchhhhhhhhhcc
Confidence 999999999999999865 59999999999999999999888544432221 22333456677899999999999
Q ss_pred ccceecEEEEEecCCCCCceeeeeecccccc
Q psy14740 159 VGGFGRVELVQIAGDPSRSFALKQMKKSQVM 189 (362)
Q Consensus 159 ~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~ 189 (362)
-|+||.|.++..... ...+|+|+++|..+.
T Consensus 430 vGgFGRVELV~~~~~-~~~fAlKilkK~hIV 459 (732)
T KOG0614|consen 430 VGGFGRVELVKVNSQ-KATFALKILKKKHIV 459 (732)
T ss_pred cCccceEEEEEeccc-chHHHHHHHhHhhcc
Confidence 999999999996644 336999999886443
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=181.74 Aligned_cols=156 Identities=33% Similarity=0.626 Sum_probs=136.7
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+.+.+|.+..+||.|+|+.|.++... .+.+.+|+|++++.-+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~------------------------------------- 288 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELV------------------------------------- 288 (593)
T ss_pred cccccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhc-------------------------------------
Confidence 46789999999999999999999865 5678999999987622
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.+.....-.+.|..+.... +||.++.++.+|+.+..+++|.||++||+|.-.+++++.+|
T Consensus 289 -------------------nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklp 349 (593)
T KOG0695|consen 289 -------------------NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 349 (593)
T ss_pred -------------------CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCc
Confidence 1222233356677777665 89999999999999999999999999999999898888999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.++++...|+.||.|||++|||+||+|.+|+|++..|++||+|+|+|+.-..
T Consensus 350 eeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 350 EEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred HHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999999999999999999999999999999999999999999986543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=182.34 Aligned_cols=144 Identities=38% Similarity=0.728 Sum_probs=126.5
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
+|.|+||.||++... .+++.+++|.+.+...
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~------------------------------------------------ 31 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADM------------------------------------------------ 31 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhh------------------------------------------------
Confidence 589999999999854 4578899998765311
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVV 316 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~ 316 (362)
........+.+|+.+++.++||||+++++.+..+...|++||++++++|.+++.+.+.+++..+..++.|++
T Consensus 32 --------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~ 103 (265)
T cd05579 32 --------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIV 103 (265)
T ss_pred --------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHH
Confidence 112334567889999999999999999999999999999999999999999998877899999999999999
Q ss_pred HHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 317 EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 317 ~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 104 ~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 104 LALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 99999999999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=183.15 Aligned_cols=151 Identities=28% Similarity=0.452 Sum_probs=130.4
Q ss_pred cCcEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+|++.+.+|+|+||.||++... ...+..+|+|.+....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~-------------------------------------- 45 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------------------------------------- 45 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--------------------------------------
Confidence 46788899999999999999854 2346789999876431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcC-C
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKG-N 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~ 302 (362)
. ......+.+|+++++.++||||+++++++.. ....+++|||+++++|.+++.... .
T Consensus 46 -------------------~-~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~ 105 (284)
T cd05038 46 -------------------E-EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ 105 (284)
T ss_pred -------------------c-hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccc
Confidence 0 0234568899999999999999999998876 567999999999999999997654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=179.10 Aligned_cols=149 Identities=26% Similarity=0.404 Sum_probs=127.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.+|+|+||.||++.... +..+++|.+.++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~iK~~~~~~--------------------------------------- 42 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGS--------------------------------------- 42 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC--CccEEEEecCCCh---------------------------------------
Confidence 45789999999999999999997442 4568888765421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
...+.+.+|+.+++.++||||+++++.+.. ...|++|||+++++|.+++.+. ..++
T Consensus 43 ---------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~ 100 (260)
T cd05073 43 ---------------------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP 100 (260)
T ss_pred ---------------------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccC
Confidence 112457889999999999999999999877 7789999999999999999763 3478
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+..+..
T Consensus 101 ~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 101 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 888999999999999999999999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=185.37 Aligned_cols=152 Identities=22% Similarity=0.324 Sum_probs=129.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||.|+||.||++.+. .+++.+++|.+.....
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~--------------------------------------- 43 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKE--------------------------------------- 43 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccc---------------------------------------
Confidence 567889999999999999999865 4577899998754310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
.......+.+|+.+++.++||||+++++++... +..|++|||++ ++|.+++.... .++
T Consensus 44 ------------------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~ 104 (293)
T cd07843 44 ------------------KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFL 104 (293)
T ss_pred ------------------cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCC
Confidence 111223467899999999999999999988777 88999999995 59988887643 589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999999999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=179.40 Aligned_cols=147 Identities=26% Similarity=0.402 Sum_probs=125.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+...||+|+||.||++.... +..+++|.+....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~---------------------------------------- 42 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGT---------------------------------------- 42 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC--CceEEEEEcccCC----------------------------------------
Confidence 3568999999999999999998543 3458888765421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~ 305 (362)
.....+.+|+.+++.++|||++++++++. .+..|++|||+++++|.+++.... .++.
T Consensus 43 --------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 101 (260)
T cd05069 43 --------------------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKL 101 (260)
T ss_pred --------------------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCH
Confidence 11245778999999999999999999875 456899999999999999997532 4788
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 102 PQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 9999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=180.61 Aligned_cols=144 Identities=28% Similarity=0.414 Sum_probs=124.9
Q ss_pred EecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 156 TLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
.+|+|+||.||++.+....+. .+|+|.+.....
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------------------------- 36 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--------------------------------------------- 36 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCccc---------------------------------------------
Confidence 589999999999986543333 689998765410
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTRFY 311 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~ 311 (362)
......+.+|+.+++.++||||+++++.+.. ..++++|||+++++|.+++.+.. .+++..++.+
T Consensus 37 -------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (257)
T cd05040 37 -------------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102 (257)
T ss_pred -------------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHH
Confidence 0345668899999999999999999999888 88999999999999999997754 5899999999
Q ss_pred HHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 103 ~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred HHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence 99999999999999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=179.48 Aligned_cols=146 Identities=36% Similarity=0.501 Sum_probs=123.5
Q ss_pred cccCcEEE-EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 147 RLSDLRVI-TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 147 ~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..++|.+- .+||-|-.|.|..+.+ +.+++.+|+|++.-.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~-k~T~ekfALKvL~Ds--------------------------------------- 98 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVH-KRTQEKFALKVLLDS--------------------------------------- 98 (400)
T ss_pred chhhheehhhhhccccCCceEEEEe-ccchhhhHHHHHhcC---------------------------------------
Confidence 35667665 5799999999999984 467899999987432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
....+|+++.-.. .|||||.++++|+. ...+.+|||.++||.|.+.++.+
T Consensus 99 -------------------------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~ 153 (400)
T KOG0604|consen 99 -------------------------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR 153 (400)
T ss_pred -------------------------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc
Confidence 3356788775554 79999999999864 46789999999999999999887
Q ss_pred CC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecC
Q psy14740 301 GN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~--l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~ 357 (362)
+. |++.++..|++||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|+.-.
T Consensus 154 g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 154 GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 64 999999999999999999999999999999999999974 5579999999998754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=177.24 Aligned_cols=151 Identities=28% Similarity=0.470 Sum_probs=133.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.+|+|++|.+|.+.+. ..++.+++|.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~----------------------------------------- 38 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKI----------------------------------------- 38 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEeccccc-----------------------------------------
Confidence 5788999999999999999855 4577899998865310
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.......+.+|+++++.++|||++++++++.+....+++||++++++|.+++.....+++..+.
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~ 102 (254)
T cd06627 39 ----------------KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA 102 (254)
T ss_pred ----------------CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHH
Confidence 1123456889999999999999999999999999999999999999999999887789999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 103 ~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 103 VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred HHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 9999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=179.48 Aligned_cols=151 Identities=28% Similarity=0.456 Sum_probs=132.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.+|.|+||.||++... .++..+++|.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 38 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEK----------------------------------------- 38 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCC-----------------------------------------
Confidence 47899999999999999999855 457789999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---CCCCH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---GNFDD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~ 305 (362)
.......+.+|+.+++.++||||+++++.+......|++||++++++|.+++... ..+++
T Consensus 39 -----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~ 101 (267)
T cd06610 39 -----------------CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE 101 (267)
T ss_pred -----------------cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCH
Confidence 0113456789999999999999999999999999999999999999999999764 35899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 102 ~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 102 AIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999999999999999999999999999999999999999876654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=178.04 Aligned_cols=149 Identities=28% Similarity=0.429 Sum_probs=129.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.+|.|+||.||++.+.. +..+++|.+.....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~~~--------------------------------------- 41 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREGAM--------------------------------------- 41 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC--CCeEEEEECCCCCC---------------------------------------
Confidence 4578999999999999999997542 56789998754310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
....+.+|+++++.++|||++++++++......+++|||+++++|.+++... ..+++.
T Consensus 42 ---------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 100 (256)
T cd05112 42 ---------------------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE 100 (256)
T ss_pred ---------------------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHH
Confidence 1234678999999999999999999999999999999999999999998764 458999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.|+.|||+++++|+||||+||+++.++.++|+|||+++....
T Consensus 101 ~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 101 TLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999999999999999999999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=182.21 Aligned_cols=144 Identities=31% Similarity=0.599 Sum_probs=119.0
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|+||.||++... .+++.+|+|.+.+....
T Consensus 2 ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~----------------------------------------------- 33 (278)
T cd05606 2 IGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIK----------------------------------------------- 33 (278)
T ss_pred cccCCCeEEEEEEEe-cCCCEEEEEEeeccccc-----------------------------------------------
Confidence 799999999999854 45789999988653110
Q ss_pred hhccccccccchhhhhhHHH---HHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSE---KEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
..........| ..+++...||+|+++++.+..++..|+||||++|++|.+++...+.+++..+..++.
T Consensus 34 ---------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ 104 (278)
T cd05606 34 ---------MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA 104 (278)
T ss_pred ---------cchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 00000112223 334455689999999999999999999999999999999998777899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.
T Consensus 105 ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred HHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=204.77 Aligned_cols=158 Identities=26% Similarity=0.424 Sum_probs=138.0
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCC----ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSR----SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
..-....+...||+|.||.||.+...+.++. .||+|.+.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----------------------------------- 733 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----------------------------------- 733 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-----------------------------------
Confidence 3445677889999999999999997765554 3788877543
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.+......|++|+.+|++++||||+++.++..+....+|++||++||+|..++++.
T Consensus 734 -----------------------~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r 790 (1025)
T KOG1095|consen 734 -----------------------SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESR 790 (1025)
T ss_pred -----------------------CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcc
Confidence 34456678999999999999999999999999999999999999999999999875
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 301 ------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 301 ------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
..++..+...++.+++.|+.||+++++|||||...|+|++....+||+|||+|+.+....|
T Consensus 791 ~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~y 857 (1025)
T KOG1095|consen 791 PAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDY 857 (1025)
T ss_pred cccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchh
Confidence 2378899999999999999999999999999999999999999999999999997766554
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=179.90 Aligned_cols=145 Identities=24% Similarity=0.459 Sum_probs=127.2
Q ss_pred EecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 156 TLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
.||+|+||.||.+.... ..+..+++|.+....
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---------------------------------------------- 35 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---------------------------------------------- 35 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeecccc----------------------------------------------
Confidence 58999999999998654 226678999875431
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---------CCCC
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---------GNFD 304 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~l~ 304 (362)
.......+.+|+.++..++||||+++++++.....++++|||+++++|.+++... ..++
T Consensus 36 ------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 103 (262)
T cd00192 36 ------------SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103 (262)
T ss_pred ------------chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCC
Confidence 0113456889999999999999999999999999999999999999999999875 6789
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++....
T Consensus 104 ~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999999999999999999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=194.42 Aligned_cols=143 Identities=30% Similarity=0.554 Sum_probs=126.2
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
-+||+|+||+||.++ +.++....|||.+...
T Consensus 581 vVLGKGTYG~VYA~R-D~~tqvrIaIKEIpek------------------------------------------------ 611 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAAR-DMDTQVRIAIKEIPEK------------------------------------------------ 611 (1226)
T ss_pred EEeecCceeEEEeec-cccceeEEEeeecccc------------------------------------------------
Confidence 369999999999998 4466777899987543
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCC--CHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNF--DDATTRFY 311 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l--~~~~~~~~ 311 (362)
..+.-+.+..|+.+.+.++|.|||++.+++..++++-|.||-++||+|.+++.. -+++ ++..+-++
T Consensus 612 -----------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fY 680 (1226)
T KOG4279|consen 612 -----------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFY 680 (1226)
T ss_pred -----------cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHH
Confidence 233445678999999999999999999999999999999999999999999975 3677 79999999
Q ss_pred HHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecC
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~ 357 (362)
.+||++||.|||++.|+|||||-+|+|++ ..|.+||+|||.++++-
T Consensus 681 tkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 681 TKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred HHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 99999999999999999999999999998 48999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=182.86 Aligned_cols=153 Identities=35% Similarity=0.683 Sum_probs=131.4
Q ss_pred CcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+|++.+.||.|+||.||++...+ ..+..+++|.+.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~--------------------------------------- 41 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI--------------------------------------- 41 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH---------------------------------------
Confidence 47889999999999999988543 3467899998865311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+..|+.++..+ +||||+++++.+......|+||||+++++|.+++.....+++.
T Consensus 42 ----------------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 105 (288)
T cd05583 42 ----------------VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES 105 (288)
T ss_pred ----------------HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHH
Confidence 01122335577899999999 6999999999999999999999999999999998877779999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=179.42 Aligned_cols=142 Identities=25% Similarity=0.375 Sum_probs=122.7
Q ss_pred EecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 156 TLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
.||+|+||.||++.....+ ...+++|.+....
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~---------------------------------------------- 35 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH---------------------------------------------- 35 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEeccccc----------------------------------------------
Confidence 5899999999999765433 3678999875431
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
.......+..|+.+++.++||||+++++++. .+..+++|||+++++|.+++.....+++..+..++.
T Consensus 36 ------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (257)
T cd05060 36 ------------IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH 102 (257)
T ss_pred ------------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHH
Confidence 0123456788999999999999999999876 456899999999999999998877899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|++.||.|||.++++|+||||+||+++.++.++|+|||+++.+
T Consensus 103 qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred HHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=185.12 Aligned_cols=142 Identities=24% Similarity=0.462 Sum_probs=116.2
Q ss_pred EEecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 155 TTLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
..||+|+||.||++.... ..+..+|+|.+....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---------------------------------------------- 40 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---------------------------------------------- 40 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----------------------------------------------
Confidence 579999999999998543 345788999775321
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--ccceEEEEEeccCCcchHHHHHhc---------CC
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--DKKYLYMLMESCLGGELWTILRDK---------GN 302 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---------~~ 302 (362)
....+.+|+.+++.++||||+++++++. .+..+|++|||+ +++|.+++... ..
T Consensus 41 ---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~ 104 (317)
T cd07867 41 ---------------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA-EHDLWHIIKFHRASKANKKPMQ 104 (317)
T ss_pred ---------------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee-CCcHHHHHHhhhccccCCCCcc
Confidence 1123678999999999999999999874 456789999998 56887776421 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe----cCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~----~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+|+.+..
T Consensus 105 l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 7889999999999999999999999999999999999 4567899999999986643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=188.77 Aligned_cols=150 Identities=24% Similarity=0.432 Sum_probs=128.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|.+.+.||.|+||.||++... .+++.+++|.+....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~----------------------------------------- 42 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAF----------------------------------------- 42 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEecccc-----------------------------------------
Confidence 67899999999999999999855 457889999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.+++.++||||+++++++.. ...+|+||||+ +++|.+++...+.++
T Consensus 43 ----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~ 105 (334)
T cd07855 43 ----------------DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLT 105 (334)
T ss_pred ----------------ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccCCCCC
Confidence 011223456789999999999999999998753 35789999999 578999998777799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 106 EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=211.01 Aligned_cols=153 Identities=30% Similarity=0.472 Sum_probs=135.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
-+|.-...+|.|.||.||-+.+. ++|+-.|+|.++..+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~----------------------------------------- 1272 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQD----------------------------------------- 1272 (1509)
T ss_pred eeeccccccCCcceeeeEEeecC-CccchhhhhhhhcCc-----------------------------------------
Confidence 45677778999999999999844 678999999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
........+.+|..++..++|||++++|++-.+.+.++|.||||++|+|.+++...+..++...
T Consensus 1273 ----------------~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt 1336 (1509)
T KOG4645|consen 1273 ----------------SDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVT 1336 (1509)
T ss_pred ----------------cccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHH
Confidence 1123345578899999999999999999999999999999999999999999988777899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+.+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+.++
T Consensus 1337 ~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1337 RVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999999999999999999999999999999999999988654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=178.43 Aligned_cols=141 Identities=27% Similarity=0.441 Sum_probs=122.3
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||+|+||.||++... .+..+++|.+...
T Consensus 2 ~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~------------------------------------------------- 30 (250)
T cd05085 2 LLGKGNFGEVFKGTLK--DKTPVAVKTCKED------------------------------------------------- 30 (250)
T ss_pred ccCCCCCceEEEEEec--CCcEEEEEecCCc-------------------------------------------------
Confidence 5899999999999743 3678999987542
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~q 314 (362)
........+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... ..+++..+..++.|
T Consensus 31 ---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 101 (250)
T cd05085 31 ---------LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALD 101 (250)
T ss_pred ---------CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 01122345788999999999999999999999999999999999999999988753 35789999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.||.|+|++|++|+||||+||+++.++.++|+|||++...
T Consensus 102 i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 143 (250)
T cd05085 102 AAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQE 143 (250)
T ss_pred HHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceec
Confidence 999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=177.47 Aligned_cols=151 Identities=26% Similarity=0.418 Sum_probs=129.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.||+|+||.||++... .+++.+++|.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~----------------------------------------- 38 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQM----------------------------------------- 38 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEecccc-----------------------------------------
Confidence 5889999999999999999865 4678899998754311
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
.......+.+|+.+++.++|||++++++.+...+..++||||+++++|.+++... ..+++..
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08220 39 ----------------TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102 (256)
T ss_pred ----------------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHH
Confidence 1123456788999999999999999999999999999999999999999999764 3489999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.+|.|||++|++|+||||+||+++.+ +.++|+|||++..+..
T Consensus 103 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999999999999999999999999999865 4689999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=182.62 Aligned_cols=106 Identities=21% Similarity=0.237 Sum_probs=95.5
Q ss_pred hhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 251 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
..+.+|+.+++.++||||+++++++..+...|+||||+++++|..++.+ .+.+++..+..++.|++.||.|||+++|+|
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 140 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH 140 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccC
Confidence 4577889999999999999999999999999999999999999998875 356899999999999999999999999999
Q ss_pred ecCCCCcEEecCCC-------cEEEEecccceec
Q psy14740 330 RDLKPENLLLSTSG-------YVKLVDFGFAKKL 356 (362)
Q Consensus 330 rDikp~NIl~~~~~-------~~kl~DFG~a~~~ 356 (362)
|||||+||+++..+ .++++|||++...
T Consensus 141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred CCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence 99999999997643 4899999987644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-22 Score=181.07 Aligned_cols=149 Identities=30% Similarity=0.471 Sum_probs=127.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+...+|+|+||.||++... .+++.+++|.+....
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~---------------------------------------- 59 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS---------------------------------------- 59 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc----------------------------------------
Confidence 578999999999999999999854 457889999875321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHh--
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRD-- 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-- 299 (362)
.....+..|+.+++.+ +|||++++++++... +.+|+||||+++++|.++++.
T Consensus 60 --------------------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~ 119 (291)
T cd06639 60 --------------------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119 (291)
T ss_pred --------------------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhh
Confidence 1123456788888888 899999999987643 468999999999999998763
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 --KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 --~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+.
T Consensus 120 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 3468999999999999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=184.51 Aligned_cols=152 Identities=22% Similarity=0.373 Sum_probs=125.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCC----ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSR----SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
....+|+..+.||+|+||.||++.+... ++ .+++|.+....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~-~~~~~~~vaiK~~~~~~---------------------------------- 48 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPE-GETVKIPVAIKILNETT---------------------------------- 48 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecC-CCcceeeEEEEeccccC----------------------------------
Confidence 3567889999999999999999986533 33 45777654320
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.+++.++||||+++++++... ..+++++|+++|+|.+++....
T Consensus 49 ------------------------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~ 103 (303)
T cd05110 49 ------------------------GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK 103 (303)
T ss_pred ------------------------CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc
Confidence 111223577899999999999999999988654 4778999999999999987644
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 -NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 -~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 104 ~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 104 DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 58999999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=180.40 Aligned_cols=107 Identities=20% Similarity=0.267 Sum_probs=98.1
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATTRFYTACVVEAFDYLHSRNII 328 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~al~~lH~~~ii 328 (362)
...+.+|+.+++.++||||+++++++.. +..+++|||+++++|.+++.... .++...+..++.|++.||.|||++||+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 4567889999999999999999998877 77899999999999999998765 689999999999999999999999999
Q ss_pred eecCCCCcEEecCCC-------cEEEEecccceecC
Q psy14740 329 YRDLKPENLLLSTSG-------YVKLVDFGFAKKLI 357 (362)
Q Consensus 329 HrDikp~NIl~~~~~-------~~kl~DFG~a~~~~ 357 (362)
||||||+||+++.++ .++|+|||+++.+.
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 999999999999887 79999999998743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=169.37 Aligned_cols=150 Identities=29% Similarity=0.536 Sum_probs=126.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++...+..||.|+||.|.+.++. .++...|+|.+.-.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~t------------------------------------------ 82 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRAT------------------------------------------ 82 (282)
T ss_pred hhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhh------------------------------------------
Confidence 44455677999999999998865 56888999987532
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHH----hcCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR----DKGNF 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l 303 (362)
.....+.+.++|+++... ..+|.++++|+.+.....+|+.||.+ ..||..+.+ ..+..
T Consensus 83 ----------------vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~i 145 (282)
T KOG0984|consen 83 ----------------VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTI 145 (282)
T ss_pred ----------------cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcC
Confidence 224456677888887655 48999999999999999999999999 778877654 45679
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..+-+++..++.||.|||++ .+||||+||+|||++.+|++|+||||++..+.+
T Consensus 146 pE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 146 PEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred chHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999999999999999999976 899999999999999999999999999987754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=187.35 Aligned_cols=151 Identities=23% Similarity=0.362 Sum_probs=126.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 53 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPF--------------------------------------- 53 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccc---------------------------------------
Confidence 3578999999999999999999855 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ...|+||||+ .++|.+.+...
T Consensus 54 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 114 (353)
T cd07850 54 ------------------QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD 114 (353)
T ss_pred ------------------cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEecc-CCCHHHHHhhc
Confidence 1112234567899999999999999999987543 3579999999 56888887653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 115 --l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 115 --LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 89999999999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=181.16 Aligned_cols=153 Identities=16% Similarity=0.231 Sum_probs=129.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCC---CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD---PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.-++|.+.+.||+|+||.||.+.+... .+..+++|.+...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~------------------------------------- 46 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH------------------------------------- 46 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-------------------------------------
Confidence 346789999999999999999997652 2567888876421
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
........+.+|+.+++.++||||+++++++.. +...+++++|+++++|.+++...
T Consensus 47 ---------------------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~ 105 (280)
T cd05043 47 ---------------------ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105 (280)
T ss_pred ---------------------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccc
Confidence 112234567889999999999999999997654 57799999999999999998653
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 ------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||+++.+.
T Consensus 106 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~ 168 (280)
T cd05043 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLF 168 (280)
T ss_pred cccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence 348899999999999999999999999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=180.93 Aligned_cols=147 Identities=25% Similarity=0.432 Sum_probs=127.0
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.||.|++|.||++.+. .++..+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~------------------------------------------ 37 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDA------------------------------------------ 37 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccc------------------------------------------
Confidence 5889999999999999999854 457889999876431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc---CCCCHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---GNFDDA 306 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~ 306 (362)
.......+.+|+.+++.++||||+++++.+.+.+..++||||++ ++|.+++... ..+++.
T Consensus 38 ----------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 100 (284)
T cd07836 38 ----------------EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPN 100 (284)
T ss_pred ----------------cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHH
Confidence 01122446679999999999999999999999999999999996 5888887653 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 101 TVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=178.15 Aligned_cols=150 Identities=30% Similarity=0.546 Sum_probs=134.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||.|+||.||++.+.. +++.+++|.+....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~----------------------------------------- 38 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDG----------------------------------------- 38 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCc-----------------------------------------
Confidence 468899999999999999998664 67889999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+..|+..+..++|||++++++++.....++++|||+++++|.+++.....+++..+
T Consensus 39 -----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 101 (264)
T cd06623 39 -----------------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL 101 (264)
T ss_pred -----------------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHH
Confidence 012345688999999999999999999999999999999999999999999988778999999
Q ss_pred HHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+..+.
T Consensus 102 ~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 102 AYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred HHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999999 999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=180.69 Aligned_cols=105 Identities=26% Similarity=0.480 Sum_probs=96.6
Q ss_pred hhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC----------------CCCHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----------------NFDDATTRFYT 312 (362)
Q Consensus 250 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~ 312 (362)
...+.+|+.++..+ +||||+++++++...+.+|++|||+++++|.+++.... .++...+..++
T Consensus 39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 118 (270)
T cd05047 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118 (270)
T ss_pred HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence 34578899999999 89999999999999999999999999999999987532 37889999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.|++.||+|||++|++||||||+||+++.++.++|+|||+++
T Consensus 119 ~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred HHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999999999999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=180.52 Aligned_cols=106 Identities=17% Similarity=0.212 Sum_probs=96.7
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----GNFDDATTRFYTACVVEAFDYLHSR 325 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~al~~lH~~ 325 (362)
...+.+|+.+++.++||||+++++.+......|+||||+++++|.+++.+. ...+...+..++.|++.||.|||++
T Consensus 39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 118 (268)
T cd05086 39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118 (268)
T ss_pred HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 456889999999999999999999999999999999999999999998753 2356778889999999999999999
Q ss_pred CcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
+++||||||+|||++.++.++|+|||++..
T Consensus 119 ~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CeeccCCccceEEEcCCccEEecccccccc
Confidence 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=179.16 Aligned_cols=151 Identities=27% Similarity=0.390 Sum_probs=127.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-.+|.+.+.+|.|+||.||++.+... ....+++|......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------------------------------------- 46 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------------------------------------- 46 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--------------------------------------
Confidence 45688999999999999999986432 23468888764320
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
.....+.+.+|+.+++.++||||+++++++.+ ...|++|||+++++|.+++.... .++
T Consensus 47 --------------------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~ 105 (270)
T cd05056 47 --------------------SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLD 105 (270)
T ss_pred --------------------CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCC
Confidence 11234567889999999999999999998875 45789999999999999997644 589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=180.51 Aligned_cols=149 Identities=28% Similarity=0.533 Sum_probs=123.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~----------------------------------------- 38 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATV----------------------------------------- 38 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCC-----------------------------------------
Confidence 47899999999999999999855 458899999875420
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHH-HhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNF 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l 303 (362)
.......+..|..+ ++..+||||+++++++..++..|++|||+ .++|.+++.. ...+
T Consensus 39 -----------------~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~ 100 (283)
T cd06617 39 -----------------NSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTI 100 (283)
T ss_pred -----------------CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh-cccHHHHHHHhccCCCCC
Confidence 00112234455554 56679999999999999999999999999 4788877754 2358
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.+.
T Consensus 101 ~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred CHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999999999999997 99999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=178.38 Aligned_cols=145 Identities=28% Similarity=0.434 Sum_probs=125.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+.+|.+.+.+|+|+||.||.+.. .++.+++|.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~---------------------------------------- 40 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCD---------------------------------------- 40 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc---CCCceEEEeecCc----------------------------------------
Confidence 457799999999999999998763 4667899976431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 304 (362)
.....+.+|+.+++.++|||++++++++..+ ..+++|||+++++|.+++.... .++
T Consensus 41 ---------------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~ 98 (254)
T cd05083 41 ---------------------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVS 98 (254)
T ss_pred ---------------------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCC
Confidence 0124578899999999999999999998654 4799999999999999987643 478
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 99 ~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 99 VIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 9999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=182.97 Aligned_cols=153 Identities=24% Similarity=0.401 Sum_probs=128.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||.|+||.||++... .+++.+|+|.+.....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~-------------------------------------- 45 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNE-------------------------------------- 45 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccC--------------------------------------
Confidence 4688999999999999999999855 5678899998754210
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
.........+|+.+++.++||||+++++++... +.+|+||||++ ++|.+++... ..+
T Consensus 46 -------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l 105 (309)
T cd07845 46 -------------------RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPF 105 (309)
T ss_pred -------------------CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCC
Confidence 011122356799999999999999999998654 56899999995 5888887753 568
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+..
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999999999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=180.20 Aligned_cols=150 Identities=24% Similarity=0.399 Sum_probs=125.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||.|.+|.||++.+. .+++.+++|.+....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~---------------------------------------- 39 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQ---------------------------------------- 39 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhcc----------------------------------------
Confidence 367999999999999999999865 457889999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC--CCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~ 305 (362)
........+.+|+.+++.++||||+++++++.....+|+||||++ ++|.+.+..... +++
T Consensus 40 -----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 101 (294)
T PLN00009 40 -----------------EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNP 101 (294)
T ss_pred -----------------ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCH
Confidence 011123457789999999999999999999999999999999994 688887765433 578
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||+++++|+||+|+||+++. ++.+||+|||++...
T Consensus 102 ~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 102 RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 889999999999999999999999999999999985 567999999999754
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=181.23 Aligned_cols=150 Identities=28% Similarity=0.495 Sum_probs=131.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.+|.|+||.||++... .+++.+++|.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 38 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEE----------------------------------------- 38 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccc-----------------------------------------
Confidence 36788899999999999999855 457889999875321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+|+.+++.++||||+++++.+.++..+|+++||+++++|.+++... ++++..+
T Consensus 39 -----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~ 100 (274)
T cd06609 39 -----------------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYI 100 (274)
T ss_pred -----------------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHH
Confidence 1122345778999999999999999999999999999999999999999998764 7899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 101 ~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 101 AFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=183.07 Aligned_cols=152 Identities=24% Similarity=0.423 Sum_probs=126.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++...||+|+||.||++... .+++.+|+|.+....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~--------------------------------------- 49 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMEN--------------------------------------- 49 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccC---------------------------------------
Confidence 4678999999999999999999855 457889999875321
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--------ceEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--------KYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~ 298 (362)
........+.+|+.+++.++||||+++++++... ...|+||||+ +++|.+++.
T Consensus 50 ------------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~ 110 (310)
T cd07865 50 ------------------EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLS 110 (310)
T ss_pred ------------------CcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCC-CcCHHHHHH
Confidence 0011123356799999999999999999987654 3469999999 568888776
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 299 DKG-NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~~~-~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 111 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 543 68999999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=170.69 Aligned_cols=169 Identities=16% Similarity=0.061 Sum_probs=115.3
Q ss_pred EEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 154 ITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 154 ~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
...||+|+||.||++.+. +++.+|+|++.+...-.... + ..+........
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~---~---------------------~~~~~~~~~~~---- 51 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDR---D---------------------KYIEGDPRFRS---- 51 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeH---H---------------------HHhcCCccccc----
Confidence 457999999999999855 58899999997652100000 0 00000000000
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
.................|...+..+.|+++.....+.... .|+||||++|+++........+++...+..++.
T Consensus 52 -----~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~ 124 (190)
T cd05145 52 -----RYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYE 124 (190)
T ss_pred -----ccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHH
Confidence 0000000001122346799999999999875554443332 489999998876554433345688899999999
Q ss_pred HHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 314 CVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 314 ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
|++.++.++|+ +||+||||||+||+++ ++.++|+|||+|+.+..+.
T Consensus 125 ~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 125 QVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred HHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCCCC
Confidence 99999999999 9999999999999998 8899999999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=178.79 Aligned_cols=145 Identities=35% Similarity=0.622 Sum_probs=121.0
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
+.+|.|+||.||++... ..++.+|+|.+.+...
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~---------------------------------------------- 34 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDM---------------------------------------------- 34 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhh----------------------------------------------
Confidence 46899999999999854 4578899998765311
Q ss_pred hhhhccccccccchhhhhhHHHHHHH-hhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIM-GEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
........+..|..++ ...+|||++++++++...+.+|++|||+++++|.+++...+.+++..+..++.
T Consensus 35 ----------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ 104 (260)
T cd05611 35 ----------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA 104 (260)
T ss_pred ----------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHH
Confidence 0011112234454444 34589999999999999999999999999999999998877899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++..
T Consensus 105 qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 105 EVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=182.21 Aligned_cols=152 Identities=26% Similarity=0.376 Sum_probs=128.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|.....+|+|+||.||.+... .+++.+++|.+....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~---------------------------------------- 52 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSG---------------------------------------- 52 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccc----------------------------------------
Confidence 356888999999999999999855 457889999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 306 (362)
.........+.+|+++++.++||||+++++++...+..|+||||++ +++.+++.. ...+++.
T Consensus 53 ----------------~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~ 115 (307)
T cd06607 53 ----------------KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEV 115 (307)
T ss_pred ----------------cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHH
Confidence 1112233557889999999999999999999999999999999995 677776653 4568999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 116 ~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999999999999999999999999999999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=179.66 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=128.5
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
-|+....||.|+||.||++... .++..+|+|.+....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~------------------------------------------ 41 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEE------------------------------------------ 41 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEecccc------------------------------------------
Confidence 3667788999999999999854 457789999864321
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.......+.+|+.+++.++||||+++++.+..++..|+||||+++++|.+++.. ..+++..+.
T Consensus 42 ----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~ 104 (277)
T cd06641 42 ----------------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIA 104 (277)
T ss_pred ----------------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHH
Confidence 112235678899999999999999999999999999999999999999998865 468999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 105 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred HHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=180.86 Aligned_cols=150 Identities=29% Similarity=0.473 Sum_probs=130.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|+.++.||.|+||.||.+.+. ..+..+|+|.+....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~----------------------------------------- 41 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEE----------------------------------------- 41 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccc-----------------------------------------
Confidence 34677788999999999999855 457789999875321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+|+.+++.++||||+++++.+.++...|+||||+++++|.+++.. +++++..+
T Consensus 42 -----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~ 103 (277)
T cd06640 42 -----------------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQI 103 (277)
T ss_pred -----------------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHH
Confidence 112335688899999999999999999999999999999999999999998865 56899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|+|+.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 104 ~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred HHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999999999999999999999999999999999999999976643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=180.95 Aligned_cols=149 Identities=25% Similarity=0.407 Sum_probs=127.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+.++.||.|+||.||++... .+++.+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------ 37 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDT------------------------------------------ 37 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEccccc------------------------------------------
Confidence 4789999999999999999854 457889999875321
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~ 307 (362)
........+.+|+++++.++||||+++++++.+.+..|++|||+. ++|..++... ..+++..
T Consensus 38 ---------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~ 101 (284)
T cd07860 38 ---------------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPL 101 (284)
T ss_pred ---------------cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHH
Confidence 011122457889999999999999999999999999999999994 6888887653 4589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 102 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=179.99 Aligned_cols=150 Identities=20% Similarity=0.356 Sum_probs=124.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++... .+++.+++|.+....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~----------------------------------------- 38 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEM----------------------------------------- 38 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhc-----------------------------------------
Confidence 46899999999999999999865 457889999865421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccce-----EEEEEeccCCcchHHHHHhc--
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKY-----LYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-- 300 (362)
........+.+|+.+++.+ +||||+++++++...+. .|++|||+++ +|.+++...
T Consensus 39 ----------------~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~ 101 (295)
T cd07837 39 ----------------DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGR 101 (295)
T ss_pred ----------------cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcc
Confidence 0111234577899999999 46999999998876655 8999999965 888887642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceecC
Q psy14740 301 ---GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ---~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+|||+++.+.
T Consensus 102 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 102 GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence 34799999999999999999999999999999999999998 8899999999998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=177.17 Aligned_cols=148 Identities=30% Similarity=0.499 Sum_probs=126.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.......+|+|+||.||++.+. .++..+++|.+...
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~------------------------------------------ 44 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPER------------------------------------------ 44 (268)
T ss_pred ccCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCC------------------------------------------
Confidence 34445568999999999999855 45778999976542
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC--CH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF--DD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l--~~ 305 (362)
.....+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++... ..+ ++
T Consensus 45 -----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 107 (268)
T cd06624 45 -----------------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE 107 (268)
T ss_pred -----------------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcH
Confidence 1122346788999999999999999999999999999999999999999998764 445 88
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++..+
T Consensus 108 ~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 889999999999999999999999999999999976 679999999998765
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=180.97 Aligned_cols=149 Identities=28% Similarity=0.437 Sum_probs=129.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.+|+|+||.||++... .+++.+++|.+...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~---------------------------------------- 56 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQ---------------------------------------- 56 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEecccc----------------------------------------
Confidence 578999999999999999999854 346789999864321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.+++.+ ..++...
T Consensus 57 -------------------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~ 116 (293)
T cd06647 57 -------------------QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQ 116 (293)
T ss_pred -------------------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHH
Confidence 11234578899999999999999999999999999999999999999999875 3588999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 117 ~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 117 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred HHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999999999999999999999999999999999999999887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=182.04 Aligned_cols=148 Identities=31% Similarity=0.521 Sum_probs=130.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.||.|+||.||++.+. .+++.+++|.+....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------ 38 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEI------------------------------------------ 38 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEeccc------------------------------------------
Confidence 5677888999999999999865 457889999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~ 308 (362)
.......+.+|+++++.++||||+++++.+.....+++++||+++++|.+++... ..+++..+
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (265)
T cd06605 39 ----------------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL 102 (265)
T ss_pred ----------------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHH
Confidence 1123456788999999999999999999999999999999999999999999875 67899999
Q ss_pred HHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 309 RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.|++.||.|+|+ .|++|+||||+||+++.++.++|+|||.+..+
T Consensus 103 ~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 103 GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred HHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999999 99999999999999999999999999998755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=176.99 Aligned_cols=151 Identities=29% Similarity=0.494 Sum_probs=128.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++...+|.|+||.||++.+.. +++.+++|.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~------------------------------------------ 37 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGN------------------------------------------ 37 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEeccc------------------------------------------
Confidence 58889999999999999998654 57789999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--ccceEEEEEeccCCcchHHHHHh----cCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--DKKYLYMLMESCLGGELWTILRD----KGNF 303 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~----~~~l 303 (362)
........+..|+.+++.++||||+++++.+. .....|++|||+++++|.+++.. ..++
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l 102 (265)
T cd08217 38 ---------------MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102 (265)
T ss_pred ---------------CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence 11223456788999999999999999999764 34568999999999999999875 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHH-----HCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLH-----SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH-----~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..++.++.|++.||.|+| +.+++|+||||+||+++.++.++|+|||++..+..
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999999999999999 99999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=179.61 Aligned_cols=149 Identities=26% Similarity=0.417 Sum_probs=128.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.|+..+.+|.|+||.||++.+. .+++.+++|.+....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~------------------------------------------ 38 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDT------------------------------------------ 38 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCC------------------------------------------
Confidence 4677889999999999999865 457889999875420
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcC---CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN---CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.......+.+|+.+++.+. |||++++++++......|++|||+++++|.+++.. +.+++.
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~ 101 (277)
T cd06917 39 ----------------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEK 101 (277)
T ss_pred ----------------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHH
Confidence 1112345678888988886 99999999999999999999999999999998865 478999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 102 ~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=179.91 Aligned_cols=147 Identities=23% Similarity=0.432 Sum_probs=125.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+...+|+|+||.||.+... ..++.+|+|.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~------------------------------------------ 42 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT------------------------------------------ 42 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcC------------------------------------------
Confidence 45777888999999999999855 45788999987532
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHhc-
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
......+..|+.++..+ +||||+++++.+.. ...+|++|||+++++|.+++...
T Consensus 43 ------------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~ 104 (272)
T cd06637 43 ------------------GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 104 (272)
T ss_pred ------------------CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc
Confidence 01124567889999888 79999999998864 24689999999999999998863
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+
T Consensus 105 ~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 105 GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 35899999999999999999999999999999999999999999999999999765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=176.10 Aligned_cols=142 Identities=28% Similarity=0.432 Sum_probs=124.1
Q ss_pred EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchh
Q psy14740 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 235 (362)
Q Consensus 156 ~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~ 235 (362)
.||.|+||.||.+.... ++.+++|.+.....
T Consensus 2 ~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~----------------------------------------------- 32 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLP----------------------------------------------- 32 (251)
T ss_pred ccccCCCceEEEEEEeC--CCcEEEEeccccCC-----------------------------------------------
Confidence 58999999999998543 78899998754310
Q ss_pred hhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHH
Q psy14740 236 SERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTAC 314 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~q 314 (362)
......+..|+++++.++||||+++++++......|++|||+++++|.+++... ..++...+..++.|
T Consensus 33 -----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~ 101 (251)
T cd05041 33 -----------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101 (251)
T ss_pred -----------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 123356788999999999999999999999999999999999999999998653 45889999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|||+++++||||||+||+++.++.++|+|||+++...
T Consensus 102 ~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 102 AAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9999999999999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=184.88 Aligned_cols=151 Identities=21% Similarity=0.380 Sum_probs=127.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-++|++...||+|+||.||++... .++..+|+|.+.+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 52 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPF--------------------------------------- 52 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccc---------------------------------------
Confidence 3567999999999999999999854 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------eEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++.... .+++||+++ +++|.+++..
T Consensus 53 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~- 112 (343)
T cd07880 53 ------------------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH- 112 (343)
T ss_pred ------------------cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-
Confidence 11122345778999999999999999999886543 469999998 8899888764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 113 ~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 113 EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 579999999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=178.44 Aligned_cols=150 Identities=34% Similarity=0.563 Sum_probs=127.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|..++.+|.|++|.||.+.... +++.+++|.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~----------------------------------------- 38 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDP----------------------------------------- 38 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCC-----------------------------------------
Confidence 468899999999999999999654 57889999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHh----cCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRD----KGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~ 302 (362)
.......+.+|+++++.++||||+++++++.. .+.+|++|||+++++|.+++.. ...
T Consensus 39 -----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 101 (287)
T cd06621 39 -----------------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101 (287)
T ss_pred -----------------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCC
Confidence 11234567889999999999999999998754 3478999999999999887653 245
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 8899999999999999999999999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=191.59 Aligned_cols=146 Identities=23% Similarity=0.348 Sum_probs=118.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.||+|+||.||++.+. ..++.||+|++....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~---------------------------------------- 166 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP---------------------------------------- 166 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch----------------------------------------
Confidence 478999999999999999999865 457889999885321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc------CCcceeeeeeeeecc-ceEEEEEeccCCcchHHHHHhc
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA------NCDFIVKLYKTFKDK-KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........|+.++..+ +|++++++++++..+ .++|+||+++ +++|.+++.+.
T Consensus 167 --------------------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~ 225 (467)
T PTZ00284 167 --------------------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH 225 (467)
T ss_pred --------------------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc
Confidence 0112234455555554 455689999888754 5789999998 88999988887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCC----------------cEEEEeccccee
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSG----------------YVKLVDFGFAKK 355 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~----------------~~kl~DFG~a~~ 355 (362)
+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||.+..
T Consensus 226 ~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~ 297 (467)
T PTZ00284 226 GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297 (467)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcccc
Confidence 889999999999999999999998 5999999999999998765 499999998754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=183.68 Aligned_cols=145 Identities=26% Similarity=0.493 Sum_probs=125.0
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.....||.|+||.||++... .++..+++|.+...
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~-------------------------------------------- 58 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLR-------------------------------------------- 58 (292)
T ss_pred HhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecc--------------------------------------------
Confidence 333466999999999999854 45778999986432
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 310 (362)
.......+.+|+.+++.++||||+++++.+..++..|++|||+++++|.+++.. +.+++..+..
T Consensus 59 ---------------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~ 122 (292)
T cd06658 59 ---------------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAT 122 (292)
T ss_pred ---------------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHH
Confidence 112234578899999999999999999999999999999999999999998754 4689999999
Q ss_pred HHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 311 ~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 123 ~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=174.16 Aligned_cols=151 Identities=32% Similarity=0.578 Sum_probs=132.2
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.+|.|+||.||.+.+.. +++.+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~------------------------------------------ 37 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSN------------------------------------------ 37 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeeccc------------------------------------------
Confidence 58899999999999999999654 57789999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----CCCCH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----GNFDD 305 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~ 305 (362)
........+.+|+++++.++|||++++++.+...+..++++|++++++|.+++... ..+++
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 102 (258)
T cd08215 38 ---------------MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE 102 (258)
T ss_pred ---------------CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCH
Confidence 11233455788999999999999999999999999999999999999999998764 56999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 103 ~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 103 EQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999999999999999999999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=177.25 Aligned_cols=144 Identities=25% Similarity=0.396 Sum_probs=119.6
Q ss_pred cCcEEEEEe--cccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 149 SDLRVITTL--GVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 149 ~~~~~~~~l--g~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
++|.+.+.+ |+|+||.||++... .++..+++|.+.+....
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~------------------------------------- 55 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFN------------------------------------- 55 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcc-------------------------------------
Confidence 455555554 99999999999855 45778999987543100
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
..|......+ +||||+++++.+..++.+|+||||+++++|.+++.....+++
T Consensus 56 ---------------------------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~ 108 (267)
T PHA03390 56 ---------------------------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE 108 (267)
T ss_pred ---------------------------hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCH
Confidence 0122222222 799999999999999999999999999999999988778999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 109 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 109 AEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999999999999999999999988 99999999987654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=177.45 Aligned_cols=150 Identities=25% Similarity=0.337 Sum_probs=123.6
Q ss_pred cEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
|++.+.||+|+||.||++.... .+++.+|+|.+...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~------------------------------------------ 38 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD------------------------------------------ 38 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc------------------------------------------
Confidence 5677889999999999998653 34678999987542
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------eEEEEEeccCCcchHHHHHhc--
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.........+.+|+.+++.++||||+++++++.... ..+++++|+++++|..++...
T Consensus 39 ---------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 103 (273)
T cd05074 39 ---------------IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103 (273)
T ss_pred ---------------cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence 112223456788999999999999999999875432 357899999999998876432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 ----GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ----~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05074 104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164 (273)
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccccc
Confidence 147889999999999999999999999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=177.76 Aligned_cols=106 Identities=20% Similarity=0.245 Sum_probs=95.9
Q ss_pred hhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 251 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
..+..|+.+++.++||||+++++++..+...+++|||+++++|..++... ..+++..+..++.|++.||.|||+++|+|
T Consensus 49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 128 (262)
T cd05077 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVH 128 (262)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeEC
Confidence 45778899999999999999999999888999999999999998888753 46899999999999999999999999999
Q ss_pred ecCCCCcEEecCCCc-------EEEEecccceec
Q psy14740 330 RDLKPENLLLSTSGY-------VKLVDFGFAKKL 356 (362)
Q Consensus 330 rDikp~NIl~~~~~~-------~kl~DFG~a~~~ 356 (362)
|||||+|||++.++. ++++|||++..+
T Consensus 129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred CCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 999999999987654 899999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=176.03 Aligned_cols=148 Identities=26% Similarity=0.465 Sum_probs=131.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.+|+|+||.||++.... +++.+++|.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~----------------------------------------- 40 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEE----------------------------------------- 40 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHH-----------------------------------------
Confidence 578899999999999999998653 46789999874320
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
....+.+|+.+++.++||||+++++.+.....+|+++|++++++|.+++.. ...+++..
T Consensus 41 --------------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~ 100 (256)
T cd06612 41 --------------------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE 100 (256)
T ss_pred --------------------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHH
Confidence 145688999999999999999999999999999999999999999999875 34689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 101 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 101 IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999999999999999999999999999999999999999886643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=166.31 Aligned_cols=151 Identities=23% Similarity=0.353 Sum_probs=130.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+....|++++.||+|+||++|++.... +++.||||+-...
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~--------------------------------------- 51 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSK--------------------------------------- 51 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeecc-CCceEEEEeeccc---------------------------------------
Confidence 467899999999999999999999664 5889999986543
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHHHH-hcCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l 303 (362)
....++..|..+...+++ ..|+.+..+..+.++-.+|||++ |.||.+++. +.+.+
T Consensus 52 ----------------------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~f 108 (341)
T KOG1163|consen 52 ----------------------AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRF 108 (341)
T ss_pred ----------------------CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhh
Confidence 223457789999988864 78999999998999999999999 999999887 44679
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~~ 359 (362)
+..++...+.|++.-++|+|.+++|||||||+|+|..- ...+.|+|||+|+++.+.
T Consensus 109 tmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 109 TMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred hHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999999999999999999999999999999999974 356899999999987543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=184.27 Aligned_cols=152 Identities=21% Similarity=0.418 Sum_probs=128.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+...||.|+||.||.+.+. .+++.+++|.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 42 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAF---------------------------------------- 42 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccc----------------------------------------
Confidence 357999999999999999999855 568899999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........+.+|+.+++.++||||+++++++... ...|++|||+ +++|.+++...+.
T Consensus 43 -----------------~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~ 104 (337)
T cd07858 43 -----------------DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQT 104 (337)
T ss_pred -----------------cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCC
Confidence 0111223466899999999999999999987544 3589999999 5789999988778
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++....
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999999999999999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=183.79 Aligned_cols=149 Identities=21% Similarity=0.408 Sum_probs=125.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||.+.+. .+++.+|+|.+....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 42 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFE---------------------------------------- 42 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccc----------------------------------------
Confidence 468999999999999999999855 457889999875320
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.......+.+|+.+++.++||||+++++++... ...|+++||+ +++|.+.+.. +.
T Consensus 43 ------------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~ 102 (336)
T cd07849 43 ------------------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKT-QH 102 (336)
T ss_pred ------------------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc-ccCHHHHHhc-CC
Confidence 111234467899999999999999999876543 3589999999 4688887754 56
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 9999999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=192.63 Aligned_cols=154 Identities=25% Similarity=0.369 Sum_probs=136.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..+..++.++||.|+||+|+....... ....||||.++-+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-------------------------------------- 668 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-------------------------------------- 668 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--------------------------------------
Confidence 345668889999999999999986543 2357899998765
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
.....+..|+.|+.||.+.+||||+++.++.-....+.||+||+++|+|..+++.+ +.|
T Consensus 669 --------------------ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqf 728 (996)
T KOG0196|consen 669 --------------------YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQF 728 (996)
T ss_pred --------------------ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCce
Confidence 23455678999999999999999999999998888999999999999999999865 569
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.-+++-|+.|+.||-+.+++||||...|||++.+-.+|++|||++|.+.+
T Consensus 729 tviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 729 TVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999999999999999999999999999999999999999998854
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=182.42 Aligned_cols=150 Identities=25% Similarity=0.383 Sum_probs=124.6
Q ss_pred CcEEEEEecccceecEEEEEecCC-CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGD-PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+|++.+.||+|+||.||++..... .+..+|+|.+....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~----------------------------------------- 39 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF----------------------------------------- 39 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-----------------------------------------
Confidence 478999999999999999996532 16789999875320
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
......+.+.+|+.+++.+ +||||+++++.... ...+|++++++ +++|.+++.....+
T Consensus 40 ----------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~ 102 (332)
T cd07857 40 ----------------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPL 102 (332)
T ss_pred ----------------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCC
Confidence 0111234577899999998 69999999986432 24689999998 57999998877789
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 103 ~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 103 TDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 999999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=176.44 Aligned_cols=108 Identities=22% Similarity=0.313 Sum_probs=95.5
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeee-ccceEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFK-DKKYLYMLMESCLGGELWTILRDKG-NFDDATTRFYTACVVEAFDYLHSRNI 327 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~al~~lH~~~i 327 (362)
...+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.+++.+.. ..+...+..++.|++.||.|||+.++
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 119 (262)
T cd05058 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119 (262)
T ss_pred HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 356788999999999999999999754 4567899999999999999997643 46777888899999999999999999
Q ss_pred EeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 328 iHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+||||||+||+++.++.++|+|||+++.+.
T Consensus 120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 120 VHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred cccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=181.96 Aligned_cols=147 Identities=27% Similarity=0.470 Sum_probs=127.0
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|+..+.||+|+||.||.+.+. ..++.+++|.+....
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~------------------------------------------- 41 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEE------------------------------------------- 41 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEecccc-------------------------------------------
Confidence 445566899999999999854 457789999875321
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 310 (362)
.......+.+|+.+++.++||||+++++++..+...|+||||+++++|.+++.. +.+++..+..
T Consensus 42 ---------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~ 105 (277)
T cd06642 42 ---------------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIAT 105 (277)
T ss_pred ---------------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHH
Confidence 112235678999999999999999999999999999999999999999998864 5689999999
Q ss_pred HHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 311 ~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred HHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 99999999999999999999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=180.60 Aligned_cols=152 Identities=26% Similarity=0.434 Sum_probs=127.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.+|+|+||.||++... .+++.+++|.+....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~--------------------------------------- 44 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDN--------------------------------------- 44 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecc---------------------------------------
Confidence 4578999999999999999999965 457789999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----------eEEEEEeccCCcchHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----------YLYMLMESCLGGELWTI 296 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~ 296 (362)
........+.+|+.+++.++||||+++++++.+.. .+|++|||+++ ++..+
T Consensus 45 ------------------~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 105 (302)
T cd07864 45 ------------------EKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGL 105 (302)
T ss_pred ------------------cccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHH
Confidence 00112234677999999999999999999887654 79999999965 77776
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 297 LRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 297 l~~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++.+.
T Consensus 106 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 167 (302)
T cd07864 106 LESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167 (302)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccccc
Confidence 6653 468999999999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=182.03 Aligned_cols=144 Identities=29% Similarity=0.496 Sum_probs=124.5
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
.....+|.|+||.||.+... .+++.+++|.+....
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~-------------------------------------------- 58 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRK-------------------------------------------- 58 (297)
T ss_pred HhhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecc--------------------------------------------
Confidence 33446899999999999854 457789999874321
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~ 311 (362)
......+.+|+.+++.++||||+++++.+..++..|++|||+++++|..++.. ..+++..+..+
T Consensus 59 ---------------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~ 122 (297)
T cd06659 59 ---------------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATV 122 (297)
T ss_pred ---------------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHH
Confidence 11234477899999999999999999999999999999999999999987755 56899999999
Q ss_pred HHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 123 ~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 123 CESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=174.48 Aligned_cols=150 Identities=25% Similarity=0.405 Sum_probs=129.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||++.+. .+++.+++|.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~----------------------------------------- 38 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSM----------------------------------------- 38 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhc-----------------------------------------
Confidence 5889999999999999999855 4577899998764310
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCCCH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNFDD 305 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 305 (362)
.......+.+|+.+++.++||||+++++++......|++|||+++++|.+++.+ ...+++
T Consensus 39 ----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08530 39 ----------------SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102 (256)
T ss_pred ----------------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence 112234567899999999999999999999999999999999999999998866 245899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 103 QEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred HHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 9999999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=179.33 Aligned_cols=108 Identities=17% Similarity=0.167 Sum_probs=97.0
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATTRFYTACVVEAFDYLHSRNII 328 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~al~~lH~~~ii 328 (362)
...+..|..+++.++||||+++++++..++..++||||+++++|.+++..++ .+++.....++.|++.||.|||++||+
T Consensus 43 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii 122 (258)
T cd05078 43 SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122 (258)
T ss_pred HHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3457789999999999999999999999889999999999999999997654 589999999999999999999999999
Q ss_pred eecCCCCcEEecCCCc--------EEEEecccceecC
Q psy14740 329 YRDLKPENLLLSTSGY--------VKLVDFGFAKKLI 357 (362)
Q Consensus 329 HrDikp~NIl~~~~~~--------~kl~DFG~a~~~~ 357 (362)
||||||+||+++.++. ++++|||++....
T Consensus 123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 9999999999987654 6999999986543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=176.39 Aligned_cols=149 Identities=26% Similarity=0.470 Sum_probs=128.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.+|.|+||.||++.... .++.+++|.+....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~--------------------------------------- 43 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIE--------------------------------------- 43 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCc---------------------------------------
Confidence 35789999999999999999998653 47789999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHh
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~ 299 (362)
.....+.+|+.+++.+ +||||+++++++... ..+|++|||+++++|.+++..
T Consensus 44 ---------------------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 102 (275)
T cd06608 44 ---------------------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG 102 (275)
T ss_pred ---------------------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHH
Confidence 1234578899999998 799999999998653 458999999999999998865
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 300 ----KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 300 ----~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 103 ~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 103 LRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred HhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 346899999999999999999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=183.30 Aligned_cols=151 Identities=22% Similarity=0.425 Sum_probs=130.7
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++...||.|+||.||++... .+++.+++|.+.+..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~------------------------------------------ 37 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVF------------------------------------------ 37 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeecccc------------------------------------------
Confidence 5889999999999999999854 457889999875421
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
......+.+.+|+.+++.++||||+++++++...+ .+|++|+|++ ++|.+++.+...++
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~ 101 (330)
T cd07834 38 ---------------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLT 101 (330)
T ss_pred ---------------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCC
Confidence 11223356788999999999999999999987765 7999999995 68999998777899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....+
T Consensus 102 ~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999999999999999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=190.13 Aligned_cols=151 Identities=23% Similarity=0.339 Sum_probs=126.2
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
+....||+|+|-+||++.+. ..+-.||=-.++-.+
T Consensus 43 k~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d-------------------------------------------- 77 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRD-------------------------------------------- 77 (632)
T ss_pred ehhhhcccccceeeeecccc-ccchhhHHHHHhHHH--------------------------------------------
Confidence 45567999999999999854 456555533222211
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--eEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
........+++..|+.+|+.|+||||+++|++|.+.+ .+.+|+|++..|+|..|+++.+..+...++
T Consensus 78 -----------~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik 146 (632)
T KOG0584|consen 78 -----------VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIK 146 (632)
T ss_pred -----------hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHH
Confidence 2233455688999999999999999999999998765 488999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHCC--cEeecCCCCcEEecC-CCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRN--IIYRDLKPENLLLST-SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~~ 358 (362)
.|++||+.||.|||++. |||||||-+||+|+. -|.|||+|+|+|.....
T Consensus 147 ~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 147 SWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred HHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999999985 999999999999985 58999999999975543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=173.94 Aligned_cols=145 Identities=45% Similarity=0.807 Sum_probs=127.5
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
+|.|+||.||.+... ..++.+++|.+.+..
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~------------------------------------------------- 30 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKK------------------------------------------------- 30 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhh-------------------------------------------------
Confidence 689999999999865 457889999886541
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVV 316 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~ 316 (362)
.........+..|+.+++.++||||+++++.+..+...|++||++++++|.+++.....+++..+..++.|++
T Consensus 31 -------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~ 103 (250)
T cd05123 31 -------IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIV 103 (250)
T ss_pred -------hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 1111234567889999999999999999999999999999999999999999998877899999999999999
Q ss_pred HHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 317 EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 317 ~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.||.|+|+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 ~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 104 LALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=171.80 Aligned_cols=152 Identities=31% Similarity=0.467 Sum_probs=133.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|+..+.+|+|++|.||.+.... +++.+++|.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~------------------------------------------ 37 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSG------------------------------------------ 37 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccc------------------------------------------
Confidence 47888999999999999998653 57789999875431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+.+|+.+++.++||||+++++.+... ..+++++|++++++|.+++.+...+++..
T Consensus 38 ---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 102 (260)
T cd06606 38 ---------------DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV 102 (260)
T ss_pred ---------------cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHH
Confidence 0122346678999999999999999999999888 89999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 103 ~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999999999999999999999999999999999999999877544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=180.89 Aligned_cols=150 Identities=21% Similarity=0.403 Sum_probs=126.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-++|.+.+.||+|+||.||++... .+++.+|+|.+.+..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 54 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPF--------------------------------------- 54 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcc---------------------------------------
Confidence 3478999999999999999999854 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++... ...|++++++ +++|.+++..
T Consensus 55 ------------------~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~- 114 (345)
T cd07877 55 ------------------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC- 114 (345)
T ss_pred ------------------hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-
Confidence 0111234567899999999999999999987543 3478899987 8899888765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 115 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 46999999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=176.34 Aligned_cols=150 Identities=25% Similarity=0.425 Sum_probs=128.9
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.+|.|+||.||++... .+++.+++|.+....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~------------------------------------------- 36 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMEN------------------------------------------- 36 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEeccc-------------------------------------------
Confidence 678899999999999999855 457789999886531
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc-CCCCHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-GNFDDAT 307 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~ 307 (362)
........+.+|+.+++.++|||++++++++... +..|++|||++ ++|.+++... ..+++..
T Consensus 37 --------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 101 (287)
T cd07840 37 --------------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQ 101 (287)
T ss_pred --------------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHH
Confidence 0112234577899999999999999999999887 89999999995 5898888764 4799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 102 ~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9999999999999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=187.80 Aligned_cols=141 Identities=24% Similarity=0.409 Sum_probs=125.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
++...-.+-||+|+-|.||+.+.. ++.||||.++.-
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~---netVAVKKV~el----------------------------------------- 158 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLH---NETVAVKKVREL----------------------------------------- 158 (904)
T ss_pred HHHhhhhhhhccCcccceeeeecc---CceehhHHHhhh-----------------------------------------
Confidence 333334455999999999999854 678999976431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
-..++..|++++||||+.+.+++...-.++||||||+.|.|..+++....++...
T Consensus 159 -------------------------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~l 213 (904)
T KOG4721|consen 159 -------------------------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSL 213 (904)
T ss_pred -------------------------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHH
Confidence 2457888999999999999999999999999999999999999999988999999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+.
T Consensus 214 lv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 214 LVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred HHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999999999999999999999999999999999998664
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=181.59 Aligned_cols=162 Identities=20% Similarity=0.335 Sum_probs=130.2
Q ss_pred cCcEE-EEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 149 SDLRV-ITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 149 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
++|.. ...||.|+||.||++.+. ..++.+|+|.+..........
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~---------------------------------- 52 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVT---------------------------------- 52 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccc----------------------------------
Confidence 45554 467999999999999855 457889999886542110000
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
+.............+.+|+.+++.++||||+++++++..++..+++|||++ ++|.+++.....+++..
T Consensus 53 -----------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~ 120 (335)
T PTZ00024 53 -----------KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQ 120 (335)
T ss_pred -----------cchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHH
Confidence 000001111222357789999999999999999999999999999999995 69999998777899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 121 ~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence 99999999999999999999999999999999999999999999998765
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-21 Score=169.94 Aligned_cols=150 Identities=30% Similarity=0.580 Sum_probs=132.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.+|+|++|.||++.... +++.+++|.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~------------------------------------------ 37 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLES------------------------------------------ 37 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccc------------------------------------------
Confidence 57888999999999999999654 57789999875531
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATT 308 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~ 308 (362)
......+.+|+++++.++|||++++++.+......++++||+++++|.+++... ..+++..+
T Consensus 38 -----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~ 100 (253)
T cd05122 38 -----------------KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI 100 (253)
T ss_pred -----------------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHH
Confidence 123456788999999999999999999999999999999999999999998775 57899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 101 ~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 101 AYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred HHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999999999999999999999999999999999999999999876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=174.41 Aligned_cols=160 Identities=29% Similarity=0.422 Sum_probs=129.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++...||+|+||.||.+.....+++.+++|.+........
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~-------------------------------------- 42 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-------------------------------------- 42 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc--------------------------------------
Confidence 477888999999999999997765678899998754311000
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~ 304 (362)
............+.+|+.++.. ++||||+++++++...+..+++|||+++++|.+++.. ...++
T Consensus 43 -----------~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~ 111 (269)
T cd08528 43 -----------KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111 (269)
T ss_pred -----------cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCC
Confidence 0011122334556778888865 7999999999999999999999999999999988743 24589
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 166 (269)
T cd08528 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166 (269)
T ss_pred HHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence 99999999999999999996 7899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=186.09 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=127.2
Q ss_pred EEecccceecEEEEEecCC-CC--CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 155 TTLGVGGFGRVELVQIAGD-PS--RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
+.||.|.||.||.+..... .+ -.||||..+..
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--------------------------------------------- 429 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--------------------------------------------- 429 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccC---------------------------------------------
Confidence 4699999999999986543 22 35777776542
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHHHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDATTRF 310 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~ 310 (362)
......+.|+.|+.+|++++||||+++++++.+. ..|||||+++-|.|..+++.++ .++......
T Consensus 430 -------------~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~l 495 (974)
T KOG4257|consen 430 -------------CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTL 495 (974)
T ss_pred -------------CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHH
Confidence 1223467799999999999999999999998654 5999999999999999998765 589999999
Q ss_pred HHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 311 ~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
++.|++.||.|||+...+||||-..|||+.+...+||+|||++|.+....|
T Consensus 496 y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 496 YCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred HHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999999999999999999999999999999999998876654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=178.96 Aligned_cols=152 Identities=24% Similarity=0.419 Sum_probs=125.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.+++|.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~--------------------------------------- 45 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHN--------------------------------------- 45 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEecc---------------------------------------
Confidence 3689999999999999999999855 457789999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--------ceEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--------KYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~ 298 (362)
..........+|+++++.++||||+++++.+... ..+|++|+|+. +++...+.
T Consensus 46 ------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~ 106 (311)
T cd07866 46 ------------------EKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLE 106 (311)
T ss_pred ------------------CCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHh
Confidence 0011123456899999999999999999876433 35799999984 56777665
Q ss_pred h-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 299 D-KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~-~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus 107 ~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 107 NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 4 3469999999999999999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=179.01 Aligned_cols=150 Identities=21% Similarity=0.389 Sum_probs=127.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||.|+||.||++... .+++.+++|.+.+..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 47 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPF--------------------------------------- 47 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccc---------------------------------------
Confidence 3567999999999999999999855 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+..|+.+++.++||||+++++++.. ...+|++|||+ +++|.++++. .++++
T Consensus 48 ------------------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~ 107 (328)
T cd07856 48 ------------------STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEK 107 (328)
T ss_pred ------------------cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCH
Confidence 011123456789999999999999999998865 56789999998 6789888764 46888
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 108 ~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 108 QFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=177.99 Aligned_cols=151 Identities=26% Similarity=0.398 Sum_probs=127.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|.....||+|+||.||++... .++..+++|.+....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~----------------------------------------- 62 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSG----------------------------------------- 62 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCC-----------------------------------------
Confidence 34677888999999999999855 457889999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
.........+.+|+.+++.++|||++++++++..+...|+||||++ ++|.+++.. ..++++..
T Consensus 63 ---------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~ 126 (317)
T cd06635 63 ---------------KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE 126 (317)
T ss_pred ---------------CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHH
Confidence 1112233567889999999999999999999999999999999995 577776654 45689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 127 ~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 99999999999999999999999999999999999999999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=175.88 Aligned_cols=148 Identities=23% Similarity=0.422 Sum_probs=126.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|++.+.+|.|+||.||++.+. ..++.+++|.+...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~----------------------------------------- 52 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT----------------------------------------- 52 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecC-----------------------------------------
Confidence 478899999999999999999865 45778999986432
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeee------ccceEEEEEeccCCcchHHHHHhc
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFK------DKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
......+..|+.+++.+ +||||+++++++. ..+.+|++|||+++++|.+++...
T Consensus 53 -------------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~ 113 (282)
T cd06636 53 -------------------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113 (282)
T ss_pred -------------------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc
Confidence 11224467788888888 7999999999884 346799999999999999998753
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 114 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 34888999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=175.80 Aligned_cols=148 Identities=25% Similarity=0.406 Sum_probs=127.4
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.+|.|++|.||++.+. .++..+++|.+....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~------------------------------------------- 36 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLET------------------------------------------- 36 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeeccc-------------------------------------------
Confidence 567889999999999999855 457889999875431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~ 308 (362)
........+.+|+++++.++|||++++++++.+++..|++|||+ +++|.+++.... .+++..+
T Consensus 37 --------------~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~ 101 (283)
T cd07835 37 --------------EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLI 101 (283)
T ss_pred --------------ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHH
Confidence 01112244678999999999999999999999999999999999 578999887655 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 102 ~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred HHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 9999999999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=175.46 Aligned_cols=146 Identities=27% Similarity=0.475 Sum_probs=126.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.-...||+|++|.||++.... .++.+++|.+...
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~------------------------------------------- 55 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLR------------------------------------------- 55 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-CCCEEEEEEEecc-------------------------------------------
Confidence 34455789999999999998553 4778999976322
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.......+.+|+.+++.++||||+++++++...+..|+++||+++++|.+++.. .+++...+.
T Consensus 56 ----------------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~ 118 (285)
T cd06648 56 ----------------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA 118 (285)
T ss_pred ----------------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHH
Confidence 111234478899999999999999999999999999999999999999999877 678999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 119 ~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 119 TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 99999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=175.90 Aligned_cols=108 Identities=31% Similarity=0.393 Sum_probs=97.6
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-------GNFDDATTRFYTACVVEAFDYL 322 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~ql~~al~~l 322 (362)
...+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... ..++...+..++.|++.||.||
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (269)
T cd05044 43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122 (269)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999999999998642 2377899999999999999999
Q ss_pred HHCCcEeecCCCCcEEecCCC-----cEEEEecccceecC
Q psy14740 323 HSRNIIYRDLKPENLLLSTSG-----YVKLVDFGFAKKLI 357 (362)
Q Consensus 323 H~~~iiHrDikp~NIl~~~~~-----~~kl~DFG~a~~~~ 357 (362)
|+.+++|+||||+||+++.++ .++|+|||+++.+.
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~ 162 (269)
T cd05044 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162 (269)
T ss_pred HhCCcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence 999999999999999999877 89999999987653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=174.01 Aligned_cols=146 Identities=23% Similarity=0.410 Sum_probs=121.9
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.+|+|+||.||++... .+++.+|+|.+.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~------------------------------------------ 37 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFK------------------------------------------ 37 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccC------------------------------------------
Confidence 678899999999999999855 4577899998754210
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
........+|+.++..+ +|||++++++++.++ +.+++||||++ ++|.+.+... ..+++.
T Consensus 38 ----------------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~ 100 (282)
T cd07831 38 ----------------SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEK 100 (282)
T ss_pred ----------------CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHH
Confidence 00112235688888888 599999999999887 88999999995 5788777653 468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||+.|++|+||||+||+++. +.++|+|||+++.+.
T Consensus 101 ~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 101 RVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 99999999999999999999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=186.52 Aligned_cols=152 Identities=23% Similarity=0.426 Sum_probs=132.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-+-|.++..+|.|.||.||++... .+++..|+|+....
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~---------------------------------------- 55 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPT---------------------------------------- 55 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCC----------------------------------------
Confidence 5677999999999999999999855 45778899986432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
......+..|.++++.. +|||++.+|++|. .++.+|||||||.|||..++++.-
T Consensus 56 --------------------~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~ 115 (953)
T KOG0587|consen 56 --------------------EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNT 115 (953)
T ss_pred --------------------ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhh
Confidence 22335577788888886 7999999999985 357899999999999999999853
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..+.++.+.+|++.++.|+.+||.+.++|||||-.|||++.++.|||+|||++.+++..
T Consensus 116 ~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 116 KGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred cccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 46999999999999999999999999999999999999999999999999999988654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=172.20 Aligned_cols=150 Identities=25% Similarity=0.499 Sum_probs=128.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|++.+.+|.|+||.||++.... ++..+++|.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~----------------------------------------- 38 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKM----------------------------------------- 38 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhc-----------------------------------------
Confidence 47889999999999999998654 467799998754310
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++.+...+..|+++||+++++|.+++.... .+++..
T Consensus 39 ----------------~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (257)
T cd08225 39 ----------------PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ 102 (257)
T ss_pred ----------------cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHH
Confidence 11123456789999999999999999999999999999999999999999987643 478999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+..+.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999999999999999999999999998875 46999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=171.40 Aligned_cols=102 Identities=25% Similarity=0.415 Sum_probs=92.4
Q ss_pred HHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCC
Q psy14740 256 EKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPE 335 (362)
Q Consensus 256 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~ 335 (362)
|...+....||||+++++++...+.+|++|||+++++|.+++.+...+++..+..++.|++.||.|||++|++||||||+
T Consensus 35 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ 114 (237)
T cd05576 35 ERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPN 114 (237)
T ss_pred HHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 33444455799999999999999999999999999999999987777999999999999999999999999999999999
Q ss_pred cEEecCCCcEEEEecccceecC
Q psy14740 336 NLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 336 NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
||+++.++.++++|||.+..+.
T Consensus 115 Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 115 NILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred HEEEcCCCCEEEecccchhccc
Confidence 9999999999999999876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=181.18 Aligned_cols=151 Identities=30% Similarity=0.474 Sum_probs=126.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.+|+|+||.||++.+. .+++.+++|.+.+..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~--------------------------------------- 44 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAF--------------------------------------- 44 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeecccc---------------------------------------
Confidence 3567888999999999999999854 457789999874320
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+.+|+.+++.+ +||||+++++++... ..+|+||||++ ++|..++... .+
T Consensus 45 ------------------~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~ 104 (337)
T cd07852 45 ------------------RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-IL 104 (337)
T ss_pred ------------------CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CC
Confidence 0011223466799999999 999999999987643 46899999995 6999888764 78
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.....++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.+.
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 899999999999999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=173.92 Aligned_cols=148 Identities=31% Similarity=0.522 Sum_probs=126.6
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.||.|+||.||.+... ++++.+++|.+.+...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~------------------------------------------ 37 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFY------------------------------------------ 37 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhcc------------------------------------------
Confidence 578889999999999999854 4577899998754310
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDAT 307 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~ 307 (362)
........+|+..++.++ ||||+++++++..++..|+||||+ +++|.+.+.... .+++..
T Consensus 38 ----------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~ 100 (283)
T cd07830 38 ----------------SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESV 100 (283)
T ss_pred ----------------chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHH
Confidence 011123456888899998 999999999999999999999999 889999887654 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||+++....
T Consensus 101 ~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 101 IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 999999999999999999999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=174.48 Aligned_cols=149 Identities=27% Similarity=0.429 Sum_probs=129.0
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|+..+.+|+|.||.||.+... .+++.+++|.+....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~------------------------------------------- 36 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDN------------------------------------------- 36 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEecccc-------------------------------------------
Confidence 567788999999999999855 457889999886531
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~ 309 (362)
........+..|+.+++.++|||++++++++...+.++++||+++ ++|.+++.+. ..+++..+.
T Consensus 37 --------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~ 101 (282)
T cd07829 37 --------------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIK 101 (282)
T ss_pred --------------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHH
Confidence 112223456789999999999999999999999999999999996 6999999875 579999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+++....
T Consensus 102 ~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 9999999999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=174.98 Aligned_cols=144 Identities=19% Similarity=0.288 Sum_probs=125.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+..+++.+|+|.||+|+++.+. |+.||+|++.-.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr------------------------------------------ 245 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR------------------------------------------ 245 (513)
T ss_pred heeEEEEEecCccccceeecccc---CCceEEEEeccc------------------------------------------
Confidence 45689999999999999999988 457999998532
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhh--cCCcceeeeeeeeecc----ceEEEEEeccCCcchHHHHHhcCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE--ANCDFIVKLYKTFKDK----KYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
..+.+.+|.+|.+. ++|+||+.+++.-... ..+|||++|.+.|||++++.+ ..
T Consensus 246 --------------------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~t 304 (513)
T KOG2052|consen 246 --------------------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NT 304 (513)
T ss_pred --------------------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-cc
Confidence 34668889999887 5999999999875433 359999999999999999988 57
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSR--------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~--------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.+.+..++..++.||+|||.. .|.|||||..|||+.++|.+.|+|+|+|-....
T Consensus 305 v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 305 VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 99999999999999999999953 599999999999999999999999999976543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-21 Score=174.71 Aligned_cols=148 Identities=28% Similarity=0.430 Sum_probs=125.2
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.....+|+|+||.||++... .+++.+++|.+....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~------------------------------------------- 58 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSG------------------------------------------- 58 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccc-------------------------------------------
Confidence 566778999999999999854 457889999875431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~ 309 (362)
.........+..|+.+++.++|||++++++++.+....|++|||+. +++.+++.. ..++++..+.
T Consensus 59 -------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~ 124 (313)
T cd06633 59 -------------KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA 124 (313)
T ss_pred -------------cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHH
Confidence 1112233557889999999999999999999999999999999994 677777754 4568999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 125 ~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 125 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 99999999999999999999999999999999999999999988643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=181.47 Aligned_cols=160 Identities=29% Similarity=0.404 Sum_probs=133.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+...||.|+|++||++-+. ...+.+|+|+-.-.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlN------------------------------------------ 499 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLN------------------------------------------ 499 (775)
T ss_pred HHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhc------------------------------------------
Confidence 46778888999999999999855 45788999974321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee-ccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK-DKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
+.|.........+...+|..|.+.++||.||++|++|. +.+.+|-|+|||+|.+|.-+++.++.+++..
T Consensus 500 ----------K~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKE 569 (775)
T KOG1151|consen 500 ----------KNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKE 569 (775)
T ss_pred ----------cchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHH
Confidence 00112222345567889999999999999999999986 5677999999999999999999988999999
Q ss_pred HHHHHHHHHHHHHHHHHC--CcEeecCCCCcEEecC---CCcEEEEecccceecCCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSR--NIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~--~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~~~~ 361 (362)
++.|+.||+.||.||... .|||-||||.|||+-. .|.+||+|||+++.+.+..|
T Consensus 570 ARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy 628 (775)
T KOG1151|consen 570 ARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY 628 (775)
T ss_pred HHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence 999999999999999976 5999999999999954 47899999999999987765
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=168.56 Aligned_cols=149 Identities=23% Similarity=0.353 Sum_probs=127.3
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.+...++|+++..+|.|.|++|+.+... .+++.++||++++-
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPV------------------------------------- 74 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPV------------------------------------- 74 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhccccc-CCCceEEEeeechH-------------------------------------
Confidence 4456789999999999999999999865 45678999998653
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
....+.+|+.||..+. ||||++++++..++ ...-+++|++.+.+...+..
T Consensus 75 -------------------------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-- 127 (338)
T KOG0668|consen 75 -------------------------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-- 127 (338)
T ss_pred -------------------------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh--
Confidence 2355889999999995 99999999998765 45889999998888777653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~ 358 (362)
.++...++.++.+++.||.|||+.||.|||+||.|++|+.. -.++|+|+|+|..+-+
T Consensus 128 -tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 128 -TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred -hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 48889999999999999999999999999999999999964 5699999999977643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=174.13 Aligned_cols=161 Identities=20% Similarity=0.258 Sum_probs=115.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-.+|++.+.||+|+||.||++....+. +..+++|......- .. ..+.
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~----~~------------------~~e~--------- 59 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TI------------------VMET--------- 59 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC----ch------------------hhHH---------
Confidence 368999999999999999999865431 34556664321100 00 0000
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.............+...+..++|+|++++++.+.... +.+++++++ ..++.+++....
T Consensus 60 -----------------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 121 (294)
T PHA02882 60 -----------------LVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK 121 (294)
T ss_pred -----------------HHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc
Confidence 0000001112234445566789999999998765433 457888887 557777776655
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+|+.+.
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 122 CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177 (294)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence 57889999999999999999999999999999999999999999999999998763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=178.17 Aligned_cols=140 Identities=16% Similarity=0.248 Sum_probs=119.8
Q ss_pred Eeccc--ceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 156 TLGVG--GFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 156 ~lg~G--~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
.||.| +||.||++.+. .+++.+|+|.+....
T Consensus 5 ~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~---------------------------------------------- 37 (328)
T cd08226 5 EIGRGFCNLTSVYLARHT-PTGTLVTVRITDLEN---------------------------------------------- 37 (328)
T ss_pred HhCCcccCceeEEEEEEc-CCCcEEEEEEecccc----------------------------------------------
Confidence 35555 99999999854 458899999875421
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATTRFY 311 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~ 311 (362)
........+.+|+.+++.++||||+++++++..++..|++|||+.+++|.+++... ..+++..+..+
T Consensus 38 -----------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~ 106 (328)
T cd08226 38 -----------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNI 106 (328)
T ss_pred -----------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHH
Confidence 01123356788999999999999999999999999999999999999999998764 34899999999
Q ss_pred HHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
+.|++.||.|||++|++||||||+||+++.++.++++||+.+
T Consensus 107 ~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 999999999999999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=173.85 Aligned_cols=150 Identities=30% Similarity=0.489 Sum_probs=132.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
....|.....+|+|+||.||.+.+.. .+..+++|.+....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~--------------------------------------- 56 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRK--------------------------------------- 56 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCc---------------------------------------
Confidence 34567888899999999999998654 46789999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
. ....+..|+++++.++|||++++++.+...+..|+++||+++++|.+++.... .++.
T Consensus 57 --------------------~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~ 115 (286)
T cd06614 57 --------------------Q-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE 115 (286)
T ss_pred --------------------h-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCH
Confidence 0 33557889999999999999999999999999999999999999999998866 7999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 116 ~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 116 PQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999999999999999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-22 Score=179.20 Aligned_cols=146 Identities=24% Similarity=0.323 Sum_probs=127.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+....+.+.+|+|.||.||+++.. ++.||||++...
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~~---------------------------------------- 244 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD---NRLVAVKIFPEQ---------------------------------------- 244 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc---CceeEEEecCHH----------------------------------------
Confidence 3556778889999999999999855 578999998543
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhh--cCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE--ANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..+.+..|.+|.+. ++|+||+++++.-.... .++||++|.+.|+|.++++.+
T Consensus 245 ----------------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n 302 (534)
T KOG3653|consen 245 ----------------------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN 302 (534)
T ss_pred ----------------------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc
Confidence 34668889999887 48999999999876555 799999999999999999874
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSR---------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~---------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+......++..++.||+|||+- .|+|||||..|||+..++++.|+|||+|.++..
T Consensus 303 -tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 303 -TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred -cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 589999999999999999999953 599999999999999999999999999998864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=174.64 Aligned_cols=142 Identities=26% Similarity=0.479 Sum_probs=123.5
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
..||+|+||.||++... .+++.+++|.+...
T Consensus 26 ~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~------------------------------------------------ 56 (292)
T cd06657 26 IKIGEGSTGIVCIATVK-SSGKLVAVKKMDLR------------------------------------------------ 56 (292)
T ss_pred HHcCCCCCeEEEEEEEc-CCCeEEEEEEeccc------------------------------------------------
Confidence 56899999999999854 45788999976321
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q 314 (362)
.......+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++.. ..+++..+..++.|
T Consensus 57 -----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~q 124 (292)
T cd06657 57 -----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLA 124 (292)
T ss_pred -----------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHH
Confidence 112334578899999999999999999999999999999999999999998754 56899999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 125 l~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 9999999999999999999999999999999999999887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-23 Score=174.81 Aligned_cols=151 Identities=22% Similarity=0.426 Sum_probs=123.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|.-...+|+|+||+||+++ .+..++.||+|...-..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr-~~n~~kkvalkkvlmen---------------------------------------- 54 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKAR-SKNTGKKVALKKVLMEN---------------------------------------- 54 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHh-hcCccchhHHHHHHHhc----------------------------------------
Confidence 3455666789999999999998 44567778887643210
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--------cceEEEEEeccCCcchHHHHHh
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--------KKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
..........+|+.+|..++|+|++.+...+.. ...+|+||++| ..+|.-++..
T Consensus 55 -----------------eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn 116 (376)
T KOG0669|consen 55 -----------------EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSN 116 (376)
T ss_pred -----------------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcC
Confidence 011223446789999999999999999887643 24599999999 6789998876
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 K-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
. .+++...+..++.+++.||.|+|+..|+|||+||.|+||+.+|.+||+|||+++.+.
T Consensus 117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 117 RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 5 469999999999999999999999999999999999999999999999999997664
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=179.59 Aligned_cols=150 Identities=21% Similarity=0.420 Sum_probs=128.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+...||+|+||.||++... .+++.+++|.+....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~---------------------------------------- 52 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPF---------------------------------------- 52 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEeccccc----------------------------------------
Confidence 567999999999999999999865 457789999875320
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccce------EEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKY------LYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++...+. .|+|+||+ +++|.+++.. .
T Consensus 53 -----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~ 113 (343)
T cd07851 53 -----------------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-Q 113 (343)
T ss_pred -----------------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-C
Confidence 111223456789999999999999999998766554 89999998 7899998875 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 114 ~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 69999999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=172.69 Aligned_cols=150 Identities=28% Similarity=0.481 Sum_probs=128.3
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+.+.||.|++|.||++... .+++.+++|.+....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------------------------------------- 36 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRF------------------------------------------- 36 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEecccc-------------------------------------------
Confidence 567788999999999999854 457889999875431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~ 309 (362)
........+.+|+.+++.++||||+++++++..++.++++|||++ ++|.+++.. ...+++..+.
T Consensus 37 --------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~ 101 (283)
T cd05118 37 --------------ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIK 101 (283)
T ss_pred --------------ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHH
Confidence 111234567789999999999999999999999999999999995 588887766 3578999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+..+..+
T Consensus 102 ~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 102 SYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred HHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 99999999999999999999999999999999999999999999776543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=178.14 Aligned_cols=147 Identities=27% Similarity=0.449 Sum_probs=123.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-.+|.+.+.||.|+||.||++... .+++.+++|.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~---------------------------------------- 42 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTD---------------------------------------- 42 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCC----------------------------------------
Confidence 368999999999999999999854 567889999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--------------ceEEEEEeccCCcch
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--------------KYLYMLMESCLGGEL 293 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L 293 (362)
......+.+|+++++.++||||+++++++... ...|++|||++ ++|
T Consensus 43 -------------------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 102 (342)
T cd07854 43 -------------------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDL 102 (342)
T ss_pred -------------------CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccH
Confidence 12235577899999999999999999876543 35899999995 689
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceec
Q psy14740 294 WTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356 (362)
Q Consensus 294 ~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~ 356 (362)
.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+|||+++.+
T Consensus 103 ~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~ 165 (342)
T cd07854 103 ANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165 (342)
T ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence 888764 46899999999999999999999999999999999999985 567899999999765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-22 Score=184.02 Aligned_cols=153 Identities=25% Similarity=0.409 Sum_probs=135.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+.....+||-|.||+||...+.+- .-.+|+|.++..
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKED------------------------------------------ 303 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKED------------------------------------------ 303 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhc------------------------------------------
Confidence 3445667899999999999998754 557899987543
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~ 306 (362)
......|+.|+.+|+.++|||+|++.+++..+..+|||+||+..|+|.+++.+.. .++..
T Consensus 304 ------------------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~av 365 (1157)
T KOG4278|consen 304 ------------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAV 365 (1157)
T ss_pred ------------------chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchh
Confidence 2345679999999999999999999999999999999999999999999998654 37788
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~~ 362 (362)
.+.+++.||.+|++||..+++|||||-..|.|+..+..+|++|||+++.+.++.|+
T Consensus 366 vLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 366 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 88899999999999999999999999999999999999999999999999988774
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-21 Score=174.17 Aligned_cols=109 Identities=22% Similarity=0.319 Sum_probs=100.6
Q ss_pred hhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy14740 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDDATTRFYTACVVEAFDYLHSRN 326 (362)
Q Consensus 249 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~al~~lH~~~ 326 (362)
....+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++... ..+++..+..++.|++.||.|||+++
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ 121 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456889999999999999999999999999999999999999999998763 35899999999999999999999999
Q ss_pred cEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 327 iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|+||||||+||+++.++.++|+|||.+..+.
T Consensus 122 ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred eecCCCCcceEEEecCCceEEecCccceeec
Confidence 9999999999999999999999999887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=164.10 Aligned_cols=103 Identities=17% Similarity=0.202 Sum_probs=83.3
Q ss_pred hhhHHHHHHHhhc-----CCcceeeeeeeeeccc---eEE-EEEec--cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHH
Q psy14740 251 QHIMSEKEIMGEA-----NCDFIVKLYKTFKDKK---YLY-MLMES--CLGGELWTILRDKGNFDDATTRFYTACVVEAF 319 (362)
Q Consensus 251 ~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al 319 (362)
..+.+|+.+++.+ +||||+++|++++++. .++ +|||| +++++|.+++++ +.+++. ..++.|++.++
T Consensus 41 ~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l 117 (210)
T PRK10345 41 KEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKL 117 (210)
T ss_pred HHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHH
Confidence 4578999999999 6799999999998873 434 78999 557999999976 346665 35678888888
Q ss_pred -HHHHHCCcEeecCCCCcEEecCC----CcEEEEecccceec
Q psy14740 320 -DYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKL 356 (362)
Q Consensus 320 -~~lH~~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~~~ 356 (362)
+|||+++|+||||||+|||++.. +.++|+||+-++.+
T Consensus 118 ~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 118 KRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred HHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence 99999999999999999999743 37999995444433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=169.61 Aligned_cols=148 Identities=26% Similarity=0.398 Sum_probs=122.6
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++.+.+|.|+||.||++.+. .+++.+|+|.+....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~------------------------------------------- 36 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPL------------------------------------------- 36 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-CCCCEEEEEEecccc-------------------------------------------
Confidence 678899999999999999965 357889999886431
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeeeccce-----EEEEEeccCCcchHHHHHhcC-
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFKDKKY-----LYMLMESCLGGELWTILRDKG- 301 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~- 301 (362)
........+.+|+.+++.+ +|||++++++++...+. ++++||+++ ++|.+++....
T Consensus 37 --------------~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~ 101 (287)
T cd07838 37 --------------SEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK 101 (287)
T ss_pred --------------ccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccC
Confidence 0111123345677766655 69999999999987776 999999995 58988887643
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 -NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 -~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 102 ~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 102 PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 48999999999999999999999999999999999999999999999999997763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-22 Score=168.11 Aligned_cols=153 Identities=27% Similarity=0.512 Sum_probs=127.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++.+.+.-+|+|+.|.|+..... .++...|+|.+.+.+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~--------------------------------------- 129 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTG--------------------------------------- 129 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecccC---------------------------------------
Confidence 4566777888999999999999855 467889999987642
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
.....++++..+.++... ++|+||+.+++|..+..+++.||.+ ...+..++++ .++++
T Consensus 130 -------------------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piP 189 (391)
T KOG0983|consen 130 -------------------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIP 189 (391)
T ss_pred -------------------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCch
Confidence 122335566677776665 5999999999999999999999998 6667777665 45799
Q ss_pred HHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLH-SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH-~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
|..+-++...++.||.||. .+||+|||+||+|||+|..|++||||||++.++.++
T Consensus 190 E~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 190 ERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9999999999999999997 568999999999999999999999999999887654
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-22 Score=170.71 Aligned_cols=150 Identities=29% Similarity=0.490 Sum_probs=124.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++.+-...||.|.||.|++-.+. .+++..|+|.++-.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~------------------------------------------ 100 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSN------------------------------------------ 100 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeec------------------------------------------
Confidence 33444567999999999998854 67899999988532
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-----cCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-----KGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~ 302 (362)
.....+.+++.|.+...+ -++||||++|+..-.++..|+.||++ ..||..+.+. +..
T Consensus 101 ----------------n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ 163 (361)
T KOG1006|consen 101 ----------------NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSR 163 (361)
T ss_pred ----------------cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhcc
Confidence 234566778888887655 48999999999988888899999999 7788776542 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..|....+.||.||.. ..|||||+||+|||++..|.+||||||+|.++.+
T Consensus 164 ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 164 IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9999999999999999999974 5899999999999999999999999999977643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=174.11 Aligned_cols=149 Identities=26% Similarity=0.487 Sum_probs=122.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.....||+|+||.||.+.+. .+++.+|+|.+.+..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~----------------------------------------- 41 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTV----------------------------------------- 41 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhcc-----------------------------------------
Confidence 45566678999999999999865 457889999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHH-----hcCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-----DKGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~ 302 (362)
.......+..|+.++.++. ||||+++++++..++..+++||++ ++++.++.. ....
T Consensus 42 -----------------~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~ 103 (288)
T cd06616 42 -----------------DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSV 103 (288)
T ss_pred -----------------ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc-cCCHHHHHHHHHHhhcCC
Confidence 0123355788999999985 999999999999889999999998 455554332 2356
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.+.
T Consensus 104 l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999999999999999999997 499999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=174.82 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=126.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|.....+|.|+||.||++... .+++.+++|.+....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~----------------------------------------- 52 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSG----------------------------------------- 52 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEeccc-----------------------------------------
Confidence 34666788999999999999865 457789999875321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
........++.+|+++++.++|||++++++++......|+||||+. +++.+++.. ..++++..
T Consensus 53 ---------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~ 116 (308)
T cd06634 53 ---------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE 116 (308)
T ss_pred ---------------ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHH
Confidence 1112233557789999999999999999999999999999999995 677776654 44689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+.
T Consensus 117 ~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=172.44 Aligned_cols=152 Identities=30% Similarity=0.541 Sum_probs=125.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.+|+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~------------------------------------- 53 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGN------------------------------------- 53 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCC-------------------------------------
Confidence 46788999999999999999999865 4578899998864310
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l 303 (362)
......+..|..++... +||||+++++++......|++|||+ ++++.+++.. ...+
T Consensus 54 ---------------------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l 111 (296)
T cd06618 54 ---------------------KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPI 111 (296)
T ss_pred ---------------------hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCC
Confidence 11123455666666665 5999999999999999999999998 5577777655 3568
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.|+.|||+ +||+||||+|+||+++.++.++|+|||++..+.
T Consensus 112 ~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 112 PEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999999999999999999997 699999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=169.71 Aligned_cols=152 Identities=24% Similarity=0.399 Sum_probs=123.6
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+.+.||+|+||.||++.... .+..+++|++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~----------------------------------------- 38 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPV----------------------------------------- 38 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccc-----------------------------------------
Confidence 57889999999999999998553 345566666543211
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cCCCCH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KGNFDD 305 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 305 (362)
.........++..|+.+++.++||||+++++++.+....+++|||+++++|.+++.. ...+++
T Consensus 39 -------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~ 105 (260)
T cd08222 39 -------------GELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE 105 (260)
T ss_pred -------------cccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCH
Confidence 000111223456788999999999999999999999999999999999999988764 345899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||+++.+.
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999999999999999999999999975 679999999987664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=178.46 Aligned_cols=151 Identities=29% Similarity=0.441 Sum_probs=126.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-..|++++.||.|+-+.||++... + .+.+|+|.+.-
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~-~~iyalkkv~~----------------------------------------- 395 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-D-KQIYALKKVVL----------------------------------------- 395 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-C-CcchhhhHHHH-----------------------------------------
Confidence 4467889999999999999999843 3 44566665422
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC-CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~ 304 (362)
...+......+..|+.+|.++ .|.+|+++|++-..++++|+|||+= ..+|.+++++... .+
T Consensus 396 ----------------~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~ 458 (677)
T KOG0596|consen 396 ----------------LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDP 458 (677)
T ss_pred ----------------hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCc
Confidence 223445567789999999999 6999999999999999999999974 7899999987654 44
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...++++..||+.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 459 ~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 459 DWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred hHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 47899999999999999999999999999999999 578999999999987644
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=175.28 Aligned_cols=148 Identities=20% Similarity=0.372 Sum_probs=123.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+...||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 52 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPF---------------------------------------- 52 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCcc----------------------------------------
Confidence 468999999999999999999854 457889999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++... ..+|++|||+ ..+|..+.. .
T Consensus 53 -----------------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--~ 112 (342)
T cd07879 53 -----------------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMG--H 112 (342)
T ss_pred -----------------ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccc-ccCHHHHHc--C
Confidence 1112234577899999999999999999988654 3469999998 457776653 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 113 ~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 6899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-22 Score=172.29 Aligned_cols=149 Identities=25% Similarity=0.439 Sum_probs=125.2
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+.+.-+.||.|.||.||.+.+. .+++.+++|.+..-
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnv------------------------------------------- 89 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNV------------------------------------------- 89 (449)
T ss_pred cCCCCCcccccceeEEEeccCC-CCccchhHhhcchH-------------------------------------------
Confidence 3445577999999999999855 45888999876431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
......-+++.+|..+|.-.+|.|+....+..+-. ..+|+++|++ ..+|.+++-+..+++
T Consensus 90 --------------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls 154 (449)
T KOG0664|consen 90 --------------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALT 154 (449)
T ss_pred --------------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCC
Confidence 11222345688999999999999999998887543 2478899998 789999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+.++.+..||+.||.|||+.+|+||||||.|+|++++..+||||||+|+...
T Consensus 155 ~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 155 PDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred cchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence 99999999999999999999999999999999999999999999999998654
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-22 Score=188.72 Aligned_cols=151 Identities=26% Similarity=0.429 Sum_probs=134.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
--++|.++.++|+|+||+||++++. .+++..|+|+++-.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLe---------------------------------------- 51 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLE---------------------------------------- 51 (829)
T ss_pred CccchhheeeecCCcccchhhhccc-ccCchhhheeeecc----------------------------------------
Confidence 4578999999999999999999854 56889999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.....+-+++|+-+++.++||||+.+++.|...+.+|+.||||.||+|.++..-.+++++.
T Consensus 52 -------------------p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgplsel 112 (829)
T KOG0576|consen 52 -------------------PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSEL 112 (829)
T ss_pred -------------------CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhH
Confidence 1122344677888999999999999999999999999999999999999988777889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.+..+..+.|+.|||+.|-+|||||-.||+++..|.+|++|||.+.+++
T Consensus 113 qiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 113 QIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred HHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 999999999999999999999999999999999999999999999987654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=158.82 Aligned_cols=148 Identities=15% Similarity=0.174 Sum_probs=113.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-.+|++++.+|.|+||.||++.. .+..+++|.+.+...-. +.|
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~------------------------~~~---------- 72 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRT------------------------ERF---------- 72 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCch------------------------HHH----------
Confidence 47899999999999999999764 25579999986541100 000
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--------ceEEEEEeccCCcchHHHHHh
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--------KYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~ 299 (362)
......-..+.+|+..+.++.||+|+.+.+++... ...+++|||++|.+|.++..
T Consensus 73 ----------------~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~- 135 (232)
T PRK10359 73 ----------------LKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE- 135 (232)
T ss_pred ----------------HHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-
Confidence 00001122367899999999999999999886543 35899999999999988632
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++. ...+++.++..+|+.|++|||+||+||+++.+| ++|+|||..+...
T Consensus 136 ---~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 136 ---ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred ---ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 3332 456899999999999999999999999999888 9999999887653
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=161.30 Aligned_cols=147 Identities=26% Similarity=0.393 Sum_probs=123.3
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+.+.+|+|-||.+.++.+. .++..+++|.+.+..
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p~----------------------------------------- 61 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRPQ----------------------------------------- 61 (378)
T ss_pred hhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcch-----------------------------------------
Confidence 56888899999999999999966 457789999886642
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeee-eeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..+..|.+|..---.+ .|.||+.-|++ |+..+++.+++||++.|+|.+-+.. ..+-+.
T Consensus 62 -------------------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~ 121 (378)
T KOG1345|consen 62 -------------------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEA 121 (378)
T ss_pred -------------------hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHH
Confidence 2345677777664445 58999998885 7888999999999999999987765 348888
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~~~kl~DFG~a~~~~ 357 (362)
..+.++.|+++|+.|+|+++++|||||.+||||-. .-++||||||..+..+
T Consensus 122 ~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 122 NTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred HHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999999999999999999999999999953 4579999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=161.14 Aligned_cols=171 Identities=13% Similarity=0.008 Sum_probs=116.1
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
-|.+.+.||+|+||.||.+.+...+++++|+|.+.....-..+... ...+. ..|.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~----~~~~~----------~~~~----------- 83 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDR----YVDGD----------FRFK----------- 83 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhh----hcccc----------hhhc-----------
Confidence 4678889999999999999733346889999998754210000000 00000 0000
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.............+..|+.++..+.+. .+++++.. . ..++||||++|.+|.........+....
T Consensus 84 ----------~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~ 149 (237)
T smart00090 84 ----------YRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEE 149 (237)
T ss_pred ----------cCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHH
Confidence 000000001123467899999999653 34444432 2 3589999998888877654445567777
Q ss_pred HHHHHHHHHHHHHHHHHCC-cEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~-iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
+..++.|++.++.+||++| ++||||||+||+++ ++.++|+|||.|.....+.
T Consensus 150 ~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 150 EFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred HHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 8899999999999999999 99999999999999 8899999999998776553
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=160.03 Aligned_cols=151 Identities=23% Similarity=0.386 Sum_probs=129.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.--.|++.++||+|+||..+...+. -++++||||.-...
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrk---------------------------------------- 64 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRK---------------------------------------- 64 (449)
T ss_pred ecccceeccccccCcceeeeccccc-ccCceEEEEecccc----------------------------------------
Confidence 3457999999999999999999865 45889999975432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
....++..|....+.| ..++|+..|.+...+.+-.+|||++ |.||.+++.-+ +.|+
T Consensus 65 ---------------------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FS 122 (449)
T KOG1165|consen 65 ---------------------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFS 122 (449)
T ss_pred ---------------------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCccc
Confidence 1224466777777777 5799999999999999999999999 99999998754 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-----CcEEEEecccceecCCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-----GYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-----~~~kl~DFG~a~~~~~~~ 360 (362)
..++..++.|++.-++++|++.+|+|||||+|+||... ..+.++|||+|+.+.+|.
T Consensus 123 vKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 123 VKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred HHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 99999999999999999999999999999999999753 358999999999988764
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=178.83 Aligned_cols=152 Identities=24% Similarity=0.360 Sum_probs=130.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
++..+.+.||+|+||.|+.+.|...+++ .||+|+++...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~--------------------------------------- 150 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS--------------------------------------- 150 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc---------------------------------------
Confidence 3445666799999999999998876654 67899886531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
.......|.+|+.+|.+++|||++++|++..+ ....+|||+++.|+|.+.+.+. ..|.
T Consensus 151 -------------------l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~ll 210 (1039)
T KOG0199|consen 151 -------------------LNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILL 210 (1039)
T ss_pred -------------------cchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcccccee
Confidence 11145679999999999999999999999877 5688999999999999999873 3478
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
-.....|+.||+.|+.||.++++|||||-..|+|+.....|||+|||+.+-+...
T Consensus 211 v~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 211 VSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 8899999999999999999999999999999999999999999999999988643
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-20 Score=163.08 Aligned_cols=148 Identities=24% Similarity=0.354 Sum_probs=125.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+...+|+|+||.|-.+.+... +..+|+|+++.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V----------------------------------------- 125 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNV----------------------------------------- 125 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHH-----------------------------------------
Confidence 46789999999999999999986654 889999998643
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC--c----ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC--D----FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
....+..+.|+++++++.+ | -++.+.+||...++.+||+|.+ |.|+.+++..++
T Consensus 126 -------------------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~ 185 (415)
T KOG0671|consen 126 -------------------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN 185 (415)
T ss_pred -------------------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCC
Confidence 2234556789999999832 3 4788899999999999999998 889999998764
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--------------------CCcEEEEecccceecC
Q psy14740 302 --NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--------------------SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 --~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--------------------~~~~kl~DFG~a~~~~ 357 (362)
+++...++.++.|++.+++|||+.+++|-||||+|||+.+ +..++++|||.|..-.
T Consensus 186 y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~ 263 (415)
T KOG0671|consen 186 YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH 263 (415)
T ss_pred ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec
Confidence 6899999999999999999999999999999999999932 2248999999997543
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=173.96 Aligned_cols=147 Identities=31% Similarity=0.452 Sum_probs=123.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|.+...+|.|+|+.|..+.. ..+++.+++|++.+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~-~~t~~~~~vkii~~~~---------------------------------------- 359 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCES-SPTDQEPAVKIISKRA---------------------------------------- 359 (612)
T ss_pred chhhccccccCCCCccceeeeec-cccccchhheeccccc----------------------------------------
Confidence 45678888899999999999984 4668889999986541
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
....+|+.++... +||||+++++++.++.+.|+|||.+.|+.+.+.+...+.+. .
T Consensus 360 -----------------------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~ 415 (612)
T KOG0603|consen 360 -----------------------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-S 415 (612)
T ss_pred -----------------------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-H
Confidence 1223456555554 89999999999999999999999999998888777655454 7
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe-cCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-STSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~-~~~~~~kl~DFG~a~~~~~~ 359 (362)
.+..|+++|+.|+.|||++|++|||+||+|||+ +..++++|+|||.++.+...
T Consensus 416 e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 416 EASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 888899999999999999999999999999999 68999999999999887544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=172.11 Aligned_cols=105 Identities=27% Similarity=0.313 Sum_probs=84.4
Q ss_pred hhHHHHHHHhhcCCcce-----eeeeeeeec--------cceEEEEEeccCCcchHHHHHhcC-----------------
Q psy14740 252 HIMSEKEIMGEANCDFI-----VKLYKTFKD--------KKYLYMLMESCLGGELWTILRDKG----------------- 301 (362)
Q Consensus 252 ~~~~E~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------- 301 (362)
....|+..+.+++|.++ +++.+++.. .+..|+||||+++++|.+++....
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 35567777777766554 556555432 356899999999999999886321
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 -------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 -------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++...++.++.|++.+|.|+|+++|+||||||+||+++.++.++|+|||+++.+
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 1345678889999999999999999999999999999999999999999999754
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=164.79 Aligned_cols=145 Identities=26% Similarity=0.413 Sum_probs=121.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
+|.+...||+|+||.||.+.+.......+|+|+.....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~------------------------------------------ 56 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL------------------------------------------ 56 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc------------------------------------------
Confidence 89999999999999999999765444578888765421
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcC----Ccceeeeeeee-eccceEEEEEeccCCcchHHHHHhc--CC
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN----CDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDK--GN 302 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~ 302 (362)
......+..|..++..+. .++++.+++.+ ..+++.|+||+.+ |.+|.++.... +.
T Consensus 57 -----------------~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~ 118 (322)
T KOG1164|consen 57 -----------------GSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGR 118 (322)
T ss_pred -----------------cCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCC
Confidence 111124677888888875 36899999999 5888999999998 99999988654 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-----CcEEEEecccce
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-----GYVKLVDFGFAK 354 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-----~~~kl~DFG~a~ 354 (362)
++..++..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+|+
T Consensus 119 fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 119 FSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred cCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999999999999999999999999999999865 369999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-19 Score=152.89 Aligned_cols=150 Identities=40% Similarity=0.688 Sum_probs=131.1
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+...+|.|++|.||++... ..++.+++|.+.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~------------------------------------------ 37 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKT------------------------------------------ 37 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccc------------------------------------------
Confidence 567889999999999999865 3467899998765310
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC-CCHHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTR 309 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~ 309 (362)
......+.+|++.++.++|+|++++++.+......++++|++++++|.+++..... +++..+.
T Consensus 38 ----------------~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 101 (225)
T smart00221 38 ----------------EKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEAR 101 (225)
T ss_pred ----------------hHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHH
Confidence 01345678899999999999999999999988999999999998899999987666 8999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+..+..+
T Consensus 102 ~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 102 FYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999999999999999999999999999999999999999999877543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=149.50 Aligned_cols=95 Identities=16% Similarity=0.121 Sum_probs=80.1
Q ss_pred hhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEee
Q psy14740 252 HIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330 (362)
Q Consensus 252 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHr 330 (362)
.+.+|+++|+++. |+++++++++ +..|++|+|++|.+|.+.+.. . ...++.|++.+|.++|++||+||
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHr 115 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHN 115 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccC
Confidence 4788999999995 5889999886 347999999999998754321 1 13577899999999999999999
Q ss_pred cC-CCCcEEecCCCcEEEEecccceecC
Q psy14740 331 DL-KPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 331 Di-kp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|| ||+|||++.++.++|+|||+|....
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99 7999999999999999999998554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=175.70 Aligned_cols=81 Identities=27% Similarity=0.403 Sum_probs=68.3
Q ss_pred eccceEEEEEeccCCcchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCC
Q psy14740 276 KDKKYLYMLMESCLGGELWTILRDKGN--------------------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPE 335 (362)
Q Consensus 276 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~ 335 (362)
......++||||+++++|.+++..... .....+..++.|++.||.|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 355679999999999999998875321 123456789999999999999999999999999
Q ss_pred cEEecC-CCcEEEEecccceec
Q psy14740 336 NLLLST-SGYVKLVDFGFAKKL 356 (362)
Q Consensus 336 NIl~~~-~~~~kl~DFG~a~~~ 356 (362)
|||++. ++.+||+|||+|+.+
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccc
Confidence 999985 679999999999865
|
|
| >PRK09392 ftrB transcriptional activator FtrB; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=154.47 Aligned_cols=126 Identities=16% Similarity=0.149 Sum_probs=116.4
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
+.|+..|+|+.| ++++++.|+..+..+.|++|++|+++|++++.+|+|.+|.|+++... +|+ +..+..+++|++||+
T Consensus 7 ~~l~~~~~f~~L-~~~~~~~l~~~~~~~~~~~ge~l~~~g~~~~~~~~v~~G~v~~~~~~-~~~-~~~i~~~~~g~~~g~ 83 (236)
T PRK09392 7 IRLRNLPLFADM-ADATFERLMRGAFLQRFPPGTMLITEGEPADFLFVVLDGLVELSASS-QDR-ETTLAILRPVSTFIL 83 (236)
T ss_pred HHHhcCccccCC-CHHHHHHHHhhcceeecCCCCEEEeCCCccceEEEEEeCEEEEEEcC-CCc-eEEEEEeCCCchhhh
Confidence 468999999999 99999999999999999999999999999999999999999999865 434 478999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
.+++.+.|+.++++|+ ++|+++.|+.+.|.+++.++|.+...+...+..
T Consensus 84 ~~~~~~~~~~~~~~A~--~~~~~~~i~~~~~~~l~~~~p~l~~~~~~~l~~ 132 (236)
T PRK09392 84 AAVVLDAPYLMSARTL--TRSRVLMIPAELVREAMSEDPGFMRAVVFELAG 132 (236)
T ss_pred HHHhCCCCCceEEEEc--CceEEEEEeHHHHHHHHHHCHHHHHHHHHHHHH
Confidence 9999999999999999 569999999999999999999999887776654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=147.31 Aligned_cols=144 Identities=40% Similarity=0.673 Sum_probs=125.7
Q ss_pred ecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhh
Q psy14740 157 LGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETS 236 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~ 236 (362)
||+|.+|.||++... .+++.+++|.+.....
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~------------------------------------------------ 31 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDS------------------------------------------------ 31 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccc------------------------------------------------
Confidence 689999999999855 3578899998865410
Q ss_pred hhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHH
Q psy14740 237 ERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACV 315 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql 315 (362)
......+.+|+..++.+.|++++++++++......+++||++++++|.+++... ..++...+..++.++
T Consensus 32 ----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l 101 (215)
T cd00180 32 ----------SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQI 101 (215)
T ss_pred ----------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHH
Confidence 003456889999999999999999999999989999999999889999999865 468999999999999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceecCCC
Q psy14740 316 VEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 316 ~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~~~ 359 (362)
+.++.+||+.|++|+||+|.||+++. ++.++|+|||.+......
T Consensus 102 ~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 102 LEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 99999999999999999999999999 899999999999876543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=162.70 Aligned_cols=151 Identities=25% Similarity=0.355 Sum_probs=128.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-.+|.+....|+|-|++|-.+.+. ..++.||||++.+..+
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~--------------------------------------- 470 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEV--------------------------------------- 470 (752)
T ss_pred cceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchH---------------------------------------
Confidence 367899999999999999999865 4567999999976422
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC------CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN------CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
+...=+.|++||++|+ --|+++++..|....++|+|+|.+ ..+|.+++++.+
T Consensus 471 ---------------------M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG 528 (752)
T KOG0670|consen 471 ---------------------MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG 528 (752)
T ss_pred ---------------------HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC
Confidence 3344567999999984 248999999999999999999998 789999999765
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecCCCC
Q psy14740 302 ---NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 302 ---~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~~~ 360 (362)
.+....++.|+.|+..||.+|-.+||+|.||||+|||++.. ..+||||||.|.......
T Consensus 529 ~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 529 RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred cccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc
Confidence 48889999999999999999999999999999999999864 568999999998765543
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=171.86 Aligned_cols=111 Identities=29% Similarity=0.512 Sum_probs=95.3
Q ss_pred hhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHC
Q psy14740 251 QHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-N---FDDATTRFYTACVVEAFDYLHSR 325 (362)
Q Consensus 251 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~---l~~~~~~~~~~ql~~al~~lH~~ 325 (362)
....+|+.+|+.. +||||+++|+.-.+..+.||..|.| ..+|.+++.... . ......+..+.|++.||++||+.
T Consensus 547 ~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl 625 (903)
T KOG1027|consen 547 DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL 625 (903)
T ss_pred HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc
Confidence 3467899999988 6999999999999999999999999 889999998631 1 11245678899999999999999
Q ss_pred CcEeecCCCCcEEecC---C--CcEEEEecccceecCCCCCC
Q psy14740 326 NIIYRDLKPENLLLST---S--GYVKLVDFGFAKKLIGPRYS 362 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~---~--~~~kl~DFG~a~~~~~~~~~ 362 (362)
+|+||||||.||||+. + .+++|+|||+|+++..+..|
T Consensus 626 ~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 626 KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9999999999999976 3 46899999999999876543
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=172.82 Aligned_cols=151 Identities=21% Similarity=0.303 Sum_probs=128.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCC---CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDP---SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...+...+||+|+||+||+..+.... +-+||||++...
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--------------------------------------- 736 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--------------------------------------- 736 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---------------------------------------
Confidence 34566778999999999999876541 236778776432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
........++.|+-+|..++|||++++.++..... +-||++|++.|+|.++++.++ ++-
T Consensus 737 -------------------t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~ig 796 (1177)
T KOG1025|consen 737 -------------------TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIG 796 (1177)
T ss_pred -------------------CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcccc
Confidence 22233466899999999999999999999987665 889999999999999998754 588
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
......|..||++|+.|||.++++||||-..|+|+..-..+|+.|||+|+-+..
T Consensus 797 sq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 797 SQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 889999999999999999999999999999999999999999999999987754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=149.30 Aligned_cols=102 Identities=26% Similarity=0.314 Sum_probs=89.2
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
...+.+|+.++..+.|++++....++...+..+++|||++|++|.+++..... ....++.+++.+|.++|+.|++|
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence 34578899999999999988777777677788999999999999998865322 77889999999999999999999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceec
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+|++|.||+++ ++.++|+|||+++..
T Consensus 119 ~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 119 GDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999999 789999999998753
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-19 Score=158.18 Aligned_cols=145 Identities=26% Similarity=0.419 Sum_probs=125.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
....|..+..+|+|+|+.||.+..... ..+.+|+|.+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-------------------------------------- 75 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-------------------------------------- 75 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--------------------------------------
Confidence 346788999999999999999885542 5678999987543
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
....++..|+++|..+ .+.||+++.+++..++.+.+||||++...-.++... +
T Consensus 76 -----------------------s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l 129 (418)
T KOG1167|consen 76 -----------------------SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---L 129 (418)
T ss_pred -----------------------cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---C
Confidence 1235588999999998 699999999999999999999999988888887754 7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEeccccee
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKK 355 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~ 355 (362)
+...++.+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|..
T Consensus 130 ~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 130 SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 78999999999999999999999999999999999985 57789999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.9e-18 Score=147.95 Aligned_cols=109 Identities=43% Similarity=0.815 Sum_probs=101.4
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
...+.+|+..++.++|||++++++.+......++++|++++++|.+++.....++...+..++.+++.++.+||+.+++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 46688899999999999999999999988999999999988899999987666899999999999999999999999999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+||+|+||+++.++.++|+|||.+..+..
T Consensus 111 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 111 RDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred CCcCHHHeEECCCCcEEEccccceeeecc
Confidence 99999999999999999999999987654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=8e-19 Score=153.01 Aligned_cols=108 Identities=26% Similarity=0.413 Sum_probs=95.1
Q ss_pred chhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy14740 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFD 320 (362)
Q Consensus 247 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~ 320 (362)
....++..+|..++..++|+||++++.+|-- ...+|+|||++ ..+|.+.+. -.++-..+.+++.|++.|+.
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIK 132 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHH
Confidence 3345667889999999999999999999843 24589999999 778888876 34788999999999999999
Q ss_pred HHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 321 ~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|+|+.||+||||||+||++..++.+||.|||+|+.-.
T Consensus 133 ~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 133 HLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 9999999999999999999999999999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-18 Score=144.60 Aligned_cols=99 Identities=18% Similarity=0.216 Sum_probs=83.0
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
..++.+|..++..+.|+++....-++...+..+++|||++|++|.+++..... .++.|++.+|.++|+.|++|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence 35678899999999888765555555556667999999999999988764321 78899999999999999999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceec
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+|++|.||+++ ++.++++|||+++..
T Consensus 114 ~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999 889999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=177.78 Aligned_cols=138 Identities=22% Similarity=0.284 Sum_probs=115.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..+.....+|+|+||.||++... ..+..+|+|.+...+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~----------------------------------------- 727 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVN----------------------------------------- 727 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCc-----------------------------------------
Confidence 34566778999999999999854 457789999874321
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.....|+.++++++||||+++++++.+++..|+||||+++++|.++++. +++...
T Consensus 728 ----------------------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~ 782 (968)
T PLN00113 728 ----------------------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERR 782 (968)
T ss_pred ----------------------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHH
Confidence 0112457889999999999999999999999999999999999999963 888999
Q ss_pred HHHHHHHHHHHHHHH---HCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 309 RFYTACVVEAFDYLH---SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 309 ~~~~~ql~~al~~lH---~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
..++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.
T Consensus 783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999 6699999999999999988877765 55543
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.2e-18 Score=166.88 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=129.0
Q ss_pred cEEEEEecccceecEEEEEecCCC------CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDP------SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..+.+.+|+|.||.|+++.-.+.. ...+|+|.++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~-------------------------------------- 339 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN-------------------------------------- 339 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccc--------------------------------------
Confidence 345568999999999998744321 346777776543
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
......+.+..|+++|+.+ .||||+.+.++....+.+++|+||+..|+|..+++..+
T Consensus 340 --------------------~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~ 399 (609)
T KOG0200|consen 340 --------------------ASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVT 399 (609)
T ss_pred --------------------cCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhcccc
Confidence 2234567789999999998 69999999999988899999999999999999998755
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 302 --------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 302 --------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
.++..+...++.||+.|++||++..++||||-..|||+..+..+||+|||+|+......
T Consensus 400 ~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 400 ESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred ccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCC
Confidence 38889999999999999999999999999999999999999999999999999665443
|
|
| >PRK11753 DNA-binding transcriptional dual regulator Crp; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-17 Score=141.23 Aligned_cols=118 Identities=24% Similarity=0.328 Sum_probs=107.3
Q ss_pred ccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCC-Ccc
Q psy14740 15 HLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD-DLR 93 (362)
Q Consensus 15 ~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~-~~r 93 (362)
.+ ++++++.++..++.+.|++|++|+.+|++.+.+|+|++|.|+++..+.+ |++..+..++||++|||.+++.+ .++
T Consensus 7 ~~-~~~~~~~l~~~~~~~~~~kg~~l~~~g~~~~~~y~V~~G~v~~~~~~~~-g~~~~~~~~~~g~~~g~~~~~~~~~~~ 84 (211)
T PRK11753 7 PQ-TDPTLEWFLSHCHIHKYPAKSTLIHAGEKAETLYYIVKGSVAVLIKDEE-GKEMILSYLNQGDFIGELGLFEEGQER 84 (211)
T ss_pred CC-CHHHHHHHHhhCeEEEeCCCCEEEeCCCCCCeEEEEEeCEEEEEEECCC-CCEEEEEEcCCCCEEeehhhccCCCCc
Confidence 35 9999999999999999999999999999999999999999999998887 55588999999999999999986 478
Q ss_pred eeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 94 ~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+++++|. ++|+++.|+.++|.+++..+|.+...++..+..+
T Consensus 85 ~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~~~~~ 125 (211)
T PRK11753 85 SAWVRAK--TACEVAEISYKKFRQLIQVNPDILMALSAQMARR 125 (211)
T ss_pred eEEEEEc--CcEEEEEEcHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 8999999 6699999999999999999999988777666544
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=152.09 Aligned_cols=133 Identities=28% Similarity=0.387 Sum_probs=112.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-.+|.++++||-|.|++||++.+. ...+.||+|+.+-.++
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKSAqh--------------------------------------- 116 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKSAQH--------------------------------------- 116 (590)
T ss_pred CceEEEEEeccccccceeEEEeec-cCCeEEEEEEEehhhH---------------------------------------
Confidence 378999999999999999999865 4578999999765422
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-----C---cceeeeeeeeec----cceEEEEEeccCCcchHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-----C---DFIVKLYKTFKD----KKYLYMLMESCLGGELWT 295 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 295 (362)
..+..+.|+.+|+++. | .+||++++.|.. +.++++|+|++ |.+|..
T Consensus 117 ---------------------YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLk 174 (590)
T KOG1290|consen 117 ---------------------YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLK 174 (590)
T ss_pred ---------------------HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHH
Confidence 2345678999998872 3 479999998864 46899999999 999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCC
Q psy14740 296 ILRDK--GNFDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTS 342 (362)
Q Consensus 296 ~l~~~--~~l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~ 342 (362)
+|+.. +.++...++.|++||+.||.|||. +||||-||||+|||+..+
T Consensus 175 lI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 175 LIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred HHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 99864 469999999999999999999995 699999999999999754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=143.83 Aligned_cols=160 Identities=17% Similarity=0.109 Sum_probs=109.8
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+.+.||+|+||.||.+... +++.+|+|++..+... +...... . +
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~---------------------------~~~~~~~-~----~ 62 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTS---------------------------FRKVKRK-R----D 62 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccch---------------------------hhhhcch-H----H
Confidence 667788999999999999753 5889999987653200 0000000 0 0
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
+.. .+.. .............|..++..+.|+ .++..++ ....+++|||++|++|..+... ...
T Consensus 63 ~~~----~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~ 127 (198)
T cd05144 63 YLG----DRKH-ASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDP 127 (198)
T ss_pred HHh----cccc-chhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccH
Confidence 000 0000 000011223467788888888777 3444443 2346899999999998765421 345
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.+++.++.++|+.|++|+||||+||+++.++.++|+|||+|..+..+
T Consensus 128 ~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 128 EEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred HHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCCc
Confidence 678889999999999999999999999999999999999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=163.73 Aligned_cols=98 Identities=22% Similarity=0.230 Sum_probs=86.8
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiH 329 (362)
..++.+|++++..++|++++....++......++||||++|++|.+++. ....++.|++.+|.+||++|++|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH 451 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH 451 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence 3567899999999999999887777666677899999999999999875 34678899999999999999999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceec
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|||||+|||+ .++.++|+|||+|+..
T Consensus 452 rDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 452 GDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999 6788999999999864
|
|
| >COG0664 Crp cAMP-binding proteins - catabolite gene activator and regulatory subunit of cAMP-dependent protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.1e-17 Score=139.84 Aligned_cols=131 Identities=26% Similarity=0.352 Sum_probs=115.2
Q ss_pred ccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~ 86 (362)
+...++|..+ +.+.+..+......+.+++|++||++||+++.+|+|.+|.|+++....+ |++.++..++||++|||.+
T Consensus 2 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~g~~l~~~g~~~~~~y~v~~G~v~~~~~~~~-G~~~~~~~~~~g~~fg~~~ 79 (214)
T COG0664 2 LKENPLLNLL-PSELLELLALKLEVRKLPKGEVLFTEGEEADSLYIILSGIVKLYANTED-GREIILGFLGPGDFFGELA 79 (214)
T ss_pred cccccccccC-CHHHHHHHhhhceeEeeCCCCEEEcCCCcCceEEEEEEeEEEEEEECCC-CcEEEEEEecCCchhhhHH
Confidence 3456777767 7888888888889999999999999999999999999999999999998 5568999999999999999
Q ss_pred ccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhh
Q psy14740 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNE 141 (362)
Q Consensus 87 l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~ 141 (362)
++.+.|++++++|+ +++++|.++++.|..++...|.+...++..+..+.....
T Consensus 80 l~~~~~~~~~~~a~--~~~~~~~~~~~~~~~~~~~~p~l~~~l~~~~~~~l~~~~ 132 (214)
T COG0664 80 LLGGDPRSASAVAL--TDVEVLEIPRKDFLELLAESPKLALALLRLLARRLRQAL 132 (214)
T ss_pred HhcCCCccceEEEc--ceEEEEEecHHHHHHHHhhCcHHHHHHHHHHHHHHHHHH
Confidence 99999999999999 559999999999999887789998888877765544433
|
|
| >cd00038 CAP_ED effector domain of the CAP family of transcription factors; members include CAP (or cAMP receptor protein (CRP)), which binds cAMP, FNR (fumarate and nitrate reduction), which uses an iron-sulfur cluster to sense oxygen) and CooA, a heme containing CO sensor | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-17 Score=125.20 Aligned_cols=114 Identities=27% Similarity=0.452 Sum_probs=105.9
Q ss_pred cccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCC
Q psy14740 12 YFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDD 91 (362)
Q Consensus 12 lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~ 91 (362)
+|..+ +++++..++..++.+.|++|++|+.+|++.+.+|+|.+|.+++...+.+ +.+..+..+.+|++||+..++.+.
T Consensus 1 ~f~~l-~~~~~~~l~~~~~~~~~~~g~~l~~~~~~~~~~~~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~~g~~~~~~~~ 78 (115)
T cd00038 1 LFSGL-DDEELEELADALEERRFPAGEVIIRQGDPADSLYIVLSGSVEVYKLDED-GREQIVGFLGPGDLFGELALLGNG 78 (115)
T ss_pred CcccC-CHHHHHHHHhhceeeeeCCCCEEEcCCCCCCeEEEEEeCEEEEEEECCC-CcEEEEEecCCccCcChHHHhcCC
Confidence 57888 9999999999999999999999999999999999999999999998887 455889999999999999999889
Q ss_pred cceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhh
Q psy14740 92 LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 129 (362)
Q Consensus 92 ~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~ 129 (362)
++.++++|. ++|.+|.|+++.|..++.++|.+...+
T Consensus 79 ~~~~~~~a~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 114 (115)
T cd00038 79 PRSATVRAL--TDSELLVLPRSDFRRLLQEYPELARRL 114 (115)
T ss_pred CCCceEEEc--CceEEEEEeHHHHHHHHHHCcHhHHhc
Confidence 999999999 559999999999999999999987654
|
In all cases binding of the effector leads to conformational changes and the ability to activate transcription. Cyclic nucleotide-binding domain similar to CAP are also present in cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) and vertebrate cyclic nucleotide-gated ion-channels. Cyclic nucleotide-monophosphate binding domain; proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues; the best studied is the prokaryotic catabolite gene activator, CAP, where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure; three conserved glycine residues are thought to be essential for maintenance of |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=139.62 Aligned_cols=103 Identities=16% Similarity=0.229 Sum_probs=82.6
Q ss_pred hhhhHHHHHHHhhcCCcce--eeeeeeeecc-ce---EEEEEeccCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDFI--VKLYKTFKDK-KY---LYMLMESCLG-GELWTILRDKGNFDDATTRFYTACVVEAFDYL 322 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~l 322 (362)
..++.+|+.++..+.|++| +..++..... .. .++|||+++| .+|.+++.. .++++.. +.|++.+|.+|
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~l 158 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARF 158 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHH
Confidence 4567899999999988775 6666653322 22 3599999987 689888765 3555543 56899999999
Q ss_pred HHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 323 HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 323 H~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|++||+||||||.|||++.++.++|+|||.++...
T Consensus 159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred HHCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 99999999999999999998999999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-17 Score=136.60 Aligned_cols=99 Identities=18% Similarity=0.124 Sum_probs=72.3
Q ss_pred HHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccCCcchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEe
Q psy14740 254 MSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCLGGELWT-ILRDKGNFDDATTRFYTACVVEAFDYLHS-RNIIY 329 (362)
Q Consensus 254 ~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~~~~ql~~al~~lH~-~~iiH 329 (362)
..|...+..+.+. .+++++... ..+++|||++++++.. .+... ... ..+..++.+++.++.++|. ++|+|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDLN----RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEecC----CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence 3455666665433 345555432 3589999998854321 11111 111 6678899999999999999 99999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+||||+||+++ ++.++|+|||.+.....+
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccccCc
Confidence 99999999999 899999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK10402 DNA-binding transcriptional activator YeiL; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=138.51 Aligned_cols=110 Identities=19% Similarity=0.273 Sum_probs=101.2
Q ss_pred HHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCC
Q psy14740 24 TIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPE 103 (362)
Q Consensus 24 ~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~ 103 (362)
.|++.++.+.|++|++|+.+||+.+.+|+|.+|.|+++..+.+ |++.++..+.||++|||.+++.+.+++++++|. +
T Consensus 26 ~i~~~~~~~~~~kge~l~~~G~~~~~~y~V~~G~v~v~~~~~~-G~e~~~~~~~~g~~~G~~~~~~~~~~~~~~~A~--~ 102 (226)
T PRK10402 26 DVSADTELFHFLAREYIVQEGQQPSYLFYLTRGRAKLYATLAN-GKVSLIDFFAAPCFIGEIELIDKDHETKAVQAI--E 102 (226)
T ss_pred HHHhhhhheeeCCCCEEEcCCCCCceEEEEEeCEEEEEEECCC-CCEeeeeecCCCCeEEeehhhcCCCCCccEEEe--c
Confidence 4777889999999999999999999999999999999999888 555889999999999999999999999999999 5
Q ss_pred CeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 104 GVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 104 ~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+|+++.|+.+.|.+++..+|.+...++..+..+
T Consensus 103 ~~~i~~i~~~~~~~ll~~~p~~~~~~~~~l~~~ 135 (226)
T PRK10402 103 ECWCLALPMKDCRPLLLNDALFLRKLCKFLSHK 135 (226)
T ss_pred cEEEEEEEHHHHHHHHhcCHHHHHHHHHHHHHH
Confidence 699999999999999999999999887776654
|
|
| >PF00027 cNMP_binding: Cyclic nucleotide-binding domain; InterPro: IPR000595 Proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues [, , ] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=117.90 Aligned_cols=90 Identities=34% Similarity=0.462 Sum_probs=84.6
Q ss_pred eEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEEEEe
Q psy14740 32 TFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVID 111 (362)
Q Consensus 32 ~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~ 111 (362)
++|++|++|+++|++.+.+|+|++|.+++...+.+ ++...+..+.+|++||+.+++.+.++.++++|. ++|+++.|+
T Consensus 2 ~~~~~g~~i~~~g~~~~~~~~i~~G~v~~~~~~~~-~~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~a~--~~~~~~~i~ 78 (91)
T PF00027_consen 2 KTYKKGEVIYRQGDPCDHIYIILSGEVKVSSINED-GKEQIIFFLGPGDIFGEIELLTGKPSPFTVIAL--TDSEVLRIP 78 (91)
T ss_dssp EEESTTEEEEETTSBESEEEEEEESEEEEEEETTT-SEEEEEEEEETTEEESGHHHHHTSBBSSEEEES--SSEEEEEEE
T ss_pred eEECCCCEEEeCCCcCCEEEEEEECceEEEeceec-ceeeeecceeeeccccceeecCCCccEEEEEEc--cCEEEEEEe
Confidence 68999999999999999999999999999999987 555789999999999999999999999999999 569999999
Q ss_pred hhhHHHHhhchHH
Q psy14740 112 QETFNQLISSLDE 124 (362)
Q Consensus 112 ~~~f~~l~~~~p~ 124 (362)
+++|.+++.++|+
T Consensus 79 ~~~~~~~~~~~p~ 91 (91)
T PF00027_consen 79 REDFLQLLQQDPE 91 (91)
T ss_dssp HHHHHHHHHHSHH
T ss_pred HHHHHHHHHhCcC
Confidence 9999999999885
|
The best studied of these proteins is the prokaryotic catabolite gene activator (also known as the cAMP receptor protein) (gene crp) where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure. There are six invariant amino acids in this domain, three of which are glycine residues that are thought to be essential for maintenance of the structural integrity of the beta-barrel. cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) contain two tandem copies of the cyclic nucleotide-binding domain. The cAPK's are composed of two different subunits, a catalytic chain and a regulatory chain, which contains both copies of the domain. The cGPK's are single chain enzymes that include the two copies of the domain in their N-terminal section. Vertebrate cyclic nucleotide-gated ion-channels also contain this domain. Two such cations channels have been fully characterised, one is found in rod cells where it plays a role in visual signal transduction.; PDB: 1O7F_A 2BYV_E 3E97_A 3U10_A 2H6B_A 3SHR_A 2OZ6_A 1WGP_A 3LA2_A 3LA3_B .... |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.5e-16 Score=140.53 Aligned_cols=149 Identities=40% Similarity=0.657 Sum_probs=127.2
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+...+|.|+||.||.+... ..+++|.+.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~----------------------------------------- 36 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLES----------------------------------------- 36 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhcc-----------------------------------------
Confidence 678899999999999999865 56788887654211
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCc-ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC---CCCHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD-FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG---NFDDA 306 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~ 306 (362)
.......+.+|+.++..+.|+ +|+++++.+......+++++++.++++.+++.... .++..
T Consensus 37 ---------------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 101 (384)
T COG0515 37 ---------------KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSES 101 (384)
T ss_pred ---------------chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHH
Confidence 012456688899999999988 79999999988888899999999999998777654 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~~ 359 (362)
....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++.+...
T Consensus 102 ~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999999999999999999999999999999888 7999999999866543
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=162.06 Aligned_cols=126 Identities=16% Similarity=0.207 Sum_probs=115.7
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.++++++|+++ +++.+.+|+..++.+.|++||.|+.|||+++.+|||.+|+|++.... + +.+.++..+++|++|||+
T Consensus 375 ~l~~~~lF~~~-s~~~l~~L~~~~~~~~~~pge~I~~qge~~~~lY~I~~G~V~i~~~~-~-~~e~~l~~l~~Gd~FGE~ 451 (823)
T PLN03192 375 VVEKVYLFKGV-SREILLLLVTKMKAEYIPPREDVIMQNEAPDDVYIVVSGEVEIIDSE-G-EKERVVGTLGCGDIFGEV 451 (823)
T ss_pred HHhhCcchhcC-CHHHHHHHHHhhheeeeCCCCEEEECCCCCceEEEEEecEEEEEEec-C-CcceeeEEccCCCEecch
Confidence 46789999999 99999999999999999999999999999999999999999997532 3 566889999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+++.+.|+++||+|. +.|+++.|++++|.++++.+|+....++..+..+
T Consensus 452 ~~l~~~p~~~t~ra~--~~s~ll~l~~~~f~~ll~~~p~d~~~i~~~~l~~ 500 (823)
T PLN03192 452 GALCCRPQSFTFRTK--TLSQLLRLKTSTLIEAMQTRQEDNVVILKNFLQH 500 (823)
T ss_pred HHhcCCCCCCeEEEc--ccEEEEEEEHHHHHHHHHHhhHHHHHHHHHHHHH
Confidence 999999999999999 5599999999999999999999998888877654
|
|
| >PRK11161 fumarate/nitrate reduction transcriptional regulator; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.5e-16 Score=135.53 Aligned_cols=126 Identities=16% Similarity=0.184 Sum_probs=110.3
Q ss_pred ccccccccccCCHHHHHHHHhhcc-eeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSS-QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~-~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
+++.+.|..+ ++++++.|...+. .+.|++|++||++||+.+++|+|.+|.|+++..+.+ |++.++..+.||++||+.
T Consensus 15 ~~~~~~~~~l-~~~~l~~L~~~~~~~~~~~kge~l~~~Gd~~~~ly~v~~G~v~~~~~~~~-G~e~i~~~~~~gd~~g~~ 92 (235)
T PRK11161 15 ISQLCIPFTL-NEHELDQLDNIIERKKPIQKGQTLFKAGDELKSLYAIRSGTIKSYTITEQ-GDEQITGFHLAGDLVGFD 92 (235)
T ss_pred ccccccccCC-CHHHHHHHHHhhhhceeecCCCEeECCCCCcceEEEEeeceEEEEEECCC-CCEEEEEeccCCceeccc
Confidence 7777777788 9999999999886 568999999999999999999999999999999888 566889999999999998
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
+++.+ ++.++++|+ ++++++.|+++.|.+++..+|.+...++..+..+.
T Consensus 93 ~~~~~-~~~~~~~a~--~~~~i~~ip~~~f~~l~~~~p~~~~~~~~~~~~~~ 141 (235)
T PRK11161 93 AIGSG-QHPSFAQAL--ETSMVCEIPFETLDDLSGKMPKLRQQIMRLMSGEI 141 (235)
T ss_pred cccCC-CCcceEEEe--ccEEEEEEEHHHHHHHHHHChHHHHHHHHHHHHHH
Confidence 76544 556789999 56999999999999999999999988877766543
|
|
| >smart00100 cNMP Cyclic nucleotide-monophosphate binding domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-15 Score=118.73 Aligned_cols=116 Identities=32% Similarity=0.426 Sum_probs=104.2
Q ss_pred cccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc--C
Q psy14740 12 YFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ--G 89 (362)
Q Consensus 12 lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~--~ 89 (362)
+|.++ +++.++.++..++.+.|++|++|+++|++.+.+|+|.+|.+++...+.+ +.+..+..+.+|++||+..++ .
T Consensus 1 ~f~~l-~~~~~~~l~~~~~~~~~~~g~~l~~~g~~~~~~y~v~~G~v~~~~~~~~-g~~~~~~~~~~g~~~g~~~~~~~~ 78 (120)
T smart00100 1 LFKNL-DAEELRELADALEPVRYPAGEVIIRQGDVGDSFYIILSGEVRVYKVLED-GREQILGILGPGDFFGELALLTNS 78 (120)
T ss_pred CcCCC-CHHHHHHHHHhceEEEeCCCCEEEeCCCcCCcEEEEEeeEEEEEEECCC-CceEEEEeecCCceechhhhccCC
Confidence 47888 9999999999999999999999999999999999999999999988776 556889999999999999988 4
Q ss_pred CCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhh
Q psy14740 90 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 131 (362)
Q Consensus 90 ~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~ 131 (362)
..++..+++|. ++++++.++.+.|...+...+.+..+.+.
T Consensus 79 ~~~~~~~~~~~--~~~~v~~~~~~~~~~~~~~~~~~~~~~~~ 118 (120)
T smart00100 79 RRAASATAVAL--ELATLLRIDFRDFLQLLQENPQLLLELLL 118 (120)
T ss_pred CcccceEEEEE--eeEEEEccCHHHHHHHHHHhHHHHHHHHh
Confidence 46788889998 55999999999999999999988766543
|
Catabolite gene activator protein (CAP) is a prokaryotic homologue of eukaryotic cNMP-binding domains, present in ion channels, and cNMP-dependent kinases. |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=158.87 Aligned_cols=145 Identities=21% Similarity=0.293 Sum_probs=116.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
....|.+-+.+|.|+||.||.+.... ++.+|+|+-.+.... .
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~W------------------E------------------ 737 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPW------------------E------------------ 737 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCce------------------e------------------
Confidence 44678899999999999999998543 889999987664211 1
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC---CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN---CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
+..-.+++.+|+ -|.|..++..+...+.-++|+||.+.|+|.++++..+.+
T Consensus 738 --------------------------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m 791 (974)
T KOG1166|consen 738 --------------------------FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVM 791 (974)
T ss_pred --------------------------eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCC
Confidence 111112222332 256777778888888899999999999999999987889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-------CCcEEEEeccccee
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-------SGYVKLVDFGFAKK 355 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-------~~~~kl~DFG~a~~ 355 (362)
++..+.++..|++.-+++||.++|||+||||+|+|+.. +-.++|+|||.+-.
T Consensus 792 ~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 792 DEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred CchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999999999999999999999999999999999953 23589999999854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=121.56 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=108.9
Q ss_pred EEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
+...+|.|.++.||.+...+ ..+++|...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~--------------------------------------------- 33 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD---EDYVLKINPSRE--------------------------------------------- 33 (155)
T ss_pred cceecccccccceEEEEecC---CeEEEEecCCCC---------------------------------------------
Confidence 35679999999999998543 578999865431
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCC--cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANC--DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 310 (362)
. ...+..|..++..+.| +++++++.+....+..+++|||+++.++..+ +......
T Consensus 34 -------------~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~ 90 (155)
T cd05120 34 -------------K---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKED 90 (155)
T ss_pred -------------c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHH
Confidence 0 2457789999999976 5899999988888889999999988777653 4556677
Q ss_pred HHHHHHHHHHHHHHC---CcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 311 YTACVVEAFDYLHSR---NIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 311 ~~~ql~~al~~lH~~---~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
++.+++.++..+|.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 91 ~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 91 IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 889999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN02868 acyl-CoA thioesterase family protein | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.2e-15 Score=140.28 Aligned_cols=117 Identities=23% Similarity=0.338 Sum_probs=104.4
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|+++ +++++++|+..++.+.|++|++||++||+.+.+|+|++|.|++.+.+.+| +..+..+++|++|||.
T Consensus 9 ~L~~~~~F~~L-~~~~l~~l~~~~~~~~~~~Ge~I~~~Gd~~~~lyiI~~G~V~v~~~~~~g--e~~l~~l~~Gd~fG~~ 85 (413)
T PLN02868 9 FLGSVPLLQRL-PSSSLKKIAEVVVPKRYGKGEYVVREGEPGDGLYFIWKGEAEVSGPAEEE--SRPEFLLKRYDYFGYG 85 (413)
T ss_pred HHhcCcccccC-CHHHHHHHHHhceEEEECCCCEEEeCCCcCceEEEEEeCEEEEEEECCCC--cEEEEEeCCCCEeehh
Confidence 47899999999 99999999999999999999999999999999999999999999988774 4789999999999985
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 129 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~ 129 (362)
+.+.++.++++|. ++|+++.|+++.|..+....+-..++.
T Consensus 86 --l~~~~~~~~~~A~--~d~~v~~ip~~~~~~~~~~~~~~~~~~ 125 (413)
T PLN02868 86 --LSGSVHSADVVAV--SELTCLVLPHEHCHLLSPKSIWDSDKT 125 (413)
T ss_pred --hCCCCcccEEEEC--CCEEEEEEcHHHHhhhcccccccccCC
Confidence 6888999999999 669999999999987776655444433
|
|
| >TIGR03697 NtcA_cyano global nitrogen regulator NtcA, cyanobacterial | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=123.64 Aligned_cols=98 Identities=21% Similarity=0.268 Sum_probs=88.3
Q ss_pred CCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCc--ceeeEEecCCCCeEEEEEehhh
Q psy14740 37 GDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL--RTANIVAADPEGVSCLVIDQET 114 (362)
Q Consensus 37 g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~--r~~~~~A~~~~~~~~~~i~~~~ 114 (362)
|+.||++||+.+++|+|.+|.|++++.+.+ |++..+..++||++|||.+++.+.+ +.++++|. ++|+++.|+++.
T Consensus 1 g~~l~~~g~~~~~~~~i~~G~v~~~~~~~~-G~e~~l~~~~~g~~~G~~~~~~~~~~~~~~~~~A~--~~~~v~~i~~~~ 77 (193)
T TIGR03697 1 GKTIFFPGDPAEKVYFLRRGAVKLSRVYES-GEEITVALLRENSVFGVLSLITGHRSDRFYHAVAF--TRVELLAVPIEQ 77 (193)
T ss_pred CCceecCCCCCCcEEEEEecEEEEEEeCCC-CcEeeeEEccCCCEeeeeeeccCCCCccceEEEEe--cceEEEEeeHHH
Confidence 789999999999999999999999999888 5558899999999999999998764 56889999 669999999999
Q ss_pred HHHHhhchHHHHHhhhhhhhHHh
Q psy14740 115 FNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 115 f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
|..++..+|.+...++..+..+.
T Consensus 78 ~~~l~~~~p~l~~~~~~~l~~~l 100 (193)
T TIGR03697 78 VEKAIEEDPDLSMLLLQGLSSRI 100 (193)
T ss_pred HHHHHHHChHHHHHHHHHHHHHH
Confidence 99999999999998888776543
|
Members of this protein family, found in the cyanobacteria, are the global nitrogen regulator NtcA. This DNA-binding transcriptional regulator is required for expressing many different ammonia-repressible genes. The consensus NtcA-binding site is G T A N(8)T A C. |
| >KOG0498|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-15 Score=146.35 Aligned_cols=122 Identities=16% Similarity=0.316 Sum_probs=111.2
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeee-
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFG- 83 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fG- 83 (362)
+-++++|+|++. ++.-|.+|+..++..-|.+|++|++|||+.+.||||.+|.+++...+. |.+..++.|+|||+||
T Consensus 419 ~lv~~vpLF~~m-d~~~L~al~~rlk~~~f~pge~iireGd~v~~myFI~rG~le~~~~~~--g~~~~~~~L~~Gd~~Ge 495 (727)
T KOG0498|consen 419 DLVRKVPLFAGM-DDGLLDALCSRLKPEYFTPGEYIIREGDPVTDMYFIVRGSLESITTDG--GGFFVVAILGPGDFFGE 495 (727)
T ss_pred HHHhhCchhhcC-CHHHHHHHHHHhhhhccCCCCeEEecCCccceeEEEEeeeEEEEEccC--CceEEEEEecCCCccch
Confidence 346889999999 999999999999999999999999999999999999999999987664 4557899999999999
Q ss_pred cccccCC-CcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhh
Q psy14740 84 EKALQGD-DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 131 (362)
Q Consensus 84 E~~l~~~-~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~ 131 (362)
|+.+... -|.++||+|+ +.|+++.|.+++|..+++..|.+..++++
T Consensus 496 El~~~~~~~p~t~TVral--t~~el~~L~~~dL~~V~~~f~~~~~~~l~ 542 (727)
T KOG0498|consen 496 ELLTWCLDLPQTRTVRAL--TYCELFRLSADDLKEVLQQFRRLGSKFLQ 542 (727)
T ss_pred HHHHHHhcCCCCceeehh--hhhhHHhccHHHHHHHHHHhHHHHHHHHH
Confidence 7777766 7889999999 55999999999999999999999888776
|
|
| >PRK09391 fixK transcriptional regulator FixK; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.6e-14 Score=123.92 Aligned_cols=106 Identities=16% Similarity=0.204 Sum_probs=93.4
Q ss_pred HhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCe
Q psy14740 26 VYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGV 105 (362)
Q Consensus 26 ~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~ 105 (362)
...++.+.|++|++||.+||+++++|+|++|.|+++..+.+ |++.++..+.||++||+. .+.+++++++|+ ++|
T Consensus 35 ~~~~~~~~~~kge~l~~~Gd~~~~ly~I~~G~vkl~~~~~~-G~e~i~~~~~~Gd~fG~~---~~~~~~~~~~A~--~ds 108 (230)
T PRK09391 35 GLVASEFSYKKGEEIYGEGEPADYVYQVESGAVRTYRLLSD-GRRQIGAFHLPGDVFGLE---SGSTHRFTAEAI--VDT 108 (230)
T ss_pred cceeeeEEECCCCEEECCCCCCCeEEEEEeCEEEEEEECCC-CcEEEEEEecCCceeccc---CCCcCCeEEEEc--Cce
Confidence 34457899999999999999999999999999999999988 455789999999999974 466789999999 569
Q ss_pred EEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 106 SCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 106 ~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
+++.|+.+.|..++..+|.+...++..+..+.
T Consensus 109 ~v~~i~~~~f~~l~~~~p~l~~~l~~~l~~~l 140 (230)
T PRK09391 109 TVRLIKRRSLEQAAATDVDVARALLSLTAGGL 140 (230)
T ss_pred EEEEEEHHHHHHHHhhChHHHHHHHHHHHHHH
Confidence 99999999999999999999998887766543
|
|
| >KOG1113|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=6e-15 Score=130.16 Aligned_cols=115 Identities=30% Similarity=0.488 Sum_probs=105.7
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
+.|+++|++..| ...++..+++......|++|+.|+.||++++.||+|.+|+|.+.+... + ..+ .+++||+|||
T Consensus 240 ~~l~s~pil~~l-~k~er~kv~dal~~k~y~~G~~Vi~qg~~ge~f~~i~eGEvdv~~~~~--~--v~v-kl~~~dyfge 313 (368)
T KOG1113|consen 240 PFLESVPILESL-EKLERAKVADALGTKSYKDGERVIVQGDQGEHFYIIEEGEVDVLKKRD--G--VEV-KLKKGDYFGE 313 (368)
T ss_pred hhhhcchhhHHH-HHHHHHhhhcccceeeccCCceEEeccCCcceEEEecccccchhhccC--C--eEE-Eechhhhcch
Confidence 468899999999 999999999999999999999999999999999999999999987762 2 556 9999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 127 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~ 127 (362)
++++.+.||.|||.|.++ ..|..+++..|++++....++..
T Consensus 314 ~al~~~~pr~Atv~a~~~--~kc~~~dk~~ferllgpc~dilk 354 (368)
T KOG1113|consen 314 LALLKNLPRAATVVAKGR--LKCAKLDKPRFERLLGPCQDILK 354 (368)
T ss_pred HHHHhhchhhceeeccCC--ceeeeeChHHHHHHhhHHHHHHH
Confidence 999999999999999954 99999999999999998877654
|
|
| >PRK13918 CRP/FNR family transcriptional regulator; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-14 Score=119.86 Aligned_cols=97 Identities=19% Similarity=0.272 Sum_probs=81.7
Q ss_pred hcceeEecCCCEEEecCC--CCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCe
Q psy14740 28 FSSQTFYKEGDYIIRQGA--RGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGV 105 (362)
Q Consensus 28 ~~~~~~~~~g~~i~~~g~--~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~ 105 (362)
..+.+.|++|++||++|| +++.+|+|++|.|++++.+.+ |++.++..+.||++|||.+++ +.++++++.|+ ++|
T Consensus 5 ~~~~~~~~kg~~l~~~Gd~~~~~~~y~I~~G~vr~~~~~~~-G~e~~l~~~~~Gd~~G~~~~~-~~~~~~~~~A~--~~~ 80 (202)
T PRK13918 5 VVDTVTYRPGAVILYPGVPGPSDMLYRVRSGLVRLHTVDDE-GNALTLRYVRPGEYFGEEALA-GAERAYFAEAV--TDS 80 (202)
T ss_pred ccceeEecCCCEEEcCCCCCCCCeEEEEEeeEEEEEEECCC-CCEEEEEEecCCCeechHHhc-CCCCCceEEEc--Cce
Confidence 457889999999999999 679999999999999999988 555899999999999997665 57889999999 669
Q ss_pred EEEEEehhhHHHHhhchHHHHHhhhhhhh
Q psy14740 106 SCLVIDQETFNQLISSLDEIRTKYVDETS 134 (362)
Q Consensus 106 ~~~~i~~~~f~~l~~~~p~~~~~~~~~~~ 134 (362)
+++.|+++.| +|.+...++..+.
T Consensus 81 ~v~~i~~~~~------~~~~~~~l~~~l~ 103 (202)
T PRK13918 81 RIDVLNPALM------SAEDNLVLTQHLV 103 (202)
T ss_pred EEEEEEHHHc------ChhhHHHHHHHHH
Confidence 9999999987 3555555544443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=6e-14 Score=134.05 Aligned_cols=102 Identities=18% Similarity=0.203 Sum_probs=73.1
Q ss_pred hhHHHHHHHhhcC-----Ccc--eeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHH
Q psy14740 252 HIMSEKEIMGEAN-----CDF--IVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVE-AFDYL 322 (362)
Q Consensus 252 ~~~~E~~~l~~l~-----h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~-al~~l 322 (362)
.+.+|+..+..+. +|+ ++++|. ......++||||++|.+|.++.... ...+ ...++.+++. .+..+
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 4667777776652 343 333332 2334579999999999998876532 1222 2334455544 46788
Q ss_pred HHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 323 HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 323 H~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
|..|++|+|+||.||+++.++.++++|||++..+.+
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0500|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=125.82 Aligned_cols=119 Identities=24% Similarity=0.425 Sum_probs=107.7
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
+.|+++++|+.- .+.-|.+|.-.++..-|.||++|.+.||.+..||||.+|.+.|...+ |. .+...+..|++|||
T Consensus 307 dTLkkV~iF~~c-e~~lL~elVLklk~qvfSPgDyICrKGdvgkEMyIVk~G~L~Vv~dD---g~-t~~~~L~~G~~FGE 381 (536)
T KOG0500|consen 307 DTLKKVRIFQDC-EAGLLVELVLKLKPQVFSPGDYICRKGDVGKEMYIVKEGKLAVVADD---GV-TVFVTLKAGSVFGE 381 (536)
T ss_pred HHHHhhhHHHhc-chhHHHHHHHHhcceeeCCCCeEEecCcccceEEEEEccEEEEEecC---Cc-EEEEEecCCceeee
Confidence 468999999999 99999999999999999999999999999999999999999997544 33 56889999999999
Q ss_pred ccccC------CCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhh
Q psy14740 85 KALQG------DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130 (362)
Q Consensus 85 ~~l~~------~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~ 130 (362)
++++. +..|+|+++.+ .-+.+++++++++.+.+...|+.+..+.
T Consensus 382 isIlni~g~~~gNRRtanvrSv--GYSDlfvLskdDl~~aL~eYP~a~~~L~ 431 (536)
T KOG0500|consen 382 ISILNIKGNKNGNRRTANVRSV--GYSDLFVLSKDDLWEALSEYPDARKRLE 431 (536)
T ss_pred eEEEEEcCcccCCcceeeeeee--ccceeeEeeHHHHHHHHHhCCHHHHHHH
Confidence 99882 46899999999 5599999999999999999999877655
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.8e-14 Score=138.04 Aligned_cols=174 Identities=16% Similarity=0.257 Sum_probs=100.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+.+|.. +.+|+|++|.||.+... ++|+.||+|+..++-. +.+..-+..+..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~--------------------------~~I~~Dl~~l~~~ 170 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDIL--------------------------PVIDADLALMYRL 170 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchH--------------------------HHHHHHHHHHHHH
Confidence 455666 78999999999999855 4588999999987511 0000000000000
Q ss_pred ---hhhccchhhhhccccccccchhh------hhhHHHHHHHhhc----CCcceeeeeeeee-ccceEEEEEeccCCcch
Q psy14740 228 ---RTKYVDETSERRRAPQIVETRQQ------QHIMSEKEIMGEA----NCDFIVKLYKTFK-DKKYLYMLMESCLGGEL 293 (362)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~~------~~~~~E~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L 293 (362)
..+... ..++..+...-.... -.+.+|+..+.++ .+.+.+.+-.+|. .....++||||++|+++
T Consensus 171 a~~l~~~~~--~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l 248 (537)
T PRK04750 171 ARWVERLLP--DGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPV 248 (537)
T ss_pred HHHHHHhCc--ccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccH
Confidence 000000 000000000111111 2344555544444 2333333333332 24457899999999999
Q ss_pred HHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecCC
Q psy14740 294 WTI--LRDKG----NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLIG 358 (362)
Q Consensus 294 ~~~--l~~~~----~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~~ 358 (362)
.++ +...+ .+.+..+..++.|+ +..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 249 ~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 249 SDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 874 23322 24445555555555 468999999999999999888 999999999988754
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.7e-14 Score=139.11 Aligned_cols=104 Identities=27% Similarity=0.414 Sum_probs=92.9
Q ss_pred hHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC
Q psy14740 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDL 332 (362)
Q Consensus 253 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDi 332 (362)
+..|..+-..+.|||++.......+....+-.||||++ +|..++.+.+.+....+..++.|++.|+.|+|+.||.|||+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 55677777788999998888877776666666999998 99999998778999999999999999999999999999999
Q ss_pred CCCcEEecCCCcEEEEecccceecC
Q psy14740 333 KPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 333 kp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
||+|+++..+|.+||+|||.+..+.
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred ccccEEEecCCceEEeecCcceeec
Confidence 9999999999999999999987654
|
|
| >COG2905 Predicted signal-transduction protein containing cAMP-binding and CBS domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.8e-13 Score=124.52 Aligned_cols=131 Identities=22% Similarity=0.367 Sum_probs=115.5
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|.++|.|+.| ++++++.|...+...-|++||+|+..|.|..++|+|.+|.|.+.... |+ ++..+..||.||-
T Consensus 7 ~Fl~~~pPF~~L-~~eel~~L~~~l~v~yy~kge~ii~~~~p~~~l~vi~kG~vev~~~~---g~--v~~~~~~gdlFg~ 80 (610)
T COG2905 7 QFLQQHPPFSQL-PAEELEQLMGALEVKYYRKGEIIIYAGSPVHYLYVIRKGVVEVRSDG---GE--VLDRLAAGDLFGF 80 (610)
T ss_pred HHHhcCCCcccC-CHHHHHHHHhhhccccccCCCeeecCCCCcceeEEEEeceeeEEcCC---Ce--eeeeeccCccccc
Confidence 368999999999 99999999999999999999999999999999999999999997432 33 7999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhh-hhhhh
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRR-LNEEF 143 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~-~~~~~ 143 (362)
.+++...+.+..+.|. +|+.|+.||++.|.++..++|.+++-+..+.+++.. +.+.+
T Consensus 81 ~~l~~~~~~~~~~~ae--edsl~y~lp~s~F~ql~~~n~~f~~ff~~~~akR~~~~~~~~ 138 (610)
T COG2905 81 SSLFTELNKQRYMAAE--EDSLCYLLPKSVFMQLMEENPEFADFFLRSLAKRLRDIADRL 138 (610)
T ss_pred hhhcccCCCcceeEee--ccceEEecCHHHHHHHHHhCcHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998888888888 679999999999999999999999877766665544 44433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.7e-14 Score=144.85 Aligned_cols=92 Identities=17% Similarity=0.244 Sum_probs=72.6
Q ss_pred hhcCC-cceeeeeeeee-------ccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeec
Q psy14740 261 GEANC-DFIVKLYKTFK-------DKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRD 331 (362)
Q Consensus 261 ~~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrD 331 (362)
+.+.| +||.++++++. ....++.+||++ +++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34556 68888888772 234578888987 77999999753 4599999999999999999999999999999
Q ss_pred CCCCcEEecCCCcEEEEecccc
Q psy14740 332 LKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 332 ikp~NIl~~~~~~~kl~DFG~a 353 (362)
|||+|||++..+.+|++|||++
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~ 127 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASC 127 (793)
T ss_pred CCchhEEEcccCcEEEeecccc
Confidence 9999999965544444444443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-12 Score=110.67 Aligned_cols=102 Identities=15% Similarity=0.080 Sum_probs=77.2
Q ss_pred hHHHHHHHhhcCC--cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEe
Q psy14740 253 IMSEKEIMGEANC--DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYL-HSRNIIY 329 (362)
Q Consensus 253 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~l-H~~~iiH 329 (362)
..+|...|+++.. -++++++.+ ..-++||||+.+..+..-.-+...+++.....+..+++.++..+ |+.|++|
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3478888888742 456666654 35789999996654432211223466667778889999999988 8999999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+||+|.|||+. ++.++|+|||.|.....|
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 99999999996 578999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=122.92 Aligned_cols=155 Identities=18% Similarity=0.234 Sum_probs=124.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCC----CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDP----SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
.++++...+.+|+||+||.+.+...+ .+.+.+|.++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--------------------------------------- 324 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--------------------------------------- 324 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---------------------------------------
Confidence 34667778999999999999765321 23344444432
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeee-eccceEEEEEeccCCcchHHHHHhc---
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDK--- 300 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--- 300 (362)
..++.....+++|.-.+..+.|||+..+.++. ++....+.++.+...|+|..++.-.
T Consensus 325 -------------------~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~ 385 (563)
T KOG1024|consen 325 -------------------HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGD 385 (563)
T ss_pred -------------------cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccC
Confidence 22334455678899899999999999998875 4556788999999889999998721
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCCC
Q psy14740 301 -----GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 301 -----~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~~ 361 (362)
..++..+...++.|+..|++|||++|+||.||-..|.+|++.-++||+|-.++|.+-+.+|
T Consensus 386 ~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DY 451 (563)
T KOG1024|consen 386 DPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDY 451 (563)
T ss_pred CCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccc
Confidence 2367788899999999999999999999999999999999999999999999999877776
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-14 Score=136.20 Aligned_cols=145 Identities=37% Similarity=0.600 Sum_probs=122.9
Q ss_pred ecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 157 LGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 157 lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
+|+|.||.|+++...+ +.+.-+++|++.+......
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~------------------------------------------- 38 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR------------------------------------------- 38 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccc-------------------------------------------
Confidence 6899999999987533 4567789998877522110
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
...+-..|..++..++ ||.+++++..++.+...++++++..|++|..-+.+...+++.....+..
T Consensus 39 --------------~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~a 104 (612)
T KOG0603|consen 39 --------------DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLA 104 (612)
T ss_pred --------------cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHH
Confidence 0113455777888886 9999999999999999999999999999999888777789999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++....
T Consensus 105 elaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 105 ELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred HHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 999999999999999999999999999999999999999987643
|
|
| >KOG0499|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.4e-13 Score=123.30 Aligned_cols=116 Identities=27% Similarity=0.444 Sum_probs=104.8
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|.++.||++. +..-+..++-.++...|-+|+.|.+.||.|..||||..|.|+|.--. ..+.++.+|..|++|||+
T Consensus 528 ~lSKVqLFq~C-dr~mirDmllrLRsV~yLPgDfVCkKGeiGkEMYIIk~GqvQVlGGp---~~~~Vl~tL~~GsVFGEI 603 (815)
T KOG0499|consen 528 ILSKVQLFQGC-DRQMIRDMLLRLRSVLYLPGDFVCKKGEIGKEMYIIKHGQVQVLGGP---DGTKVLVTLKAGSVFGEI 603 (815)
T ss_pred hhhHHHHhhhh-HHHHHHHHHHHhhceeecCCceeeecccccceeEEeecceEEEecCC---CCCEEEEEecccceeeee
Confidence 57889999999 99999999999999999999999999999999999999999997322 335889999999999999
Q ss_pred ccc---CCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHH
Q psy14740 86 ALQ---GDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 127 (362)
Q Consensus 86 ~l~---~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~ 127 (362)
+|+ ++..|+|+|+|. .-|.+++++++++..++..+|+-..
T Consensus 604 SLLaigG~nRRTAnV~a~--Gf~nLfvL~KkdLneil~~YP~sq~ 646 (815)
T KOG0499|consen 604 SLLAIGGGNRRTANVVAH--GFANLFVLDKKDLNEILVHYPDSQR 646 (815)
T ss_pred eeeeecCCCccchhhhhc--ccceeeEecHhHHHHHHHhCccHHH
Confidence 988 457899999999 5599999999999999999998654
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.8e-13 Score=118.50 Aligned_cols=90 Identities=31% Similarity=0.425 Sum_probs=76.5
Q ss_pred cCCcceeeeeeeeec---------------------------cceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHH
Q psy14740 263 ANCDFIVKLYKTFKD---------------------------KKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV 315 (362)
Q Consensus 263 l~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql 315 (362)
.+||||+++...|.+ +..+|+||..+ ..+|.+++..+ ..+......++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHH
Confidence 379999999998743 23689999998 78999999764 57778888899999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEec--CCC--cEEEEecccce
Q psy14740 316 VEAFDYLHSRNIIYRDLKPENLLLS--TSG--YVKLVDFGFAK 354 (362)
Q Consensus 316 ~~al~~lH~~~iiHrDikp~NIl~~--~~~--~~kl~DFG~a~ 354 (362)
++|+.|||.+||.|||+|.+|||+. +++ .++++|||+|-
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999999999999999995 333 47899999873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-12 Score=106.80 Aligned_cols=128 Identities=23% Similarity=0.215 Sum_probs=93.4
Q ss_pred EEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 154 ITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 154 ~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
++.++.|.++.||.+... ++.+++|......
T Consensus 3 ~~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~---------------------------------------------- 33 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---NKKYVVRIPGNGT---------------------------------------------- 33 (170)
T ss_pred eeecCCcccCceEEEEEC---CeEEEEEeCCCCc----------------------------------------------
Confidence 466889999999999843 5679999864431
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcc-eeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF-IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
........|+.+++.+.+.+ +++++.... ...++|||+++|.++.+. .. .....+
T Consensus 34 --------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~~---~~~~~~ 89 (170)
T cd05151 34 --------------ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----DF---SDPENL 89 (170)
T ss_pred --------------ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----cc---cCHHHH
Confidence 01123567888888875433 455555543 235799999999887643 11 123456
Q ss_pred HHHHHHHHHHHHCCc-----EeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 313 ACVVEAFDYLHSRNI-----IYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 313 ~ql~~al~~lH~~~i-----iHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 90 ~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 90 EKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 789999999999985 9999999999998 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.8e-11 Score=97.84 Aligned_cols=99 Identities=21% Similarity=0.200 Sum_probs=77.0
Q ss_pred hhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy14740 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328 (362)
Q Consensus 249 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~ii 328 (362)
...+-.+|+.++..+.--.|+...=+..+++...|+|||++|..|.+.+... . ..++..+-.-+.-||..||+
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCee
Confidence 3456788999999886545554444555677788999999998888888764 2 33455555667889999999
Q ss_pred eecCCCCcEEecCCCcEEEEeccccee
Q psy14740 329 YRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 329 HrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
|+||.++||++...+ +.++|||++..
T Consensus 115 HGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 115 HGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred cCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999997654 99999999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-10 Score=101.70 Aligned_cols=76 Identities=28% Similarity=0.362 Sum_probs=52.5
Q ss_pred EEEEEeccCCcchHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 281 LYMLMESCLGGELWTILRD---KGNF----DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 281 ~~lv~e~~~~~~L~~~l~~---~~~l----~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
.+++|+-+ .++|.+++.- .... ....-..+..|++..+++||+.|++|+||||+|++++.+|.+.|+||+..
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 47788877 7888887642 2212 12222445589999999999999999999999999999999999999987
Q ss_pred eecC
Q psy14740 354 KKLI 357 (362)
Q Consensus 354 ~~~~ 357 (362)
...+
T Consensus 193 ~r~g 196 (288)
T PF14531_consen 193 VRAG 196 (288)
T ss_dssp EETT
T ss_pred eecC
Confidence 6543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=95.78 Aligned_cols=103 Identities=20% Similarity=0.169 Sum_probs=70.6
Q ss_pred hhhhHHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccC--CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHH
Q psy14740 250 QQHIMSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCL--GGELWTILRDKGNFDDATTRFYTACVVEAFDY-LHS 324 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~-lH~ 324 (362)
.....+|.+.|..+..- ++++++.+. .-.+||||++ |..+..+.... ++......++.+++..+.. +|.
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~ 125 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHK 125 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHh
Confidence 45577899999998654 577777553 2479999998 66665544321 2245556677777775555 589
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.||+|+|+.+.||+++.+ .+.++|||.|.....|
T Consensus 126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~p 159 (188)
T PF01163_consen 126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSHP 159 (188)
T ss_dssp TTEEESS-STTSEEEETT-CEEE--GTTEEETTST
T ss_pred cCceecCCChhhEEeecc-eEEEEecCcceecCCc
Confidence 999999999999999877 9999999999877654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.7e-10 Score=90.49 Aligned_cols=109 Identities=21% Similarity=0.210 Sum_probs=80.0
Q ss_pred hhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCC-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Q psy14740 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG-GELWTILRDKG--NFDDATTRFYTACVVEAFDYLHS 324 (362)
Q Consensus 248 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~--~l~~~~~~~~~~ql~~al~~lH~ 324 (362)
-...+..+|+.++.++.--.|...--++.+...-.|.|||++| .++.+++...- .........++.++-+.+.-||.
T Consensus 52 Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 52 LTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence 3456678999999987543444433345455556788999976 47777776532 23333446788889899999999
Q ss_pred CCcEeecCCCCcEEecCCC---cEEEEecccceec
Q psy14740 325 RNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKL 356 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~ 356 (362)
.+|+|+||..+||++.+++ .+.++|||++..-
T Consensus 132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999999999999997654 3589999998643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.4e-10 Score=97.24 Aligned_cols=140 Identities=17% Similarity=0.240 Sum_probs=100.5
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
+.++.|..+.+|++...+ ++.+++|........
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~--------------------------------------------- 36 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALL--------------------------------------------- 36 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccC---------------------------------------------
Confidence 568999999999998542 567999987543110
Q ss_pred hhhhccccccccchhhhhhHHHHHHHhhcCC--cceeeeeeeeecc---ceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANC--DFIVKLYKTFKDK---KYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.....+..|..+++.+.+ .++++++.+.... +..+++||+++|.++.+.+.. ..+++....
T Consensus 37 -------------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~ 102 (223)
T cd05154 37 -------------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERR 102 (223)
T ss_pred -------------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHH
Confidence 122456789999998865 3467777776554 367899999999888765421 235555666
Q ss_pred HHHHHHHHHHHHHHH--------------------------------------------------------CCcEeecCC
Q psy14740 310 FYTACVVEAFDYLHS--------------------------------------------------------RNIIYRDLK 333 (362)
Q Consensus 310 ~~~~ql~~al~~lH~--------------------------------------------------------~~iiHrDik 333 (362)
.++.+++.+|..||+ ..++|+|++
T Consensus 103 ~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~ 182 (223)
T cd05154 103 ALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYR 182 (223)
T ss_pred HHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCC
Confidence 666666666666662 346999999
Q ss_pred CCcEEecC--CCcEEEEeccccee
Q psy14740 334 PENLLLST--SGYVKLVDFGFAKK 355 (362)
Q Consensus 334 p~NIl~~~--~~~~kl~DFG~a~~ 355 (362)
|.||+++. ++.+.|+||+.+..
T Consensus 183 ~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 183 LGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccEEEcCCCCcEEEEEecccccc
Confidence 99999998 56789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=123.46 Aligned_cols=146 Identities=16% Similarity=0.225 Sum_probs=117.8
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
++...+.||++.|=.|.++++.. | .+.+|++-+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--G-~vVvKVFvk~~------------------------------------------ 58 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--G-LVVVKVFVKQD------------------------------------------ 58 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--c-eEEEEEEeccC------------------------------------------
Confidence 78889999999999999987543 4 49999986652
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
...+.+...+...|+. ...+++||.+.+-.+.......|+|=+|. ..+|++.+..+.-+...+.+
T Consensus 59 -------------p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKk 123 (1431)
T KOG1240|consen 59 -------------PTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKK 123 (1431)
T ss_pred -------------CCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHH
Confidence 1122223333444555 55679999999998888888889998998 78999999876667888899
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.|+.|++.||.-+|..||.|+|||.+|||+..=+=+.|+||..-+.
T Consensus 124 WiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 124 WIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC
Confidence 9999999999999999999999999999998877789999986553
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-11 Score=121.32 Aligned_cols=154 Identities=23% Similarity=0.385 Sum_probs=125.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|.+.+.+|+|+|+.+-.....+++...++.|.+....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------------------------------------- 58 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------------------------------------- 58 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC----------------------------------------
Confidence 4567888889999999999998777766667777654431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHH-HhcC-CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKG-NFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~-~l~ 304 (362)
.+.....+...|..+-+.+. |+|++++++...+.+..++.+++..|+++...+ .... ..+
T Consensus 59 -----------------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~ 121 (601)
T KOG0590|consen 59 -----------------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTS 121 (601)
T ss_pred -----------------CccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCC
Confidence 11122233444666666665 999999999999999999999999999999988 5444 678
Q ss_pred HHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEecCCC-cEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLH-SRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH-~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~ 358 (362)
...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 122 ~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 122 SSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 8889999999999999999 99999999999999999999 999999999987644
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.9e-09 Score=93.59 Aligned_cols=104 Identities=14% Similarity=0.021 Sum_probs=77.7
Q ss_pred hhHHHHHHHhhcCCcceee--eeeeeec-----cceEEEEEeccCCc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q psy14740 252 HIMSEKEIMGEANCDFIVK--LYKTFKD-----KKYLYMLMESCLGG-ELWTILRD--KGNFDDATTRFYTACVVEAFDY 321 (362)
Q Consensus 252 ~~~~E~~~l~~l~h~~i~~--~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~--~~~l~~~~~~~~~~ql~~al~~ 321 (362)
...+|...+..+..-+|+. +..++.. ...-++|||++++. +|.+++.. ..+.+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3667777777663222222 2223321 23578999999876 89888864 2345667788899999999999
Q ss_pred HHHCCcEeecCCCCcEEecC-------CCcEEEEeccccee
Q psy14740 322 LHSRNIIYRDLKPENLLLST-------SGYVKLVDFGFAKK 355 (362)
Q Consensus 322 lH~~~iiHrDikp~NIl~~~-------~~~~kl~DFG~a~~ 355 (362)
||..||+|+|++|.|||++. +..+.|+||+.++.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999975 46799999998854
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.9e-10 Score=110.89 Aligned_cols=172 Identities=32% Similarity=0.507 Sum_probs=111.2
Q ss_pred CCeeecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhh-hhHHhhhhhhhhhccccCcEEEEEe
Q psy14740 79 GDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE-TSERRRLNEEFRSLRLSDLRVITTL 157 (362)
Q Consensus 79 G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 157 (362)
-.+|=|+.|....+++-.- ..++....+.|..++....-..++-+.. ..+-.... ..--.-++|..|+.+
T Consensus 21 s~yf~e~~l~~~~~~~~~p-------arllecepeefy~lle~aeg~~~~p~~~~s~~~~~as--~~~p~e~df~~Ikli 91 (1205)
T KOG0606|consen 21 SQYFYEMSLQEAHEKSPSP-------ARLLECEPEEFYHLLEAAEGHARKPMTDESPESRGAS--RRAPSESDFNTIKLI 91 (1205)
T ss_pred cchhhhhhhhhhhhccCCc-------hhhccCCHHHHHHHHHhhhccccCCCCCCCccccccc--ccCCCccccceeEee
Confidence 5678888877665554431 2333334788888876644443321111 11000000 111246789999999
Q ss_pred cccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccchhhh
Q psy14740 158 GVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 237 (362)
Q Consensus 158 g~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~~~~ 237 (362)
-.|+||.||.+.+. .+.+.+|+|+ ++....
T Consensus 92 sngAygavylvrh~-~trqrfa~ki-Nkq~li------------------------------------------------ 121 (1205)
T KOG0606|consen 92 SNGAYGAVYLVRHK-ETRQRFAMKI-NKQNLI------------------------------------------------ 121 (1205)
T ss_pred ccCCCCceeeeecc-ccccchhhcc-cccchh------------------------------------------------
Confidence 99999999999854 5677888854 332110
Q ss_pred hccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHH
Q psy14740 238 RRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVE 317 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~ 317 (362)
.+ +++.....|.++ |+....++.-++++... +.
T Consensus 122 ----------------lR--nilt~a~npfvv---------------------gDc~tllk~~g~lPvdm--------vl 154 (1205)
T KOG0606|consen 122 ----------------LR--NILTFAGNPFVV---------------------GDCATLLKNIGPLPVDM--------VL 154 (1205)
T ss_pred ----------------hh--ccccccCCccee---------------------chhhhhcccCCCCcchh--------hH
Confidence 00 022233344443 66677777666666544 67
Q ss_pred HHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 318 AFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 318 al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++|+|+.||+|||+||+|.+|..-|++|++|||+++..
T Consensus 155 a~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 155 AVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred HhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 999999999999999999999999999999999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=88.28 Aligned_cols=159 Identities=19% Similarity=0.180 Sum_probs=107.1
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
.+...||-|.=|.||.+... .+.++++|.-+-+ +.+|.+.-..-..+..+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~G---------------------------rtsFrkvk~~R~y~~~~- 143 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLG---------------------------RTSFRKVKRNRDYLADK- 143 (304)
T ss_pred hhccccccCccceEEEEECC--CCCEEEEEEeecC---------------------------chhhhhhcchhhhhccc-
Confidence 34567899999999999854 4788999975443 23333322111111100
Q ss_pred cchhhhhccccccccc--hhhhhhHHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 232 VDETSERRRAPQIVET--RQQQHIMSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
...++ -......+|.++|.++... .+++.+++ +...+|||+++|..|...- ++.+.
T Consensus 144 -----------~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en 203 (304)
T COG0478 144 -----------EHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVEN 203 (304)
T ss_pred -----------cCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccC
Confidence 11111 1233467899999998655 67777665 4578999999887776532 23444
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
...++..|+.-+.-+-..||+|+|+++=||+++.+|.++++||--+.....|+
T Consensus 204 ~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~hp~ 256 (304)
T COG0478 204 PDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPISHPD 256 (304)
T ss_pred HHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccccCCCCC
Confidence 55556666666666669999999999999999999999999998877665543
|
|
| >KOG2968|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.3e-10 Score=107.73 Aligned_cols=112 Identities=15% Similarity=0.324 Sum_probs=98.0
Q ss_pred HHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecC
Q psy14740 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAAD 101 (362)
Q Consensus 22 ~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~ 101 (362)
+..+=-++.+..+.+|+.+++|||++|++|+|++|+++-...... ++..++..++.||.+|++.++.+.||..|+.|+
T Consensus 501 lr~~D~AldWv~l~~g~alyrqgD~Sd~iyvVl~GRlRsv~~~~~-~k~~i~~EygrGd~iG~~E~lt~~~R~tTv~Av- 578 (1158)
T KOG2968|consen 501 LRKLDFALDWVRLEPGQALYRQGDSSDSIYVVLNGRLRSVIRQSG-GKKEIVGEYGRGDLIGEVEMLTKQPRATTVMAV- 578 (1158)
T ss_pred HhhhhhhcceEEeccccHHHhcCCccCcEEEEecCeehhhhhccC-ccchhhhhccCcceeehhHHhhcCCccceEEEE-
Confidence 445555668999999999999999999999999999987655444 454589999999999999999999999999999
Q ss_pred CCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 102 PEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 102 ~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.++++..||..-|..+..++|++..++.+.+..+
T Consensus 579 -RdSelariPe~l~~~ik~ryP~v~~rl~~ll~~~ 612 (1158)
T KOG2968|consen 579 -RDSELARIPEGLLNFIKLRYPQVVTRLIKLLAEK 612 (1158)
T ss_pred -eehhhhhccHHHHHHHHHhccHHHHHHHHHHHHH
Confidence 7799999999999999999999998877766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=88.06 Aligned_cols=108 Identities=17% Similarity=0.173 Sum_probs=82.6
Q ss_pred hhhhHHHHHHHhhcCCcc--eeeeeeeeecc----ceEEEEEeccCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDF--IVKLYKTFKDK----KYLYMLMESCLGG-ELWTILRDKGNFDDATTRFYTACVVEAFDYL 322 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~~~~ql~~al~~l 322 (362)
..+..+|...+..+..-. .++...+.... ...++++|++++. +|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 345677777766653222 33334443321 3468999999874 8999988754577788889999999999999
Q ss_pred HHCCcEeecCCCCcEEecCCC---cEEEEecccceecC
Q psy14740 323 HSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLI 357 (362)
Q Consensus 323 H~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~~ 357 (362)
|.+||+|+|++|.|||++.++ .+.++||+-++...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999999999887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-09 Score=100.48 Aligned_cols=107 Identities=24% Similarity=0.326 Sum_probs=93.9
Q ss_pred HHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCc
Q psy14740 254 MSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVE----AFDYLHSRNI 327 (362)
Q Consensus 254 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~ql~~----al~~lH~~~i 327 (362)
.+|..-.+++ .|+|.++.+..|...+..|+-+|++ +.+|.++...... ++...++....+... ||.++|+.++
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~ 243 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI 243 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence 4455555566 5899999999999999999999999 7888888876544 889999999999999 9999999999
Q ss_pred EeecCCCCcEEecCC-CcEEEEecccceecCCCCC
Q psy14740 328 IYRDLKPENLLLSTS-GYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 328 iHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~~~~ 361 (362)
+|-|+||.||+...+ ..++++|||+...+.++.+
T Consensus 244 ~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~ 278 (524)
T KOG0601|consen 244 VHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNF 278 (524)
T ss_pred cccccchhheecccccceeecCCcceeEEccCCcc
Confidence 999999999999999 7899999999999887764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=5e-09 Score=99.76 Aligned_cols=153 Identities=21% Similarity=0.264 Sum_probs=119.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
....+|..+..+|.|.|+.++.+......+..|++|.+.++-.-
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~------------------------------------ 305 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT------------------------------------ 305 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc------------------------------------
Confidence 34577889999999999999988755456677888877654110
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
......-..|+-+...+ .|.+++..+..|...+..|+-.|||+++++...+.....++
T Consensus 306 ---------------------~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d 364 (524)
T KOG0601|consen 306 ---------------------FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLD 364 (524)
T ss_pred ---------------------hHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcC
Confidence 00111123455555554 58899999998888888899999999998877664444588
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEeccccee
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKK 355 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~ 355 (362)
+...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||++..
T Consensus 365 ~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 365 EDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 88899999999999999999999999999999999886 7789999998864
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.71 E-value=8e-08 Score=92.84 Aligned_cols=100 Identities=16% Similarity=0.236 Sum_probs=87.1
Q ss_pred hhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEee
Q psy14740 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH-SRNIIYR 330 (362)
Q Consensus 252 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH-~~~iiHr 330 (362)
...+-+.-|+.++||||+++++.++..+..|+|+|.+ ..|..++++ +....+..-+.||+.||.||| +++++|+
T Consensus 55 ~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHg 129 (690)
T KOG1243|consen 55 LAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHG 129 (690)
T ss_pred HHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeec
Confidence 3556677788999999999999999999999999987 456677765 347778889999999999997 7889999
Q ss_pred cCCCCcEEecCCCcEEEEecccceec
Q psy14740 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 331 Dikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+|.-+.++++..|..||++|-.+...
T Consensus 130 Nv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 130 NVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred cEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 99999999999999999999887654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=91.79 Aligned_cols=173 Identities=15% Similarity=0.124 Sum_probs=103.1
Q ss_pred EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccch
Q psy14740 155 TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~~ 234 (362)
+.++.++-|.||.+.... |+.||||+..++- ++.++.-+..++.+.+-....
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi--------------------------~~~i~~DL~il~~~a~~~~~~ 182 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGI--------------------------RERIEADLKLLRRLARLIKRL 182 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCCh--------------------------HHHHHHHHHHHHHHHHHHHHc
Confidence 568999999999999664 8899999988751 111222222222111111110
Q ss_pred hhh-hcccccccc------chhhhhhHHHHHHHhhc-----CCcceeeeeeeeeccceEEEEEeccCCcchHHHH--Hhc
Q psy14740 235 TSE-RRRAPQIVE------TRQQQHIMSEKEIMGEA-----NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL--RDK 300 (362)
Q Consensus 235 ~~~-~~~~~~~~~------~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~ 300 (362)
... ++..+...- -...-.+.+|+..+.++ +.|++.-..=+++....-.++|||++|..+.+.. +.
T Consensus 183 ~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~- 261 (517)
T COG0661 183 PPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS- 261 (517)
T ss_pred CCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-
Confidence 010 111111111 11233456677666654 3454433333444456678999999999998874 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...+...+.....++ -+..+-..|+.|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 262 ~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 262 AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 335533333222222 13334458999999999999999999999999999987754
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.5e-08 Score=93.90 Aligned_cols=97 Identities=25% Similarity=0.340 Sum_probs=88.3
Q ss_pred HhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-EeecCCCCcE
Q psy14740 260 MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTRFYTACVVEAFDYLHSRNI-IYRDLKPENL 337 (362)
Q Consensus 260 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~al~~lH~~~i-iHrDikp~NI 337 (362)
|+.+.|.|+.++++...++...++|.+||..|+|.+.+.. .-.++......+++.++.||.|+|.-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4568999999999999999999999999999999999986 3458888888999999999999998766 9999999999
Q ss_pred EecCCCcEEEEecccceec
Q psy14740 338 LLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 338 l~~~~~~~kl~DFG~a~~~ 356 (362)
+++....+||+|||+....
T Consensus 81 lvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred eeeeeEEEEechhhhcccc
Confidence 9999999999999998765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.1e-08 Score=80.37 Aligned_cols=59 Identities=24% Similarity=0.227 Sum_probs=53.4
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 291 GELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 291 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|+|.+++... .++++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec
Confidence 6899999864 46999999999999999999999999 999999999999999 99998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.9e-07 Score=76.73 Aligned_cols=72 Identities=28% Similarity=0.360 Sum_probs=55.2
Q ss_pred eeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 275 FKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 275 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
+......+++|||++|..|.++.. +++. +...+..++.-+|+.|+.|+|.+|.|+++..+ .++++||+..+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 334456779999999988876532 3332 33456677899999999999999999999855 59999998776
Q ss_pred e
Q psy14740 355 K 355 (362)
Q Consensus 355 ~ 355 (362)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0501|consensus | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.3e-08 Score=90.66 Aligned_cols=117 Identities=15% Similarity=0.282 Sum_probs=98.9
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
-..++|-|+-- ++-=++.|+-........||+.|++.|+..|.+++|++|.++|... ..++++|++||+||..
T Consensus 549 VFnEHpaFRLA-SDGCLRaLAm~f~~~H~APGDLlYHtGESvDaLcFvVsGSLEVIQD------DEVVAILGKGDVFGD~ 621 (971)
T KOG0501|consen 549 VFNEHPAFRLA-SDGCLRALAMEFQTNHCAPGDLLYHTGESVDALCFVVSGSLEVIQD------DEVVAILGKGDVFGDE 621 (971)
T ss_pred hhccCcceeec-cchhHHHHHHHHHhccCCCcceeeecCCccceEEEEEecceEEeec------CcEEEEeecCccchhH
Confidence 34678899888 8889999999999999999999999999999999999999999843 3579999999999986
Q ss_pred cccCC--CcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhh
Q psy14740 86 ALQGD--DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 131 (362)
Q Consensus 86 ~l~~~--~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~ 131 (362)
---.+ ....|+|+|+ +-|-+..|.++.+...+.-+..++..+.+
T Consensus 622 FWK~~t~~qs~ANVRAL--TYcDLH~IKrd~Ll~VLdFYtAFanSFaR 667 (971)
T KOG0501|consen 622 FWKENTLGQSAANVRAL--TYCDLHMIKRDKLLKVLDFYTAFANSFAR 667 (971)
T ss_pred Hhhhhhhhhhhhhhhhh--hhhhhhHHhHHHHHHHHHHHHHHHHHhhh
Confidence 43333 3457899999 55999999999999999888877654433
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.6e-08 Score=83.57 Aligned_cols=103 Identities=14% Similarity=0.201 Sum_probs=85.3
Q ss_pred hhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-
Q psy14740 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRN- 326 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~al~~lH~~~- 326 (362)
-+.|..|.-.|+-..||||..+.+.+..+..+.++..|++.|+|+..+..... .+..++..++..++.|+.|||+..
T Consensus 231 srdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep 310 (448)
T KOG0195|consen 231 SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP 310 (448)
T ss_pred cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch
Confidence 34577777788888999999999999999999999999999999999987654 678899999999999999999874
Q ss_pred -cEeecCCCCcEEecCCCcE--EEEeccc
Q psy14740 327 -IIYRDLKPENLLLSTSGYV--KLVDFGF 352 (362)
Q Consensus 327 -iiHrDikp~NIl~~~~~~~--kl~DFG~ 352 (362)
|..--+....++++.+-+. ..+|--+
T Consensus 311 ~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 311 MIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred hhhhhhcccceEEecchhhhheeccccee
Confidence 4445678889999987654 4455333
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.48 E-value=5e-06 Score=78.48 Aligned_cols=103 Identities=14% Similarity=0.161 Sum_probs=84.4
Q ss_pred HHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCC-cchHHHHHh---------------cCCCCHHHHHHHHHH
Q psy14740 255 SEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLG-GELWTILRD---------------KGNFDDATTRFYTAC 314 (362)
Q Consensus 255 ~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~~---------------~~~l~~~~~~~~~~q 314 (362)
.-++.++++.|+|+|++.++|.. ...+.+|++|+++ ++|.++.-. +...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 45678899999999999998863 3458999999986 477775421 123678999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..||.++|+.|+..+-+.|.+||+..+.+++|..-|....+.
T Consensus 402 LtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 402 LTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 9999999999999999999999999988888888776655443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.4e-06 Score=71.14 Aligned_cols=107 Identities=16% Similarity=0.148 Sum_probs=79.0
Q ss_pred hhhhHHHHHHHhhcCCcc--eeeeeee--eecc--ceEEEEEeccCC-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q psy14740 250 QQHIMSEKEIMGEANCDF--IVKLYKT--FKDK--KYLYMLMESCLG-GELWTILRDK--GNFDDATTRFYTACVVEAFD 320 (362)
Q Consensus 250 ~~~~~~E~~~l~~l~h~~--i~~~~~~--~~~~--~~~~lv~e~~~~-~~L~~~l~~~--~~l~~~~~~~~~~ql~~al~ 320 (362)
...+.+|...+..+..-+ ++++... ...+ -.-+||+|-++| .+|.+++... .+.++..-..++.++...+.
T Consensus 63 ~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia 142 (216)
T PRK09902 63 RPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFK 142 (216)
T ss_pred chHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHH
Confidence 355788988888873222 4443311 1112 237899997744 5898887653 24567777889999999999
Q ss_pred HHHHCCcEeecCCCCcEEecCCCc--EEEEecccceec
Q psy14740 321 YLHSRNIIYRDLKPENLLLSTSGY--VKLVDFGFAKKL 356 (362)
Q Consensus 321 ~lH~~~iiHrDikp~NIl~~~~~~--~kl~DFG~a~~~ 356 (362)
-||+.|+.|+|+.+.||+++.++. +.++||--++..
T Consensus 143 ~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 143 KMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 999999999999999999987677 999999877643
|
|
| >KOG2968|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.1e-06 Score=84.87 Aligned_cols=167 Identities=17% Similarity=0.205 Sum_probs=109.3
Q ss_pred CCCEEEecCCCCCeEEEEeeeEEEEEEecCCC-----CcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEEEE
Q psy14740 36 EGDYIIRQGARGDTFFIISKGKVKVTMKQPNS-----TEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVI 110 (362)
Q Consensus 36 ~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~-----~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i 110 (362)
...+|.++|+...++|.|..|.+.+....-+. ..+..+...+||+++|-++++.+.|...+++|. +|+.++.|
T Consensus 393 eitiiv~q~a~~~gl~~ii~g~l~v~~sm~~~s~~~~~~~~~~f~v~pG~ivgyla~lt~e~S~~tirAr--sdt~v~~i 470 (1158)
T KOG2968|consen 393 EITIIVEQGARDVGLYYIIKGSLSVYQSMYDVSGNLVLAGMLLFVVGPGEIVGYLAILTNEPSFITIRAR--SDTRVLFI 470 (1158)
T ss_pred ceEEEEecccccceeeEEeecceeeeehhcccccccccccceEEEecCCceechhhhhcCCcceEEEEEe--cceEEEEe
Confidence 34558999999999999999999876532211 234678889999999999999999999999999 77999999
Q ss_pred ehhhHHHHhhchHH----HHHhhhhhhhHHhhh-hhhhhhccccCcEEEEEecccce---------ecEEEEEecCCCCC
Q psy14740 111 DQETFNQLISSLDE----IRTKYVDETSERRRL-NEEFRSLRLSDLRVITTLGVGGF---------GRVELVQIAGDPSR 176 (362)
Q Consensus 111 ~~~~f~~l~~~~p~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~lg~G~~---------g~v~~~~~~~~~~~ 176 (362)
++.+|.+++..+|. +...+...++.+... -.++.+..++.-+.+ ..+|.- |....+... +.++
T Consensus 471 srs~l~~~~~~~p~I~L~ia~svl~~lsp~lr~~D~AldWv~l~~g~al--yrqgD~Sd~iyvVl~GRlRsv~~~-~~~k 547 (1158)
T KOG2968|consen 471 SRSDLERFLDAEPLIYLRIAHSVLRRLSPFLRKLDFALDWVRLEPGQAL--YRQGDSSDSIYVVLNGRLRSVIRQ-SGGK 547 (1158)
T ss_pred eHHHHHHHHHhCceEEEehhhHHHHhcCHHHhhhhhhcceEEeccccHH--HhcCCccCcEEEEecCeehhhhhc-cCcc
Confidence 99999999999994 443333333322211 122222222111111 112222 222223222 2234
Q ss_pred ceeeeeeccccccc-----cccccccceeeeCCCCc
Q psy14740 177 SFALKQMKKSQVMN-----LDDLRTANIVAADPEGV 207 (362)
Q Consensus 177 ~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v 207 (362)
.-.+..+.+++.+| .+..|..|++|+....+
T Consensus 548 ~~i~~EygrGd~iG~~E~lt~~~R~tTv~AvRdSel 583 (1158)
T KOG2968|consen 548 KEIVGEYGRGDLIGEVEMLTKQPRATTVMAVRDSEL 583 (1158)
T ss_pred chhhhhccCcceeehhHHhhcCCccceEEEEeehhh
Confidence 44566677888888 35788888888765433
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=2e-05 Score=68.87 Aligned_cols=102 Identities=16% Similarity=0.140 Sum_probs=60.5
Q ss_pred hhHHHHHHHhhcCCc--ceeeeeeeeeccceEEEEEeccCCcc-hH--------------HHHHh-----c----CCCCH
Q psy14740 252 HIMSEKEIMGEANCD--FIVKLYKTFKDKKYLYMLMESCLGGE-LW--------------TILRD-----K----GNFDD 305 (362)
Q Consensus 252 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~-L~--------------~~l~~-----~----~~l~~ 305 (362)
...+|.++++.+..- .+++.+.+....+...++||+++|.+ +. ..+.+ + ...+.
T Consensus 38 ~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l 117 (226)
T TIGR02172 38 TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF 117 (226)
T ss_pred HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH
Confidence 357788888887432 35677777777777889999998863 11 11111 0 00110
Q ss_pred H-HHHHHHHHH----------HH-HHHHHH----HCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 306 A-TTRFYTACV----------VE-AFDYLH----SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 306 ~-~~~~~~~ql----------~~-al~~lH----~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
. ....+..++ .. ...+|. ...++|+|+.|.||+++.++ +.++||+.+.
T Consensus 118 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 118 QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 0 001111111 11 112222 22478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.1e-05 Score=68.11 Aligned_cols=100 Identities=19% Similarity=0.092 Sum_probs=69.2
Q ss_pred HHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCCcch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEe
Q psy14740 254 MSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLGGEL-WTILRDKGNFDDATTRFYTACVVEAFDYLHS-RNIIY 329 (362)
Q Consensus 254 ~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~-~~iiH 329 (362)
..|...|+++. +=.+++.+.+.. -.+||||+..... .-.++. -++....+..+..+++..+.-|-. .+++|
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVH 190 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVH 190 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence 35666666652 344556565543 5799999944311 112221 123344677788888888887776 99999
Q ss_pred ecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 330 RDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 330 rDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+||+.=|||+. ++.+.++|||-|.....|
T Consensus 191 gDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 191 GDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred ccchhhheEEE-CCeEEEEECccccccCCC
Confidence 99999999998 889999999998776554
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-06 Score=78.21 Aligned_cols=89 Identities=22% Similarity=0.346 Sum_probs=76.8
Q ss_pred HhhcCCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cE
Q psy14740 260 MGEANCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILRDK----GNFDDATTRFYTACVVEAFDYLHSRN--II 328 (362)
Q Consensus 260 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~al~~lH~~~--ii 328 (362)
+-.+.|.|+++++.+|.+.. ...++.||+..|++.+++++. ..+......+|..||++||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 34457999999999987654 378899999999999999753 35888999999999999999999885 99
Q ss_pred eecCCCCcEEecCCCcEEEE
Q psy14740 329 YRDLKPENLLLSTSGYVKLV 348 (362)
Q Consensus 329 HrDikp~NIl~~~~~~~kl~ 348 (362)
|+++..+-|++..+|.+|+.
T Consensus 201 hgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cCCcchhheeecCCceEEec
Confidence 99999999999999888864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=4.5e-05 Score=66.56 Aligned_cols=31 Identities=32% Similarity=0.521 Sum_probs=21.8
Q ss_pred CCcEeecCCCCcEEec-CCCcEEEEeccccee
Q psy14740 325 RNIIYRDLKPENLLLS-TSGYVKLVDFGFAKK 355 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~ 355 (362)
..++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 4699999999999999 666678999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.2e-07 Score=85.54 Aligned_cols=77 Identities=29% Similarity=0.415 Sum_probs=67.9
Q ss_pred ceEEEEEeccCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 279 KYLYMLMESCLGGELWTILRDKG---NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 279 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.++||.|++|...+|.+++.... ..+......++.|+..|++| ++.+|||+||.||.+..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997543 35677888999999999999 9999999999999999999999999999876
Q ss_pred cCC
Q psy14740 356 LIG 358 (362)
Q Consensus 356 ~~~ 358 (362)
...
T Consensus 406 ~~~ 408 (516)
T KOG1033|consen 406 QDK 408 (516)
T ss_pred ccc
Confidence 543
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.16 E-value=1e-05 Score=78.37 Aligned_cols=85 Identities=14% Similarity=0.200 Sum_probs=58.6
Q ss_pred eeeeeeeeeccceEEEEEeccCCcchHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC----
Q psy14740 268 IVKLYKTFKDKKYLYMLMESCLGGELWTI--LRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---- 341 (362)
Q Consensus 268 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---- 341 (362)
|+++|..+. ..-.++|||++|..+.++ +.+. .++...+..-+.+.. +.-+-..|.+|+|-+|.||++..
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCC
Confidence 555555443 447899999999877654 4443 355554444443332 22334678999999999999984
Q ss_pred CCcEEEEecccceecC
Q psy14740 342 SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 342 ~~~~kl~DFG~a~~~~ 357 (362)
++.+.+.|||+.+.+.
T Consensus 341 ~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccEEEEccccccccc
Confidence 6689999999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.8e-05 Score=65.62 Aligned_cols=103 Identities=14% Similarity=0.096 Sum_probs=63.1
Q ss_pred hhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHH----------------HhcC-------CCCHH-
Q psy14740 252 HIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL----------------RDKG-------NFDDA- 306 (362)
Q Consensus 252 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----------------~~~~-------~l~~~- 306 (362)
...+|+.+++.+. +--+++++.+...++..++||++++|.++.... .+-. ++...
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~ 116 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRL 116 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhH
Confidence 3567888887773 345777788777667789999999987776431 0000 11100
Q ss_pred --HHHHH---HH----------------HHHHHHHHH-------HHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 307 --TTRFY---TA----------------CVVEAFDYL-------HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 307 --~~~~~---~~----------------ql~~al~~l-------H~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
..... +. .....+..| ....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 117 DRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 00000 00 011111222 12348999999999999988778899999885
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF04831 Popeye: Popeye protein conserved region; InterPro: IPR006916 The Popeye (POP) family of proteins, is restricted to vertebrates and is preferentially expressed in developing and adult striated muscle | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00022 Score=56.56 Aligned_cols=105 Identities=18% Similarity=0.278 Sum_probs=86.1
Q ss_pred ccCCHHHHHHHHhh-cceeEecCCCEEEecC-CCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc---c--
Q psy14740 15 HLVNQGVILTIVYF-SSQTFYKEGDYIIRQG-ARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA---L-- 87 (362)
Q Consensus 15 ~l~~~~~~~~l~~~-~~~~~~~~g~~i~~~g-~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~---l-- 87 (362)
+. +..+..+|+.+ +.++.+++|+.-.-|| .+.|.+-++++|+++|+. +...+..+.|-++..--. +
T Consensus 14 ~V-s~~~Fk~iv~~~~~i~~L~~~~~YAvE~~T~~drLSlLLsGr~~Vs~------~g~fLH~I~p~qFlDSPEW~s~~~ 86 (153)
T PF04831_consen 14 KV-SRQQFKKIVGCCCEIRTLKKGETYAVEGKTPIDRLSLLLSGRMRVSC------DGRFLHYIYPYQFLDSPEWESLRP 86 (153)
T ss_pred CC-CHHHHHHHHhhhceEEEecCCceeeecCCcccceEeEEEcCcEEEEE------CCEeeEeecccccccChhhhcccc
Confidence 34 88999999998 6789999999999999 556999999999999984 336788888877665321 1
Q ss_pred cCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHh
Q psy14740 88 QGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 128 (362)
Q Consensus 88 ~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~ 128 (362)
-.+.....|++|. ++|+.+..+|+.+..++..+|-++.-
T Consensus 87 s~~~~FQVTitA~--~~Cryl~W~R~kL~~~l~~~~~L~~v 125 (153)
T PF04831_consen 87 SEDDKFQVTITAE--EDCRYLCWPREKLYLLLAKDPFLAAV 125 (153)
T ss_pred CCCCeEEEEEEEc--CCcEEEEEEHHHHHHHHhhCHHHHHH
Confidence 2445678999999 66999999999999999999988753
|
It is represented by a conserved region which includes three potential transmembrane domains []. The strong conservation of POP genes during evolution and their preferential expression in heart and skeletal muscle suggest that these novel proteins may have an important function in these tissues in vertebrates.; GO: 0016020 membrane |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00014 Score=75.64 Aligned_cols=42 Identities=17% Similarity=0.196 Sum_probs=31.4
Q ss_pred hhhHHHHHHHhhcC-Ccce--eeeeeeeecc---ceEEEEEeccCCcc
Q psy14740 251 QHIMSEKEIMGEAN-CDFI--VKLYKTFKDK---KYLYMLMESCLGGE 292 (362)
Q Consensus 251 ~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~ 292 (362)
..+.+|..+|+.+. |+++ ++++.++.+. +..|+|||+++|..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 34778999999885 6655 7777776554 46899999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00033 Score=59.61 Aligned_cols=99 Identities=22% Similarity=0.323 Sum_probs=70.4
Q ss_pred hhhHHHHHHHhhc------CCcceeeeeeeeeccceEEEEEeccC------CcchHHHHHhcCCCCHHHHHHHHHHHHHH
Q psy14740 251 QHIMSEKEIMGEA------NCDFIVKLYKTFKDKKYLYMLMESCL------GGELWTILRDKGNFDDATTRFYTACVVEA 318 (362)
Q Consensus 251 ~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~l~~~~~~~~~~ql~~a 318 (362)
....+|+.-...+ .+.+|+++|++.+++...-+|+|.+. ..+|.+++.+ +.+++ .....+ -.-
T Consensus 56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L---~~f 130 (199)
T PF10707_consen 56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQAL---DEF 130 (199)
T ss_pred HHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHH---HHH
Confidence 3344555444443 48899999999999988999999864 2478888854 44665 333333 334
Q ss_pred HHHHHHCCcEeecCCCCcEEecCC--C--cEEEEe-cccce
Q psy14740 319 FDYLHSRNIIYRDLKPENLLLSTS--G--YVKLVD-FGFAK 354 (362)
Q Consensus 319 l~~lH~~~iiHrDikp~NIl~~~~--~--~~kl~D-FG~a~ 354 (362)
..||-+++|+.+|++|.||++... + .+.|+| ||...
T Consensus 131 ~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 131 KRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred HHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 578889999999999999999643 2 588888 66544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00062 Score=57.71 Aligned_cols=146 Identities=22% Similarity=0.212 Sum_probs=87.6
Q ss_pred cCcEEEEEecccce-ecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 149 SDLRVITTLGVGGF-GRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 149 ~~~~~~~~lg~G~~-g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+++.++.||.|.- |.|++++.. ++.||+|+...-......-. ....+... . .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~--~~~~~~~~--~---------------~---- 90 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYT--RERFAGHE--T---------------S---- 90 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccc--cccccccc--c---------------c----
Confidence 68899999999999 999999965 55899999432111110000 00000000 0 0
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcce--eeeeeeeecc------------------ceEEEE
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFI--VKLYKTFKDK------------------KYLYML 284 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i--~~~~~~~~~~------------------~~~~lv 284 (362)
..........|..|.....++ .+.+. +++|++..-. ...-||
T Consensus 91 ---------------~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIV 155 (207)
T PF13095_consen 91 ---------------LSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIV 155 (207)
T ss_pred ---------------cchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEE
Confidence 000011223566676666555 44555 7777775211 124567
Q ss_pred EeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 285 MESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 285 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
.||.+... .+.... +.+|.+-+..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 156 KD~v~~~~---------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 156 KDFVPDDP---------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred EeecCCcc---------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 77765433 233333 446667788999999999999999985 3578999965
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=97.72 E-value=5.9e-06 Score=83.81 Aligned_cols=94 Identities=28% Similarity=0.370 Sum_probs=82.1
Q ss_pred hcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC
Q psy14740 262 EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341 (362)
Q Consensus 262 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~ 341 (362)
...+|.++.....+.-....+++++|+.+++|...++.-+..+++-++.+...+..++++||...+.|+|++|.|+++..
T Consensus 860 ~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 860 TPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred cCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence 34567777776666667789999999999999999988777888888888999999999999999999999999999999
Q ss_pred CCcEEEEeccccee
Q psy14740 342 SGYVKLVDFGFAKK 355 (362)
Q Consensus 342 ~~~~kl~DFG~a~~ 355 (362)
++..++.|||..+.
T Consensus 940 ~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSK 953 (1205)
T ss_pred cCCcccCccccccc
Confidence 99999999995543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00031 Score=57.79 Aligned_cols=132 Identities=22% Similarity=0.173 Sum_probs=88.0
Q ss_pred EEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
....|++|++|.||++.+.+ ..+|+|+-+..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~---~~~a~Kvrr~d---------------------------------------------- 56 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG---GEVALKVRRRD---------------------------------------------- 56 (201)
T ss_pred hhhhhhcccccEEEEeeccC---ceEEEEEecCC----------------------------------------------
Confidence 44569999999999998763 46888865432
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCCccee-eeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIV-KLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~ 311 (362)
.....+..|+++|..++-.++. ++|.+.. -++.|||+.|..|.+.-... +...+
T Consensus 57 ---------------s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~---~rk~l--- 111 (201)
T COG2112 57 ---------------SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG---DRKHL--- 111 (201)
T ss_pred ---------------cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc---cHHHH---
Confidence 2345688999999988755443 4444432 34559999888888765421 22222
Q ss_pred HHHHHHHHHHHHHCCcEeecCC-CCcEEecCCCcEEEEecccceecCCC
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLK-PENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDik-p~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++++---|-..||-|..|+ |...++-.++.+.|+||-.|+.-..|
T Consensus 112 -~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 112 -LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred -HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 234444344567799998887 55555555669999999999854444
|
|
| >PRK11832 putative DNA-binding transcriptional regulator; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00064 Score=57.56 Aligned_cols=96 Identities=7% Similarity=0.090 Sum_probs=77.3
Q ss_pred HHHHHhhcceeEecCCCEE-EecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEec
Q psy14740 22 ILTIVYFSSQTFYKEGDYI-IRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAA 100 (362)
Q Consensus 22 ~~~l~~~~~~~~~~~g~~i-~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~ 100 (362)
...|...+++..+++|..+ +......+.+|+|.+|.|.+. .. + ...+.+...-..||=...+.+....+..+|.
T Consensus 15 ~~~L~~~g~~~~~~~~~~~i~~~~~~~~~~~ll~~G~vsir-r~-d---~ll~~t~~aP~IlGl~~~~~~~~~~~~l~ae 89 (207)
T PRK11832 15 DKCLSRYGTRFEFNNEKQVIFSSDVNNEDTFVILEGVISLR-RE-E---NVLIGITQAPYIMGLADGLMKNDIPYKLISE 89 (207)
T ss_pred HHHhhccCCeEecCCCcEEeccccCCCceEEEEEeceEEEE-ec-C---CeEEEeccCCeEeecccccCCCCceEEEEEc
Confidence 5566667789999999997 555555578999999999994 32 2 2678888999999987777776667889998
Q ss_pred CCCCeEEEEEehhhHHHHhhchHH
Q psy14740 101 DPEGVSCLVIDQETFNQLISSLDE 124 (362)
Q Consensus 101 ~~~~~~~~~i~~~~f~~l~~~~p~ 124 (362)
++|+++.|+.++|.++++++.-
T Consensus 90 --~~c~~~~i~~~~~~~iie~~~L 111 (207)
T PRK11832 90 --GNCTGYHLPAKQTITLIEQNQL 111 (207)
T ss_pred --CccEEEEeeHHHHHHHHHHhch
Confidence 5599999999999999987653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0002 Score=60.57 Aligned_cols=97 Identities=18% Similarity=0.169 Sum_probs=75.5
Q ss_pred HHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q psy14740 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTI---LRDKGNFDDATTRFYTACVVEAFDYLHS---RN 326 (362)
Q Consensus 254 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~~~~ql~~al~~lH~---~~ 326 (362)
..|.-+++.+.+ ++++++++++. -+++.|+...+++... +..-...++.....++.+++..+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888865 69999999984 3568899876655421 1111235788889999999999999987 45
Q ss_pred cEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 327 iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
+.-+|++|+|+-++.++.+|++|...+-
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 7779999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00043 Score=60.85 Aligned_cols=30 Identities=30% Similarity=0.444 Sum_probs=25.7
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.+++|+|+.|.||+++.++..-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876656799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0042 Score=56.68 Aligned_cols=43 Identities=12% Similarity=0.018 Sum_probs=31.6
Q ss_pred hhhHHHHHHHhhcC-C--cceeeeeeeeec---cceEEEEEeccCCcch
Q psy14740 251 QHIMSEKEIMGEAN-C--DFIVKLYKTFKD---KKYLYMLMESCLGGEL 293 (362)
Q Consensus 251 ~~~~~E~~~l~~l~-h--~~i~~~~~~~~~---~~~~~lv~e~~~~~~L 293 (362)
..+..|+..|+.+. + -.++++++++.. .+..++|||+++|.++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 34778999888873 2 367888876643 3668999999988654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0023 Score=56.15 Aligned_cols=30 Identities=23% Similarity=0.396 Sum_probs=26.5
Q ss_pred CCcEeecCCCCcEEecC-CCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLST-SGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~ 354 (362)
.+++|+|+.|.|||++. ++.+.++||-.|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36999999999999997 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.007 Score=57.24 Aligned_cols=30 Identities=20% Similarity=0.367 Sum_probs=25.1
Q ss_pred HCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 324 ~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
...++|+|+.|.||++..+ .++++||-+|.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 3468999999999999766 58999998664
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.005 Score=56.48 Aligned_cols=30 Identities=37% Similarity=0.582 Sum_probs=27.2
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.+++|+|+++.|++++.++.+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0063 Score=55.37 Aligned_cols=30 Identities=33% Similarity=0.494 Sum_probs=26.8
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.+++|+|+.|.|++++.++.+.|+||+.|.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0028 Score=56.48 Aligned_cols=28 Identities=29% Similarity=0.568 Sum_probs=25.1
Q ss_pred CcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.++|+|+.|.||+++.++ +.++||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999877 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0012 Score=59.66 Aligned_cols=94 Identities=16% Similarity=0.103 Sum_probs=64.0
Q ss_pred hHHHHHHHhhcC-Cc-ceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEee
Q psy14740 253 IMSEKEIMGEAN-CD-FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330 (362)
Q Consensus 253 ~~~E~~~l~~l~-h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHr 330 (362)
..+|...|+.+. |. -+++.++. +..++|||++.|..|.+.-+- .+... +...++.-+--|..+|+||+
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~~---ly~~lm~~Iv~la~~GlIHg 226 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPPT---LYDDLMGLIVRLANHGLIHG 226 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec---CChHH---HHHHHHHHHHHHHHcCceec
Confidence 456777787773 21 24444433 457899999988888764321 22222 22333334455789999999
Q ss_pred cCCCCcEEecCCCcEEEEecccceec
Q psy14740 331 DLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 331 Dikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
|..-=||++..++.++++||--+...
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999999755433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.016 Score=53.28 Aligned_cols=30 Identities=33% Similarity=0.491 Sum_probs=26.1
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.+++|+|++|.||+++.+...-++||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866656899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.01 Score=54.23 Aligned_cols=29 Identities=31% Similarity=0.468 Sum_probs=26.2
Q ss_pred CcEeecCCCCcEEecCC----CcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTS----GYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~----~~~kl~DFG~a~ 354 (362)
.++|+|+.|.|||++.+ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999874 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG3542|consensus | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0027 Score=61.60 Aligned_cols=110 Identities=14% Similarity=0.267 Sum_probs=84.0
Q ss_pred ccccccccccCCHHHHHHHHhhcceeE-ecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTF-YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~-~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
+.+.|-|+++ +....++|+..|-... -.+|.+|...|+.-|++|+|+.|.|+|.+.+. + ...+.-|+.||--
T Consensus 283 MhqlpAFAnm-tMSvrReLC~vMvFaVVe~AGtivL~dgeeLDSWsVIlNG~VEv~~PdG--k----~e~l~mGnSFG~~ 355 (1283)
T KOG3542|consen 283 MHQLPAFANM-TMSVRRELCLVMVFAVVEDAGTIVLADGEELDSWSVILNGCVEVVKPDG--K----REELKMGNSFGAE 355 (1283)
T ss_pred HHhchHhhcc-cHHHHHHHHHHHHHHHHhhcCeEEecCCcccceeEEEecceEEEecCCC--c----eEEeecccccCCC
Confidence 4567889999 8888899888776333 47899999999999999999999999987653 2 3356679999976
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHH
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 124 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~ 124 (362)
.-.+..-...-+++.. .||....|...+|-+++.....
T Consensus 356 PT~dkqym~G~mRTkV-DDCqFVciaqqDycrIln~vek 393 (1283)
T KOG3542|consen 356 PTPDKQYMIGEMRTKV-DDCQFVCIAQQDYCRILNTVEK 393 (1283)
T ss_pred CCcchhhhhhhhheec-ccceEEEeehhhHHHHHHHHHh
Confidence 6555443333444433 5799999999999998866443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 362 | ||||
| 3shr_A | 299 | Crystal Structure Of Cgmp-Dependent Protein Kinase | 7e-29 | ||
| 3shr_A | 299 | Crystal Structure Of Cgmp-Dependent Protein Kinase | 7e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-28 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-28 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-28 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-28 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-28 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-28 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-28 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-28 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-28 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3tnp_B | 416 | Structure And Allostery Of The Pka Riib Tetrameric | 2e-09 | ||
| 3tnp_B | 416 | Structure And Allostery Of The Pka Riib Tetrameric | 9e-06 | ||
| 3tnq_A | 416 | Structure And Allostery Of The Pka Riib Tetrameric | 2e-09 | ||
| 3tnq_A | 416 | Structure And Allostery Of The Pka Riib Tetrameric | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 2qvs_B | 310 | Crystal Structure Of Type Iia Holoenzyme Of Camp-De | 1e-08 | ||
| 2qvs_B | 310 | Crystal Structure Of Type Iia Holoenzyme Of Camp-De | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 1cx4_A | 305 | Crystal Structure Of A Deletion Mutant Of The Type | 3e-08 | ||
| 1cx4_A | 305 | Crystal Structure Of A Deletion Mutant Of The Type | 5e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-08 | ||
| 4din_B | 381 | Novel Localization And Quaternary Structure Of The | 9e-08 | ||
| 4din_B | 381 | Novel Localization And Quaternary Structure Of The | 6e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-07 | ||
| 1rl3_A | 288 | Crystal Structure Of Camp-free R1a Subunit Of Pka L | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 1ne4_A | 283 | Crystal Structure Of Rp-Camp Binding R1a Subunit Of | 6e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2qcs_B | 291 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3cf6_E | 694 | Structure Of Epac2 In Complex With Cyclic-Amp And R | 2e-05 | ||
| 2byv_E | 999 | Structure Of The Camp Responsive Exchange Factor Ep | 2e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-05 | ||
| 1o7f_A | 469 | Crystal Structure Of The Regulatory Domain Of Epac2 | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3of1_A | 246 | Crystal Structure Of Bcy1, The Yeast Regulatory Sub | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-04 | ||
| 4f7z_A | 999 | Conformational Dynamics Of Exchange Protein Directl | 2e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-04 |
| >pdb|3SHR|A Chain A, Crystal Structure Of Cgmp-Dependent Protein Kinase Reveals Novel Site Of Interchain Communication Length = 299 | Back alignment and structure |
|
| >pdb|3SHR|A Chain A, Crystal Structure Of Cgmp-Dependent Protein Kinase Reveals Novel Site Of Interchain Communication Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TNP|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric Holoenzyme Length = 416 | Back alignment and structure |
|
| >pdb|3TNP|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric Holoenzyme Length = 416 | Back alignment and structure |
|
| >pdb|3TNQ|A Chain A, Structure And Allostery Of The Pka Riib Tetrameric Holoenzyme Length = 416 | Back alignment and structure |
|
| >pdb|3TNQ|A Chain A, Structure And Allostery Of The Pka Riib Tetrameric Holoenzyme Length = 416 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QVS|B Chain B, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent Protein Kinase Length = 310 | Back alignment and structure |
|
| >pdb|2QVS|B Chain B, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent Protein Kinase Length = 310 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1CX4|A Chain A, Crystal Structure Of A Deletion Mutant Of The Type Ii Beta Regulatory Subunit Of Camp-Dependent Protein Kinase Length = 305 | Back alignment and structure |
|
| >pdb|1CX4|A Chain A, Crystal Structure Of A Deletion Mutant Of The Type Ii Beta Regulatory Subunit Of Camp-Dependent Protein Kinase Length = 305 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4DIN|B Chain B, Novel Localization And Quaternary Structure Of The Pka Ri Beta Holoenzyme Length = 381 | Back alignment and structure |
|
| >pdb|4DIN|B Chain B, Novel Localization And Quaternary Structure Of The Pka Ri Beta Holoenzyme Length = 381 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1RL3|A Chain A, Crystal Structure Of Camp-free R1a Subunit Of Pka Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1NE4|A Chain A, Crystal Structure Of Rp-Camp Binding R1a Subunit Of Camp- Dependent Protein Kinase Length = 283 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|B Chain B, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 291 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3CF6|E Chain E, Structure Of Epac2 In Complex With Cyclic-Amp And Rap Length = 694 | Back alignment and structure |
|
| >pdb|2BYV|E Chain E, Structure Of The Camp Responsive Exchange Factor Epac2 In Its Auto-Inhibited State Length = 999 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1O7F|A Chain A, Crystal Structure Of The Regulatory Domain Of Epac2 Length = 469 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OF1|A Chain A, Crystal Structure Of Bcy1, The Yeast Regulatory Subunit Of Pka Length = 246 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F7Z|A Chain A, Conformational Dynamics Of Exchange Protein Directly Activated By Camp Length = 999 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 362 | |||
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-63 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-52 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-52 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-45 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-44 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-43 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-42 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-41 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-40 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-40 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 6e-40 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-39 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-39 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-37 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-37 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-36 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-36 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-36 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-36 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-35 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-35 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-35 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-34 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-34 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 9e-33 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 5e-26 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-29 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-27 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-27 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 3e-27 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 5e-21 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 3e-27 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 7e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-27 | |
| 1vp6_A | 138 | CNBD, cyclic-nucleotide binding domain of mesorhiz | 2e-26 | |
| 1vp6_A | 138 | CNBD, cyclic-nucleotide binding domain of mesorhiz | 8e-05 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-26 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-26 | |
| 3gyd_A | 187 | CNMP-BD protein, cyclic nucleotide-binding domain; | 7e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-26 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-25 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-25 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 2e-25 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 6e-22 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-25 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 5e-25 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-25 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 7e-25 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 7e-24 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-24 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-24 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-24 | |
| 3idb_B | 161 | CAMP-dependent protein kinase type II-beta regulat | 7e-24 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-24 | |
| 2d93_A | 134 | RAP guanine nucleotide exchange factor 6; CNMP_bin | 8e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-24 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-24 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 1e-23 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 3e-16 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-23 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-23 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-23 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-22 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-22 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-22 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-22 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-22 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-22 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-21 | |
| 3pna_A | 154 | CAMP-dependent protein kinase type I-alpha regula | 5e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-21 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 9e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 9e-21 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-20 | |
| 3mdp_A | 142 | Cyclic nucleotide-binding domain (CNMP-BD) protei; | 1e-20 | |
| 3ocp_A | 139 | PRKG1 protein; serine/threonine kinase, TF2I and I | 2e-20 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-20 | |
| 2pqq_A | 149 | Putative transcriptional regulator; APC7345, strep | 2e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-20 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-20 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-20 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-19 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-19 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-18 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-18 | |
| 1wgp_A | 137 | Probable cyclic nucleotide-gated ION channel 6; cy | 4e-18 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-18 | |
| 2z69_A | 154 | DNR protein; beta barrel, dimerization helix, tran | 7e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-17 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-17 | |
| 3d0s_A | 227 | Transcriptional regulatory protein; CAMP receptor | 2e-17 | |
| 4ev0_A | 216 | Transcription regulator, CRP family; CAMP binding, | 3e-17 | |
| 2bgc_A | 238 | PRFA; bacterial infection, human pathogen, transcr | 4e-17 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-17 | |
| 3la7_A | 243 | Global nitrogen regulator; activator, DNA-binding, | 2e-16 | |
| 3kcc_A | 260 | Catabolite gene activator; helix-turn-helix, CAMP, | 2e-16 | |
| 1zyb_A | 232 | Transcription regulator, CRP family; NP_813211.1, | 2e-16 | |
| 3ryp_A | 210 | Catabolite gene activator; CAMP receptor protein ( | 2e-16 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-16 | |
| 3dkw_A | 227 | DNR protein; CRP-FNR, HTH, beta barrel, dimerizati | 3e-16 | |
| 3e6c_C | 250 | CPRK, cyclic nucleotide-binding protein; CPRK, hal | 3e-16 | |
| 3fx3_A | 237 | Cyclic nucleotide-binding protein; helix_TURN_heli | 3e-16 | |
| 3e97_A | 231 | Transcriptional regulator, CRP/FNR family; YP_6044 | 6e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-15 | |
| 2gau_A | 232 | Transcriptional regulator, CRP/FNR family; structu | 1e-15 | |
| 2oz6_A | 207 | Virulence factor regulator; winged helix, helix-tu | 2e-15 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-15 | |
| 1o5l_A | 213 | Transcriptional regulator, CRP family; TM1171, str | 4e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-15 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-15 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 7e-15 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-14 | |
| 2fmy_A | 220 | COOA, carbon monoxide oxidation system transcripti | 2e-14 | |
| 4ava_A | 333 | Lysine acetyltransferase; allosteric regulation, d | 2e-14 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-14 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-14 | |
| 1ft9_A | 222 | Carbon monoxide oxidation system transcription reg | 4e-14 | |
| 2ptm_A | 198 | Hyperpolarization-activated (IH) channel; ION chan | 5e-14 | |
| 3bpz_A | 202 | Potassium/sodium hyperpolarization-activated cycli | 8e-14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-14 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-14 | |
| 3iwz_A | 230 | CAP-like, catabolite activation-like protein; XCC, | 9e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-13 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-13 | |
| 4f8a_A | 160 | Potassium voltage-gated channel subfamily H membe; | 4e-13 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-13 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-13 | |
| 3dv8_A | 220 | Transcriptional regulator, CRP/FNR family; cyclic | 7e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-13 | |
| 3b02_A | 195 | Transcriptional regulator, CRP family; structural | 3e-12 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-12 | |
| 3ukn_A | 212 | Novel protein similar to vertebrate potassium VOL | 5e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-12 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-12 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-11 | |
| 2zcw_A | 202 | TTHA1359, transcriptional regulator, FNR/CRP famil | 1e-11 | |
| 3beh_A | 355 | MLL3241 protein; transmembrane protein, membrane p | 1e-11 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-11 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-10 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-10 | |
| 2byv_E | 999 | RAP guanine nucleotide exchange factor 4; EPAC2, C | 9e-10 | |
| 2byv_E | 999 | RAP guanine nucleotide exchange factor 4; EPAC2, C | 9e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-09 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-09 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-09 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-09 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-09 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-08 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-08 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-08 | |
| 3cf6_E | 694 | RAP guanine nucleotide exchange factor (GEF) 4; EP | 4e-08 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-08 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-08 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-08 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-07 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-07 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-07 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-07 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-07 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-06 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-06 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 9e-06 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-04 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-04 |
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-63
Identities = 74/240 (30%), Positives = 110/240 (45%), Gaps = 60/240 (25%)
Query: 120 SSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFA 179
S+ E K ++ ++ + +L I TLG G FGRV LV+ +A
Sbjct: 13 ESVKEFLAKAKEDFLKKWE-TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES-GNHYA 70
Query: 180 LKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET-SER 238
+K + K +V ++ K ++ T +E+
Sbjct: 71 MKILDKQKV--------------------------------------VKLKQIEHTLNEK 92
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298
R I+ N F+VKL +FKD LYM+ME GGE+++ LR
Sbjct: 93 R-------------------ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
G F + RFY A +V F+YLHS ++IYRDLKPENLL+ GY+++ DFGFAK++ G
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 59/214 (27%)
Query: 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPE 205
L D +++ TLG G FGRV L++ + R +A+K +KK V
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIV----------------- 44
Query: 206 GVSCLVIDQETFNQLISSLDEIRTKYVDET-SERRRAPQIVETRQQQHIMSEKEIMGEAN 264
+R K V+ T ER ++
Sbjct: 45 ---------------------VRLKQVEHTNDERL-------------------MLSIVT 64
Query: 265 CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS 324
FI++++ TF+D + ++M+M+ GGEL+++LR F + +FY A V A +YLHS
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
++IIYRDLKPEN+LL +G++K+ DFGFAK +
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 57/219 (26%)
Query: 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAAD 203
R R D + LG G F V L + SR +A+K ++K +
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELAT-SREYAIKILEKRHI--------------- 68
Query: 204 PEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA 263
I+ V E+++M
Sbjct: 69 -----------------------IKENKVPYV------------------TRERDVMSRL 87
Query: 264 NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
+ F VKLY TF+D + LY + GEL +R G+FD+ TRFYTA +V A +YLH
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ II+RDLKPEN+LL+ ++++ DFG AK L
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 63/237 (26%)
Query: 121 SLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFAL 180
++D ++Y D ++ R L ++ D V+ +G G FG V+LV+ + +A+
Sbjct: 46 NIDNFLSRYKDTINKIRDL-----RMKAEDYEVVKVIGRGAFGEVQLVRHKST-RKVYAM 99
Query: 181 KQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRR 240
K + K +++ D + ER
Sbjct: 100 KLLSKFEMIKRSD-------------SAFFW------------------------EERD- 121
Query: 241 APQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300
IM AN ++V+L+ F+D +YLYM+ME GG+L ++
Sbjct: 122 ------------------IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-N 162
Query: 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ + RFYTA VV A D +HS I+RD+KP+N+LL SG++KL DFG K+
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 38/116 (32%), Positives = 70/116 (60%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ VE + +++ E +IM F+V L+ +F+D++ ++M+++ LGG+L L+ +
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH 111
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
F + T + + +V A DYL ++ II+RD+KP+N+LL G+V + DF A L
Sbjct: 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 53/236 (22%), Positives = 103/236 (43%), Gaps = 61/236 (25%)
Query: 126 RTKYVDETSER-RRLNEEFRSLRLS--DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQ 182
R K + E E + + + +RL D ++ +G G FG V +V++ + + FA+K
Sbjct: 48 REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKI 106
Query: 183 MKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAP 242
+ K +++ + +C + ER
Sbjct: 107 LNKWEMLKRAE-------------TAC-------------------FR-----EERD--- 126
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKG 301
++ + +I L+ F+D LY++M+ +GG+L T+L + +
Sbjct: 127 ----------------VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ RFY A +V A D +H + ++RD+KP+N+L+ +G+++L DFG KL+
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 57/217 (26%)
Query: 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAAD 203
R L D + LG G FG V L + + ++ I+A
Sbjct: 4 RQWALEDFEIGRPLGKGKFGNVYLAR-----------------------EKQSKFILALK 40
Query: 204 PEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA 263
V+ + Q+ + + + E EI
Sbjct: 41 -------VLFKA---------------------------QLEKAGVEHQLRREVEIQSHL 66
Query: 264 NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
I++LY F D +Y+++E G ++ L+ FD+ T Y + A Y H
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
S+ +I+RD+KPENLLL ++G +K+ DFG++ R
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 61/236 (25%)
Query: 126 RTKYVDETSERRR-LNEEFRSLRLS--DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQ 182
+ KYV + + + + +RL D ++ +G G F V +V++ + +A+K
Sbjct: 35 QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-GQVYAMKI 93
Query: 183 MKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAP 242
M K ++ + VSC + ER
Sbjct: 94 MNKWDMLKRGE-------------VSC-------------------FR-----EERD--- 113
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
++ + +I +L+ F+D+ YLY++ME +GG+L T+L G
Sbjct: 114 ----------------VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 303 -FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
RFY A +V A D +H ++RD+KP+N+LL G+++L DFG KL
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 37/118 (31%), Positives = 64/118 (54%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
Q+ + + + E EI I+++Y F D+K +Y+++E GEL+ L+ G
Sbjct: 51 QLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR 110
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
FD+ + + + +A Y H R +I+RD+KPENLL+ G +K+ DFG++ R
Sbjct: 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 57/228 (25%)
Query: 134 SERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQ--IAGDPSRSFALKQMKKSQVMNL 191
S +N +R ++ LG GG+G+V V+ + + FA+K +KK
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------ 55
Query: 192 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQ 251
A IV K T
Sbjct: 56 -----AMIVR--------------------------NAKDTAHT---------------- 68
Query: 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
+E+ I+ E FIV L F+ LY+++E GGEL+ L +G F + T FY
Sbjct: 69 --KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
A + A +LH + IIYRDLKPEN++L+ G+VKL DFG K+ I
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-40
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 59/232 (25%)
Query: 130 VDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQ--IAGDPSRSFALKQMKKSQ 187
+ E + + E S ++ LG G FG+V LV+ D + +A+K
Sbjct: 5 IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----- 59
Query: 188 VMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVET 247
L+ A +
Sbjct: 60 ------LKKATLKV---------------------------------------------- 67
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
R + E++I+ E N FIVKL+ F+ + LY++++ GG+L+T L + F +
Sbjct: 68 RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED 127
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+FY A + A D+LHS IIYRDLKPEN+LL G++KL DFG +K+ I
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 58/231 (25%)
Query: 130 VDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQ 187
V L + + + ++ LG G +G+V LV+ D + +A+K
Sbjct: 35 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV----- 89
Query: 188 VMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVET 247
L+ A IV
Sbjct: 90 ------LKKATIVQKA-------------------------------------------- 99
Query: 248 RQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
+ +H +E++++ F+V L+ F+ + L+++++ GGEL+T L + F +
Sbjct: 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 159
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ Y +V A ++LH IIYRD+K EN+LL ++G+V L DFG +K+ +
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 46/117 (39%), Positives = 74/117 (63%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
I++ ++++HIMSE+ ++ + F+V L+ +F+ LY +++ GGEL+ L+ +
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + RFY A + A YLHS NI+YRDLKPEN+LL + G++ L DFG K+ I
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 37/117 (31%), Positives = 65/117 (55%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
++ + M EK ++ A F+ ++ TF+ K+ L+ +ME GG+L ++
Sbjct: 55 VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 114
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
FD + FY A ++ +LHS+ I+YRDLK +N+LL G++K+ DFG K+ +
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 41/116 (35%), Positives = 64/116 (55%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
I+ + H ++E ++ F+ L F+ L +ME GGEL+ L + F
Sbjct: 43 IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF 102
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ RFY A +V A +YLHSR+++YRD+K ENL+L G++K+ DFG K+ I
Sbjct: 103 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 63/289 (21%)
Query: 81 FFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSL-----DEIRTKYVDETSE 135
+ ++ L + + + + + + F I + ++ K+++
Sbjct: 112 YIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKF 171
Query: 136 RRRLN----EEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNL 191
R E L ++D V +G GGFG V + A D + +A+K + K ++
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMK 230
Query: 192 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQ 251
A +ER
Sbjct: 231 QGETLAL-------------------------------------NERI------------ 241
Query: 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
++ ++ +C FIV + F L +++ GG+L L G F +A RFY
Sbjct: 242 -ML---SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
A ++ +++H+R ++YRDLKP N+LL G+V++ D G A +
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 39/117 (33%), Positives = 68/117 (58%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ + + +EK + +A N F+V L+ F+ + L+ ++E GG+L ++ +
Sbjct: 47 VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK 106
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ RFY+A + A +YLH R IIYRDLK +N+LL + G++KL D+G K+ + P
Sbjct: 107 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-36
Identities = 44/117 (37%), Positives = 67/117 (57%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
I++ + M+EK I+ A N F+ +L+ F+ L+ +ME GG+L ++
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR 120
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
FD+A RFY A ++ A +LH + IIYRDLK +N+LL G+ KL DFG K+ I
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 44/245 (17%), Positives = 91/245 (37%), Gaps = 56/245 (22%)
Query: 119 ISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSF 178
+ S+ +I + Y + + + E + ++D R+I TL G F ++ L + + +
Sbjct: 3 LGSMKDILSNYSNLIYLNKYVKE--KDKYINDYRIIRTLNQGKFNKIILCEKDN---KFY 57
Query: 179 ALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 238
ALK+ +KS + D +
Sbjct: 58 ALKKYEKSLLEKKRDF------------------------------------------TK 75
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298
+I + +E +I+ + ++ + + +Y++ E +
Sbjct: 76 SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135
Query: 299 DKGNFDDATT--------RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVD 349
D T + V+ +F Y+H+ +NI +RD+KP N+L+ +G VKL D
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 350 FGFAK 354
FG ++
Sbjct: 196 FGESE 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 39/117 (33%), Positives = 68/117 (58%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ + + +EK + +A N F+V L+ F+ + L+ ++E GG+L ++ +
Sbjct: 90 VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK 149
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ RFY+A + A +YLH R IIYRDLK +N+LL + G++KL D+G K+ + P
Sbjct: 150 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+++ + M EK ++ F+ +L+ F+ LY +ME GG+L ++ G
Sbjct: 58 VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR 117
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + FY A + +L S+ IIYRDLK +N++L + G++K+ DFG K+ I
Sbjct: 118 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 56/244 (22%), Positives = 89/244 (36%), Gaps = 64/244 (26%)
Query: 123 DEIRTKYVDETSERRRL---NEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFA 179
+++D R L E + + LG GGFG V Q+ + +A
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT-GKLYA 214
Query: 180 LKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 239
K++ K ++ + E++
Sbjct: 215 CKKLNKKRLKKRKG-------------YQGAM------------------------VEKK 237
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL----WT 295
I+ + + FIV L F+ K L ++M GG++ +
Sbjct: 238 -------------------ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278
Query: 296 ILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ D F + FYTA +V ++LH RNIIYRDLKPEN+LL G V++ D G A +
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 356 LIGP 359
L
Sbjct: 339 LKAG 342
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/250 (23%), Positives = 97/250 (38%), Gaps = 56/250 (22%)
Query: 110 IDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQ 169
+ Q+ I + + T + N ++L+D + LG G FG+V L +
Sbjct: 302 LRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSE 361
Query: 170 IAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229
G +A+K +KK V+ DD V C +
Sbjct: 362 RKGT-DELYAVKILKKDVVIQDDD-------------VECTM------------------ 389
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
E+R ++ F+ +L+ F+ LY +ME
Sbjct: 390 ------VEKR----VLALP--------------GKPPFLTQLHSCFQTMDRLYFVMEYVN 425
Query: 290 GGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
GG+L ++ G F + FY A + +L S+ IIYRDLK +N++L + G++K+ D
Sbjct: 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 485
Query: 350 FGFAKKLIGP 359
FG K+ I
Sbjct: 486 FGMCKENIWD 495
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 44/117 (37%), Positives = 66/117 (56%), Gaps = 1/117 (0%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303
IV + H ++E ++ + F+ L +F+ L +ME GGEL+ L + F
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF 245
Query: 304 DDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ RFY A +V A DYLHS +N++YRDLK ENL+L G++K+ DFG K+ I
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-33
Identities = 62/129 (48%), Positives = 89/129 (68%), Gaps = 5/129 (3%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81
+ + +T Y+ G+YIIRQGARGDTFFIISKGKV VT + + + ++RTL KGD+
Sbjct: 173 LSKLADVLEETHYENGEYIIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDW 232
Query: 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNE 141
FGEKALQG+D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + +
Sbjct: 233 FGEKALQGEDVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEA 290
Query: 142 E---FRSLR 147
E F +L+
Sbjct: 291 EAAFFANLK 299
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 34/231 (14%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
Y + II++G G +++ GKV+VT E + T+ G FGE A+ + R
Sbjct: 67 YGKDSCIIKEGDVGSLVYVMEDGKVEVTK------EGVKLCTMGPGKVFGELAILYNCTR 120
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET------------SERRRLNE 141
TA + V ID++ F ++ I+ E +L +
Sbjct: 121 TATVKTLVN--VKLWAIDRQCFQTIMMRTGLIKHTEYMEFLKSVPTFQSLPEEILSKLAD 178
Query: 142 EFRSLRLSDLRVITTLGVGG-------FGRVELVQIAGDPSRSFALKQMKKSQV---MNL 191
+ I G G G+V + + L+ + K L
Sbjct: 179 VLEETHYENGEYIIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDWFGEKAL 238
Query: 192 --DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRR 240
+D+RTAN++AA E V+CLVID+++F LI LD++ K ++ + +
Sbjct: 239 QGEDVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAK 287
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 51/239 (21%), Positives = 88/239 (36%), Gaps = 62/239 (25%)
Query: 123 DEIRTKYVDETSERRRL---NEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFA 179
Y+D R L E + + + R LG GGFG V Q+ + +A
Sbjct: 155 VAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT-GKMYA 213
Query: 180 LKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 239
K+++K ++ + + +E++
Sbjct: 214 CKKLEKKRIKKRKG-------------EAMAL------------------------NEKQ 236
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
I+ + N F+V L ++ K L +++ GG+L +
Sbjct: 237 -------------------ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277
Query: 300 KGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
G F +A FY A + + LH I+YRDLKPEN+LL G++++ D G A +
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 245 VETRQQQHIMSEKEIMG--EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ + +E + + + D I++LY +Y+YM+ME C +L + L+ K +
Sbjct: 65 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS 123
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D + Y ++EA +H I++ DLKP N L+ G +KL+DFG A ++
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM 176
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 251 QHIMSEKEIMG--EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+E + + + D I++LY +Y+YM+ME C +L + L+ K + D
Sbjct: 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ Y ++EA +H I++ DLKP N L+ G +KL+DFG A ++
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-31
Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 245 VETRQQQHIMSEKEIMG--EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ + +E + + + D I++LY +Y+YM+ME C +L + L+ K +
Sbjct: 46 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS 104
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D + Y ++EA +H I++ DLKP N L+ G +KL+DFG A ++
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM 157
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 30/118 (25%), Positives = 56/118 (47%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+++ Q++ + E I +V + F+D ++++++E C L + + +
Sbjct: 52 LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 111
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
+ R+Y +V YLH +I+RDLK NL L+ VK+ DFG A K+
Sbjct: 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 30/118 (25%), Positives = 56/118 (47%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+++ Q++ + E I +V + F+D ++++++E C L + + +
Sbjct: 78 LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 137
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
+ R+Y +V YLH +I+RDLK NL L+ VK+ DFG A K+
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 48/214 (22%), Positives = 84/214 (39%), Gaps = 58/214 (27%)
Query: 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEG 206
++ D +V LG G F V + + T VA
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAE-----------------------SIHTGLEVAIK--- 42
Query: 207 VSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD 266
+ID++ + + Q + +E +I +
Sbjct: 43 ----MIDKK---------------------------AMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 267 FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLHSR 325
I++LY F+D Y+Y+++E C GE+ L+++ F + R + ++ YLHS
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
I++RDL NLLL+ + +K+ DFG A +L P
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 248 RQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDD 305
+ + ++E + V+L + +++ LY+ E C G L G +
Sbjct: 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE 156
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A Y + A +LHS+ +++ D+KP N+ L G KL DFG +L
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 46/223 (20%), Positives = 78/223 (34%), Gaps = 27/223 (12%)
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQ-----------VMNLDDLRT 196
L+D I +G GGFG V + D ++A+K+++ V L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
Query: 197 ANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSE 256
IV + + I DE + S +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM------------DAPSVK 111
Query: 257 KEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF---DDATTRFYTA 313
M + V + K YLY+ M+ C L + + + +
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ EA ++LHS+ +++RDLKP N+ + VK+ DFG +
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 14/123 (11%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKD-------------KKYLYMLMESCLGGELW 294
+ I+SE ++ N ++V+ Y + + K L++ ME C G L+
Sbjct: 44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY 103
Query: 295 TILRDKGNFDD-ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
++ + ++EA Y+HS+ II+RDLKP N+ + S VK+ DFG A
Sbjct: 104 DLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 354 KKL 356
K +
Sbjct: 164 KNV 166
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 29/111 (26%), Positives = 60/111 (54%), Gaps = 2/111 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDD 305
++++ E ++ IV+ ++F++ LY++M+ C GG+L+ + + F +
Sbjct: 65 KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + A ++H R I++RD+K +N+ L+ G V+L DFG A+ L
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 31/118 (26%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81
LT+ +++G I+ QG GD FFII +G V ++ + E + L D+
Sbjct: 173 RLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDY 232
Query: 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139
FGE AL + + A +VA P + C+ +D+ F +++ +I + + + + L
Sbjct: 233 FGEIALLMNRPKAATVVARGP--LKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSL 288
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 42/229 (18%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ G+ +I+QG GD F++I +G++ V + ++ ++ +G FGE AL R
Sbjct: 67 FIAGETVIQQGDEGDNFYVIDQGEMDVYV------NNEWATSVGEGGSFGELALIYGTPR 120
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET------------SERRRLNE 141
A + A V ID++++ +++ + K +E ER + +
Sbjct: 121 AATVKAKTN--VKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVAD 178
Query: 142 EFRSLRLSDLRVITTLGVGG-------FGRVELVQIAGDPSRSFALKQMKKSQV---MNL 191
++ D + I G G G ++Q + + ++ S + L
Sbjct: 179 ALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIAL 238
Query: 192 --DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 238
+ + A +VA P + C+ +D+ F +++ +I + + + +
Sbjct: 239 LMNRPKAATVVARGP--LKCVKLDRPRFERVLGPCSDILKRNIQQYNSF 285
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 2/114 (1%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81
LT+ +++G+ I+ QG GD F+II++G V ++ + E + L D+
Sbjct: 264 RLTVADALEPVQFEDGEKIVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDY 323
Query: 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135
FGE AL + R A +VA P + C+ +D+ F +++ EI + + +
Sbjct: 324 FGEIALLLNRPRAATVVARGP--LKCVKLDRPRFERVLGPCSEILKRNIQRYNS 375
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 7e-21
Identities = 43/228 (18%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ G+ +I+QG GD F+++ +G+V V + +++ + +G FGE AL R
Sbjct: 158 HIAGETVIQQGNEGDNFYVVDQGEVDVYV------NGEWVTNISEGGSFGELALIYGTPR 211
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD------------ETSERRRLNE 141
A + A + ID++++ +++ + K + E ER + +
Sbjct: 212 AATVKAKTD--LKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLEKWERLTVAD 269
Query: 142 EFRSLRLSDLRVITTLGVGG-------FGRVELVQIAGDPSRSFALKQMKKSQV---MNL 191
++ D I G G G ++Q + ++ S + L
Sbjct: 270 ALEPVQFEDGEKIVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDYFGEIAL 329
Query: 192 --DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 237
+ R A +VA P + C+ +D+ F +++ EI + + +
Sbjct: 330 LLNRPRAATVVARGP--LKCVKLDRPRFERVLGPCSEILKRNIQRYNS 375
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 38/129 (29%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLG 290
V + S + A +I+ R + + E + IVKL++ F D+ + +++ME G
Sbjct: 31 VHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90
Query: 291 GELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKL 347
GEL+ ++ K +F + + +V A ++H +++RDLKPENLL + +K+
Sbjct: 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 348 VDFGFAKKL 356
+DFGFA+
Sbjct: 151 IDFGFARLK 159
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 9/118 (7%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGN--- 302
R M E E++ + N IVKL+ ++ ++ ++ME C G L+T+L + N
Sbjct: 49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKL 356
++ VV ++L I++R++KP N++ KL DFG A++L
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 9/118 (7%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGN--- 302
R M E E++ + N IVKL+ ++ ++ ++ME C G L+T+L + N
Sbjct: 49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKL 356
++ VV ++L I++R++KP N++ KL DFG A++L
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >1vp6_A CNBD, cyclic-nucleotide binding domain of mesorhizobium LOTI CNG potassium channel; dimer helical bundle beta barrel core with cyclic AMP bound; HET: CMP; 1.70A {Mesorhizobium loti} SCOP: b.82.3.2 PDB: 3cl1_A* 2k0g_A* 2kxl_A 3clp_A* 1u12_A 3co2_A Length = 138 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-26
Identities = 35/110 (31%), Positives = 42/110 (38%), Gaps = 10/110 (9%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
G I R G GD F + +G V V P L G FFGE AL +
Sbjct: 38 TVPAGAVICRIGEPGDRMFFVVEGSVSVATPNP--------VELGPGAFFGEMALISGEP 89
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE 142
R+A + AA VS L + F L SS EI + ERR
Sbjct: 90 RSATVSAATT--VSLLSLHSADFQMLCSSSPEIAEIFRKTALERRGAAAS 137
|
| >1vp6_A CNBD, cyclic-nucleotide binding domain of mesorhizobium LOTI CNG potassium channel; dimer helical bundle beta barrel core with cyclic AMP bound; HET: CMP; 1.70A {Mesorhizobium loti} SCOP: b.82.3.2 PDB: 3cl1_A* 2k0g_A* 2kxl_A 3clp_A* 1u12_A 3co2_A Length = 138 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-05
Identities = 17/50 (34%), Positives = 22/50 (44%), Gaps = 2/50 (4%)
Query: 192 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRA 241
+ R+A + AA VS L + F L SS EI + ERR A
Sbjct: 87 GEPRSATVSAATT--VSLLSLHSADFQMLCSSSPEIAEIFRKTALERRGA 134
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 34/252 (13%), Positives = 74/252 (29%), Gaps = 41/252 (16%)
Query: 112 QETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIA 171
+ T + S+ D + + + T + R+ E R L T LG
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVESEL-GERPRTLVRGTVLGQEDPYAYLEATDQ 95
Query: 172 GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231
SF + ++ + + + +
Sbjct: 96 ET-GESFEVHVPYFTERPPSNAI-------------------------------KQMKEE 123
Query: 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-----YLYMLME 286
V R + + + +++ + ++++ +D +LY M+
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 287 SCL---GGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG 343
S L G L + + T V+ LH +++ L+P +++L G
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 344 YVKLVDFGFAKK 355
V L F +
Sbjct: 244 GVFLTGFEHLVR 255
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 1/108 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
+ + E + IV LY ++ ++ + ME GG L +++ G +
Sbjct: 94 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL 153
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKL 356
+Y +E +YLH+R I++ D+K +N+LLS+ G L DFG A L
Sbjct: 154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIM----GEANCDFIVKLYKTFKDKKYLYMLM 285
K +D T + + V+ ++ + E +I+ G N I++L T++ + +++
Sbjct: 48 KIIDVTGGGSFSAEEVQELREA-TLKEVDILRKVSGHPN---IIQLKDTYETNTFFFLVF 103
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYV 345
+ GEL+ L +K + TR ++E LH NI++RDLKPEN+LL +
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163
Query: 346 KLVDFGFAKKL 356
KL DFGF+ +L
Sbjct: 164 KLTDFGFSCQL 174
|
| >3gyd_A CNMP-BD protein, cyclic nucleotide-binding domain; nucleotide binding protein, structural genomics; HET: MSE CMP; 1.79A {Methylobacillus flagellatus KT} Length = 187 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-26
Identities = 26/123 (21%), Positives = 51/123 (41%), Gaps = 8/123 (6%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
++ +G GD +I G+V V PN + I + G GE ++ R
Sbjct: 67 APRDCQLLTEGDPGDYLLLILTGEVNVIKDIPNK-GIQTIAKVGAGAIIGEMSMIDGMPR 125
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY----VDETSER-RRLNEEFRSLRL 148
+A+ VA+ P V+ ++ QL++++ ++ K + + R R + L
Sbjct: 126 SASCVASLP--TDFAVLSRDALYQLLANMPKLGNKVLIRLLQLLTARFRESYDRILPKTL 183
Query: 149 SDL 151
+L
Sbjct: 184 GEL 186
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 3/115 (2%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
+ + I+ E E++ + + I+KL++ +D Y++ E GGEL+ + + F
Sbjct: 60 AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKL 356
+ V Y+H NI++RDLKPEN+LL + +K++DFG +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 30/132 (22%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 232 VDETSERRRAPQIVETRQ---QQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMES 287
++ + + A +I+E + + + E E++ + +++L + F+++ Y++ E
Sbjct: 33 INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92
Query: 288 CLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY--- 344
GG + + + + +F++ V A D+LH++ I +RDLKPEN+L
Sbjct: 93 MRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSP 152
Query: 345 VKLVDFGFAKKL 356
VK+ DF +
Sbjct: 153 VKICDFDLGSGI 164
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 29/123 (23%), Positives = 65/123 (52%), Gaps = 4/123 (3%)
Query: 238 RRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
+R++ ++ I E I+ + ++ L+ ++++ + +++E GGEL+ L
Sbjct: 47 KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVKLVDFGFA 353
K + + + +++ +YLH++ I + DLKPEN++L ++KL+DFG A
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
Query: 354 KKL 356
++
Sbjct: 167 HEI 169
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 30/122 (24%), Positives = 64/122 (52%), Gaps = 4/122 (3%)
Query: 239 RRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298
R++ ++ I E I+ + I+ L+ ++++ + +++E GGEL+ L
Sbjct: 48 RQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA 107
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVKLVDFGFAK 354
K + + + +++ +YLH++ I + DLKPEN++L ++KL+DFG A
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 355 KL 356
++
Sbjct: 168 EI 169
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} Length = 246 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 7/104 (6%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81
+ Y+ G+ IIR+G +G+ F++I G V V+ K + I L D+
Sbjct: 141 RAKLADALDTKIYQPGETIIREGDQGENFYLIEYGAVDVSKK-----GQGVINKLKDHDY 195
Query: 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 125
FGE AL D R A + A + + F +L+ ++
Sbjct: 196 FGEVALLNDLPRQATVTATKR--TKVATLGKSGFQRLLGPAVDV 237
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} Length = 246 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-22
Identities = 40/216 (18%), Positives = 76/216 (35%), Gaps = 35/216 (16%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+G II+QG +GD F+++ KG V + + + G FGE AL + R
Sbjct: 35 VPKGATIIKQGDQGDYFYVVEKGTVDFY------VNDNKVNSSGPGSSFGELALMYNSPR 88
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRV 153
A +VA +D+ TF +++ + D+ + + +SL D
Sbjct: 89 AATVVATSD--CLLWALDRLTFRKILLGSSFKKRLMYDDLLKSMPV---LKSLTTYDRAK 143
Query: 154 ITT-LGVGGFGRVELVQIAGDPSRSF--------ALKQMKKSQVMNL------------- 191
+ L + E + GD +F + + + + L
Sbjct: 144 LADALDTKIYQPGETIIREGDQGENFYLIEYGAVDVSKKGQGVINKLKDHDYFGEVALLN 203
Query: 192 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227
D R A + A + + F +L+ ++
Sbjct: 204 DLPRQATVTATKR--TKVATLGKSGFQRLLGPAVDV 237
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 41/229 (17%), Positives = 82/229 (35%), Gaps = 61/229 (26%)
Query: 132 ETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNL 191
+ ++ L + L++ R+ +G G F V D ALK+++ +M+
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLD-GVPVALKKVQIFDLMDA 73
Query: 192 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQ 251
+E L+ L+
Sbjct: 74 KARADCI---------------KEI--DLLKQLN-------------------------- 90
Query: 252 HIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL----RDKGNFDDAT 307
H ++K Y +F + L +++E G+L ++ + K + T
Sbjct: 91 H-------------PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y + A +++HSR +++RD+KP N+ ++ +G VKL D G +
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 34/129 (26%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 232 VDETSERRRAPQIVETRQQQH-IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLG 290
+ +++ A ++++ + + +E ++ + I+KL + F+ + +++E G
Sbjct: 73 KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 291 GELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKL 347
GEL+ + +KG + + ++EA YLH I++RDLKPENLL +T +K+
Sbjct: 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKI 192
Query: 348 VDFGFAKKL 356
DFG +K +
Sbjct: 193 ADFGLSKIV 201
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 12/121 (9%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYL------YMLMESCLGGELWTILRDKG 301
+ ++ E +IM + N +V + + L + ME C GG+L L
Sbjct: 54 KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE 113
Query: 302 N---FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKK 355
N + R + + A YLH II+RDLKPEN++L K++D G+AK+
Sbjct: 114 NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173
Query: 356 L 356
L
Sbjct: 174 L 174
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 6/130 (4%)
Query: 232 VDETSERRRAPQIVETRQQQHIMSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLG 290
+ + + A +I++ ++ E EI+ I+ L + D KY+Y++ E G
Sbjct: 42 IHKATNMEFAVKIIDKSKRD-PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 291 GELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVK 346
GEL + + F + + + +YLH++ +++RDLKP N+L ++
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160
Query: 347 LVDFGFAKKL 356
+ DFGFAK+L
Sbjct: 161 ICDFGFAKQL 170
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 36/123 (29%), Positives = 64/123 (52%), Gaps = 4/123 (3%)
Query: 238 RRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
+RR ++ I E I+ E I+ L+ F++K + +++E GGEL+ L
Sbjct: 40 KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 99
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVKLVDFGFA 353
+K + + + +++ YLHS+ I + DLKPEN++L + +KL+DFG A
Sbjct: 100 AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
Query: 354 KKL 356
K+
Sbjct: 160 HKI 162
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 44/130 (33%), Positives = 66/130 (50%), Gaps = 6/130 (4%)
Query: 232 VDETSERRRAPQIVETRQ---QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC 288
V + + RRA + + E EIM + I++LY+TF+D +Y++ME C
Sbjct: 29 VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88
Query: 289 LGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---V 345
GGEL+ + K F ++ V+ A Y H N+ +RDLKPEN L T +
Sbjct: 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL 148
Query: 346 KLVDFGFAKK 355
KL+DFG A +
Sbjct: 149 KLIDFGLAAR 158
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* Length = 416 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 38/122 (31%), Positives = 59/122 (48%), Gaps = 7/122 (5%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTE-----EKYIRTL 76
L +V Y +G+ II QG D+FFI+ G+VK+TMK+ +E I
Sbjct: 283 RLKVVDVIGTKVYNDGEQIIAQGDLADSFFIVESGEVKITMKRKGKSEVEENGAVEIARC 342
Query: 77 YKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136
++G +FGE AL + R A+ A V CL +D + F +L+ EI + + E+
Sbjct: 343 FRGQYFGELALVTNKPRAASAHAIGT--VKCLAMDVQAFERLLGPCMEIMKRNIATYEEQ 400
Query: 137 RR 138
Sbjct: 401 LV 402
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* Length = 416 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 41/241 (17%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92
KEG+++I QG GD F++I +G + +K + + FGE AL +
Sbjct: 172 LVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDG--VGRCVGNYDNRGSFGELALMYNTP 229
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLR 152
+ A I A P + +D+ TF ++I + + K + E +SL +S+
Sbjct: 230 KAATITATSP--GALWGLDRVTFRRIIVKNNAKKRKMYESFIESLPF---LKSLEVSERL 284
Query: 153 -VITTLGVGGFGRVELVQIAGDPSRSF------------------ALKQMKKSQVMNL-- 191
V+ +G + E + GD + SF +++ ++
Sbjct: 285 KVVDVIGTKVYNDGEQIIAQGDLADSFFIVESGEVKITMKRKGKSEVEENGAVEIARCFR 344
Query: 192 -----------DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRR 240
+ R A+ A V CL +D + F +L+ EI + + E+
Sbjct: 345 GQYFGELALVTNKPRAASAHAIGT--VKCLAMDVQAFERLLGPCMEIMKRNIATYEEQLV 402
Query: 241 A 241
A
Sbjct: 403 A 403
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 238 RRRAPQIVETRQQQHIMSEKEIM----GEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL 293
R ++ E I+ G + I+ L +++ +++++ + GEL
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPH---IITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 294 WTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+ L +K + TR ++EA +LH+ NI++RDLKPEN+LL + ++L DFGF+
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 354 KKL 356
L
Sbjct: 248 CHL 250
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 232 VDETSERRRAPQIVETRQ-----QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLME 286
V + + A I+ T++ Q + E I IV+L+ + ++ + Y++ +
Sbjct: 31 VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90
Query: 287 SCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-- 344
GGEL+ + + + +A ++EA + H +++R+LKPENLLL++
Sbjct: 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGA 150
Query: 345 -VKLVDFGFAKKLIGP 359
VKL DFG A ++ G
Sbjct: 151 AVKLADFGLAIEVEGE 166
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
+ R Q + E I + IV+L+ + +++ + Y++ + GGEL+ + + +
Sbjct: 44 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS 103
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKL 356
+A ++E+ Y HS I++R+LKPENLLL++ VKL DFG A ++
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 10/130 (7%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF----IVKLYKTFKDKKYLYMLM 285
K + R R E ++ + +++L F+ ++ +++
Sbjct: 62 KVIP----RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 286 E-SCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SG 343
E +L+ + +KG + +R + VV A + HSR +++RD+K EN+L+ G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177
Query: 344 YVKLVDFGFA 353
KL+DFG
Sbjct: 178 CAKLIDFGSG 187
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 33/123 (26%), Positives = 62/123 (50%), Gaps = 4/123 (3%)
Query: 238 RRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
+RR ++ I E I+ E ++ L++ +++K + +++E GGEL+ L
Sbjct: 46 KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST----SGYVKLVDFGFA 353
+K + + + ++ YLHS I + DLKPEN++L +K++DFG A
Sbjct: 106 AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 354 KKL 356
K+
Sbjct: 166 HKI 168
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 232 VDETSERRRAPQIVETRQ---QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC 288
+ + A + V T ++ + E + M +V L+ F+D + M+ E
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 289 LGGELW-TILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYV 345
GGEL+ + + + Y V + ++H N ++ DLKPEN++ +T S +
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 346 KLVDFGFAKKL 356
KL+DFG L
Sbjct: 297 KLIDFGLTAHL 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 38/133 (28%), Positives = 71/133 (53%), Gaps = 8/133 (6%)
Query: 232 VDETSERRRAPQIVETRQ-----QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLME 286
V +T+ A +I+ T++ Q + E I + IV+L+ + +++ + Y++ +
Sbjct: 49 VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108
Query: 287 SCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SG 343
GGEL+ + + + +A ++E+ Y HS I++R+LKPENLLL++
Sbjct: 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 344 YVKLVDFGFAKKL 356
VKL DFG A ++
Sbjct: 169 AVKLADFGLAIEV 181
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 30/125 (24%), Positives = 62/125 (49%), Gaps = 3/125 (2%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMES-C 288
K++ + E+ +E + + E I+ I+K+ F+++ + ++ME
Sbjct: 55 KFIKK--EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHG 112
Query: 289 LGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV 348
G +L+ + D+ + +V A YL ++II+RD+K EN++++ +KL+
Sbjct: 113 SGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI 172
Query: 349 DFGFA 353
DFG A
Sbjct: 173 DFGSA 177
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 32/129 (24%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 232 VDETSERRRAPQIVETRQ---QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC 288
+ + A + ++ + +E ++ + + IV L ++ + Y++M+
Sbjct: 29 KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88
Query: 289 LGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YV 345
GGEL+ + ++G + + V+ A YLH I++RDLKPENLL T +
Sbjct: 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI 148
Query: 346 KLVDFGFAK 354
+ DFG +K
Sbjct: 149 MITDFGLSK 157
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--- 302
+ + E I IV+L +T+ LYM+ E G +L + + +
Sbjct: 66 PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 125
Query: 303 -FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIG 358
+ +A Y ++EA Y H NII+RD+KP +LL++ S VKL FG A +L
Sbjct: 126 VYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
Query: 359 P 359
Sbjct: 186 S 186
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* Length = 161 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-24
Identities = 31/131 (23%), Positives = 58/131 (44%), Gaps = 15/131 (11%)
Query: 13 FVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKY 72
F +L + + ++ + KEG+++I QG GD F++I +G + +K +
Sbjct: 46 FKNL-DPEQMSQVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDG--VGRC 102
Query: 73 IRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 132
+ FGE AL + R A I A P + +D+ TF ++I
Sbjct: 103 VGNYDNRGSFGELALMYNTPRAATITATSP--GALWGLDRVTFRRIIV----------KN 150
Query: 133 TSERRRLNEEF 143
+++R++ E F
Sbjct: 151 NAKKRKMYESF 161
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 34/131 (25%), Positives = 71/131 (54%), Gaps = 6/131 (4%)
Query: 232 VDETSERRRAPQIVETRQ---QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC 288
+ + + A +I++TR ++ + +E +M + + +++LY F+ K + ++ME
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 289 LGGELW-TILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYV 345
GGEL+ I+ + N + T + + E ++H I++ DLKPEN+L + +
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI 228
Query: 346 KLVDFGFAKKL 356
K++DFG A++
Sbjct: 229 KIIDFGLARRY 239
|
| >2d93_A RAP guanine nucleotide exchange factor 6; CNMP_binding domain, PDZ domain containing guanine nucleotide exchange factor 2, PDZ-GEF2, RA-GEF-2; NMR {Homo sapiens} Length = 134 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-24
Identities = 13/94 (13%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
+ + G I+ G D++++I G V+++ + + L+ G+ FG
Sbjct: 42 EVVEQAGAIILEDGQELDSWYVILNGTVEIS------HPDGKVENLFMGNSFGITPTLDK 95
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 124
+ + + I Q+ + ++++ +++
Sbjct: 96 QYMHGIVRTKV-DDCQFVCIAQQDYWRILNHVEK 128
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 39/114 (34%), Positives = 61/114 (53%), Gaps = 3/114 (2%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
V T ++ E ++ + I+KLY F+DK+ Y++ME GGEL+ + + F+
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKK 355
+ V+ YLH NI++RDLKPENLLL + +K+VDFG +
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 232 VDETSERRRAPQIVETR---QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC 288
V++ + R + + T + + +E IM + + ++ L+ F+DK + +++E
Sbjct: 71 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 289 LGGELW-TILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYV 345
GGEL+ I + +A Y E ++H +I++ D+KPEN++ T + V
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV 190
Query: 346 KLVDFGFAKKL 356
K++DFG A KL
Sbjct: 191 KIIDFGLATKL 201
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 38/112 (33%), Positives = 62/112 (55%), Gaps = 4/112 (3%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF--DDAT 307
Q + E + IV+ +F + ++ + ME GG L +LR K G ++ T
Sbjct: 64 QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLIG 358
FYT ++E YLH I++RD+K +N+L++T SG +K+ DFG +K+L G
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 Length = 469 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 12 YFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEK 71
HL ++ K G + QG G +++II KG V V + +
Sbjct: 344 ALSHLSTTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG-----KG 398
Query: 72 YIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 131
+ TL++GD FG+ AL D R A+IV + + L +D+E FN+++ ++ + +
Sbjct: 399 VVCTLHEGDDFGKLALVNDAPRAASIVLRE-DNCHFLRVDKEDFNRILRDVEANTVRLKE 457
Query: 132 ETSERRRLNE 141
+ L +
Sbjct: 458 HDQDVLVLEK 467
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 Length = 469 | Back alignment and structure |
|---|
Score = 78.8 bits (193), Expect = 3e-16
Identities = 24/85 (28%), Positives = 40/85 (47%), Gaps = 4/85 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNS-TEEKYIRTLYKGDFFGEKALQGDDL 92
++G + RQG G ++ + G + V + + +S + I TL G FGE ++ +
Sbjct: 70 LEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE-SILDNTP 128
Query: 93 RTANIVAADPEGVSCLVIDQETFNQ 117
R A IV + L I+QE F
Sbjct: 129 RHATIVTRES--SELLRIEQEDFKA 151
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 40/114 (35%), Positives = 63/114 (55%), Gaps = 4/114 (3%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
E ++ +E EI+ + N I+K+ F + Y Y+++E GGEL+ + +
Sbjct: 55 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE 113
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKL 356
AT + Y ++ A YLH II+RDLKPEN+LLS+ +K+ DFG +K L
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 50/204 (24%)
Query: 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQE 215
LG G +G V L + A+K +KKSQ + E +
Sbjct: 43 KLGSGAYGEVLLCKEKNG-HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI-------- 93
Query: 216 TFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF 275
+EI ++ + N I+KL+ F
Sbjct: 94 --------YNEIS------------------------LLKS---LDHPN---IIKLFDVF 115
Query: 276 KDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPE 335
+DKKY Y++ E GGEL+ + ++ FD+ ++ YLH NI++RD+KPE
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175
Query: 336 NLLLSTSGY---VKLVDFGFAKKL 356
N+LL +K+VDFG +
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFF 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 34/130 (26%), Positives = 67/130 (51%), Gaps = 5/130 (3%)
Query: 232 VDETSERRRAPQIVETRQQQH--IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
V+ +S++ + V+ + + E I+ A I+ L+++F+ + L M+ E
Sbjct: 25 VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 290 GGELW-TILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVK 346
G +++ I ++ Y V EA +LHS NI + D++PEN++ T S +K
Sbjct: 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIK 144
Query: 347 LVDFGFAKKL 356
+++FG A++L
Sbjct: 145 IIEFGQARQL 154
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 41/199 (20%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 156 TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQE 215
+G G +G V+L D + +A+K + K +++ + +
Sbjct: 20 EIGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 216 TFNQLISSLDEIRT-KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKT 274
Q+ EI K +D +++ E++ + N
Sbjct: 79 PIEQVYQ---EIAILKKLD----------------HPNVVKLVEVLDDPN---------- 109
Query: 275 FKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKP 334
+ +LYM+ E G + + + RFY +++ +YLH + II+RD+KP
Sbjct: 110 ---EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165
Query: 335 ENLLLSTSGYVKLVDFGFA 353
NLL+ G++K+ DFG +
Sbjct: 166 SNLLVGEDGHIKIADFGVS 184
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 3/114 (2%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
+ + I+ E E++ + + I+KL++ +D Y++ E GGEL+ + + F
Sbjct: 60 AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKK 355
+ V Y+H NI++RDLKPEN+LL + +K++DFG +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 37/133 (27%), Positives = 71/133 (53%), Gaps = 9/133 (6%)
Query: 232 VDETSERRRAPQIVETRQ------QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLM 285
D+ + + A +++ RQ ++ ++ E +++ + + I+KLY+ F+DK Y Y++
Sbjct: 46 KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105
Query: 286 ESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-- 343
E GGEL+ + + F + V+ Y+H I++RDLKPENLLL +
Sbjct: 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 165
Query: 344 -YVKLVDFGFAKK 355
++++DFG +
Sbjct: 166 ANIRIIDFGLSTH 178
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 30/116 (25%), Positives = 60/116 (51%), Gaps = 6/116 (5%)
Query: 247 TRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGEL--WTILRDKGNF 303
+ I+ E ++ A C ++ L++ +++ + +++E GGE+ +
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS---GYVKLVDFGFAKKL 356
+ ++E YLH NI++ DLKP+N+LLS+ G +K+VDFG ++K+
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 40/114 (35%), Positives = 63/114 (55%), Gaps = 4/114 (3%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
E ++ +E EI+ + N I+K+ F + Y Y+++E GGEL+ + +
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE 238
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKL 356
AT + Y ++ A YLH II+RDLKPEN+LLS+ +K+ DFG +K L
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 1/109 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
+ I+ E +++ E N +IV Y F + + ME GG L +L+ G +
Sbjct: 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 134
Query: 310 FYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ V++ YL I++RD+KP N+L+++ G +KL DFG + +LI
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 31/114 (27%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGEL----WTILRDKGNFD 304
+ I +E E++ + I+K+++ F+D +Y++ME+C GGEL +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS 122
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKK 355
+ ++ A Y HS++++++DLKPEN+L + +K++DFG A+
Sbjct: 123 EGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 6e-23
Identities = 29/255 (11%), Positives = 70/255 (27%), Gaps = 41/255 (16%)
Query: 110 IDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQ 169
+ T + S+ D + + + T + R+ E R L T LG
Sbjct: 40 NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE-RPRTLVRGTVLGQEDPYAYLEAT 98
Query: 170 IAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229
SF + ++ + ++ + +E
Sbjct: 99 DQET-GESFEVHVPYFTERPPSNAIK---------------QMKEEVL------------ 130
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLM 285
R + + + +++ + ++++ +D ++
Sbjct: 131 ----RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 286 ESC----LGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
G L + + T V+ LH +++ L+P +++L
Sbjct: 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 246
Query: 342 SGYVKLVDFGFAKKL 356
G V L F +
Sbjct: 247 RGGVFLTGFEHLVRD 261
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 19/124 (15%), Positives = 40/124 (32%), Gaps = 16/124 (12%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-----F 303
+ E + + +K Y + ++ E G L + N
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-----------SGYVKLVDFGF 352
+ ++ + +H II+ D+KP+N +L S + L+D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 353 AKKL 356
+ +
Sbjct: 230 SIDM 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 33/111 (29%), Positives = 52/111 (46%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+I I E + + I+KLY+ +M+ME GGEL+ + G
Sbjct: 48 KIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR 107
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
++ R ++ A DY H +++RDLKPEN+LL K+ DFG +
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 39/238 (16%), Positives = 72/238 (30%), Gaps = 44/238 (18%)
Query: 130 VDETSERRRLNEEFRSL---RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKS 186
V T + SL L+++ L VG V LV+ + FALK
Sbjct: 40 VTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMG 98
Query: 187 QVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVE 246
+ +L + + TF R E
Sbjct: 99 AENSRSELER---------------LHEATFAAA-----------------RLLGESPEE 126
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKY--LYMLMESC------LGGELWTILR 298
R ++ ++ + + + +L D +LM + L L +
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+G+ TA ++ L S+ +++ P+NL + G + L D K+
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 42/117 (35%), Positives = 67/117 (57%), Gaps = 10/117 (8%)
Query: 256 EKEIMGE-ANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGN--FDDATT 308
E E+ + C IV++ +++ +K L ++ME GGEL++ ++D+G+ F +
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLIGPRYS 362
+ EA YLHS NI +RD+KPENLL ++ +KL DFGFAK+ G +Y
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD 176
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 39/103 (37%), Positives = 56/103 (54%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
Q + E IM N IVKL++ + +K LY++ME GGE++ L G + R
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+V A Y H + I++RDLK ENLLL +K+ DFGF+
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 28/128 (21%), Positives = 61/128 (47%), Gaps = 8/128 (6%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF--IVKLYKTFKDKKYLYMLMES 287
K+V+ + R E + E ++ + + F +++L F+ +++E
Sbjct: 74 KHVE----KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 288 CLG-GELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYV 345
+L+ + ++G + R + V+EA + H+ +++RD+K EN+L+ G +
Sbjct: 130 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 346 KLVDFGFA 353
KL+DFG
Sbjct: 190 KLIDFGSG 197
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 11/120 (9%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTIL----RDKG 301
++Q ++SE ++ E IV+ Y D+ LY++ME C GG+L +++ +++
Sbjct: 47 AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 106
Query: 302 NFDDATTRFYTACVVEAFDYLHSRN-----IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D+ + A H R+ +++RDLKP N+ L VKL DFG A+ L
Sbjct: 107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-22
Identities = 21/116 (18%), Positives = 44/116 (37%), Gaps = 8/116 (6%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTIL----RDK 300
++ E ++ N I++L ++ ++L+ G LW +
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + + +H++ +RDLKP N+LL G L+D G +
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 29/126 (23%), Positives = 47/126 (37%), Gaps = 18/126 (14%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKD----------------KKYLYMLMESCLGGE 292
+ E + + + + IV + K L++ ME C G
Sbjct: 47 NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106
Query: 293 LWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDF 350
L + + D + + DY+HS+ +I RDLKP N+ L + VK+ DF
Sbjct: 107 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 351 GFAKKL 356
G L
Sbjct: 167 GLVTSL 172
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-22
Identities = 36/135 (26%), Positives = 68/135 (50%), Gaps = 12/135 (8%)
Query: 232 VDETSERRRAPQIVETRQQQHIMSEKEIMG-EANCDFIVKLYKTFKD----KKYLYMLME 286
+ ++ A +++ + E + + IV + +++ K+ L ++ME
Sbjct: 49 FHRRTGQKCALKLLYDSPK--ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 287 SCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY 344
GGEL++ ++++G+ F + + A +LHS NI +RD+KPENLL ++
Sbjct: 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK 166
Query: 345 ---VKLVDFGFAKKL 356
+KL DFGFAK+
Sbjct: 167 DAVLKLTDFGFAKET 181
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 41/224 (18%), Positives = 75/224 (33%), Gaps = 74/224 (33%)
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
L+D I LG GGFG V + D ++A+K+++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVD-DCNYAIKRIRLP--------------------- 41
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
+ R + M E + + +
Sbjct: 42 -------------------------NRELAREKV------------MREVKALAKLEHPG 64
Query: 268 IVKLYKTFKDK------------KYLYMLMESCLGGELWTILRDKGN---FDDATTRFYT 312
IV+ + + +K YLY+ M+ C L + + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ EA ++LHS+ +++RDLKP N+ + VK+ DFG +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 28/86 (32%), Positives = 44/86 (51%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+VK Y ++ Y+ +E C GGEL+ + + + + ++ YLH I
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFA 353
+RD+KPENLLL +K+ DFG A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA 152
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 32/107 (29%), Positives = 59/107 (55%), Gaps = 1/107 (0%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTR 309
+ + E EI+ + +IVKL + L++++E C GG + I+ + + +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++EA ++LHS+ II+RDLK N+L++ G ++L DFG + K
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 28/87 (32%), Positives = 44/87 (50%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+VK Y ++ Y+ +E C GGEL+ + + + + ++ YLH I
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAK 354
+RD+KPENLLL +K+ DFG A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLAT 153
|
| >3pna_A CAMP-dependent protein kinase type I-alpha regula subunit; beta-barrel, CAMP-binding, catalytic subunit, transferase; HET: CMP; 1.50A {Bos taurus} PDB: 3fhi_B* 3iia_A 3plq_A* 1u7e_B* 3pvb_B* Length = 154 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-21
Identities = 24/97 (24%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ G+ +I+QG GD F++I +G++ V + ++ ++ +G FGE AL R
Sbjct: 66 FIAGETVIQQGDEGDNFYVIDQGEMDVYV------NNEWATSVGEGGSFGELALIYGTPR 119
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEI-RTKY 129
A + A V ID++++ +++ R Y
Sbjct: 120 AATVKAKTN--VKLWGIDRDSYRRILMGSTLRKRKMY 154
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 2/89 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV+ + +L ++ME GGEL+ + + G F + RF+ ++ Y HS I
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 328 IYRDLKPENLLL--STSGYVKLVDFGFAK 354
+RDLK EN LL S + +K+ DFG++K
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSK 166
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 33/111 (29%), Positives = 53/111 (47%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+I I E + + I+KLY+ ++M+ME GGEL+ + G
Sbjct: 53 KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR 112
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
D+ +R ++ DY H +++RDLKPEN+LL K+ DFG +
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 1/111 (0%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ ++ + E + I+KLY + M++E GGEL+ + +K
Sbjct: 46 LLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR 104
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+ R + ++ A +Y H I++RDLKPENLLL + VK+ DFG +
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 22/154 (14%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESC 288
+ R A + + + E +++ E + +++ Y + ++LY+ +E C
Sbjct: 32 VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91
Query: 289 LGGELWTILRDKGNFDDATTRFYTAC-------VVEAFDYLHSRNIIYRDLKPENLLLST 341
L ++ K D+ + +LHS II+RDLKP+N+L+ST
Sbjct: 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 342 SGY-------------VKLVDFGFAKKLIGPRYS 362
S + + DFG KKL + S
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 2/110 (1%)
Query: 250 QQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
+ I+ + ++ + +C +IV+ + TF +++ ME R +G +
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126
Query: 309 RFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
T +V+A YL +I+RD+KP N+LL G +KL DFG + +L+
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 41/135 (30%), Positives = 75/135 (55%), Gaps = 12/135 (8%)
Query: 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKD----KKYLYMLME 286
++ ++ + A ++++ + E E+ + C IV++ +++ +K L ++ME
Sbjct: 82 FNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 287 SCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY 344
GGEL++ ++D+G+ F + + EA YLHS NI +RD+KPENLL ++
Sbjct: 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 199
Query: 345 ---VKLVDFGFAKKL 356
+KL DFGFAK+
Sbjct: 200 NAILKLTDFGFAKET 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 1/104 (0%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
+ +E IM + +V++YK++ + L++LME GG L I+ + ++
Sbjct: 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVC 147
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V++A YLH++ +I+RD+K +++LL+ G VKL DFGF ++
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
|
| >3mdp_A Cyclic nucleotide-binding domain (CNMP-BD) protei; structural genomics, joint center for structural genomics; HET: MSE; 1.90A {Geobacter metallireducens} Length = 142 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-20
Identities = 22/144 (15%), Positives = 54/144 (37%), Gaps = 7/144 (4%)
Query: 1 MSKNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKV 60
M L++ +F L + I S + + G I ++ ++ D ++ +G V++
Sbjct: 2 MISPERLRVYRFFASL-TDEQLKDIALISEEKSFPTGSVIFKENSKADNLMLLLEGGVEL 60
Query: 61 TMKQPNSTE--EKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQL 118
+ + ++ G FG +L T++ A P V + I+ ++
Sbjct: 61 FYSNGGAGSAANSTVCSVVPGAIFGVSSLIKPYHYTSSARATKP--VRVVDINGARLREM 118
Query: 119 ISSLDEIRTKYVDETSER--RRLN 140
+ + ++ + RL+
Sbjct: 119 SENNQALGQVLMNNVAAAVLARLH 142
|
| >3ocp_A PRKG1 protein; serine/threonine kinase, TF2I and IRAG, transferase; HET: CMP; 2.49A {Homo sapiens} PDB: 3od0_A* 3ogj_A* Length = 139 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-20
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 10/118 (8%)
Query: 13 FVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKY 72
+L I IV Y + II++G G +++ GKV+VT E
Sbjct: 31 MKNL-ELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEVT------KEGVK 83
Query: 73 IRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI-RTKY 129
+ T+ G FGE A+ + RTA + V ID++ F ++ I T+Y
Sbjct: 84 LCTMGPGKVFGELAILYNCTRTATVKTLVN--VKLWAIDRQCFQTIMMRTGLIKHTEY 139
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 1/106 (0%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
+ I E ++ + + ++ K Y ++ L+++ME GG +L G D+
Sbjct: 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIAT 123
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+++ DYLHS I+RD+K N+LLS G VKL DFG A +L
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
|
| >2pqq_A Putative transcriptional regulator; APC7345, streptomyces coelicolor structural genomics, PSI-2, protein structure initiative; 2.00A {Streptomyces coelicolor A3} Length = 149 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-20
Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 4/118 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
GD + +G GD +++++GKVK+ P+ E + + + GE +L R
Sbjct: 33 LARGDTLFHEGDPGDRLYVVTEGKVKLHRTSPDG-RENMLAVVGPSELIGELSLFDPGPR 91
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSD 150
TA A V L + ++ E+ T + + R R+ N+ L SD
Sbjct: 92 TATGTALTE--VKLLALGHGDLQPWLNVRPEVATALLRAVARRLRKTNDAMSDLVFSD 147
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 8/139 (5%)
Query: 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCL 289
Y R A + + E +++ E++ +++ + T KD+++ Y+ +E C
Sbjct: 42 YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC- 100
Query: 290 GGELWTILRDKG-NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---- 344
L + K +LHS NI++RDLKP N+L+S
Sbjct: 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKI 160
Query: 345 -VKLVDFGFAKKLIGPRYS 362
+ DFG KKL R+S
Sbjct: 161 KAMISDFGLCKKLAVGRHS 179
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 1/104 (0%)
Query: 253 IMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
I++E +M E IV ++ L+++ME GG L ++ + D+
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVC 122
Query: 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++A ++LHS +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 1/109 (0%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDAT 307
Q I+ E IM + + +VK Y ++ L+++ME C G + I+R + +
Sbjct: 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE 126
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++ +YLH I+RD+K N+LL+T G+ KL DFG A +L
Sbjct: 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 42/161 (26%)
Query: 238 RRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297
+ + + + + I +E +M + + I +LY+ ++D++Y+ ++ME C GG L L
Sbjct: 60 NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 298 RDKGNFDDATTRFYTAC----------------------------------------VVE 317
+ +
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 318 AFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKL 356
A YLH++ I +RD+KPEN L ST S +KLVDFG +K+
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 29/118 (24%), Positives = 59/118 (50%), Gaps = 5/118 (4%)
Query: 245 VETRQQQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGG---ELWTILRDK 300
V +++Q+ ++ + +I M +C F V Y + +++ ME ++
Sbjct: 44 VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG 103
Query: 301 GNFDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ +V+A ++LHS ++I+RD+KP N+L++ G VK+ DFG + L+
Sbjct: 104 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 8/115 (6%)
Query: 250 QQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-----KGNF 303
Q+ ++ + ++ M ++C +IV+ Y + ++ ME +
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVI 122
Query: 304 DDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ T V+A ++L II+RD+KP N+LL SG +KL DFG + +L+
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 31/106 (29%), Positives = 50/106 (47%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
Q I+ E + + ++ + + +++ME CLG + K +
Sbjct: 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
T ++ YLHS N+I+RD+K N+LLS G VKL DFG A +
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYK----TFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
++Q E E++ IV+ Y T K KK + ++ E G L T L+
Sbjct: 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK 127
Query: 305 DATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356
R + +++ +LH+R II+RDLK +N+ ++ +G VK+ D G A
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
++ E + M + + IV Y +F K L+++M+ GG + I++ + +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 311 ----YTACVV----EAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A ++ E +YLH I+RD+K N+LL G V++ DFG + L
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 28/90 (31%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 268 IVKLYK--TFKDKKYLYMLMESCLGG--ELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
+++L ++K+ +YM+ME C+ G E+ + + F Y +++ +YLH
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
S+ I+++D+KP NLLL+T G +K+ G A
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >1wgp_A Probable cyclic nucleotide-gated ION channel 6; cyclic nucleotide monophosphate, CNMP, CNMP-binding, structural genomics; NMR {Arabidopsis thaliana} SCOP: b.82.3.2 Length = 137 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 4e-18
Identities = 16/99 (16%), Positives = 33/99 (33%), Gaps = 11/99 (11%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL--- 87
+ E Y++R+G + I +G+++ + L +GDF G++ L
Sbjct: 31 PCLFTEKSYLVREGDPVNEMLFIIRGRLESVTTDGGRSGFYNRSLLKEGDFCGDELLTWA 90
Query: 88 ------QGDDLRTANIVAADPEGVSCLVIDQETFNQLIS 120
T + A V + + + S
Sbjct: 91 LDPKSGSNLPSSTRTVKALTE--VEAFALIADELKFVAS 127
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 2/110 (1%)
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFDDATT 308
+ E + N IV TF L+++ G ++ ++
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358
+ V++A DY+H ++R +K ++L+S G V L +I
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
|
| >2z69_A DNR protein; beta barrel, dimerization helix, transcription regulator; 2.10A {Pseudomonas aeruginosa} Length = 154 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-18
Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 5/117 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDL 92
+G Y+ RQG F+ + G VK+ P +EK + + + F E +
Sbjct: 40 LDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPEG-QEKILEVTNERNTFAEAMMFMDTPN 98
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRL 148
A A P + + + + + + + S R + +E +L L
Sbjct: 99 YVATAQAVVP--SQLFRFSNKAYLRQLQDNTPLALALLAKLSTRLHQRIDEIETLSL 153
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 2/93 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
+V L + F+ K+ L+++ E + L + + T ++A ++ H N
Sbjct: 64 LVNLLEVFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
I+RD+KPEN+L++ +KL DFGFA+ L GP
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 25/145 (17%), Positives = 52/145 (35%), Gaps = 31/145 (21%)
Query: 248 RQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL----RDKGN 302
+Q+ + E +V+ + + + ++ + E C GG L + R
Sbjct: 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG------------------- 343
F +A + V Y+HS ++++ D+KP N+ +S +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 344 YVKLVDFGFAKKL------IG-PRY 361
K+ D G ++ G R+
Sbjct: 172 MFKIGDLGHVTRISSPQVEEGDSRF 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
+V L + K KK Y++ E + + L N D + Y ++ + HS N
Sbjct: 86 LVNLLEVCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
II+RD+KPEN+L+S SG VKL DFGFA+ L P
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
|
| >3d0s_A Transcriptional regulatory protein; CAMP receptor protein (CRP), dimer, inactive(APO, unliganded allostery, DNA binding, cyclic AMP; 2.00A {Mycobacterium tuberculosis} PDB: 3i54_A* 3i59_A* 3mzh_A* 3h3u_A* 3r6s_A* Length = 227 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 19/178 (10%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ G + +G GD +II GKVK+ + P+ E + + D FGE ++ R
Sbjct: 34 FPRGHTVFAEGEPGDRLYIIISGKVKIGRRAPDG-RENLLTIMGPSDMFGELSIFDPGPR 92
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
T++ V + +D++ I+ EI + + + R RR N L +D+
Sbjct: 93 TSSATTITE--VRAVSMDRDALRSWIADRPEISEQLLRVLARRLRRTNNNLADLIFTDVP 150
Query: 152 -RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
RV L ++L Q G +Q +++ A +V A E V+
Sbjct: 151 GRVAKQL-------LQLAQRFGTQEGGALRVTHDLTQ----EEI--AQLVGASRETVN 195
|
| >4ev0_A Transcription regulator, CRP family; CAMP binding, winged helix-turn-helix motif, DNA binding, transcription activator; HET: CMP; 2.40A {Thermus thermophilus} Length = 216 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-17
Identities = 32/127 (25%), Positives = 55/127 (43%), Gaps = 6/127 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
Y +G I QG G ++++ GKV++ +E+ + L G+ FGE +L + R
Sbjct: 27 YPQGKPIFYQGDLGQALYLVASGKVRLFRTHLGG-QERTLALLGPGELFGEMSLLDEGER 85
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
+A+ VA + L + +E + LI L + + R R + E L +
Sbjct: 86 SASAVAVED--TELLALFREDYLALIRRLPLVAHNLAALLARRLREADLELDLLSFEEAR 143
Query: 152 -RVITTL 157
RV L
Sbjct: 144 NRVAYAL 150
|
| >2bgc_A PRFA; bacterial infection, human pathogen, transcriptional regulat transcription; HET: PR3; 2.3A {Listeria monocytogenes} SCOP: a.4.5.4 b.82.3.3 PDB: 2beo_A* 1omi_A Length = 238 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 13/127 (10%), Positives = 34/127 (26%), Gaps = 4/127 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ + + I Q + + G K+T N ++ + +
Sbjct: 23 FHKKELIFNQWDPQEYCIFLYDGITKLTSISENG-TIMNLQYYKGAFVIMSGFIDTETSV 81
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
+ E + VI +L+S ++ +F ++
Sbjct: 82 GYYNLEVISEQATAYVIKINELKELLSKNLTHFFYVFQTLQKQVSYSLAKFNDFSINGKL 141
Query: 152 -RVITTL 157
+ + L
Sbjct: 142 GSICSQL 148
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 13/124 (10%)
Query: 249 QQQHIMSEKEIMGE-ANCDFIVKLY-------KTFKDKKYLYMLMESCLGGELWTIL--- 297
+ + I+ E M + + IV+ + + ++L+ G+L L
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+G T A ++H + II+RDLK ENLLLS G +KL DFG A
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 356 LIGP 359
+
Sbjct: 188 ISHY 191
|
| >3la7_A Global nitrogen regulator; activator, DNA-binding, transcription, transcription regulation; HET: BOG; 1.90A {Anabaena} PDB: 3la2_A* 3la3_A* 2xko_A* 2xgx_A* 2xhk_A* 2xkp_A* Length = 243 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 34/180 (18%), Positives = 62/180 (34%), Gaps = 21/180 (11%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL- 92
++ I G + + + KG VK++ EE + L + FG +L +
Sbjct: 48 FERNKTIFFPGDPAERVYFLLKGAVKLSRVYEAG-EEITVALLRENSVFGVLSLLTGNKS 106
Query: 93 -RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSD 150
R + VA P V L E Q + E+ + S R + +L D
Sbjct: 107 DRFYHAVAFTP--VELLSAPIEQVEQALKENPELSMLMLRGLSSRILQTEMMIETLAHRD 164
Query: 151 L--RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
+ R+++ L + L + G P +K S + A + + V+
Sbjct: 165 MGSRLVSFL-------LILCRDFGVPCADGITIDLKLSH----QAI--AEAIGSTRVTVT 211
|
| >3kcc_A Catabolite gene activator; helix-turn-helix, CAMP, CAMP-binding, DNA-binding nucleotide-binding, transcription, transcription regulation; HET: CMP; 1.66A {Escherichia coli} Length = 260 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 7/128 (5%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDL 92
Y +I QG + +T + I KG V V +K +E + L +GDF GE L +
Sbjct: 74 YPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEG-KEMILSYLNQGDFIGELGLFEEGQE 132
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL 151
R+A + A I + F QLI +I + + + R + +E+ +L +
Sbjct: 133 RSAWVRAKTA--CEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLLV 190
Query: 152 --RVITTL 157
R+ TL
Sbjct: 191 TGRIAQTL 198
|
| >1zyb_A Transcription regulator, CRP family; NP_813211.1, structural genomics, joint center for structura genomics, JCSG; 2.15A {Bacteroides thetaiotaomicron} SCOP: a.4.5.4 b.82.3.2 Length = 232 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 30/179 (16%), Positives = 57/179 (31%), Gaps = 26/179 (14%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+K G+ II+ G + KG++ + + I + ++L G +
Sbjct: 48 HKAGETIIKSGNPCTQLCFLLKGEISIVTNAKEN-IYTVIEQIEAPYLIEPQSLFGMNTN 106
Query: 94 -TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL 151
++ VA V + I + + D R Y++ S R + L DL
Sbjct: 107 YASSYVAHTE--VHTVCISKAFVLSDLFRYDIFRLNYMNIVSNRAQNLYSRLWDEPTLDL 164
Query: 152 --RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
++I + P K + +DDL A + +S
Sbjct: 165 KSKIIRF----------FLSHCEKPQGEKTFK-------VKMDDL--ARCLDDTRLNIS 204
|
| >3ryp_A Catabolite gene activator; CAMP receptor protein (CRP), allostery, DNA binding cyclic A transcription regulator; HET: CMP; 1.60A {Escherichia coli} PDB: 2cgp_A* 3hif_A 1g6n_A* 3ryr_A* 1i5z_A* 1j59_A* 1lb2_A* 1run_A* 1zrc_A* 1zrd_A* 1zre_A* 1zrf_A* 2gzw_A* 2wc2_A 3iyd_G* 3n4m_A* 3qop_A* 3rdi_A* 3rou_A* 3rpq_A* ... Length = 210 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 7/128 (5%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDL 92
Y +I QG + +T + I KG V V +K +E + L +GDF GE L +
Sbjct: 24 YPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEG-KEMILSYLNQGDFIGELGLFEEGQE 82
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL 151
R+A + A I + F QLI +I + + + R + +E+ +L D+
Sbjct: 83 RSAWVRAKTA--CEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDV 140
Query: 152 --RVITTL 157
R+ TL
Sbjct: 141 TGRIAQTL 148
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 28/121 (23%), Positives = 56/121 (46%), Gaps = 9/121 (7%)
Query: 245 VETRQQQHIMSEKEIMGEA-NCDFIVKLYKTF------KDKKYLYMLMESCLGGELWTIL 297
V +++ I E ++ + + I Y F L+++ME C G + ++
Sbjct: 59 VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 298 R--DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ + + ++ +LH +I+RD+K +N+LL+ + VKLVDFG + +
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 356 L 356
L
Sbjct: 179 L 179
|
| >3dkw_A DNR protein; CRP-FNR, HTH, beta barrel, dimerization helix, homodimer, transcription regulator; 3.60A {Pseudomonas aeruginosa} Length = 227 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 31/179 (17%), Positives = 60/179 (33%), Gaps = 23/179 (12%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDL 92
+G Y+ RQG F+ + G VK+ P +EK + + + F E +
Sbjct: 37 LDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPEG-QEKILEVTNERNTFAEAMMFMDTPN 95
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL 151
A A P + + + + + + + S R + +E +L L +
Sbjct: 96 YVATAQAVVP--SQLFRFSNKAYLRQLQDNTPLALALLAKLSTRLHQRIDEIETLSLKNA 153
Query: 152 --RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
RV+ L + L A + + + + A ++ PE S
Sbjct: 154 THRVVRYL-------LTLAAHAPGENCRVEIP-------VAKQLV--AGHLSIQPETFS 196
|
| >3e6c_C CPRK, cyclic nucleotide-binding protein; CPRK, halorespiration; HET: DNA 3C4; 1.80A {Desulfitobacterium hafniense} SCOP: a.4.5.4 b.82.3.2 PDB: 3e6b_A* 3e5u_C* 3e6d_A 3e5x_A* 3e5q_A 2h6b_A* 2h6c_A Length = 250 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 22/178 (12%), Positives = 51/178 (28%), Gaps = 22/178 (12%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ +G +I G + + +GK+K+ + + EK + G+ G
Sbjct: 37 FAKGSAVIMPGEEITSMIFLVEGKIKLDIIFEDG-SEKLLYYAGGNSLIGKLYPTG---N 92
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
A +P +++ + + +++ + + + + +
Sbjct: 93 NIYATAMEP--TRTCWFSEKSLRTVFRTDEDMIFEIFKNYLTKVAYYARQVAEMNTYNPT 150
Query: 152 -RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
R++ EL G M SQ + I VS
Sbjct: 151 IRILRLF-------YELCSSQGKRVGDTYEITMPLSQ----KSI--GEITGVHHVTVS 195
|
| >3fx3_A Cyclic nucleotide-binding protein; helix_TURN_helix, CAMP regulatory protein, structural genomi 2, protein structure initiative; 2.20A {Ruegeria pomeroyi} PDB: 3h3z_A* Length = 237 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 33/178 (18%), Positives = 53/178 (29%), Gaps = 23/178 (12%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
Y G+ + Q + ++ G VK+ P E + +G+ FGE +
Sbjct: 39 YDRGETLFLQEEKAQAIHVVIDGWVKLFRMTPTG-SEAVVSVFTRGESFGEAVALRNTPY 97
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
+ A P + I F L+ EI + T L + L+
Sbjct: 98 PVSAEAVTP--CEVMHIPSPVFVSLMRRDPEICISILATTFGHLHSLVAQLEQLKAQTGA 155
Query: 152 -RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
RV L +EL L K + A + PE +S
Sbjct: 156 QRVAEFL-------LELCDCDTGACE-VTLP-YDKMLI--------AGRLGMKPESLS 196
|
| >3e97_A Transcriptional regulator, CRP/FNR family; YP_604437.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE; 1.86A {Deinococcus geothermalis dsm 11300} Length = 231 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-16
Identities = 23/126 (18%), Positives = 54/126 (42%), Gaps = 5/126 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
++ + ++ Q A G+ +++ G V+V+ E+ + +Y GE A+ R
Sbjct: 34 FQPDELVVEQDAEGEALHLVTTGVVRVSRVSLGG-RERVLGDIYAPGVVGETAVLAHQER 92
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRL-SDL 151
+A++ A P V L++ +E F ++ + + + R LN+E + ++
Sbjct: 93 SASVRALTP--VRTLMLHREHFELILRRHPRVLWNLAEMLARRVTFLNDELIAFGQNTEA 150
Query: 152 RVITTL 157
+
Sbjct: 151 ALTHVF 156
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 24/87 (27%), Positives = 45/87 (51%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
IV + ++ Y++ME G L + G T +T +++ + H I
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAK 354
++RD+KP+N+L+ ++ +K+ DFG AK
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >2gau_A Transcriptional regulator, CRP/FNR family; structural genomics, porphyromona gingivalis, PSI, protein structure initiative; 1.90A {Porphyromonas gingivalis} SCOP: a.4.5.4 b.82.3.2 Length = 232 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 20/127 (15%), Positives = 45/127 (35%), Gaps = 6/127 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
K+ + +G + F + +GK+K+ + R + G FFG + ++
Sbjct: 38 CKKASTVFSEGDIPNNLFYLYEGKIKILREGVYG-RFHISRIVKPGQFFGMRPYFAEETC 96
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
++ +A + L I E L+ ++ ++ +L +
Sbjct: 97 SSTAIAVEN--SKVLAIPVEAIEALLKGNTSFCRYFLKALAKELGYAERRTVTLTQKHVR 154
Query: 152 -RVITTL 157
R+ TL
Sbjct: 155 GRLAETL 161
|
| >2oz6_A Virulence factor regulator; winged helix, helix-turn-helix, transcription factor, CAMP-B proteins, CAMP receptor protein; HET: CMP; 2.80A {Pseudomonas aeruginosa} SCOP: a.4.5.4 b.82.3.2 Length = 207 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 37/131 (28%), Positives = 52/131 (39%), Gaps = 10/131 (7%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL----QG 89
Y II G R +T F I KG V + ++ + E I L GDFFGE L
Sbjct: 18 YTAKSTIIYAGDRCETLFFIIKGSVTILIEDDDG-REMIIGYLNSGDFFGELGLFEKEGS 76
Query: 90 DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRL 148
+ R+A + A I F +L EI + ++R R+ + L
Sbjct: 77 EQERSAWVRAKVE--CEVAEISYAKFRELSQQDSEILYTLGSQMADRLRKTTRKVGDLAF 134
Query: 149 SDL--RVITTL 157
D+ RV TL
Sbjct: 135 LDVTGRVARTL 145
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATTRFYTACVVEAFDYLHSRN 326
IVKLY KK L ++ E L +L +L +G + T + + ++ Y H R
Sbjct: 62 IVKLYDVIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++ G +K+ DFG A+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
IV L ++ L ++ E + +L +L + D+ + Y ++ + H
Sbjct: 81 IVSLIDVIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
I++RDLKP+NLL+++ G +KL DFG A+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1o5l_A Transcriptional regulator, CRP family; TM1171, structural GE JCSG, PSI, protein structure initiative, joint center for S genomics; 2.30A {Thermotoga maritima} SCOP: b.82.3.2 Length = 213 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-15
Identities = 27/183 (14%), Positives = 63/183 (34%), Gaps = 35/183 (19%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL-QGDDL 92
+++G+ + Q + I+ +G +K N + I + + +
Sbjct: 27 FRKGEIVKHQDDPIEDVLILLEGTLKTEHVSENG-KTLEIDEIKPVQIIASGFIFSSEPR 85
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL 151
N+VA + L I +E F L+ E+ ++ + SE R ++E+ L L
Sbjct: 86 FPVNVVAGEN--SKILSIPKEVFLDLLMKDRELLLFFLKDVSEHFRVVSEKLFFLTTKTL 143
Query: 152 --RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLD----DLRTANIVAADPE 205
+++ L ++ M + + + L +L + +
Sbjct: 144 REKLMNFL----------------------VRHMNEKRELTLPVTLEEL--SRLFGCARP 179
Query: 206 GVS 208
+S
Sbjct: 180 ALS 182
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 268 IVKLY-----KTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYL 322
IV+++ Y++ME G L K +A Y ++ A YL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYL 198
Query: 323 HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
HS ++Y DLKPEN++L+ +KL+D G ++
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
IV L+ +K L ++ E L +L L D GN + + + ++ Y H +
Sbjct: 62 IVTLHDIIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++ G +KL DFG A+
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 30/118 (25%), Positives = 51/118 (43%), Gaps = 1/118 (0%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
+ Q+ + E ++M ++K K L + E GG L I++ +
Sbjct: 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 306 ATTRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ R A + YLHS NII+RDL N L+ + V + DFG A+ ++ +
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 26/87 (29%), Positives = 41/87 (47%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+V ++ + LY+ M G +L +LR +G + A D H+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAK 354
+RD+KPEN+L+S + LVDFG A
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 6e-15
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
IV+L+ K L ++ E +L D + + +++ + HSRN
Sbjct: 63 IVRLHDVLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++ +G +KL +FG A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRN 326
I+ L F K + ++ + + +L I++D + + Y ++ +YLH
Sbjct: 74 IIGLLDAFGHKSNISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
I++RDLKP NLLL +G +KL DFG AK
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 7e-15
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
IVKL + LY++ E L +L + + Y +++ + HS
Sbjct: 64 IVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+NLL++T G +KL DFG A+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 2/88 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC-VVEAFDYLHSRN 326
+V +L ++ C G L++++RD D A +V+ YLH++
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 327 IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
I+++DLK +N+ +G V + DFG
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFS 177
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
I++L L+++ E +L + + + + ++ ++ HSR
Sbjct: 95 IIELKSVIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 328 IYRDLKPENLLLSTS-----GYVKLVDFGFAK 354
++RDLKP+NLLLS S +K+ DFG A+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2fmy_A COOA, carbon monoxide oxidation system transcription RE COOA-1; DNA transcription regulator, DNA binding protein; HET: HEM; 2.20A {Carboxydothermus hydrogenoformans} PDB: 2hkx_A* Length = 220 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 27/180 (15%), Positives = 54/180 (30%), Gaps = 31/180 (17%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTE--EKYIRTLYKGDFFGEKALQGDD 91
Y + + + F++ G+V+V + + E E + L GD F
Sbjct: 32 YSKKAILYTPNTERNLVFLVKSGRVRVYL----AYEDKEFTLAILEAGDIFCT------- 80
Query: 92 LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSD 150
A I A + + L D F ++ V + + L D
Sbjct: 81 HTRAFIQAMED--TTILYTDIRNFQNIVVEFPAFSLNMVKVLGDLLKNSLTIINGLVFKD 138
Query: 151 L--RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
R+ L V+ G ++ + +++ A ++ + VS
Sbjct: 139 ARLRLAEFL-------VQAAMDTGLKVPQGIKLELGLNT----EEI--ALMLGTTRQTVS 185
|
| >4ava_A Lysine acetyltransferase; allosteric regulation, domain coupling; HET: ACO; 1.70A {Mycobacterium tuberculosis} PDB: 4avb_A* 4avc_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 4/97 (4%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81
++++ G ++RQG +F +IS G +V+ + I G
Sbjct: 29 LVSLAASVQPLRAAAGQVLLRQGEPAVSFLLISSGSAEVSHVGDD--GVAIIARALPGMI 86
Query: 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQL 118
GE AL D R+A + +P ++ + F +
Sbjct: 87 VGEIALLRDSPRSATVTTIEP--LTGWTGGRGAFATM 121
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 281 LYMLMESCLGGELWTILRDKGNFDDATTRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLL 339
L ++ + C G L+ L + A DYLH+++II+RDLK N+ L
Sbjct: 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153
Query: 340 STSGYVKLVDFGFAK 354
VK+ DFG A
Sbjct: 154 HEDNTVKIGDFGLAT 168
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 25/91 (27%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 268 IVKLYKTFKDKKYLYMLMESC---LGG--ELWTILRDKGNFDDATTRFYTACVVEAFDYL 322
IV+LY + L ++ E L + T+ + +++ +++ +
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 323 HSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
H I++RDLKP+NLL++ G +KL DFG A
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 9/121 (7%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
QI +++ + E + N IVKLY + + ++ME GG L+ +L
Sbjct: 38 QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEP 95
Query: 303 FD--DATTRFYTA-CVVEAFDYLHSRN---IIYRDLKPENLLLSTSGYV-KLVDFGFAKK 355
A + YLHS +I+RDLKP NLLL G V K+ DFG A
Sbjct: 96 LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
Query: 356 L 356
+
Sbjct: 156 I 156
|
| >1ft9_A Carbon monoxide oxidation system transcription regulator; heme sensor, catabolite gene activator protein; HET: HEM; 2.60A {Rhodospirillum rubrum} SCOP: a.4.5.4 b.82.3.1 Length = 222 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 21/178 (11%), Positives = 54/178 (30%), Gaps = 27/178 (15%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ +G + + F++ G+++V + E + L GD F
Sbjct: 28 HAKGSLVCTGEGDENGVFVVVDGRLRVYLVGEE--REISLFYLTSGDMFCM-------HS 78
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
+ A + D TF Q + + + + L D+
Sbjct: 79 GCLVEATER--TEVRFADIRTFEQKLQTCPSMAWGLIAILGRALTSCMRTIEDLMFHDIK 136
Query: 152 -RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
R+ ++ G ++ + + + +++ AN++ + + S
Sbjct: 137 QRIAGFF-------IDHANTTGRQTQGGVIVSVDFTV----EEI--ANLIGSSRQTTS 181
|
| >2ptm_A Hyperpolarization-activated (IH) channel; ION channel, cyclic nucleotide binding domain, C-linker, CAM SPHCN1, HCN; HET: CMP; 1.93A {Strongylocentrotus purpuratus} Length = 198 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-14
Identities = 24/118 (20%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 19 QGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYK 78
+ +V ++ DY+I++G GD F I +G V + ++ +L
Sbjct: 84 SNFVTRVVTLLEFEVFQPADYVIQEGTFGDRMFFIQQGIVDII-----MSDGVIATSLSD 138
Query: 79 GDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136
G +FGE L + R A++ + + + FNQ++ +R + R
Sbjct: 139 GSYFGEICLLTRERRVASVKCE--TYCTLFSLSVQHFNQVLDEFPAMRKTMEEIAVRR 194
|
| >3bpz_A Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2; CNBD, C-linker, pacemaker, HCN, HCN2, CAP, PKA, CAMP, ION channel; HET: CMP; 1.65A {Mus musculus} PDB: 3ffq_A 1q3e_A* 1q43_A* 1q5o_A* 3u10_A* 2q0a_A* 3etq_A* 3u11_A* 3otf_A* 3u0z_A* Length = 202 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-14
Identities = 28/113 (24%), Positives = 47/113 (41%), Gaps = 9/113 (7%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
++ GDYIIR+G G + I G V V T+ L G +FGE L
Sbjct: 97 FEVFQPGDYIIREGTIGKKMYFIQHGVVSVL------TKGNKEMKLSDGSYFGEICLLTR 150
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEE 142
RTA++ A + + FN+++ +R + +R R+ ++
Sbjct: 151 GRRTASVRAD--TYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKK 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 24/73 (32%), Positives = 40/73 (54%)
Query: 282 YMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
Y++ME G L I+ +G A +A ++ H II+RD+KP N+++S
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 342 SGYVKLVDFGFAK 354
+ VK++DFG A+
Sbjct: 152 TNAVKVMDFGIAR 164
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD--DATTRFYTA-CVVEAFDYLHS 324
IV L ++ E G L+ +L G + D R A V + +YLH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 325 RN--IIYRDLKPENLLLSTSGYVKLVDFGFAK 354
RN I++R+LK NLL+ VK+ DFG ++
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
|
| >3iwz_A CAP-like, catabolite activation-like protein; XCC, pathogenicity, CRP, CLP, C-DI-GMP receptor, quorum SENS binding, transcription; 2.30A {Xanthomonas campestris PV} Length = 230 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-14
Identities = 26/133 (19%), Positives = 44/133 (33%), Gaps = 12/133 (9%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD-DL 92
Y + R G T + + G V + ++ + E + G+F GE L + D
Sbjct: 39 YPTRTDVFRPGDPAGTLYYVISGSVSIIAEEDDD-RELVLGYFGSGEFVGEMGLFIESDT 97
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLD-----EIRTKYVDETSER-RRLNEEFRSL 146
R + I E QL + I + S+R + L
Sbjct: 98 REVILRTRTQ--CELAEISYERLQQLFQTSLSPDAPRILYAIGVQLSKRLLDTTRKASRL 155
Query: 147 RLSDL--RVITTL 157
D+ R++ TL
Sbjct: 156 AFLDVTDRIVRTL 168
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+ E EI+ D IVK ++ L ++ME G L L+ K D
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YT+ + + +YL ++ I+RDL N+L+ VK+ DFG K L
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 12/113 (10%)
Query: 256 EKEIMGEANCDFIVKLYKTF------KDKKYLYMLMESCLGGELWTILRD----KGNFDD 305
E +IM +V L F KD+ +L +++E + ++ R K
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPM 140
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-STSGYVKLVDFGFAKKLI 357
+ Y ++ + Y+HS I +RD+KP+NLLL SG +KL+DFG AK LI
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+ E EI+ D IVK ++ L ++ME G L L+ K D
Sbjct: 85 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YT+ + + +YL ++ I+RDL N+L+ VK+ DFG K L
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 255 SEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC 314
E IM N IVKLY + M+ME G+L+ L DK + + +
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 315 -VVEAFDYLHSRN--IIYRDLKPENLLLSTSGY-----VKLVDFGFAK 354
+ +Y+ ++N I++RDL+ N+ L + K+ DFG ++
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
|
| >4f8a_A Potassium voltage-gated channel subfamily H membe; probable regulatory domain of potassium channel, membrane PR transport protein; 2.20A {Mus musculus} Length = 160 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-13
Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 10/126 (7%)
Query: 19 QGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYK 78
G + + GD I G D+ + G ++V +++ + L K
Sbjct: 40 DGCLRALAMEFQTVHCAPGDLIYHAGESVDSLCFVVSGSLEVI------QDDEVVAILGK 93
Query: 79 GDFFGEKALQGDDL--RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136
GD FG+ + L AN+ A VI ++ +++ +
Sbjct: 94 GDVFGDVFWKEATLAQSCANVRALTY--CDLHVIKRDALQKVLEFYTAFSHSFSRNLILT 151
Query: 137 RRLNEE 142
L +
Sbjct: 152 YNLRKR 157
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 268 IVKLY-----KTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFD 320
+V+L + + ++ E + +L T L T + + D
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LH+ I++RDLKPEN+L+++ G VKL DFG A+
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 256 EKEIMGEANCDFIVKLYKTF------KDKKYLYMLMESCLGGELWTILRD----KGNFDD 305
E +IM + + IV+L F KD+ YL ++++ + ++ + R K
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPV 155
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-STSGYVKLVDFGFAKKLI 357
+ Y + + Y+HS I +RD+KP+NLLL + +KL DFG AK+L+
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-13
Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 268 IVKLY-----KTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFD 320
+V+L+ + L ++ E + +L T L T + ++ D
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LHS +++RDLKP+N+L+++SG +KL DFG A+
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 3/113 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRD-KGNF 303
QQ+ E +I+ + DFIVK ++ L ++ME G L L+ +
Sbjct: 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL 124
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
D + Y++ + + +YL SR ++RDL N+L+ + +VK+ DFG AK L
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
|
| >3dv8_A Transcriptional regulator, CRP/FNR family; cyclic nucleotide-binding domain, structural genomics, joint for structural genomics; 2.55A {Eubacterium rectale atcc 33656} Length = 220 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-13
Identities = 16/129 (12%), Positives = 36/129 (27%), Gaps = 8/129 (6%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGD--FFGEKALQGDD 91
K+G I ++ G+++ + E + L+ D +
Sbjct: 31 VKKGTIIHNGNMDCTGLLLVKSGQLRTYILSDEG-REITLYRLFDMDMCLLSASCIMRSI 89
Query: 92 LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSD 150
I A +I E + ++ + + + R + +
Sbjct: 90 QFEVTIEAEKD--TDLWIIPAEIYKGIMKDSAPVANYTNELMATRFSDVMWLIEQIMWKS 147
Query: 151 L--RVITTL 157
L RV + L
Sbjct: 148 LDKRVASFL 156
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 3/113 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRD-KGNF 303
+ E EI+ + IVK T + ++ME G L L K
Sbjct: 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ Y + + DYL SR ++RDL N+L+ + VK+ DFG K +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
|
| >3b02_A Transcriptional regulator, CRP family; structural genomics, riken structural genomics/proteomics in RSGI; 1.92A {Thermus thermophilus} PDB: 2zdb_A Length = 195 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-12
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ + I +G T + + +G V+V P+ +R + GD+FGE+AL+G
Sbjct: 4 FARKETIYLRGEEARTLYRLEEGLVRVVELLPDG-RLITLRHVLPGDYFGEEALEGKA-Y 61
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSDL- 151
A ++ + E + + + RR+ L+ +L
Sbjct: 62 RYTAEAMTE--AVVQGLEPRAMDH------EALHRVARNLARQMRRVQAYEAHLQTGELR 113
Query: 152 -RVITTL 157
R+ L
Sbjct: 114 ARIARYL 120
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 275 FKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKP 334
FK + Y +M+ME LG +L I G F +T +++ +Y+H ++ D+K
Sbjct: 121 FKGRSYRFMVME-RLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA 179
Query: 335 ENLLLSTSGY--VKLVDFGFAKKLIGPR 360
NLLL V L D+G + +
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >3ukn_A Novel protein similar to vertebrate potassium VOL channel, subfamily H (EAG-related)...; KCNH, ELK, ERG, CNBD, CNBHD, C-linker, ION channel; 2.20A {Danio rerio} PDB: 3ukt_B 3ukv_B Length = 212 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 24/124 (19%), Positives = 47/124 (37%), Gaps = 10/124 (8%)
Query: 19 QGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYK 78
+G + ++ +F G+++IRQG + + G ++V + + L K
Sbjct: 88 RGCLRSLSLIIKTSFCAPGEFLIRQGDALQAIYFVCSGSMEV------LKDNTVLAILGK 141
Query: 79 GDFFGEKALQGDDL--RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136
GD G +L + + AN+ A I + +++ E K+V E
Sbjct: 142 GDLIGSDSLTKEQVIKTNANVKAL--TYCDLQYISLKGLREVLRLYPEYAQKFVSEIQHD 199
Query: 137 RRLN 140
N
Sbjct: 200 LTYN 203
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 3/112 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
+ + E +I+ + I+K L ++ME G L L + +
Sbjct: 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIG 132
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
A + + E YLH+++ I+RDL N+LL VK+ DFG AK +
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 30/115 (26%), Positives = 52/115 (45%), Gaps = 1/115 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
+ + E I+ + + IV+L K+ +Y++ME GG+ T LR +G
Sbjct: 154 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK 213
Query: 308 TRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
T +YL S+ I+RDL N L++ +K+ DFG +++ Y
Sbjct: 214 TLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 24/89 (26%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 268 IVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
I+ L KD + ++ E + + + D RFY +++A DY HS
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM 149
Query: 326 NIIYRDLKPENLLL-STSGYVKLVDFGFA 353
I++RD+KP N+++ ++L+D+G A
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 11/79 (13%), Positives = 27/79 (34%), Gaps = 4/79 (5%)
Query: 280 YLYMLMESCLGGELWTILRDKGNFD-DATTRFYTAC-VVEAFDYLHSRN--IIYRDLKPE 335
+ ++ G L+ +L + NF D + A + +LH+ I L
Sbjct: 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR 142
Query: 336 NLLLSTSGYVKLVDFGFAK 354
++++ ++
Sbjct: 143 SVMIDEDMTARISMADVKF 161
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 16/101 (15%)
Query: 268 IVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGN---------FDDATTRFYTACVV 316
++ L K F + +++L + +LW I++ + ++
Sbjct: 80 VISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 317 EAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFA 353
+ YLH+ +++RDLKP N+L+ G VK+ D GFA
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-11
Identities = 51/355 (14%), Positives = 107/355 (30%), Gaps = 98/355 (27%)
Query: 25 IVYFSSQTFYKEGD-YIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYI---------R 74
I+ F D ++ + I+SK ++ + ++
Sbjct: 21 ILSVFEDAFVDNFDCKDVQDMPKS----ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE 76
Query: 75 TLYKGDFFGEKALQGD------DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 128
+ + F E L+ + ++T P ++ + I+Q ++L +
Sbjct: 77 EMVQ-KFVEE-VLRINYKFLMSPIKTEQR---QPSMMTRMYIEQR--DRLYNDNQVFAKY 129
Query: 129 YVDETSERRRLNEEFRS--LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKS 186
V R + + R L L + + GV G G+ + A D S+ ++
Sbjct: 130 NV----SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV---ALDVCLSYKVQCKMDF 182
Query: 187 QV--MNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQI 244
++ +NL + + V + + ID + I+ + +E RR
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKL-LYQIDPN-WTSRSDHSSNIKLRIHSIQAELRR---- 236
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
K K Y E+CL L +L +
Sbjct: 237 -----------------------------LLKSKPY-----ENCL---L--VLLN----- 252
Query: 305 DATTRFYTACVVEAFDYLHSRNIIY-RDLKPENLLLS-TSGYVKLVDF--GFAKK 355
A AF+ L + ++ R + + L + T+ ++ L
Sbjct: 253 -----VQNAKAWNAFN-LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
|
| >2zcw_A TTHA1359, transcriptional regulator, FNR/CRP family; stationary phase, DNA-binding, transcription regulation; 1.50A {Thermus thermophilus} Length = 202 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 29/129 (22%), Positives = 46/129 (35%), Gaps = 16/129 (12%)
Query: 34 YKEGDYIIRQGARG--DTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDD 91
+K GD I+ G G D + + +G V++ +R + G FFGE+AL G +
Sbjct: 10 FKAGDVILYPGVPGPRDRAYRVLEGLVRLEAVDEEG-NALTLRLVRPGGFFGEEALFGQE 68
Query: 92 LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSLRLSD 150
R AA V + + +L+ L S+ L
Sbjct: 69 -RIYFAEAATD--VRLEPLPENPDPELLKDL-------AQHLSQGLAEAYRRIERLATQR 118
Query: 151 L--RVITTL 157
L R+ L
Sbjct: 119 LKNRMAAAL 127
|
| >3beh_A MLL3241 protein; transmembrane protein, membrane protein; HET: LDA; 3.10A {Mesorhizobium loti} PDB: 2zd9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 40/141 (28%), Positives = 52/141 (36%), Gaps = 10/141 (7%)
Query: 2 SKNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVT 61
+N +L + V++ IV G I R G GD F + +G V V
Sbjct: 224 VRNWQLVAAVPLFQKLGPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVA 283
Query: 62 MKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISS 121
P L G FFGE AL + R+A + AA VS L + F L SS
Sbjct: 284 TPNPV--------ELGPGAFFGEMALISGEPRSATVSAATT--VSLLSLHSADFQMLCSS 333
Query: 122 LDEIRTKYVDETSERRRLNEE 142
EI + ERR
Sbjct: 334 SPEIAEIFRKTALERRGAAAS 354
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 18/115 (15%)
Query: 253 IMSEKEI--MGEANCDFIVKLY--------KTFKDKKYLYMLMESC---LGGELWTILRD 299
I + +EI + + +V L + K +Y++ + C L G +L +
Sbjct: 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG----LLSN 116
Query: 300 KG-NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
F + + ++ Y+H I++RD+K N+L++ G +KL DFG A
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 14/99 (14%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTAC-VVEAFDYLHSRN 326
I+ L + L ++ME GG L +L K A + +YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI--PPDILVNWAVQIARGMNYLHDEA 125
Query: 327 ---IIYRDLKPENLLLSTSGY--------VKLVDFGFAK 354
II+RDLK N+L+ +K+ DFG A+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 8/135 (5%)
Query: 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYM--- 283
I+ T+ + + + + + KYL +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHH----KSVIVNPSQNKYLNVIME 118
Query: 284 LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-STS 342
+ L L + +R + Y + A ++HS I +RD+KP+NLL+ S
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 343 GYVKLVDFGFAKKLI 357
+KL DFG AKKLI
Sbjct: 179 NTLKLCDFGSAKKLI 193
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 10/125 (8%)
Query: 245 VETRQQQH--IMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
+E + + + E + + D I ++Y KY M++E LG L +
Sbjct: 41 LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE-LLGPSLEDLFDLCD 99
Query: 302 -NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-----VKLVDFGFAKK 355
F T ++ +Y+HS+N+IYRD+KPEN L+ G + ++DF AK+
Sbjct: 100 RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
Query: 356 LIGPR 360
I P
Sbjct: 160 YIDPE 164
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 2/115 (1%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR--DKGNFDDA 306
+ + + E +M E +V+L + Y++ E G L LR ++
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 318
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
+ + A +YL +N I+R+L N L+ + VK+ DFG ++ + G Y
Sbjct: 319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 26/122 (21%), Positives = 49/122 (40%), Gaps = 7/122 (5%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-F 303
+ Q + A C I +Y ++ + ++++ LG L +L G F
Sbjct: 45 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID-LLGPSLEDLLDLCGRKF 103
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-----VKLVDFGFAKKLIG 358
T ++ +H ++++YRD+KP+N L+ + +VDFG K
Sbjct: 104 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
Query: 359 PR 360
P
Sbjct: 164 PV 165
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 25/115 (21%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307
+ + E ++M + + +V+LY ++ +Y++ E G L L+ G +
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 308 TRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
A + Y+ N ++RDL+ N+L+ + K+ DFG A+ + Y
Sbjct: 364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 5/102 (4%)
Query: 263 ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDY 321
I + + Y M+ME LG L + F T ++ +Y
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 322 LHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIGPR 360
+HS+N I+RD+KP+N L+ V ++DFG AKK R
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
++ + + F + ++ M E L L+ +++ F R + +++ D LH
Sbjct: 161 VIHMLENFTFRNHICMTFE-LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 326 NIIYRDLKPENLLLSTSGY--VKLVDFG 351
II+ DLKPEN+LL G +K++DFG
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 24/95 (25%), Positives = 38/95 (40%), Gaps = 16/95 (16%)
Query: 275 FKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACV-------VEAFDYLHSRNI 327
K Y +M+M+ G +L I RF V ++ +Y+H
Sbjct: 121 KNGKSYRFMIMDR-FGSDLQKIYEANAK------RFSRKTVLQLSLRILDILEYIHEHEY 173
Query: 328 IYRDLKPENLLLSTSGY--VKLVDFGFAKKLIGPR 360
++ D+K NLLL+ V LVD+G A +
Sbjct: 174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 3/111 (2%)
Query: 254 MSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTRF 310
++E +M + +V+L ++K LY++ E G L LR +G
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
++ V EA +YL N ++RDL N+L+S K+ DFG K+ +
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 272 YKTFKDKKYLYMLMESCLGGELWTILR--DKGNFDDATTRFYTACVVEAFDYLHSRNIIY 329
KY ++++ LG L + L K + + +++A ++LH ++
Sbjct: 124 GFGVHQDKYRFLVLP-SLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182
Query: 330 RDLKPENLLLSTSGY--VKLVDFGFAKK 355
++ EN+ + V L +GFA +
Sbjct: 183 GNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 25/114 (21%), Positives = 51/114 (44%), Gaps = 3/114 (2%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308
+ + E ++M + + +V+LY ++ +Y++ E G L L+ G +
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 309 RFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
A + Y+ N ++RDL+ N+L+ + K+ DFG A+ + Y
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
++ + E M + + IVKL + ++++ME C GEL + L+ K + D A
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLA 491
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ Y + A YL S+ ++RD+ N+L+S++ VKL DFG ++ +
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
++ + E M + + IVKL + ++++ME C GEL + L+ K + D A
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLA 116
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ Y + A YL S+ ++RD+ N+L+S++ VKL DFG ++ +
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 26/110 (23%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+ + I+ E +M + + +L + ++ + G L +R+ K N
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + +YL R +++RDL N+L+ T +VK+ DFG AK L
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 5/102 (4%)
Query: 263 ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDATTRFYTACVVEAFDY 321
I + + Y ++M+ LG L + T ++ ++
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 322 LHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIGPR 360
+HS++ ++RD+KP+N L+ + V ++DFG AKK
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
|
| >2byv_E RAP guanine nucleotide exchange factor 4; EPAC2, CAMP-GEF2, CAMP, cyclic nucleotide, regulation, auto-inhibition, CDC25 homology domain; 2.7A {Mus musculus} Length = 999 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 9e-10
Identities = 29/141 (20%), Positives = 57/141 (40%), Gaps = 10/141 (7%)
Query: 33 FYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEE-KYIRTLYKGDFFGEKALQGDD 91
++G + RQG G ++ + G + V + + +S ++ I TL G FGE ++ +
Sbjct: 69 NLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE-SILDNT 127
Query: 92 LRTANIVAADPEGVSC--LVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSLRLS 149
R A IV + L I+QE F L + + + + R+
Sbjct: 128 PRHATIVTRES----SELLRIEQEDFKALWEKYRQYMAGLLAPP--YGVMETGSNNDRIP 181
Query: 150 DLRVITTLGVGGFGRVELVQI 170
D + + + G++ + I
Sbjct: 182 DKENVPSEKILRAGKILRIAI 202
|
| >2byv_E RAP guanine nucleotide exchange factor 4; EPAC2, CAMP-GEF2, CAMP, cyclic nucleotide, regulation, auto-inhibition, CDC25 homology domain; 2.7A {Mus musculus} Length = 999 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 9e-08
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
++ K G + QG G +++II KG V V + + + TL++GD FG+ AL D
Sbjct: 363 ESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG-----KGVVCTLHEGDDFGKLALVND 417
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135
R A+IV + + L +D+E FN+++ + E T + E +
Sbjct: 418 APRAASIVLRE-DNCHFLRVDKEDFNRILRDV-EANTVRLKEHDQ 460
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 30/117 (25%), Positives = 55/117 (47%), Gaps = 3/117 (2%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR--DKGNFD 304
+ + ++E +M D +VKL+ K+ +Y++ E G L L+ +
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
++A + E ++ RN I+RDL+ N+L+S S K+ DFG A+ + Y
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 254 MSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTRF 310
++E +M + +V+L ++K LY++ E G L LR +G
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
++ V EA +YL N ++RDL N+L+S K+ DFG K
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 28/110 (25%), Positives = 51/110 (46%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+Q+ + E IMG+ + I++L K + ++ E G L LR+ G F
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 147
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL + N ++RDL N+L++++ K+ DFG ++ L
Sbjct: 148 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 1/109 (0%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
E + M + + +VK Y + +Y++ E G L LR G + +
Sbjct: 51 FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 314 C-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
V E +L S I+RDL N L+ VK+ DFG + ++ +Y
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
RQ++ +SE IMG+ + I++L + ++ E G L T LR G F
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V YL ++RDL N+L+ ++ K+ DFG ++ L
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 14/95 (14%)
Query: 268 IVKLY--------KTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEA 318
+VK+ + F + Y+ + + +S + + R + + ++
Sbjct: 114 VVKVLDIVIPKDVEKFDEL-YVVLEIADS----DFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 319 FDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
Y+HS I++RDLKP N L++ VK+ DFG A
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 23/111 (20%), Positives = 44/111 (39%), Gaps = 2/111 (1%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+ Q + +G + IV+L L ++ + G L +R +G
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + YL +++R+L N+LL + V++ DFG A L
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 272 YKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRD 331
+ F+D +Y++ME + L +++ D + ++ +LHS II+RD
Sbjct: 136 LEEFQD---VYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
Query: 332 LKPENLLLSTSGYVKLVDFGFAKKL 356
LKP N+++ + +K++DFG A+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTA 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 1/111 (0%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
+ + +++E +M + + +IV++ + + ++ME G L L+ + D
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKD 116
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V YL N ++RDL N+LL T Y K+ DFG +K L
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 26/110 (23%), Positives = 48/110 (43%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+Q++ + E IMG+ + I++L K + ++ E G L + LR F
Sbjct: 88 KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL ++RDL N+L++++ K+ DFG + L
Sbjct: 148 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 1/113 (0%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDATT 308
++ + E E+M + + +V+LY ++ + ++ E G L LR +G F T
Sbjct: 47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL 106
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
V E YL +I+RDL N L+ + +K+ DFG + ++ +Y
Sbjct: 107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 2/103 (1%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFDDATTRFY 311
+ E +M E +V+L + Y++ E G L LR+ + +
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ A +YL +N I+RDL N L+ + VK+ DFG ++
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 28/109 (25%), Positives = 54/109 (49%), Gaps = 1/109 (0%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
+ E ++M + + +V+LY ++ ++++ E G L LR+ +
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 314 C-VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
V EA +YL S+ ++RDL N L++ G VK+ DFG ++ ++ Y
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 23/111 (20%), Positives = 47/111 (42%), Gaps = 2/111 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+ ++E IM + + ++ L + + +++ G+L +R+ N
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ V + YL S+ ++RDL N +L VK+ DFG A+ +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 26/110 (23%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+ + I+ E +M + + +L + ++ + G L +R+ K N
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + + +YL R +++RDL N+L+ T +VK+ DFG AK L
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 2/112 (1%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304
+ + E M + +++LY + M+ E G L LR +G+F
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
T Y V E YL S+ I+RDL NLLL+T VK+ DFG + L
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 24/84 (28%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 272 YKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
+ F D YL M M++ +L I+ F + ++ +++ Y+HS +++R
Sbjct: 98 LRNFYDF-YLVMPFMQT----DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHR 150
Query: 331 DLKPENLLLSTSGYVKLVDFGFAK 354
DLKP NL ++ +K++DFG A+
Sbjct: 151 DLKPGNLAVNEDCELKILDFGLAR 174
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 13/103 (12%)
Query: 268 IVKLYKTF-------KDKKYLYM---LMESCLGGELWTILRDKGNFDDATTRFYTACVVE 317
IV+L F + YL + + L R + + + ++
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 318 AFDYLH--SRNIIYRDLKPENLLL-STSGYVKLVDFGFAKKLI 357
+ LH S N+ +RD+KP N+L+ G +KL DFG AKKL
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 22/111 (19%), Positives = 47/111 (42%), Gaps = 2/111 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+ ++E IM + + ++ L + + +++ G+L +R+ N
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ V + +L S+ ++RDL N +L VK+ DFG A+ +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 267 FIVKLYKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
+ KD Y+ LME+ +L+ +L+ + + ++ ++ Y+HS
Sbjct: 94 IRAPTIEQMKDV-YIVQDLMET----DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFA 353
N+++RDLKP NLLL+T+ +K+ DFG A
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 18/89 (20%), Positives = 37/89 (41%), Gaps = 7/89 (7%)
Query: 267 FIVKLYKTFKDKKYLYM-LMESCLGGELWTILR-DKGNFDDATTRFYTACVVEAFDYLHS 324
F+ YL LM + +L ++ + +++ ++ LH
Sbjct: 98 FVHFEEPAMHKL-YLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152
Query: 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+++RDL P N+LL+ + + + DF A
Sbjct: 153 AGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 25/111 (22%), Positives = 47/111 (42%), Gaps = 2/111 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305
+Q + + E +M N ++ L + ++L+ G+L +R + N
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ V +YL + ++RDL N +L S VK+ DFG A+ +
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 272 YKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
F D YL M M + +L +++ + + +F +++ Y+H+ II+R
Sbjct: 99 LDDFTDF-YLVMPFMGT----DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHR 152
Query: 331 DLKPENLLLSTSGYVKLVDFGFA 353
DLKP NL ++ +K++DFG A
Sbjct: 153 DLKPGNLAVNEDCELKILDFGLA 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 8e-09
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
++ MSE IM + IVKL +++ +++ME GEL L K +
Sbjct: 55 DNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVL 113
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
T Y+ + +A YL S N ++RD+ N+L+++ VKL DFG ++ +
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+ +M E +IM + + +IV+L + + L ++ME GG L L + +
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS 436
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V YL +N ++R+L N+LL Y K+ DFG +K L
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 22/88 (25%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 267 FIVKLYKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
I F + Y+ + + +S +L + + + + ++ +++H
Sbjct: 94 IIPDDLLKFDEL-YIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFA 353
II+RDLKP N LL+ VK+ DFG A
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 24/121 (19%), Positives = 45/121 (37%), Gaps = 12/121 (9%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLY------KTFKDKKYLYMLMESCLGGELWTILRDKG 301
+ + E M E + + KL + +++ G+L L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 302 NFDDATT------RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
++ + + +YL SRN I+RDL N +L+ V + DFG ++K
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 356 L 356
+
Sbjct: 187 I 187
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 272 YKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
+ F D YL LM + +L I++ + D +F ++ Y+HS +II+R
Sbjct: 103 LEEFNDV-YLVTHLMGA----DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 331 DLKPENLLLSTSGYVKLVDFGFA 353
DLKP NL ++ +K++DFG A
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLA 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 26/119 (21%), Positives = 51/119 (42%), Gaps = 10/119 (8%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
R++ ++E +M E NC +V+L + ++ME G+L + LR
Sbjct: 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 308 TRFYTACVVE----AFD------YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + A + YL++ ++RDL N +++ VK+ DFG + +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 10/120 (8%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
+ + + E I+ + N IV+ ++LME GG+L + LR+
Sbjct: 74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 307 TTRFYTACVVE-AFD------YLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKL 356
+ ++ A D YL + I+RD+ N LL+ G K+ DFG A+ +
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 272 YKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
+ F+D Y+ M LM++ L +++ D + ++ +LHS II+R
Sbjct: 99 LEEFQDV-YIVMELMDA----NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 331 DLKPENLLLSTSGYVKLVDFGFA 353
DLKP N+++ + +K++DFG A
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLA 174
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 27/133 (20%)
Query: 244 IVETRQQQHIMSEKEI--MGEANCDFIVKLY----KTFKDKKYLYMLMESCLGGELWTIL 297
I +R+++ E EI + I+ K L+++ + G L+ L
Sbjct: 72 IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131
Query: 298 RDKGNFDDATTRFYTACVVEAFD------YLHSR--------NIIYRDLKPENLLLSTSG 343
T + A +LH I +RDLK +N+L+ +G
Sbjct: 132 NRY------TVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 344 YVKLVDFGFAKKL 356
+ D G A +
Sbjct: 185 TCCIADLGLAVRH 197
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
IV L + F + +L ++ E L L+ +LR+ TR + + A +L +
Sbjct: 118 IVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 326 --NIIYRDLKPENLLLSTSGY--VKLVDFGFA 353
+II+ DLKPEN+LL +K+VDFG +
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 13/86 (15%), Positives = 25/86 (29%), Gaps = 2/86 (2%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+ ++ + ++ E GG L + + A + A D H +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRAGV 150
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFA 353
P + +S G V L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 10/120 (8%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
+ + + E I+ + N IV+ ++L+E GG+L + LR+
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 307 TTRFYTACVVE-AFD------YLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKL 356
+ ++ A D YL + I+RD+ N LL+ G K+ DFG A+ +
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 22/105 (20%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
V++ + F+ ++ ++ E LG + +++ G F R + ++ ++LHS
Sbjct: 79 CVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN 137
Query: 326 NIIYRDLKPENLLLSTSGY-------------------VKLVDFG 351
+ + DLKPEN+L S Y +K+VDFG
Sbjct: 138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >3cf6_E RAP guanine nucleotide exchange factor (GEF) 4; EPAC, rapgef4, CAMP, SP-camps, GEF, gunanine nucleotide exchange factor, G-protein, GTP-binding, nucleotide-binding; HET: SP1; 2.20A {Mus musculus} Length = 694 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90
++ K G + QG G +++II KG V V + + + TL++GD FG+ AL D
Sbjct: 58 ESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG-----KGVVCTLHEGDDFGKLALVND 112
Query: 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135
R A+IV + + L +D+E FN+++ ++ + + +
Sbjct: 113 APRAASIVLRE-DNCHFLRVDKEDFNRILRDVEANTVRLKEHDQD 156
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 16/125 (12%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
++ E + +V L + L M+ C G+L L + D
Sbjct: 54 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 308 TRFYTACVVEAFD----------------YLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
+ V A + YL S +++++DL N+L+ VK+ D G
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173
Query: 352 FAKKL 356
+++
Sbjct: 174 LFREV 178
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+ +M E +IM + + +IV+L + + L ++ME GG L L + +
Sbjct: 52 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS 110
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V YL +N ++RDL N+LL Y K+ DFG +K L
Sbjct: 111 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 16/33 (48%), Positives = 25/33 (75%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
YLHS +++RD+KP N+LL+ +VK+ DFG +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 23/132 (17%), Positives = 44/132 (33%), Gaps = 25/132 (18%)
Query: 244 IVETRQQQHIMSEKEIMGEANC--DFIVKLY----KTFKDKKYLYMLMESCLGGELWTIL 297
I +R ++ E E+ + I+ + L+++ G L+ L
Sbjct: 38 IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL 97
Query: 298 RDKGNFDDATTRFYTAC-----VVEAFDYLHSR--------NIIYRDLKPENLLLSTSGY 344
+ T + + +LH I +RDLK +N+L+ +G
Sbjct: 98 QLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151
Query: 345 VKLVDFGFAKKL 356
+ D G A
Sbjct: 152 CCIADLGLAVMH 163
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 22/105 (20%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
V + F ++ + E LG + L++ + R + A +LH
Sbjct: 84 CVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 326 NIIYRDLKPENLLLSTSGY-------------------VKLVDFG 351
+ + DLKPEN+L S + +++ DFG
Sbjct: 143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 8/84 (9%)
Query: 272 YKTFKDKKYLYM-LMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYR 330
Y+ ME+ +L +L +G + R + ++ Y+HS N+++R
Sbjct: 91 LTELNSV-YIVQEYMET----DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHR 144
Query: 331 DLKPENLLLSTSGY-VKLVDFGFA 353
DLKP NL ++T +K+ DFG A
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLA 168
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 17/33 (51%), Positives = 25/33 (75%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
LH N+I+RDLKP NLL++++ +K+ DFG A
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 25/121 (20%), Positives = 50/121 (41%), Gaps = 11/121 (9%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLY-----KTFKDKKYLYMLMESCLGGELWTILR--- 298
R+ + +SE M + + +++L + + +++ G+L T L
Sbjct: 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136
Query: 299 ---DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ T + + +YL +RN ++RDL N +L V + DFG +KK
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 356 L 356
+
Sbjct: 197 I 197
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 26/115 (22%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 256 EKEIMGEANC--DFIVKLY----KTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
E EI + I+ K LY++ + G L+ L+ D +
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSML 137
Query: 310 FYTACVVEAFDYLHSRN--------IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V +LH+ I +RDLK +N+L+ +G + D G A K
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
++ E E++ + IVK Y D L M+ E G+L LR G
Sbjct: 59 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 308 TRFYTACVVEAFD----------------YLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
YL S++ ++RDL N L+ + VK+ DFG
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 352 FAKKL 356
++ +
Sbjct: 179 MSRDV 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 7/112 (6%)
Query: 254 MSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRDKG--NFDDATTR 309
++E +M + +V+LY T ++ +Y++ E G L L+
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
A + E ++ RN I+RDL+ N+L+S + K+ DFG A+ + Y
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 26/125 (20%), Positives = 43/125 (34%), Gaps = 15/125 (12%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
+Q E E++ IV+ + + + L M+ E G+L LR G
Sbjct: 84 ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 307 TTRFYTACVVE---------AFD------YLHSRNIIYRDLKPENLLLSTSGYVKLVDFG 351
A YL + ++RDL N L+ VK+ DFG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 352 FAKKL 356
++ +
Sbjct: 204 MSRDI 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 9/119 (7%)
Query: 247 TRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306
+ +M + + +V Y ++ E G L T L+ N +
Sbjct: 53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 307 TTRFYTAC-VVEAFDYLHSRNIIYRDLKPENLLLSTSGY--------VKLVDFGFAKKL 356
+ A + A +L +I+ ++ +N+LL +KL D G + +
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 24/128 (18%)
Query: 254 MSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313
+SE ++ + N ++KLY L +++E G L LR+ +
Sbjct: 74 LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 314 CVVEAFD------------------------YLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
+ D YL +++RDL N+L++ +K+ D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 350 FGFAKKLI 357
FG ++ +
Sbjct: 194 FGLSRDVY 201
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 31/136 (22%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 244 IVETRQQQHIMSEKEIMGEA--NCDFIVKLY-----KTFKDKKYLYMLMESCLGGELWTI 296
+ +Q+ ++EK I D I + T + ++ME G L
Sbjct: 43 VFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY 102
Query: 297 LRDKGNFDDATTRFYTAC-VVEAFDYLHS---------RNIIYRDLKPENLLLSTSGYVK 346
L + D + A V YLH+ I +RDL N+L+ G
Sbjct: 103 LSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160
Query: 347 LVDFGFAKKLIGPRYS 362
+ DFG + +L G R
Sbjct: 161 ISDFGLSMRLTGNRLV 176
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 15/115 (13%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
MSE +IM + IV L + ++ E C G+L LR K + F
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 313 --------------ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353
+ V + +L S+N I+RD+ N+LL+ K+ DFG A
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 28/122 (22%), Positives = 45/122 (36%), Gaps = 19/122 (15%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
MSE +++ IV L ++ E C G+L LR K + +
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 313 ACVVEAF------------------DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ +L S+N I+RDL N+LL+ K+ DFG A+
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 355 KL 356
+
Sbjct: 194 DI 195
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 39/216 (18%), Positives = 75/216 (34%), Gaps = 66/216 (30%)
Query: 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLV 211
++ LG G F V L + D+ VA +V
Sbjct: 22 ILVRKLGWGHFSTVWLAK-----------------------DMVNNTHVAM------KIV 52
Query: 212 IDQETFNQLISSLDEIRT-KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK 270
+ + + ++ DEI+ + V++ + + I+K
Sbjct: 53 RGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM--------------------GANHILK 90
Query: 271 LYKTFK----DKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHS 324
L F + ++ M+ E LG L +++ + + + ++ DY+H
Sbjct: 91 LLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 149
Query: 325 R-NIIYRDLKPENLLLSTSGY------VKLVDFGFA 353
R II+ D+KPEN+L+ +K+ D G A
Sbjct: 150 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 28/111 (25%)
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVEAFDYLHSR 325
IVK + F ++ ++ E LG L+ I+ F + Y +++A +YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 326 NIIYRDLKPENLLLSTSGY-------------------------VKLVDFG 351
++ + DLKPEN+LL + +KL+DFG
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 28/133 (21%), Positives = 42/133 (31%), Gaps = 24/133 (18%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
Q E +M E + IVKL K + +L E G+L LR +
Sbjct: 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 308 TRFYTACVVEAFD------------------------YLHSRNIIYRDLKPENLLLSTSG 343
YL R ++RDL N L+ +
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211
Query: 344 YVKLVDFGFAKKL 356
VK+ DFG ++ +
Sbjct: 212 VVKIADFGLSRNI 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 46/234 (19%), Positives = 84/234 (35%), Gaps = 38/234 (16%)
Query: 149 SDLRVITTLGVGGFGRV---ELVQIAGDPSRS-FALKQMKK--SQVMNLDDLRTA----- 197
L++ LG G FG+V + I + A+K +K+ + + +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 198 -----NIVAA-----DPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVET 247
N+V P G ++++ F L + L R ++V +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT----------- 130
Query: 248 RQQQHIMSEKEIMGEANCDFIVKL-----YKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ K+ +G D +L ++ ++ S + E K
Sbjct: 131 -KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
Y+ V + ++L SR I+RDL N+LLS VK+ DFG A+ +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 34/121 (28%), Positives = 48/121 (39%), Gaps = 18/121 (14%)
Query: 254 MSEKEIMGEANC-DFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311
MSE +I+ +V L K L +++E C G L T LR K N
Sbjct: 78 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 312 TACVVEAF----------------DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
+ ++L SR I+RDL N+LLS VK+ DFG A+
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 356 L 356
+
Sbjct: 198 I 198
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 14/34 (41%), Positives = 22/34 (64%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+LH + I+RD+K N+LL + K+ DFG A+
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
+SE E+M I+ L LY+++E G L L+ + + +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 313 ----------------ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
V +YL S+ I+RDL N+L++ +K+ DFG A+ +
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 17/119 (14%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
+SE E+M I+ L LY+++E G L LR + +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 313 ACVVEAF----------------DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
E +YL S+ I+RDL N+L++ + +K+ DFG A+
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 17/34 (50%), Positives = 24/34 (70%)
Query: 321 YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
YLH+R II+RD+K N+LL + K+ DFG +K
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 17/120 (14%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
+SE E+M I+ L LY+++E G L LR + +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 313 ACVVEAFD----------------YLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
E YL S+ I+RDL N+L++ + +K+ DFG A+ +
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 15/46 (32%), Positives = 21/46 (45%), Gaps = 10/46 (21%)
Query: 321 YLHSR----------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
YLH I +RD+K +N+LL + + DFG A K
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 25/119 (21%), Positives = 42/119 (35%), Gaps = 17/119 (14%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
E E++ + I+ L + + YLY+ +E G L LR +
Sbjct: 73 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 313 ACVVEAF----------------DYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
DYL + I+RDL N+L+ + K+ DFG ++
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 24/128 (18%)
Query: 254 MSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312
MSE ++M + + IV L +Y++ E C G+L LR K Y
Sbjct: 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 313 ACVVEAF-----------------------DYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
++L ++ ++RDL N+L++ VK+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 350 FGFAKKLI 357
FG A+ ++
Sbjct: 216 FGLARDIM 223
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 8/84 (9%)
Query: 264 NCDFIVKLYKTFKDK----KYLYMLMESCLGGELWTILRDKGN--FDDATTRFYTACVVE 317
N + +V+L FK ++ M+ E LG L + + V++
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 318 AFDYLHSR-NIIYRDLKPENLLLS 340
DYLH++ II+ D+KPEN+LLS
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLS 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 32/209 (15%), Positives = 65/209 (31%), Gaps = 17/209 (8%)
Query: 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVS 208
L+ +G G FG V A+K + + DL + E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI---ADHTPVAIKIIA----IEGPDLVNGSHQKTFEEILP 72
Query: 209 CLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI 268
++I +E L+S RT+ + V+ ++ +
Sbjct: 73 EIIISKEL--SLLSGEVCNRTEGFIGL----NSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR-NI 327
+ D+ ++ + E G +L + + A + + + + +
Sbjct: 127 DRPDFFKDDQLFIVLEFEFG-GIDLEQMRTKLSSLATAKSILH--QLTASLAVAEASLRF 183
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+RDL N+LL + KL K
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 16/37 (43%), Positives = 20/37 (54%), Gaps = 3/37 (8%)
Query: 321 YLH---SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
YLH II+RD+K N+LL + DFG AK
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 362 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.93 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 99.92 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.91 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 3mdp_A | 142 | Cyclic nucleotide-binding domain (CNMP-BD) protei; | 99.91 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.91 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.9 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.9 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.9 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3idb_B | 161 | CAMP-dependent protein kinase type II-beta regulat | 99.88 | |
| 2pqq_A | 149 | Putative transcriptional regulator; APC7345, strep | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 3gyd_A | 187 | CNMP-BD protein, cyclic nucleotide-binding domain; | 99.87 | |
| 2z69_A | 154 | DNR protein; beta barrel, dimerization helix, tran | 99.87 | |
| 4f7z_A | 999 | RAP guanine nucleotide exchange factor 4; cyclic n | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.86 | |
| 4ev0_A | 216 | Transcription regulator, CRP family; CAMP binding, | 99.86 | |
| 3dn7_A | 194 | Cyclic nucleotide binding regulatory protein; stru | 99.86 | |
| 3e97_A | 231 | Transcriptional regulator, CRP/FNR family; YP_6044 | 99.86 | |
| 1zyb_A | 232 | Transcription regulator, CRP family; NP_813211.1, | 99.86 | |
| 3ocp_A | 139 | PRKG1 protein; serine/threonine kinase, TF2I and I | 99.85 | |
| 3d0s_A | 227 | Transcriptional regulatory protein; CAMP receptor | 99.85 | |
| 3fx3_A | 237 | Cyclic nucleotide-binding protein; helix_TURN_heli | 99.85 | |
| 4f8a_A | 160 | Potassium voltage-gated channel subfamily H membe; | 99.85 | |
| 3dv8_A | 220 | Transcriptional regulator, CRP/FNR family; cyclic | 99.85 | |
| 2ptm_A | 198 | Hyperpolarization-activated (IH) channel; ION chan | 99.84 | |
| 3iwz_A | 230 | CAP-like, catabolite activation-like protein; XCC, | 99.84 | |
| 1wgp_A | 137 | Probable cyclic nucleotide-gated ION channel 6; cy | 99.84 | |
| 3ukn_A | 212 | Novel protein similar to vertebrate potassium VOL | 99.84 | |
| 3pna_A | 154 | CAMP-dependent protein kinase type I-alpha regula | 99.84 | |
| 1vp6_A | 138 | CNBD, cyclic-nucleotide binding domain of mesorhiz | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 3dkw_A | 227 | DNR protein; CRP-FNR, HTH, beta barrel, dimerizati | 99.83 | |
| 2gau_A | 232 | Transcriptional regulator, CRP/FNR family; structu | 99.83 | |
| 4ava_A | 333 | Lysine acetyltransferase; allosteric regulation, d | 99.83 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 99.83 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 99.82 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 99.82 | |
| 3bpz_A | 202 | Potassium/sodium hyperpolarization-activated cycli | 99.82 | |
| 3ryp_A | 210 | Catabolite gene activator; CAMP receptor protein ( | 99.81 | |
| 2oz6_A | 207 | Virulence factor regulator; winged helix, helix-tu | 99.81 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 99.8 | |
| 3kcc_A | 260 | Catabolite gene activator; helix-turn-helix, CAMP, | 99.79 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 99.78 | |
| 2fmy_A | 220 | COOA, carbon monoxide oxidation system transcripti | 99.78 | |
| 1o5l_A | 213 | Transcriptional regulator, CRP family; TM1171, str | 99.78 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 99.78 | |
| 2d93_A | 134 | RAP guanine nucleotide exchange factor 6; CNMP_bin | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 1ft9_A | 222 | Carbon monoxide oxidation system transcription reg | 99.76 | |
| 3e6c_C | 250 | CPRK, cyclic nucleotide-binding protein; CPRK, hal | 99.75 | |
| 2bgc_A | 238 | PRFA; bacterial infection, human pathogen, transcr | 99.74 | |
| 3la7_A | 243 | Global nitrogen regulator; activator, DNA-binding, | 99.72 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 99.7 | |
| 3b02_A | 195 | Transcriptional regulator, CRP family; structural | 99.66 | |
| 4f7z_A | 999 | RAP guanine nucleotide exchange factor 4; cyclic n | 99.64 | |
| 3beh_A | 355 | MLL3241 protein; transmembrane protein, membrane p | 99.63 | |
| 3cf6_E | 694 | RAP guanine nucleotide exchange factor (GEF) 4; EP | 99.62 | |
| 2zcw_A | 202 | TTHA1359, transcriptional regulator, FNR/CRP famil | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.99 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.48 | |
| 3idb_B | 161 | CAMP-dependent protein kinase type II-beta regulat | 92.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.9 | |
| 3rns_A | 227 | Cupin 2 conserved barrel domain protein; structura | 86.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.36 | |
| 3fjs_A | 114 | Uncharacterized protein with RMLC-like cupin fold; | 83.27 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.19 | |
| 1dgw_A | 178 | Canavalin; duplicated swiss-roll beta barrels, loo | 80.52 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=283.65 Aligned_cols=154 Identities=39% Similarity=0.658 Sum_probs=140.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~-------------------------------------- 70 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI-------------------------------------- 70 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH--------------------------------------
T ss_pred CccccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHC--------------------------------------
Confidence 4578999999999999999999965 5688999999976421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+.+|+++|+.++||||++++++|++++.+|+|||||+||+|.+++.+.+.+++.
T Consensus 71 ------------------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~ 132 (311)
T 4aw0_A 71 ------------------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132 (311)
T ss_dssp ------------------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHH
T ss_pred ------------------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHH
Confidence 11223466899999999999999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 133 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999999999999999999999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.81 Aligned_cols=153 Identities=25% Similarity=0.513 Sum_probs=130.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++++.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~--------------------------------------- 61 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISR--------------------------------------- 61 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEET-TTCCEEEEEEEECTT---------------------------------------
T ss_pred cccceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHH---------------------------------------
Confidence 3689999999999999999999965 568899999987541
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 304 (362)
........+.+|+.+|+.++||||+++++++.+++.+|||||||+||+|.+++...+ .++
T Consensus 62 ------------------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~ 123 (350)
T 4b9d_A 62 ------------------MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123 (350)
T ss_dssp ------------------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCC
T ss_pred ------------------CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCC
Confidence 112234678899999999999999999999999999999999999999999997543 479
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 124 e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999999999999999999999999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=270.82 Aligned_cols=154 Identities=30% Similarity=0.531 Sum_probs=129.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~--------------------------------------- 50 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKV--------------------------------------- 50 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC----------------------------------------
T ss_pred EeeCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHH---------------------------------------
Confidence 4689999999999999999999854 568899999987641
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........++.+|+.+|+.++||||+++++++.+++.+|+||||+ +|+|.+++.+.+++++.
T Consensus 51 -----------------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~ 112 (275)
T 3hyh_A 51 -----------------LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQ 112 (275)
T ss_dssp ----------------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHH
T ss_pred -----------------cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHH
Confidence 112223456889999999999999999999999999999999999 78999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 113 ~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 113 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred HHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999999999999999999999999999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.35 Aligned_cols=153 Identities=40% Similarity=0.662 Sum_probs=131.0
Q ss_pred ccCcEEEEEecccceecEEEEEec--CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIA--GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-++|++++.||+|+||.||++++. +.+++.||+|++.+...
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------------------------------------- 65 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL------------------------------------- 65 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE-------------------------------------
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc-------------------------------------
Confidence 468999999999999999999864 34578899999876421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
......++.+|+.+|+.++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++
T Consensus 66 --------------------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e 125 (304)
T 3ubd_A 66 --------------------KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125 (304)
T ss_dssp --------------------EEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCH
T ss_pred --------------------ChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCH
Confidence 111123467899999999999999999999999999999999999999999998889999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 126 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999999999999999999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=273.77 Aligned_cols=150 Identities=26% Similarity=0.452 Sum_probs=135.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|++.+.||+|+||.||++.+. .+++.||+|.+.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~---------------------------------------- 111 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRK---------------------------------------- 111 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCc----------------------------------------
Confidence 356999999999999999999965 568899999986431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
....+.+.+|+.+|+.++||||++++++|.+++.+|||||||+||+|.+++.+ +.+++..
T Consensus 112 -------------------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~ 171 (346)
T 4fih_A 112 -------------------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQ 171 (346)
T ss_dssp -------------------CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHH
T ss_pred -------------------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHH
Confidence 11234578999999999999999999999999999999999999999999876 5799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 172 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 172 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999999999999999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=272.06 Aligned_cols=147 Identities=26% Similarity=0.426 Sum_probs=132.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.++.|.+.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~--------------------------------------- 95 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV--------------------------------------- 95 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT---------------------------------------
T ss_pred chhheEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH---------------------------------------
Confidence 3567899999999999999999955 568899999985431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
...+|+.+|+.++|||||++++++.+++.+||||||++||+|.+++++.+++++.
T Consensus 96 -------------------------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~ 150 (336)
T 4g3f_A 96 -------------------------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED 150 (336)
T ss_dssp -------------------------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHH
T ss_pred -------------------------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHH
Confidence 1246999999999999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~ 358 (362)
.++.++.|++.||.|||++||+||||||+|||++.+| .+||+|||+|+.+..
T Consensus 151 ~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred HHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999999999999999999999999887 699999999987643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=275.94 Aligned_cols=150 Identities=26% Similarity=0.452 Sum_probs=135.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|++++.||+|+||.||++.+. .+++.||+|.+....
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~---------------------------------------- 188 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRK---------------------------------------- 188 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTT----------------------------------------
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccc----------------------------------------
Confidence 356999999999999999999965 568899999986431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
....+.+.+|+.+|+.++||||++++++|.+++.+|||||||+||+|.+++.. +.+++..
T Consensus 189 -------------------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~ 248 (423)
T 4fie_A 189 -------------------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQ 248 (423)
T ss_dssp -------------------CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHH
T ss_pred -------------------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHH
Confidence 11234578999999999999999999999999999999999999999999875 5799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 249 ~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 249 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999999999999999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=263.73 Aligned_cols=154 Identities=23% Similarity=0.390 Sum_probs=132.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
+.-++|.+.+.||+|+||.||++.+.+ .++..||+|.+...
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----------------------------------- 54 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----------------------------------- 54 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----------------------------------
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----------------------------------
Confidence 345789999999999999999998643 34678999988542
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.....+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++.+.
T Consensus 55 ------------------------~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~ 110 (299)
T 4asz_A 55 ------------------------SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110 (299)
T ss_dssp ------------------------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTS
T ss_pred ------------------------ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC
Confidence 1223456899999999999999999999999999999999999999999999753
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 ------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 ~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 180 (299)
T 4asz_A 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 180 (299)
T ss_dssp HHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCC
Confidence 3589999999999999999999999999999999999999999999999999986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=259.13 Aligned_cols=150 Identities=23% Similarity=0.379 Sum_probs=131.0
Q ss_pred cCc-EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 149 SDL-RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 149 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+| ++...||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~---------------------------------------- 63 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRK---------------------------------------- 63 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred CceEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhh----------------------------------------
Confidence 344 67788999999999999865 568899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
......+.+.+|+.+|+.++|||||+++++|.+ +..+|+||||++||+|.+++.+.+.+
T Consensus 64 -----------------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l 126 (290)
T 3fpq_A 64 -----------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM 126 (290)
T ss_dssp -----------------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred -----------------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCC
Confidence 112234668999999999999999999999865 45699999999999999999988899
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecC-CCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLST-SGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||.|||+++ |+||||||+|||++. +|.+||+|||+|+..
T Consensus 127 ~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 127 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999999999999999 999999999999974 789999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=262.03 Aligned_cols=151 Identities=26% Similarity=0.470 Sum_probs=125.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++++.||+|+||.||++.+. .+++.||+|.+....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~---------------------------------------- 42 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPN---------------------------------------- 42 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECS----------------------------------------
T ss_pred chhCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccC----------------------------------------
Confidence 457999999999999999999865 468899999985431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------------eEEEEEeccCCcchHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------------YLYMLMESCLGGELWT 295 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~ 295 (362)
.....+.+.+|+.+|+.++||||++++++|.+.+ ++|+|||||++|+|.+
T Consensus 43 ------------------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~ 104 (299)
T 4g31_A 43 ------------------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD 104 (299)
T ss_dssp ------------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHH
T ss_pred ------------------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHH
Confidence 1223456889999999999999999999986543 4799999999999999
Q ss_pred HHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 296 ILRDKGN---FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 296 ~l~~~~~---l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..... .+...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 105 ~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~ 169 (299)
T 4g31_A 105 WMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169 (299)
T ss_dssp HHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred HHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecC
Confidence 9987654 4456788999999999999999999999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=260.40 Aligned_cols=157 Identities=22% Similarity=0.380 Sum_probs=134.6
Q ss_pred hhccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHh
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQ 219 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~ 219 (362)
.+...+++++.+.||+|+||.||++...+ ..++.||||.+...
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--------------------------------- 67 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--------------------------------- 67 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC----------------------------------
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc---------------------------------
Confidence 34567789999999999999999998643 35678999998542
Q ss_pred hccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 220 LISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
......+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++..
T Consensus 68 -------------------------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~ 122 (308)
T 4gt4_A 68 -------------------------AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 122 (308)
T ss_dssp -------------------------CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHT
T ss_pred -------------------------cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHh
Confidence 1122345689999999999999999999999999999999999999999999964
Q ss_pred c----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 K----------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~----------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
. ..+++..+..++.|++.||.|||+++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 123 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~ 197 (308)
T 4gt4_A 123 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197 (308)
T ss_dssp TCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGG
T ss_pred hCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccC
Confidence 2 3488999999999999999999999999999999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=260.12 Aligned_cols=153 Identities=24% Similarity=0.371 Sum_probs=129.0
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..+++.+.+.||+|+||.||++.+.+ .+++.||+|.+...
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------------------------------------ 82 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------------------------------------ 82 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC------------------------------------
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC------------------------------------
Confidence 45678999999999999999998643 34678999998542
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.....+.+.+|+.+|+.++|||||++++++.+++.+|+||||+++|+|.+++.+.
T Consensus 83 -----------------------~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~ 139 (329)
T 4aoj_A 83 -----------------------SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 139 (329)
T ss_dssp -----------------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSC
T ss_pred -----------------------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCc
Confidence 1223456899999999999999999999999999999999999999999999753
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 -------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 -------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 140 ~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210 (329)
T ss_dssp C-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccC
Confidence 3589999999999999999999999999999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.03 Aligned_cols=161 Identities=29% Similarity=0.516 Sum_probs=137.9
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.+++.||+|+||.||++++. .+++.||+|++.+......
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~--------------------------------- 230 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMK--------------------------------- 230 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHT---------------------------------
T ss_pred CCchHHeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchh---------------------------------
Confidence 457899999999999999999999955 6789999999977522110
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
...........++.+++.++||||++++++|.+++.+|+||||++||+|.+++.+.+.++
T Consensus 231 --------------------~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~ 290 (689)
T 3v5w_A 231 --------------------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290 (689)
T ss_dssp --------------------TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCC
T ss_pred --------------------hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCC
Confidence 001111223344667777899999999999999999999999999999999999888999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 291 E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 291 EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999999999999999999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=254.97 Aligned_cols=150 Identities=26% Similarity=0.360 Sum_probs=129.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...+++.+.+.||+|+||.||++.+.+ .+|+|+++..+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~----~vAvK~~~~~~-------------------------------------- 70 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG----DVAVKILKVVD-------------------------------------- 70 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS----EEEEEECCCSS--------------------------------------
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC----cEEEEEEEecC--------------------------------------
Confidence 456788999999999999999998542 48999875421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
......+.+.+|+.+|+.++||||+++++++.. +.+||||||+++|+|.+++... .+++
T Consensus 71 -------------------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~ 130 (307)
T 3omv_A 71 -------------------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQ 130 (307)
T ss_dssp -------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCC
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCC
Confidence 112334678999999999999999999998754 5689999999999999999754 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 131 ~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 131 MFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999999999999999999999999999999999999999999998653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=261.72 Aligned_cols=150 Identities=23% Similarity=0.432 Sum_probs=132.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~----------------------------------------- 91 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAF----------------------------------------- 91 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTT-----------------------------------------
T ss_pred CCeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccc-----------------------------------------
Confidence 57999999999999999999955 568899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHhcCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.......++.+|+.+|+.++||||+++++++.. .+.+|+||||+ +|+|.+++.+.++
T Consensus 92 ----------------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~~~ 154 (398)
T 4b99_A 92 ----------------DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP 154 (398)
T ss_dssp ----------------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC-SEEHHHHHTSSSC
T ss_pred ----------------cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC-CCCHHHHHHhcCC
Confidence 112234567899999999999999999998653 46799999999 5789999988889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 155 l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 155 LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9999999999999999999999999999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.78 Aligned_cols=147 Identities=23% Similarity=0.327 Sum_probs=129.4
Q ss_pred ccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.++|++.+.||+|+||.||++.+.. .+++.||+|.+.+..
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------------------------------------- 61 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------------------------------------- 61 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--------------------------------------
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--------------------------------------
Confidence 4679999999999999999998642 356789999875431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
...++.+|+++|+.+ +||||++++++|.+++++|+||||+++++|.++++ .++
T Consensus 62 -----------------------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~ 115 (361)
T 4f9c_A 62 -----------------------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLS 115 (361)
T ss_dssp -----------------------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCC
T ss_pred -----------------------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCC
Confidence 123467899999988 79999999999999999999999999999999984 599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 116 ~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 116 FQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999999999999999999999876 8999999999987643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=248.82 Aligned_cols=154 Identities=30% Similarity=0.412 Sum_probs=130.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.+.+. ..+.||+|.+...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~------------------------------------ 105 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------------------------------------ 105 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT------------------------------------
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc------------------------------------
Confidence 457899999999999999999986643 2356888877543
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
......+.+.+|+.+|+.++| |||+++++++.. ++.+|+|||||++|+|.+++++.
T Consensus 106 ----------------------~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~ 163 (353)
T 4ase_A 106 ----------------------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 163 (353)
T ss_dssp ----------------------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHT
T ss_pred ----------------------cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhc
Confidence 112234568999999999965 899999998865 46799999999999999999752
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 ----------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ----------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||+++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~ 237 (353)
T 4ase_A 164 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 237 (353)
T ss_dssp GGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTT
T ss_pred ccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhccc
Confidence 2378999999999999999999999999999999999999999999999999997744
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=241.87 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=122.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|.+.+.||+|+||.||++.+. ++.||||.+...+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~----------------------------------------- 38 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE----------------------------------------- 38 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---TEEEEEEEECGGG-----------------------------------------
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc-----------------------------------------
Confidence 46788899999999999999864 6789999885421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........|+..+..++||||+++++++..++ .+||||||+++|+|.++++. .+++
T Consensus 39 -------------------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~ 98 (303)
T 3hmm_A 39 -------------------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVT 98 (303)
T ss_dssp -------------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBC
T ss_pred -------------------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCC
Confidence 00111234555667789999999999987653 68999999999999999976 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSR--------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~--------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 99 ~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999999999999987 999999999999999999999999999987643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=259.50 Aligned_cols=153 Identities=27% Similarity=0.422 Sum_probs=135.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|.+.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~--------------------------------------- 194 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPH--------------------------------------- 194 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS---------------------------------------
T ss_pred CccccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccc---------------------------------------
Confidence 3578999999999999999999955 568899999986531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~ 305 (362)
......+.+|+.+|+.++||||++++++|.+++.+|+||||++||+|.+++.. .+.+++
T Consensus 195 --------------------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e 254 (573)
T 3uto_A 195 --------------------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254 (573)
T ss_dssp --------------------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEH
T ss_pred --------------------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCH
Confidence 11235578999999999999999999999999999999999999999998864 457999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC--CcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS--GYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~--~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 255 ~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999999999999999999999999854 89999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-30 Score=233.40 Aligned_cols=156 Identities=41% Similarity=0.771 Sum_probs=138.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++... .+++.+|+|++.+...
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------------------- 44 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIV------------------------------------- 44 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-------------------------------------
Confidence 35789999999999999999999855 5688999999876411
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.+.+.+++
T Consensus 45 -------------------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~ 105 (318)
T 1fot_A 45 -------------------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN 105 (318)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCH
T ss_pred -------------------hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCH
Confidence 1112335577899999999999999999999999999999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 106 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 106 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999999999999999999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-30 Score=235.11 Aligned_cols=153 Identities=34% Similarity=0.636 Sum_probs=137.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++... .+++.+|+|++.+...
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~-------------------------------------- 43 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI-------------------------------------- 43 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH--------------------------------------
T ss_pred ChHHeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHh--------------------------------------
Confidence 5789999999999999999999854 5688999999876421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||++|++|.+++.+.+.+++.
T Consensus 44 ------------------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~ 105 (337)
T 1o6l_A 44 ------------------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 105 (337)
T ss_dssp ------------------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHH
T ss_pred ------------------hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHH
Confidence 11223456788999999999999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 106 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999999999999999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=236.10 Aligned_cols=154 Identities=36% Similarity=0.656 Sum_probs=135.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~------------------------------------- 61 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVI------------------------------------- 61 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHh-------------------------------------
Confidence 46789999999999999999999865 5688999999876411
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+..|..+++.+ +||||+++++++.+.+.+|+||||++|++|.+++.+.+.++
T Consensus 62 -------------------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~ 122 (353)
T 3txo_A 62 -------------------LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122 (353)
T ss_dssp -------------------HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCC
T ss_pred -------------------cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence 1122345578899999987 79999999999999999999999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 123 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999999999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=232.07 Aligned_cols=154 Identities=33% Similarity=0.562 Sum_probs=138.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~-------------------------------------- 52 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQ-------------------------------------- 52 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGG--------------------------------------
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhc--------------------------------------
Confidence 35789999999999999999999865 458899999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+.+++
T Consensus 53 -------------------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 113 (328)
T 3fe3_A 53 -------------------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE 113 (328)
T ss_dssp -------------------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCH
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCH
Confidence 1122345678999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 114 ~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 114 KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999999999999999999999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=234.40 Aligned_cols=157 Identities=46% Similarity=0.820 Sum_probs=140.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++++.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------------------- 79 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV------------------------------------- 79 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHh-------------------------------------
Confidence 46789999999999999999999855 5688999999866421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.+.+.+++
T Consensus 80 -------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~ 140 (350)
T 1rdq_E 80 -------------------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140 (350)
T ss_dssp -------------------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCH
T ss_pred -------------------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCH
Confidence 1122345678899999999999999999999999999999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999999999999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=236.74 Aligned_cols=157 Identities=32% Similarity=0.624 Sum_probs=140.2
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~------------------------------------ 53 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKC------------------------------------ 53 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHH------------------------------------
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhc------------------------------------
Confidence 346789999999999999999999855 5688999999866421
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||++|++|.+++.....++
T Consensus 54 --------------------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~ 113 (384)
T 4fr4_A 54 --------------------VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113 (384)
T ss_dssp --------------------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCC
T ss_pred --------------------ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCC
Confidence 112234567899999999999999999999999999999999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 114 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999999999999999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=237.24 Aligned_cols=155 Identities=34% Similarity=0.627 Sum_probs=136.5
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|++.+.||+|+||.||++++. .+++.+|+|++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~------------------------------------ 90 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELV------------------------------------ 90 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGT------------------------------------
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhc------------------------------------
Confidence 346789999999999999999999865 5688999999876521
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+..|..++..+ +||||+++++++.+.+.+|+||||+++++|..++.+.+.+
T Consensus 91 --------------------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l 150 (396)
T 4dc2_A 91 --------------------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 150 (396)
T ss_dssp --------------------C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSC
T ss_pred --------------------cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCC
Confidence 1122334577899999887 8999999999999999999999999999999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 151 ~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999999999999999999999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=232.65 Aligned_cols=154 Identities=33% Similarity=0.627 Sum_probs=138.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|++.+..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~-------------------------------------- 46 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKEL-------------------------------------- 46 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGG--------------------------------------
T ss_pred CchhheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHH--------------------------------------
Confidence 46789999999999999999999865 568899999987642
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.........+.+|..++..+ +||||+++++++.+.+.+|+||||+++++|.+++.+.+.++
T Consensus 47 ------------------~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~ 108 (345)
T 3a8x_A 47 ------------------VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 108 (345)
T ss_dssp ------------------SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCC
T ss_pred ------------------hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence 11223345678899999887 89999999999999999999999999999999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 109 ~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999999999999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=236.75 Aligned_cols=155 Identities=37% Similarity=0.657 Sum_probs=137.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~------------------------------------- 107 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEM------------------------------------- 107 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred cCccccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhh-------------------------------------
Confidence 36789999999999999999999965 5688999999876421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||++||+|.+++.. ..+++
T Consensus 108 -------------------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e 167 (410)
T 3v8s_A 108 -------------------IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPE 167 (410)
T ss_dssp -------------------HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCH
T ss_pred -------------------hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCH
Confidence 1112234578899999999999999999999999999999999999999999876 56999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 168 ~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999999999999999999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=239.03 Aligned_cols=156 Identities=29% Similarity=0.616 Sum_probs=137.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~------------------------------------- 112 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEM------------------------------------- 112 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHH-------------------------------------
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHh-------------------------------------
Confidence 35689999999999999999999965 5578899999876421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
........+.+|..++..++||||+++++++.+.+.+|+||||+++|+|.+++.+ .+.++
T Consensus 113 -------------------~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~ 173 (437)
T 4aw2_A 113 -------------------LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173 (437)
T ss_dssp -------------------HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCC
T ss_pred -------------------hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCC
Confidence 1112234578899999999999999999999999999999999999999999987 46799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 174 e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 174 EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999999999999999999999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=232.33 Aligned_cols=154 Identities=34% Similarity=0.619 Sum_probs=136.0
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~------------------------------------- 55 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV------------------------------------- 55 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH-------------------------------------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHh-------------------------------------
Confidence 46789999999999999999999965 5688999999876421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+..|..++..+ +||||+++++++.+.+.+|+||||++||+|.+++.+.+.++
T Consensus 56 -------------------~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~ 116 (345)
T 1xjd_A 56 -------------------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD 116 (345)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCC
T ss_pred -------------------hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence 1112334567889999876 99999999999999999999999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999999999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=236.78 Aligned_cols=156 Identities=31% Similarity=0.602 Sum_probs=138.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++... .+++.+|+|++.+...
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~------------------------------------- 99 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDM------------------------------------- 99 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHh-------------------------------------
Confidence 35689999999999999999999865 5688999999876421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
........+.+|..++..++||||+++++++.+.+.+|+||||++|++|.+++.+.+ .++
T Consensus 100 -------------------~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~ 160 (412)
T 2vd5_A 100 -------------------LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160 (412)
T ss_dssp -------------------HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCC
T ss_pred -------------------hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCC
Confidence 112233557889999999999999999999999999999999999999999998754 799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 161 ~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 161 AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999999999999999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=225.09 Aligned_cols=154 Identities=22% Similarity=0.326 Sum_probs=137.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. ..++.+|+|.+...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~---------------------------------------- 47 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIP---------------------------------------- 47 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECC----------------------------------------
T ss_pred hhccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccC----------------------------------------
Confidence 3468999999999999999999855 45788999988543
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+++++.
T Consensus 48 ----------------~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 111 (294)
T 4eqm_A 48 ----------------PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD 111 (294)
T ss_dssp ----------------SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHH
T ss_pred ----------------ccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHH
Confidence 1112234466889999999999999999999999999999999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 112 ~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999999999999999999999999999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=231.72 Aligned_cols=155 Identities=32% Similarity=0.590 Sum_probs=136.4
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.+.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~------------------------------------ 58 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV------------------------------------ 58 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHH------------------------------------
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh------------------------------------
Confidence 356899999999999999999999865 4578899999876421
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+..|..++..+ +||||+++++++.+.+.+|+||||++|++|.+++...+.+
T Consensus 59 --------------------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~ 118 (353)
T 2i0e_A 59 --------------------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 118 (353)
T ss_dssp --------------------HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred --------------------hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCC
Confidence 1122345578899999887 8999999999999999999999999999999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 119 ~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 119 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999999999999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-29 Score=232.23 Aligned_cols=154 Identities=36% Similarity=0.664 Sum_probs=129.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++++.||+|+||.||++++. .+++.+|+|++.+....
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~------------------------------------ 77 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAIL------------------------------------ 77 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC------------------------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhh------------------------------------
Confidence 46789999999999999999999965 56889999999765321
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHH-HhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEI-MGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
.......+..|..+ ++.++||||+++++++.+.+.+|+||||++|++|.+++.+.+.++
T Consensus 78 --------------------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~ 137 (373)
T 2r5t_A 78 --------------------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL 137 (373)
T ss_dssp ---------------------------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCC
T ss_pred --------------------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCC
Confidence 11223345666666 567899999999999999999999999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 138 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999999999999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=227.33 Aligned_cols=155 Identities=28% Similarity=0.470 Sum_probs=137.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~-------------------------------------- 46 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQL-------------------------------------- 46 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHH--------------------------------------
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHH--------------------------------------
Confidence 35789999999999999999999965 458899999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.........+.+|+.+++.++||||+++++++..++.+|+||||+ +|+|.+++...+.+++
T Consensus 47 ------------------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~ 107 (336)
T 3h4j_B 47 ------------------LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE 107 (336)
T ss_dssp ------------------HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCH
T ss_pred ------------------ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCH
Confidence 111123356889999999999999999999999999999999999 8899999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 108 DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99999999999999999999999999999999999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=226.92 Aligned_cols=157 Identities=25% Similarity=0.406 Sum_probs=137.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+.....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~------------------------------------- 52 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRA------------------------------------- 52 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTT-------------------------------------
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEcccccc-------------------------------------
Confidence 456999999999999999999855 568899999987642110
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.........+.+|+.+++.++||||+++++++.+.+.+|+||||++|++|.+++...+.+++..
T Consensus 53 ----------------~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~ 116 (361)
T 2yab_A 53 ----------------SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE 116 (361)
T ss_dssp ----------------CSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHH
T ss_pred ----------------ccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHH
Confidence 0011134568899999999999999999999999999999999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.+..
T Consensus 117 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 999999999999999999999999999999998776 799999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=225.08 Aligned_cols=157 Identities=37% Similarity=0.646 Sum_probs=130.9
Q ss_pred hccccCcEEEEEecccceecEEEEEec--CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIA--GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
....++|++.+.||+|+||.||++... ..+++.+|+|++.+....
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~--------------------------------- 59 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV--------------------------------- 59 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------------------
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh---------------------------------
Confidence 345789999999999999999999864 246789999998764211
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++...+.
T Consensus 60 ----------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 117 (327)
T 3a62_A 60 ----------------------RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI 117 (327)
T ss_dssp ---------------------------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS
T ss_pred ----------------------hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC
Confidence 0112234567899999999999999999999999999999999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999999999999999999999999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=219.38 Aligned_cols=151 Identities=25% Similarity=0.435 Sum_probs=131.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 39 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDD---------------------------------------- 39 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSC----------------------------------------
T ss_pred CCCceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccC----------------------------------------
Confidence 468999999999999999999865 458899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHH-hcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||+++ ++.+.+. ..+.+++.
T Consensus 40 -----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~ 101 (292)
T 3o0g_A 40 -----------------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE 101 (292)
T ss_dssp -----------------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHH
T ss_pred -----------------CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHH
Confidence 1122345678899999999999999999999999999999999965 5555554 45679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999999999999999999999999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=219.60 Aligned_cols=151 Identities=26% Similarity=0.397 Sum_probs=135.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+.
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~---------------------------------------- 46 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRF---------------------------------------- 46 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCC----------------------------------------
T ss_pred ChhHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccC----------------------------------------
Confidence 4678999999999999999999865 45788999987432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~ 305 (362)
.......+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.. ...+++
T Consensus 47 -------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 107 (310)
T 3s95_A 47 -------------------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107 (310)
T ss_dssp -------------------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCH
T ss_pred -------------------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCH
Confidence 123346688999999999999999999999999999999999999999999987 456999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 108 ~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 9999999999999999999999999999999999999999999999998763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=234.87 Aligned_cols=157 Identities=27% Similarity=0.459 Sum_probs=139.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.+.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~------------------------------------- 54 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKI------------------------------------- 54 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhc-------------------------------------
Confidence 46789999999999999999999865 4688999999865411
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++.+.+.+++
T Consensus 55 -------------------~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~ 115 (476)
T 2y94_A 55 -------------------RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115 (476)
T ss_dssp -------------------HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCH
T ss_pred -------------------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCH
Confidence 1112345688999999999999999999999999999999999999999999988788999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....+
T Consensus 116 ~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999999999999999999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=219.61 Aligned_cols=151 Identities=26% Similarity=0.425 Sum_probs=134.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 57 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQ--------------------------------------- 57 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGG---------------------------------------
T ss_pred hhhceeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeeccc---------------------------------------
Confidence 3568999999999999999999854 568899999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++.. ..+++.
T Consensus 58 --------------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~ 116 (297)
T 3fxz_A 58 --------------------QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEG 116 (297)
T ss_dssp --------------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHH
T ss_pred --------------------ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHH
Confidence 11234578899999999999999999999999999999999999999999976 469999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred HHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999999999999999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=224.10 Aligned_cols=151 Identities=28% Similarity=0.458 Sum_probs=133.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.+|+|++.....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-------------------------------------- 45 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRA-------------------------------------- 45 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC----------------------------------------
T ss_pred HhhhceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccc--------------------------------------
Confidence 3689999999999999999999865 4588999999854310
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++.....+++.
T Consensus 46 --------------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 105 (323)
T 3tki_A 46 --------------------VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP 105 (323)
T ss_dssp -------------------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHH
T ss_pred --------------------cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHH
Confidence 112245788999999999999999999999999999999999999999999877789999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 106 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 99999999999999999999999999999999999999999999999765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=231.02 Aligned_cols=153 Identities=25% Similarity=0.416 Sum_probs=134.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~---------------------------------------- 48 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKK---------------------------------------- 48 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCS----------------------------------------
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEccc----------------------------------------
Confidence 467999999999999999999855 458899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+.+...+.+++..
T Consensus 49 -----------------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~ 111 (444)
T 3soa_A 49 -----------------LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD 111 (444)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHH
T ss_pred -----------------CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHH
Confidence 112234568899999999999999999999999999999999999999999999888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec---CCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS---TSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~---~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.+
T Consensus 112 ~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999999999999999999999998 457899999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=236.35 Aligned_cols=156 Identities=30% Similarity=0.557 Sum_probs=137.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~------------------------------------- 222 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRI------------------------------------- 222 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred ccccceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhh-------------------------------------
Confidence 45688999999999999999999855 5688999999866421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l 303 (362)
........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+
T Consensus 223 -------------------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l 283 (576)
T 2acx_A 223 -------------------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283 (576)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCC
T ss_pred -------------------hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCC
Confidence 112233557889999999999999999999999999999999999999999987654 39
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 284 ~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 284 PEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999999999999999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=219.93 Aligned_cols=150 Identities=26% Similarity=0.405 Sum_probs=133.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~----------------------------------------- 41 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK----------------------------------------- 41 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-----------------------------------------
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-----------------------------------------
Confidence 578999999999999999999855 55788999987532
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~ 306 (362)
......+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.... .+++.
T Consensus 42 -------------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~ 102 (321)
T 1tki_A 42 -------------------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER 102 (321)
T ss_dssp -------------------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHH
T ss_pred -------------------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHH
Confidence 1123457889999999999999999999999999999999999999999997653 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.+..
T Consensus 103 ~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999999999999999999999999999987 78999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=224.54 Aligned_cols=153 Identities=28% Similarity=0.463 Sum_probs=134.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~---------------------------------------- 66 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKK---------------------------------------- 66 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT----------------------------------------
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEccc----------------------------------------
Confidence 357999999999999999999854 568899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+.+...+.+++..
T Consensus 67 -----------------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~ 129 (362)
T 2bdw_A 67 -----------------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 129 (362)
T ss_dssp -----------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHH
T ss_pred -----------------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHH
Confidence 112234568899999999999999999999999999999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC---CcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS---GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~---~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 130 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999999999999999999999999864 4599999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-28 Score=224.76 Aligned_cols=154 Identities=25% Similarity=0.402 Sum_probs=134.1
Q ss_pred cccCcEEEEEecccceecEEEEEecC------CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG------DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
..++|.+.+.||+|+||.||++.+.+ ..+..+|+|.+...
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---------------------------------- 124 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---------------------------------- 124 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----------------------------------
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----------------------------------
Confidence 45789999999999999999998643 23456899987543
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.+ +||||+++++++...+.+|+||||+++++|.+++..
T Consensus 125 ------------------------~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 180 (370)
T 2psq_A 125 ------------------------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 180 (370)
T ss_dssp ------------------------CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred ------------------------cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHh
Confidence 1122345688999999999 899999999999999999999999999999999986
Q ss_pred cC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 KG----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 255 (370)
T 2psq_A 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255 (370)
T ss_dssp TCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTC
T ss_pred hCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCc
Confidence 43 378899999999999999999999999999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=219.80 Aligned_cols=155 Identities=26% Similarity=0.410 Sum_probs=135.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~--------------------------------------- 50 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTK--------------------------------------- 50 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCST---------------------------------------
T ss_pred cceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccc---------------------------------------
Confidence 56999999999999999999855 56889999998764211
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
..........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++...+.+++..+
T Consensus 51 --------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 116 (326)
T 2y0a_A 51 --------------SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116 (326)
T ss_dssp --------------TCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHH
T ss_pred --------------cccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHH
Confidence 000112345688999999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.+.
T Consensus 117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999999999999999999998877 79999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=233.59 Aligned_cols=154 Identities=36% Similarity=0.648 Sum_probs=129.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------------------------------------- 186 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVI------------------------------------- 186 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhh-------------------------------------
Confidence 35688999999999999999999855 5688999999865411
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++...+.+++
T Consensus 187 -------------------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 247 (446)
T 4ejn_A 187 -------------------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 247 (446)
T ss_dssp -------------------C-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCH
T ss_pred -------------------hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCH
Confidence 1122334567899999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus 248 ~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999999998 99999999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=222.69 Aligned_cols=154 Identities=25% Similarity=0.364 Sum_probs=132.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 49 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADL--------------------------------------- 49 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTT---------------------------------------
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccc---------------------------------------
Confidence 3578999999999999999999965 457899999986531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.........+.+|+.+++.++||||+++++++.... ..|+||||+++++|.+++...+.
T Consensus 50 -----------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~ 112 (311)
T 3ork_A 50 -----------------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP 112 (311)
T ss_dssp -----------------TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS
T ss_pred -----------------cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC
Confidence 112233456889999999999999999999987553 45999999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999999999999999999999999999999999999997653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=223.18 Aligned_cols=149 Identities=26% Similarity=0.406 Sum_probs=131.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 57 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGA--------------------------------------- 57 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESST---------------------------------------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCc---------------------------------------
Confidence 4578999999999999999999965 468899999986431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.....+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+.+++.
T Consensus 58 ---------------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 116 (361)
T 3uc3_A 58 ---------------------AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED 116 (361)
T ss_dssp ---------------------TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred ---------------------cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHH
Confidence 11244778999999999999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc--EEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY--VKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~--~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+..
T Consensus 117 ~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999999999999999999999999987665 999999998743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=233.21 Aligned_cols=156 Identities=35% Similarity=0.561 Sum_probs=137.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~------------------------------------- 223 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRL------------------------------------- 223 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHh-------------------------------------
Confidence 46789999999999999999999854 5688999999866421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----C
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----G 301 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~ 301 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||++|++|.+++... .
T Consensus 224 -------------------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~ 284 (543)
T 3c4z_A 224 -------------------KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284 (543)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSC
T ss_pred -------------------hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccc
Confidence 11123456788999999999999999999999999999999999999999998763 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 285 ~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 599999999999999999999999999999999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=214.84 Aligned_cols=155 Identities=32% Similarity=0.519 Sum_probs=136.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-------------------------------------- 46 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQ-------------------------------------- 46 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHH--------------------------------------
T ss_pred eecccEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccc--------------------------------------
Confidence 36789999999999999999999865 457789999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++.....+++
T Consensus 47 ------------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~ 108 (279)
T 3fdn_A 47 ------------------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 108 (279)
T ss_dssp ------------------HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCH
T ss_pred ------------------cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCH
Confidence 11122345678999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 109 ~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999999999999999999999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=219.26 Aligned_cols=153 Identities=24% Similarity=0.449 Sum_probs=130.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~---------------------------------------- 43 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPN---------------------------------------- 43 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCS----------------------------------------
T ss_pred hhcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCC----------------------------------------
Confidence 567999999999999999999965 457899999986431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----------------------------
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK---------------------------- 279 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---------------------------- 279 (362)
.....+.+.+|+.+++.++||||+++++++.+..
T Consensus 44 ------------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (332)
T 3qd2_B 44 ------------------RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM 105 (332)
T ss_dssp ------------------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------
T ss_pred ------------------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcc
Confidence 1223456889999999999999999999875432
Q ss_pred -----------------------------eEEEEEeccCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCc
Q psy14740 280 -----------------------------YLYMLMESCLGGELWTILRDKGN---FDDATTRFYTACVVEAFDYLHSRNI 327 (362)
Q Consensus 280 -----------------------------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~ql~~al~~lH~~~i 327 (362)
++|+||||+++++|.+++..... .++..++.++.|++.||.|||++||
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 185 (332)
T 3qd2_B 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185 (332)
T ss_dssp --------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCe
Confidence 48999999999999999987543 4566789999999999999999999
Q ss_pred EeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 328 iHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+||||||+||+++.++.+||+|||+++.+...
T Consensus 186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred eecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 99999999999999999999999999877543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=222.24 Aligned_cols=156 Identities=26% Similarity=0.381 Sum_probs=132.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.+|+|++.......
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------------------------------- 64 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTS-------------------------------------- 64 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHT--------------------------------------
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccc--------------------------------------
Confidence 57999999999999999999855 568899999986532100
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----CCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----GNFD 304 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~ 304 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+.+... ..++
T Consensus 65 ----------------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~ 128 (351)
T 3c0i_A 65 ----------------SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128 (351)
T ss_dssp ----------------SSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCC
T ss_pred ----------------cccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCC
Confidence 01112356889999999999999999999999999999999999999998877543 2489
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc---EEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~---~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.+...
T Consensus 129 ~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 186 (351)
T 3c0i_A 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence 9999999999999999999999999999999999986554 999999999877543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=232.04 Aligned_cols=151 Identities=23% Similarity=0.365 Sum_probs=124.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.||+|.+.+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~----------------------------------------- 89 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRV----------------------------------------- 89 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-C--CEEEEEEECST-----------------------------------------
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechh-----------------------------------------
Confidence 478999999999999999999855 45889999988542
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........++.+|+.+|+.++||||+++++++. ....+|+|||++ +++|.+++.....
T Consensus 90 ----------------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~ 152 (458)
T 3rp9_A 90 ----------------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY 152 (458)
T ss_dssp ----------------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCC
T ss_pred ----------------hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCC
Confidence 112233466889999999999999999999984 335799999998 7899999988778
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999999999999999999999999999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=219.02 Aligned_cols=155 Identities=25% Similarity=0.338 Sum_probs=135.0
Q ss_pred ccccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
...++|++.+.||+|+||.||++.+... .+..+|+|.+...
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~------------------------------------- 88 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG------------------------------------- 88 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-------------------------------------
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-------------------------------------
Confidence 3567899999999999999999986532 2345999988543
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
........+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++... ..
T Consensus 89 ---------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 147 (325)
T 3kul_A 89 ---------------------YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147 (325)
T ss_dssp ---------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTC
T ss_pred ---------------------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccC
Confidence 11223456889999999999999999999999999999999999999999999754 57
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 148 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999999999999999999999999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=239.28 Aligned_cols=155 Identities=32% Similarity=0.590 Sum_probs=136.7
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|.+++.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~------------------------------------ 379 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV------------------------------------ 379 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHH------------------------------------
T ss_pred cccccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEecccc------------------------------------
Confidence 346789999999999999999999965 4688899999876411
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+..|..++..+ +||+|+++++++.+.+.+|+||||+++++|.+++...+.+
T Consensus 380 --------------------~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~ 439 (674)
T 3pfq_A 380 --------------------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439 (674)
T ss_dssp --------------------HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred --------------------ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCC
Confidence 1122345678899999887 7999999999999999999999999999999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 440 ~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 440 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999999999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=223.74 Aligned_cols=152 Identities=16% Similarity=0.248 Sum_probs=136.1
Q ss_pred cccCcEEEEEeccc--ceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVG--GFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G--~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|++.+.||+| +||.||++.+. .+++.+|+|.+....
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~------------------------------------- 64 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEA------------------------------------- 64 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGG-------------------------------------
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccc-------------------------------------
Confidence 57889999999999 99999999965 468899999986531
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GN 302 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~ 302 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||+++++|.+++... ..
T Consensus 65 --------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 124 (389)
T 3gni_B 65 --------------------CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG 124 (389)
T ss_dssp --------------------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTC
T ss_pred --------------------cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccC
Confidence 11234456788999999999999999999999999999999999999999999875 56
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.+..+
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999999999999999999999999999999999999988654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=217.24 Aligned_cols=153 Identities=24% Similarity=0.393 Sum_probs=131.9
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
+...++|++.+.||+|+||.||++.+. .++.+|+|.+....
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~------------------------------------- 57 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDA------------------------------------- 57 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC----------------------------------------
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccc-------------------------------------
Confidence 345789999999999999999999864 37889999885431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||++ ++|.+++... ..+
T Consensus 58 --------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~ 116 (311)
T 3niz_A 58 --------------------EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGL 116 (311)
T ss_dssp -----------------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCC
T ss_pred --------------------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCC
Confidence 112234567899999999999999999999999999999999995 5888877654 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 117 ~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999999999999999999999999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=215.94 Aligned_cols=152 Identities=26% Similarity=0.415 Sum_probs=135.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 40 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESE---------------------------------------- 40 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCC----------------------------------------
T ss_pred cccceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccc----------------------------------------
Confidence 578999999999999999999865 458899999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++...+..++||||+++++|.+++...+.+++..
T Consensus 41 -----------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~ 103 (311)
T 4agu_A 41 -----------------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL 103 (311)
T ss_dssp -----------------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHH
T ss_pred -----------------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHH
Confidence 112234567889999999999999999999999999999999999999999988777899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999999999999999999999999999999999999999998765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=226.74 Aligned_cols=152 Identities=23% Similarity=0.418 Sum_probs=133.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.||+|.+.+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~----------------------------------------- 62 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRM----------------------------------------- 62 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECST-----------------------------------------
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCch-----------------------------------------
Confidence 578999999999999999999865 56888999998642
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........++.+|+.+|+.++||||+++++++... ..+|+||||+ +++|.+++.....
T Consensus 63 ----------------~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~ 125 (432)
T 3n9x_A 63 ----------------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF 125 (432)
T ss_dssp ----------------TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSCC
T ss_pred ----------------hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccCC
Confidence 11223346688999999999999999999998766 5799999998 5799999988778
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 126 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999999999999999999999999999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=214.82 Aligned_cols=150 Identities=28% Similarity=0.474 Sum_probs=131.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+ ..++.+|+|.+....
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~---------------------------------------- 38 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEK---------------------------------------- 38 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSS----------------------------------------
T ss_pred CccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccc----------------------------------------
Confidence 46899999999999999999986 357889999885431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
........+.+|+.+++.++||||+++++++..++.+|+||||++ ++|.+++... +.+++.
T Consensus 39 -----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 100 (288)
T 1ob3_A 39 -----------------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESV 100 (288)
T ss_dssp -----------------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHH
T ss_pred -----------------cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHH
Confidence 111223557889999999999999999999999999999999995 5999988764 569999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 999999999999999999999999999999999999999999999997653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=222.26 Aligned_cols=156 Identities=31% Similarity=0.615 Sum_probs=136.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
..+++|++.+.||+|+||.||++.... .+++.+|+|++.+....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 96 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV---------------------------------- 96 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE----------------------------------
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh----------------------------------
Confidence 356899999999999999999998643 46789999998764211
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........+.+|+.+++.+ +||||+++++++...+.+|+||||+++++|.+++.....
T Consensus 97 ---------------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 155 (355)
T 1vzo_A 97 ---------------------QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 155 (355)
T ss_dssp ---------------------EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC
T ss_pred ---------------------hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC
Confidence 1112234466799999999 699999999999999999999999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999999999999999999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=223.93 Aligned_cols=153 Identities=25% Similarity=0.400 Sum_probs=135.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---------------------------------------- 150 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRET---------------------------------------- 150 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTT----------------------------------------
T ss_pred chHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEcccc----------------------------------------
Confidence 4578999999999999999999965 45788999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
........+.+|+.+|+.++||||+++++++...+.+|+||||+++++|.+++...+ .+++
T Consensus 151 ------------------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 212 (377)
T 3cbl_A 151 ------------------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212 (377)
T ss_dssp ------------------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCH
T ss_pred ------------------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCH
Confidence 112233567899999999999999999999999999999999999999999998654 5999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 213 ~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999999999999999999999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=211.51 Aligned_cols=154 Identities=29% Similarity=0.528 Sum_probs=136.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~-------------------------------------- 49 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAM-------------------------------------- 49 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH--------------------------------------
T ss_pred ccccceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhh--------------------------------------
Confidence 6788999999999999999999854 4578899999865311
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++... ..+++
T Consensus 50 ------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 111 (278)
T 3cok_A 50 ------------------YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111 (278)
T ss_dssp ------------------HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCH
T ss_pred ------------------hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCH
Confidence 11123456889999999999999999999999999999999999999999999865 56999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999999999999999999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=216.68 Aligned_cols=154 Identities=27% Similarity=0.420 Sum_probs=137.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~--------------------------------------- 78 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSL--------------------------------------- 78 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGG---------------------------------------
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhh---------------------------------------
Confidence 4578999999999999999999855 567889999986541
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++...+.+++.
T Consensus 79 -----------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~ 141 (335)
T 2owb_A 79 -----------------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 141 (335)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHH
T ss_pred -----------------hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHH
Confidence 112234456888999999999999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 142 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 142 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999999999999999999999999999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-27 Score=211.90 Aligned_cols=154 Identities=27% Similarity=0.420 Sum_probs=137.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~--------------------------------------- 52 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSL--------------------------------------- 52 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGG---------------------------------------
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhh---------------------------------------
Confidence 4578999999999999999999855 557889999886541
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...+.+++.
T Consensus 53 -----------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 115 (294)
T 2rku_A 53 -----------------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 115 (294)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHH
T ss_pred -----------------ccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHH
Confidence 112233456888999999999999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 116 ~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999999999999999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-27 Score=209.88 Aligned_cols=152 Identities=26% Similarity=0.412 Sum_probs=134.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+..++|++.+.||+|+||.||++.+.. +..+|+|.+....
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-------------------------------------- 44 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKG--QYDVAVKMIKEGS-------------------------------------- 44 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECBTT--------------------------------------
T ss_pred echhheeeeeeeccCCCceEEEEEecC--ceeEEEEEeccCC--------------------------------------
Confidence 356889999999999999999997553 5679999886431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
.....+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++...+ .++
T Consensus 45 ----------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 102 (268)
T 3sxs_A 45 ----------------------MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE 102 (268)
T ss_dssp ----------------------BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCC
T ss_pred ----------------------CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCC
Confidence 112457889999999999999999999999999999999999999999998754 599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....+
T Consensus 103 ~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 103 PSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999999999999999999999999999999999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=212.12 Aligned_cols=155 Identities=32% Similarity=0.554 Sum_probs=137.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~------------------------------------- 52 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQL------------------------------------- 52 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHH-------------------------------------
T ss_pred hhhhhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEccccc-------------------------------------
Confidence 35789999999999999999999865 4577899998865311
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...+.+++
T Consensus 53 -------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 113 (284)
T 2vgo_A 53 -------------------EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE 113 (284)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCH
T ss_pred -------------------chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCH
Confidence 1112235678999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999999999999999999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=218.62 Aligned_cols=160 Identities=24% Similarity=0.407 Sum_probs=137.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+.+......
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~------------------------------------ 65 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLED------------------------------------ 65 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTT------------------------------------
T ss_pred ccceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccc------------------------------------
Confidence 468999999999999999999855 4588999999876532110
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCc-chHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGG-ELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.++||||+++++++.+.+.+++|||++.++ +|.+++.....+++.
T Consensus 66 ---------------~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~ 130 (335)
T 3dls_A 66 ---------------CWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP 130 (335)
T ss_dssp ---------------SEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHH
T ss_pred ---------------cccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHH
Confidence 0011223455778999999999999999999999999999999998766 999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..+
T Consensus 131 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999999999999999999999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=215.88 Aligned_cols=177 Identities=24% Similarity=0.456 Sum_probs=131.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccc-cceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRT-ANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|++.+........... .......+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 68 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP-------------------- 68 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC---------------------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccc--------------------
Confidence 45789999999999999999999855 457899999987653221110000 00000000
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
..............+.+|+.+++.++||||+++++++.+ .+.+|+||||+++++|.+++. .++
T Consensus 69 --------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~ 133 (298)
T 2zv2_A 69 --------------APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKP 133 (298)
T ss_dssp --------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSC
T ss_pred --------------cccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCC
Confidence 000011112234668899999999999999999999876 578999999999999988654 357
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 134 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 189 (298)
T 2zv2_A 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 99999999999999999999999999999999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-27 Score=215.46 Aligned_cols=152 Identities=25% Similarity=0.333 Sum_probs=131.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+.+.||+|+||.||++.+. .+++.+|+|++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------------------------------- 47 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISF--------------------------------------- 47 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGG---------------------------------------
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccc---------------------------------------
Confidence 467999999999999999999865 4578999999864311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--eEEEEEeccCCcchHHHHHhcC---C
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTILRDKG---N 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~---~ 302 (362)
......+.+|+.+++.++||||+++++++.... ..|+||||+++++|.+++.... .
T Consensus 48 -------------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 108 (319)
T 4euu_A 48 -------------------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108 (319)
T ss_dssp -------------------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTC
T ss_pred -------------------cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccC
Confidence 112345678999999999999999999987654 7899999999999999998643 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe----cCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~----~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++.+..
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9999999999999999999999999999999999999 7778899999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=215.12 Aligned_cols=153 Identities=27% Similarity=0.422 Sum_probs=131.2
Q ss_pred ccccCcEEEEEecccceecEEEEEe---cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQI---AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
...++|++.+.||+|+||.||++.. ...+++.+|+|.+...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------------------------------ 50 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------------------------------------ 50 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC------------------------------------
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC------------------------------------
Confidence 3568899999999999999999984 3345788999987542
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
.......+.+|+.+++.++||||+++++++... ..+++||||+++++|.+++...
T Consensus 51 -----------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 107 (295)
T 3ugc_A 51 -----------------------TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 107 (295)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC
T ss_pred -----------------------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc
Confidence 122345688999999999999999999987543 5689999999999999999875
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 G-NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~-~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 108 KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 4 49999999999999999999999999999999999999999999999999998664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-27 Score=214.53 Aligned_cols=156 Identities=25% Similarity=0.316 Sum_probs=133.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-------------------------------------- 71 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETL-------------------------------------- 71 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGG--------------------------------------
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCccc--------------------------------------
Confidence 35789999999999999999999855 457889999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.........+.+|+.+++.++||||+++++++..++.+|++|||+++++|.+++...+.+++
T Consensus 72 ------------------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 133 (309)
T 2h34_A 72 ------------------SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP 133 (309)
T ss_dssp ------------------GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCH
T ss_pred ------------------ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCH
Confidence 11223346688999999999999999999999999999999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 134 ~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred HHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999999999999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=216.42 Aligned_cols=152 Identities=26% Similarity=0.414 Sum_probs=129.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
....+|++.+.||+|+||.||++... ++.+|+|++....
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~-------------------------------------- 72 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQD-------------------------------------- 72 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEECCCC--------------------------------------
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC---CCcEEEEEecCCC--------------------------------------
Confidence 45688999999999999999999853 6679999886531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC---
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--- 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--- 302 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++.....
T Consensus 73 -------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 133 (309)
T 3p86_A 73 -------------------FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133 (309)
T ss_dssp -------------------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHH
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCC
Confidence 1122345688999999999999999999999999999999999999999999986543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++...
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999999999999999 9999999999999999999999999997543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=220.48 Aligned_cols=154 Identities=27% Similarity=0.389 Sum_probs=135.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
...++|.+.+.||+|+||.||++.+.+ .+++.+|+|.+.+..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------------------------------- 89 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---------------------------------- 89 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----------------------------------
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----------------------------------
Confidence 356889999999999999999999764 345789999886431
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.......+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++...
T Consensus 90 ------------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 145 (343)
T 1luf_A 90 ------------------------SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145 (343)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred ------------------------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhC
Confidence 1223456889999999999999999999999999999999999999999999763
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 -----------------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 -----------------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225 (343)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred cccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccc
Confidence 468999999999999999999999999999999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-27 Score=210.49 Aligned_cols=156 Identities=28% Similarity=0.462 Sum_probs=138.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||.+.+. .+++.+|+|.+....
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~-------------------------------------- 48 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQK-------------------------------------- 48 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHH--------------------------------------
T ss_pred ceeccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEecccc--------------------------------------
Confidence 45789999999999999999999865 457899999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.........+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++...+.+++
T Consensus 49 ------------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 110 (276)
T 2h6d_A 49 ------------------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE 110 (276)
T ss_dssp ------------------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCH
T ss_pred ------------------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCH
Confidence 11122345678999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999999999999999999999999999999999987643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=228.76 Aligned_cols=154 Identities=30% Similarity=0.536 Sum_probs=136.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~--------------------------------------- 64 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQV--------------------------------------- 64 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTC---------------------------------------
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhc---------------------------------------
Confidence 357999999999999999999855 5688999999865421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+.+...+.+++..
T Consensus 65 -----------------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 127 (484)
T 3nyv_A 65 -----------------KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127 (484)
T ss_dssp -----------------CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHH
T ss_pred -----------------ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHH
Confidence 112234568899999999999999999999999999999999999999999998888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 128 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999999999999999999999 4678999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-27 Score=208.99 Aligned_cols=151 Identities=32% Similarity=0.495 Sum_probs=134.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .++..+|+|.+.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~---------------------------------------- 46 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYF---------------------------------------- 46 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhc----------------------------------------
Confidence 457999999999999999999865 457789999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...+.+++..
T Consensus 47 -------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 107 (277)
T 3f3z_A 47 -------------------VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD 107 (277)
T ss_dssp -------------------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHH
T ss_pred -------------------cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHH
Confidence 1123567889999999999999999999999999999999999999999998888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+++.+..
T Consensus 108 ~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999999999999999999999999 7788999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=214.90 Aligned_cols=151 Identities=25% Similarity=0.400 Sum_probs=117.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 42 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDS--------------------------------------- 42 (317)
T ss_dssp ----------------CEEEEEECS-SSCCEEEEEEEECCS---------------------------------------
T ss_pred cccceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeeccc---------------------------------------
Confidence 3578999999999999999999854 568899999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc------
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK------ 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------ 300 (362)
.......+.+|+.+++.++||||+++++++..++.+|+||||++ ++|.+++...
T Consensus 43 -------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~ 102 (317)
T 2pmi_A 43 -------------------EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTP 102 (317)
T ss_dssp -------------------TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCC
T ss_pred -------------------ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccc
Confidence 11123457789999999999999999999999999999999996 6999988753
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 103 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 103 RGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 358999999999999999999999999999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=208.76 Aligned_cols=153 Identities=28% Similarity=0.464 Sum_probs=135.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 43 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKK---------------------------------------- 43 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeeccc----------------------------------------
Confidence 478999999999999999999855 457889999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++..++..|++|||+++++|.+.+.....+++..
T Consensus 44 -----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 106 (284)
T 3kk8_A 44 -----------------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106 (284)
T ss_dssp -----------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred -----------------CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHH
Confidence 122234567899999999999999999999999999999999999999999998888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc---EEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~---~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 107 ~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred HHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999999999999999999999999986655 99999999977654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=218.80 Aligned_cols=148 Identities=19% Similarity=0.247 Sum_probs=127.3
Q ss_pred cccCcEEEEEecccceecEEEEEe----cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQI----AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++.+ ....++.+|+|.+.+.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------------------------------ 106 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------------------------------------ 106 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------------------------------------
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------------------------------------
Confidence 346799999999999999999952 3345788999988543
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC---CcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN---CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
....+..|+.++..+. ||||+++++++...+..|+||||+++++|.+++..
T Consensus 107 --------------------------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 160 (365)
T 3e7e_A 107 --------------------------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINL 160 (365)
T ss_dssp --------------------------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHH
T ss_pred --------------------------ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHH
Confidence 1234567777777775 99999999999999999999999999999999974
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-----------CCcEEEEecccceec
Q psy14740 300 -----KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-----------SGYVKLVDFGFAKKL 356 (362)
Q Consensus 300 -----~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-----------~~~~kl~DFG~a~~~ 356 (362)
...+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 161 ~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 161 YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233 (365)
T ss_dssp HHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEG
T ss_pred hhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhh
Confidence 356999999999999999999999999999999999999988 899999999999765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=214.38 Aligned_cols=155 Identities=22% Similarity=0.377 Sum_probs=134.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
...++|.+.+.||+|+||.||++.+.. ..++.+|+|.+...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------------------------------- 64 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----------------------------------- 64 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-----------------------------------
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-----------------------------------
Confidence 356789999999999999999998632 33478999987542
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++....
T Consensus 65 -----------------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (314)
T 2ivs_A 65 -----------------------ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121 (314)
T ss_dssp -----------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTT
T ss_pred -----------------------CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHh
Confidence 112234568899999999999999999999999999999999999999999998643
Q ss_pred C------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 N------------------------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~------------------------l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
. +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~ 201 (314)
T 2ivs_A 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201 (314)
T ss_dssp TSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECT
T ss_pred hccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccc
Confidence 2 8899999999999999999999999999999999999999999999999998764
Q ss_pred C
Q psy14740 358 G 358 (362)
Q Consensus 358 ~ 358 (362)
.
T Consensus 202 ~ 202 (314)
T 2ivs_A 202 E 202 (314)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=219.19 Aligned_cols=152 Identities=26% Similarity=0.428 Sum_probs=133.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~--------------------------------------- 88 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPY--------------------------------------- 88 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS---------------------------------------
T ss_pred cccceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccc---------------------------------------
Confidence 3578999999999999999999855 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
......+.+|+.+|+.++||||+++++++.+...+|+||||+++++|.+++.... .+++
T Consensus 89 --------------------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~ 148 (387)
T 1kob_A 89 --------------------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 148 (387)
T ss_dssp --------------------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCH
T ss_pred --------------------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCH
Confidence 1122457899999999999999999999999999999999999999999987643 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.+..
T Consensus 149 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 149 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999999999999999999999999974 47799999999987754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=217.40 Aligned_cols=147 Identities=28% Similarity=0.469 Sum_probs=129.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~---------------------------------------- 59 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSK---------------------------------------- 59 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTT----------------------------------------
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEccc----------------------------------------
Confidence 467999999999999999999865 468899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
....+|++++..+ +||||+++++++.+++.+|+||||++|++|.+.+...+.+++.
T Consensus 60 -----------------------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~ 116 (342)
T 2qr7_A 60 -----------------------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER 116 (342)
T ss_dssp -----------------------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHH
T ss_pred -----------------------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence 1235688888887 7999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC----CcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++||+||||||+|||+..+ +.+||+|||+++.+..
T Consensus 117 ~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred HHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999999999999999999998543 3599999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=209.29 Aligned_cols=149 Identities=26% Similarity=0.384 Sum_probs=132.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+.. ++.+|+|.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--------------------------------------- 46 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGA--------------------------------------- 46 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEEECTTS---------------------------------------
T ss_pred ChhhceeeheecCCCccEEEEEEecC--CCeEEEEEecccc---------------------------------------
Confidence 45789999999999999999998653 6679999886531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
...+.+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++... ..+++
T Consensus 47 ---------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 105 (269)
T 4hcu_A 47 ---------------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA 105 (269)
T ss_dssp ---------------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCH
T ss_pred ---------------------cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCH
Confidence 11245789999999999999999999999999999999999999999999754 45899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 106 ~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 106 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999999999999999999999999999999999999999997553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=213.91 Aligned_cols=157 Identities=24% Similarity=0.412 Sum_probs=136.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------------------- 51 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSR-------------------------------------- 51 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSS--------------------------------------
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEeccccc--------------------------------------
Confidence 356999999999999999999865 45889999998764210
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
..........+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++...+.+++..
T Consensus 52 ---------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 116 (321)
T 2a2a_A 52 ---------------ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE 116 (321)
T ss_dssp ---------------SCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHH
T ss_pred ---------------ccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHH
Confidence 00011134568899999999999999999999999999999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.+..
T Consensus 117 ~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 999999999999999999999999999999999887 799999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=208.52 Aligned_cols=154 Identities=21% Similarity=0.377 Sum_probs=132.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 48 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPL---------------------------------------- 48 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCC----------------------------------------
T ss_pred cchhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccc----------------------------------------
Confidence 467999999999999999999865 457899999886531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----CC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----GN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~ 302 (362)
........+.+|+..+..+ +||||+++++++.+++..|+||||+++++|.+++... ..
T Consensus 49 -----------------~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 111 (289)
T 1x8b_A 49 -----------------AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111 (289)
T ss_dssp -----------------TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCC
T ss_pred -----------------cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccC
Confidence 1122345678899999998 9999999999999999999999999999999999764 56
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-------------------CcEEEEecccceecCCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-------------------GYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-------------------~~~kl~DFG~a~~~~~~ 359 (362)
+++..++.++.|++.||.|||++||+||||||+||+++.+ ..++|+|||+++....+
T Consensus 112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc
Confidence 9999999999999999999999999999999999999844 47999999999877543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=212.51 Aligned_cols=153 Identities=19% Similarity=0.191 Sum_probs=132.2
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCC------CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHH
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPS------RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFN 218 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~ 218 (362)
....++|.+.+.||+|+||.||++.+..... ..+|+|.+.+.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-------------------------------- 51 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-------------------------------- 51 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--------------------------------
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--------------------------------
Confidence 3456889999999999999999998654321 45888877432
Q ss_pred hhccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHH
Q psy14740 219 QLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 298 (362)
.......+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.
T Consensus 52 ---------------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 104 (289)
T 4fvq_A 52 ---------------------------HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK 104 (289)
T ss_dssp ---------------------------GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHH
T ss_pred ---------------------------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHH
Confidence 12233568899999999999999999999999999999999999999999998
Q ss_pred hcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc--------EEEEecccceec
Q psy14740 299 DKGN-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY--------VKLVDFGFAKKL 356 (362)
Q Consensus 299 ~~~~-l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~--------~kl~DFG~a~~~ 356 (362)
..+. +++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 105 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~ 171 (289)
T 4fvq_A 105 KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171 (289)
T ss_dssp HTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence 7554 999999999999999999999999999999999999998877 999999999755
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=216.64 Aligned_cols=153 Identities=24% Similarity=0.365 Sum_probs=130.0
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~-------------------------------------- 71 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEH-------------------------------------- 71 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------------------------------------
T ss_pred cchhhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccc--------------------------------------
Confidence 35789999999999999999999855 458899999986431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+++.+|+||||++ ++|.+++.....+++
T Consensus 72 -------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~ 131 (329)
T 3gbz_A 72 -------------------EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSM 131 (329)
T ss_dssp ---------------------------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCH
T ss_pred -------------------cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCH
Confidence 111223456789999999999999999999999999999999995 699999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-----CCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-----TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-----~~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 132 ~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999999999999999999999999999999995 44569999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=226.23 Aligned_cols=165 Identities=29% Similarity=0.470 Sum_probs=134.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|++.+....... .
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~-~-------------------------------- 79 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGR-Y-------------------------------- 79 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC-----------------------------------------
T ss_pred cccceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhccccc-c--------------------------------
Confidence 3578999999999999999999965 46789999998764211000 0
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.............+.+|+.+++.++||||+++++++.++..+|+||||+++++|.+.+...+.+++.
T Consensus 80 -------------~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~ 146 (504)
T 3q5i_A 80 -------------SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146 (504)
T ss_dssp ---------------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHH
T ss_pred -------------cccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHH
Confidence 0000111234466889999999999999999999999999999999999999999999888889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 147 ~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 201 (504)
T 3q5i_A 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201 (504)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCC
Confidence 9999999999999999999999999999999998776 699999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=226.93 Aligned_cols=152 Identities=32% Similarity=0.545 Sum_probs=130.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .++..+|+|++.+...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~---------------------------------------- 75 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSV---------------------------------------- 75 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-------------------------------------------
T ss_pred cCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEecccc----------------------------------------
Confidence 46999999999999999999865 4578899999865411
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+|+.+++.++||||+++++++.+...+|+||||+++++|.+.+.....+++..+
T Consensus 76 -----------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~ 138 (494)
T 3lij_A 76 -----------------STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA 138 (494)
T ss_dssp -------------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHH
T ss_pred -----------------CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHH
Confidence 111235678999999999999999999999999999999999999999999988888999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 139 ~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 139 AVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred HHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999999999999999999999976 45599999999987643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=225.73 Aligned_cols=156 Identities=19% Similarity=0.212 Sum_probs=125.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+ +++.||+|.+.+......
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~----------------------------------- 59 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLV----------------------------------- 59 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCB-----------------------------------
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCcccc-----------------------------------
Confidence 357789999999999999999986 468899999876421000
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC--------------------------Ccceeeeeeeeec---
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--------------------------CDFIVKLYKTFKD--- 277 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------------------------h~~i~~~~~~~~~--- 277 (362)
........+.+.+|+.+++.++ ||||+++++++.+
T Consensus 60 ----------------~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~ 123 (336)
T 2vuw_A 60 ----------------NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123 (336)
T ss_dssp ----------------TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTC
T ss_pred ----------------ccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhcc
Confidence 0011223456788999888876 6666666666654
Q ss_pred ----------cceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEecCCC---
Q psy14740 278 ----------KKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH-SRNIIYRDLKPENLLLSTSG--- 343 (362)
Q Consensus 278 ----------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH-~~~iiHrDikp~NIl~~~~~--- 343 (362)
.+.+|+||||+++|++.+.+.+ +.+++..++.++.|++.||.||| ++||+||||||+|||++.++
T Consensus 124 ~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~ 202 (336)
T 2vuw_A 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202 (336)
T ss_dssp CSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSE
T ss_pred ccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcc
Confidence 7889999999999977666644 56899999999999999999999 99999999999999999887
Q ss_pred -----------------cEEEEecccceecC
Q psy14740 344 -----------------YVKLVDFGFAKKLI 357 (362)
Q Consensus 344 -----------------~~kl~DFG~a~~~~ 357 (362)
.+||+|||+|+.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 233 (336)
T 2vuw_A 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLER 233 (336)
T ss_dssp EEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred eeeeccCccccccCCCceEEEeeccccEecC
Confidence 89999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=219.66 Aligned_cols=154 Identities=25% Similarity=0.407 Sum_probs=134.2
Q ss_pred cccCcEEEEEecccceecEEEEEecC------CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG------DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
..++|.+.+.||+|+||.||++.+.+ ..+..+|+|.+...
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---------------------------------- 112 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---------------------------------- 112 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----------------------------------
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----------------------------------
Confidence 45789999999999999999998653 22346899987543
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.+ +||||+++++++...+..|+||||+++++|.+++..
T Consensus 113 ------------------------~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 168 (382)
T 3tt0_A 113 ------------------------ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 168 (382)
T ss_dssp ------------------------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred ------------------------cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHH
Confidence 1123346688999999999 999999999999999999999999999999999986
Q ss_pred cC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 KG----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 243 (382)
T 3tt0_A 169 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243 (382)
T ss_dssp TCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSC
T ss_pred hcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccccccc
Confidence 43 489999999999999999999999999999999999999999999999999987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=214.99 Aligned_cols=156 Identities=29% Similarity=0.408 Sum_probs=135.0
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
....+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------------------------------------ 62 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESD------------------------------------ 62 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCS------------------------------------
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCC------------------------------------
Confidence 3346889999999999999999999855 558899999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+.+|+.+++.++||||+++++++...+..|+||||+++++|.++....+.+
T Consensus 63 ---------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~ 121 (331)
T 4aaa_A 63 ---------------------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGL 121 (331)
T ss_dssp ---------------------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCC
T ss_pred ---------------------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCC
Confidence 11223455788999999999999999999999999999999999999999888777789
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 122 ~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 122 DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999999999999999999999999999999999999999999999997654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=210.15 Aligned_cols=150 Identities=26% Similarity=0.462 Sum_probs=130.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+..+|+|.+....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-------------------------------------- 60 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-------------------------------------- 60 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS--------------------------------------
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC--------------------------------------
Confidence 35678999999999999999999865 36679999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
.....+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++.. ...++
T Consensus 61 ----------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 118 (283)
T 3gen_A 61 ----------------------MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118 (283)
T ss_dssp ----------------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCC
T ss_pred ----------------------CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCC
Confidence 1124578899999999999999999999999999999999999999999976 45699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 119 ~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999999999999999999999999999999999997653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=215.68 Aligned_cols=146 Identities=28% Similarity=0.462 Sum_probs=127.7
Q ss_pred cCcEEE---EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 149 SDLRVI---TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 149 ~~~~~~---~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+|.+. +.||+|+||.||++.+. .+++.+|+|.+.+.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~--------------------------------------- 47 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHK-KSNQAFAVKIISKR--------------------------------------- 47 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---------------------------------------
T ss_pred hccccccCCCccccCCCeEEEEEEEC-CCCCEEEEEEEChh---------------------------------------
Confidence 345554 67999999999999865 45889999988542
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
......+|+.+++.+. ||||+++++++.+....|+||||+++++|.+++...+.++
T Consensus 48 -----------------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 104 (325)
T 3kn6_A 48 -----------------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS 104 (325)
T ss_dssp -----------------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCC
T ss_pred -----------------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCC
Confidence 1244678999999996 9999999999999999999999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~~ 357 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 105 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999999999999999999998765 89999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=210.64 Aligned_cols=153 Identities=27% Similarity=0.384 Sum_probs=131.0
Q ss_pred ccCcEEEEEecccceecEEEEEe---cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQI---AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...|++.+.||+|+||.||++.+ ...+++.+|+|.+....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~------------------------------------- 62 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES------------------------------------- 62 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC----------------------------------------
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-------------------------------------
Confidence 45699999999999999999984 23457889999886431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhc-C
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDK-G 301 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~ 301 (362)
.......+.+|+.+++.++||||+++++++... ..+|+||||+++++|.+++... .
T Consensus 63 ---------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 121 (302)
T 4e5w_A 63 ---------------------GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121 (302)
T ss_dssp -----------------------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT
T ss_pred ---------------------cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc
Confidence 112335678999999999999999999998876 6799999999999999999654 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 122 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 699999999999999999999999999999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=227.43 Aligned_cols=152 Identities=27% Similarity=0.500 Sum_probs=134.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|++.+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------------------------------- 60 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASA--------------------------------------- 60 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHH---------------------------------------
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccc---------------------------------------
Confidence 467999999999999999999855 4588999999865311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++++.+...+|+||||+++++|.+.+...+.+++..
T Consensus 61 ------------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 122 (486)
T 3mwu_A 61 ------------------KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122 (486)
T ss_dssp ------------------BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred ------------------cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHH
Confidence 11234568899999999999999999999999999999999999999999998888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec---CCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS---TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~---~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 123 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999999999999999999995 45679999999997654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=221.43 Aligned_cols=154 Identities=23% Similarity=0.355 Sum_probs=128.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
....+|.+.+.||+|+||.||++.... ..+..+|+|.+...
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~------------------------------------- 84 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG------------------------------------- 84 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-------------------------------------
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-------------------------------------
Confidence 345789999999999999999998542 34667999988543
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-C
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-N 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~ 302 (362)
........+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++...+ .
T Consensus 85 ---------------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 143 (373)
T 2qol_A 85 ---------------------YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143 (373)
T ss_dssp ---------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTC
T ss_pred ---------------------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCC
Confidence 112234568899999999999999999999999999999999999999999998654 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999999999999999999999999999999999999999998664
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=218.59 Aligned_cols=153 Identities=30% Similarity=0.423 Sum_probs=131.9
Q ss_pred cccCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.+. ..+++.+|+|.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------------------------- 64 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------------------------- 64 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----------------------------------
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-----------------------------------
Confidence 5688999999999999999999853 2345789999885431
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccc-eEEEEEeccCCcchHHHHHhc
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~ 300 (362)
.......+.+|+.+++.+ +||||+++++++...+ .+++||||+++++|.+++...
T Consensus 65 -----------------------~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 121 (359)
T 3vhe_A 65 -----------------------THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121 (359)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTT
T ss_pred -----------------------CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhc
Confidence 122345688999999999 7899999999987754 499999999999999999764
Q ss_pred CC------------------------------------------------------------------CCHHHHHHHHHH
Q psy14740 301 GN------------------------------------------------------------------FDDATTRFYTAC 314 (362)
Q Consensus 301 ~~------------------------------------------------------------------l~~~~~~~~~~q 314 (362)
.. +++..+..++.|
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 201 (359)
T 3vhe_A 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201 (359)
T ss_dssp TTSBCSCC------------------------------------------------------CTTTTCBCHHHHHHHHHH
T ss_pred cccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHH
Confidence 32 889999999999
Q ss_pred HHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 315 VVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 315 l~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 202 l~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred HHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 9999999999999999999999999999999999999998663
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=214.51 Aligned_cols=148 Identities=27% Similarity=0.408 Sum_probs=131.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 46 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKS---------------------------------------- 46 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTC----------------------------------------
T ss_pred cCCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEecccc----------------------------------------
Confidence 468999999999999999999854 458899999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
....+.+|+.+++.+ +||||+++++++...+..|+||||+ +++|.+++... +.+++
T Consensus 47 ---------------------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~ 104 (330)
T 2izr_A 47 ---------------------RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL 104 (330)
T ss_dssp ---------------------SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred ---------------------chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCH
Confidence 123478899999999 9999999999999999999999999 99999999863 57999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc-----EEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-----VKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~-----~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.+..
T Consensus 105 ~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 105 KTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999999999999999999999999999999999998887 99999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=219.32 Aligned_cols=155 Identities=24% Similarity=0.380 Sum_probs=132.1
Q ss_pred hhccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHh
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQ 219 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~ 219 (362)
.....++|++.+.||+|+||.||++...+ ..++.+|+|.+...
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------------------------- 112 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------------------------------- 112 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---------------------------------
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---------------------------------
Confidence 34456889999999999999999998543 34568999987532
Q ss_pred hccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 220 LISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.++||||+++++++......|+||||+++++|.+++..
T Consensus 113 -------------------------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 167 (367)
T 3l9p_A 113 -------------------------CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 167 (367)
T ss_dssp -------------------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHH
T ss_pred -------------------------cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHh
Confidence 1122334678899999999999999999999999999999999999999999986
Q ss_pred cC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceec
Q psy14740 300 KG-------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKL 356 (362)
Q Consensus 300 ~~-------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~ 356 (362)
.+ .++...++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 168 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234 (367)
T ss_dssp HSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred hccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence 43 488999999999999999999999999999999999999554 5999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=212.31 Aligned_cols=154 Identities=29% Similarity=0.403 Sum_probs=135.2
Q ss_pred cccCcEEEEEecccceecEEEEEe----cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQI----AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++.. ...+++.+|+|.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------------------------- 65 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------------------------- 65 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----------------------------------
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-----------------------------------
Confidence 457899999999999999999985 33456789999886431
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.+++.+ +||||+++++++..++..++||||+++++|.+++....
T Consensus 66 -----------------------~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (313)
T 1t46_A 66 -----------------------HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122 (313)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTT
T ss_pred -----------------------hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcc
Confidence 112345688999999999 99999999999999999999999999999999997643
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 ------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 197 (313)
T 1t46_A 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197 (313)
T ss_dssp TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTS
T ss_pred cccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccc
Confidence 389999999999999999999999999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=215.67 Aligned_cols=153 Identities=26% Similarity=0.439 Sum_probs=131.9
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++.+.+ ..+..+|+|.+....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------------------------- 87 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------------------------------- 87 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------------------------
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-----------------------------------
Confidence 46789999999999999999998632 345679999886431
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.+++.+ +||||+++++++...+.+|+||||+++++|.+++....
T Consensus 88 -----------------------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 144 (344)
T 1rjb_A 88 -----------------------DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144 (344)
T ss_dssp ---------------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred -----------------------CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcc
Confidence 112345688999999999 99999999999999999999999999999999997643
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 -----------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 -----------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~ 223 (344)
T 1rjb_A 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223 (344)
T ss_dssp TCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGG
T ss_pred ccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccc
Confidence 27899999999999999999999999999999999999999999999999998664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=217.75 Aligned_cols=151 Identities=23% Similarity=0.438 Sum_probs=123.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.||+|.+.+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~---------------------------------------- 45 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDA---------------------------------------- 45 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEET-TTCCEEEEEEECC-----------------------------------------
T ss_pred ccCceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEeccc----------------------------------------
Confidence 4678999999999999999999855 55889999988542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
...........+|+.+++.+. ||||+++++++..+ ..+|+||||++ ++|.+++.. +.+
T Consensus 46 -----------------~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~ 106 (388)
T 3oz6_A 46 -----------------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NIL 106 (388)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCC
T ss_pred -----------------ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCC
Confidence 112233456788999999996 99999999998654 37999999995 799998876 579
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 107 ~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 107 EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 999999999999999999999999999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=207.16 Aligned_cols=156 Identities=28% Similarity=0.461 Sum_probs=135.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.+|+|.+.+.....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~-------------------------------------- 45 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSS-------------------------------------- 45 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTT--------------------------------------
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccc--------------------------------------
Confidence 56999999999999999999865 457899999987642110
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.........+.+|+.+++.++||||+++++++......|+||||+++++|.+++.....+++..+
T Consensus 46 ---------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 110 (283)
T 3bhy_A 46 ---------------SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 110 (283)
T ss_dssp ---------------CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHH
T ss_pred ---------------cccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHH
Confidence 01112345688999999999999999999999999999999999999999999988788999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.+..
T Consensus 111 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 99999999999999999999999999999998776 899999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=208.67 Aligned_cols=151 Identities=27% Similarity=0.503 Sum_probs=130.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++... .++..+|+|.+.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~---------------------------------------- 59 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDR---------------------------------------- 59 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred hhheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccc----------------------------------------
Confidence 467999999999999999999855 457889999886531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc----CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK----GNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l 303 (362)
.......+.+|+.+++.++||||+++++++.+....|+||||+++++|.+++... ..+
T Consensus 60 ------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 121 (285)
T 3is5_A 60 ------------------SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121 (285)
T ss_dssp ------------------CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCC
T ss_pred ------------------cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCC
Confidence 1122456789999999999999999999999999999999999999999988543 579
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec---CCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS---TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~---~~~~~kl~DFG~a~~~~ 357 (362)
++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+++.+.
T Consensus 122 ~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999999999999999999999999999994 46789999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=214.44 Aligned_cols=155 Identities=23% Similarity=0.326 Sum_probs=120.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCC--CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPS--RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|++.+.||+|+||.||++.+....+ ..+|+|.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~------------------------------------- 63 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI------------------------------------- 63 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-----------------------------------------
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc-------------------------------------
Confidence 45789999999999999999998654322 378999875431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceE------EEEEeccCCcchHHHHH
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYL------YMLMESCLGGELWTILR 298 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~ 298 (362)
........+.+|+.+++.++||||+++++++...... +++|||+++++|.+++.
T Consensus 64 --------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 123 (323)
T 3qup_A 64 --------------------IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123 (323)
T ss_dssp ----------------------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHH
T ss_pred --------------------cCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHH
Confidence 1122346688999999999999999999998876654 99999999999999986
Q ss_pred hcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 299 DKG------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 299 ~~~------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~ 189 (323)
T 3qup_A 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189 (323)
T ss_dssp HHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred hhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence 532 589999999999999999999999999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=213.07 Aligned_cols=154 Identities=25% Similarity=0.407 Sum_probs=133.3
Q ss_pred cccCcEEEEEecccceecEEEEEecC------CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG------DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
..++|.+.+.||+|+||.||++.+.+ ..+..+|+|.+...
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---------------------------------- 78 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---------------------------------- 78 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----------------------------------
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----------------------------------
Confidence 45789999999999999999998653 34567999987542
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.+ +||||+++++++...+.+|+||||+++++|.+++..
T Consensus 79 ------------------------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 134 (334)
T 2pvf_A 79 ------------------------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134 (334)
T ss_dssp ------------------------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHT
T ss_pred ------------------------CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHH
Confidence 1122345688999999999 899999999999999999999999999999999986
Q ss_pred cC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 KG----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 209 (334)
T 2pvf_A 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209 (334)
T ss_dssp TSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTT
T ss_pred hccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccc
Confidence 43 388999999999999999999999999999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=216.11 Aligned_cols=148 Identities=29% Similarity=0.448 Sum_probs=123.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~---------------------------------------- 90 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV---------------------------------------- 90 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------------------------------------
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch----------------------------------------
Confidence 457999999999999999999865 457889999885431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
....+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++...+.+++..
T Consensus 91 ---------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 149 (349)
T 2w4o_A 91 ---------------------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149 (349)
T ss_dssp -----------------------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHH
T ss_pred ---------------------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHH
Confidence 12346789999999999999999999999999999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 150 ~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999999999999999999999975 8899999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=215.89 Aligned_cols=154 Identities=28% Similarity=0.467 Sum_probs=137.0
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.....++|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~------------------------------------- 69 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLE------------------------------------- 69 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECC-------------------------------------
T ss_pred cccccccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccc-------------------------------------
Confidence 3456788999999999999999999865 45788999987543
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++...+.+
T Consensus 70 ---------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 128 (360)
T 3eqc_A 70 ---------------------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 128 (360)
T ss_dssp ---------------------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSC
T ss_pred ---------------------cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCC
Confidence 11223456889999999999999999999999999999999999999999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.+
T Consensus 129 ~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 129 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999999996 9999999999999999999999999998643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=208.51 Aligned_cols=153 Identities=26% Similarity=0.426 Sum_probs=124.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|++.+.||+|+||.||++.+... .+..+|+|.+...
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-------------------------------------- 54 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------------------------------------- 54 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------------------------------------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--------------------------------------
Confidence 467899999999999999999986542 2446888876532
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l 303 (362)
........+.+|+.+++.++||||+++++++. .+..|+||||+++++|.+++...+ .+
T Consensus 55 --------------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~ 113 (281)
T 1mp8_A 55 --------------------TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSL 113 (281)
T ss_dssp --------------------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTS
T ss_pred --------------------CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCC
Confidence 11223456889999999999999999999985 456899999999999999998654 69
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 114 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 114 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 9999999999999999999999999999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=210.65 Aligned_cols=148 Identities=29% Similarity=0.469 Sum_probs=130.9
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.|.....||+|+||.||++... .+++.+|+|.+....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~------------------------------------------ 82 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRK------------------------------------------ 82 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT------------------------------------------
T ss_pred hhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccc------------------------------------------
Confidence 3677789999999999999855 458899999885431
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++.. ..+++..+.
T Consensus 83 -----------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~ 144 (321)
T 2c30_A 83 -----------------QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIA 144 (321)
T ss_dssp -----------------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHH
T ss_pred -----------------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHH
Confidence 11234578999999999999999999999999999999999999999998865 569999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 145 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 9999999999999999999999999999999999999999999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=215.75 Aligned_cols=150 Identities=21% Similarity=0.385 Sum_probs=125.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||.+.+. .+++.+|+|.+.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~---------------------------------------- 62 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPF---------------------------------------- 62 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTT----------------------------------------
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccc----------------------------------------
Confidence 578999999999999999999854 568899999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......++.+|+.+++.++||||+++++++... ..+|+||||+ +++|.+++.. .
T Consensus 63 -----------------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~ 123 (367)
T 1cm8_A 63 -----------------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-E 123 (367)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-C
T ss_pred -----------------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-C
Confidence 1123345688999999999999999999998765 3469999999 8999999876 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 124 ~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 124 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 79999999999999999999999999999999999999999999999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=208.79 Aligned_cols=150 Identities=35% Similarity=0.611 Sum_probs=130.6
Q ss_pred cccCcEEE-EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 147 RLSDLRVI-TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 147 ~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+++|.+. +.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~--------------------------------------- 54 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC--------------------------------------- 54 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS---------------------------------------
T ss_pred cccchhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEeccc---------------------------------------
Confidence 46788888 77999999999999865 45889999987432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHH-hhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIM-GEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
....+|+.++ +..+||||+++++++.. ...+|+||||+++++|.+++...
T Consensus 55 -------------------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 109 (299)
T 3m2w_A 55 -------------------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109 (299)
T ss_dssp -------------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC
T ss_pred -------------------------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc
Confidence 2356788887 55699999999999876 77899999999999999999875
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCCCCC
Q psy14740 301 G--NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIGPRY 361 (362)
Q Consensus 301 ~--~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~~~~ 361 (362)
. .+++..++.++.|++.||.|||++||+||||||+||+++. ++.++|+|||+++...+..|
T Consensus 110 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (299)
T 3m2w_A 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY 175 (299)
T ss_dssp TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCGG
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccccC
Confidence 4 5999999999999999999999999999999999999998 78899999999998876554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=208.03 Aligned_cols=150 Identities=28% Similarity=0.468 Sum_probs=134.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 44 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKR---------------------------------------- 44 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred ecceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeecc----------------------------------------
Confidence 578999999999999999999855 457889999885431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++.....+++..
T Consensus 45 ------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 106 (276)
T 2yex_A 45 ------------------AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD 106 (276)
T ss_dssp ------------------CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHH
T ss_pred ------------------chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHH
Confidence 11233567899999999999999999999999999999999999999999998777899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 107 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999999999999999999999999999999999999999765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-27 Score=213.92 Aligned_cols=150 Identities=23% Similarity=0.353 Sum_probs=128.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+.+.||+|+||.||++.+. .+++.+|+|.+.....
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------------------------------- 40 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHE--------------------------------------- 40 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------------------------------------------
T ss_pred CCceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccc---------------------------------------
Confidence 468999999999999999999865 4578899998854310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~ 306 (362)
......+.+|+.+++.++||||+++++++...+.+|+||||++ ++|.+++...+ .+++.
T Consensus 41 -------------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 100 (324)
T 3mtl_A 41 -------------------EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH 100 (324)
T ss_dssp ----------------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHH
T ss_pred -------------------cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHH
Confidence 1111234568999999999999999999999999999999995 68998887654 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 999999999999999999999999999999999999999999999997654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=220.92 Aligned_cols=152 Identities=16% Similarity=0.079 Sum_probs=124.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~---------------------------------------- 110 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTE---------------------------------------- 110 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC----------------------------------------
T ss_pred CceEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeecc----------------------------------------
Confidence 467999999999999999999854 458899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHH---HHhhcCCcceeeee-------eeeeccc-----------------e
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKE---IMGEANCDFIVKLY-------KTFKDKK-----------------Y 280 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------~~~~~~~-----------------~ 280 (362)
.......+.+.+|+. +++.++||||++++ +++..++ .
T Consensus 111 ----------------~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 174 (377)
T 3byv_A 111 ----------------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 174 (377)
T ss_dssp -----------------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEES
T ss_pred ----------------ccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEE
Confidence 112234466889994 45556899999998 5554442 3
Q ss_pred EEEEEeccCCcchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 281 LYMLMESCLGGELWTILRDKGNFDD-------ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 281 ~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
.|++|||+ +|+|.+++...+.+++ ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence 89999999 7899999987655555 778889999999999999999999999999999999999999999999
Q ss_pred eecC
Q psy14740 354 KKLI 357 (362)
Q Consensus 354 ~~~~ 357 (362)
+...
T Consensus 254 ~~~~ 257 (377)
T 3byv_A 254 VRDG 257 (377)
T ss_dssp EETT
T ss_pred eecC
Confidence 8643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=221.22 Aligned_cols=158 Identities=30% Similarity=0.459 Sum_probs=130.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|++.+......
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~------------------------------------ 176 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIG------------------------------------ 176 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC------------------------------------
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhccc------------------------------------
Confidence 468999999999999999999855 5688999999876422110
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
..........+.+|+.+|+.++||||+++++++.. ...|+||||+++++|.+++...+.+++..
T Consensus 177 ---------------~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 240 (419)
T 3i6u_A 177 ---------------SAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEAT 240 (419)
T ss_dssp -----------------------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHH
T ss_pred ---------------ccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHH
Confidence 00111223457899999999999999999999865 45899999999999999988878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC---cEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG---YVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~---~~kl~DFG~a~~~~~ 358 (362)
++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 241 ~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 999999999999999999999999999999997544 599999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=212.48 Aligned_cols=148 Identities=21% Similarity=0.237 Sum_probs=128.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. ++.||+|.+....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~--------------------------------------- 59 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD--------------------------------------- 59 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG---------------------------------------
T ss_pred chhhchhhheecccCceEEEEEEEC---CCEEEEEEeecCc---------------------------------------
Confidence 4678999999999999999999854 6789999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........|+.+++.++||||+++++++.... .+|+||||+++++|.+++.. ..
T Consensus 60 ---------------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~ 117 (322)
T 3soc_A 60 ---------------------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NV 117 (322)
T ss_dssp ---------------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CC
T ss_pred ---------------------hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cC
Confidence 11233456888899999999999999987643 47999999999999999976 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC----------CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSR----------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~----------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 118 ~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 99999999999999999999999 999999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=209.50 Aligned_cols=152 Identities=25% Similarity=0.390 Sum_probs=135.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. ..+..+|+|.+...
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~---------------------------------------- 49 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED---------------------------------------- 49 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC----------------------------------------
T ss_pred cccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcC----------------------------------------
Confidence 5678999999999999999999965 45778999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
......+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++... ..++
T Consensus 50 --------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~ 109 (288)
T 3kfa_A 50 --------------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109 (288)
T ss_dssp --------------------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSC
T ss_pred --------------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCcc
Confidence 112356789999999999999999999999999999999999999999999864 3489
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....+
T Consensus 110 ~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 110 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred HhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999999999999999999999999999999999999999866543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=218.65 Aligned_cols=152 Identities=25% Similarity=0.333 Sum_probs=131.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+.+.||+|+||.||++.+. .+++.+|+|.+.....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~--------------------------------------- 47 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISF--------------------------------------- 47 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGG---------------------------------------
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccc---------------------------------------
Confidence 467999999999999999999865 4588999999864311
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--eEEEEEeccCCcchHHHHHhcC---C
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTILRDKG---N 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~---~ 302 (362)
......+.+|+.+++.++||||+++++++...+ ..|+||||+++++|.+++.... .
T Consensus 48 -------------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 108 (396)
T 4eut_A 48 -------------------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108 (396)
T ss_dssp -------------------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTC
T ss_pred -------------------cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccC
Confidence 112345678999999999999999999987654 7899999999999999997643 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe----cCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~----~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 109 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9999999999999999999999999999999999999 6777899999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=211.18 Aligned_cols=158 Identities=31% Similarity=0.461 Sum_probs=129.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------------------------------ 51 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIG------------------------------------ 51 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC------------------------------------------
T ss_pred hhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhc------------------------------------
Confidence 367999999999999999999855 4578999999866421100
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
..........+.+|+.+++.++||||+++++++..++ .|+||||+++++|.+++.....+++..
T Consensus 52 ---------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~ 115 (322)
T 2ycf_A 52 ---------------SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEAT 115 (322)
T ss_dssp ------------------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHH
T ss_pred ---------------ccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHH
Confidence 0011123345789999999999999999999987665 899999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc---EEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~---~kl~DFG~a~~~~~ 358 (362)
++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.+..
T Consensus 116 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 9999999999999999999999999999999987654 99999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=226.34 Aligned_cols=152 Identities=24% Similarity=0.380 Sum_probs=134.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. ..+..+|+|.+....
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~--------------------------------------- 257 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT--------------------------------------- 257 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS---------------------------------------
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc---------------------------------------
Confidence 4578999999999999999999865 347789999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
.....+.+|+.+|+.++||||+++++++...+.+|+||||+++++|.+++... ..++
T Consensus 258 ---------------------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~ 316 (495)
T 1opk_A 258 ---------------------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316 (495)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSC
T ss_pred ---------------------cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCC
Confidence 12356889999999999999999999999999999999999999999999864 3589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.+.
T Consensus 317 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 317 AVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999999999999999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=222.09 Aligned_cols=151 Identities=24% Similarity=0.369 Sum_probs=125.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~---------------------------------------- 98 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRP---------------------------------------- 98 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESG----------------------------------------
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECcc----------------------------------------
Confidence 3678999999999999999999855 45888999998653
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........++.+|+.+++.++||||+++++++... ..+|+||||++ ++|.+.+..
T Consensus 99 -----------------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~- 159 (464)
T 3ttj_A 99 -----------------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM- 159 (464)
T ss_dssp -----------------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS-
T ss_pred -----------------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh-
Confidence 11223345678999999999999999999998654 46899999995 567776653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 160 -~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 160 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 499999999999999999999999999999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=217.18 Aligned_cols=146 Identities=35% Similarity=0.584 Sum_probs=125.8
Q ss_pred cccCcEEE-EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 147 RLSDLRVI-TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 147 ~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+++|.+. +.||.|+||.||++.+. .+++.+|+|.+...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~--------------------------------------- 98 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC--------------------------------------- 98 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS---------------------------------------
T ss_pred ccccceeccceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc---------------------------------------
Confidence 46778887 68999999999999854 56889999987432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..+.+|+.++.. .+||||+++++++.. ..++|+||||+++++|.+++...
T Consensus 99 -------------------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 153 (400)
T 1nxk_A 99 -------------------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153 (400)
T ss_dssp -------------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC
T ss_pred -------------------------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh
Confidence 235678887744 589999999998875 67799999999999999999864
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecC
Q psy14740 301 G--NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~--~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~ 357 (362)
+ .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 154 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp ---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 3 5999999999999999999999999999999999999987 7889999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=210.00 Aligned_cols=153 Identities=31% Similarity=0.480 Sum_probs=133.3
Q ss_pred cccCcEEEEEecccceecEEEEEe---cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQI---AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
..++|++.+.||+|+||.||++.. ....++.+|+|.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------------------------------- 63 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------------------------------------- 63 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-------------------------------------
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-------------------------------------
Confidence 457899999999999999999985 2345778999987543
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--ccceEEEEEeccCCcchHHHHHhc-
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--DKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.....+.+.+|+.+++.++||||+++++++. ....+|+||||+++++|.+++...
T Consensus 64 ----------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (327)
T 3lxl_A 64 ----------------------GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR 121 (327)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG
T ss_pred ----------------------CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc
Confidence 1223356889999999999999999999875 556799999999999999999863
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 122 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 122 ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 4699999999999999999999999999999999999999999999999999987643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=230.10 Aligned_cols=108 Identities=15% Similarity=0.197 Sum_probs=99.9
Q ss_pred hhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy14740 248 RQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRN 326 (362)
Q Consensus 248 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~ 326 (362)
...+.+.+|+++|+++ .||||+++++++++++.+||||||++|++|.+++.+.+++++. .|+.||+.||.|+|++|
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G 359 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG 359 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC
Confidence 4556799999999999 7999999999999999999999999999999999988888765 47899999999999999
Q ss_pred cEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 327 iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=206.95 Aligned_cols=154 Identities=25% Similarity=0.371 Sum_probs=132.7
Q ss_pred cccCcEEEE-EecccceecEEEEEec-CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVIT-TLGVGGFGRVELVQIA-GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+|.+.+ .||+|+||.||++.+. ...++.+|+|.+....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------------------------------------- 56 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------------------------------------- 56 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------------------------------
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-------------------------------------
Confidence 457899998 9999999999999643 3446789999886431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.+++.++||||+++++++ ..+..|+||||+++++|.+++...+.++
T Consensus 57 --------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 115 (291)
T 1xbb_A 57 --------------------NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVK 115 (291)
T ss_dssp ----------------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCC
T ss_pred --------------------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCC
Confidence 1122346688999999999999999999998 5567899999999999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 116 ~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 116 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999999999999999999999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=206.49 Aligned_cols=161 Identities=24% Similarity=0.362 Sum_probs=137.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.....-..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~----------------------------------- 58 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSF----------------------------------- 58 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTC-----------------------------------
T ss_pred hhhccceeeeecCCCceEEEEEEEc-CcCceEEEEEEeccccccc-----------------------------------
Confidence 4688999999999999999999865 4578999999865411000
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
...........+.+|+.+++.+. ||||+++++++...+..|+||||+++++|.+++.....+++
T Consensus 59 ---------------~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 123 (298)
T 1phk_A 59 ---------------SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123 (298)
T ss_dssp ---------------CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCH
T ss_pred ---------------CHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCH
Confidence 00011223456789999999995 99999999999999999999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 124 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 99999999999999999999999999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=212.33 Aligned_cols=150 Identities=26% Similarity=0.428 Sum_probs=131.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-.+|++.+.||+|+||.||++.+. +++.+|+|.+....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--------------------------------------- 45 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEE--------------------------------------- 45 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTT---------------------------------------
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccc---------------------------------------
Confidence 4567999999999999999999853 47789999886431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC--cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC--DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.++..++| |||+++++++.....+|+|||+ .+++|.+++...+.++
T Consensus 46 ------------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~ 106 (343)
T 3dbq_A 46 ------------------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID 106 (343)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCC
T ss_pred ------------------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCC
Confidence 112234568899999999976 9999999999999999999995 5899999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.+.
T Consensus 107 ~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 107 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999999999999999999999999999999996 6789999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=212.91 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=131.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~----------------------------------------- 91 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSG----------------------------------------- 91 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCS-----------------------------------------
T ss_pred hheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEcccc-----------------------------------------
Confidence 45899999999999999999854 457889999886431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
.........+.+|+.+++.++||||+++++++..++..|+||||++ |+|.+++.. ...+++..
T Consensus 92 ---------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~ 155 (348)
T 1u5q_A 92 ---------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE 155 (348)
T ss_dssp ---------------SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHH
T ss_pred ---------------ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHH
Confidence 1122334568899999999999999999999999999999999995 688887754 45799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 156 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99999999999999999999999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=207.52 Aligned_cols=157 Identities=23% Similarity=0.417 Sum_probs=129.9
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
....+.+|++.+.||+|+||.||++... .+++.+|+|.+....
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~------------------------------------ 69 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFD------------------------------------ 69 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTS------------------------------------
T ss_pred ccccccceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhh------------------------------------
Confidence 3346789999999999999999999855 457899999886531
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD---- 299 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---- 299 (362)
.........+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..
T Consensus 70 --------------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 129 (310)
T 2wqm_A 70 --------------------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129 (310)
T ss_dssp --------------------SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHT
T ss_pred --------------------ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhccc
Confidence 11223446688999999999999999999999999999999999999999998864
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 130 KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 3468999999999999999999999999999999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=212.35 Aligned_cols=152 Identities=22% Similarity=0.400 Sum_probs=129.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 54 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMEN--------------------------------------- 54 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSS---------------------------------------
T ss_pred cccceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEeccc---------------------------------------
Confidence 5789999999999999999999965 457899999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--------cceEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--------KKYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~ 298 (362)
........+.+|+.+++.++||||+++++++.. .+.+|+||||++ ++|.+.+.
T Consensus 55 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~ 115 (351)
T 3mi9_A 55 ------------------EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLS 115 (351)
T ss_dssp ------------------CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHH
T ss_pred ------------------ccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHh
Confidence 111223456789999999999999999999876 456899999995 57777666
Q ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 299 DK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 116 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 43 569999999999999999999999999999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.25 Aligned_cols=149 Identities=24% Similarity=0.449 Sum_probs=129.8
Q ss_pred ccCcEEE-EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 148 LSDLRVI-TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 148 ~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+.|.+. +.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 50 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQP--------------------------------------- 50 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCS---------------------------------------
T ss_pred ceeEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCc---------------------------------------
Confidence 4578885 67999999999999854 468899999985431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
......+.+|+.++..+ +||||+++++++.+++.+|+||||+++++|.+++...+.+++
T Consensus 51 --------------------~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 110 (316)
T 2ac3_A 51 --------------------GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE 110 (316)
T ss_dssp --------------------SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCH
T ss_pred --------------------chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCH
Confidence 11235678899999885 799999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc---EEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~---~kl~DFG~a~~~ 356 (362)
..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.+
T Consensus 111 ~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred HHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999999999999999999999999987765 999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=211.55 Aligned_cols=153 Identities=23% Similarity=0.389 Sum_probs=125.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCce----eeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSF----ALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
+..++|++.+.||+|+||.||++.+.. +++.+ |+|.+...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~----------------------------------- 55 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREA----------------------------------- 55 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------------------------------------
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccc-----------------------------------
Confidence 456889999999999999999998653 34445 55544321
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
........+.+|+.+++.++||||+++++++..+. .+++++++++++|.+++...
T Consensus 56 -----------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~ 111 (327)
T 3poz_A 56 -----------------------TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK 111 (327)
T ss_dssp ---------------------------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST
T ss_pred -----------------------cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC
Confidence 11223456889999999999999999999998765 78899999999999999864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 112 DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 5699999999999999999999999999999999999999999999999999986643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=211.29 Aligned_cols=157 Identities=21% Similarity=0.282 Sum_probs=128.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+.. +++.+++|+..+.-.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~------------------------------------- 51 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIE------------------------------------- 51 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEEC-------------------------------------
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEecc-------------------------------------
Confidence 356789999999999999999998654 455544443322100
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
..........+.+|+.+++.++||||+++++++. .+..++||||+++++|.+++... +.++
T Consensus 52 -----------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 113 (325)
T 3kex_A 52 -----------------DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALG 113 (325)
T ss_dssp -----------------CTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSC
T ss_pred -----------------ccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCC
Confidence 0011122345678999999999999999999886 45689999999999999999764 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 114 ~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp TTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999999999999999999999999999999999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=211.86 Aligned_cols=156 Identities=25% Similarity=0.444 Sum_probs=133.4
Q ss_pred hhhhhccccCcEEEEEecccceecEEEEEecCCCCCc--eeeeeeccccccccccccccceeeeCCCCceEEEeehhhHH
Q psy14740 141 EEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRS--FALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFN 218 (362)
Q Consensus 141 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~ 218 (362)
..++....++|++.+.||+|+||.||++.+.. ++.. +++|.+...
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~-------------------------------- 63 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEY-------------------------------- 63 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC--------------------------------
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccc--------------------------------
Confidence 34566678999999999999999999998654 3443 488876532
Q ss_pred hhccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHH
Q psy14740 219 QLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL 297 (362)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 297 (362)
........+.+|+.+++.+ +||||+++++++.+.+.+|+||||+++++|.+++
T Consensus 64 --------------------------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 117 (327)
T 1fvr_A 64 --------------------------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117 (327)
T ss_dssp --------------------------------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred --------------------------cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHH
Confidence 1112335578999999999 9999999999999999999999999999999999
Q ss_pred HhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 298 RDKG----------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 298 ~~~~----------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~ 191 (327)
T 1fvr_A 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191 (327)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred HhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcc
Confidence 7653 689999999999999999999999999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=209.00 Aligned_cols=151 Identities=24% Similarity=0.361 Sum_probs=126.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~----------------------------------------- 94 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPF----------------------------------------- 94 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSC-----------------------------------------
T ss_pred hheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccc-----------------------------------------
Confidence 57999999999999999999865 458899999875431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
...........|+..+..+ +||||+++++++.+++.+|+||||+ +++|.+++... ..+++.
T Consensus 95 ----------------~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~ 157 (311)
T 3p1a_A 95 ----------------RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEA 157 (311)
T ss_dssp ----------------CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHH
T ss_pred ----------------cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHH
Confidence 1111223344555555554 9999999999999999999999999 77898888764 459999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999999999999999999999999999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=207.42 Aligned_cols=155 Identities=24% Similarity=0.338 Sum_probs=126.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~------------------------------------- 48 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGG------------------------------------- 48 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCC-------------------------------------
T ss_pred cccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEeccccc-------------------------------------
Confidence 4578999999999999999999854 45889999998653110
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~ 298 (362)
.........+.+|+.+++.+ +||||+++++++.... .++++||+++ ++|.+++.
T Consensus 49 -----------------~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 110 (308)
T 3g33_A 49 -----------------GGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD 110 (308)
T ss_dssp -----------------TTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred -----------------ccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence 01111223456777777766 5999999999987654 5899999995 69999998
Q ss_pred hcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 299 DKGN--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~~~~--l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.... +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+.
T Consensus 111 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 171 (308)
T 3g33_A 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171 (308)
T ss_dssp TCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTST
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccC
Confidence 7544 9999999999999999999999999999999999999999999999999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=219.08 Aligned_cols=148 Identities=29% Similarity=0.483 Sum_probs=131.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++... ++.+|+|.+....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~-------------------------------------- 228 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA-------------------------------------- 228 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--------------------------------------
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--------------------------------------
Confidence 45788999999999999999999864 5689999885431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-eEEEEEeccCCcchHHHHHhcCC--
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-YLYMLMESCLGGELWTILRDKGN-- 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-- 302 (362)
..+.+.+|+.+|+.++||||+++++++.... .+|+||||+++++|.+++...+.
T Consensus 229 -----------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~ 285 (450)
T 1k9a_A 229 -----------------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285 (450)
T ss_dssp -----------------------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTT
T ss_pred -----------------------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCC
Confidence 2356889999999999999999999876554 79999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 286 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 7999999999999999999999999999999999999999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=210.12 Aligned_cols=154 Identities=25% Similarity=0.358 Sum_probs=129.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCC---CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDP---SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
...++|.+.+.||+|+||.||++...... +..+|+|.+....
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----------------------------------- 85 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----------------------------------- 85 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-----------------------------------
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-----------------------------------
Confidence 35678999999999999999999865433 2358999875421
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-C
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-G 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 301 (362)
.......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++... .
T Consensus 86 -----------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 142 (333)
T 1mqb_A 86 -----------------------TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG 142 (333)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT
T ss_pred -----------------------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC
Confidence 1223456889999999999999999999999999999999999999999999764 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 143 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 143 EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 69999999999999999999999999999999999999999999999999998764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=206.37 Aligned_cols=147 Identities=13% Similarity=0.031 Sum_probs=127.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~---------------------------------------- 68 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQG---------------------------------------- 68 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTC----------------------------------------
T ss_pred cCcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECccc----------------------------------------
Confidence 367999999999999999999864 457899999986541
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.........+.+|+.+++.++||||+++++++...+..|+||||++|++|.++++.. .....
T Consensus 69 ----------------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~ 130 (286)
T 3uqc_A 69 ----------------VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVG 130 (286)
T ss_dssp ----------------CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHH
T ss_pred ----------------ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHH
Confidence 111234466889999999999999999999999999999999999999999999642 46667
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccc
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFA 353 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a 353 (362)
+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|..
T Consensus 131 ~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 131 AIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 8889999999999999999999999999999999999999987754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-26 Score=213.19 Aligned_cols=147 Identities=27% Similarity=0.465 Sum_probs=122.9
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
...+.||+|+||.||++... .+++.+|+|++....
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~-------------------------------------------- 126 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRG-------------------------------------------- 126 (373)
T ss_dssp EEEEECC-----CEEEEEET-TTCCEEEEEEEECCS--------------------------------------------
T ss_pred ecceEEecCcCEEEEEEEEc-CCCcEEEEEEEcccc--------------------------------------------
Confidence 33678999999999999855 457899999886431
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHHHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRF 310 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~ 310 (362)
......+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++... ..+++..+..
T Consensus 127 ---------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~ 191 (373)
T 2x4f_A 127 ---------------MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191 (373)
T ss_dssp ---------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHH
T ss_pred ---------------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 122356789999999999999999999999999999999999999999988654 4699999999
Q ss_pred HHHHHHHHHHHHHHCCcEeecCCCCcEEe--cCCCcEEEEecccceecCC
Q psy14740 311 YTACVVEAFDYLHSRNIIYRDLKPENLLL--STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 311 ~~~ql~~al~~lH~~~iiHrDikp~NIl~--~~~~~~kl~DFG~a~~~~~ 358 (362)
++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 192 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred HHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999999999999999999999999999 4667899999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=212.33 Aligned_cols=159 Identities=25% Similarity=0.387 Sum_probs=136.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.||+|++........
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~------------------------------------ 135 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLS------------------------------------ 135 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCC------------------------------------
T ss_pred hhhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccC------------------------------------
Confidence 467999999999999999999864 4588999999865410000
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.+ +||||+++++++......|+||||+++++|.+++.....+++.
T Consensus 136 ---------------~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~ 200 (365)
T 2y7j_A 136 ---------------PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK 200 (365)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHH
T ss_pred ---------------HHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHH
Confidence 001122345678999999999 8999999999999999999999999999999999887889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.+..
T Consensus 201 ~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 9999999999999999999999999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-26 Score=210.21 Aligned_cols=150 Identities=29% Similarity=0.448 Sum_probs=130.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---------------------------------------- 71 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI---------------------------------------- 71 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC----------------------------------------
T ss_pred ecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc----------------------------------------
Confidence 3478999999999999999999965 45789999988532
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-----CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-----CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.........|+.+++.+. ||||+++++++...+..|+|||++ +++|.+++....
T Consensus 72 --------------------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~ 130 (360)
T 3llt_A 72 --------------------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN 130 (360)
T ss_dssp --------------------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT
T ss_pred --------------------hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC
Confidence 112344667889998885 999999999999999999999999 999999998754
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-------------------------CCcEEEEecccce
Q psy14740 302 --NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-------------------------SGYVKLVDFGFAK 354 (362)
Q Consensus 302 --~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-------------------------~~~~kl~DFG~a~ 354 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 131 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~ 210 (360)
T 3llt_A 131 YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210 (360)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence 4999999999999999999999999999999999999975 7889999999998
Q ss_pred ecCC
Q psy14740 355 KLIG 358 (362)
Q Consensus 355 ~~~~ 358 (362)
....
T Consensus 211 ~~~~ 214 (360)
T 3llt_A 211 FKSD 214 (360)
T ss_dssp ETTS
T ss_pred ecCC
Confidence 6543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=211.64 Aligned_cols=153 Identities=23% Similarity=0.390 Sum_probs=132.7
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||++.+.+ .+++.+|+|.+....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----------------------------------- 67 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----------------------------------- 67 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----------------------------------
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-----------------------------------
Confidence 45789999999999999999998653 346679999875421
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
.......+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...
T Consensus 68 -----------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 124 (322)
T 1p4o_A 68 -----------------------SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 124 (322)
T ss_dssp -----------------------CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHH
T ss_pred -----------------------CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhch
Confidence 1223345889999999999999999999999999999999999999999998753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~ 189 (322)
T 1p4o_A 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189 (322)
T ss_dssp HHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred hhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccc
Confidence 346899999999999999999999999999999999999999999999999997653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=214.76 Aligned_cols=162 Identities=19% Similarity=0.318 Sum_probs=129.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.+... .++.+|+|.+..... .+.+-+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------------------------~~~~e~- 84 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---------------------------PLFTEL- 84 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---------------------------HHHHHH-
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---------------------------hHHHHH-
Confidence 345899999999999999999986543 357899998765310 000000
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc----ceEEEEEeccCCcchHHHHH
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK----KYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~ 298 (362)
.............|...+..++||||+++++++... .+.|+||||+ +++|.+++.
T Consensus 85 --------------------~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~ 143 (364)
T 3op5_A 85 --------------------KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143 (364)
T ss_dssp --------------------HHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHH
T ss_pred --------------------HHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHH
Confidence 001111223456788888999999999999998764 5689999999 999999998
Q ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec--CCCcEEEEecccceecC
Q psy14740 299 DK-GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS--TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 299 ~~-~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~--~~~~~kl~DFG~a~~~~ 357 (362)
.. +.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 144 ~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205 (364)
T ss_dssp HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESS
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecc
Confidence 75 5799999999999999999999999999999999999999 88999999999998763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=214.71 Aligned_cols=154 Identities=29% Similarity=0.484 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|++.+....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------------------- 65 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIR-------------------------------------- 65 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHH--------------------------------------
T ss_pred hhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhc--------------------------------------
Confidence 467999999999999999999854 55788999998654210
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-------
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK------- 300 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------- 300 (362)
.........+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...
T Consensus 66 ----------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~ 129 (345)
T 3hko_A 66 ----------------QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129 (345)
T ss_dssp ----------------C---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTE
T ss_pred ----------------ccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccc
Confidence 012234467889999999999999999999999999999999999999999988520
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC--cE
Q psy14740 301 ---------------------------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG--YV 345 (362)
Q Consensus 301 ---------------------------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~--~~ 345 (362)
..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 209 (345)
T 3hko_A 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209 (345)
T ss_dssp EEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCE
T ss_pred cccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceE
Confidence 1136778889999999999999999999999999999998766 89
Q ss_pred EEEecccceec
Q psy14740 346 KLVDFGFAKKL 356 (362)
Q Consensus 346 kl~DFG~a~~~ 356 (362)
||+|||+++.+
T Consensus 210 kl~Dfg~a~~~ 220 (345)
T 3hko_A 210 KLVDFGLSKEF 220 (345)
T ss_dssp EECCCTTCEEG
T ss_pred EEeeccccccc
Confidence 99999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=207.30 Aligned_cols=150 Identities=29% Similarity=0.488 Sum_probs=132.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 46 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSP---------------------------------------- 46 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC-----------------------------------------
T ss_pred hccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEeccc----------------------------------------
Confidence 457999999999999999999865 457899999986431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
......+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.+++...+.+++..
T Consensus 47 -------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 107 (304)
T 2jam_A 47 -------------------AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD 107 (304)
T ss_dssp ------------------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHH
T ss_pred -------------------ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHH
Confidence 0112357789999999999999999999999999999999999999999998888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+++...
T Consensus 108 ~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999999999999999999 678899999999987543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-26 Score=207.04 Aligned_cols=149 Identities=28% Similarity=0.407 Sum_probs=129.3
Q ss_pred cEEEEEecccceecEEEEEec---CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 151 LRVITTLGVGGFGRVELVQIA---GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
|++.+.||+|+||.||++... ..+++.+|+|.+...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----------------------------------------- 71 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----------------------------------------- 71 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-----------------------------------------
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-----------------------------------------
Confidence 499999999999999987643 235778999998643
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++.+ ...+|+||||+++++|.+++... .+++
T Consensus 72 -----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 133 (318)
T 3lxp_A 72 -----------------AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGL 133 (318)
T ss_dssp -----------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCH
T ss_pred -----------------cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCH
Confidence 112234568899999999999999999999877 46799999999999999999764 5999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999999999999999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=210.46 Aligned_cols=153 Identities=27% Similarity=0.433 Sum_probs=132.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCC----CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDP----SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|.+.+.||+|+||.||.+.+.+.. ...+|+|.+...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------------------------------ 87 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST------------------------------------ 87 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT------------------------------------
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc------------------------------------
Confidence 5678999999999999999999865432 246888887542
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
........+.+|+.+++.+ +||||+++++++...+.+|+||||+++++|.+++...
T Consensus 88 ----------------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (333)
T 2i1m_A 88 ----------------------AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145 (333)
T ss_dssp ----------------------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHH
T ss_pred ----------------------cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhc
Confidence 1122345688999999999 8999999999999999999999999999999998753
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 -------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 -------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215 (333)
T ss_dssp HHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGG
T ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccc
Confidence 357999999999999999999999999999999999999999999999999998653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-26 Score=206.17 Aligned_cols=154 Identities=19% Similarity=0.287 Sum_probs=128.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCC--CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPS--RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+|++.+.||+|+||.||++......+ ..+++|.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-------------------------------------- 64 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------------------------------------- 64 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--------------------------------------
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--------------------------------------
Confidence 45679999999999999999998654332 35788876532
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeee-eeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
........+.+|+.+++.++||||++++++ +..++..|++|||+++++|.+++... ..
T Consensus 65 --------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~ 124 (298)
T 3f66_A 65 --------------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124 (298)
T ss_dssp --------------------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCC
T ss_pred --------------------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccC
Confidence 122334568899999999999999999998 45667899999999999999999763 45
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 125 ~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999999999999999999999999999999999999986643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=204.13 Aligned_cols=153 Identities=23% Similarity=0.380 Sum_probs=124.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. ++.+|+|.+.....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~------------------------------------- 43 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPD------------------------------------- 43 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET---TEEEEEEEC------------------------------------------
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCc-------------------------------------
Confidence 45789999999999999999999854 66899998765310
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.......+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.. +.+++
T Consensus 44 ------------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~ 104 (271)
T 3dtc_A 44 ------------------EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPP 104 (271)
T ss_dssp -----------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-SCCCH
T ss_pred ------------------ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-CCCCH
Confidence 01122345688999999999999999999999999999999999999999998864 57999
Q ss_pred HHHHHHHHHHHHHHHHHHHCC---cEeecCCCCcEEecC--------CCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRN---IIYRDLKPENLLLST--------SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~---iiHrDikp~NIl~~~--------~~~~kl~DFG~a~~~~ 357 (362)
..++.++.|++.||.|||++| |+||||||+||+++. ++.++|+|||+++.+.
T Consensus 105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 167 (271)
T 3dtc_A 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence 999999999999999999999 999999999999986 6789999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=206.74 Aligned_cols=150 Identities=23% Similarity=0.363 Sum_probs=129.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++... .+++.+|+|.+...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---------------------------------------- 65 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCH---------------------------------------- 65 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEES----------------------------------------
T ss_pred CCeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecC----------------------------------------
Confidence 4578999999999999999999864 45789999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee----ccceEEEEEeccCCcchHHHHHh---
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK----DKKYLYMLMESCLGGELWTILRD--- 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~--- 299 (362)
.......+.+|+.+++.++||||+++++++. .....|+||||+++++|.+++..
T Consensus 66 -------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 126 (317)
T 2buj_A 66 -------------------EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD 126 (317)
T ss_dssp -------------------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHT
T ss_pred -------------------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHh
Confidence 1223456789999999999999999999986 34579999999999999999875
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 300 -KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 300 -~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 127 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 356999999999999999999999999999999999999999999999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=204.02 Aligned_cols=151 Identities=24% Similarity=0.363 Sum_probs=131.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
...|++...||+|+||.||++.+. .++..+|+|.+....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~---------------------------------------- 63 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRK---------------------------------------- 63 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred ceeEEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchh----------------------------------------
Confidence 345889999999999999999855 557889999876431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
........+.+|+.+++.++||||+++++++.. ...+|+||||+++++|.+++...+.+
T Consensus 64 -----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 126 (290)
T 1t4h_A 64 -----------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM 126 (290)
T ss_dssp -----------------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSC
T ss_pred -----------------hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCC
Confidence 122334668899999999999999999998765 46799999999999999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEec-CCCcEEEEecccceec
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLS-TSGYVKLVDFGFAKKL 356 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~ 356 (362)
++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 127 ~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 127 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999999999999 99999999999997 7899999999999644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=202.92 Aligned_cols=148 Identities=26% Similarity=0.373 Sum_probs=132.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||.+.+. +++.+|+|.+....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~--------------------------------------- 44 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA--------------------------------------- 44 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTT---------------------------------------
T ss_pred chhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccC---------------------------------------
Confidence 3578999999999999999999865 35679999886531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
...+.+.+|+.+++.++||||+++++++..++..|++|||+++++|.+++... ..+++
T Consensus 45 ---------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 103 (267)
T 3t9t_A 45 ---------------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA 103 (267)
T ss_dssp ---------------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCH
T ss_pred ---------------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCH
Confidence 01245788999999999999999999999999999999999999999999865 45899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 104 ~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 104 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999999999999999765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=203.06 Aligned_cols=147 Identities=27% Similarity=0.444 Sum_probs=129.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~----------------------------------------- 47 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYN----------------------------------------- 47 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECC-----------------------------------------
T ss_pred ccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEeccc-----------------------------------------
Confidence 367999999999999999999865 45789999987542
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----------------cceEEEEEeccCCc
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----------------KKYLYMLMESCLGG 291 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~ 291 (362)
...+.+|+.+++.++||||+++++++.. ...+|+||||++++
T Consensus 48 ----------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 105 (284)
T 2a19_B 48 ----------------------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKG 105 (284)
T ss_dssp ----------------------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSC
T ss_pred ----------------------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCC
Confidence 1246789999999999999999998754 45689999999999
Q ss_pred chHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 292 ELWTILRDK--GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 292 ~L~~~l~~~--~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 106 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 174 (284)
T 2a19_B 106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174 (284)
T ss_dssp BHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSC
T ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccc
Confidence 999999754 5699999999999999999999999999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=206.03 Aligned_cols=145 Identities=19% Similarity=0.288 Sum_probs=124.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+ +++.+|+|.+...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---------------------------------------- 42 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---------------------------------------- 42 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG----------------------------------------
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc----------------------------------------
Confidence 467899999999999999999985 3678999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhh--cCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE--ANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
....+..|.+++.. ++||||+++++++.. ...+|+||||+++++|.++++.
T Consensus 43 ----------------------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~- 99 (301)
T 3q4u_A 43 ----------------------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL- 99 (301)
T ss_dssp ----------------------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-
T ss_pred ----------------------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-
Confidence 12334566777666 799999999998543 4569999999999999999965
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLH--------SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH--------~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 100 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 164 (301)
T 3q4u_A 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164 (301)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence 57999999999999999999999 9999999999999999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=214.24 Aligned_cols=150 Identities=27% Similarity=0.461 Sum_probs=130.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. . ++.+|+|.+....
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~-~~~vaiK~~~~~~--------------------------------------- 92 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE-K-KQIYAIKYVNLEE--------------------------------------- 92 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-T-CCEEEEEEEECTT---------------------------------------
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC-C-CCEEEEEEEeccc---------------------------------------
Confidence 3456999999999999999999854 3 7889999886531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.+++.++ ||||+++++++...+.+|+||| +.+++|.+++.....++
T Consensus 93 ------------------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~ 153 (390)
T 2zmd_A 93 ------------------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSID 153 (390)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCC
T ss_pred ------------------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCC
Confidence 11233466889999999996 5999999999999999999999 55899999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.+.
T Consensus 154 ~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 154 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999999999999999999999999999999999995 6899999999998764
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=205.93 Aligned_cols=151 Identities=25% Similarity=0.405 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 40 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDT---------------------------------------- 40 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC--------------------------------------------
T ss_pred cchhhhhhhhccCCCeeEEEEEEc-CCCceEEEEEeecCc----------------------------------------
Confidence 678999999999999999999865 457899999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~ 305 (362)
........+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++... ..+++
T Consensus 41 -----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~ 102 (299)
T 2r3i_A 41 -----------------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPL 102 (299)
T ss_dssp ---------------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCH
T ss_pred -----------------cchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEccc-CCHHHHHHhhhccCCCH
Confidence 011223557889999999999999999999999999999999995 7999998765 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 103 ~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 154 (299)
T 2r3i_A 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence 9999999999999999999999999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=204.15 Aligned_cols=151 Identities=27% Similarity=0.453 Sum_probs=134.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.+.|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 59 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEE---------------------------------------- 59 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTT----------------------------------------
T ss_pred HHHHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccc----------------------------------------
Confidence 466999999999999999999855 457899999886431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......+.+|+.+++.++||||+++++++.....+|+||||+++++|.+++.. +++++..
T Consensus 60 ------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~ 120 (303)
T 3a7i_A 60 ------------------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQ 120 (303)
T ss_dssp ------------------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHH
T ss_pred ------------------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHH
Confidence 112345688999999999999999999999999999999999999999999875 5799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.+..
T Consensus 121 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999999999999999999999999999999999999987644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=204.96 Aligned_cols=155 Identities=30% Similarity=0.430 Sum_probs=126.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|++.+.||+|+||.||++.+...+++ .+|+|.+....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~------------------------------------- 58 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV------------------------------------- 58 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------------------------------------
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc-------------------------------------
Confidence 457899999999999999999986544343 68999876531
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
.........+.+|+.+++.++||||+++++++..+. .++|||++++++|.+++... ..+
T Consensus 59 -------------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~ 118 (291)
T 1u46_A 59 -------------------LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHF 118 (291)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGS
T ss_pred -------------------cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCc
Confidence 112234466889999999999999999999998765 88999999999999998764 569
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+..
T Consensus 119 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 119 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 9999999999999999999999999999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=212.09 Aligned_cols=155 Identities=26% Similarity=0.419 Sum_probs=126.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|.+.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~-------------------------------------- 48 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHR-------------------------------------- 48 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC-------------------------------------------
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCc--------------------------------------
Confidence 4678999999999999999999854 4588999999865311
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
..........+.+|+.+++.++||||+++++++.+.+..|+||||++ ++|.+++.... .+++
T Consensus 49 ----------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~ 111 (346)
T 1ua2_A 49 ----------------SEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTP 111 (346)
T ss_dssp -----------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCCSSCCS
T ss_pred ----------------chhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcCcCCCH
Confidence 00111223457889999999999999999999999999999999995 58988887643 5899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999999999999999999999999999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=208.42 Aligned_cols=156 Identities=22% Similarity=0.339 Sum_probs=126.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+.. +++.+++|+..+.-.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~------------------------------------- 53 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELR------------------------------------- 53 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEEC-------------------------------------
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeec-------------------------------------
Confidence 456889999999999999999998654 455665554332100
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
..........+.+|+.+++.++||||+++++++..+. .+++++++++++|.+++... ..++
T Consensus 54 -----------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~ 115 (327)
T 3lzb_A 54 -----------------EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG 115 (327)
T ss_dssp -----------------CCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCC
T ss_pred -----------------cccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCC
Confidence 0111223456889999999999999999999998765 78899999999999999764 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 116 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred HHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999999999999999999999999999999999999998664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=219.81 Aligned_cols=149 Identities=27% Similarity=0.416 Sum_probs=130.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||++.+.. +..+|+|.+....
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~-------------------------------------- 224 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGS-------------------------------------- 224 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT--TEEEEEEEECTTS--------------------------------------
T ss_pred echHHeEEEEEcccCCceEEEEEEECC--ccEEEEEEecCCC--------------------------------------
Confidence 345789999999999999999998653 5679999886431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l 303 (362)
...+.+.+|+.+|+.++||||+++++++. .+.+|+||||+++|+|.+++... ..+
T Consensus 225 ----------------------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 281 (454)
T 1qcf_A 225 ----------------------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ 281 (454)
T ss_dssp ----------------------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTC
T ss_pred ----------------------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCC
Confidence 12356889999999999999999999986 56789999999999999999754 368
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+...+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 282 ~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999999999999999999999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=207.80 Aligned_cols=155 Identities=24% Similarity=0.292 Sum_probs=125.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|.+.+.||+|+||.||++....+ +++.+|+|.+....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~------------------------------------- 74 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN------------------------------------- 74 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-------------------------------------
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-------------------------------------
Confidence 457899999999999999999986543 34579999875431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHHh
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.++||||+++++++...+ ..|++|||+++++|.+++..
T Consensus 75 --------------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 134 (313)
T 3brb_A 75 --------------------SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134 (313)
T ss_dssp --------------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHH
T ss_pred --------------------cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHH
Confidence 11223456889999999999999999999987654 35999999999999999843
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 ------KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ------~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199 (313)
T ss_dssp TTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred hhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 34599999999999999999999999999999999999999999999999999986643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=204.51 Aligned_cols=153 Identities=28% Similarity=0.494 Sum_probs=131.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+++|.+....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 43 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGS--------------------------------------- 43 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTT---------------------------------------
T ss_pred chhheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEccc---------------------------------------
Confidence 5689999999999999999999865 457899999886431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeee--eccceEEEEEeccCCcchHHHHHhc----
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF--KDKKYLYMLMESCLGGELWTILRDK---- 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~---- 300 (362)
......+.+.+|+.+++.++||||+++++++ .....+|+||||+++++|.+++...
T Consensus 44 ------------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 105 (279)
T 2w5a_A 44 ------------------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105 (279)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTT
T ss_pred ------------------CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccC
Confidence 1122345688999999999999999999977 4467899999999999999998753
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRN-----IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~-----iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 106 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~ 167 (279)
T 2w5a_A 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167 (279)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence 24999999999999999999999999 9999999999999999999999999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=208.59 Aligned_cols=154 Identities=31% Similarity=0.441 Sum_probs=132.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
...++|++.+.||+|+||.||++.+.+ .+++.+|+|.+.+..
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------------------------------- 69 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---------------------------------- 69 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------------------------
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----------------------------------
Confidence 356789999999999999999998532 456789999886431
Q ss_pred cchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeecc-ceEEEEEeccCCcchHHHHHh
Q psy14740 222 SSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDK-KYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 299 (362)
.......+.+|+.++..+ +||||+++++++... ..+|++|||+++++|.+++..
T Consensus 70 ------------------------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 125 (316)
T 2xir_A 70 ------------------------THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125 (316)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHT
T ss_pred ------------------------CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHh
Confidence 122335688999999999 799999999998765 459999999999999999986
Q ss_pred cCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KGN----------------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~~----------------l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 199 (316)
T 2xir_A 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199 (316)
T ss_dssp CTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccc
Confidence 543 7899999999999999999999999999999999999999999999999998664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=210.79 Aligned_cols=150 Identities=22% Similarity=0.271 Sum_probs=132.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++...||+|+||.||++.+. +++.+|+|.+...
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~---------------------------------------- 74 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPE---------------------------------------- 74 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSC----------------------------------------
T ss_pred HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEeccc----------------------------------------
Confidence 4578999999999999999999843 4788999976542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC----C
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----N 302 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~ 302 (362)
.......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++.... .
T Consensus 75 -------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 135 (321)
T 2qkw_B 75 -------------------SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135 (321)
T ss_dssp -------------------CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCC
T ss_pred -------------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccc
Confidence 11234568899999999999999999999999999999999999999999886543 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 136 MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred cCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 8999999999999999999999999999999999999999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=204.29 Aligned_cols=149 Identities=24% Similarity=0.409 Sum_probs=130.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++... .+..+|+|.+....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--------------------------------------- 49 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS--------------------------------------- 49 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS---------------------------------------
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc---------------------------------------
Confidence 4578999999999999999999854 35679999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG--NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 304 (362)
.....+.+|+.+++.++||||+++++++.. +..|+||||+++++|.+++.... .++
T Consensus 50 ---------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~ 107 (279)
T 1qpc_A 50 ---------------------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLT 107 (279)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCC
T ss_pred ---------------------ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCC
Confidence 113457899999999999999999999864 45899999999999999997543 699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 108 ~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999999999999999999999999999999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=204.52 Aligned_cols=151 Identities=28% Similarity=0.451 Sum_probs=128.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|.+.+.||+|+||.||.+.+. .+++.+|+|.+....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-------------------------------------- 66 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVES-------------------------------------- 66 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTS--------------------------------------
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchH--------------------------------------
Confidence 34678999999999999999999855 458899999875421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
....+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+++.. ...++
T Consensus 67 -----------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 123 (314)
T 3com_A 67 -----------------------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT 123 (314)
T ss_dssp -----------------------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCC
T ss_pred -----------------------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCC
Confidence 124578899999999999999999999999999999999999999999874 45799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 124 EDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999999999999999999999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=202.43 Aligned_cols=154 Identities=28% Similarity=0.364 Sum_probs=130.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
...++|.+.+.||+|+||.||++.+.... +..+|+|.+.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~------------------------------------ 52 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC------------------------------------ 52 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS------------------------------------
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc------------------------------------
Confidence 35678999999999999999999865433 3458999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-C
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-N 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~ 302 (362)
.......+.+|+.+++.++||||+++++++..+ ..|+||||+++++|.+++...+ .
T Consensus 53 ----------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~ 109 (281)
T 3cc6_A 53 ----------------------TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNS 109 (281)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTT
T ss_pred ----------------------CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcccc
Confidence 122346688999999999999999999998754 4689999999999999997654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999999999999999999999999999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=212.13 Aligned_cols=147 Identities=33% Similarity=0.438 Sum_probs=123.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.||+|+||.||++.+. .+++.||+|.+....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~--------------------------------------- 44 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDP--------------------------------------- 44 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCT---------------------------------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCc---------------------------------------
Confidence 3578999999999999999999855 468899999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee------------------------------
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK------------------------------ 276 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------------------------------ 276 (362)
....+|+.+++.++||||+++++++.
T Consensus 45 ------------------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (383)
T 3eb0_A 45 ------------------------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHH 100 (383)
T ss_dssp ------------------------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------------------
T ss_pred ------------------------chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccccc
Confidence 11236999999999999999999983
Q ss_pred --------ccceEEEEEeccCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCC
Q psy14740 277 --------DKKYLYMLMESCLGGELWTILR----DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSG 343 (362)
Q Consensus 277 --------~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~ 343 (362)
...++++||||++ ++|.+.+. ....+++..++.++.|++.||.|||++||+||||||+||+++ .++
T Consensus 101 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~ 179 (383)
T 3eb0_A 101 KSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179 (383)
T ss_dssp ---------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT
T ss_pred ccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC
Confidence 3445899999996 67776665 346799999999999999999999999999999999999998 688
Q ss_pred cEEEEecccceecCC
Q psy14740 344 YVKLVDFGFAKKLIG 358 (362)
Q Consensus 344 ~~kl~DFG~a~~~~~ 358 (362)
.+||+|||+|+.+..
T Consensus 180 ~~kl~Dfg~a~~~~~ 194 (383)
T 3eb0_A 180 TLKLCDFGSAKKLIP 194 (383)
T ss_dssp EEEECCCTTCEECCT
T ss_pred cEEEEECCCCcccCC
Confidence 999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=202.43 Aligned_cols=153 Identities=27% Similarity=0.497 Sum_probs=134.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~---------------------------------------- 59 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKAS---------------------------------------- 59 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGG----------------------------------------
T ss_pred hhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccc----------------------------------------
Confidence 568999999999999999999865 457889999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+.+++.++||||+++++++...+..|++||++++++|.+++...+.+++..
T Consensus 60 -----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 122 (287)
T 2wei_A 60 -----------------AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122 (287)
T ss_dssp -----------------BSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred -----------------cchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHH
Confidence 112234568899999999999999999999999999999999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC---CcEEEEecccceecCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS---GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~---~~~kl~DFG~a~~~~~ 358 (362)
+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||+++....
T Consensus 123 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999999999999999999999999754 4699999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=204.98 Aligned_cols=148 Identities=26% Similarity=0.483 Sum_probs=129.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~--------------------------------------- 56 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKS--------------------------------------- 56 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC------------------------------------------
T ss_pred CccceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCC---------------------------------------
Confidence 3578999999999999999999965 457889999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~ 305 (362)
......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++.. ...+++
T Consensus 57 --------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~ 116 (302)
T 2j7t_A 57 --------------------EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116 (302)
T ss_dssp ---------------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCH
T ss_pred --------------------HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCH
Confidence 12235678899999999999999999999999999999999999999998875 456999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 117 ~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999999999999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=204.69 Aligned_cols=152 Identities=22% Similarity=0.289 Sum_probs=128.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...|.+.+.||+|+||.||++.+... .+..+|+|.+...
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--------------------------------------- 60 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--------------------------------------- 60 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---------------------------------------
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---------------------------------------
Confidence 34567779999999999999986543 2236888887542
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceE-EEEEeccCCcchHHHHHh-cCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYL-YMLMESCLGGELWTILRD-KGNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~l 303 (362)
........+.+|+.+++.++||||+++++++...+.. +++|||+.+++|.+++.. ...+
T Consensus 61 -------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~ 121 (298)
T 3pls_A 61 -------------------TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP 121 (298)
T ss_dssp -------------------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCC
T ss_pred -------------------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCC
Confidence 1123346688999999999999999999999766554 999999999999999986 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 122 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 122 TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999999999999999999999999999999999999999997553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=206.02 Aligned_cols=146 Identities=23% Similarity=0.391 Sum_probs=129.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|++...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---------------------------------------- 72 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---------------------------------------- 72 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC----------------------------------------
T ss_pred CCCceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEeccc----------------------------------------
Confidence 4578999999999999999999855 45789999987532
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
....+.+|+.+++.++ ||||+++++++.+ ....++||||+++++|.+++.. +
T Consensus 73 ----------------------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~ 127 (330)
T 3nsz_A 73 ----------------------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---L 127 (330)
T ss_dssp ----------------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---C
T ss_pred ----------------------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---C
Confidence 1245788999999996 9999999999987 6779999999999999998853 8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~ 358 (362)
++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 128 ~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999999999999999999999999999776 899999999987643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=206.43 Aligned_cols=154 Identities=27% Similarity=0.410 Sum_probs=132.5
Q ss_pred ccccCcEEEEEecccceecEEEEEe---cCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQI---AGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
....+|++.+.||+|+||.||++.. ...+++.+|+|.+...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------------------------------ 81 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------------------------------------ 81 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC------------------------------------
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC------------------------------------
Confidence 3457899999999999999999985 2345788999987542
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc--eEEEEEeccCCcchHHHHHhc
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK--YLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~ 300 (362)
.......+.+|+.+++.++||||+++++++...+ .+++||||+++++|.+++...
T Consensus 82 -----------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 138 (326)
T 2w1i_A 82 -----------------------TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 138 (326)
T ss_dssp -----------------------CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS
T ss_pred -----------------------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc
Confidence 1223456889999999999999999999876543 789999999999999999875
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 301 -GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 -~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 139 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 139 KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 3599999999999999999999999999999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=204.36 Aligned_cols=149 Identities=33% Similarity=0.570 Sum_probs=130.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||.+.+. .+++.+|+|.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~----------------------------------------- 42 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT----------------------------------------- 42 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-----------------------------------------
T ss_pred cccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-----------------------------------------
Confidence 357999999999999999999855 45789999987432
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-------------cceEEEEEeccCCcchH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-------------KKYLYMLMESCLGGELW 294 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~ 294 (362)
......+.+|+.+++.++||||+++++++.+ ....|+||||+++++|.
T Consensus 43 -------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (303)
T 1zy4_A 43 -------------------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY 103 (303)
T ss_dssp -------------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHH
T ss_pred -------------------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHH
Confidence 1223567899999999999999999998754 46799999999999999
Q ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 295 TILRDKG-NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 295 ~~l~~~~-~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 104 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 167 (303)
T 1zy4_A 104 DLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167 (303)
T ss_dssp HHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred HhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence 9998643 57889999999999999999999999999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=210.59 Aligned_cols=150 Identities=25% Similarity=0.363 Sum_probs=126.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 62 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPF--------------------------------------- 62 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTT---------------------------------------
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEecccc---------------------------------------
Confidence 4678999999999999999999854 457889999886421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------eEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~ 300 (362)
........+.+|+.+++.++||||+++++++...+ .+|+||||++ ++|.+.+.
T Consensus 63 ------------------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-- 121 (371)
T 2xrw_A 63 ------------------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-- 121 (371)
T ss_dssp ------------------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--
T ss_pred ------------------CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--
Confidence 11233456789999999999999999999987654 7899999995 68888885
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 459999999999999999999999999999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=211.67 Aligned_cols=166 Identities=23% Similarity=0.417 Sum_probs=136.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+ +++.+|+|.+..............
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~----------------------------- 76 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKS----------------------------- 76 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCC-----------------------------
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccc-----------------------------
Confidence 468999999999999999999996 588999999876432111000000
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHH------HHh-
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTI------LRD- 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~- 299 (362)
.............+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|.++ +..
T Consensus 77 -------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~ 143 (348)
T 2pml_X 77 -------------NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143 (348)
T ss_dssp -------------SSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS
T ss_pred -------------cchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc
Confidence 000111122336789999999999999999999999999999999999999999998 655
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 -KGNFDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 -~~~l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++.+.
T Consensus 144 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 203 (348)
T 2pml_X 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203 (348)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECB
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccc
Confidence 4579999999999999999999999 999999999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.03 Aligned_cols=152 Identities=28% Similarity=0.431 Sum_probs=130.1
Q ss_pred cccCcEEEE-EecccceecEEEEEec-CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVIT-TLGVGGFGRVELVQIA-GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|.+.+ .||+|+||.||++.+. ...+..+|+|.+...
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-------------------------------------- 48 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------------------------------------- 48 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------------------------------------
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--------------------------------------
Confidence 346788887 9999999999999753 335678999988643
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCC
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 303 (362)
......+.+.+|+.+++.++||||+++++++ ..+..|+|||++++++|.+++... ..+
T Consensus 49 --------------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 107 (287)
T 1u59_A 49 --------------------TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI 107 (287)
T ss_dssp --------------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTS
T ss_pred --------------------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccC
Confidence 1123345688999999999999999999999 455699999999999999998654 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 108 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 108 PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999999999999999999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=218.88 Aligned_cols=149 Identities=23% Similarity=0.391 Sum_probs=128.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+.+ +..+|+|.+....
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--------------------------------------- 220 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT--------------------------------------- 220 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS---------------------------------------
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC--CceEEEEEeccCC---------------------------------------
Confidence 45789999999999999999998654 4569999886431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
...+.+.+|+.+|+.++||||+++++++.. +..|+||||+++++|.+++... ..++
T Consensus 221 ---------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~ 278 (452)
T 1fmk_A 221 ---------------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLR 278 (452)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCC
T ss_pred ---------------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCC
Confidence 112457899999999999999999999876 6689999999999999999753 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 279 ~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 279 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999999999999999999999999999999999999999987644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=212.64 Aligned_cols=150 Identities=21% Similarity=0.406 Sum_probs=116.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~---------------------------------------- 66 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPF---------------------------------------- 66 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTT----------------------------------------
T ss_pred CCceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccc----------------------------------------
Confidence 478999999999999999999855 568899999885421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++... ..+|++||++ +++|.+++.. .
T Consensus 67 -----------------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~ 127 (367)
T 2fst_X 67 -----------------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-Q 127 (367)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------C
T ss_pred -----------------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-C
Confidence 1122345678999999999999999999998653 5689999999 8999998876 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 128 ~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 128 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999999999999999999999999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=206.99 Aligned_cols=151 Identities=26% Similarity=0.441 Sum_probs=119.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||.+.+. .+++.+|+|.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 52 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEK--------------------------------------- 52 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC------------------------------------------
T ss_pred chhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhh---------------------------------------
Confidence 4688999999999999999999854 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-------
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD------- 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------- 299 (362)
.......+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++..
T Consensus 53 -------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 113 (303)
T 2vwi_A 53 -------------------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 113 (303)
T ss_dssp --------------------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTT
T ss_pred -------------------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcccc
Confidence 011234577899999999999999999999999999999999999999999874
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 300 -KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 300 -~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+
T Consensus 114 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp TTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 345899999999999999999999999999999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=208.35 Aligned_cols=158 Identities=23% Similarity=0.357 Sum_probs=130.8
Q ss_pred hhhhhccccCcEEEEEecccceecEEEEEec----CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhh
Q psy14740 141 EEFRSLRLSDLRVITTLGVGGFGRVELVQIA----GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQET 216 (362)
Q Consensus 141 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~ 216 (362)
..+.....++|++.+.||+|+||.||++... ..+++.+|+|.+...
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------------------------ 71 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------------------------------ 71 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS------------------------------
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc------------------------------
Confidence 3445556789999999999999999999843 235678999987532
Q ss_pred HHhhccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHH
Q psy14740 217 FNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTI 296 (362)
Q Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 296 (362)
........+.+|+.+++.++||||+++++++...+..|+||||+++++|.++
T Consensus 72 ----------------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 123 (327)
T 2yfx_A 72 ----------------------------CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123 (327)
T ss_dssp ----------------------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred ----------------------------cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 1122345678899999999999999999999999999999999999999999
Q ss_pred HHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceec
Q psy14740 297 LRDKG-------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKL 356 (362)
Q Consensus 297 l~~~~-------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~ 356 (362)
+.... .+++..+..++.|++.||.|||++||+||||||+||+++. +..++|+|||+++.+
T Consensus 124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193 (327)
T ss_dssp HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred HHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence 98653 3889999999999999999999999999999999999984 446999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=201.68 Aligned_cols=149 Identities=20% Similarity=0.287 Sum_probs=131.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 47 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--------------------------------------- 47 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT---------------------------------------
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCC---------------------------------------
Confidence 4578999999999999999999854 458899999875321
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
....+.+|+.+++.+ +|||++++++++......|+||||+ +++|.+++...+ +++
T Consensus 48 ----------------------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~ 104 (298)
T 1csn_A 48 ----------------------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS 104 (298)
T ss_dssp ----------------------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCC
T ss_pred ----------------------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCC
Confidence 123477899999999 8999999999999999999999999 999999998654 599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc-----EEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-----VKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~-----~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.+..
T Consensus 105 ~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 105 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999999999999999999999999999999999987765 99999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=203.37 Aligned_cols=153 Identities=26% Similarity=0.450 Sum_probs=122.1
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-------------------------------------- 44 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATV-------------------------------------- 44 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC-----------------------------------------
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeeccc--------------------------------------
Confidence 35688999999999999999999865 457899999885431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh----cC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----KG 301 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~ 301 (362)
........+..+...++.++||||+++++++.+++..|+||||++ ++|.+++.. ..
T Consensus 45 -------------------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~ 104 (290)
T 3fme_A 45 -------------------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQ 104 (290)
T ss_dssp -------------------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTC
T ss_pred -------------------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCC
Confidence 011122334455556788899999999999999999999999995 688777653 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.+.
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 105 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 799999999999999999999998 99999999999999999999999999997653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=209.55 Aligned_cols=151 Identities=23% Similarity=0.309 Sum_probs=131.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++... +++.+|+|.+.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-------------------------------------- 67 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERT-------------------------------------- 67 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----------------------------------------
T ss_pred HhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccC--------------------------------------
Confidence 5678999999999999999999743 478899999865310
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC----C
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----N 302 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~ 302 (362)
......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... .
T Consensus 68 --------------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 127 (326)
T 3uim_A 68 --------------------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127 (326)
T ss_dssp ----------------------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCC
T ss_pred --------------------chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCC
Confidence 1112357899999999999999999999999999999999999999999998643 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSR---NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~---~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.+.
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 89999999999999999999999 99999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=213.39 Aligned_cols=152 Identities=19% Similarity=0.284 Sum_probs=122.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..|.+.+.||+|+||.||++...... ...+|+|.+...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---------------------------------------- 128 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---------------------------------------- 128 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----------------------------------------
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----------------------------------------
Confidence 45788999999999999999865433 245788876432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeee-eccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
........+.+|+.+++.++||||+++++++ ..++..|+||||+++++|.+++.... .++
T Consensus 129 ------------------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 190 (373)
T 3c1x_A 129 ------------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190 (373)
T ss_dssp ------------------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCB
T ss_pred ------------------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCC
Confidence 1123446688999999999999999999985 45568899999999999999997643 588
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 191 ~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999999999999999999999999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=208.48 Aligned_cols=149 Identities=22% Similarity=0.369 Sum_probs=129.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~----------------------------------------- 63 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPF----------------------------------------- 63 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCT-----------------------------------------
T ss_pred cccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccc-----------------------------------------
Confidence 358999999999999999999855 45788999988542
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
........+.+|+.+++.++||||+++++++... ...|+|||++ +++|.+++.. +.
T Consensus 64 -----------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~-~~~L~~~l~~-~~ 124 (364)
T 3qyz_A 64 -----------------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QH 124 (364)
T ss_dssp -----------------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC-SEEHHHHHHH-CC
T ss_pred -----------------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc-CcCHHHHHHh-CC
Confidence 1122345678999999999999999999998654 4699999999 5699998876 56
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 9999999999999999999999999999999999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=203.77 Aligned_cols=148 Identities=29% Similarity=0.477 Sum_probs=125.0
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. ++.+|+|.+...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--------------------------------------- 55 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--------------------------------------- 55 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC---------------------------------------
T ss_pred CChhhceEEeEEecCCCceEEEEEEc---CCEEEEEEecch---------------------------------------
Confidence 45789999999999999999999854 678999987532
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhcCC--
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDKGN-- 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-- 302 (362)
...+.+.+|+.+++.++||||+++++++.. .+.+|+||||+++++|.+++...+.
T Consensus 56 ----------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 113 (278)
T 1byg_A 56 ----------------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113 (278)
T ss_dssp ----------------------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHH
T ss_pred ----------------------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccccc
Confidence 123457889999999999999999998654 4579999999999999999986543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 8999999999999999999999999999999999999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=200.13 Aligned_cols=159 Identities=25% Similarity=0.354 Sum_probs=131.9
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
+....++|++.+.||+|+||.||++.+. .+++.+|+|.+.......
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~--------------------------------- 59 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEG--------------------------------- 59 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTC---------------------------------
T ss_pred hhhhhccceehhccccCCceeEEEEEEc-CCceEEEEEEeecccccc---------------------------------
Confidence 3456689999999999999999999865 457889999886542100
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
........+.+.+|+.+++.++||||+++++++.+.. ++||||+++++|.+.+... ..
T Consensus 60 -------------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~ 118 (287)
T 4f0f_A 60 -------------------ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHP 118 (287)
T ss_dssp -------------------CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSC
T ss_pred -------------------chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCC
Confidence 0001112356889999999999999999999997766 6999999999998887654 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCc-----EEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGY-----VKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~-----~kl~DFG~a~~~~ 357 (362)
+++..+..++.|++.||.|||++| |+||||||+||+++.++. +||+|||+++...
T Consensus 119 ~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~ 180 (287)
T 4f0f_A 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc
Confidence 999999999999999999999999 999999999999988776 9999999997543
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-25 Score=208.09 Aligned_cols=220 Identities=20% Similarity=0.311 Sum_probs=169.3
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|++| +++++..|+..+..+.|++|++||++||+++.||||++|.|+|+. ..+ +.+..+..+++|++|||+
T Consensus 146 ~L~~~~lF~~L-~~~~l~~l~~~~~~~~~~~Ge~I~~qGd~~d~~YiI~sG~v~v~~-~~~-G~~~~v~~l~~G~~fGe~ 222 (416)
T 3tnp_B 146 ACKDILLFKNL-DPEQMSQVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYV-KCD-GVGRCVGNYDNRGSFGEL 222 (416)
T ss_dssp HHTTSHHHHTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEECEEEEEE-ECS-SCEEEEEEEESCCEECGG
T ss_pred HHhCCHhHhcC-CHHHHHHHHHhcEEEEeCCCCEEEeCCCCCceEEEEEeeEEEEEE-ecC-CCEEEEEEecCCCEEeeH
Confidence 47889999999 999999999999999999999999999999999999999999998 444 556889999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhhc---cccCcEEEEE------
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSL---RLSDLRVITT------ 156 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~------ 156 (362)
+++.+.||++||+|. ++|++|.|++++|..++..+|.....++..+.....+...+... .+........
T Consensus 223 all~~~pr~atv~A~--~d~~l~~i~r~~f~~ll~~~~~~~~~~~~~~L~~v~lf~~Ls~~el~~L~~~l~~~~~~~Ge~ 300 (416)
T 3tnp_B 223 ALMYNTPKAATITAT--SPGALWGLDRVTFRRIIVKNNAKKRKMYESFIESLPFLKSLEVSERLKVVDVIGTKVYNDGEQ 300 (416)
T ss_dssp GGTSCCCCSSEEEES--SSEEEEEEEHHHHHHHHHHHHHHHSSSSSSSGGGCGGGTTCCHHHHHHHHHHCEEEEECTTCE
T ss_pred HHhcCCCcccEEEEc--cCeEEEEEeehhhhhhhhcchhHHHHHHHHHHhhchHhhcCCHHHHHHHHhhceEEEECCCCE
Confidence 999999999999999 56999999999999999999999877665554443333222111 1111111122
Q ss_pred -ecccce---------ecEEEEEecCCC------CCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehh
Q psy14740 157 -LGVGGF---------GRVELVQIAGDP------SRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQE 215 (362)
Q Consensus 157 -lg~G~~---------g~v~~~~~~~~~------~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~ 215 (362)
+-+|.- |.|...... .. ++...+..+.++++||. +.++.+++.|.++ +.|+.|+++
T Consensus 301 I~~eGd~~~~~yiI~sG~v~v~~~~-~~~~~~~~g~~~~l~~l~~G~~fGE~all~~~~r~~tv~A~~~--~~ll~I~~~ 377 (416)
T 3tnp_B 301 IIAQGDLADSFFIVESGEVKITMKR-KGKSEVEENGAVEIARCFRGQYFGELALVTNKPRAASAHAIGT--VKCLAMDVQ 377 (416)
T ss_dssp EECTTSCCCEEEEEEEEEEEEECC-------------CEEEEECTTCEESGGGGTCCSCCSSEEEEEEE--EEEEEEEHH
T ss_pred EEeCCCcCCEEEEEEeCEEEEEEec-CCcccccCCceeEEEEeCCCCEecHHHHhCCCCceeEEEEcCC--eEEEEEEHH
Confidence 222222 444433321 22 55678889999999993 5788899999864 999999999
Q ss_pred hHHhhccchHHhhhhccc
Q psy14740 216 TFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 216 ~f~~~~~~~~~~~~~~~~ 233 (362)
.|.++++...++..+...
T Consensus 378 ~f~~ll~~~p~i~~~~~~ 395 (416)
T 3tnp_B 378 AFERLLGPCMEIMKRNIA 395 (416)
T ss_dssp HHHHHHCCHHHHHTCC--
T ss_pred HHHHHhcchHHHHHHHHH
Confidence 999999999888765443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=223.47 Aligned_cols=145 Identities=26% Similarity=0.398 Sum_probs=126.5
Q ss_pred EEecccceecEEEEEec-CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 155 TTLGVGGFGRVELVQIA-GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
+.||+|+||.||++.+. ...++.+|+|++....
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------------------------------------------- 408 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------------------------------------- 408 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG----------------------------------------------
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc----------------------------------------------
Confidence 47999999999999653 3345789999886531
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
........+.+|+.+|+.++||||+++++++.. +.+++||||+++++|.+++...+.+++..+..++.
T Consensus 409 -----------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~ 476 (635)
T 4fl3_A 409 -----------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 476 (635)
T ss_dssp -----------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHH
T ss_pred -----------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHH
Confidence 112234668999999999999999999999865 45899999999999999998888899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 477 qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 477 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred HHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999999999999999999999999999999999999998664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=200.29 Aligned_cols=151 Identities=11% Similarity=0.149 Sum_probs=132.4
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. ++.+|+|.+....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~-------------------------------------- 45 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRD-------------------------------------- 45 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTT--------------------------------------
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccc--------------------------------------
Confidence 46789999999999999999999864 6779999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc--ceEEEEEeccCCcchHHHHHhcC--
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK--KYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
........+.+|+.+++.++||||+++++++.+. ..+++||||+++++|.+++....
T Consensus 46 -------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 106 (271)
T 3kmu_A 46 -------------------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106 (271)
T ss_dssp -------------------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSC
T ss_pred -------------------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccC
Confidence 1122345688999999999999999999999877 78999999999999999998754
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 107 ~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 107 VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 4899999999999999999999999 999999999999999999999999887544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=210.19 Aligned_cols=161 Identities=19% Similarity=0.283 Sum_probs=126.6
Q ss_pred cccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..++|.+.+.||+|+||.||++.+.. ..+..+|+|........ +.+-.
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---------------------------~~~e~--- 84 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP---------------------------LFSEL--- 84 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH---------------------------HHHHH---
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc---------------------------hHHHH---
Confidence 45789999999999999999999754 24678899987653110 00000
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..........+.+|+.+++.++||||+++++++.. ....|+||||+ +++|.+++...
T Consensus 85 ------------------~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 145 (345)
T 2v62_A 85 ------------------KFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145 (345)
T ss_dssp ------------------HHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG
T ss_pred ------------------HHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc
Confidence 00111123457789999999999999999999877 78899999999 99999999877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC--cEEEEecccceec
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG--YVKLVDFGFAKKL 356 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~--~~kl~DFG~a~~~ 356 (362)
+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 146 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~ 203 (345)
T 2v62_A 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203 (345)
T ss_dssp GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEES
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceec
Confidence 7899999999999999999999999999999999999999877 9999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=209.46 Aligned_cols=145 Identities=17% Similarity=0.252 Sum_probs=124.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCC-------CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD-------PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
.++|.+.+.||+|+||.||++.+... .++.+|+|.+.+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------------------------------- 86 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------------------------------- 86 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------------------------------
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------------------------------
Confidence 47899999999999999999997643 4788999987532
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceee---------------eeeeeec-cceEEEE
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVK---------------LYKTFKD-KKYLYML 284 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv 284 (362)
..+.+|+.+++.++||||++ +++++.. ...+|+|
T Consensus 87 ------------------------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 136 (352)
T 2jii_A 87 ------------------------------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV 136 (352)
T ss_dssp ------------------------------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEE
T ss_pred ------------------------------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEE
Confidence 34778999999999999988 4555544 6789999
Q ss_pred EeccCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC--cEEEEecccceecC
Q psy14740 285 MESCLGGELWTILRDK--GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG--YVKLVDFGFAKKLI 357 (362)
Q Consensus 285 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~--~~kl~DFG~a~~~~ 357 (362)
|||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.+.
T Consensus 137 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~ 212 (352)
T 2jii_A 137 LPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212 (352)
T ss_dssp EECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSS
T ss_pred ecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeecc
Confidence 9999 99999999875 6799999999999999999999999999999999999999988 89999999997653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=204.78 Aligned_cols=158 Identities=24% Similarity=0.384 Sum_probs=126.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+........
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~----------------------------------- 72 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGW----------------------------------- 72 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC-------------------------------------
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEeccccccc-----------------------------------
Confidence 3568999999999999999999854 4578999999865422110
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc----CCcceeeeeeeeeccceEEEEEec-cCCcchHHHHHhcC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA----NCDFIVKLYKTFKDKKYLYMLMES-CLGGELWTILRDKG 301 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~ 301 (362)
........+.+|+.++..+ +||||+++++++...+..+++||+ +.+++|.+++...+
T Consensus 73 ------------------~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~ 134 (312)
T 2iwi_A 73 ------------------SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG 134 (312)
T ss_dssp ------------------------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC
T ss_pred ------------------ccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC
Confidence 0011234466788888888 899999999999999999999999 78999999999888
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+||+++ .++.++|+|||+++.+..
T Consensus 135 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~ 192 (312)
T 2iwi_A 135 PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192 (312)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc
Confidence 899999999999999999999999999999999999999 789999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=204.28 Aligned_cols=148 Identities=26% Similarity=0.399 Sum_probs=123.3
Q ss_pred hccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 145 SLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 145 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
...+++|++.+.||+|+||.||++.. +++.+|+|++....
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~------------------------------------- 48 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN------------------------------------- 48 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG-------------------------------------
T ss_pred CcChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc-------------------------------------
Confidence 45689999999999999999999975 36789999875431
Q ss_pred HHhhhhccchhhhhccccccccchhhhhhHHHHHH--HhhcCCcceeeeeeee-----eccceEEEEEeccCCcchHHHH
Q psy14740 225 DEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEI--MGEANCDFIVKLYKTF-----KDKKYLYMLMESCLGGELWTIL 297 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l 297 (362)
...+..|.++ +..++||||+++++.+ .....+|+||||+++++|.+++
T Consensus 49 -------------------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 103 (336)
T 3g2f_A 49 -------------------------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103 (336)
T ss_dssp -------------------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHH
T ss_pred -------------------------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHH
Confidence 1223344444 4458999999999743 2344689999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 298 RDKGNFDDATTRFYTACVVEAFDYLHSR---------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 298 ~~~~~l~~~~~~~~~~ql~~al~~lH~~---------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
... ..++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 104 ~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 104 SLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172 (336)
T ss_dssp HHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred hhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence 764 468899999999999999999999 999999999999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=205.26 Aligned_cols=152 Identities=26% Similarity=0.444 Sum_probs=130.0
Q ss_pred cCcEEE-EEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 149 SDLRVI-TTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 149 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
++|.+. +.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 66 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRR---------------------------------------- 66 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEE----------------------------------------
T ss_pred hEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhh----------------------------------------
Confidence 456676 78999999999999865 458899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
........+.+|+.+++.+ .||||+++++++...+.+|+||||+++++|.+++... ..++
T Consensus 67 -----------------~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 129 (327)
T 3lm5_A 67 -----------------RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129 (327)
T ss_dssp -----------------TTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCC
T ss_pred -----------------cchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCC
Confidence 1112345678899999998 5699999999999999999999999999999988643 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.+..
T Consensus 130 ~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 130 ENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999999999999999999999999999999987 78999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.25 Aligned_cols=150 Identities=24% Similarity=0.333 Sum_probs=123.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..-++|++.+.||+|+||.||++.+. ..+|+|.+....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~-------------------------------------- 58 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTA-------------------------------------- 58 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSS--------------------------------------
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccC--------------------------------------
Confidence 45578999999999999999999743 248999875431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
......+.+.+|+.+++.++||||++++++. .....++||||+++++|.+++... ..++
T Consensus 59 -------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 118 (289)
T 3og7_A 59 -------------------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFE 118 (289)
T ss_dssp -------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CC
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCC
Confidence 1223346688999999999999999999965 556689999999999999998643 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 119 ~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999999999999999999999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=203.31 Aligned_cols=150 Identities=23% Similarity=0.411 Sum_probs=130.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 61 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG--------------------------------------- 61 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS---------------------------------------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCc---------------------------------------
Confidence 4578999999999999999999865 457899999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHh
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
.....+.+|+.+++.+ +||||+++++++.. .+.+|+||||+++++|.+++..
T Consensus 62 ---------------------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 120 (326)
T 2x7f_A 62 ---------------------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120 (326)
T ss_dssp ---------------------STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHH
T ss_pred ---------------------ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHh
Confidence 1224578899999998 89999999999876 4689999999999999999986
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 K--GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~--~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..+.
T Consensus 121 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 121 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp SGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 4 469999999999999999999999999999999999999999999999999987653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=203.51 Aligned_cols=159 Identities=23% Similarity=0.364 Sum_probs=135.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+........
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~----------------------------------- 84 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDW----------------------------------- 84 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCE-----------------------------------
T ss_pred ccCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhh-----------------------------------
Confidence 4678999999999999999999855 4578999999876422110
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCC-cchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLG-GELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l 303 (362)
........+.+|+.+++.++ ||||+++++++..++..+++||++.+ ++|.+++...+.+
T Consensus 85 ------------------~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l 146 (320)
T 3a99_A 85 ------------------GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 146 (320)
T ss_dssp ------------------EECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSC
T ss_pred ------------------hhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCC
Confidence 01112345678999999995 59999999999999999999999976 8999999988889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~~~ 359 (362)
++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+++.+...
T Consensus 147 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~ 203 (320)
T 3a99_A 147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203 (320)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence 9999999999999999999999999999999999999 7899999999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-25 Score=205.27 Aligned_cols=150 Identities=23% Similarity=0.383 Sum_probs=130.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~---------------------------------------- 47 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPF---------------------------------------- 47 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC----------------------------------------
T ss_pred cccceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeeccc----------------------------------------
Confidence 4578999999999999999999855 45788999988532
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++... ...|++||++ +++|.+++.. +
T Consensus 48 ------------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~ 107 (353)
T 2b9h_A 48 ------------------DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-Q 107 (353)
T ss_dssp ------------------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC-SEEHHHHHHH-C
T ss_pred ------------------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc-CccHHHHHhh-c
Confidence 1122345577899999999999999999987653 6799999999 4799998876 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 108 ~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 79999999999999999999999999999999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=202.61 Aligned_cols=153 Identities=26% Similarity=0.475 Sum_probs=127.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||.+.+. .+++.+|+|++.+...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~--------------------------------------- 43 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKL--------------------------------------- 43 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHH---------------------------------------
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEeccccc---------------------------------------
Confidence 578999999999999999999854 5678999999865411
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeee--eccceEEEEEeccCCcchHHHHHh--cCCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF--KDKKYLYMLMESCLGGELWTILRD--KGNF 303 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~--~~~l 303 (362)
.........+.+|+.+++.++||||+++++++ ......|+||||++++ |.+++.. ...+
T Consensus 44 ----------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~ 106 (305)
T 2wtk_C 44 ----------------RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRF 106 (305)
T ss_dssp ----------------HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSC
T ss_pred ----------------cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccccc
Confidence 00112345688999999999999999999998 4556899999999655 7777765 3469
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.
T Consensus 107 ~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999999999999999999999999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=204.42 Aligned_cols=145 Identities=22% Similarity=0.355 Sum_probs=125.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. ++.+|+|.+...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---------------------------------------- 71 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---------------------------------------- 71 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGG----------------------------------------
T ss_pred cccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecc----------------------------------------
Confidence 3578999999999999999999854 678999987432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc--CCcceeeeeeeeecc----ceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA--NCDFIVKLYKTFKDK----KYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
.......|.+++... +||||+++++++... ..+|+||||+++++|.++++.
T Consensus 72 ----------------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~- 128 (337)
T 3mdy_A 72 ----------------------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS- 128 (337)
T ss_dssp ----------------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-
T ss_pred ----------------------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-
Confidence 112244556666554 999999999998776 789999999999999999976
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSR--------NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~--------~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193 (337)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence 4699999999999999999999999 99999999999999999999999999997664
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.80 Aligned_cols=149 Identities=23% Similarity=0.397 Sum_probs=130.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+.+ +..+|+|.+....
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-------------------------------------- 303 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-------------------------------------- 303 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS--------------------------------------
T ss_pred cchhhhhhheecccCCCeEEEEEEECC--CceEEEEEeCCCC--------------------------------------
Confidence 345789999999999999999998654 4569999886531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNF 303 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l 303 (362)
...+.+.+|+.+|+.++||||+++++++.. ..+|+||||+++++|.+++... ..+
T Consensus 304 ----------------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l 360 (535)
T 2h8h_A 304 ----------------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL 360 (535)
T ss_dssp ----------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTC
T ss_pred ----------------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCC
Confidence 112458899999999999999999999876 6689999999999999999753 469
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 361 ~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 361 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999999999999999999999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-25 Score=202.51 Aligned_cols=152 Identities=24% Similarity=0.390 Sum_probs=128.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+...+++.+|+|.+.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------------------------------- 50 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--------------------------------------- 50 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------------------------------------
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc---------------------------------------
Confidence 47899999999999999999997656688899998865310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHh
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
.......+.+|+.+++.+ +||||+++++++. ....+++||||++ ++|.+++..
T Consensus 51 ------------------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~ 111 (326)
T 1blx_A 51 ------------------EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK 111 (326)
T ss_dssp ------------------TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHH
T ss_pred ------------------cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHh
Confidence 111223456777777766 8999999999986 5678999999996 699999986
Q ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KG--NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~--~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 112 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171 (326)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence 43 48999999999999999999999999999999999999999999999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=209.88 Aligned_cols=152 Identities=16% Similarity=0.153 Sum_probs=111.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~----------------------------------------- 99 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGA----------------------------------------- 99 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCS-----------------------------------------
T ss_pred eeeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecc-----------------------------------------
Confidence 45999999999999999999965 457899999987641
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc--CCcceeeeeee-------eecc-----------------ceEE
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA--NCDFIVKLYKT-------FKDK-----------------KYLY 282 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~-------~~~~-----------------~~~~ 282 (362)
.........+.+|+.+++.+ +||||++++.. +..+ ..+|
T Consensus 100 ---------------~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (371)
T 3q60_A 100 ---------------ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164 (371)
T ss_dssp ---------------TTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred ---------------cccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence 11223344567785555544 69998886533 3221 4489
Q ss_pred EEEeccCCcchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 283 MLMESCLGGELWTILRDK-GNFDDATT------RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 283 lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
+||||++ ++|.+++... ..++.... ..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 165 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp EEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred EEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeee
Confidence 9999997 8999999864 33444444 56779999999999999999999999999999999999999999987
Q ss_pred cCC
Q psy14740 356 LIG 358 (362)
Q Consensus 356 ~~~ 358 (362)
...
T Consensus 244 ~~~ 246 (371)
T 3q60_A 244 VGT 246 (371)
T ss_dssp TTC
T ss_pred cCC
Confidence 643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-25 Score=202.31 Aligned_cols=151 Identities=25% Similarity=0.362 Sum_probs=130.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+...+++.+|+|++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------------------------------- 51 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------------------------------------- 51 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----------------------------------------
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----------------------------------------
Confidence 3478999999999999999999875666889999987542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcc------eeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF------IVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
......+.+|+.+++.++|++ ++++++++...+.+|+||||+ +++|.+++...
T Consensus 52 --------------------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~ 110 (339)
T 1z57_A 52 --------------------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110 (339)
T ss_dssp --------------------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred --------------------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc
Confidence 112345678888888887664 999999999999999999999 89999999876
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-------------------CCcEEEEecccceecCC
Q psy14740 301 G--NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-------------------SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 ~--~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-------------------~~~~kl~DFG~a~~~~~ 358 (362)
+ ++++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 111 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence 5 5899999999999999999999999999999999999987 66799999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=206.24 Aligned_cols=159 Identities=18% Similarity=0.274 Sum_probs=127.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||++.+. .++.+|+|.+........
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~----------------------------------- 62 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGR----------------------------------- 62 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTS-----------------------------------
T ss_pred hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccc-----------------------------------
Confidence 3578999999999999999999854 378899999865421100
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHhc-
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
...........+.+.+|+.+++.++||||+++++++. ....+|+||||++ ++|.+.+...
T Consensus 63 -------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 128 (362)
T 3pg1_A 63 -------------TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR 128 (362)
T ss_dssp -------------CEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT
T ss_pred -------------hhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc
Confidence 0001122334467899999999999999999999983 3457999999995 7888877654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 129 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 36999999999999999999999999999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=201.00 Aligned_cols=148 Identities=26% Similarity=0.442 Sum_probs=122.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~----------------------------------------- 47 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLT----------------------------------------- 47 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECC-----------------------------------------
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecC-----------------------------------------
Confidence 478999999999999999999865 45789999987532
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--------------ccceEEEEEeccCCcch
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--------------DKKYLYMLMESCLGGEL 293 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L 293 (362)
.......+.+|+.+++.++||||+++++++. .....|+||||++ ++|
T Consensus 48 ------------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 108 (320)
T 2i6l_A 48 ------------------DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDL 108 (320)
T ss_dssp ------------------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEH
T ss_pred ------------------ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCH
Confidence 1223456789999999999999999998873 3467999999995 799
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecC
Q psy14740 294 WTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 294 ~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~ 357 (362)
.+++.. +++++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+++.+.
T Consensus 109 ~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~ 172 (320)
T 2i6l_A 109 ANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172 (320)
T ss_dssp HHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred HHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence 998865 5799999999999999999999999999999999999997 56799999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=201.58 Aligned_cols=148 Identities=22% Similarity=0.273 Sum_probs=127.9
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
...+.||+|+||.||++.. .++.+|+|.+....
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-------------------------------------------- 66 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMV-------------------------------------------- 66 (307)
T ss_dssp TTCCEEEECSSEEEEEEES---SSCEEEEEEECCCT--------------------------------------------
T ss_pred ccCCccccCCCeEEEEEEE---CCceEEEEEEeccc--------------------------------------------
Confidence 3447899999999999984 36789999886431
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh---cCCCCHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD---KGNFDDATT 308 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~ 308 (362)
..........+.+|+.+++.++||||+++++++.+.+..|++|||+++++|.+++.. ..++++..+
T Consensus 67 -----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 135 (307)
T 2nru_A 67 -----------DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135 (307)
T ss_dssp -----------TSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHH
T ss_pred -----------CcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHH
Confidence 111223446688999999999999999999999999999999999999999999874 245899999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 136 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184 (307)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence 9999999999999999999999999999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=220.61 Aligned_cols=150 Identities=28% Similarity=0.426 Sum_probs=128.3
Q ss_pred cCcEEEE-EecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 149 SDLRVIT-TLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 149 ~~~~~~~-~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
+++.+.+ .||+|+||.||++.+.. ..+..||+|.+.+..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--------------------------------------- 375 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--------------------------------------- 375 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---------------------------------------
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---------------------------------------
Confidence 4456666 79999999999997653 235679999986431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
.......+.+|+.+|+.++||||+++++++.. +.+|+||||+++++|.+++... ..+++
T Consensus 376 -------------------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~ 435 (613)
T 2ozo_A 376 -------------------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPV 435 (613)
T ss_dssp -------------------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCH
T ss_pred -------------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCH
Confidence 12234668899999999999999999999876 5699999999999999998754 45999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 436 ~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999999999999999999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-25 Score=199.07 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=128.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
++++.....||+|+||.||++.+. .+++.+|+|.+...+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 59 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERD---------------------------------------- 59 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEET-TTCCEEEEEEEECCC----------------------------------------
T ss_pred ccCCCCcEEEeecCcEEEEEEEEC-CCCeEEEEEEccCCc----------------------------------------
Confidence 444555568999999999999865 457889999875431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC---CCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG---NFD 304 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~ 304 (362)
......+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .++
T Consensus 60 -------------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 120 (295)
T 2clq_A 60 -------------------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120 (295)
T ss_dssp -------------------C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTC
T ss_pred -------------------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCcc
Confidence 1223567899999999999999999999999999999999999999999998642 467
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+|+||||+||+++. ++.++|+|||+++.+.
T Consensus 121 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 8999999999999999999999999999999999987 8999999999998764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=208.48 Aligned_cols=149 Identities=25% Similarity=0.405 Sum_probs=127.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|++.+.||+|+||.||++.+. .+++.||+|.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~----------------------------------------- 133 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE----------------------------------------- 133 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-----------------------------------------
T ss_pred cCcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-----------------------------------------
Confidence 357999999999999999999855 45789999998543
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc------CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA------NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
......+.+|+.+++.+ +||||+++++++...+.+++|||++ +++|.+++....
T Consensus 134 -------------------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~ 193 (429)
T 3kvw_A 134 -------------------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNK 193 (429)
T ss_dssp -------------------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT
T ss_pred -------------------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhcc
Confidence 11224456677777765 6789999999999999999999999 579999887653
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc--EEEEecccceecCC
Q psy14740 302 --NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY--VKLVDFGFAKKLIG 358 (362)
Q Consensus 302 --~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~--~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 194 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 194 FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 4999999999999999999999999999999999999999887 99999999976544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=209.61 Aligned_cols=145 Identities=28% Similarity=0.438 Sum_probs=120.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 91 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK---------------------------------------- 91 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----------------------------------------
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----------------------------------------
Confidence 457999999999999999999965 457899999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHh--
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRD-- 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~-- 299 (362)
....+|+++|+.++||||+++++++.. ..++++||||++ ++|.+++..
T Consensus 92 -----------------------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 147 (420)
T 1j1b_A 92 -----------------------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYS 147 (420)
T ss_dssp -----------------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHH
T ss_pred -----------------------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHh
Confidence 112369999999999999999998743 235789999995 566665542
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-CcEEEEecccceecC
Q psy14740 300 --KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-GYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 --~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-~~~kl~DFG~a~~~~ 357 (362)
...+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 148 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 4569999999999999999999999999999999999999965 678999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=224.43 Aligned_cols=150 Identities=26% Similarity=0.403 Sum_probs=127.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+...+++.+|+|.+....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---------------------------------------- 118 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---------------------------------------- 118 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----------------------------------------
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----------------------------------------
Confidence 4789999999999999999999765467889999875421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccce-----EEEEEeccCCcchHHHHHhcCC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKY-----LYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.......+.+|+.+++.++||||+++++++...+. .|+||||++|++|.+++.. .
T Consensus 119 ------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~ 178 (681)
T 2pzi_A 119 ------------------DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--K 178 (681)
T ss_dssp ------------------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--C
T ss_pred ------------------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--C
Confidence 12234567899999999999999999999887655 7999999999999998764 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||++||+||||||+|||++.+ .+||+|||+++.+..
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999999999999999999999999999999999875 899999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=201.81 Aligned_cols=150 Identities=32% Similarity=0.419 Sum_probs=128.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-.+|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---------------------------------------- 64 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSN---------------------------------------- 64 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEES----------------------------------------
T ss_pred cCceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCC----------------------------------------
Confidence 3458999999999999999999965 45789999987432
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeee--------eccceEEEEEeccCCcchHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTF--------KDKKYLYMLMESCLGGELWTIL 297 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--------~~~~~~~lv~e~~~~~~L~~~l 297 (362)
.......+.+|+.+++.+. ||||+++++++ .....++++|||+ +|+|.+++
T Consensus 65 -------------------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l 124 (337)
T 3ll6_A 65 -------------------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFL 124 (337)
T ss_dssp -------------------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHH
T ss_pred -------------------chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHH
Confidence 1223355788999999995 99999999988 3455689999999 58999888
Q ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 298 RD---KGNFDDATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 298 ~~---~~~l~~~~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.. .+.+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++.+.
T Consensus 125 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp HHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 65 456999999999999999999999999 9999999999999999999999999998664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=207.09 Aligned_cols=149 Identities=21% Similarity=0.359 Sum_probs=126.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|.+.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 79 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPF---------------------------------------- 79 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTT----------------------------------------
T ss_pred cccEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccc----------------------------------------
Confidence 368999999999999999999855 468899999886431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceE------EEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYL------YMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++...+.. |+||||+ .++|.+++. .
T Consensus 80 -----------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--~ 139 (371)
T 4exu_A 80 -----------------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMG--M 139 (371)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECC-CEEHHHHTT--S
T ss_pred -----------------cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccc-cccHHHHhh--c
Confidence 1223346678999999999999999999999876654 9999999 478988874 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 140 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 59999999999999999999999999999999999999999999999999997653
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=205.28 Aligned_cols=216 Identities=20% Similarity=0.342 Sum_probs=170.3
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|++| +++++..|+.++..+.|++|++||++||+++.+|+|++|.|++++. + ..+..+++|++|||+
T Consensus 131 ~l~~~~lF~~L-~~~~l~~l~~~~~~~~~~~ge~I~~~Gd~~~~~yiI~~G~v~v~~~----~--~~v~~l~~G~~fGe~ 203 (381)
T 4din_B 131 AISKNVLFAHL-DDNERSDIFDAMFPVTHIAGETVIQQGNEGDNFYVVDQGEVDVYVN----G--EWVTNISEGGSFGEL 203 (381)
T ss_dssp HHTTCTTSSSC-CHHHHHHHHHHCEEEECCTTCBSSCTTSBCCEEEECSSSEEEEEET----T--EEEEEEESSCCBCGG
T ss_pred HHhCChhhhcC-CHHHHHHHHHhceEEEECCCCEEEeCCCCCCeEEEEEeeEEEEEEC----C--eEeeeCCCCCEEEch
Confidence 47889999999 9999999999999999999999999999999999999999999952 2 468899999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhh---------ccccCcEEEEE
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRS---------LRLSDLRVITT 156 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 156 (362)
+++.+.||++||+|. ++|++|.|+++.|.+++..+|.+..+++..+..+......+.. .....|.-.+.
T Consensus 204 all~~~~r~atv~A~--~~~~l~~i~~~~f~~ll~~~~~~~~~~~~~~L~~v~~f~~Ls~~el~~l~~~~~~~~~~~ge~ 281 (381)
T 4din_B 204 ALIYGTPRAATVKAK--TDLKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLEKWERLTVADALEPVQFEDGEK 281 (381)
T ss_dssp GGTSCCBCSSEEEES--SSCEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHCSTTTTCCTTHHHHHHTTCBCCCBCSSCB
T ss_pred HHhcCCCcceEEEEC--CCEEEEEEchHHHHHhhhhhhHHHHHHHHHHhhhhHHHHhccHHHHHHHHHhhhhccCCCCCE
Confidence 999999999999999 5699999999999999999999988777666554433332211 11122221111
Q ss_pred -ecccce---------ecEEEEEecCCCCCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 157 -LGVGGF---------GRVELVQIAGDPSRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 157 -lg~G~~---------g~v~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
+.+|.- |.|.......+.++...+..+.++++||. +.++.+++.|.++ +.|+.|+++.|.+++
T Consensus 282 I~~eGd~~~~~yiI~~G~v~v~~~~~~~~~~~~v~~l~~Gd~fGe~all~~~~r~~tv~A~~~--~~ll~i~~~~f~~ll 359 (381)
T 4din_B 282 IVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDYFGEIALLLNRPRAATVVARGP--LKCVKLDRPRFERVL 359 (381)
T ss_dssp SSCTTSBCCEEEEEEESCEEEECCSSSSSCCCEEEEECTTCEECTTGGGSCCBCSSEEEESSC--BEEEEEEHHHHHHHH
T ss_pred EEeCCCcCCEEEEEEeCEEEEEEecCCCCceEEEEEeCCCCEechHHHhCCCCceeEEEEcCC--EEEEEEeHHHHHHHH
Confidence 222332 44444432223344667888999999983 5788999999765 999999999999999
Q ss_pred cchHHhhhhcc
Q psy14740 222 SSLDEIRTKYV 232 (362)
Q Consensus 222 ~~~~~~~~~~~ 232 (362)
+...++..+..
T Consensus 360 ~~~~~i~~~~~ 370 (381)
T 4din_B 360 GPCSEILKRNI 370 (381)
T ss_dssp CCHHHHHHTTH
T ss_pred hhhHHHHHHHH
Confidence 99988876533
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-24 Score=194.05 Aligned_cols=217 Identities=26% Similarity=0.381 Sum_probs=166.8
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|..+ +++++..|+..++.+.|++|++||++||+++.+|+|++|.|++... ...+..+.||++|||+
T Consensus 40 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~yiI~~G~v~v~~~------g~~~~~~~~G~~fGe~ 112 (299)
T 3shr_A 40 AILDNDFMKNL-ELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEVTKE------GVKLCTMGPGKVFGEL 112 (299)
T ss_dssp HHHTCTTTTTS-CHHHHHHHHHHCEEEEECTTCEEECTTCBCCCEEEEEESCEEEEET------TEEEEEECTTCEESCS
T ss_pred HHhhCHHHHcC-CHHHHHHHHHhcCeEEECCCCEEEcCCCcCceEEEEEEEEEEEEEC------CEEEEEeCCCCeeeHh
Confidence 46889999999 9999999999999999999999999999999999999999999642 2679999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhhc---cccCcEEEEEecc---
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSL---RLSDLRVITTLGV--- 159 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~lg~--- 159 (362)
+++.+.||++||+|. ++|++|.|++++|..++...|.........+.....+...+... .+........+..
T Consensus 113 ~ll~~~~~~~tv~a~--~~~~l~~i~~~~~~~i~~~~~~~~~~~~~~~l~~~~~f~~l~~~~l~~l~~~~~~~~~~~g~~ 190 (299)
T 3shr_A 113 AILYNCTRTATVKTL--VNVKLWAIDRQCFQTIMMRTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEY 190 (299)
T ss_dssp GGGTTTBCCSEEEES--SCEEEEEECHHHHHHHHHHHHHHHHHHHHHHHTTSHHHHHSCHHHHHHHTTTCEEEEECTTCE
T ss_pred HHhcCCCCCcEEEEc--CCeEEEEEcHHHHHHHhhHhHHHHHHHHHHHHhhCHHhhhCCHHHHHHHHHhccEEEECCCCE
Confidence 999999999999999 55999999999999999999987765544443332222222110 1111112222222
Q ss_pred ----cce---------ecEEEEEecCCCCCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehhhHHhhc
Q psy14740 160 ----GGF---------GRVELVQIAGDPSRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQETFNQLI 221 (362)
Q Consensus 160 ----G~~---------g~v~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~ 221 (362)
|.- |.|.........++...+..+.+++++|. +.++.+++.|. +.+.++.++++.|.+++
T Consensus 191 I~~~G~~~~~~yiI~~G~v~~~~~~~~~g~~~~~~~l~~G~~fGe~~ll~~~~~~~tv~a~--~~~~l~~i~~~~f~~ll 268 (299)
T 3shr_A 191 IIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDWFGEKALQGEDVRTANVIAA--EAVTCLVIDRDSFKHLI 268 (299)
T ss_dssp EECTTCEECEEEEEEESEEEEEECCSSSCCCEEEEEEETTCEECGGGGSSSEECSSEEEES--SSEEEEEEEHHHHHHHH
T ss_pred EEeCCCCCCEEEEEEeeEEEEEEecCCCCcceEEEEcCCCCEeChHHHhCCCCcceEEEEC--CCEEEEEEeHHHHHHHH
Confidence 322 44544443324567788889999999984 56788888885 45999999999999999
Q ss_pred cchHHhhhhccc
Q psy14740 222 SSLDEIRTKYVD 233 (362)
Q Consensus 222 ~~~~~~~~~~~~ 233 (362)
...+++......
T Consensus 269 ~~~p~~~~~~~~ 280 (299)
T 3shr_A 269 GGLDDVSNKAYE 280 (299)
T ss_dssp TTCCCCCHHHHH
T ss_pred ccHHHHHHHHHH
Confidence 887766554433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=202.12 Aligned_cols=145 Identities=19% Similarity=0.261 Sum_probs=128.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|.+.+.||+|+||.||++.+. ++.+|+|.+...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~----------------------------------------- 76 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR----------------------------------------- 76 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG-----------------------------------------
T ss_pred cccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch-----------------------------------------
Confidence 468999999999999999999863 678999987532
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhh--cCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE--ANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
....+.+|.+++.. ++||||+++++++.... .+|+||||+++++|.+++.+ .
T Consensus 77 ---------------------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~ 134 (342)
T 1b6c_B 77 ---------------------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-Y 134 (342)
T ss_dssp ---------------------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-C
T ss_pred ---------------------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-c
Confidence 12346778888887 79999999999988775 89999999999999999976 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLH--------SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH--------~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 135 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 6999999999999999999999 89999999999999999999999999999977643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=200.46 Aligned_cols=146 Identities=29% Similarity=0.491 Sum_probs=123.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. ++.+|+|.+...
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--------------------------------------- 42 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--------------------------------------- 42 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET---TEEEEEEECSST---------------------------------------
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh---------------------------------------
Confidence 45688999999999999999999864 567999987432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC---C
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG---N 302 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~ 302 (362)
.....+.+|+.+++.++||||+++++++.+ ..|+||||+++++|.+++.... .
T Consensus 43 ----------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~ 98 (307)
T 2eva_A 43 ----------------------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY 98 (307)
T ss_dssp ----------------------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEEC
T ss_pred ----------------------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCc
Confidence 123567899999999999999999998874 4799999999999999998654 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcEeecCCCCcEEecCCCc-EEEEecccceecC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHS---RNIIYRDLKPENLLLSTSGY-VKLVDFGFAKKLI 357 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~---~~iiHrDikp~NIl~~~~~~-~kl~DFG~a~~~~ 357 (362)
++...+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+++.+.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 7889999999999999999999 89999999999999998886 7999999997653
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=189.99 Aligned_cols=216 Identities=19% Similarity=0.272 Sum_probs=162.9
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|.++ +++++..|+..++.+.|++|++|+++||+++.+|+|++|.|+++. + + ..+..++||++|||
T Consensus 7 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~v~~---~-~--~~~~~~~~g~~fGe 79 (246)
T 3of1_A 7 KSIRNNFLFNKL-DSDSKRLVINCLEEKSVPKGATIIKQGDQGDYFYVVEKGTVDFYV---N-D--NKVNSSGPGSSFGE 79 (246)
T ss_dssp HHHHTCTTTTTS-CHHHHHHHHTTCEEEEECTTCEEECTTCCCCEEEEEEECCEEEES---T-T--SCCEEECTTCEECH
T ss_pred HHHhcCHhhHhC-CHHHHHHHHHhhceEEECCCCEEEecCCCCCEEEEEEeeEEEEEE---C-C--EEEEecCCCCeeeh
Confidence 357899999999 999999999999999999999999999999999999999999984 2 2 23689999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhhc---cccCcEEEEE-----
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRSL---RLSDLRVITT----- 156 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~----- 156 (362)
++++.+.||++|++|. ++|++|.|++++|..++..+|.....+...+.........+... .+........
T Consensus 80 ~~l~~~~~~~~tv~a~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~~~f~~l~~~~l~~l~~~~~~~~~~~g~ 157 (246)
T 3of1_A 80 LALMYNSPRAATVVAT--SDCLLWALDRLTFRKILLGSSFKKRLMYDDLLKSMPVLKSLTTYDRAKLADALDTKIYQPGE 157 (246)
T ss_dssp HHHHHTCCCSSEEEES--SCEEEEEEEHHHHHHTTTTTTSHHHHHSHHHHHHCGGGTTCCHHHHHHHHHTCEEEEECTTC
T ss_pred hHHhcCCCCCcEEEEC--CCeEEEEEEhHHHHHHHHHhHHHHHHHHHHHHhhChhhhcCCHHHHHHHHHhhheEEeCCCC
Confidence 9999999999999999 55999999999999999999988776665555443333322111 1111111122
Q ss_pred --ecccceecEEEEEecCC-----CCCceeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 157 --LGVGGFGRVELVQIAGD-----PSRSFALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 157 --lg~G~~g~v~~~~~~~~-----~~~~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
+.+|.-+.-......|. .... .+..+.+++++| .+.++.+++.|.. .+.++.++++.|.++++..
T Consensus 158 ~i~~~g~~~~~~y~I~~G~v~v~~~~~~-~~~~l~~g~~fGe~~~~~~~~~~~~v~a~~--~~~~~~i~~~~f~~ll~~~ 234 (246)
T 3of1_A 158 TIIREGDQGENFYLIEYGAVDVSKKGQG-VINKLKDHDYFGEVALLNDLPRQATVTATK--RTKVATLGKSGFQRLLGPA 234 (246)
T ss_dssp EEECTTSBCCEEEEEEECEEEEEETTTE-EEEEEETTCEECHHHHHHTCBCSSEEEESS--CEEEEEEEHHHHHHHCTTH
T ss_pred EEEeCCCcCCEEEEEEecEEEEEEcCCc-eEEEcCCCCcccHHHHhCCCCcccEEEECC--CEEEEEEeHHHHHHHhccH
Confidence 22233222211111210 0111 567788899998 3678899999985 4999999999999999998
Q ss_pred HHhhhhcc
Q psy14740 225 DEIRTKYV 232 (362)
Q Consensus 225 ~~~~~~~~ 232 (362)
+++..+..
T Consensus 235 ~~~~~~~~ 242 (246)
T 3of1_A 235 VDVLKLND 242 (246)
T ss_dssp HHHHHHTC
T ss_pred HHHHhccC
Confidence 88876543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=218.99 Aligned_cols=152 Identities=26% Similarity=0.427 Sum_probs=130.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCC--CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD--PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.++|.+.+.||+|+||.||++.+... .+..+|+|.+...
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--------------------------------------- 429 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--------------------------------------- 429 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---------------------------------------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---------------------------------------
Confidence 46799999999999999999986532 3456888876432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
........+.+|+.+++.++||||+++++++. .+..|+||||+++++|.+++...+ .++
T Consensus 430 -------------------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~ 489 (656)
T 2j0j_A 430 -------------------TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLD 489 (656)
T ss_dssp -------------------TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCC
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCC
Confidence 11223456889999999999999999999985 456899999999999999998654 689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 490 ~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999999999999999999999999999999999999987644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=198.25 Aligned_cols=150 Identities=27% Similarity=0.459 Sum_probs=129.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.-.+|++.+.||+|+||.||++.+. +++.+|+|.+....
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--------------------------------------- 64 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEE--------------------------------------- 64 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSS---------------------------------------
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEecccc---------------------------------------
Confidence 4567999999999999999999854 37789999886431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
........+.+|+.++..++ ||||+++++++...+.+|++|| +.+++|.+++...+.++
T Consensus 65 ------------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~ 125 (313)
T 3cek_A 65 ------------------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSID 125 (313)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCC
T ss_pred ------------------ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCC
Confidence 11223456889999999997 5999999999999999999999 45899999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++.+.
T Consensus 126 ~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999999999999999999999999999999996 5899999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=205.00 Aligned_cols=146 Identities=29% Similarity=0.421 Sum_probs=119.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|++.+.||+|+||.||++.+.. +..+|+|.+.+..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~--~~~~aikk~~~~~--------------------------------------- 76 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE--SDEVAIKKVLQDK--------------------------------------- 76 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT--TEEEEEEEEECCT---------------------------------------
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC--CCeEEEEEEecCc---------------------------------------
Confidence 34679999999999999999998653 3348888764321
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc------ceEEEEEeccCCcchHHHHH--
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK------KYLYMLMESCLGGELWTILR-- 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~-- 298 (362)
....+|+.+++.++||||+++++++... .++|+||||++++ +.+.+.
T Consensus 77 ------------------------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~ 131 (394)
T 4e7w_A 77 ------------------------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHY 131 (394)
T ss_dssp ------------------------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHH
T ss_pred ------------------------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHH
Confidence 1123699999999999999999998443 3489999999654 444332
Q ss_pred --hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec-CCCcEEEEecccceecCC
Q psy14740 299 --DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-TSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 299 --~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~~ 358 (362)
....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 132 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 245799999999999999999999999999999999999999 799999999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=204.00 Aligned_cols=149 Identities=20% Similarity=0.351 Sum_probs=127.3
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
..+|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------------------------------- 61 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPF---------------------------------------- 61 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTT----------------------------------------
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccc----------------------------------------
Confidence 468999999999999999999855 468899999886431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccce------EEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKY------LYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~ 301 (362)
........+.+|+.+++.++||||+++++++...+. +|++|||++ ++|.+++..
T Consensus 62 -----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-- 121 (353)
T 3coi_A 62 -----------------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL-- 121 (353)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS--
T ss_pred -----------------cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC--
Confidence 112234567899999999999999999999877643 599999995 788887753
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 59999999999999999999999999999999999999999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=203.77 Aligned_cols=134 Identities=26% Similarity=0.394 Sum_probs=113.1
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~----------------------------------------- 73 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA----------------------------------------- 73 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-----------------------------------------
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-----------------------------------------
Confidence 478999999999999999999855 45788999998542
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC--------Ccceeeeeeeee----ccceEEEEEeccCCcchHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--------CDFIVKLYKTFK----DKKYLYMLMESCLGGELWT 295 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~ 295 (362)
......+.+|+.+++.+. ||||+++++++. ....+|+||||+ +++|.+
T Consensus 74 -------------------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~ 133 (397)
T 1wak_A 74 -------------------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLK 133 (397)
T ss_dssp -------------------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHH
T ss_pred -------------------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHH
Confidence 112345778999998884 888999999987 567899999999 666666
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCC
Q psy14740 296 ILRDK--GNFDDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSG 343 (362)
Q Consensus 296 ~l~~~--~~l~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~ 343 (362)
.+... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred HHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 66543 4699999999999999999999998 999999999999998775
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=194.29 Aligned_cols=148 Identities=24% Similarity=0.350 Sum_probs=123.7
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------------------- 46 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT---------------------------------------- 46 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC------------------------------------------
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc----------------------------------------
Confidence 468999999999999999999855 457889999754321
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeee-eeccceEEEEEeccCCcchHHHHHh-cCCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~ 305 (362)
....+.+|+.+++.++|++++..+.. +...+..+++|||+ +++|.+++.. ...+++
T Consensus 47 ---------------------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~ 104 (296)
T 4hgt_A 47 ---------------------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL 104 (296)
T ss_dssp ----------------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCH
T ss_pred ---------------------cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCH
Confidence 12347889999999988776665554 56778899999999 9999999985 456999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++.+..
T Consensus 105 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 105 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999999999999999999999999999999999 7889999999999987654
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-23 Score=188.54 Aligned_cols=212 Identities=21% Similarity=0.373 Sum_probs=168.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|+++ +++++..|+..++.+.|++|++|+++||+++.+|+|++|.|++.. + + ..+..++||++|||.
T Consensus 40 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~---~-g--~~~~~l~~G~~fGe~ 112 (291)
T 2qcs_B 40 AIEKNVLFSHL-DDNERSDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYV---N-N--EWATSVGEGGSFGEL 112 (291)
T ss_dssp HTTTCHHHHTS-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCEEEEEEECCEEEEE---T-T--EEEEEECTTCEECGG
T ss_pred HHhcChhhhhC-CHHHHHHHHHhccEEEECCCCEEEeCCCCCceEEEEeeeEEEEEE---C-C--eEEEEcCCCCccchH
Confidence 47899999999 999999999999999999999999999999999999999999987 2 2 569999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhhhhh------------ccccCcEE
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEEFRS------------LRLSDLRV 153 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~ 153 (362)
+++.+.||++|++|. ++|++|.|++++|..++..+|.+...++..+..+..+...++. ..+..-.+
T Consensus 113 ~l~~~~~~~~tv~a~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~~lf~~l~~~~~~~l~~~~~~~~~~~g~~ 190 (291)
T 2qcs_B 113 ALIYGTPRAATVKAK--TNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQK 190 (291)
T ss_dssp GGTCCCBCSSEEEES--SCEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHTCGGGTTCCHHHHHHHHHHCEEEEECTTCE
T ss_pred HHhcCCCCceEEEEC--CCEEEEEEEhHHHHHHHhhhHHHHHHHHHHHHhhchHhhhCCHHHHHHHHhhcEEEEECCCCE
Confidence 999999999999999 5599999999999999999999988777665554433322211 11111112
Q ss_pred EEEecccce---------ecEEEEEecCCCCCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehhhHHh
Q psy14740 154 ITTLGVGGF---------GRVELVQIAGDPSRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQETFNQ 219 (362)
Q Consensus 154 ~~~lg~G~~---------g~v~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~~f~~ 219 (362)
+ +-+|.- |.|.......+.++...+..+.+++.||. +.++.++++|..+ +.++.++++.|.+
T Consensus 191 i--~~~g~~~~~~y~i~~G~v~~~~~~~~~~~~~~~~~l~~G~~fGe~~ll~~~~~~~tv~a~~~--~~~~~i~~~~f~~ 266 (291)
T 2qcs_B 191 I--VVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPKAATVVARGP--LKCVKLDRPRFER 266 (291)
T ss_dssp E--ECTTSCCCEEEEEEEEEEEEEEECSTTSCEEEEEEECTTCEECSGGGTCCCCCSSEEEEEEE--EEEEEEEHHHHHH
T ss_pred E--EeCCccCCEEEEEEeCEEEEEEecCCCCccEEEEEeCCCCEecHHHHcCCCCcceEEEECCc--EEEEEEcHHHHHH
Confidence 1 222221 55555443333335578888999999994 4678889999865 9999999999999
Q ss_pred hccchHHhhhh
Q psy14740 220 LISSLDEIRTK 230 (362)
Q Consensus 220 ~~~~~~~~~~~ 230 (362)
++...+++..+
T Consensus 267 ~l~~~p~~~~~ 277 (291)
T 2qcs_B 267 VLGPCSDILKR 277 (291)
T ss_dssp HHCCHHHHHTT
T ss_pred HhccHHHHHHH
Confidence 99988776654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=198.55 Aligned_cols=152 Identities=24% Similarity=0.474 Sum_probs=126.5
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-------------------------------------- 59 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTV-------------------------------------- 59 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCC--------------------------------------
T ss_pred cCHHHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeeccc--------------------------------------
Confidence 45689999999999999999999855 457899999885431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHH-HHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-----
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKE-IMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD----- 299 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----- 299 (362)
.......+..|.. +++.++||||+++++++..++..|+||||++ ++|.+++..
T Consensus 60 --------------------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~ 118 (327)
T 3aln_A 60 --------------------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118 (327)
T ss_dssp --------------------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTT
T ss_pred --------------------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhh
Confidence 1112233455555 6777899999999999999999999999995 588887763
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 300 KGNFDDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 300 ~~~l~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.+.
T Consensus 119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred cccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 45699999999999999999999999 99999999999999999999999999997654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=206.72 Aligned_cols=145 Identities=23% Similarity=0.448 Sum_probs=114.3
Q ss_pred cEEE-EEecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 151 LRVI-TTLGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 151 ~~~~-~~lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
|.+. +.||+|+||.||++.+.. ..++.+|+|.+....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------------------------------------- 60 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----------------------------------------- 60 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----------------------------------------
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----------------------------------------
Confidence 4543 479999999999998643 357789999885431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee--ccceEEEEEeccCCcchHHHHHhc------
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK--DKKYLYMLMESCLGGELWTILRDK------ 300 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~------ 300 (362)
....+.+|+.+|+.++||||+++++++. ....+|+||||+ +++|.+++...
T Consensus 61 --------------------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~ 119 (405)
T 3rgf_A 61 --------------------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKAN 119 (405)
T ss_dssp --------------------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC-SEEHHHHHHHHHHHC--
T ss_pred --------------------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC-CCCHHHHHHHhcccccc
Confidence 1134678999999999999999999984 477899999999 56888877632
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe----cCCCcEEEEecccceecC
Q psy14740 301 ---GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL----STSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ---~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~----~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 120 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183 (405)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecC
Confidence 148999999999999999999999999999999999999 677899999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=198.40 Aligned_cols=150 Identities=20% Similarity=0.290 Sum_probs=127.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+....++.+|+|++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------------------------------- 56 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------------------------------------- 56 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----------------------------------------
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----------------------------------------
Confidence 3478999999999999999999976555578999998542
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcc------eeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF------IVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
......+.+|+.+++.++|++ ++.+++++...+.+|+||||+ ++++.+.+...
T Consensus 57 --------------------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~ 115 (355)
T 2eu9_A 57 --------------------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN 115 (355)
T ss_dssp --------------------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred --------------------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc
Confidence 112345678999999887766 999999999999999999999 66777776654
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe-------------------cCCCcEEEEecccceecC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL-------------------STSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~-------------------~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 116 ~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 193 (355)
T 2eu9_A 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193 (355)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc
Confidence 369999999999999999999999999999999999999 567899999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=201.90 Aligned_cols=150 Identities=27% Similarity=0.363 Sum_probs=113.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 60 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDP--------------------------------------- 60 (360)
T ss_dssp HHTTEEEC----------CEEEEET-TTCCEEEEEEEECCT---------------------------------------
T ss_pred hccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCc---------------------------------------
Confidence 5789999999999999999999865 457899999874421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-------eEEEEEeccCCcchHHHHH-
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-------YLYMLMESCLGGELWTILR- 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------~~~lv~e~~~~~~L~~~l~- 298 (362)
.......+++..+..++||||+++++++...+ ++++||||+++ +|...+.
T Consensus 61 ---------------------~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 118 (360)
T 3e3p_A 61 ---------------------RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118 (360)
T ss_dssp ---------------------TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHH
T ss_pred ---------------------cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHH
Confidence 11234567778888899999999999986533 38999999965 4444333
Q ss_pred ---hcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCcEEecC-CCcEEEEecccceecCC
Q psy14740 299 ---DKGNFDDATTRFYTACVVEAFDYLH--SRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 299 ---~~~~l~~~~~~~~~~ql~~al~~lH--~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~~ 358 (362)
....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+++.+..
T Consensus 119 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184 (360)
T ss_dssp HHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT
T ss_pred HhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC
Confidence 4456899999999999999999999 999999999999999996 89999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=192.95 Aligned_cols=149 Identities=24% Similarity=0.350 Sum_probs=126.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--------------------------------------- 46 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--------------------------------------- 46 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCS---------------------------------------
T ss_pred eccEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCc---------------------------------------
Confidence 3578999999999999999999854 457899999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeee-eeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYK-TFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
....+.+|+.+++.++|++++..+. ++...+..++||||+ +++|.+++.. ...++
T Consensus 47 ----------------------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~ 103 (296)
T 3uzp_A 47 ----------------------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFS 103 (296)
T ss_dssp ----------------------SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCC
T ss_pred ----------------------chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCC
Confidence 1234788999999998877655555 446678899999999 9999999974 45699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++.+..
T Consensus 104 ~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 104 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999999999999999999999999999999999 4788999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=197.23 Aligned_cols=148 Identities=30% Similarity=0.454 Sum_probs=120.9
Q ss_pred cccCcEEEE-EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 147 RLSDLRVIT-TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 147 ~~~~~~~~~-~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..++|.+.. .||+|+||.||++.+. .+++.+|+|++....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-------------------------------------- 66 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSP-------------------------------------- 66 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESSH--------------------------------------
T ss_pred ccceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcH--------------------------------------
Confidence 457899965 5999999999999865 458899999875420
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.........++.++||||+++++++.. ...+|+||||+++++|.+++....
T Consensus 67 -------------------------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 121 (336)
T 3fhr_A 67 -------------------------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121 (336)
T ss_dssp -------------------------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-
T ss_pred -------------------------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC
Confidence 011122233556799999999999876 556999999999999999998653
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCC
Q psy14740 302 --NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 --~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 122 ~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 122 DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 5999999999999999999999999999999999999976 45599999999986643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=194.68 Aligned_cols=153 Identities=27% Similarity=0.502 Sum_probs=119.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-------------------------------------- 62 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSG-------------------------------------- 62 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTS--------------------------------------
T ss_pred hhhccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccc--------------------------------------
Confidence 35789999999999999999999865 457899999986531
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
........+..+..+++.++||||+++++++..++.+|+||||+ ++.+..+... ...++
T Consensus 63 -------------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~ 122 (318)
T 2dyl_A 63 -------------------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122 (318)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCC
T ss_pred -------------------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCC
Confidence 00111233445556778889999999999999999999999999 6677666654 45799
Q ss_pred HHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.+.
T Consensus 123 ~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 123 ERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999999999999995 99999999999999999999999999997653
|
| >3mdp_A Cyclic nucleotide-binding domain (CNMP-BD) protei; structural genomics, joint center for structural genomics; HET: MSE; 1.90A {Geobacter metallireducens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-24 Score=170.58 Aligned_cols=131 Identities=15% Similarity=0.287 Sum_probs=117.3
Q ss_pred CCCcccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceE---EEEec
Q psy14740 1 MSKNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKY---IRTLY 77 (362)
Q Consensus 1 m~~~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~---~~~l~ 77 (362)
|.....|+++|+|+++ +++++..++..++.+.|++|++|+++|++++.+|+|++|.|+++..+.+ +++.. +..++
T Consensus 2 M~~~~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~~~ 79 (142)
T 3mdp_A 2 MISPERLRVYRFFASL-TDEQLKDIALISEEKSFPTGSVIFKENSKADNLMLLLEGGVELFYSNGG-AGSAANSTVCSVV 79 (142)
T ss_dssp CCCTTGGGGSHHHHTS-CHHHHHHHHHTEEEEEECTTCEEECTTSBCCEEEEEEESCEEEECC----------CEEEEEC
T ss_pred CccHHHHhhCchhccC-CHHHHHHHHHhhcEEecCCCCEEEeCCCCCCcEEEEEeCEEEEEEECCC-CCceEeeeEEEec
Confidence 7778899999999999 9999999999999999999999999999999999999999999988877 44467 99999
Q ss_pred CCCeeecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 78 KGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 78 ~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
||++|||.+++.+.|++++++|. ++|+++.|++++|.+++..+|.+...+++.+..
T Consensus 80 ~G~~fG~~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~p~~~~~l~~~l~~ 135 (142)
T 3mdp_A 80 PGAIFGVSSLIKPYHYTSSARAT--KPVRVVDINGARLREMSENNQALGQVLMNNVAA 135 (142)
T ss_dssp TTCEECGGGSSTTCBCSSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHH
T ss_pred CCCEechHHHcCCCCceEEEEEC--CcEEEEEEeHHHHHHHHHHChHHHHHHHHHHHH
Confidence 99999999999999999999999 559999999999999999999999888877664
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=202.25 Aligned_cols=149 Identities=23% Similarity=0.387 Sum_probs=126.3
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
...++|++.+.||+|+||.||++.+.+ .+++|.+....
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~-------------------------------------- 67 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIER-------------------------------------- 67 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS----SEEEEECCCCS--------------------------------------
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC----eEEEEEeecCC--------------------------------------
Confidence 457899999999999999999998542 48999876431
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~ 304 (362)
........+.+|+.+++.++||||+++++++...+.++++|||+++++|.+++...+ .++
T Consensus 68 -------------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~ 128 (319)
T 2y4i_B 68 -------------------DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128 (319)
T ss_dssp -------------------CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCC
T ss_pred -------------------CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCC
Confidence 011123446678899999999999999999999999999999999999999998754 699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
+..+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||+++..
T Consensus 129 ~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999999999999999999998 689999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=205.99 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=127.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.||+|++....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--------------------------------------- 44 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT--------------------------------------- 44 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTC---------------------------------------
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc---------------------------------------
Confidence 3578999999999999999999855 457899999765421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~ 304 (362)
....+..|+.+++.++| ++++.+..++...+..++||||+ +++|.+++.. .+.++
T Consensus 45 ----------------------~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~ 101 (483)
T 3sv0_A 45 ----------------------KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLS 101 (483)
T ss_dssp ----------------------SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCC
T ss_pred ----------------------ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCC
Confidence 12347889999999976 56666667777888999999999 9999999985 45799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEe---cCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLL---STSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~---~~~~~~kl~DFG~a~~~~~ 358 (362)
+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 102 ~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999999999999999999999999999999999 5789999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-24 Score=202.12 Aligned_cols=144 Identities=25% Similarity=0.348 Sum_probs=119.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|.+.+.||+|+||.|+.... .+++.||+|.+.+..
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~----------------------------------------- 60 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPEC----------------------------------------- 60 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTT-----------------------------------------
T ss_pred EEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHH-----------------------------------------
Confidence 4589999999999999765432 347889999885431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~ 306 (362)
.....+|+.+++.+ +||||+++++++.+....|+|||++ +++|.+++.... .+++.
T Consensus 61 ---------------------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~-~g~L~~~l~~~~~~~~~~ 118 (432)
T 3p23_A 61 ---------------------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGL 118 (432)
T ss_dssp ---------------------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC-SEEHHHHHHSSSCCCCSS
T ss_pred ---------------------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC-CCCHHHHHHhcCCCccch
Confidence 12356799999998 8999999999999999999999999 579999997653 45666
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---C--CcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---S--GYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~--~~~kl~DFG~a~~~~ 357 (362)
.+..++.|++.||.|||++||+||||||+|||++. + ..+||+|||+|+.+.
T Consensus 119 ~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred hHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 77899999999999999999999999999999953 2 358899999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=214.70 Aligned_cols=154 Identities=29% Similarity=0.427 Sum_probs=128.6
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
..+++|++.+.||.|+||.||++.+. .+++.+|+|.+...
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~--------------------------------------- 50 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQE--------------------------------------- 50 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSC---------------------------------------
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEeccc---------------------------------------
Confidence 35688999999999999999999854 55889999987542
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHh
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+++.++||||+++++++.. ++..|+||||+++++|.+++..
T Consensus 51 -------------------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~ 111 (676)
T 3qa8_A 51 -------------------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111 (676)
T ss_dssp -------------------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHS
T ss_pred -------------------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHh
Confidence 112234568899999999999999999998765 6778999999999999999986
Q ss_pred cC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCc---EEEEecccceecCC
Q psy14740 300 KG---NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY---VKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~~---~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~---~kl~DFG~a~~~~~ 358 (362)
.. .+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++.+..
T Consensus 112 ~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 112 FENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp SSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 43 5899999999999999999999999999999999999997664 99999999987644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=201.15 Aligned_cols=145 Identities=27% Similarity=0.361 Sum_probs=117.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|.+.+.||+|+||+||.... .+++.||+|.+...
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~------------------------------------------ 50 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLID------------------------------------------ 50 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG------------------------------------------
T ss_pred heeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH------------------------------------------
Confidence 3455668899999999987543 34789999987432
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCC----
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF---- 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---- 303 (362)
....+.+|+.+++.+ +||||+++++++.+++.+|+||||+ +++|.+++......
T Consensus 51 --------------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~ 109 (434)
T 2rio_A 51 --------------------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENL 109 (434)
T ss_dssp --------------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHTC-------
T ss_pred --------------------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-CCCHHHHHhccCCCchhh
Confidence 113457899999876 8999999999999999999999999 57999999865432
Q ss_pred ---CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC-------------CcEEEEecccceecCC
Q psy14740 304 ---DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS-------------GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ---~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~-------------~~~kl~DFG~a~~~~~ 358 (362)
++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 110 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 110 KLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180 (434)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred hhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence 223456799999999999999999999999999999754 4899999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=196.51 Aligned_cols=150 Identities=23% Similarity=0.337 Sum_probs=126.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
...+|.+.+.||+|+||.||++.+. .+++.+|+|.+....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 56 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK--------------------------------------- 56 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH---------------------------------------
T ss_pred cCCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCCc---------------------------------------
Confidence 4578999999999999999999855 457899999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-----------Ccceeeeeeeeeccc----eEEEEEeccCCc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-----------CDFIVKLYKTFKDKK----YLYMLMESCLGG 291 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~ 291 (362)
.....+.+|+.+++.++ ||||+++++++...+ .++++||++ ++
T Consensus 57 ---------------------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~ 114 (373)
T 1q8y_A 57 ---------------------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GE 114 (373)
T ss_dssp ---------------------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CE
T ss_pred ---------------------cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CC
Confidence 12244677888888775 899999999987654 799999999 99
Q ss_pred chHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEecC------CCcEEEEecccceecCC
Q psy14740 292 ELWTILRDK--GNFDDATTRFYTACVVEAFDYLHSR-NIIYRDLKPENLLLST------SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 292 ~L~~~l~~~--~~l~~~~~~~~~~ql~~al~~lH~~-~iiHrDikp~NIl~~~------~~~~kl~DFG~a~~~~~ 358 (362)
+|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+|||++. .+.+||+|||+++.+..
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 115 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp EHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred CHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence 999999863 4599999999999999999999998 9999999999999953 34799999999987643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=195.54 Aligned_cols=150 Identities=27% Similarity=0.364 Sum_probs=125.7
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.+|+|++....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--------------------------------------- 91 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNKK--------------------------------------- 91 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSSH---------------------------------------
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEeccH---------------------------------------
Confidence 3578999999999999999999855 457889999985431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Cc-----ceeeeeeeeeccceEEEEEeccCCcchHHHHHhc
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CD-----FIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
.....+..|+.+++.++ |+ +|+++++++...+.+|+||||+ +++|.+++...
T Consensus 92 ---------------------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 149 (382)
T 2vx3_A 92 ---------------------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT 149 (382)
T ss_dssp ---------------------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred ---------------------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC-CCCHHHHHhhc
Confidence 12244567777777764 34 5999999999999999999999 56999998865
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCcEEec--CCCcEEEEecccceecCC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLH--SRNIIYRDLKPENLLLS--TSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH--~~~iiHrDikp~NIl~~--~~~~~kl~DFG~a~~~~~ 358 (362)
+.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 150 ~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 35899999999999999999999 57999999999999995 477899999999987654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=186.81 Aligned_cols=152 Identities=16% Similarity=0.070 Sum_probs=109.9
Q ss_pred EEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
+.+.||+|+||.||++.+ .+++.+|+|.+..+.........
T Consensus 94 ~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~------------------------------------- 134 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKE------------------------------------- 134 (282)
T ss_dssp EEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------------------------------------
T ss_pred ecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhh-------------------------------------
Confidence 339999999999999996 55889999998654210000000
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
.+.+....-.......+.+|+.+|+.++ | +++++++.. +..|+||||++|++|.+ +.. .....++
T Consensus 135 ----~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~ 199 (282)
T 1zar_A 135 ----KRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVL 199 (282)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHH
T ss_pred ----hhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHH
Confidence 0000000000023456889999999998 4 566665543 45699999999999988 421 2345799
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+....+
T Consensus 200 ~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp HHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEETTST
T ss_pred HHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeECCCC
Confidence 9999999999999999999999999999 999999999999977544
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=166.40 Aligned_cols=122 Identities=23% Similarity=0.340 Sum_probs=112.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++++..|+..++.+.|++|++|+++||+++.+|+|++|.|+++. +.+ |++..+..++||++|||+
T Consensus 39 ~l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~-~~~-g~~~~~~~~~~G~~fGe~ 115 (161)
T 3idb_B 39 ACKDILLFKNL-DPEQMSQVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYV-KCD-GVGRCVGNYDNRGSFGEL 115 (161)
T ss_dssp HHTTCHHHHTS-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESEEEEEE-EET-TEEEEEEEEESCCEECGG
T ss_pred HHhCCHhhhcC-CHHHHHHHHHhcceeEeCCCCEEEeCCCCCcEEEEEEeCEEEEEE-cCC-CCeEEEEEcCCCCEechH
Confidence 47889999999 999999999999999999999999999999999999999999998 555 666899999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 132 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~ 132 (362)
+++.+.+++++|+|. ++|+++.|++++|.+++..+|.++.+++..
T Consensus 116 ~~~~~~~~~~~v~A~--~~~~~~~i~~~~~~~l~~~~p~~~~~~~~~ 160 (161)
T 3idb_B 116 ALMYNTPRAATITAT--SPGALWGLDRVTFRRIIVKNNAKKRKMYES 160 (161)
T ss_dssp GGTCCCCCSSEEEES--SSEEEEEEEHHHHHHHHHHHHHTSCCC---
T ss_pred HHHcCCCcccEEEEC--CCeEEEEEeHHHHHHHHHHCHHHHHHHHhc
Confidence 999999999999999 559999999999999999999988766543
|
| >2pqq_A Putative transcriptional regulator; APC7345, streptomyces coelicolor structural genomics, PSI-2, protein structure initiative; 2.00A {Streptomyces coelicolor A3} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-22 Score=160.36 Aligned_cols=129 Identities=21% Similarity=0.333 Sum_probs=120.0
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|..+ +++++..++..++.+.|++|++|+++|++++.+|+|++|.|+++..+.+ |++..+..++||++|||
T Consensus 5 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~~G~ 82 (149)
T 2pqq_A 5 DVLRRNPLFAAL-DDEQSAELRASMSEVTLARGDTLFHEGDPGDRLYVVTEGKVKLHRTSPD-GRENMLAVVGPSELIGE 82 (149)
T ss_dssp GGGTSSTTTTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSEECEEEEEEESCEEEEEECTT-SSEEEEEEECTTCEESG
T ss_pred HHhhhChhhhcC-CHHHHHHHHHhceEEEeCCCCEEECCCCCCCeEEEEEecEEEEEEECCC-CcEEEEEEcCCcCEech
Confidence 468899999999 9999999999999999999999999999999999999999999998887 55588999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
.+++.+.|+.++++|. ++|+++.|++++|..++..+|.+...+...+..+.
T Consensus 83 ~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~p~~~~~~~~~~~~~l 133 (149)
T 2pqq_A 83 LSLFDPGPRTATGTAL--TEVKLLALGHGDLQPWLNVRPEVATALLRAVARRL 133 (149)
T ss_dssp GGGTSCEECSSEEEES--SCEEEEEEEGGGHHHHHHHCTHHHHHHHHHHHHHH
T ss_pred HHhcCCCCcceEEEEc--cceEEEEEeHHHHHHHHHhCcHHHHHHHHHHHHHH
Confidence 9999999999999999 55999999999999999999999988887766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=200.99 Aligned_cols=141 Identities=16% Similarity=0.130 Sum_probs=106.9
Q ss_pred EEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 154 ITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 154 ~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
.+.||+|+||.||++... ++.+++|.........
T Consensus 341 ~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~------------------------------------------- 374 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRD------------------------------------------- 374 (540)
T ss_dssp -------CCEEEEEEECS---SCEEEEEEECCCTTSC-------------------------------------------
T ss_pred CCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccc-------------------------------------------
Confidence 457999999999999533 5678888764321100
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
+........+++.+|+++++.++||||+++..++...+..|+||||+++++|.+++.. +..++.
T Consensus 375 --------~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~ 438 (540)
T 3en9_A 375 --------ERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAY 438 (540)
T ss_dssp --------HHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHH
T ss_pred --------hhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHH
Confidence 0111122345689999999999999999555554466667999999999999999875 568999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
|++.||.|||++||+||||||+|||++. .+||+|||+|+.+..
T Consensus 439 qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 439 KIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp HHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred HHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999999999999999998 999999999998754
|
| >3gyd_A CNMP-BD protein, cyclic nucleotide-binding domain; nucleotide binding protein, structural genomics; HET: MSE CMP; 1.79A {Methylobacillus flagellatus KT} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=165.96 Aligned_cols=122 Identities=18% Similarity=0.258 Sum_probs=115.5
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++++..++..++.+.|++|++|+++|++++.+|+|++|.|+++..+.+ |++..+..++||++|||+
T Consensus 40 ~L~~~~~f~~l-~~~~l~~l~~~~~~~~~~~ge~i~~~G~~~~~ly~I~~G~v~v~~~~~~-g~~~~~~~~~~G~~fGe~ 117 (187)
T 3gyd_A 40 IVNKIKLFGDF-SNEEVRYLCSYMQCYAAPRDCQLLTEGDPGDYLLLILTGEVNVIKDIPN-KGIQTIAKVGAGAIIGEM 117 (187)
T ss_dssp HHTTCCSSCCC-CHHHHHHHHTTCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEEEEETT-TEEEEEEEEETTCEESHH
T ss_pred HHhcCHhhhcC-CHHHHHHHHHhcEEEEeCCCCEEEcCCCCCCeEEEEEeCEEEEEEECCC-CCeEEEEEccCCCeeeeH
Confidence 57899999999 9999999999999999999999999999999999999999999999887 556889999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 131 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~ 131 (362)
+++.+.|++++|+|. ++|+++.|++++|.+++..+|.+...++.
T Consensus 118 ~~l~~~~~~~~v~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~l~~ 161 (187)
T 3gyd_A 118 SMIDGMPRSASCVAS--LPTDFAVLSRDALYQLLANMPKLGNKVLI 161 (187)
T ss_dssp HHHHCCCCSSEEEEE--EEEEEEEEEHHHHHHHHHHCHHHHHHHHH
T ss_pred HHhCCCCeeEEEEEC--CCeEEEEEcHHHHHHHHHHChHHHHHHHH
Confidence 999999999999999 55999999999999999999999988773
|
| >2z69_A DNR protein; beta barrel, dimerization helix, transcription regulator; 2.10A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-22 Score=160.53 Aligned_cols=128 Identities=18% Similarity=0.238 Sum_probs=115.9
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|..+ +++++..++..++.+.|++|++|+++|++++.+|+|++|.|+++..+.+ +++..+..++||++|||.
T Consensus 13 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~G~~~G~~ 90 (154)
T 2z69_A 13 LLQSHHLFEPL-SPVQLQELLASSDLVNLDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPE-GQEKILEVTNERNTFAEA 90 (154)
T ss_dssp HHTTSTTTTTS-CHHHHHHHHHTCEEEEECTTCEEECTTSBCCEEEEEEESCEEEECCCC------CCEEECTTEEESGG
T ss_pred HhhcChhhcCC-CHHHHHHHHhhCcEEEecCCCEEecCCCccceEEEEEeCEEEEEEECCC-CCEEEEEEccCCCeeccH
Confidence 47899999999 9999999999999999999999999999999999999999999988777 555789999999999999
Q ss_pred cccCCCc-ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 86 ALQGDDL-RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 86 ~l~~~~~-r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
+++.+.+ +.++++|. ++|+++.|++++|..++..+|.+...++..+..+.
T Consensus 91 ~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~p~~~~~l~~~~~~rl 141 (154)
T 2z69_A 91 MMFMDTPNYVATAQAV--VPSQLFRFSNKAYLRQLQDNTPLALALLAKLSTRL 141 (154)
T ss_dssp GGGSSCSBCSSEEEES--SSEEEEEEEHHHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred hhccCCCCCceEEEEc--cceEEEEECHHHHHHHHHHChHHHHHHHHHHHHHH
Confidence 9999988 99999999 55999999999999999999999998888776543
|
| >4f7z_A RAP guanine nucleotide exchange factor 4; cyclic nucleotide, regulation, auto-IN CDC25 homology domain, exocytosis; 2.60A {Mus musculus} PDB: 2byv_E | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-21 Score=198.30 Aligned_cols=118 Identities=25% Similarity=0.358 Sum_probs=107.8
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCC-CcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNS-TEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~-~~~~~~~~l~~G~~fGE 84 (362)
.|+++.+|+++ ++.++..|+.++....|++|++||+|||++++||||++|.|.|.....++ +.+..+..++||+.|||
T Consensus 43 ~Lk~~~~f~~l-~~~~l~~l~~~m~ye~~~~Ge~IfrqGd~gd~fYIIlsGsV~V~i~~~~~~~~~~~v~~l~~G~sFGE 121 (999)
T 4f7z_A 43 RLKGVKAFEKF-HPNLLRQICLCGYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE 121 (999)
T ss_dssp HHTTCTTTTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESEEEEEECSSSCTTSCEEEEEEETTCEECG
T ss_pred HHhCCHhhhcC-CHHHHHHHHhheEEEEECCCCEEEcCCCcCCEEEEEEeeEEEEEEecCCCCCCceeEEEecCCcchhh
Confidence 47889999999 99999999999999999999999999999999999999999999865442 44678999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 127 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~ 127 (362)
+++++.||+|||+|. ++|++|+|++++|+.++..+|+...
T Consensus 122 -all~n~pRtaTv~a~--~~s~l~~l~r~~F~~i~~~~~e~~~ 161 (999)
T 4f7z_A 122 -SILDNTPRHATIVTR--ESSELLRIEQEDFKALWEKYRQYMA 161 (999)
T ss_dssp -GGGGTCCCSSEEEES--SSEEEEEEEHHHHHHHHHHHHHHHT
T ss_pred -hhccCCCcceEEEec--cceEEEEEEHHHHHHHHHhChHHHH
Confidence 899999999999999 5599999999999999988876544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-22 Score=188.19 Aligned_cols=151 Identities=15% Similarity=0.056 Sum_probs=110.9
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
..|...+.||+|+||.||++.+. .+++.+|+|++....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~----------------------------------------- 115 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTE----------------------------------------- 115 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSC-----------------------------------------
T ss_pred eeEEEecccccCCCEEEEEEEec-CCCCceEEEEEecCC-----------------------------------------
Confidence 45788899999999999999965 458899999876331
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cce---------------------eeeeeeeec-----cceE
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFI---------------------VKLYKTFKD-----KKYL 281 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------------------~~~~~~~~~-----~~~~ 281 (362)
.......+.+.+|+.+++.+.| +|. ..+...+.. ...+
T Consensus 116 ---------------~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (413)
T 3dzo_A 116 ---------------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180 (413)
T ss_dssp ---------------C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSE
T ss_pred ---------------CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccce
Confidence 1111223557778888887765 211 111111111 1236
Q ss_pred EEEEeccCCcchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 282 YMLMESCLGGELWTILRD-------KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 282 ~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
+++|+++ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 181 ~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~ 259 (413)
T 3dzo_A 181 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259 (413)
T ss_dssp EEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCE
T ss_pred EEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEecccee
Confidence 7888876 8999998852 2237788889999999999999999999999999999999999999999999998
Q ss_pred ecC
Q psy14740 355 KLI 357 (362)
Q Consensus 355 ~~~ 357 (362)
...
T Consensus 260 ~~~ 262 (413)
T 3dzo_A 260 RDG 262 (413)
T ss_dssp ETT
T ss_pred ecC
Confidence 653
|
| >4ev0_A Transcription regulator, CRP family; CAMP binding, winged helix-turn-helix motif, DNA binding, transcription activator; HET: CMP; 2.40A {Thermus thermophilus} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=166.37 Aligned_cols=126 Identities=24% Similarity=0.378 Sum_probs=115.5
Q ss_pred ccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~ 86 (362)
|+++|+|+++ +++++..++..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++..+..++||++|||.+
T Consensus 1 L~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~~G~~~ 78 (216)
T 4ev0_A 1 MKGSPLFHGL-APEEVDLALSYFQRRLYPQGKPIFYQGDLGQALYLVASGKVRLFRTHLG-GQERTLALLGPGELFGEMS 78 (216)
T ss_dssp ---CGGGTTC-CHHHHHHHHTTCEEEEECTTCEEECTTCBCCEEEEEEESCEEEEEECSS-SCEEEEEEECTTCEECHHH
T ss_pred CCCChhhcCC-CHHHHHHHHHhheEEEeCCCCEEEeCCCCCCEEEEEEeCEEEEEEECCC-CCEEEEEEecCCCEEeehh
Confidence 5789999999 9999999999999999999999999999999999999999999999888 5558999999999999999
Q ss_pred ccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 87 l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
++.+.|++++++|. ++|+++.|++++|..++..+|.+...+...+..+
T Consensus 79 ~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 126 (216)
T 4ev0_A 79 LLDEGERSASAVAV--EDTELLALFREDYLALIRRLPLVAHNLAALLARR 126 (216)
T ss_dssp HHHCCBCSSEEEES--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred hcCCCCcceEEEEc--CCEEEEEEcHHHHHHHHHHCcHHHHHHHHHHHHH
Confidence 99999999999999 5599999999999999999999998877666544
|
| >3dn7_A Cyclic nucleotide binding regulatory protein; structural genomics, APC88869, cyclic nucleotide binding REG protein, PSI-2; 1.80A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=164.04 Aligned_cols=129 Identities=12% Similarity=0.124 Sum_probs=117.7
Q ss_pred cccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeee
Q psy14740 4 NPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFG 83 (362)
Q Consensus 4 ~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fG 83 (362)
..-++.+|+|.++ ++++++.++..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++.++..++||++||
T Consensus 6 ~~l~~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~l~~~G~~~~~~y~i~~G~v~~~~~~~~-G~e~~~~~~~~g~~~g 83 (194)
T 3dn7_A 6 TALINHIRKFIFL-TDEDAGTLSAFFQLKKVRKKETLLKTGEICRINYFVVKGCLRLFFIDEK-GIEQTTQFAIENWWLS 83 (194)
T ss_dssp HHHHHHHHTTSCC-CHHHHHHHHTTCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTT-SCEEEEEEEETTCEEC
T ss_pred HHHHHHHHHhCCC-CHHHHHHHHHhCEEEEEcCCCEEECCCCeeeEEEEeecCeEEEEEECCC-CCEEEEEEccCCcEEe
Confidence 3456889999999 9999999999999999999999999999999999999999999999888 5568899999999999
Q ss_pred cc-cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 84 EK-ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 84 E~-~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
|+ +++.+.|++++++|+ ++|+++.|++++|.+++..+|.+...+...+..+
T Consensus 84 e~~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~~~~~ 135 (194)
T 3dn7_A 84 DYMAFQKQQPADFYIQSV--ENCELLSITYTEQENLFERIPALERYFRLVYQKS 135 (194)
T ss_dssp CHHHHHHTCBCSSEEEES--SCEEEEEEEHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred ehHHHhcCCCCceEEEEE--CCEEEEEEeHHHHHHHHHhCHHHHHHHHHHHHHH
Confidence 98 678999999999999 5699999999999999999999988776655443
|
| >3e97_A Transcriptional regulator, CRP/FNR family; YP_604437.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE; 1.86A {Deinococcus geothermalis dsm 11300} | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-21 Score=168.41 Aligned_cols=132 Identities=17% Similarity=0.331 Sum_probs=120.4
Q ss_pred CCcccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCe
Q psy14740 2 SKNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF 81 (362)
Q Consensus 2 ~~~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~ 81 (362)
.....|+++|+|.++ +++++..++..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++.++..++||++
T Consensus 3 ~~~~~L~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~ 80 (231)
T 3e97_A 3 GRLDDLKRSPLFQNV-PEDAMREALKVVTERNFQPDELVVEQDAEGEALHLVTTGVVRVSRVSLG-GRERVLGDIYAPGV 80 (231)
T ss_dssp CCHHHHHTSGGGTTC-CHHHHHHHHHTEEEEEECTTCBCCCTTCTTTCEEEECSSEEEEEEECC---CEEEEEEEESSEE
T ss_pred hHHHHHhcChhhccC-CHHHHHHHHHhcEEEEECCCCEEEeCCCCCCeEEEEEecEEEEEEECCC-CceEEEEecCCCCE
Confidence 344578999999999 9999999999999999999999999999999999999999999999888 55588999999999
Q ss_pred eecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 82 FGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 82 fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
|||.+++.+.|++++++|. ++|+++.|+++.|..++..+|.+...++..+..+.
T Consensus 81 ~G~~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~l 134 (231)
T 3e97_A 81 VGETAVLAHQERSASVRAL--TPVRTLMLHREHFELILRRHPRVLWNLAEMLARRV 134 (231)
T ss_dssp ESTTTTTCCCCCCEEEEES--SCEEEEEECHHHHHHHHHHCHHHHHHHHHHHHHHH
T ss_pred EeeHHHhCCCCceEEEEEC--CcEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHHH
Confidence 9999999999999999999 55999999999999999999999988887766543
|
| >1zyb_A Transcription regulator, CRP family; NP_813211.1, structural genomics, joint center for structura genomics, JCSG; 2.15A {Bacteroides thetaiotaomicron} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.86 E-value=9.2e-21 Score=165.57 Aligned_cols=129 Identities=18% Similarity=0.182 Sum_probs=119.7
Q ss_pred ccccccccccccCCHHHHHHHHhh--cceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYF--SSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~--~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
..|+++|+|..+ ++++++.|+.. ++.+.|++|++|+++||+++.+|+|++|.|+++..+.+ |++..+..++||++|
T Consensus 18 ~~l~~~~lf~~l-~~~~~~~l~~~~~~~~~~~~~ge~i~~~G~~~~~~y~i~~G~v~~~~~~~~-G~~~~l~~~~~G~~f 95 (232)
T 1zyb_A 18 DTLLQLPLFQGL-CHEDFTSILDKVKLHFIKHKAGETIIKSGNPCTQLCFLLKGEISIVTNAKE-NIYTVIEQIEAPYLI 95 (232)
T ss_dssp TTGGGSGGGTTC-CHHHHHHHHHTSCCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECGG-GSCEEEEEEESSEEE
T ss_pred HHHhcCccccCC-CHHHHHHHHhhCCcEEEEECCCCEEECCCCcccEEEEEEeeEEEEEEECCC-CCEEEEEEccCCCee
Confidence 468999999999 99999999998 99999999999999999999999999999999998887 555899999999999
Q ss_pred ecccccCCCc-ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 83 GEKALQGDDL-RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 83 GE~~l~~~~~-r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
||.+++.+.+ ++++++|. ++|+++.|++++|..++..+|.+...++..+..+.
T Consensus 96 G~~~~~~~~~~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~l~~~l~~~l 149 (232)
T 1zyb_A 96 EPQSLFGMNTNYASSYVAH--TEVHTVCISKAFVLSDLFRYDIFRLNYMNIVSNRA 149 (232)
T ss_dssp CGGGGSSSCCBCSSEEEES--SCEEEEEEEHHHHHHTGGGSHHHHHHHHHHHHHHH
T ss_pred eehHHhCCCCCCceEEEEc--cceEEEEEEHHHHHHHhccCHHHHHHHHHHHHHHH
Confidence 9999999988 99999999 56999999999999999999999998887766543
|
| >3ocp_A PRKG1 protein; serine/threonine kinase, TF2I and IRAG, transferase; HET: CMP; 2.49A {Homo sapiens} PDB: 3od0_A* 3ogj_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=155.23 Aligned_cols=115 Identities=24% Similarity=0.335 Sum_probs=100.7
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++++..|+..++.+.|++|++|+++|++++.+|+|++|.|++.. + + ..+..+++|++|||+
T Consensus 24 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~---~-g--~~~~~~~~G~~fGe~ 96 (139)
T 3ocp_A 24 AILDNDFMKNL-ELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEVTK---E-G--VKLCTMGPGKVFGEL 96 (139)
T ss_dssp HHHHCTTTTTS-CHHHHHHHHHHCEEEEECSSCEEECTTSCCCEEEEEEECCEEEEE---T-T--EEEEEECTTCEESCH
T ss_pred HHhcCHhhhcC-CHHHHHHHHHhcEEEecCCCCEEEeCCCcCCEEEEEEeCEEEEEE---C-C--EEEEEeCCCCEeccH
Confidence 46789999999 999999999999999999999999999999999999999999964 2 2 578999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 129 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~ 129 (362)
+++.+.+++++++|. ++|+++.|++++|.+++..+|.++++.
T Consensus 97 ~~l~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~r~~ 138 (139)
T 3ocp_A 97 AILYNCTRTATVKTL--VNVKLWAIDRQCFQTIMMRTGLIKHTE 138 (139)
T ss_dssp HHHHCCCCSSEEEES--SCEEEEEEEHHHHHHHHTC--------
T ss_pred HHHCCCCcceEEEEC--cceEEEEEcHHHHHHHHhhChHhhhhc
Confidence 999999999999999 559999999999999999999987653
|
| >3d0s_A Transcriptional regulatory protein; CAMP receptor protein (CRP), dimer, inactive(APO, unliganded allostery, DNA binding, cyclic AMP; 2.00A {Mycobacterium tuberculosis} PDB: 3i54_A* 3i59_A* 3mzh_A* 3h3u_A* 3r6s_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-21 Score=166.81 Aligned_cols=128 Identities=21% Similarity=0.365 Sum_probs=119.3
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|.++ +++++..++..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++..+..++||++|||
T Consensus 6 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~G~~~G~ 83 (227)
T 3d0s_A 6 EILARAGIFQGV-EPSAIAALTKQLQPVDFPRGHTVFAEGEPGDRLYIIISGKVKIGRRAPD-GRENLLTIMGPSDMFGE 83 (227)
T ss_dssp HHHTTSSTTSSC-CSSTTHHHHTTSCEEEECTTCEEECTTCCCCEEEEEEESCEEEEEECTT-SCEEEEEEECTTCEESC
T ss_pred HHHhcChhhcCC-CHHHHHHHHhhCeEEEeCCCCEEEcCCCcCCEEEEEEeeEEEEEEECCC-CcEEEEEEecCCCEEee
Confidence 368999999999 9999999999999999999999999999999999999999999999888 55588999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.|++++++|. ++|+++.|++++|..++..+|.+...++..+..+
T Consensus 84 ~~~~~~~~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 133 (227)
T 3d0s_A 84 LSIFDPGPRTSSATTI--TEVRAVSMDRDALRSWIADRPEISEQLLRVLARR 133 (227)
T ss_dssp HHHHSCSCCSSEEEES--SCEEEEEEEHHHHHHTTSSCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCceeEEEEc--ccEEEEEEeHHHHHHHHHHChHHHHHHHHHHHHH
Confidence 9999999999999999 5599999999999999999999998887766544
|
| >3fx3_A Cyclic nucleotide-binding protein; helix_TURN_helix, CAMP regulatory protein, structural genomi 2, protein structure initiative; 2.20A {Ruegeria pomeroyi} PDB: 3h3z_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-20 Score=165.66 Aligned_cols=128 Identities=16% Similarity=0.193 Sum_probs=119.6
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|.++ +++++..|+..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++..+..++||++|||
T Consensus 11 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~G~~~G~ 88 (237)
T 3fx3_A 11 AIARNSLLIRSL-PEQHVDALLSQAVWRSYDRGETLFLQEEKAQAIHVVIDGWVKLFRMTPT-GSEAVVSVFTRGESFGE 88 (237)
T ss_dssp HHHTTSHHHHTS-CHHHHHHHHTTCEEEEECTTCEEECTTSCCCEEEEEEESEEEEEEECTT-SCEEEEEEEETTEEECH
T ss_pred HHHhCCHhhccC-CHHHHHHHHhhCEEEEECCCCEEEcCCCccceEEEEEeeEEEEEEECCC-CCEEEEEEeCCCCEech
Confidence 458999999999 9999999999999999999999999999999999999999999998888 55689999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.|++++++|. ++|+++.|++++|..++..+|.+...++..+..+
T Consensus 89 ~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 138 (237)
T 3fx3_A 89 AVALRNTPYPVSAEAV--TPCEVMHIPSPVFVSLMRRDPEICISILATTFGH 138 (237)
T ss_dssp HHHHHTCCCSSEEEES--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCceEEEC--CceEEEEEcHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 9999999999999999 5599999999999999999999998887766654
|
| >4f8a_A Potassium voltage-gated channel subfamily H membe; probable regulatory domain of potassium channel, membrane PR transport protein; 2.20A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.2e-21 Score=155.79 Aligned_cols=119 Identities=18% Similarity=0.286 Sum_probs=110.9
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|+++ +++++..++..++.+.|++|++|+++|++++.+|+|.+|.|+++. .+..+..++||++|||.
T Consensus 28 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~------~~~~~~~~~~G~~fG~~ 100 (160)
T 4f8a_A 28 VFKEHPAFRLA-SDGCLRALAMEFQTVHCAPGDLIYHAGESVDSLCFVVSGSLEVIQ------DDEVVAILGKGDVFGDV 100 (160)
T ss_dssp HHTTCGGGTTC-CHHHHHHHHTTCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEE------TTEEEEEEETTCEEECC
T ss_pred HHHhCHhhhhC-CHHHHHHHHHhceeeeeCCCCEEEeCCCCccEEEEEEeeEEEEEE------CCEEEEEecCCCEeCcH
Confidence 57889999999 999999999999999999999999999999999999999999985 23689999999999999
Q ss_pred cccCC--CcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhh
Q psy14740 86 ALQGD--DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 133 (362)
Q Consensus 86 ~l~~~--~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~ 133 (362)
+++.+ .+++++++|. ++|+++.|++++|.+++..+|.+...+++.+
T Consensus 101 ~~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l 148 (160)
T 4f8a_A 101 FWKEATLAQSCANVRAL--TYCDLHVIKRDALQKVLEFYTAFSHSFSRNL 148 (160)
T ss_dssp TTTCSSCCBCSSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHC
T ss_pred HHhcCcccceEEEEEEC--CceEEEEEcHHHHHHHHHHHHHHHHHHHHHH
Confidence 99988 7999999999 5599999999999999999999998877665
|
| >3dv8_A Transcriptional regulator, CRP/FNR family; cyclic nucleotide-binding domain, structural genomics, joint for structural genomics; 2.55A {Eubacterium rectale atcc 33656} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-20 Score=161.09 Aligned_cols=128 Identities=12% Similarity=0.125 Sum_probs=118.1
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCe--e
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDF--F 82 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~--f 82 (362)
..|+++|+|.++ ++++++.++..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++..+..++||++ |
T Consensus 3 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~G~~~~~ 80 (220)
T 3dv8_A 3 SFENYFPLWNDL-NTAQKKLISDNLITQHVKKGTIIHNGNMDCTGLLLVKSGQLRTYILSDE-GREITLYRLFDMDMCLL 80 (220)
T ss_dssp --CCSCGGGGTS-CHHHHHHHHTTCEEEEECTTCEEEEGGGCCCEEEEEEESCEEEEEECTT-SCEEEEEEECTTCEESG
T ss_pred chHHhChhhhcC-CHHHHHHHHhhCceEEeCCCCEEECCCCCcceEEEEEeceEEEEEECCC-CCEEEEEecCCCCeeeh
Confidence 468999999999 9999999999999999999999999999999999999999999999888 55589999999999 8
Q ss_pred ecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 83 GEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 83 GE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
||.+++.+.|++++++|. ++|+++.|++++|..++..+|.+...+...+..+
T Consensus 81 g~~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 132 (220)
T 3dv8_A 81 SASCIMRSIQFEVTIEAE--KDTDLWIIPAEIYKGIMKDSAPVANYTNELMATR 132 (220)
T ss_dssp GGGGGCTTCCCCCEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred hHHHHhCCCCCceEEEEe--eeeEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 999999999999999999 5599999999999999999999998877666544
|
| >2ptm_A Hyperpolarization-activated (IH) channel; ION channel, cyclic nucleotide binding domain, C-linker, CAM SPHCN1, HCN; HET: CMP; 1.93A {Strongylocentrotus purpuratus} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-21 Score=161.48 Aligned_cols=122 Identities=21% Similarity=0.427 Sum_probs=112.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++.+..|+..++.+.|++|++|+++||+++.+|+|.+|.|++.. .+ |. .+..+++|++|||.
T Consensus 72 ~l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~G~~~~~ly~I~~G~v~~~~--~~-g~--~~~~l~~G~~fGe~ 145 (198)
T 2ptm_A 72 LVASVPFFVGA-DSNFVTRVVTLLEFEVFQPADYVIQEGTFGDRMFFIQQGIVDIIM--SD-GV--IATSLSDGSYFGEI 145 (198)
T ss_dssp HHHHCGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCSEEEEEEECCEEEEC--TT-SC--EEEEECTTCEESCH
T ss_pred HHhcCcchhcC-CHHHHHHHHHhccceeeCCCCEEEECCCcCcEEEEEEeCEEEEEe--cC-Ce--EEEEecCCCEechH
Confidence 46789999999 999999999999999999999999999999999999999999986 33 33 78999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
+++.+.|++++|+|. ++|+++.|++++|..++..+|.+...+...+..
T Consensus 146 ~~~~~~~~~~~~~a~--~~~~l~~i~~~~f~~ll~~~p~~~~~~~~~~~~ 193 (198)
T 2ptm_A 146 CLLTRERRVASVKCE--TYCTLFSLSVQHFNQVLDEFPAMRKTMEEIAVR 193 (198)
T ss_dssp HHHHSSCCSSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHT
T ss_pred HHcCCCccceEEEEe--eEEEEEEEeHHHHHHHHHHChHHHHHHHHHHHH
Confidence 999999999999999 559999999999999999999999887766543
|
| >3iwz_A CAP-like, catabolite activation-like protein; XCC, pathogenicity, CRP, CLP, C-DI-GMP receptor, quorum SENS binding, transcription; 2.30A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-20 Score=161.45 Aligned_cols=128 Identities=19% Similarity=0.245 Sum_probs=109.0
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+..++|.+| ++++++.++..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++.++..++||++|||
T Consensus 11 ~~lr~~~lf~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~g~~~G~ 88 (230)
T 3iwz_A 11 TTVRNATPSLTL-DAGTIERFLAHSHRRRYPTRTDVFRPGDPAGTLYYVISGSVSIIAEEDD-DRELVLGYFGSGEFVGE 88 (230)
T ss_dssp -----------C-CHHHHHHHHTTSEEEEECTTCEEECTTSBCCEEEEEEESCEEEEEECTT-SCEEEEEEECTTCEESC
T ss_pred hhhhhcchhccC-CHHHHHHHHHhCeEEEeCCCCEEECCCCCCCeEEEEEeeEEEEEEECCC-CCEEEEEEecCCCEEEe
Confidence 468999999999 9999999999999999999999999999999999999999999999888 55689999999999999
Q ss_pred ccccCCC-cceeeEEecCCCCeEEEEEehhhHHHHhhch-----HHHHHhhhhhhhHH
Q psy14740 85 KALQGDD-LRTANIVAADPEGVSCLVIDQETFNQLISSL-----DEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~-~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~-----p~~~~~~~~~~~~~ 136 (362)
.+++.+. |++++++|. ++|+++.|++++|..++..+ |.+...++..+..+
T Consensus 89 ~~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~~~~~~p~~~~~~~~~l~~~ 144 (230)
T 3iwz_A 89 MGLFIESDTREVILRTR--TQCELAEISYERLQQLFQTSLSPDAPRILYAIGVQLSKR 144 (230)
T ss_dssp GGGTSCCSBCCSEEEES--SCEEEEEEEHHHHHHHHHTTTGGGHHHHHHHHHHHHHHH
T ss_pred hhhhcCCCCceeEEEEc--CcEEEEEEeHHHHHHHHHHhcccCCcHHHHHHHHHHHHH
Confidence 9999874 899999999 55999999999999999999 99998887776654
|
| >1wgp_A Probable cyclic nucleotide-gated ION channel 6; cyclic nucleotide monophosphate, CNMP, CNMP-binding, structural genomics; NMR {Arabidopsis thaliana} SCOP: b.82.3.2 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=155.99 Aligned_cols=121 Identities=16% Similarity=0.311 Sum_probs=106.5
Q ss_pred CCcccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEE--EecCC
Q psy14740 2 SKNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIR--TLYKG 79 (362)
Q Consensus 2 ~~~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~--~l~~G 79 (362)
+....|+++|+|+.+ +++++..|+..++.+.|++|++|+++||+++.+|+|++|.|++. .+.+ +++..+. .++||
T Consensus 3 ~~~~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~-~~~~-g~~~~~~~~~l~~G 79 (137)
T 1wgp_A 3 SGSSGVRRVPLFENM-DERLLDAICERLKPCLFTEKSYLVREGDPVNEMLFIIRGRLESV-TTDG-GRSGFYNRSLLKEG 79 (137)
T ss_dssp CCSCSCSSCSGGGSC-CHHHHHHHHHHCBCCCBCTTEEEECTTSBCSEEEEEEECCCEEE-CCSS-CSSSSSCEEECCTT
T ss_pred chHHHHHcCcchhhC-CHHHHHHHHHHheEEEeCCCCEEEeCCCCCCeEEEEEeeEEEEE-EcCC-CcceeeeeeeecCC
Confidence 445679999999999 99999999999999999999999999999999999999999965 5555 4444555 99999
Q ss_pred Ceeecccc---cCCCc------ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHH
Q psy14740 80 DFFGEKAL---QGDDL------RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 127 (362)
Q Consensus 80 ~~fGE~~l---~~~~~------r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~ 127 (362)
++|||+++ +.+.| ++++|+|. ++|+++.|++++|.+++.++|.++.
T Consensus 80 ~~fGe~~l~~~~~~~~~~~~~~~~~~~~A~--~~~~~~~i~~~~~~~l~~~~p~l~~ 134 (137)
T 1wgp_A 80 DFCGDELLTWALDPKSGSNLPSSTRTVKAL--TEVEAFALIADELKFVASQFRRSGP 134 (137)
T ss_dssp CBSSTHHHHHHHCSSCCSSSCBCSSEEEES--SCBEEEEEEHHHHHHHHHHHCCCTT
T ss_pred CEecHHHHHHHhccccccccccceeEEEEe--EEEEEEEECHHHHHHHHHHCHhhHh
Confidence 99999995 77774 68999999 5599999999999999999988754
|
| >3ukn_A Novel protein similar to vertebrate potassium VOL channel, subfamily H (EAG-related)...; KCNH, ELK, ERG, CNBD, CNBHD, C-linker, ION channel; 2.20A {Danio rerio} PDB: 3ukt_B 3ukv_B | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-20 Score=159.84 Aligned_cols=121 Identities=21% Similarity=0.384 Sum_probs=112.0
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|.++|+|.++ +++.+..|+..++.+.|++|++|+++||+++.+|+|.+|.|++.. + +..+..++||++|||.
T Consensus 76 ~l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~G~~~~~ly~I~~G~v~v~~---~---~~~~~~l~~G~~fGe~ 148 (212)
T 3ukn_A 76 ELLQLPLFESA-SRGCLRSLSLIIKTSFCAPGEFLIRQGDALQAIYFVCSGSMEVLK---D---NTVLAILGKGDLIGSD 148 (212)
T ss_dssp GGGGSGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCEEEEEEECCEEEES---S---SCEEEEECTTCEEECS
T ss_pred HHHhcHHhhcC-CHHHHHHHHHHhheEEeCCCCEEEECCCcccEEEEEEecEEEEEE---C---CeEEEEecCCCCcCcH
Confidence 45689999999 999999999999999999999999999999999999999999984 2 2679999999999999
Q ss_pred cccCCC--cceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 86 ALQGDD--LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 86 ~l~~~~--~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
+++.+. +++++|+|. ++|+++.|++++|..++..+|.+...++..+..
T Consensus 149 ~~~~~~~~~~~~~v~a~--~~~~l~~i~~~~f~~ll~~~p~~~~~~~~~l~~ 198 (212)
T 3ukn_A 149 SLTKEQVIKTNANVKAL--TYCDLQYISLKGLREVLRLYPEYAQKFVSEIQH 198 (212)
T ss_dssp CCSSSSCCBBCSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHH
T ss_pred HhccCCCCCcceEEEEc--ccEEEEEEeHHHHHHHHHHChHHHHHHHHHHHH
Confidence 999998 999999999 559999999999999999999999988877654
|
| >3pna_A CAMP-dependent protein kinase type I-alpha regula subunit; beta-barrel, CAMP-binding, catalytic subunit, transferase; HET: CMP; 1.50A {Bos taurus} PDB: 3fhi_B* 3iia_A 3plq_A* 1u7e_B* 3pvb_B* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.6e-21 Score=154.67 Aligned_cols=115 Identities=24% Similarity=0.413 Sum_probs=105.2
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++++..|+..++.+.|++|++|+++|++++.+|+|++|.|+++. + + ..+..+++|++|||.
T Consensus 39 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~---~-~--~~~~~~~~G~~fGe~ 111 (154)
T 3pna_A 39 AIEKNVLFSHL-DDNERSDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYV---N-N--EWATSVGEGGSFGEL 111 (154)
T ss_dssp HHHHCGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEEEE---T-T--EEEEEECTTCEECCH
T ss_pred HHHhChhhhhC-CHHHHHHHHHhceEEEECCCCEEEeCCCCCCeEEEEEecEEEEEE---C-C--EEEEEecCCCEeeeh
Confidence 47889999999 999999999999999999999999999999999999999999996 2 2 468899999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 129 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~ 129 (362)
+++.+.+++++++|. ++|+++.|++++|.+++..+|.+++++
T Consensus 112 ~~~~~~~~~~~v~A~--~~~~~~~i~~~~~~~ll~~~~~~~~~~ 153 (154)
T 3pna_A 112 ALIYGTPRAATVKAK--TNVKLWGIDRDSYRRILMGSTLRKRKM 153 (154)
T ss_dssp HHHHCCCCSSEEEES--SCEEEEEEEHHHHHHHTHHHHHHC---
T ss_pred HhhcCCCcceEEEEC--cceEEEEEeHHHHHHHHHhChHHHhhc
Confidence 999999999999999 559999999999999999999987654
|
| >1vp6_A CNBD, cyclic-nucleotide binding domain of mesorhizobium LOTI CNG potassium channel; dimer helical bundle beta barrel core with cyclic AMP bound; HET: CMP; 1.70A {Mesorhizobium loti} SCOP: b.82.3.2 PDB: 3cl1_A* 2k0g_A* 2kxl_A 3clp_A* 1u12_A 3co2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=151.00 Aligned_cols=121 Identities=31% Similarity=0.403 Sum_probs=110.9
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|.++ +++++..|+..++.+.|++|++|+++|++++.+|+|.+|.|+++..+ ...++||++|||
T Consensus 11 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~--------~~~~~~G~~~G~ 81 (138)
T 1vp6_A 11 QLVAAVPLFQKL-GPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPN--------PVELGPGAFFGE 81 (138)
T ss_dssp HHHTTCGGGGGC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEECSSS--------CEEECTTCEECH
T ss_pred HHHHhChhhhcC-CHHHHHHHHHhhcEEEeCCCCEEEeCCCCcceEEEEEeeEEEEEeCC--------cceECCCCEeee
Confidence 357899999999 99999999999999999999999999999999999999999997443 247899999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.+++++++|. ++|+++.|++++|..++..+|.+...+...+..+
T Consensus 82 ~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~p~~~~~~~~~~~~r 131 (138)
T 1vp6_A 82 MALISGEPRSATVSAA--TTVSLLSLHSADFQMLCSSSPEIAEIFRKTALER 131 (138)
T ss_dssp HHHHHCCCCSSCEEES--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred hHhccCCCceeEEEEC--CCEEEEEECHHHHHHHHHHCHHHHHHHHHHHHHh
Confidence 9999999999999999 5599999999999999999999998888776654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.5e-21 Score=168.56 Aligned_cols=164 Identities=16% Similarity=0.098 Sum_probs=110.0
Q ss_pred cEEEEEecccceecEEEEEecCCCCCc--eeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRS--FALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
|.+...||+|+||.||++.+. .+++. +|+|++...... |.. .
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~---------------------------~~~--------~ 92 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSE---------------------------FDK--------M 92 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC------------------------------------------
T ss_pred hhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccc---------------------------hhh--------H
Confidence 678899999999999999863 23677 999987553110 000 0
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcce--eeeeeeeeccceEEEEEeccCC-c----chHHHHHhcC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFI--VKLYKTFKDKKYLYMLMESCLG-G----ELWTILRDKG 301 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~ 301 (362)
.++......-..............+.+|+.+|..+.|+++ +.++.. +..++||||+.+ | +|.+....
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-- 166 (258)
T 1zth_A 93 DEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-- 166 (258)
T ss_dssp GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--
T ss_pred HHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--
Confidence 0000000000000000011123457889999999988764 334432 356899999932 3 67665432
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLH-SRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH-~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++..+..++.|++.+|.||| ++||+||||||+|||++. .++|+|||+|.....+
T Consensus 167 -~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 167 -LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp -GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred -cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 345567889999999999999 999999999999999988 9999999999887654
|
| >3dkw_A DNR protein; CRP-FNR, HTH, beta barrel, dimerization helix, homodimer, transcription regulator; 3.60A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.4e-21 Score=165.75 Aligned_cols=128 Identities=18% Similarity=0.243 Sum_probs=118.5
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|.++ ++++++.++..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++..+..++||++|||
T Consensus 9 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~g~~~G~ 86 (227)
T 3dkw_A 9 QLLQSHHLFEPL-SPVQLQELLASSDLVNLDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPE-GQEKILEVTNERNTFAE 86 (227)
T ss_dssp HHHTTSTTTSSS-CHHHHHHHHTSCEEEECCTTEEEECTTSBCCEEEEEEESCEECCBCCGG-GCCBCCCEECTTEEESC
T ss_pred HHHhcChhhcCC-CHHHHHHHHhhCEEEEECCCCEEEcCCCccceEEEEEeCEEEEEEECCC-CCEEEEEEcCCCCEeee
Confidence 358999999999 9999999999999999999999999999999999999999999988887 55578999999999999
Q ss_pred ccccCCCc-ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDL-RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~-r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.| ++++++|. ++|+++.|++++|..++..+|.+...++..+..+
T Consensus 87 ~~~~~~~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 137 (227)
T 3dkw_A 87 AMMFMDTPNYVATAQAV--VPSQLFRFSNKAYLRQLQDNTPLALALLAKLSTR 137 (227)
T ss_dssp TTTTTTCSBCSSCEEES--SCCEEEEEESHHHHHHHSSCTHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCceEEEEc--CcEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 99999999 99999999 5599999999999999999999998877766544
|
| >2gau_A Transcriptional regulator, CRP/FNR family; structural genomics, porphyromona gingivalis, PSI, protein structure initiative; 1.90A {Porphyromonas gingivalis} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=162.37 Aligned_cols=126 Identities=17% Similarity=0.228 Sum_probs=112.8
Q ss_pred cccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccc
Q psy14740 8 KLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKAL 87 (362)
Q Consensus 8 ~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l 87 (362)
..+|+|..+ ++++++.|+..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++.++..++||++|||.++
T Consensus 13 ~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~v~~G~v~~~~~~~~-g~~~~~~~~~~G~~~G~~~~ 90 (232)
T 2gau_A 13 LLRDVWSLL-NEEERELLDKEIQPFPCKKASTVFSEGDIPNNLFYLYEGKIKILREGVY-GRFHISRIVKPGQFFGMRPY 90 (232)
T ss_dssp GSHHHHTTC-CHHHHHHHHHHCEEEEECTTCEEECTTCCCCEEEEEEESCEEEEC------CCCEEEEECTTCEESHHHH
T ss_pred cccHhhhcC-CHHHHHHHHhhCeEEEECCCCEEEeCCCCCCeEEEEEeCEEEEEEECCC-CCEEEEEEeCCCCEeeeehh
Confidence 468999999 9999999999999999999999999999999999999999999988877 55588999999999999999
Q ss_pred cCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 88 QGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 88 ~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
+.+.|++++++|. ++|+++.|++++|..++..+|.+...++..+..+.
T Consensus 91 ~~~~~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~l 138 (232)
T 2gau_A 91 FAEETCSSTAIAV--ENSKVLAIPVEAIEALLKGNTSFCRYFLKALAKEL 138 (232)
T ss_dssp HHTSCCSSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHH
T ss_pred hCCCCcceEEEEe--cceEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHH
Confidence 9999999999999 55999999999999999999999988877765543
|
| >4ava_A Lysine acetyltransferase; allosteric regulation, domain coupling; HET: ACO; 1.70A {Mycobacterium tuberculosis} PDB: 4avb_A* 4avc_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=171.29 Aligned_cols=126 Identities=18% Similarity=0.269 Sum_probs=117.2
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
..|+++|+|++| +++++..|+..++.+.|++|++||++||+++.+|+|.+|.|++++.+.+| ++ .+..++||++|||
T Consensus 13 ~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~g-~~-~~~~~~~G~~fGe 89 (333)
T 4ava_A 13 EDLAGMDVFQGC-PAEGLVSLAASVQPLRAAAGQVLLRQGEPAVSFLLISSGSAEVSHVGDDG-VA-IIARALPGMIVGE 89 (333)
T ss_dssp HHHTTSGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCCEEEEEECCEEEEEECTTC-CE-EEEEECTTCEESH
T ss_pred HHHhCCHhHhcC-CHHHHHHHHhhCeEEEECCCCEEEeCCCcCCEEEEEEeeEEEEEEECCCC-cE-EEEEecCCCEeeH
Confidence 357899999999 99999999999999999999999999999999999999999999998874 43 8999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
++++.+.||+++|+|+ ++|+++.|++++|.+++ ++|.+...++..+..+
T Consensus 90 ~~l~~~~~~~~~v~A~--~~~~~~~i~~~~~~~l~-~~p~~~~~~~~~~~~~ 138 (333)
T 4ava_A 90 IALLRDSPRSATVTTI--EPLTGWTGGRGAFATMV-HIPGVGERLLRTARQR 138 (333)
T ss_dssp HHHHHTCBCSSEEEES--SCEEEEEECHHHHHHHH-HSTTHHHHHHHHHHHH
T ss_pred HHhcCCCCceEEEEEe--cCEEEEEEcHHHHHHHH-hChHHHHHHHHHHHHH
Confidence 9999999999999999 55999999999999999 8999999888776654
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-19 Score=175.05 Aligned_cols=117 Identities=26% Similarity=0.342 Sum_probs=109.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCc-ceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTE-EKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~-~~~~~~l~~G~~fGE 84 (362)
.|+++++|.++ +++++..|+..+..+.|++|++||++||+++.+|+|++|.|+++..+.+|.+ +..+..++||++|||
T Consensus 43 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~Gd~~~~~y~i~~G~v~v~~~~~~g~~~~~~~~~~~~G~~fGe 121 (469)
T 1o7f_A 43 RLKGVKAFEKF-HPNLLRQICLCGYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE 121 (469)
T ss_dssp HHTTCTTTTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCEEEEEEESCEEEEECSSSCGGGCEEEEEECTTCEECG
T ss_pred HHhCCHhhhcC-CHHHHHHHHHhceEEEECCCCEEEeCCCCCCcEEEEEeeEEEEEEecCCCCCcceEEEEccCCCCcch
Confidence 47889999999 9999999999999999999999999999999999999999999998888542 588999999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 126 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~ 126 (362)
++ +.+.|++++|+|. ++|++|.|++++|..++..+|.+.
T Consensus 122 ~~-l~~~~~~~tv~A~--~~~~l~~i~~~~~~~l~~~~p~~~ 160 (469)
T 1o7f_A 122 SI-LDNTPRHATIVTR--ESSELLRIEQEDFKALWEKYRQYM 160 (469)
T ss_dssp GG-GGTCBCSSEEEES--SSEEEEEEEHHHHHHHHHHHGGGT
T ss_pred hh-hCCCCccceEEEc--cceeEEEEcHHHHHHHHHhCHHHH
Confidence 99 9999999999999 569999999999999998888744
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=168.87 Aligned_cols=134 Identities=48% Similarity=0.808 Sum_probs=122.3
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+..|+|..+ +++++..++..+..+.|++|++|+++||+++.+|+|.+|.|+++......+++..+..+++|++|||+
T Consensus 158 ~l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~g~~I~~~G~~~~~~yiI~~G~v~~~~~~~~~g~~~~~~~l~~G~~fGe~ 236 (299)
T 3shr_A 158 FLKSVPTFQSL-PEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDWFGEK 236 (299)
T ss_dssp HHTTSHHHHHS-CHHHHHHHTTTCEEEEECTTCEEECTTCEECEEEEEEESEEEEEECCSSSCCCEEEEEEETTCEECGG
T ss_pred HHhhCHHhhhC-CHHHHHHHHHhccEEEECCCCEEEeCCCCCCEEEEEEeeEEEEEEecCCCCcceEEEEcCCCCEeChH
Confidence 46788999999 99999999999999999999999999999999999999999999987333666899999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhhhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRLNEE 142 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~~~~ 142 (362)
+++.+.||+++|+|. ++|+++.|++++|.+++..+|.+..++++.+..+....+.
T Consensus 237 ~ll~~~~~~~tv~a~--~~~~l~~i~~~~f~~ll~~~p~~~~~~~~~l~~r~~~~~~ 291 (299)
T 3shr_A 237 ALQGEDVRTANVIAA--EAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAE 291 (299)
T ss_dssp GGSSSEECSSEEEES--SSEEEEEEEHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCcceEEEEC--CCEEEEEEeHHHHHHHHccHHHHHHHHHHHHhhhhhcchh
Confidence 999999999999999 6699999999999999999999999888888776555543
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=163.64 Aligned_cols=126 Identities=25% Similarity=0.411 Sum_probs=117.1
Q ss_pred ccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~ 86 (362)
++++++|..+ +++++..++..++.+.|++|++|+++||+++.+|+|.+|.|++.+...+|++...+..++||++|||++
T Consensus 159 l~~~~lf~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~~~~~~~~~~l~~G~~fGe~~ 237 (291)
T 2qcs_B 159 LSKVSILESL-DKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIA 237 (291)
T ss_dssp HHTCGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEEEECSTTSCEEEEEEECTTCEECSGG
T ss_pred HhhchHhhhC-CHHHHHHHHhhcEEEEECCCCEEEeCCccCCEEEEEEeCEEEEEEecCCCCccEEEEEeCCCCEecHHH
Confidence 5678999999 999999999999999999999999999999999999999999998887766678899999999999999
Q ss_pred ccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 87 l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
++.+.||++||+|. ++|+++.|++++|.+++..+|.+..+.+..+..
T Consensus 238 ll~~~~~~~tv~a~--~~~~~~~i~~~~f~~~l~~~p~~~~~~~~~~~~ 284 (291)
T 2qcs_B 238 LLMNRPKAATVVAR--GPLKCVKLDRPRFERVLGPCSDILKRNIQQYNS 284 (291)
T ss_dssp GTCCCCCSSEEEEE--EEEEEEEEEHHHHHHHHCCHHHHHTTSHHHHHH
T ss_pred HcCCCCcceEEEEC--CcEEEEEEcHHHHHHHhccHHHHHHHHHHHHHH
Confidence 99999999999999 559999999999999999999998887766554
|
| >3bpz_A Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2; CNBD, C-linker, pacemaker, HCN, HCN2, CAP, PKA, CAMP, ION channel; HET: CMP; 1.65A {Mus musculus} PDB: 3ffq_A 1q3e_A* 1q43_A* 1q5o_A* 3u10_A* 2q0a_A* 3etq_A* 3u11_A* 3otf_A* 3u0z_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.1e-20 Score=157.36 Aligned_cols=122 Identities=23% Similarity=0.410 Sum_probs=109.9
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|.++ +++.+..|+..++.+.|++|++|+++||+++.+|+|.+|.|++.. .+ +.+. ++++|++|||.
T Consensus 73 ~l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~g~~~~~ly~I~~G~v~v~~--~~-g~~~---~l~~G~~fGe~ 145 (202)
T 3bpz_A 73 LVASMPLFANA-DPNFVTAMLTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLT--KG-NKEM---KLSDGSYFGEI 145 (202)
T ss_dssp HHHTCHHHHTS-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCEEEEEEECEEEEEC--TT-SCCE---EEETTCEECHH
T ss_pred HHhcCCchhcC-CHHHHHHHHHhCCceEECCCCEEEECCCcCCeEEEEeccEEEEEE--CC-CeEE---EEcCCCEeccH
Confidence 47789999999 999999999999999999999999999999999999999999974 33 3332 68999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+++.+.|++++|+|. ++|+++.|++++|..++..+|.+...+...+..+
T Consensus 146 ~~~~~~~~~~~v~a~--~~~~l~~i~~~~f~~ll~~~p~~~~~~~~~~~~r 194 (202)
T 3bpz_A 146 CLLTRGRRTASVRAD--TYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDR 194 (202)
T ss_dssp HHHHCSBCSSEEEES--SCEEEEEEEHHHHHHHHHHSGGGHHHHHHHHHHH
T ss_pred HHhcCCCcccEEEEe--eEEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 999999999999999 5599999999999999999999988777665543
|
| >3ryp_A Catabolite gene activator; CAMP receptor protein (CRP), allostery, DNA binding cyclic A transcription regulator; HET: CMP; 1.60A {Escherichia coli} PDB: 2cgp_A* 3hif_A 1g6n_A* 3ryr_A* 1i5z_A* 1j59_A* 1lb2_A* 1run_A* 1zrc_A* 1zrd_A* 1zre_A* 1zrf_A* 2gzw_A* 2wc2_A 3iyd_G* 3n4m_A* 3qop_A* 3rdi_A* 3rou_A* 3rpq_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-19 Score=153.94 Aligned_cols=122 Identities=24% Similarity=0.313 Sum_probs=109.2
Q ss_pred ccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCC
Q psy14740 11 AYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90 (362)
Q Consensus 11 ~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~ 90 (362)
+++..+ ++++++.++..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++..+..++||++|||.+++.+
T Consensus 2 ~l~~~l-~~~~l~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~~G~~~~~~~ 79 (210)
T 3ryp_A 2 VLGKPQ-TDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEE-GKEMILSYLNQGDFIGELGLFEE 79 (210)
T ss_dssp -----C-CCHHHHHHHTTSEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTT-CCEEEEEEEETTCEESCTTTTST
T ss_pred cCCCcC-CHHHHHHHHHhcEEEEeCCCCEEECCCCCCCeEEEEEeCEEEEEEECCC-CCEEEEEEcCCCCEeeeHHHhcC
Confidence 456667 9999999999999999999999999999999999999999999999888 55689999999999999999998
Q ss_pred C-cceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 91 D-LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 91 ~-~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
. |++++++|. ++|+++.|+++.|..++..+|.+...++..+..+
T Consensus 80 ~~~~~~~~~a~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 124 (210)
T 3ryp_A 80 GQERSAWVRAK--TACEVAEISYKKFRQLIQVNPDILMRLSAQMARR 124 (210)
T ss_dssp TCBCSSEEEES--SCEEEEEEEHHHHHHHHHHCTHHHHHHHHHHHHH
T ss_pred CCCceEEEEEC--CcEEEEEEcHHHHHHHHHHChHHHHHHHHHHHHH
Confidence 7 899999999 5599999999999999999999998887766554
|
| >2oz6_A Virulence factor regulator; winged helix, helix-turn-helix, transcription factor, CAMP-B proteins, CAMP receptor protein; HET: CMP; 2.80A {Pseudomonas aeruginosa} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-19 Score=151.56 Aligned_cols=117 Identities=26% Similarity=0.342 Sum_probs=106.9
Q ss_pred CCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCC----c
Q psy14740 17 VNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDD----L 92 (362)
Q Consensus 17 ~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~----~ 92 (362)
|++++++.|+..++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+ |++..+..++||++|||.+++.+. |
T Consensus 1 l~~~~l~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~g~~~G~~~~~~~~~~~~~ 79 (207)
T 2oz6_A 1 MKLKHLDKLLAHCHRRRYTAKSTIIYAGDRCETLFFIIKGSVTILIEDDD-GREMIIGYLNSGDFFGELGLFEKEGSEQE 79 (207)
T ss_dssp CCHHHHHHHHHSSEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTT-SCEEEEEEEETTCEESCTTTCC-----CB
T ss_pred CCHHHHHHHHhhcceEEECCCCEEEcCCCCCCeEEEEEeCEEEEEEECCC-CCEEEEEEcCCCCCcccHHHhcCCCCCCC
Confidence 48999999999999999999999999999999999999999999999888 555899999999999999999988 8
Q ss_pred ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 93 r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
++++++|. ++|+++.|++++|..++..+|.+...++..+..+
T Consensus 80 ~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 121 (207)
T 2oz6_A 80 RSAWVRAK--VECEVAEISYAKFRELSQQDSEILYTLGSQMADR 121 (207)
T ss_dssp CCSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred cceEEEEC--CcEEEEEECHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 99999999 5599999999999999999999998887766544
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.5e-20 Score=171.54 Aligned_cols=129 Identities=25% Similarity=0.384 Sum_probs=119.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.++++++|..+ +++++..|+..+..+.|++|++|+++|++++.+|||.+|.|++++...+|++...+..+++|++|||+
T Consensus 249 ~L~~v~~f~~L-s~~el~~l~~~~~~~~~~~ge~I~~eGd~~~~~yiI~~G~v~v~~~~~~~~~~~~v~~l~~Gd~fGe~ 327 (381)
T 4din_B 249 FLSKVSILESL-EKWERLTVADALEPVQFEDGEKIVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDYFGEI 327 (381)
T ss_dssp HHHHCSTTTTC-CTTHHHHHHTTCBCCCBCSSCBSSCTTSBCCEEEEEEESCEEEECCSSSSSCCCEEEEECTTCEECTT
T ss_pred HhhhhHHHHhc-cHHHHHHHHHhhhhccCCCCCEEEeCCCcCCEEEEEEeCEEEEEEecCCCCceEEEEEeCCCCEechH
Confidence 35778999999 99999999999999999999999999999999999999999999988776767789999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
+++.+.||++||+|. ++|+++.|++++|.+++..+|++..+.+..+....
T Consensus 328 all~~~~r~~tv~A~--~~~~ll~i~~~~f~~ll~~~~~i~~~~~~~~~~~l 377 (381)
T 4din_B 328 ALLLNRPRAATVVAR--GPLKCVKLDRPRFERVLGPCSEILKRNIQRYNSFI 377 (381)
T ss_dssp GGGSCCBCSSEEEES--SCBEEEEEEHHHHHHHHCCHHHHHHTTHHHHHHHH
T ss_pred HHhCCCCceeEEEEc--CCEEEEEEeHHHHHHHHhhhHHHHHHHHHHHHHHH
Confidence 999999999999999 55999999999999999999999988877665543
|
| >3kcc_A Catabolite gene activator; helix-turn-helix, CAMP, CAMP-binding, DNA-binding nucleotide-binding, transcription, transcription regulation; HET: CMP; 1.66A {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-18 Score=154.65 Aligned_cols=119 Identities=24% Similarity=0.335 Sum_probs=107.4
Q ss_pred cccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCC-c
Q psy14740 14 VHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDD-L 92 (362)
Q Consensus 14 ~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~-~ 92 (362)
..+ ++++++.|+..++.+.|++|++|+++|++++.+|+|++|.|+++..+.+ |++.++..++||++|||.+++.+. |
T Consensus 55 ~~l-~~~~l~~l~~~~~~~~~~~ge~i~~~G~~~~~~y~I~~G~v~~~~~~~~-G~e~~~~~~~~G~~~Ge~~~~~~~~~ 132 (260)
T 3kcc_A 55 KPQ-TDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEE-GKEMILSYLNQGDFIGELGLFEEGQE 132 (260)
T ss_dssp -----CHHHHHHHTTSEEEEECTTCEEECTTCBCCEEEEEEECEEEEEEECTT-CCEEEEEEEETTCEESCTTTTSTTCB
T ss_pred CCC-CHHHHHHHHhhCEEEEECCCCEEECCCCcCCeEEEEEeCEEEEEEECCC-CCEEEEEEcCCCCEEeehHHhCCCCC
Confidence 556 9999999999999999999999999999999999999999999999888 555899999999999999999988 8
Q ss_pred ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 93 r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
++++++|+ ++|+++.|+++.|..++..+|.+...++..+..+
T Consensus 133 ~~~~~~A~--~~~~l~~i~~~~~~~l~~~~p~l~~~l~~~l~~~ 174 (260)
T 3kcc_A 133 RSAWVRAK--TACEVAEISYKKFRQLIQVNPDILMRLSAQMARR 174 (260)
T ss_dssp CCSEEEES--SCEEEEEEEHHHHHHHHHHCTHHHHHHHHHHHHH
T ss_pred CceEEEEC--CCeEEEEEcHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 99999999 5599999999999999999999998887766554
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-19 Score=154.37 Aligned_cols=116 Identities=26% Similarity=0.389 Sum_probs=107.3
Q ss_pred ccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~ 86 (362)
+++.++|..+ +++++..++..+..+.|++|++|+++|++++.+|+|.+|.|++++...+ .+..+++|++|||++
T Consensus 127 l~~~~~f~~l-~~~~l~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~I~~G~v~v~~~~~~-----~~~~l~~g~~fGe~~ 200 (246)
T 3of1_A 127 LKSMPVLKSL-TTYDRAKLADALDTKIYQPGETIIREGDQGENFYLIEYGAVDVSKKGQG-----VINKLKDHDYFGEVA 200 (246)
T ss_dssp HHHCGGGTTC-CHHHHHHHHHTCEEEEECTTCEEECTTSBCCEEEEEEECEEEEEETTTE-----EEEEEETTCEECHHH
T ss_pred HhhChhhhcC-CHHHHHHHHHhhheEEeCCCCEEEeCCCcCCEEEEEEecEEEEEEcCCc-----eEEEcCCCCcccHHH
Confidence 5678999999 9999999999999999999999999999999999999999999876431 789999999999999
Q ss_pred ccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhh
Q psy14740 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130 (362)
Q Consensus 87 l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~ 130 (362)
++.+.||+++|+|. ++|+++.|++++|.+++...|++..+..
T Consensus 201 ~~~~~~~~~~v~a~--~~~~~~~i~~~~f~~ll~~~~~~~~~~~ 242 (246)
T 3of1_A 201 LLNDLPRQATVTAT--KRTKVATLGKSGFQRLLGPAVDVLKLND 242 (246)
T ss_dssp HHHTCBCSSEEEES--SCEEEEEEEHHHHHHHCTTHHHHHHHTC
T ss_pred HhCCCCcccEEEEC--CCEEEEEEeHHHHHHHhccHHHHHhccC
Confidence 99999999999999 5699999999999999999999876543
|
| >2fmy_A COOA, carbon monoxide oxidation system transcription RE COOA-1; DNA transcription regulator, DNA binding protein; HET: HEM; 2.20A {Carboxydothermus hydrogenoformans} PDB: 2hkx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-19 Score=152.15 Aligned_cols=121 Identities=17% Similarity=0.208 Sum_probs=110.6
Q ss_pred cccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeee
Q psy14740 4 NPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFG 83 (362)
Q Consensus 4 ~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fG 83 (362)
+..|+++|+|..+ +++++..++..++.+.|++|++|+++||+++.+|+|.+|.|+++ .+.+ |++..+..++||++||
T Consensus 3 ~~~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~-~~~~-G~~~~~~~~~~G~~~G 79 (220)
T 2fmy_A 3 QMRLTDTNLLEVL-NSEEYSGVLKEFREQRYSKKAILYTPNTERNLVFLVKSGRVRVY-LAYE-DKEFTLAILEAGDIFC 79 (220)
T ss_dssp TTCSCSSCHHHHT-TSGGGTTTGGGSEEEEECTTCEEECTTCSSCEEEEEEESEEEEE-EECS-SCEEEEEEEETTCEEE
T ss_pred hhhhhcChhhhcC-CHHHHHHHHHhhheeEeCCCCEEECCCCCCCeEEEEEecEEEEE-ECCC-CCEEEEEEcCCCCEeC
Confidence 4578999999999 99999999999999999999999999999999999999999995 6666 5668999999999999
Q ss_pred cccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 84 EKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 84 E~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
| |++++++|. ++|+++.|++++|..++..+|.+...++..+..+
T Consensus 80 ~-------~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~~~~~ 123 (220)
T 2fmy_A 80 T-------HTRAFIQAM--EDTTILYTDIRNFQNIVVEFPAFSLNMVKVLGDL 123 (220)
T ss_dssp S-------CSSSEEEES--SSEEEEEEEHHHHHHHHHHCTHHHHHHHHHHHHH
T ss_pred C-------ccceEEEEc--CcEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 9 899999999 5599999999999999999999998877766544
|
| >1o5l_A Transcriptional regulator, CRP family; TM1171, structural GE JCSG, PSI, protein structure initiative, joint center for S genomics; 2.30A {Thermotoga maritima} SCOP: b.82.3.2 | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=151.44 Aligned_cols=125 Identities=16% Similarity=0.198 Sum_probs=106.7
Q ss_pred ccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc
Q psy14740 9 LRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ 88 (362)
Q Consensus 9 ~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~ 88 (362)
+-|.|... ++.+...++..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++..+..++||++|||++++
T Consensus 3 ~~~~~~~~-~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~v~~G~v~~~~~~~~-G~~~~~~~~~~G~~~G~~~~~ 80 (213)
T 1o5l_A 3 SDKIHHHH-HHMDLKKLLPCGKVIVFRKGEIVKHQDDPIEDVLILLEGTLKTEHVSEN-GKTLEIDEIKPVQIIASGFIF 80 (213)
T ss_dssp -----------CCGGGGGGGSEEEEECTTCEEECTTCBCCEEEEEEESCEEEEEECTT-SCEEEEEEECSSEESSGGGTT
T ss_pred ccccchhh-ccCCHHHHhcccEEEEECCCCEEEcCCCccceEEEEEeeEEEEEEECCC-CCEEEEEEecCCCEeeeHHHh
Confidence 45778888 9999999999999999999999999999999999999999999999887 555899999999999999999
Q ss_pred CCC-cceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 89 GDD-LRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 89 ~~~-~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
.+. ++.++++|. ++|+++.|+++.|..++..+|.+...++..+..+.
T Consensus 81 ~~~~~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~l~~~l~~~~ 128 (213)
T 1o5l_A 81 SSEPRFPVNVVAG--ENSKILSIPKEVFLDLLMKDRELLLFFLKDVSEHF 128 (213)
T ss_dssp SSSCBCSSEEEES--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHH
T ss_pred cCCCCceEEEEEc--cceEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHHH
Confidence 876 999999999 56999999999999999999999988877766543
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=165.18 Aligned_cols=128 Identities=30% Similarity=0.500 Sum_probs=109.5
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCC-----CCcceEEEEecCC
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPN-----STEEKYIRTLYKG 79 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~-----~~~~~~~~~l~~G 79 (362)
..++++++|..+ +++++..|+..+..+.|++|++|+++|++++.+|||.+|.|++++...+ .+++..+..+++|
T Consensus 267 ~~L~~v~lf~~L-s~~el~~L~~~l~~~~~~~Ge~I~~eGd~~~~~yiI~sG~v~v~~~~~~~~~~~~g~~~~l~~l~~G 345 (416)
T 3tnp_B 267 SFIESLPFLKSL-EVSERLKVVDVIGTKVYNDGEQIIAQGDLADSFFIVESGEVKITMKRKGKSEVEENGAVEIARCFRG 345 (416)
T ss_dssp SSGGGCGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEECC------------CEEEEECTT
T ss_pred HHHhhchHhhcC-CHHHHHHHHhhceEEEECCCCEEEeCCCcCCEEEEEEeCEEEEEEecCCcccccCCceeEEEEeCCC
Confidence 357889999999 9999999999999999999999999999999999999999999977654 1445789999999
Q ss_pred CeeecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 80 DFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 80 ~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
++|||++++.+.||++||+|. ++|+++.|++++|.+++..+|.+..+.+..+..
T Consensus 346 ~~fGE~all~~~~r~~tv~A~--~~~~ll~I~~~~f~~ll~~~p~i~~~~~~~~~~ 399 (416)
T 3tnp_B 346 QYFGELALVTNKPRAASAHAI--GTVKCLAMDVQAFERLLGPCMEIMKRNIATYEE 399 (416)
T ss_dssp CEESGGGGTCCSCCSSEEEEE--EEEEEEEEEHHHHHHHHCCHHHHHTCC------
T ss_pred CEecHHHHhCCCCceeEEEEc--CCeEEEEEEHHHHHHHhcchHHHHHHHHHHHHH
Confidence 999999999999999999999 569999999999999999999998876655443
|
| >2d93_A RAP guanine nucleotide exchange factor 6; CNMP_binding domain, PDZ domain containing guanine nucleotide exchange factor 2, PDZ-GEF2, RA-GEF-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=141.95 Aligned_cols=110 Identities=15% Similarity=0.330 Sum_probs=99.6
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEec-CCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYK-EGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~-~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.|+++++|..+ +++++..|+..++.+.|+ +|++|+++|++++.+|+|++|.|+++. .+ ++. ..+++|++|||
T Consensus 17 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~--~~-g~~---~~l~~G~~fG~ 89 (134)
T 2d93_A 17 FMHQLPAFANM-TMSVRRELCSVMIFEVVEQAGAIILEDGQELDSWYVILNGTVEISH--PD-GKV---ENLFMGNSFGI 89 (134)
T ss_dssp HHHHSSTTTSS-CHHHHHHHTTTEEEEEECSSSCEEECTTCEECEEEECCBSCEEEEC--SS-SCE---EEECTTCEESC
T ss_pred HHhCCcchhhC-CHHHHHHHHHhheEEEecCCCCEEEeCCCCCCeEEEEEeCEEEEEc--CC-CcE---EEecCCCccCh
Confidence 47889999999 999999999999999999 999999999999999999999999984 33 332 56899999999
Q ss_pred ccccCCCcceeeE-EecCCCCeEEEEEehhhHHHHhhchHH
Q psy14740 85 KALQGDDLRTANI-VAADPEGVSCLVIDQETFNQLISSLDE 124 (362)
Q Consensus 85 ~~l~~~~~r~~~~-~A~~~~~~~~~~i~~~~f~~l~~~~p~ 124 (362)
.+++.+.++.+++ +|. ++|+++.|++++|..++...+.
T Consensus 90 ~~~~~~~~~~~~~~~a~--~~~~~~~i~~~~~~~l~~~~~~ 128 (134)
T 2d93_A 90 TPTLDKQYMHGIVRTKV--DDCQFVCIAQQDYWRILNHVEK 128 (134)
T ss_dssp CSSSCCEECCSEEEESS--SSEEEEEEEHHHHHHHSSCCSS
T ss_pred hHhcCCCcceeEEEEEe--cceEEEEEeHHHHHHHHHHHHh
Confidence 9999999999999 999 5699999999999999877553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.2e-19 Score=163.39 Aligned_cols=158 Identities=13% Similarity=0.043 Sum_probs=100.9
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.+...||.|+||.||.+... .++.+|+|+++.+..... ...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr----~v~-------------------------------- 138 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFR----TVK-------------------------------- 138 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCC----CCC--------------------------------
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHH----HHH--------------------------------
Confidence 789999999999999999853 488999999865421100 000
Q ss_pred ccchhhhhccccc--cccchhh--hhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 231 YVDETSERRRAPQ--IVETRQQ--QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 231 ~~~~~~~~~~~~~--~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..+++... ..+.... -....|...|..+.++++.... .+... ..++||||++|++|.++.. .+
T Consensus 139 -----~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~-p~~~~-~~~LVME~i~G~~L~~l~~------~~ 205 (397)
T 4gyi_A 139 -----ANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE-PIAQS-RHTIVMSLVDALPMRQVSS------VP 205 (397)
T ss_dssp -------CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC-EEEEE-TTEEEEECCSCEEGGGCCC------CS
T ss_pred -----HHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe-eeecc-CceEEEEecCCccHhhhcc------cH
Confidence 00000000 0000000 1123455566665443332111 11111 2379999999988865432 22
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----------cEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----------YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----------~~kl~DFG~a~~~~~~ 359 (362)
....++.|++.+|.+||++|||||||||.|||++.+| .+.|+||+-+.....|
T Consensus 206 ~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 206 DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence 3467889999999999999999999999999998776 3899999988765544
|
| >1ft9_A Carbon monoxide oxidation system transcription regulator; heme sensor, catabolite gene activator protein; HET: HEM; 2.60A {Rhodospirillum rubrum} SCOP: a.4.5.4 b.82.3.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=150.82 Aligned_cols=118 Identities=14% Similarity=0.072 Sum_probs=108.0
Q ss_pred ccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccc
Q psy14740 7 LKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86 (362)
Q Consensus 7 L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~ 86 (362)
|+++|+|..+ +++++..|+..++.+.|++|++||++|++++.+|+|.+|.|+++ .+.+ |++..+..++||++||
T Consensus 2 l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~-~~~~-G~~~~~~~~~~G~~fG--- 75 (222)
T 1ft9_A 2 PPRFNIANVL-LSPDGETFFRGFRSKIHAKGSLVCTGEGDENGVFVVVDGRLRVY-LVGE-EREISLFYLTSGDMFC--- 75 (222)
T ss_dssp CCCCCTHHHH-TSTTTTTTTTTCEEEEECTTCEEECTTCCCCCEEEEEESEEEEE-EEET-TEEEEEEEEETTCEEE---
T ss_pred cccchhhhcC-CHHHHHHHHhhCcEEEECCCCEEECCCCCCCeEEEEEecEEEEE-ECCC-CCEEEEEEcCCCCEec---
Confidence 6889999999 99999999999999999999999999999999999999999997 6666 5668999999999999
Q ss_pred ccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 87 l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.|++++++|. ++|+++.|+++.|..++..+|.+...++..+..+
T Consensus 76 ----~~~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 119 (222)
T 1ft9_A 76 ----MHSGCLVEAT--ERTEVRFADIRTFEQKLQTCPSMAWGLIAILGRA 119 (222)
T ss_dssp ----SCSSCEEEES--SCEEEEEECHHHHHHHHHHCGGGHHHHHHHHHHH
T ss_pred ----CCCCEEEEEc--cceEEEEEeHHHHHHHHHHChHHHHHHHHHHHHH
Confidence 7899999999 5599999999999999999999988777665543
|
| >3e6c_C CPRK, cyclic nucleotide-binding protein; CPRK, halorespiration; HET: DNA 3C4; 1.80A {Desulfitobacterium hafniense} SCOP: a.4.5.4 b.82.3.2 PDB: 3e6b_A* 3e5u_C* 3e6d_A 3e5x_A* 3e5q_A 2h6b_A* 2h6c_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-18 Score=149.36 Aligned_cols=122 Identities=10% Similarity=0.102 Sum_probs=109.7
Q ss_pred ccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc
Q psy14740 9 LRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ 88 (362)
Q Consensus 9 ~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~ 88 (362)
....|..+ ++++++.|+..++.+.|++|++|+++|++++.+|+|.+|.|+++..+.+ |++.++..++||++||| ++
T Consensus 13 ~~~p~~~l-~~~~l~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~-G~~~~~~~~~~G~~~G~--~l 88 (250)
T 3e6c_C 13 AIIPDNFF-PIEKLRNYTQMGLIRDFAKGSAVIMPGEEITSMIFLVEGKIKLDIIFED-GSEKLLYYAGGNSLIGK--LY 88 (250)
T ss_dssp CSSSBSCS-CCGGGGGGGGGSEEEEECTTCEEECTTCCCCSEEEEEESCEEEEEECTT-SCEEEEEEECTTCEECC--CS
T ss_pred hccchhhC-CHHHHHHHHhhCeEEEECCCCEEECCCCCCCeEEEEEeeEEEEEEECCC-CCEEEEEEecCCCEEee--ec
Confidence 33334777 9999999999999999999999999999999999999999999999888 55689999999999999 77
Q ss_pred CCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 89 GDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 89 ~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
.+. ++++++|. ++|+++.|+++.|..++..+|.+...++..+..+.
T Consensus 89 ~~~-~~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~l~~~l~~~l 134 (250)
T 3e6c_C 89 PTG-NNIYATAM--EPTRTCWFSEKSLRTVFRTDEDMIFEIFKNYLTKV 134 (250)
T ss_dssp CCS-CCEEEEES--SSEEEEEECHHHHHHHHHHCTHHHHHHHHHHHHHH
T ss_pred CCC-CceEEEEc--ccEEEEEEcHHHHHHHHHHCHHHHHHHHHHHHHHH
Confidence 778 99999999 55999999999999999999999988877665543
|
| >2bgc_A PRFA; bacterial infection, human pathogen, transcriptional regulat transcription; HET: PR3; 2.3A {Listeria monocytogenes} SCOP: a.4.5.4 b.82.3.3 PDB: 2beo_A* 1omi_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-17 Score=144.08 Aligned_cols=118 Identities=13% Similarity=0.085 Sum_probs=104.1
Q ss_pred ccCCHHHHHHHHh--hcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCc
Q psy14740 15 HLVNQGVILTIVY--FSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92 (362)
Q Consensus 15 ~l~~~~~~~~l~~--~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~ 92 (362)
++ +++++..++. .++.+.|++|++||++||+++.+|+|.+|.|+++..+.+ |++.++..+ ||++|||++++.+.+
T Consensus 3 ~l-~~~~l~~ll~~~~~~~~~~~~ge~i~~~G~~~~~~y~I~~G~v~~~~~~~~-G~e~~~~~~-~G~~~Ge~~~~~~~~ 79 (238)
T 2bgc_A 3 NA-QAEEFKKYLETNGIKPKQFHKKELIFNQWDPQEYCIFLYDGITKLTSISEN-GTIMNLQYY-KGAFVIMSGFIDTET 79 (238)
T ss_dssp -C-HHHHHHHHHHHTTCCCEEEETTCEEECTTCCCCEEEEEEESEEEEEEECTT-SCEEEEEEE-ESSEEEESBCTTTCC
T ss_pred CC-CHHHHHHHHHhCCceEEEECCCCEEEeCCCCCceEEEEEecEEEEEEECCC-CCEEEEEEc-CCCEecchhhhcCCC
Confidence 56 8999999985 589999999999999999999999999999999999888 555889999 999999999999887
Q ss_pred c--eeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 93 R--TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 93 r--~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+ .++++|++ ++|+++.|+++.|..++..+|.+...++..+..+
T Consensus 80 ~~~~~~~~a~~-~~~~v~~i~~~~~~~l~~~~p~~~~~~~~~l~~~ 124 (238)
T 2bgc_A 80 SVGYYNLEVIS-EQATAYVIKINELKELLSKNLTHFFYVFQTLQKQ 124 (238)
T ss_dssp BSCCCEEEECS-SEEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred cCcceeEEEEE-cceEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 5 67788874 3599999999999999999999998887766544
|
| >3la7_A Global nitrogen regulator; activator, DNA-binding, transcription, transcription regulation; HET: BOG; 1.90A {Anabaena} PDB: 3la2_A* 3la3_A* 2xko_A* 2xgx_A* 2xhk_A* 2xkp_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.3e-17 Score=142.65 Aligned_cols=115 Identities=20% Similarity=0.198 Sum_probs=104.3
Q ss_pred HHHHHHHHhhcc---eeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCc--c
Q psy14740 19 QGVILTIVYFSS---QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL--R 93 (362)
Q Consensus 19 ~~~~~~l~~~~~---~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~--r 93 (362)
++.++.|+..+. .+.|++|++|+++|++++.+|+|++|.|+++..+.+ |++.++..++||++|||.+++.+.| +
T Consensus 30 ~~~l~~L~~~~~~~~~~~~~~ge~i~~~G~~~~~ly~v~~G~v~~~~~~~~-G~~~~l~~~~~g~~~G~~~~~~~~~~~~ 108 (243)
T 3la7_A 30 ANVFRQMATGAFPPVVETFERNKTIFFPGDPAERVYFLLKGAVKLSRVYEA-GEEITVALLRENSVFGVLSLLTGNKSDR 108 (243)
T ss_dssp HHHHHHHCCSSCCCEEEEECTTCEEECTTSBCCEEEEEEESCEEEEEECTT-CCEEEEEEECTTCEESCHHHHSSCCSBC
T ss_pred HHHHHHHhhccchheeEEECCCCEEEcCCCCCceEEEEEeCEEEEEEECCC-CCEEEEEEecCCCEEcchHHhCCCCCcc
Confidence 577888888888 999999999999999999999999999999999888 5558999999999999999998876 5
Q ss_pred eeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 94 ~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.++++|+ ++|+++.|+++.|..++..+|.+...++..+..+
T Consensus 109 ~~~~~A~--~~~~v~~i~~~~~~~l~~~~p~~~~~l~~~l~~~ 149 (243)
T 3la7_A 109 FYHAVAF--TPVELLSAPIEQVEQALKENPELSMLMLRGLSSR 149 (243)
T ss_dssp CEEEEES--SSEEEEEEEHHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred eEEEEEc--cceEEEEEcHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 6999999 5699999999999999999999998887766554
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.9e-17 Score=157.31 Aligned_cols=118 Identities=30% Similarity=0.419 Sum_probs=103.6
Q ss_pred cccccccccccCCHHHHHHHHhhcce-eEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQ-TFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~-~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.|+++|+|.++ +++++..|+..+.. +.|++|++|+++||+++.+|||.+|.|+++... . ..+..+++|++|||
T Consensus 338 ~l~~~~~f~~l-~~~~~~~l~~~~~~~~~~~~g~~i~~~G~~~~~~yiI~~G~v~v~~~~---~--~~~~~l~~G~~fGe 411 (469)
T 1o7f_A 338 ELLHIKALSHL-STTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG---K--GVVCTLHEGDDFGK 411 (469)
T ss_dssp HHTTCGGGTTS-CHHHHHHHHHHCEEEEECSTTCEEECTTSCCCEEEEEEESEEEEEETT---T--EEEEEEETTCEECG
T ss_pred HHhcCHhhhhC-CHHHHHHHHHHhheeeEecCCCEEEeCCCcCCeEEEEEEeEEEEEEcC---C--eeEEEecCCCEEEE
Confidence 46789999999 99999999999985 589999999999999999999999999998642 2 37999999999999
Q ss_pred ccccCCCcceeeEEecCCC-CeEEEEEehhhHHHHhhchHHHHHhhhh
Q psy14740 85 KALQGDDLRTANIVAADPE-GVSCLVIDQETFNQLISSLDEIRTKYVD 131 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~-~~~~~~i~~~~f~~l~~~~p~~~~~~~~ 131 (362)
++++.+.||++||+|. + +|+++.|++++|.+++..+|.+..++.+
T Consensus 412 ~~ll~~~~~~~tv~a~--~~~~~~~~i~~~~f~~ll~~~p~~~~~l~e 457 (469)
T 1o7f_A 412 LALVNDAPRAASIVLR--EDNCHFLRVDKEDFNRILRDVEANTVRLKE 457 (469)
T ss_dssp GGGTCCSCCSSEEEES--SSSEEEEEEEHHHHHHHHHHTTCC------
T ss_pred ehhhcCCCceEEEEEe--cCCEEEEEEcHHHHHHHHHHChHHHHHHHh
Confidence 9999999999999999 5 5999999999999999999998776543
|
| >3b02_A Transcriptional regulator, CRP family; structural genomics, riken structural genomics/proteomics in RSGI; 1.92A {Thermus thermophilus} PDB: 2zdb_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6.3e-16 Score=131.00 Aligned_cols=96 Identities=16% Similarity=0.258 Sum_probs=86.4
Q ss_pred eeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEEEE
Q psy14740 31 QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVI 110 (362)
Q Consensus 31 ~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i 110 (362)
++.|++|++||++||+++.+|+|.+|.|+++..+.+ |++..+..++||++||| +++.+.|++++++|. ++|+++.|
T Consensus 1 i~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~G~~~Ge-~~~~~~~~~~~~~A~--~~~~v~~i 76 (195)
T 3b02_A 1 MKRFARKETIYLRGEEARTLYRLEEGLVRVVELLPD-GRLITLRHVLPGDYFGE-EALEGKAYRYTAEAM--TEAVVQGL 76 (195)
T ss_dssp CEEECTTCEEECTTSBCCCEEEEEESCEEEEEECTT-SCEEEEEEECTTCEECG-GGGTCSBCSSEEEES--SSEEEEEE
T ss_pred CeEcCCCCEEECCCCCCCeEEEEEeCEEEEEEECCC-CCEEEEEEecCCCEech-hhhCCCCceeEEEEC--CcEEEEEE
Confidence 368999999999999999999999999999998887 55588999999999999 999999999999999 55999999
Q ss_pred ehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 111 DQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 111 ~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
+++.|. |.+...++..+..+
T Consensus 77 ~~~~~~------p~~~~~~~~~l~~~ 96 (195)
T 3b02_A 77 EPRAMD------HEALHRVARNLARQ 96 (195)
T ss_dssp CGGGCC------HHHHHHHHHHHHHH
T ss_pred cHHHcC------HHHHHHHHHHHHHH
Confidence 999997 88887777666544
|
| >4f7z_A RAP guanine nucleotide exchange factor 4; cyclic nucleotide, regulation, auto-IN CDC25 homology domain, exocytosis; 2.60A {Mus musculus} PDB: 2byv_E | Back alignment and structure |
|---|
Probab=99.64 E-value=9.9e-16 Score=160.40 Aligned_cols=110 Identities=30% Similarity=0.398 Sum_probs=98.2
Q ss_pred cccccccccccCCHHHHHHHHhhcceeE-ecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTF-YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~-~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.|+++|+|+++ +...+..|+..+.... +++|++|++|||.++.+|||++|.|.|++.. ...+..+++||.|||
T Consensus 338 ~L~~i~~f~~L-s~~v~r~L~~~l~~~~~~kaGtvI~rQGE~gds~YIIlsG~V~V~~~~-----~~~v~~L~~Gd~FGE 411 (999)
T 4f7z_A 338 ELLHIKALSHL-STTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG-----KGVVCTLHEGDDFGK 411 (999)
T ss_dssp HHTTCGGGTTS-CHHHHHHHTTTCEEEEESSTTCEEECTTSBCCEEEEEEESEEEEEETT-----TEEEEEEETTCEECG
T ss_pred HHHhhHHHhcC-CHHHHHHHHHhhhhheeccCCCEEEeCCCcCCeEEEEEeeEEEEEEcC-----CcceEEecCCCcccc
Confidence 47889999999 9999999999998655 5789999999999999999999999998632 246899999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhch
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 122 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~ 122 (362)
+|++.+.||.|||+|.+ .+|.++.|++++|.+++...
T Consensus 412 lALL~~~PR~aTV~a~~-d~c~fl~i~k~df~~il~~~ 448 (999)
T 4f7z_A 412 LALVNDAPRAASIVLRE-DNCHFLRVDKEDGNRILRDV 448 (999)
T ss_dssp GGGTCSCBCSSEEEESS-SSEEEEEEEHHHHHHHHHHH
T ss_pred hhhccCCCeeEEEEEec-CceEEEEeeHHHHHHHHhHH
Confidence 99999999999999984 25999999999999988653
|
| >3beh_A MLL3241 protein; transmembrane protein, membrane protein; HET: LDA; 3.10A {Mesorhizobium loti} PDB: 2zd9_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-17 Score=153.58 Aligned_cols=121 Identities=31% Similarity=0.403 Sum_probs=0.4
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
+.+++.|+|+++ ++++++.++..++.+.|++||+|++|||+++.+|+|.+|.|++...+ ...++||++|||
T Consensus 228 ~~l~~~~lf~~l-s~~~l~~l~~~~~~~~~~~ge~I~~~G~~~~~ly~I~~G~v~v~~~~--------~~~l~~G~~fGe 298 (355)
T 3beh_A 228 QLVAAVPLFQKL-GPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPN--------PVELGPGAFFGE 298 (355)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred hhhhcccccccC-CHHHHHHHHHhceEEEECCCCEEEeCCCcCceEEEEEeeEEEEEECC--------eeEECCCCEEee
Confidence 357889999999 99999999999999999999999999999999999999999998653 247899999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.|++++++|. ++|+++.+++++|.+++.++|++...+.+....+
T Consensus 299 ~~~l~~~~~~~~~~A~--~~~~l~~i~~~~f~~ll~~~p~~~~~l~~~l~~r 348 (355)
T 3beh_A 299 MALISGEPRSATVSAA--TTVSLLSLHSADFQMLCSSSPEIAEIFRKTALER 348 (355)
T ss_dssp ----------------------------------------------------
T ss_pred hHHhCCCCcceEEEEC--ccEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHH
Confidence 9999999999999999 5599999999999999999999998877665543
|
| >3cf6_E RAP guanine nucleotide exchange factor (GEF) 4; EPAC, rapgef4, CAMP, SP-camps, GEF, gunanine nucleotide exchange factor, G-protein, GTP-binding, nucleotide-binding; HET: SP1; 2.20A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=152.72 Aligned_cols=116 Identities=30% Similarity=0.436 Sum_probs=106.8
Q ss_pred cccccccccccCCHHHHHHHHhhcc-eeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSS-QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~-~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.|+++++|.++ +++++..|+..+. .+.|++|++||++||+++.+|+|++|.|++++.. + .++..++||++|||
T Consensus 33 ~L~~~~lF~~L-s~~~l~~L~~~~~~~~~~~kGe~I~~eGd~~~~lyiIlsG~V~v~~~g---~--~il~~l~~Gd~fGe 106 (694)
T 3cf6_E 33 ELLHIKALSHL-STTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG---K--GVVCTLHEGDDFGK 106 (694)
T ss_dssp HHTTCGGGTTS-CHHHHHHHHTTCEEEEECSTTCEEECTTSBCCEEEEEEESEEEEEETT---T--EEEEEEETTCEECH
T ss_pred HHHcChhhccC-CHHHHHHHHHhcceEEEECCCCEEECCCCcCCeEEEEEEEEEEEEEeC---C--EEEEEeCCCCEeeh
Confidence 47889999999 9999999999998 7899999999999999999999999999998642 2 58999999999999
Q ss_pred ccccCCCcceeeEEecCCC-CeEEEEEehhhHHHHhhchHHHHHhh
Q psy14740 85 KALQGDDLRTANIVAADPE-GVSCLVIDQETFNQLISSLDEIRTKY 129 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~-~~~~~~i~~~~f~~l~~~~p~~~~~~ 129 (362)
.+++.+.+++++|+|. + +|+++.|++++|.+++..+|.+..++
T Consensus 107 ~al~~~~~~~~tv~A~--edd~~ll~I~~~~f~~ll~~~p~l~~~l 150 (694)
T 3cf6_E 107 LALVNDAPRAASIVLR--EDNCHFLRVDKEDFNRILRDVEANTVRL 150 (694)
T ss_dssp HHHHHTCBCSSEEEEC--SSSEEEEEEEHHHHHHHTTTTCCCCEEE
T ss_pred HHHhCCCCceEEEEEe--eCceEEEEEeHHHHHHHHHHCHHHHHHH
Confidence 9999999999999999 6 49999999999999999999876544
|
| >2zcw_A TTHA1359, transcriptional regulator, FNR/CRP family; stationary phase, DNA-binding, transcription regulation; 1.50A {Thermus thermophilus} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.9e-15 Score=125.25 Aligned_cols=100 Identities=22% Similarity=0.288 Sum_probs=85.2
Q ss_pred HHhhcceeEecCCCEEEecCCCC--CeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCC
Q psy14740 25 IVYFSSQTFYKEGDYIIRQGARG--DTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADP 102 (362)
Q Consensus 25 l~~~~~~~~~~~g~~i~~~g~~~--~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~ 102 (362)
|...++.+.|++|++|+++||++ +.+|+|.+|.|+++..+.+ |++..+..++||++||| +++.+.|++++++|+
T Consensus 1 l~~~~~~~~~~~g~~i~~~g~~~~~~~~y~v~~G~v~~~~~~~~-G~~~~~~~~~~g~~~G~-~~l~~~~~~~~~~A~-- 76 (202)
T 2zcw_A 1 MTQVRETVSFKAGDVILYPGVPGPRDRAYRVLEGLVRLEAVDEE-GNALTLRLVRPGGFFGE-EALFGQERIYFAEAA-- 76 (202)
T ss_dssp -----CCEEECTTCEEECSBSCCTTCCCEEEEESCEEEEEECTT-SCEEEEEEECTTCEECT-HHHHTCCBCSEEEES--
T ss_pred CCccceEEEECCCCEEECCCCCCCCCeEEEEEeCEEEEEEECCC-CcEEEEEEecCCCEeee-hhcCCCCcceEEEEc--
Confidence 35677899999999999999999 9999999999999999888 55589999999999999 989999999999999
Q ss_pred CCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 103 EGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 103 ~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
++|+++.| ++.|. |.+...++..+..
T Consensus 77 ~~~~v~~i-~~~~~------p~~~~~~~~~l~~ 102 (202)
T 2zcw_A 77 TDVRLEPL-PENPD------PELLKDLAQHLSQ 102 (202)
T ss_dssp SCEEEEEC-CSSCC------HHHHHHHHHHHHH
T ss_pred ccEEEEEE-hHhcC------HHHHHHHHHHHHH
Confidence 55999999 99886 7777766665544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.9e-12 Score=113.42 Aligned_cols=142 Identities=14% Similarity=0.099 Sum_probs=111.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+..|.+....+.|+.+.||++... ++.+++|......
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~--------------------------------------- 49 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE---NENLYLKMTDSRY--------------------------------------- 49 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS---SCEEEEEEECGGG---------------------------------------
T ss_pred HhccceeEeeccCCCCCeEEEEECC---CCcEEEEeCCccc---------------------------------------
Confidence 4567899999999999999999732 5679999875421
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
......+.+|+.+++.+ .+..++++++++...+..|+|||+++|.+|.+... +.
T Consensus 50 --------------------~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~ 104 (263)
T 3tm0_A 50 --------------------KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DE 104 (263)
T ss_dssp --------------------TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TT
T ss_pred --------------------CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----Cc
Confidence 01123578899999988 46788999999888889999999999999987531 12
Q ss_pred HHHHHHHHHHHHHHHHHHH-----------------------------------------------------------CC
Q psy14740 306 ATTRFYTACVVEAFDYLHS-----------------------------------------------------------RN 326 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~-----------------------------------------------------------~~ 326 (362)
.....++.++..+|..||+ ..
T Consensus 105 ~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 184 (263)
T 3tm0_A 105 QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV 184 (263)
T ss_dssp TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE
T ss_pred ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce
Confidence 2234677889999999998 45
Q ss_pred cEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 327 IIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 327 iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 89999999999998765567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.1e-11 Score=107.45 Aligned_cols=97 Identities=11% Similarity=0.159 Sum_probs=72.7
Q ss_pred hhhHHHHHHHhhcCCcc--eeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q psy14740 251 QHIMSEKEIMGEANCDF--IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRN-- 326 (362)
Q Consensus 251 ~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~-- 326 (362)
..+..|+.+++.+.+.+ +++++.+...++..|+|||+++|.+|. .. ..+. ..++.++...|..||+..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~ 129 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPA 129 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGG
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCC
Confidence 34678999998885433 677888888878899999999999884 21 1221 245566666777777543
Q ss_pred --------------------------------------------------------cEeecCCCCcEEecCCCcEEEEec
Q psy14740 327 --------------------------------------------------------IIYRDLKPENLLLSTSGYVKLVDF 350 (362)
Q Consensus 327 --------------------------------------------------------iiHrDikp~NIl~~~~~~~kl~DF 350 (362)
++|+|++|.||+++.++.+.|+||
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 999999999999987666679999
Q ss_pred cccee
Q psy14740 351 GFAKK 355 (362)
Q Consensus 351 G~a~~ 355 (362)
|.|..
T Consensus 210 ~~a~~ 214 (264)
T 1nd4_A 210 GRLGV 214 (264)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 99864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.1e-10 Score=106.27 Aligned_cols=103 Identities=17% Similarity=0.270 Sum_probs=82.1
Q ss_pred hhhHHHHHHHhhcC--Ccceeeeeeeeecc---ceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy14740 251 QHIMSEKEIMGEAN--CDFIVKLYKTFKDK---KYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS- 324 (362)
Q Consensus 251 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~- 324 (362)
..+.+|..+++.+. +..+++++.++.+. +..|+|||+++|..+.+.. ...++......++.++...|..||+
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 45778999999886 45688888887766 4589999999988775411 1246788888899999999999997
Q ss_pred ---------------------------------------------------------CCcEeecCCCCcEEecCCCc--E
Q psy14740 325 ---------------------------------------------------------RNIIYRDLKPENLLLSTSGY--V 345 (362)
Q Consensus 325 ---------------------------------------------------------~~iiHrDikp~NIl~~~~~~--~ 345 (362)
.+++|+|++|.|||++.++. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~ 238 (359)
T 3dxp_A 159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL 238 (359)
T ss_dssp CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence 36999999999999987653 6
Q ss_pred EEEeccccee
Q psy14740 346 KLVDFGFAKK 355 (362)
Q Consensus 346 kl~DFG~a~~ 355 (362)
.|+||+.|..
T Consensus 239 ~viDwe~a~~ 248 (359)
T 3dxp_A 239 AVLDWELSTL 248 (359)
T ss_dssp EECCCTTCEE
T ss_pred EEECcccccc
Confidence 8999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.9e-07 Score=84.12 Aligned_cols=103 Identities=19% Similarity=0.208 Sum_probs=75.6
Q ss_pred hhhHHHHHHHhhc-CCcc--eeeeeeeeeccc---eEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy14740 251 QHIMSEKEIMGEA-NCDF--IVKLYKTFKDKK---YLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS 324 (362)
Q Consensus 251 ~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~ 324 (362)
..+.+|..+|+.+ .+.. +++++......+ ..|+||++++|.++..... ..++..+...++.|+...+..||+
T Consensus 55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHc
Confidence 4578899998877 3332 455555543333 4589999999998875432 246777777788888888888875
Q ss_pred ----------------------------------------------------------CCcEeecCCCCcEEecC--CCc
Q psy14740 325 ----------------------------------------------------------RNIIYRDLKPENLLLST--SGY 344 (362)
Q Consensus 325 ----------------------------------------------------------~~iiHrDikp~NIl~~~--~~~ 344 (362)
..++|+|++|.||+++. .+.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~ 212 (304)
T 3sg8_A 133 INISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTI 212 (304)
T ss_dssp SCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEE
T ss_pred CCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCE
Confidence 23799999999999998 456
Q ss_pred EEEEeccccee
Q psy14740 345 VKLVDFGFAKK 355 (362)
Q Consensus 345 ~kl~DFG~a~~ 355 (362)
+.++||+.+..
T Consensus 213 ~~~iD~~~~~~ 223 (304)
T 3sg8_A 213 CGIIDFGDAAI 223 (304)
T ss_dssp EEECCCTTCEE
T ss_pred EEEEeCCCCcc
Confidence 78999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.4e-06 Score=78.68 Aligned_cols=103 Identities=17% Similarity=0.106 Sum_probs=68.8
Q ss_pred hhhHHHHHHHhhcCCc---ceeeeeeeee-ccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q psy14740 251 QHIMSEKEIMGEANCD---FIVKLYKTFK-DKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS-- 324 (362)
Q Consensus 251 ~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~-- 324 (362)
..+.+|..+|+.+.+. .+++++.+.. ..+..|++|++++|.++.+..- ..++......+..++...|..||+
T Consensus 54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~ 131 (306)
T 3tdw_A 54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFP 131 (306)
T ss_dssp HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 4578899999998642 3666666653 4566889999999988876321 123333333444444444444432
Q ss_pred ----------------------------------------------------------CCcEeecCCCCcEEecC---CC
Q psy14740 325 ----------------------------------------------------------RNIIYRDLKPENLLLST---SG 343 (362)
Q Consensus 325 ----------------------------------------------------------~~iiHrDikp~NIl~~~---~~ 343 (362)
..++|+|++|.||+++. ++
T Consensus 132 ~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~ 211 (306)
T 3tdw_A 132 VETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQT 211 (306)
T ss_dssp HHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSC
T ss_pred cccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCC
Confidence 24699999999999987 45
Q ss_pred c-EEEEeccccee
Q psy14740 344 Y-VKLVDFGFAKK 355 (362)
Q Consensus 344 ~-~kl~DFG~a~~ 355 (362)
. +.|+||+.+..
T Consensus 212 ~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 212 PLTGIIDFGDAAI 224 (306)
T ss_dssp CEEEECCCTTCEE
T ss_pred ceEEEEehhhcCC
Confidence 5 48999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=3.3e-06 Score=74.43 Aligned_cols=101 Identities=12% Similarity=0.158 Sum_probs=71.3
Q ss_pred hhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----
Q psy14740 251 QHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS----- 324 (362)
Q Consensus 251 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~----- 324 (362)
..+..|...|+.+. +--+++++.+..+.+..|+|||+++|.++.+..... ......+..++...|.-||.
T Consensus 64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~ 139 (272)
T 4gkh_A 64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCN 139 (272)
T ss_dssp HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGG
T ss_pred hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCccc
Confidence 34677888888773 334778888888889999999999998877654321 11122344444445555552
Q ss_pred -----------------------------------------------------CCcEeecCCCCcEEecCCCcEEEEecc
Q psy14740 325 -----------------------------------------------------RNIIYRDLKPENLLLSTSGYVKLVDFG 351 (362)
Q Consensus 325 -----------------------------------------------------~~iiHrDikp~NIl~~~~~~~kl~DFG 351 (362)
..++|+|+.|.|||++.++.+-|+||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe 219 (272)
T 4gkh_A 140 CPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG 219 (272)
T ss_dssp CCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred CCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence 127999999999999987777899999
Q ss_pred ccee
Q psy14740 352 FAKK 355 (362)
Q Consensus 352 ~a~~ 355 (362)
.+..
T Consensus 220 ~a~~ 223 (272)
T 4gkh_A 220 RVGI 223 (272)
T ss_dssp TCEE
T ss_pred cccc
Confidence 8753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=7.4e-06 Score=75.32 Aligned_cols=31 Identities=16% Similarity=0.270 Sum_probs=26.1
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
..++|+|++|.|||++.++.+.|+||+.|..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 5799999999999998644578999998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.3e-05 Score=73.16 Aligned_cols=30 Identities=27% Similarity=0.359 Sum_probs=25.7
Q ss_pred HCCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 324 ~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
...++|+|+.|.||+++.+ .++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999765 48999998775
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=4.5e-05 Score=69.32 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=27.6
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00033 Score=65.84 Aligned_cols=32 Identities=16% Similarity=0.355 Sum_probs=27.8
Q ss_pred HHCCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 323 HSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 323 H~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
+...++|+|++|.|||++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998776 99999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00071 Score=60.88 Aligned_cols=77 Identities=12% Similarity=0.097 Sum_probs=57.3
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
.-++.++.|....+|++.. .+..+++|.....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~--------------------------------------------- 70 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERS--------------------------------------------- 70 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGG---------------------------------------------
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCcc---------------------------------------------
Confidence 3457789999999999973 2557888875321
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcC---CcceeeeeeeeeccceEEEEEeccCCcch
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEAN---CDFIVKLYKTFKDKKYLYMLMESCLGGEL 293 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 293 (362)
....+..|...|+.+. ...+++++.+....+..|+|||+++|..+
T Consensus 71 -----------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 71 -----------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp -----------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred -----------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 1244678888888773 35788888888777889999999988654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00082 Score=60.01 Aligned_cols=28 Identities=25% Similarity=0.260 Sum_probs=24.5
Q ss_pred CcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.++|+|+.|.||+ ..++.+.++||..|.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 566778999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0041 Score=55.81 Aligned_cols=31 Identities=29% Similarity=0.412 Sum_probs=26.4
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.+++|+|++|.|||++.++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4699999999999998776668999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0058 Score=54.98 Aligned_cols=28 Identities=21% Similarity=0.137 Sum_probs=24.7
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
..++|+|++|.|||++ + .+.++||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 89999998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0036 Score=57.85 Aligned_cols=99 Identities=19% Similarity=0.211 Sum_probs=61.2
Q ss_pred hhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHH--------------HHHh---c-----CCCC--HH
Q psy14740 252 HIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWT--------------ILRD---K-----GNFD--DA 306 (362)
Q Consensus 252 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~l~~---~-----~~l~--~~ 306 (362)
...+|..+++.+. +.-.+++++.+.++ +||||++|.+|.. .+.+ - +... ..
T Consensus 99 ~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~ 174 (379)
T 3feg_A 99 SLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFG 174 (379)
T ss_dssp HHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHH
Confidence 3457888887763 33346677666542 8999998765431 1111 0 0111 24
Q ss_pred HHHHHHHHHHH-------------------HHHHHH----H----CCcEeecCCCCcEEecCC----CcEEEEecccce
Q psy14740 307 TTRFYTACVVE-------------------AFDYLH----S----RNIIYRDLKPENLLLSTS----GYVKLVDFGFAK 354 (362)
Q Consensus 307 ~~~~~~~ql~~-------------------al~~lH----~----~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~ 354 (362)
++..+..++-. .+.+|. . ..++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 175 ~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 175 TMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 55555544422 233332 1 258999999999999876 789999998875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.017 Score=50.90 Aligned_cols=34 Identities=12% Similarity=0.159 Sum_probs=26.5
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeec
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMK 184 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~ 184 (362)
.+..-+..+|.|..+.||++... +++.+.+|...
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~ 48 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA--DGTPLFVKALP 48 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET--TSCEEEEEECC
T ss_pred CCeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeC
Confidence 44566788999999999999843 36789999754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0074 Score=56.76 Aligned_cols=29 Identities=31% Similarity=0.528 Sum_probs=24.3
Q ss_pred CcEeecCCCCcEEecCC----------------------------CcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTS----------------------------GYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~----------------------------~~~kl~DFG~a~ 354 (362)
.++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 58999999999999875 678999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0092 Score=54.74 Aligned_cols=28 Identities=21% Similarity=0.483 Sum_probs=23.8
Q ss_pred CcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
+++|+|++|.|||++.++ +.++||..|.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999997654 8999998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0089 Score=53.95 Aligned_cols=32 Identities=31% Similarity=0.391 Sum_probs=27.4
Q ss_pred HCCcEeecCCCCcEEecCC----CcEEEEeccccee
Q psy14740 324 SRNIIYRDLKPENLLLSTS----GYVKLVDFGFAKK 355 (362)
Q Consensus 324 ~~~iiHrDikp~NIl~~~~----~~~kl~DFG~a~~ 355 (362)
...++|+|+.|.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6799999998863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.041 Score=52.11 Aligned_cols=32 Identities=6% Similarity=-0.007 Sum_probs=20.8
Q ss_pred EEEEecccceecEEEEEecCCCCCceeeeeecc
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPSRSFALKQMKK 185 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~ 185 (362)
-+..++.|--..+|++...+ .+..+.+|+..+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~ 143 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-KQAKYLIRLYGP 143 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-TTEEEEEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECC-CCceEEEEECCC
Confidence 45678888889999998542 235678887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.48 E-value=0.24 Score=46.21 Aligned_cols=28 Identities=25% Similarity=0.559 Sum_probs=25.3
Q ss_pred CcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.++|+|+.+.||+ +.++.+.++||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999998875
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* | Back alignment and structure |
|---|
Probab=92.07 E-value=0.1 Score=41.26 Aligned_cols=63 Identities=16% Similarity=0.210 Sum_probs=46.5
Q ss_pred ecEEEEEecCCCCCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 163 GRVELVQIAGDPSRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 163 g~v~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
|.|.... ...++...+..+.+++.+|. +.++.+++.|..+ +.++.++++.|.+++...+.+..
T Consensus 88 G~v~~~~--~~~g~~~~~~~~~~G~~fGe~~~~~~~~~~~~v~A~~~--~~~~~i~~~~~~~l~~~~p~~~~ 155 (161)
T 3idb_B 88 GTFDIYV--KCDGVGRCVGNYDNRGSFGELALMYNTPRAATITATSP--GALWGLDRVTFRRIIVKNNAKKR 155 (161)
T ss_dssp SEEEEEE--EETTEEEEEEEEESCCEECGGGGTCCCCCSSEEEESSS--EEEEEEEHHHHHHHHHHHHHTSC
T ss_pred CEEEEEE--cCCCCeEEEEEcCCCCEechHHHHcCCCcccEEEECCC--eEEEEEeHHHHHHHHHHCHHHHH
Confidence 4444443 23466778888888988884 5667788888765 99999999999999877666543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.90 E-value=0.19 Score=45.43 Aligned_cols=31 Identities=13% Similarity=0.226 Sum_probs=27.3
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
..++|+|+.|.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999998888899999987753
|
| >3rns_A Cupin 2 conserved barrel domain protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, unknown function; HET: MSE; 2.07A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=86.62 E-value=4.6 Score=33.80 Aligned_cols=68 Identities=16% Similarity=0.289 Sum_probs=50.2
Q ss_pred ceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc-CCCcceeeEEecCCCCeEEE
Q psy14740 30 SQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ-GDDLRTANIVAADPEGVSCL 108 (362)
Q Consensus 30 ~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~-~~~~r~~~~~A~~~~~~~~~ 108 (362)
....+.+|+.+=..--+.+.+++|++|++.++.. ++ ...+.+||++ .+ .+.|+ .+.|. ++++++
T Consensus 40 ~~~~~~~G~~~~~h~h~~~~~~~Vl~G~~~~~i~----~~---~~~l~~Gd~~----~~p~~~~H--~~~a~--~~~~~l 104 (227)
T 3rns_A 40 SLFSLAKDEEITAEAMLGNRYYYCFNGNGEIFIE----NN---KKTISNGDFL----EITANHNY--SIEAR--DNLKLI 104 (227)
T ss_dssp EEEEECTTCEEEECSCSSCEEEEEEESEEEEEES----SC---EEEEETTEEE----EECSSCCE--EEEES--SSEEEE
T ss_pred EEEEECCCCccCccccCCCEEEEEEeCEEEEEEC----CE---EEEECCCCEE----EECCCCCE--EEEEC--CCcEEE
Confidence 4667899999988888999999999999999853 23 2578898874 23 23444 45677 558888
Q ss_pred EEeh
Q psy14740 109 VIDQ 112 (362)
Q Consensus 109 ~i~~ 112 (362)
.|..
T Consensus 105 ~i~~ 108 (227)
T 3rns_A 105 EIGE 108 (227)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 7733
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.36 E-value=3.3 Score=34.59 Aligned_cols=87 Identities=13% Similarity=0.038 Sum_probs=60.2
Q ss_pred CCcceeeeeeeeeccceEEEEEeccCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC
Q psy14740 264 NCDFIVKLYKTFKDKKYLYMLMESCLGG-ELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS 342 (362)
Q Consensus 264 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~ 342 (362)
.||++ --.+-.+++.+.+.++.-+++ +... ++ .++...-+.++.+++.... -|...-+|--+.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCC
Confidence 57777 334446778888877765333 4443 33 3677777777777655433 133556788899999999999
Q ss_pred CcEEEEecccceecC
Q psy14740 343 GYVKLVDFGFAKKLI 357 (362)
Q Consensus 343 ~~~kl~DFG~a~~~~ 357 (362)
+.+++.-.|+-..+.
T Consensus 121 ~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 121 LEPFFLHVGVKESLP 135 (219)
T ss_dssp CCEEESCCEETTTBS
T ss_pred CcEEEEEcCCcccCC
Confidence 999999999865553
|
| >3fjs_A Uncharacterized protein with RMLC-like cupin fold; structural genomics, joint center for structural genomics, JCSG; HET: MSE; 1.90A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=83.27 E-value=7.7 Score=28.34 Aligned_cols=65 Identities=18% Similarity=0.265 Sum_probs=43.7
Q ss_pred ceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEE
Q psy14740 30 SQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCL 108 (362)
Q Consensus 30 ~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~ 108 (362)
....+++|..+-..--+.+.+++|++|++.+... ++ ...+.+||.+= +=.+.++ ++.+.+ ++.++
T Consensus 39 ~~~~l~~G~~~~~H~H~~~e~~~Vl~G~~~~~i~----~~---~~~l~~Gd~i~---ip~~~~H--~~~~~~--~~~~~ 103 (114)
T 3fjs_A 39 MRMVLPAGKQVGSHSVAGPSTIQCLEGEVEIGVD----GA---QRRLHQGDLLY---LGAGAAH--DVNAIT--NTSLL 103 (114)
T ss_dssp EEEEECTTCEEEEECCSSCEEEEEEESCEEEEET----TE---EEEECTTEEEE---ECTTCCE--EEEESS--SEEEE
T ss_pred EEEEECCCCccCceeCCCcEEEEEEECEEEEEEC----CE---EEEECCCCEEE---ECCCCcE--EEEeCC--CcEEE
Confidence 4567889998877766778999999999999743 22 35789998862 2233444 445553 35443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.19 E-value=3.4 Score=34.37 Aligned_cols=88 Identities=9% Similarity=0.097 Sum_probs=62.1
Q ss_pred CCcceeeeeeeeeccceEEEEEeccC-CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC
Q psy14740 264 NCDFIVKLYKTFKDKKYLYMLMESCL-GGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS 342 (362)
Q Consensus 264 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~ 342 (362)
.||+.+.. .+-...+.+.+.++.-+ +.+... ++ .++...-+.++.+++.... |...-+|--+.|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~--~~~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEE--VNRTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGG--GGGSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHH--HhcCceEEEEecceEEEcCC
Confidence 57877765 56666777777777644 334444 32 3677777888888766553 33445778899999999999
Q ss_pred CcEEEEecccceecCC
Q psy14740 343 GYVKLVDFGFAKKLIG 358 (362)
Q Consensus 343 ~~~kl~DFG~a~~~~~ 358 (362)
+.+++.-.|+-..+.+
T Consensus 116 ~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 116 GLPIAKTRGLQNVVDP 131 (215)
T ss_dssp SCEEESCCEETTTBSC
T ss_pred CCEEEEEccCccCCCC
Confidence 9999999887655433
|
| >1dgw_A Canavalin; duplicated swiss-roll beta barrels, loops with alpha helices merohedral/ hemihedral twinning, plant protein; 1.70A {Canavalia ensiformis} SCOP: b.82.1.2 PDB: 1dgr_A 1cau_A 1cav_A 1caw_A 1cax_A | Back alignment and structure |
|---|
Probab=80.52 E-value=2.1 Score=34.49 Aligned_cols=51 Identities=14% Similarity=0.271 Sum_probs=38.6
Q ss_pred cceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 29 SSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 29 ~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
+....+++|...-..-..++.+++|++|++.+...+.++ . ....+++||++
T Consensus 43 ~~~~~l~pg~~~~pHh~~a~E~~yVl~G~~~v~v~~~~~-~--~~~~l~~GDv~ 93 (178)
T 1dgw_A 43 VLEYCSKPNTLLLPHHSDSDLLVLVLEGQAILVLVNPDG-R--DTYKLDQGDAI 93 (178)
T ss_dssp EEEEEECTTEEEEEEEESSEEEEEEEESEEEEEEEETTE-E--EEEEEETTEEE
T ss_pred EEEEEecCCcEecCcCCCCCEEEEEEeEEEEEEEEeCCC-c--EEEEECCCCEE
Confidence 446678999876555344689999999999998877653 2 35689999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 362 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-24 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-24 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-24 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-04 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-22 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-22 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-21 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-20 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-20 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-20 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-19 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-18 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-16 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-16 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-15 | |
| d1cx4a2 | 147 | b.82.3.2 (A:266-412) Regulatory subunit of Protein | 6e-15 | |
| d1cx4a2 | 147 | b.82.3.2 (A:266-412) Regulatory subunit of Protein | 2e-04 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-13 | |
| d1i5za2 | 132 | b.82.3.2 (A:6-137) Catabolite gene activator prote | 1e-11 | |
| d1ne6a2 | 132 | b.82.3.2 (A:245-376) Regulatory subunit of Protein | 2e-10 | |
| d1o7fa3 | 124 | b.82.3.2 (A:322-445) Regulatory domain of Epac2, d | 6e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-09 | |
| d1ne6a1 | 136 | b.82.3.2 (A:109-244) Regulatory subunit of Protein | 2e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d1cx4a1 | 136 | b.82.3.2 (A:130-265) Regulatory subunit of Protein | 3e-09 | |
| d2oz6a2 | 134 | b.82.3.2 (A:9-142) Cyclic AMP receptor-like protei | 5e-09 | |
| d1vp6a_ | 133 | b.82.3.2 (A:) Putative ion channel CnbD {Mesorhizo | 7e-08 | |
| d2gaua2 | 142 | b.82.3.2 (A:10-151) Transcriptional regulator PG03 | 7e-07 | |
| d1o5la1 | 129 | b.82.3.2 (A:1-129) CRP-like transcriptional regula | 1e-05 | |
| d1o7fa2 | 155 | b.82.3.2 (A:13-167) Regulatory domain of Epac2, do | 3e-05 | |
| d1q3ea_ | 193 | b.82.3.2 (A:) HCN pacemaker channel {Mouse (Mus mu | 6e-05 | |
| d1wgpa_ | 137 | b.82.3.2 (A:) Probable cyclic nucleotide-gated ion | 7e-05 | |
| d2zcwa2 | 112 | b.82.3.2 (A:6-117) Transcriptional regulator TTHA1 | 0.002 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-31
Identities = 37/119 (31%), Positives = 62/119 (52%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
Q+ + + + E EI I++LY F D +Y+++E G ++ L+
Sbjct: 43 QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 102
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
FD+ T Y + A Y HS+ +I+RD+KPENLLL ++G +K+ DFG++ R
Sbjct: 103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-30
Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 1/113 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDA 306
+ + M E +I+ + IVKL F + L++L+E C GG + ++ + ++
Sbjct: 51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 110
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ ++A +YLH II+RDLK N+L + G +KL DFG + K
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-30
Identities = 33/119 (27%), Positives = 62/119 (52%), Gaps = 1/119 (0%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFD 304
++ + I+ E +++ E N +IV Y F + + ME GG L +L+ G
Sbjct: 43 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 102
Query: 305 DATTRFYTACVVEAFDYLHSRN-IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ + V++ YL ++ I++RD+KP N+L+++ G +KL DFG + +LI +
Sbjct: 103 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 57/211 (27%)
Query: 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAAD 203
R R D + LG G F V L + +L T+ A
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLAR-----------------------ELATSREYAI- 38
Query: 204 PEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA 263
K +++ I++ + ++ E+++M
Sbjct: 39 --------------------------KILEKR-------HIIKENKVPYVTRERDVMSRL 65
Query: 264 NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLH 323
+ F VKLY TF+D + LY + GEL +R G+FD+ TRFYTA +V A +YLH
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 324 SRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+ II+RDLKPEN+LL+ ++++ DFG AK
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAK 156
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (277), Expect = 1e-28
Identities = 31/117 (26%), Positives = 51/117 (43%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
+ Q I+ E + + ++ + + +++ME CLG +
Sbjct: 49 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH 108
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
K + T ++ YLHS N+I+RD+K N+LLS G VKL DFG A +
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (276), Expect = 5e-28
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 54/211 (25%)
Query: 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPE 205
L ++D V +G GGFG V + A D + +A+K + K ++ A
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLA-------- 51
Query: 206 GVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC 265
L+E ++ +C
Sbjct: 52 ------------------LNERI---------------------------MLSLVSTGDC 66
Query: 266 DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
FIV + F L +++ GG+L L G F +A RFY A ++ +++H+R
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++YRDLKP N+LL G+V++ D G A
Sbjct: 127 FVVYRDLKPANILLDEHGHVRISDLGLACDF 157
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 6e-28
Identities = 32/111 (28%), Positives = 51/111 (45%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
++I E I N + +VK Y ++ Y+ +E C GGEL+ + +
Sbjct: 43 AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE 102
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + ++ YLH I +RD+KPENLLL +K+ DFG A
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (265), Expect = 4e-27
Identities = 39/208 (18%), Positives = 74/208 (35%), Gaps = 52/208 (25%)
Query: 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSC 209
+ LG G V + +A+K + + + +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQEL---------- 52
Query: 210 LVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFI 268
++ + E +I+ + + I
Sbjct: 53 ----------------------------------------REATLKEVDILRKVSGHPNI 72
Query: 269 VKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328
++L T++ + +++ + GEL+ L +K + TR ++E LH NI+
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 329 YRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+RDLKPEN+LL +KL DFGF+ +L
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQL 160
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 104 bits (261), Expect = 5e-26
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 3/112 (2%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDA 306
++ + E + M +V L+ F+D + M+ E GGEL+ + D+ N +
Sbjct: 65 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 124
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKL 356
Y V + ++H N ++ DLKPEN++ +T S +KL+DFG L
Sbjct: 125 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 2e-25
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 213 DQETFNQL--ISSLDEIRTKY-----------------VDETSERRRAPQIVETRQQ--- 250
D+E +L I S+ + + KY +D + + A + + +QQ
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 251 QHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRF 310
+ I++E +M E IV ++ L+++ME GG L ++ + D+
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA 120
Query: 311 YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++A ++LHS +I+RD+K +N+LL G VKL DFGF ++
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (251), Expect = 6e-25
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 57/215 (26%)
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
L D +++ TLG G FGRV L++ A
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIR-----------------------SRHNGRYYA------ 33
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
V+ +E +V +Q +H E+ ++ F
Sbjct: 34 -MKVLKKE---------------------------IVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
I++++ TF+D + ++M+M+ GGEL+++LR F + +FY A V A +YLHS++I
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
IYRDLKPEN+LL +G++K+ DFGFAK + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 7e-25
Identities = 75/243 (30%), Positives = 114/243 (46%), Gaps = 58/243 (23%)
Query: 120 SSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFA 179
S+ E K ++ ++ + + +L I TLG G FGRV LV+
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQ-NTAQLDQFDRIKTLGTGSFGRVMLVK---------- 61
Query: 180 LKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 239
+ N A K +D+
Sbjct: 62 -------------HKESGNHYAM---------------------------KILDKQ---- 77
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
++V+ +Q +H ++EK I+ N F+VKL +FKD LYM+ME GGE+++ LR
Sbjct: 78 ---KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
G F + RFY A +V F+YLHS ++IYRDLKPENLL+ GY+++ DFGFAK++ G
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 360 RYS 362
++
Sbjct: 195 TWT 197
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 33/132 (25%), Positives = 67/132 (50%), Gaps = 5/132 (3%)
Query: 230 KYVDETSERRRAPQIV--ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMES 287
+ V+ +S++ + V + Q + E I+ A I+ L+++F+ + L M+ E
Sbjct: 23 RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82
Query: 288 CLGGELWTILRDKGN-FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGY-- 344
G +++ + ++ Y V EA +LHS NI + D++PEN++ T
Sbjct: 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142
Query: 345 VKLVDFGFAKKL 356
+K+++FG A++L
Sbjct: 143 IKIIEFGQARQL 154
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 2e-24
Identities = 46/221 (20%), Positives = 80/221 (36%), Gaps = 69/221 (31%)
Query: 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEG 206
R D V+ T+G G +GR + ++ I+
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIR-----------------------RKSDGKILV----- 33
Query: 207 VSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCD 266
E+ + E ++Q ++SE ++ E
Sbjct: 34 -----------------WKELDYGSMTE-------------AEKQMLVSEVNLLRELKHP 63
Query: 267 FIVKLYKTFKDK--KYLYMLMESCLGGELWTIL----RDKGNFDDATTRFYTACVVEAFD 320
IV+ Y D+ LY++ME C GG+L +++ +++ D+ + A
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 321 YLHSRN-----IIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
H R+ +++RDLKP N+ L VKL DFG A+ L
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (244), Expect = 3e-24
Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTF----KDKKYLYMLMESCLGGELWTILRDKGNFD 304
++Q E E++ IV+ Y ++ K KK + ++ E G L T L+
Sbjct: 51 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK 110
Query: 305 DATTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLL-STSGYVKLVDFGFAK 354
R + +++ +LH+R II+RDLK +N+ + +G VK+ D G A
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 99.4 bits (247), Expect = 4e-24
Identities = 31/112 (27%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-FDDA 306
+ + +E IM + + ++ L+ F+DK + +++E GGEL+ + + +A
Sbjct: 68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 127
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKL 356
Y E ++H +I++ D+KPEN++ T + VK++DFG A KL
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 4e-24
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 56/210 (26%)
Query: 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGV 207
+ D + LG G FG+V L + ++ FA+K +KK V+ DD+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVE------------ 47
Query: 208 SCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF 267
T ++ ++S F
Sbjct: 48 --------------------------------------CTMVEKRVLSLA-----WEHPF 64
Query: 268 IVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNI 327
+ ++ TF+ K+ L+ +ME GG+L ++ FD + FY A ++ +LHS+ I
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 124
Query: 328 IYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+YRDLK +N+LL G++K+ DFG K+ +
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENM 154
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (242), Expect = 7e-24
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 2/110 (1%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306
+Q Q +E ++ + I+ + L ++ + C G L+ L + F+
Sbjct: 46 QQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ DYLH+++II+RDLK N+ L VK+ DFG A
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 1e-23
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 3/117 (2%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTF-KDKKYLYMLMESCLGGELWTILRDKG 301
I Q ++E +M + +V+L ++K LY++ E G L LR +G
Sbjct: 37 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 96
Query: 302 N--FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
++ V EA +YL N ++RDL N+L+S K+ DFG K+
Sbjct: 97 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 4e-04
Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 16/120 (13%)
Query: 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQ--------VMNLDDLRTA 197
L + +L+++ T+G G FG V L G A+K +K + LR +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRG---NKVAVKCIKNDATAQAFLAEASVMTQLRHS 60
Query: 198 NIVA-----ADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQH 252
N+V + +G +V + L+ L + + + + E +
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.3 bits (239), Expect = 2e-23
Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 2/119 (1%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL--RDKGNF 303
+T + + + E +M E +V+L + Y++ E G L L ++
Sbjct: 53 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 112
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ + A +YL +N I+RDL N L+ + VK+ DFG ++ + G Y+
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 3e-23
Identities = 28/115 (24%), Positives = 52/115 (45%), Gaps = 1/115 (0%)
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301
+ + + +++E +M + + +IV++ + + + ++ME G L L+
Sbjct: 44 NEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNR 102
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ D V YL N ++RDL N+LL T Y K+ DFG +K L
Sbjct: 103 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.6 bits (237), Expect = 4e-23
Identities = 27/110 (24%), Positives = 50/110 (45%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306
+Q++ +SE IMG+ + ++ L + ++ E G L + LR G F
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL N ++RDL N+L++++ K+ DFG ++ L
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 4e-23
Identities = 42/123 (34%), Positives = 66/123 (53%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299
R I+ + H ++E ++ F+ L F+ L +ME GGEL+ L
Sbjct: 39 RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR 98
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ F + RFY A +V A +YLHSR+++YRD+K ENL+L G++K+ DFG K+ I
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 360 RYS 362
+
Sbjct: 159 GAT 161
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 1e-22
Identities = 55/248 (22%), Positives = 101/248 (40%), Gaps = 65/248 (26%)
Query: 117 QLISSLDEIRTKYVDETSERRRLNEEFRSLRLSDLRVITTLGVGGFGRVELVQIAGDPS- 175
QL++ E+RT + +E+ + + + ++ LG G +G+V LV+
Sbjct: 1 QLLTVKHELRTANLTGHAEK---------VGIENFELLKVLGTGAYGKVFLVRKISGHDT 51
Query: 176 -RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 234
+ +A+K +KK+ ++ E L+ IR
Sbjct: 52 GKLYAMKVLKKATIVQKAKTT-------------------EHTRTERQVLEHIR------ 86
Query: 235 TSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELW 294
F+V L+ F+ + L+++++ GGEL+
Sbjct: 87 -----------------------------QSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 295 TILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
T L + F + + Y +V A ++LH IIYRD+K EN+LL ++G+V L DFG +K
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 355 KLIGPRYS 362
+ +
Sbjct: 178 EFVADETE 185
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 2e-22
Identities = 30/113 (26%), Positives = 52/113 (46%)
Query: 250 QQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309
+ + E +++ E + I+ L F K + ++ + I + + +
Sbjct: 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK 103
Query: 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
Y ++ +YLH I++RDLKP NLLL +G +KL DFG AK P +
Sbjct: 104 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 2e-22
Identities = 33/113 (29%), Positives = 51/113 (45%), Gaps = 2/113 (1%)
Query: 245 VETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNF 303
E + +M E +IM + + +IV+L + + L ++ME GG L L K
Sbjct: 48 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEI 106
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ V YL +N ++RDL N+LL Y K+ DFG +K L
Sbjct: 107 PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 3e-22
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 3/118 (2%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--F 303
+ ++E +M + +V+LY + +Y++ E G L L+
Sbjct: 48 GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKL 106
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
A + E ++ RN I+RDL+ N+L+S + K+ DFG A+ + Y
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 4e-22
Identities = 29/118 (24%), Positives = 57/118 (48%), Gaps = 1/118 (0%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304
+ + + E ++M + + +V+LY ++ ++++ E G L LR+ F
Sbjct: 39 GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 98
Query: 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
V EA +YL S+ ++RDL N L++ G VK+ DFG ++ ++ Y+
Sbjct: 99 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 92.3 bits (228), Expect = 5e-22
Identities = 31/109 (28%), Positives = 51/109 (46%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307
+ E I+ E IVKLY KK L ++ E + +G + T
Sbjct: 42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT 101
Query: 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ + ++ Y H R +++RDLKP+NLL++ G +K+ DFG A+
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 2e-21
Identities = 28/135 (20%), Positives = 57/135 (42%), Gaps = 24/135 (17%)
Query: 246 ETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK---- 300
++ +++ +MSE ++M + + + IV L +Y++ E C G+L LR K
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 301 -------------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST 341
+ V + ++L ++ ++RDL N+L++
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199
Query: 342 SGYVKLVDFGFAKKL 356
VK+ DFG A+ +
Sbjct: 200 GKVVKICDFGLARDI 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.9 bits (225), Expect = 2e-21
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308
++ + +E ++ + IV L ++ +LY++M+ GGEL+ + +KG + +
Sbjct: 50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 109
Query: 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKL 356
V++A YLH I++RDLKPENLL + + + DFG +K
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 3e-21
Identities = 41/119 (34%), Positives = 66/119 (55%), Gaps = 10/119 (8%)
Query: 248 RQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGN 302
+ E E+ A C IV++ +++ +K L ++ME GGEL++ ++D+G+
Sbjct: 46 QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105
Query: 303 --FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKL 356
F + + EA YLHS NI +RD+KPENLL ++ + +KL DFGFAK+
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 7e-21
Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 59/219 (26%)
Query: 143 FRSLRLSDL-RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVA 201
FR + D LG G F V+ + +A K +KK
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKK---------------- 45
Query: 202 ADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMG 261
RR ++ I E I+
Sbjct: 46 -------------------------------------RRTKSSRRGVSREDIEREVSILK 68
Query: 262 EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDY 321
E ++ L++ +++K + +++E GGEL+ L +K + + + ++ Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 322 LHSRNIIYRDLKPENLLLSTSGY----VKLVDFGFAKKL 356
LHS I + DLKPEN++L +K++DFG A K+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 1e-20
Identities = 39/215 (18%), Positives = 80/215 (37%), Gaps = 58/215 (26%)
Query: 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLV 211
+V LG GGFG V D + A+K ++K ++ + +L
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGELP---------------- 49
Query: 212 IDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF--IV 269
+ E ++ + + F ++
Sbjct: 50 -------------------------------------NGTRVPMEVVLLKKVSSGFSGVI 72
Query: 270 KLYKTFKDKKYLYMLMESCLGG-ELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNII 328
+L F+ +++E +L+ + ++G + R + V+EA + H+ ++
Sbjct: 73 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 329 YRDLKPENLLLSTS-GYVKLVDFGFAKKLIGPRYS 362
+RD+K EN+L+ + G +KL+DFG L Y+
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 167
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 87.5 bits (216), Expect = 3e-20
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 4/121 (3%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK----KYLYMLMESCLGGELWT 295
RA + E + N IV +Y T + + Y++ME G L
Sbjct: 41 RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 100
Query: 296 ILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355
I+ +G A +A ++ H II+RD+KP N+++S + VK++DFG A+
Sbjct: 101 IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160
Query: 356 L 356
+
Sbjct: 161 I 161
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 3e-20
Identities = 25/120 (20%), Positives = 46/120 (38%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ + + I+ E +M + + +L + G L + K N
Sbjct: 48 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN 107
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
+ + + +YL R +++RDL N+L+ T +VK+ DFG AK L
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 3e-20
Identities = 31/133 (23%), Positives = 53/133 (39%), Gaps = 19/133 (14%)
Query: 249 QQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN----- 302
+++ +MSE +++ N IV L ++ E C G+L LR K +
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 303 -------------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
D ++ V + +L S+N I+RDL N+LL+ K+ D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 350 FGFAKKLIGPRYS 362
FG A+ +
Sbjct: 189 FGLARDIKNDSNY 201
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 4e-20
Identities = 28/118 (23%), Positives = 53/118 (44%), Gaps = 1/118 (0%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
++ + E E+M + + +V+LY ++ + ++ E G L LR +
Sbjct: 40 GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA 99
Query: 306 ATTR-FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
A T V E YL +I+RDL N L+ + +K+ DFG + ++ +Y+
Sbjct: 100 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 4e-20
Identities = 29/114 (25%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLY-----KTFKDKKYLYMLMESCLGGELWTILRDKGN 302
Q + E +I+ + I+ + T + K +Y++ +G +L+ +L+ +
Sbjct: 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLK-TQH 105
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ ++ ++ Y+HS N+++RDLKP NLLL+T+ +K+ DFG A+
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.3 bits (213), Expect = 5e-20
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 2/114 (1%)
Query: 244 IVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTIL-RDKGN 302
+ + + E M + +++LY + M+ E G L L + +G+
Sbjct: 49 LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH 107
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
F T Y V E YL S+ I+RDL NLLL+T VK+ DFG + L
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 2e-19
Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 2/115 (1%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-G 301
++ + E M + + IVKL + ++++ME C GEL + L+ +
Sbjct: 45 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKY 103
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ D A+ Y + A YL S+ ++RD+ N+L+S++ VKL DFG ++ +
Sbjct: 104 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.0 bits (212), Expect = 2e-19
Identities = 29/131 (22%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKD--KKYLYMLME 286
+ ++ T+ + +I++ +++ I E +I+ I+ L KD + ++ E
Sbjct: 53 EAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 287 SCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YV 345
+ + + D RFY +++A DY HS I++RD+KP N+++ +
Sbjct: 113 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 169
Query: 346 KLVDFGFAKKL 356
+L+D+G A+
Sbjct: 170 RLIDWGLAEFY 180
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 2e-19
Identities = 24/123 (19%), Positives = 50/123 (40%), Gaps = 8/123 (6%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKD--------KKYLYMLMESCLGGELWTILRD 299
+ E +I+ + +V L + + K +Y++ + C +
Sbjct: 51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110
Query: 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
F + + ++ Y+H I++RD+K N+L++ G +KL DFG A+
Sbjct: 111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170
Query: 360 RYS 362
+ S
Sbjct: 171 KNS 173
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 3e-19
Identities = 34/119 (28%), Positives = 55/119 (46%), Gaps = 10/119 (8%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTF------KDKKYLYMLMESCLGGELWTIL---R 298
+ ++ E +IM + + IV+L F KD+ YL ++++ R
Sbjct: 55 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKL 356
K + Y + + Y+HS I +RD+KP+NLLL +KL DFG AK+L
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (205), Expect = 7e-19
Identities = 30/114 (26%), Positives = 55/114 (48%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305
+ + E ++ E IV+L+ K L ++ E C G+ D
Sbjct: 41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP 100
Query: 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ + +++ + HSRN+++RDLKP+NLL++ +G +KL +FG A+ P
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.4 bits (205), Expect = 1e-18
Identities = 47/250 (18%), Positives = 70/250 (28%), Gaps = 80/250 (32%)
Query: 139 LNEEFRSLRL--SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRT 196
LN + SL +++ + +G G FGRV + G L
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG------------------LLPYEP 42
Query: 197 ANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSE 256
+VA K + E + Q E
Sbjct: 43 FTMVAV---------------------------KMLKEEAS---------ADMQADFQRE 66
Query: 257 KEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN-------------- 302
+M E + IVKL K + +L E G+L LR
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 303 ----------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGF 352
A V YL R ++RDL N L+ + VK+ DFG
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 353 AKKLIGPRYS 362
++ + Y
Sbjct: 187 SRNIYSADYY 196
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 1e-18
Identities = 25/119 (21%), Positives = 52/119 (43%), Gaps = 3/119 (2%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN--F 303
T + + E ++M + + +V+LY ++ +Y++ E G L L+ +
Sbjct: 52 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL 110
Query: 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRYS 362
A + Y+ N ++RDL+ N+L+ + K+ DFG A+ + Y+
Sbjct: 111 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 1e-18
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 17/132 (12%)
Query: 240 RAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR 298
R + + E E++ + + I+ L + + YLY+ +E G L LR
Sbjct: 44 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 103
Query: 299 DK----------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS 342
+ A V DYL + I+RDL N+L+ +
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163
Query: 343 GYVKLVDFGFAK 354
K+ DFG ++
Sbjct: 164 YVAKIADFGLSR 175
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 3e-18
Identities = 34/209 (16%), Positives = 70/209 (33%), Gaps = 60/209 (28%)
Query: 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLV 211
+ +G G +G+V + + R ALK+++
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------------------------ 45
Query: 212 IDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKL 271
++ I + +R + +V+L
Sbjct: 46 GEEGMPLSTIREVAVLR------------------------------HLETFEHPNVVRL 75
Query: 272 YKTFKDKK-----YLYMLMESCLGGEL-WTILRDKGNFDDATTRFYTACVVEAFDYLHSR 325
+ + L ++ E + + T + ++ D+LHS
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135
Query: 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
+++RDLKP+N+L+++SG +KL DFG A+
Sbjct: 136 RVVHRDLKPQNILVTSSGQIKLADFGLAR 164
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 3e-18
Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 1/110 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306
+Q+ + E IMG+ + I++L K + ++ E G L LR+K G F
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356
+ YL + N ++RDL N+L++++ K+ DFG ++ L
Sbjct: 111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 78.7 bits (193), Expect = 3e-17
Identities = 21/122 (17%), Positives = 44/122 (36%), Gaps = 6/122 (4%)
Query: 244 IVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302
+ E A C I +Y ++ + ++++ +
Sbjct: 38 EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK 97
Query: 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS-----TSGYVKLVDFGFAKKLI 357
F T ++ +H ++++YRD+KP+N L+ + + +VDFG K
Sbjct: 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 358 GP 359
P
Sbjct: 158 DP 159
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 7e-17
Identities = 23/127 (18%), Positives = 43/127 (33%), Gaps = 15/127 (11%)
Query: 244 IVETRQQQHIMSEKEIMGEANCD--FIVKLYKTFKDK----KYLYMLMESCLGGELWTIL 297
I +R+++ E EI I+ L+++ + G L+ L
Sbjct: 33 IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 298 RDKGNFDDATTRFYTACVVEAFDYLHS--------RNIIYRDLKPENLLLSTSGYVKLVD 349
+ + +LH I +RDLK +N+L+ +G + D
Sbjct: 93 NRYTVTVEGMIKLA-LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151
Query: 350 FGFAKKL 356
G A +
Sbjct: 152 LGLAVRH 158
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 9e-17
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 18/126 (14%)
Query: 249 QQQHIMSEKEIMGEANCDFIVKLYK--TFKDKKYLYMLMESCLGGELWTILRDKGN---- 302
+ + +MSE +I+ V K L +++E C G L T LR K N
Sbjct: 59 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 303 ------------FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDF 350
Y+ V + ++L SR I+RDL N+LLS VK+ DF
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
Query: 351 GFAKKL 356
G A+ +
Sbjct: 179 GLARDI 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 1e-16
Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 1/113 (0%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESC-LGGELWTILRDKGNFDDA 306
+ E ++ E N IVKL + LY++ E + +
Sbjct: 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP 102
Query: 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359
+ Y +++ + HS +++RDLKP+NLL++T G +KL DFG A+ P
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 5e-16
Identities = 26/125 (20%), Positives = 51/125 (40%), Gaps = 10/125 (8%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNF---- 303
R++ ++E +M E NC +V+L + ++ME G+L + LR
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 304 ------DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357
+ + + YL++ ++RDL N +++ VK+ DFG + +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 358 GPRYS 362
Y
Sbjct: 185 ETDYY 189
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.9 bits (183), Expect = 9e-16
Identities = 27/118 (22%), Positives = 43/118 (36%), Gaps = 4/118 (3%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYK-TFKDKKYLYMLMESCLGGELWTILRDKG 301
+ + E +I + + + Y M+ME
Sbjct: 39 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLV---DFGFAKKL 356
F T ++ +Y+HS+N I+RD+KP+N L+ LV DFG AKK
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 9e-16
Identities = 27/126 (21%), Positives = 47/126 (37%), Gaps = 17/126 (13%)
Query: 248 RQQQHIMSEKEIMGE-ANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG----- 301
+ ++SE E+M I+ L LY+++E G L L+ +
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 302 -----------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDF 350
V +YL S+ I+RDL N+L++ +K+ DF
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 351 GFAKKL 356
G A+ +
Sbjct: 180 GLARDI 185
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 1e-15
Identities = 24/121 (19%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 248 RQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDKG 301
+ E ++ + ++ L F + Y++M G L
Sbjct: 59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE 116
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
+ +F +++ Y+H+ II+RDLKP NL ++ +K++DFG A++
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 362 S 362
Sbjct: 177 G 177
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 147 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.1 bits (168), Expect = 6e-15
Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 22 ILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTE-----EKYIRTL 76
L +V Y +G+ II QG D+FFI+ G+V++TMK+ ++ I
Sbjct: 18 RLKVVDVIGTKVYNDGEQIIAQGDSADSFFIVESGEVRITMKRKGKSDIEENGAVEIARC 77
Query: 77 YKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136
+G +FGE AL + R A+ A V CL +D + F +L+ EI + + E+
Sbjct: 78 LRGQYFGELALVTNKPRAASAHAIGT--VKCLAMDVQAFERLLGPCMEIMKRNIATYEEQ 135
Query: 137 RR 138
Sbjct: 136 LV 137
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 147 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.0 bits (90), Expect = 2e-04
Identities = 13/53 (24%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 189 MNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRA 241
+ + R A+ A V CL +D + F +L+ EI + + E+ A
Sbjct: 88 LVTNKPRAASAHAIGT--VKCLAMDVQAFERLLGPCMEIMKRNIATYEEQLVA 138
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 1e-14
Identities = 22/122 (18%), Positives = 52/122 (42%), Gaps = 2/122 (1%)
Query: 243 QIVETRQQQHIMSEKEIMGEANCDFIVKLYKT-FKDKKYLYMLMESCLGGELWTILRDKG 301
+I + + ++E IM + + ++ L + + +++ G+L +R++
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 302 NFDDATTRF-YTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360
+ + V + +L S+ ++RDL N +L VK+ DFG A+ +
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 361 YS 362
+
Sbjct: 185 FD 186
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (167), Expect = 1e-13
Identities = 25/121 (20%), Positives = 48/121 (39%), Gaps = 4/121 (3%)
Query: 246 ETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYL----YMLMESCLGGELWTILRDKG 301
+ E ++ + ++ L F + L + + + L G +
Sbjct: 57 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPRY 361
D +F ++ Y+HS +II+RDLKP NL ++ +K++DFG A+
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 362 S 362
Sbjct: 177 G 177
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 2e-13
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 9/119 (7%)
Query: 242 PQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWT 295
+ E +M N I+ L F +K +Y++ME
Sbjct: 52 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 111
Query: 296 ILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354
I + D + ++ +LHS II+RDLKP N+++ + +K++DFG A+
Sbjct: 112 I---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
| >d1i5za2 b.82.3.2 (A:6-137) Catabolite gene activator protein, N-terminal domain {Escherichia coli [TaxId: 562]} Length = 132 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Catabolite gene activator protein, N-terminal domain species: Escherichia coli [TaxId: 562]
Score = 59.5 bits (143), Expect = 1e-11
Identities = 31/115 (26%), Positives = 51/115 (44%), Gaps = 5/115 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDD-L 92
Y +I QG + +T + I KG V V +K +E + L +GDF GE L +
Sbjct: 18 YPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEE-GKEMILSYLNQGDFIGELGLFEEGQE 76
Query: 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSL 146
R+A + A I + F QLI +I + + + R + +E+ +L
Sbjct: 77 RSAWVRAKTA--CEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNL 129
|
| >d1ne6a2 b.82.3.2 (A:245-376) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} Length = 132 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.3 bits (135), Expect = 2e-10
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 2/102 (1%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+++G I+ QG GD FFII +G V ++ + E + L D+FGE AL + R
Sbjct: 30 FEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPR 89
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135
A +VA P + C+ +D+ F +++ +I + + + +
Sbjct: 90 AATVVARGP--LKCVKLDRPRFERVLGPCSDILKRNIQQYNS 129
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 124 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 54.4 bits (130), Expect = 6e-10
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 6/98 (6%)
Query: 27 YFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKA 86
++ K G + QG G +++II KG V V + + TL++GD FG+ A
Sbjct: 32 VLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYGKG-----VVCTLHEGDDFGKLA 86
Query: 87 LQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 124
L D R A+IV + + L +D+E FN+++ ++
Sbjct: 87 LVNDAPRAASIVLRE-DNCHFLRVDKEDFNRILRDVEA 123
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.2 bits (134), Expect = 2e-09
Identities = 34/222 (15%), Positives = 67/222 (30%), Gaps = 62/222 (27%)
Query: 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLV 211
++ LG G F V L + + + A+K ++ +V ++
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGDKVYTEAAEDEIKLL----------- 63
Query: 212 IDQETFNQLISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKL 271
++ + KE + I+KL
Sbjct: 64 ------------------------------------QRVNDADNTKEDS--MGANHILKL 85
Query: 272 YKTF----KDKKYLYMLMESCLGGELWTILRDK-GNFDDATTRFYTACVVEAFDYLH-SR 325
F + ++ M+ E L I + + + + ++ DY+H
Sbjct: 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC 145
Query: 326 NIIYRDLKPENLLLSTSGY------VKLVDFGFAKKLIGPRY 361
II+ D+KPEN+L+ +K+ D G A
Sbjct: 146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
|
| >d1ne6a1 b.82.3.2 (A:109-244) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} Length = 136 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.2 bits (127), Expect = 2e-09
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 8/95 (8%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+ G+ +I+QG GD F++I +G++ V + +T FGE AL R
Sbjct: 48 FIAGETVIQQGDEGDNFYVIDQGEMDVYVNNEWATSVGEG------GSFGELALIYGTPR 101
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 128
A + A V ID++++ +++ + K
Sbjct: 102 AATVKAKTN--VKLWGIDRDSYRRILMGSTLRKRK 134
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.4 bits (130), Expect = 2e-09
Identities = 19/131 (14%), Positives = 40/131 (30%), Gaps = 4/131 (3%)
Query: 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCL 289
K+ + + H + KL K Y + + +
Sbjct: 30 KFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--GNAV 87
Query: 290 GGELWTILRDKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVD 349
EL + ++E + R I++ DL N+L+S G + ++D
Sbjct: 88 LMELIDAKELYRVRVE-NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIID 145
Query: 350 FGFAKKLIGPR 360
F + ++
Sbjct: 146 FPQSVEVGEEG 156
|
| >d1cx4a1 b.82.3.2 (A:130-265) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 136 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 3e-09
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
KEG+++I QG GD F++I +G + +K FGE AL + R
Sbjct: 44 VKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDGVGRCVGNYD--NRGSFGELALMYNTPR 101
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIR 126
A I A P + +D+ TF ++I + +
Sbjct: 102 AATITATSP--GALWGLDRVTFRRIIVKNNAKK 132
|
| >d2oz6a2 b.82.3.2 (A:9-142) Cyclic AMP receptor-like protein Vfr {Pseudomonas aeruginosa [TaxId: 287]} Length = 134 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Cyclic AMP receptor-like protein Vfr species: Pseudomonas aeruginosa [TaxId: 287]
Score = 52.1 bits (124), Expect = 5e-09
Identities = 29/116 (25%), Positives = 41/116 (35%), Gaps = 4/116 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
Y II G R +T F I KG V + + + + E I L GDFFGE L +
Sbjct: 17 YTAKSTIIYAGDRCETLFFIIKGSVTI-LIEDDDGREMIIGYLNSGDFFGELGLFEKEGS 75
Query: 94 TANIV--AADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSL 146
I F +L EI + ++R R+ + L
Sbjct: 76 EQERSAWVRAKVECEVAEISYAKFRELSQQDSEILYTLGSQMADRLRKTTRKVGDL 131
|
| >d1vp6a_ b.82.3.2 (A:) Putative ion channel CnbD {Mesorhizobium loti [TaxId: 381]} Length = 133 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Putative ion channel CnbD species: Mesorhizobium loti [TaxId: 381]
Score = 48.6 bits (115), Expect = 7e-08
Identities = 39/135 (28%), Positives = 51/135 (37%), Gaps = 10/135 (7%)
Query: 3 KNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTM 62
+N +L + V++ IV G I R G GD F + +G V V
Sbjct: 8 RNWQLVAAVPLFQKLGPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVAT 67
Query: 63 KQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 122
L G FFGE AL + R+A + AA VS L + F L SS
Sbjct: 68 --------PNPVELGPGAFFGEMALISGEPRSATVSAATT--VSLLSLHSADFQMLCSSS 117
Query: 123 DEIRTKYVDETSERR 137
EI + ERR
Sbjct: 118 PEIAEIFRKTALERR 132
|
| >d2gaua2 b.82.3.2 (A:10-151) Transcriptional regulator PG0396, N-terminal domain {Porphyromonas gingivalis [TaxId: 837]} Length = 142 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Transcriptional regulator PG0396, N-terminal domain species: Porphyromonas gingivalis [TaxId: 837]
Score = 46.0 bits (108), Expect = 7e-07
Identities = 17/114 (14%), Positives = 40/114 (35%), Gaps = 4/114 (3%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
K+ + +G + F + +GK+K+ + R + G FFG + ++
Sbjct: 29 CKKASTVFSEGDIPNNLFYLYEGKIKILREGVY-GRFHISRIVKPGQFFGMRPYFAEETC 87
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSL 146
++ +A + L I E L+ ++ ++ +L
Sbjct: 88 SSTAIAVEN--SKVLAIPVEAIEALLKGNTSFCRYFLKALAKELGYAERRTVTL 139
|
| >d1o5la1 b.82.3.2 (A:1-129) CRP-like transcriptional regulator TM1171, N-terminal domain {Thermotoga maritima [TaxId: 2336]} Length = 129 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: CRP-like transcriptional regulator TM1171, N-terminal domain species: Thermotoga maritima [TaxId: 2336]
Score = 42.3 bits (98), Expect = 1e-05
Identities = 19/114 (16%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 34 YKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR 93
+++G+ + Q + I+ +G +K N + +
Sbjct: 15 FRKGEIVKHQDDPIEDVLILLEGTLKTEHVSENGKTLEIDEIKPVQIIASGFIFSSEPRF 74
Query: 94 TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER-RRLNEEFRSL 146
N+VA + + I +E F L+ E+ ++ + SE R ++E+ L
Sbjct: 75 PVNVVAGENSKILS--IPKEVFLDLLMKDRELLLFFLKDVSEHFRVVSEKLFFL 126
|
| >d1o7fa2 b.82.3.2 (A:13-167) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 155 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.4 bits (96), Expect = 3e-05
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 4/109 (3%)
Query: 18 NQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQ-PNSTEEKYIRTL 76
+ ++ I ++G + RQG G ++ + G + V + + + + I TL
Sbjct: 36 HPNLLRQICLCGYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTL 95
Query: 77 YKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 125
G FGE L R A IV + L I+QE F L +
Sbjct: 96 GIGTAFGESILDNTP-RHATIVTRES--SELLRIEQEDFKALWEKYRQY 141
|
| >d1q3ea_ b.82.3.2 (A:) HCN pacemaker channel {Mouse (Mus musculus) [TaxId: 10090]} Length = 193 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: HCN pacemaker channel species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.2 bits (95), Expect = 6e-05
Identities = 26/126 (20%), Positives = 46/126 (36%), Gaps = 8/126 (6%)
Query: 13 FVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKY 72
+ + ++ ++ GDYIIR+G G + I G V T+
Sbjct: 75 LFANADPNFVTAMLTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVS------VLTKGNK 128
Query: 73 IRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDE 132
L G +FGE L RTA++ A + + FN+++ +R +
Sbjct: 129 EMKLSDGSYFGEICLLTRGRRTASVRADTY--CRLYSLSVDNFNEVLEEYPMMRRAFETV 186
Query: 133 TSERRR 138
+R
Sbjct: 187 AIDRLD 192
|
| >d1wgpa_ b.82.3.2 (A:) Probable cyclic nucleotide-gated ion channel 6 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 137 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable cyclic nucleotide-gated ion channel 6 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 40.3 bits (93), Expect = 7e-05
Identities = 15/111 (13%), Positives = 37/111 (33%), Gaps = 7/111 (6%)
Query: 17 VNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTL 76
+++ ++ I + E Y++R+G + I +G+++ + L
Sbjct: 17 MDERLLDAICERLKPCLFTEKSYLVREGDPVNEMLFIIRGRLESVTTDGGRSGFYNRSLL 76
Query: 77 YKGDFFGEKALQGDDLRTANIVAADP-------EGVSCLVIDQETFNQLIS 120
+GDF G++ L + V + + + S
Sbjct: 77 KEGDFCGDELLTWALDPKSGSNLPSSTRTVKALTEVEAFALIADELKFVAS 127
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 362 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1ne6a2 | 132 | Regulatory subunit of Protein kinase A {Cow (Bos t | 99.92 | |
| d1cx4a1 | 136 | Regulatory subunit of Protein kinase A {Rat (Rattu | 99.9 | |
| d1ne6a1 | 136 | Regulatory subunit of Protein kinase A {Cow (Bos t | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1cx4a2 | 147 | Regulatory subunit of Protein kinase A {Rat (Rattu | 99.9 | |
| d1zyba2 | 147 | Probable transcription regulator BT4300, N-termina | 99.89 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1wgpa_ | 137 | Probable cyclic nucleotide-gated ion channel 6 {Th | 99.88 | |
| d1vp6a_ | 133 | Putative ion channel CnbD {Mesorhizobium loti [Tax | 99.87 | |
| d2gaua2 | 142 | Transcriptional regulator PG0396, N-terminal domai | 99.86 | |
| d1o7fa2 | 155 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 99.86 | |
| d1o7fa3 | 124 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 99.86 | |
| d2oz6a2 | 134 | Cyclic AMP receptor-like protein Vfr {Pseudomonas | 99.85 | |
| d1i5za2 | 132 | Catabolite gene activator protein, N-terminal doma | 99.84 | |
| d1q3ea_ | 193 | HCN pacemaker channel {Mouse (Mus musculus) [TaxId | 99.82 | |
| d1o5la1 | 129 | CRP-like transcriptional regulator TM1171, N-termi | 99.82 | |
| d3e5ua2 | 139 | Chlorophenol reduction protein CprK {Desulfitobact | 99.81 | |
| d1ft9a2 | 132 | CO-sensing protein CooA, N-terminal domain {Rhodos | 99.79 | |
| d2zcwa2 | 112 | Transcriptional regulator TTHA1359, N-terminal dom | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.1 | |
| d2bgca2 | 131 | Listeriolysin regulatory protein PrfA, N-terminal | 93.84 | |
| d1ne6a2 | 132 | Regulatory subunit of Protein kinase A {Cow (Bos t | 92.24 | |
| d1yhfa1 | 112 | Hypothetical protein SPy1581 {Streptococcus pyogen | 91.47 | |
| d2b8ma1 | 108 | Hypothetical protein MJ0764 {Archaeon Methanococcu | 90.36 | |
| d1cx4a2 | 147 | Regulatory subunit of Protein kinase A {Rat (Rattu | 88.75 | |
| d1o5ua_ | 88 | Hypothetical protein TM1112 {Thermotoga maritima [ | 88.68 | |
| d1v70a_ | 105 | Hypothetical protein TTHA0104 {Thermus thermophilu | 86.23 | |
| d1fxza2 | 174 | Seed storage 7S protein {Soybean (Glycine max), pr | 85.62 | |
| d1od5a2 | 173 | Seed storage 7S protein {Soybean (Glycine max), gl | 85.2 | |
| d1o7fa3 | 124 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 84.86 | |
| d1cx4a1 | 136 | Regulatory subunit of Protein kinase A {Rat (Rattu | 83.99 | |
| d1vj2a_ | 114 | Hypothetical protein TM1459 {Thermotoga maritima [ | 83.59 | |
| d1o4ta_ | 115 | Hypothetical protein TM1287 {Thermotoga maritima [ | 82.52 | |
| g1dgw.1 | 168 | Seed storage 7S protein {Jack bean (Canavalia ensi | 82.1 | |
| d2phla2 | 162 | Seed storage 7S protein {French bean (Phaseolus vu | 80.18 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-36 Score=263.30 Aligned_cols=156 Identities=31% Similarity=0.519 Sum_probs=140.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~--------------------------------------- 43 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQ--------------------------------------- 43 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHH---------------------------------------
T ss_pred chhHeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHH---------------------------------------
Confidence 4689999999999999999999965 568899999986541
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
.........+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++.+.+.+++.
T Consensus 44 -----------------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~ 106 (263)
T d2j4za1 44 -----------------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 106 (263)
T ss_dssp -----------------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred -----------------ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHH
Confidence 111223456789999999999999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...+.
T Consensus 107 ~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 107 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999999999999999999999999999999999999999877554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-36 Score=264.94 Aligned_cols=151 Identities=28% Similarity=0.460 Sum_probs=134.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++.+.||+|+||.||++.+. .+++.+|+|.+.+...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~--------------------------------------- 43 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRA--------------------------------------- 43 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-----------------------------------------
T ss_pred CcceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhc---------------------------------------
Confidence 678999999999999999999965 4588999999865310
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
....+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++.+.+.+++..
T Consensus 44 -------------------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~ 104 (271)
T d1nvra_ 44 -------------------VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD 104 (271)
T ss_dssp ------------------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHH
T ss_pred -------------------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHH
Confidence 1122457899999999999999999999999999999999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 105 ~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred HHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999999999999999999999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-35 Score=267.22 Aligned_cols=156 Identities=34% Similarity=0.637 Sum_probs=140.9
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
+.+++|++++.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~------------------------------------- 43 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI------------------------------------- 43 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-------------------------------------
T ss_pred CchHhcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhc-------------------------------------
Confidence 35789999999999999999999855 5688999999976421
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCH
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDD 305 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 305 (362)
.......++.+|+.+|+.++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++
T Consensus 44 -------------------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e 104 (337)
T d1o6la_ 44 -------------------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104 (337)
T ss_dssp -------------------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCH
T ss_pred -------------------cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcH
Confidence 1222346688999999999999999999999999999999999999999999999889999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 105 ~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred HHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999999999999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-35 Score=261.10 Aligned_cols=153 Identities=39% Similarity=0.653 Sum_probs=138.0
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~--------------------------------------- 46 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI--------------------------------------- 46 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH---------------------------------------
T ss_pred CCCCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHc---------------------------------------
Confidence 367999999999999999999965 4588999999876421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
........+.+|+++|+.++||||+++++++.+++.+|+||||++||+|.+++...+.+++..
T Consensus 47 -----------------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~ 109 (288)
T d1uu3a_ 47 -----------------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC 109 (288)
T ss_dssp -----------------HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH
T ss_pred -----------------cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHH
Confidence 112234568899999999999999999999999999999999999999999999888999999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 110 ~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999999999999999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-34 Score=261.62 Aligned_cols=156 Identities=41% Similarity=0.767 Sum_probs=140.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++++.||+|+||.||++++. .+++.||+|++.+...
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~-------------------------------------- 42 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIV-------------------------------------- 42 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH--------------------------------------
T ss_pred chhHeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHc--------------------------------------
Confidence 3678999999999999999999965 5688999999875411
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+.+|+.+|+.++||||+++++++.+++.+|+||||++|++|..++.....+++.
T Consensus 43 ------------------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~ 104 (316)
T d1fota_ 43 ------------------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP 104 (316)
T ss_dssp ------------------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHH
T ss_pred ------------------cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccccccc
Confidence 11223466889999999999999999999999999999999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 105 ~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 105 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred HHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999999999999999999999999999999999999999987544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=258.25 Aligned_cols=150 Identities=27% Similarity=0.434 Sum_probs=134.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|++++.||+|+||.||++.+. .+++.||+|.+.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~----------------------------------------- 57 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQ----------------------------------------- 57 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGG-----------------------------------------
T ss_pred cccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEeccc-----------------------------------------
Confidence 47999999999999999999855 558899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
....+.+.+|+.+|+.++||||+++++++.+++.+|+||||++||+|.+++.+ +.+++..+
T Consensus 58 ------------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~ 118 (293)
T d1yhwa1 58 ------------------QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQI 118 (293)
T ss_dssp ------------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHH
T ss_pred ------------------ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHH
Confidence 11234588999999999999999999999999999999999999999998765 57999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 119 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999999999999999999999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=263.53 Aligned_cols=151 Identities=28% Similarity=0.454 Sum_probs=136.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++++.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~--------------------------------------- 43 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEI--------------------------------------- 43 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCC---------------------------------------
T ss_pred CccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhh---------------------------------------
Confidence 4578999999999999999999855 568899999986431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......++.+|+.+|+.++||||++++++|.+++.+|+||||++||+|.+++.+.+.+++.
T Consensus 44 -------------------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~ 104 (322)
T d1s9ja_ 44 -------------------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104 (322)
T ss_dssp -------------------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHH
T ss_pred -------------------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHH
Confidence 1223456889999999999999999999999999999999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 307 TTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
.++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 ~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999997 59999999999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-34 Score=254.96 Aligned_cols=148 Identities=30% Similarity=0.484 Sum_probs=133.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|++++.||+|+||.||++.+. .+++.+|+|.+.+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~----------------------------------------- 49 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKS----------------------------------------- 49 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSS-----------------------------------------
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCC-----------------------------------------
Confidence 46899999999999999999965 568899999986431
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDAT 307 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~ 307 (362)
....+.+.+|+++|+.++||||+++++++.+++.+|+||||+++|+|.+++.+ .+++++..
T Consensus 50 ------------------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~ 111 (288)
T d2jfla1 50 ------------------EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQ 111 (288)
T ss_dssp ------------------SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHH
T ss_pred ------------------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHH
Confidence 12335688999999999999999999999999999999999999999998765 45699999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 112 ~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 112 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999999999999999999999999999999999999999999765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-34 Score=260.66 Aligned_cols=156 Identities=46% Similarity=0.828 Sum_probs=140.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++++.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~-------------------------------------- 79 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV-------------------------------------- 79 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH--------------------------------------
T ss_pred CccCeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHc--------------------------------------
Confidence 5789999999999999999999965 5688999999865411
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+.+|+.+|+.++||||+++++++.+...+|+||||+.+|+|.+++.+.+.+++.
T Consensus 80 ------------------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~ 141 (350)
T d1rdqe_ 80 ------------------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141 (350)
T ss_dssp ------------------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHH
T ss_pred ------------------cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHH
Confidence 11223456889999999999999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.+.
T Consensus 142 ~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999999999999999999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-34 Score=257.61 Aligned_cols=152 Identities=27% Similarity=0.379 Sum_probs=135.7
Q ss_pred CcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhh
Q psy14740 150 DLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRT 229 (362)
Q Consensus 150 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~ 229 (362)
.|+.++.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~------------------------------------------ 52 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSG------------------------------------------ 52 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCS------------------------------------------
T ss_pred hcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhh------------------------------------------
Confidence 4899999999999999999865 458899999986541
Q ss_pred hccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHH
Q psy14740 230 KYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTR 309 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 309 (362)
.......+.+.+|+.+|+.++||||+++++++.+++.+|+|||||++|+|..++...+++++..++
T Consensus 53 --------------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~ 118 (309)
T d1u5ra_ 53 --------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118 (309)
T ss_dssp --------------SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHH
T ss_pred --------------ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHH
Confidence 122334466889999999999999999999999999999999999999998877777889999999
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 310 FYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 310 ~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 119 ~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred HHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999999999999999999999999999999999999999986643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-33 Score=251.50 Aligned_cols=160 Identities=24% Similarity=0.371 Sum_probs=139.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.+|+|++.+.......
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~----------------------------------- 45 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFS----------------------------------- 45 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCC-----------------------------------
T ss_pred cccCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchh-----------------------------------
Confidence 468999999999999999999854 56889999998765211000
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
..........+.+|+.+++.++ ||||+++++++.+++.+|+||||+++|+|.+++..++++++.
T Consensus 46 ---------------~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~ 110 (277)
T d1phka_ 46 ---------------AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 110 (277)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred ---------------HHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHH
Confidence 0011223456889999999996 999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 ~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 9999999999999999999999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-33 Score=250.77 Aligned_cols=157 Identities=25% Similarity=0.391 Sum_probs=137.8
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.||+|++.+.....
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~-------------------------------------- 50 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKS-------------------------------------- 50 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTT--------------------------------------
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcch--------------------------------------
Confidence 46999999999999999999965 568899999997652211
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
.......+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++.+.+.+++..+
T Consensus 51 ---------------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~ 115 (293)
T d1jksa_ 51 ---------------SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115 (293)
T ss_dssp ---------------CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHH
T ss_pred ---------------hhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHH
Confidence 11122346688999999999999999999999999999999999999999999998889999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC----cEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG----YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~----~~kl~DFG~a~~~~~~ 359 (362)
+.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+.+..+
T Consensus 116 ~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~ 170 (293)
T d1jksa_ 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred HHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence 99999999999999999999999999999998766 5999999999887543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-33 Score=254.64 Aligned_cols=151 Identities=27% Similarity=0.417 Sum_probs=125.2
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
+.|++.+.||+|+||.||++.+. .+++.||+|.+.+...
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~---------------------------------------- 47 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKAL---------------------------------------- 47 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC-------------------------------------------
T ss_pred cceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHh----------------------------------------
Confidence 45999999999999999999865 5688999999875411
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATT 308 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~ 308 (362)
......+.+|+.+|+.++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+
T Consensus 48 ------------------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~ 109 (307)
T d1a06a_ 48 ------------------EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 109 (307)
T ss_dssp -------------------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHH
T ss_pred ------------------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHH
Confidence 11124467899999999999999999999999999999999999999999988888999999
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEec---CCCcEEEEecccceecCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLS---TSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~---~~~~~kl~DFG~a~~~~~ 358 (362)
..++.|++.||.|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 110 ~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred HHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999999999999999999999995 478999999999986643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-33 Score=258.97 Aligned_cols=159 Identities=29% Similarity=0.514 Sum_probs=135.9
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.||+|++.+.....
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~------------------------------------ 44 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKM------------------------------------ 44 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CHHhCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcch------------------------------------
Confidence 5789999999999999999999955 568899999986542100
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
............|+.+++.++||||+++++++.+++.+|+||||++||+|.+++.+...+++.
T Consensus 45 -----------------~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~ 107 (364)
T d1omwa3 45 -----------------KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA 107 (364)
T ss_dssp -----------------HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHH
T ss_pred -----------------hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHH
Confidence 000111222344577778889999999999999999999999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 108 ~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred HHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-33 Score=256.99 Aligned_cols=153 Identities=25% Similarity=0.418 Sum_probs=135.0
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++++.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~--------------------------------------- 66 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPY--------------------------------------- 66 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS---------------------------------------
T ss_pred cccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcc---------------------------------------
Confidence 3567999999999999999999865 458899999986531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
......+.+|+.+|+.++||||++++++|.+++.+|+||||++||+|.+.+...+ ++++
T Consensus 67 --------------------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e 126 (352)
T d1koba_ 67 --------------------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 126 (352)
T ss_dssp --------------------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCH
T ss_pred --------------------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCH
Confidence 1123457889999999999999999999999999999999999999999876544 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEec--CCCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLS--TSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~--~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 127 ~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999999999999999999999999999999998 5789999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-34 Score=254.10 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=135.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~--------------------------------------- 54 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT--------------------------------------- 54 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC---------------------------------------
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc---------------------------------------
Confidence 4568999999999999999999865 457889999875431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
...+++.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++... ..++
T Consensus 55 ---------------------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~ 113 (287)
T d1opja_ 55 ---------------------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 113 (287)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSC
T ss_pred ---------------------chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchH
Confidence 12345889999999999999999999999999999999999999999998754 4689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.+.
T Consensus 114 ~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 114 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999999999999999999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=249.80 Aligned_cols=153 Identities=28% Similarity=0.489 Sum_probs=126.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++.+.||+|+||.||++.+. .+++.||+|.+.+...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~--------------------------------------- 42 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSM--------------------------------------- 42 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTS---------------------------------------
T ss_pred chhCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhC---------------------------------------
Confidence 578999999999999999999855 4688999999865411
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--cceEEEEEeccCCcchHHHHHh----cC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRD----KG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~ 301 (362)
.....+.+.+|+.+|+.++||||+++++++.+ ++.+|+||||+++|+|.+++.+ .+
T Consensus 43 ------------------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~ 104 (269)
T d2java1 43 ------------------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 104 (269)
T ss_dssp ------------------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTC
T ss_pred ------------------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCC
Confidence 12234568899999999999999999998854 4669999999999999999864 35
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRN-----IIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~-----iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 105 ~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 6999999999999999999999976 99999999999999999999999999987643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-33 Score=256.04 Aligned_cols=153 Identities=27% Similarity=0.426 Sum_probs=135.2
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~--------------------------------------- 63 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPH--------------------------------------- 63 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCS---------------------------------------
T ss_pred CccCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccc---------------------------------------
Confidence 3578999999999999999999865 568899999986531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~ 305 (362)
....+.+.+|+.+|+.++||||+++++++.+++.+|+||||++||+|.+++.+ .+.+++
T Consensus 64 --------------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e 123 (350)
T d1koaa2 64 --------------------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123 (350)
T ss_dssp --------------------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCH
T ss_pred --------------------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCH
Confidence 12235678999999999999999999999999999999999999999999854 457999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC--CCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST--SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~--~~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 124 ~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 124 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999999999999999999999999999964 678999999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-33 Score=251.68 Aligned_cols=151 Identities=25% Similarity=0.394 Sum_probs=134.2
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+.+.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~---------------------------------------- 42 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG---------------------------------------- 42 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT----------------------------------------
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc----------------------------------------
Confidence 678999999999999999999855 568899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~ 306 (362)
.....+.+|+.+|+.++||||++++++|.+++.+|+|||||+|++|.+++...+ ++++.
T Consensus 43 --------------------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~ 102 (321)
T d1tkia_ 43 --------------------TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER 102 (321)
T ss_dssp --------------------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHH
T ss_pred --------------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHH
Confidence 112347789999999999999999999999999999999999999999998654 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCC--CcEEEEecccceecCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTS--GYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~--~~~kl~DFG~a~~~~~~ 359 (362)
.++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 103 ~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred HHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999999999999999999999999854 57999999999887543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-32 Score=244.64 Aligned_cols=149 Identities=24% Similarity=0.383 Sum_probs=129.7
Q ss_pred cEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 151 LRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 151 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|++...||+|+||.||++.+. .+++.+|+|.+....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~------------------------------------------- 46 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRK------------------------------------------- 46 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGG-------------------------------------------
T ss_pred EEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhh-------------------------------------------
Confidence 367788999999999999865 457889999886531
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
......+.+.+|+++|+.++||||+++++++.+ +..+|+||||+++|+|.+++.+.+.+++.
T Consensus 47 --------------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~ 112 (270)
T d1t4ha_ 47 --------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK 112 (270)
T ss_dssp --------------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHH
T ss_pred --------------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHH
Confidence 112234568899999999999999999999864 45689999999999999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEec-CCCcEEEEecccceecC
Q psy14740 307 TTRFYTACVVEAFDYLHSRN--IIYRDLKPENLLLS-TSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~--iiHrDikp~NIl~~-~~~~~kl~DFG~a~~~~ 357 (362)
.++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 113 ~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999999999999 99999999999996 57899999999997543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-32 Score=250.46 Aligned_cols=154 Identities=32% Similarity=0.594 Sum_probs=135.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|.+.+.||+|+||.||++.+. .+++.||+|++.+...
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~--------------------------------------- 40 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV--------------------------------------- 40 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH---------------------------------------
T ss_pred CCCeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhc---------------------------------------
Confidence 478999999999999999999965 5688999999876421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHh-hcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMG-EANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 306 (362)
........+..|..++. .++||||+++++++.+++.+|+||||+++|+|.+++.....+++.
T Consensus 41 -----------------~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~ 103 (320)
T d1xjda_ 41 -----------------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 103 (320)
T ss_dssp -----------------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH
T ss_pred -----------------cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHH
Confidence 11223345667777665 689999999999999999999999999999999999988899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 104 ~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 104 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999999999999999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=1.1e-32 Score=248.39 Aligned_cols=155 Identities=24% Similarity=0.368 Sum_probs=126.8
Q ss_pred ccccCcEEEEEecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
...++|++.+.||+|+||.||++.+....+. .+|+|.+...
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~------------------------------------- 65 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG------------------------------------- 65 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-------------------------------------
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-------------------------------------
Confidence 3467899999999999999999986543222 4677766432
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
......+.+.+|+.+|+.++||||+++++++..++.+|+||||+++|+|.+++... +.
T Consensus 66 ---------------------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~ 124 (299)
T d1jpaa_ 66 ---------------------YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124 (299)
T ss_dssp ---------------------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTC
T ss_pred ---------------------cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCC
Confidence 12233456899999999999999999999999999999999999999999988764 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.+
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999999999999999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.6e-32 Score=243.00 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=127.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||+|+||.||++.+. +++.||+|.+.+..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~---------------------------------------- 41 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA---------------------------------------- 41 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSS----------------------------------------
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCc----------------------------------------
Confidence 368999999999999999999865 35679999886431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 306 (362)
...+.+.+|+.+++.++||||+++++++..++.+|+||||+++|+|.+++... ..+++.
T Consensus 42 --------------------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~ 101 (263)
T d1sm2a_ 42 --------------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE 101 (263)
T ss_dssp --------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHH
T ss_pred --------------------CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHH
Confidence 12245889999999999999999999999999999999999999999988754 458899
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.+
T Consensus 102 ~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred HHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 9999999999999999999999999999999999999999999999987644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=245.00 Aligned_cols=152 Identities=24% Similarity=0.392 Sum_probs=128.9
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++++.||+|+||.||++.+. .+++.||+|++....
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~---------------------------------------- 39 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDT---------------------------------------- 39 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------------------------------------------
T ss_pred CCCCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhh----------------------------------------
Confidence 468999999999999999999965 457899999986431
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHH-h-cCCCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILR-D-KGNFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~-~~~l~~ 305 (362)
.......++.+|+.+|+.++||||+++++++.+++.+|+||||+.+ ++.+++. . .+.+++
T Consensus 40 -----------------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e 101 (298)
T d1gz8a_ 40 -----------------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 101 (298)
T ss_dssp ---------------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCH
T ss_pred -----------------cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCH
Confidence 1112345688999999999999999999999999999999999955 5444443 3 346999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99999999999999999999999999999999999999999999999976643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-32 Score=241.01 Aligned_cols=146 Identities=25% Similarity=0.397 Sum_probs=126.4
Q ss_pred EEecccceecEEEEEec-CCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhccc
Q psy14740 155 TTLGVGGFGRVELVQIA-GDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVD 233 (362)
Q Consensus 155 ~~lg~G~~g~v~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~~ 233 (362)
+.||+|+||.||++.+. ...++.||+|.+....
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------------------------------------------- 46 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------------------------------------- 46 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------------------------------------------------
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh----------------------------------------------
Confidence 46999999999999754 3445789999985431
Q ss_pred hhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHH
Q psy14740 234 ETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTA 313 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 313 (362)
.+....+.+.+|+.+|++++||||+++++++..+ ..|+||||+++|+|.+++.+..++++..+..++.
T Consensus 47 -----------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~ 114 (277)
T d1xbba_ 47 -----------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114 (277)
T ss_dssp -------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHH
T ss_pred -----------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHH
Confidence 1223346789999999999999999999998654 5789999999999999999888899999999999
Q ss_pred HHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 314 CVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 314 ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 115 qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred HHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999999999999999999999999999999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=240.14 Aligned_cols=151 Identities=28% Similarity=0.429 Sum_probs=129.2
Q ss_pred cCcEEEEE-ecccceecEEEEEecC-CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 149 SDLRVITT-LGVGGFGRVELVQIAG-DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 149 ~~~~~~~~-lg~G~~g~v~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
+++.+.+. ||+|+||.||++.+.. ..+..||||.+.+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---------------------------------------- 47 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---------------------------------------- 47 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------------------------------------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----------------------------------------
Confidence 56778875 9999999999997643 23457999998643
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
......+.+.+|+.+|+.++||||+++++++..+ .+|+||||+++|+|.+++... ..+++
T Consensus 48 ------------------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~ 108 (285)
T d1u59a_ 48 ------------------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPV 108 (285)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCH
T ss_pred ------------------cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCH
Confidence 1123346689999999999999999999998654 589999999999999987654 56999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 109 ~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 109 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999999999999999999999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=246.08 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=127.5
Q ss_pred EEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhcc
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 232 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~~ 232 (362)
.++.||+|+||.||++.+. .+++.||+|++.....
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~-------------------------------------------- 36 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHR-------------------------------------------- 36 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC-------------------------------------------------
T ss_pred cceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhh--------------------------------------------
Confidence 4678999999999999854 5688999999865421
Q ss_pred chhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHH
Q psy14740 233 DETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYT 312 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~ 312 (362)
..........+.+|+.+|+.++||||+++++++.+++.+|+||||+.++++..+......+++..++.++
T Consensus 37 ----------~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~ 106 (299)
T d1ua2a_ 37 ----------SEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 106 (299)
T ss_dssp -----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHH
T ss_pred ----------hhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHH
Confidence 0111223456889999999999999999999999999999999999888887777666779999999999
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 313 ACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 313 ~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 107 ~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred HHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC
Confidence 9999999999999999999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-32 Score=241.19 Aligned_cols=150 Identities=24% Similarity=0.393 Sum_probs=130.4
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+. +++.||+|.+.+..
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~--------------------------------------- 49 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS--------------------------------------- 49 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS---------------------------------------
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCc---------------------------------------
Confidence 4478999999999999999999865 35689999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--CCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK--GNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~ 304 (362)
...+.+.+|+.+|+.++||||+++++++.+ +.+|+||||+++|+|.+++... .+++
T Consensus 50 ---------------------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~ 107 (272)
T d1qpca_ 50 ---------------------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLT 107 (272)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCC
T ss_pred ---------------------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCC
Confidence 122458899999999999999999998754 5579999999999999977643 3599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
+..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.+.
T Consensus 108 ~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999999999999999999999999999999999999999999987543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.9e-32 Score=245.30 Aligned_cols=153 Identities=25% Similarity=0.434 Sum_probs=129.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCC----CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPS----RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|++.+.||+|+||.||++.+.+... ..+|+|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~------------------------------------- 78 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK------------------------------------- 78 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------------------------------
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-------------------------------------
Confidence 4689999999999999999998765332 25777776432
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 301 (362)
........+.+|+.+|..+ +||||+++++++.+++.+|+||||+++|+|.+++....
T Consensus 79 ---------------------~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~ 137 (325)
T d1rjba_ 79 ---------------------ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137 (325)
T ss_dssp --------------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT
T ss_pred ---------------------cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccC
Confidence 1122345688999999998 89999999999999999999999999999999997532
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 ----------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ----------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~ 216 (325)
T d1rjba_ 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216 (325)
T ss_dssp CC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGG
T ss_pred CCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccC
Confidence 378899999999999999999999999999999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1e-31 Score=239.56 Aligned_cols=152 Identities=26% Similarity=0.375 Sum_probs=134.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~----------------------------------------- 44 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADL----------------------------------------- 44 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTT-----------------------------------------
T ss_pred ceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhh-----------------------------------------
Confidence 56999999999999999999965 458899999987541
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcCCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKGNFD 304 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~ 304 (362)
..+......+.+|+.+++.++||||+++++++...+ .+|+||||++|++|.+++...++++
T Consensus 45 ---------------~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~ 109 (277)
T d1o6ya_ 45 ---------------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 109 (277)
T ss_dssp ---------------TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCC
T ss_pred ---------------ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCC
Confidence 122334567899999999999999999999987643 4899999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
+..++.++.|++.||.|||++||+||||||+|||++.++..+++|||.++...
T Consensus 110 ~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 110 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 99999999999999999999999999999999999999999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=6.4e-32 Score=242.11 Aligned_cols=153 Identities=27% Similarity=0.425 Sum_probs=134.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++++.||+|+||.||++.+. +++.||+|++....
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~---------------------------------------- 38 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEK---------------------------------------- 38 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSS----------------------------------------
T ss_pred CCCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhh----------------------------------------
Confidence 468999999999999999999864 47899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......++.+|+.+|+.++||||+++++++.+++..|++|+++.++.+..+....+.+++..
T Consensus 39 -----------------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~ 101 (286)
T d1ob3a_ 39 -----------------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT 101 (286)
T ss_dssp -----------------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHH
T ss_pred -----------------cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhh
Confidence 112234668899999999999999999999999999999999997777777777677899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|.....+
T Consensus 102 ~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred hHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9999999999999999999999999999999999999999999999776543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-32 Score=241.81 Aligned_cols=149 Identities=24% Similarity=0.301 Sum_probs=127.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|.+.+.||+|+||.||+++.. ..+|+|++....
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~--------------------------------------- 42 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTA--------------------------------------- 42 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSS---------------------------------------
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEccc---------------------------------------
Confidence 4577899999999999999999743 259999986431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCCH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFDD 305 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 305 (362)
......+.+.+|+.+|+.++||||++++++.. .+.+|+||||+++|+|.+++... ..+++
T Consensus 43 ------------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~ 103 (276)
T d1uwha_ 43 ------------------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEM 103 (276)
T ss_dssp ------------------CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCH
T ss_pred ------------------CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCH
Confidence 11223466889999999999999999999865 45689999999999999999754 56999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred HHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999999999999999999999999999999999999997653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=237.45 Aligned_cols=157 Identities=24% Similarity=0.375 Sum_probs=133.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.||+|.+.+......
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~------------------------------------- 45 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDW------------------------------------- 45 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCE-------------------------------------
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccch-------------------------------------
Confidence 57999999999999999999965 4588999999876422110
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCC-cchHHHHHhcCCCCH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLG-GELWTILRDKGNFDD 305 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~ 305 (362)
.......++.+|+.+|+.++ ||||+++++++.+++.+|+|||++.+ +++.+++.+.+.+++
T Consensus 46 ----------------~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e 109 (273)
T d1xwsa_ 46 ----------------GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 109 (273)
T ss_dssp ----------------EECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCH
T ss_pred ----------------hhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCH
Confidence 11112244678999999986 89999999999999999999999976 688888888888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-CCcEEEEecccceecCCC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-~~~~kl~DFG~a~~~~~~ 359 (362)
..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 110 ~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~ 164 (273)
T d1xwsa_ 110 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc
Confidence 999999999999999999999999999999999985 479999999999876543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=242.69 Aligned_cols=148 Identities=34% Similarity=0.561 Sum_probs=127.6
Q ss_pred cccCcEEEE-EecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 147 RLSDLRVIT-TLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 147 ~~~~~~~~~-~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.+++|.++. .||+|+||.||++.+. .+++.||+|++.+.
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~--------------------------------------- 48 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC--------------------------------------- 48 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECS---------------------------------------
T ss_pred cccCEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECCc---------------------------------------
Confidence 467899886 5999999999999965 45889999987542
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhh-cCCcceeeeeeeeec----cceEEEEEeccCCcchHHHHHhc
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGE-ANCDFIVKLYKTFKD----KKYLYMLMESCLGGELWTILRDK 300 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 300 (362)
..+.+|+.++.+ .+||||++++++|.+ ..++|+|||||+||+|.+++.+.
T Consensus 49 -------------------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~ 103 (335)
T d2ozaa1 49 -------------------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 103 (335)
T ss_dssp -------------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC
T ss_pred -------------------------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc
Confidence 235678988765 489999999999865 46799999999999999999864
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCCC
Q psy14740 301 --GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 301 --~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~~ 359 (362)
..+++..++.++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+.+...
T Consensus 104 ~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 104 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 36999999999999999999999999999999999999985 467999999999877543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=235.50 Aligned_cols=151 Identities=26% Similarity=0.453 Sum_probs=133.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||+|+||+||++++. +++.||+|.+.+..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~---------------------------------------- 40 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS---------------------------------------- 40 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS----------------------------------------
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc----------------------------------------
Confidence 368889999999999999999964 46789999986541
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh-cCCCCHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD-KGNFDDA 306 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 306 (362)
...+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++.
T Consensus 41 --------------------~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~ 100 (258)
T d1k2pa_ 41 --------------------MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ 100 (258)
T ss_dssp --------------------SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHH
T ss_pred --------------------CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHH
Confidence 1224588999999999999999999999999999999999999999998664 4568999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
.+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+....
T Consensus 101 ~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 101 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred HHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999999999999999999999999999999999999999998765443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-31 Score=235.40 Aligned_cols=154 Identities=24% Similarity=0.395 Sum_probs=138.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++++.||+|+||+||++.+. .+++.||+|+++...
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~---------------------------------------- 39 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDD---------------------------------------- 39 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSC----------------------------------------
T ss_pred CCCCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhh----------------------------------------
Confidence 468999999999999999999965 568899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDAT 307 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 307 (362)
.......++.+|+.+|+.++||||+++++++.+.+..+++|+++.+++|..++...+.+++..
T Consensus 40 -----------------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~ 102 (292)
T d1unla_ 40 -----------------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI 102 (292)
T ss_dssp -----------------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHH
T ss_pred -----------------CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhH
Confidence 122345678899999999999999999999999999999999999999999888888899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 308 TRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 308 ~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+....+
T Consensus 103 ~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred HHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999999999999999999999999999999999999999999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-31 Score=235.90 Aligned_cols=154 Identities=25% Similarity=0.354 Sum_probs=128.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCC---CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPS---RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.-++|.+.+.||+|+||.||++.+....+ ..||+|.+...
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~------------------------------------- 47 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG------------------------------------- 47 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-------------------------------------
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-------------------------------------
Confidence 34678999999999999999998765432 36899987542
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 302 (362)
........+.+|+.+|+.++||||+++++++.+.+..+++|||+.++++.+++... +.
T Consensus 48 ---------------------~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 106 (283)
T d1mqba_ 48 ---------------------YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 106 (283)
T ss_dssp ---------------------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTC
T ss_pred ---------------------cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccccc
Confidence 11223456889999999999999999999999999999999999999999987754 56
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 107 ~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999999999999999999999999999999999999999987643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-31 Score=234.59 Aligned_cols=154 Identities=31% Similarity=0.430 Sum_probs=125.5
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCC--ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSR--SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
.++|++.+.||+|+||.||++.....+++ .||+|.+.+..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-------------------------------------- 48 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-------------------------------------- 48 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------------------------------
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh--------------------------------------
Confidence 46899999999999999999987655444 68999886541
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
.......+.+.+|+.+|+.++||||+++++++.++ .+++||||++++++.+.+... +.++
T Consensus 49 ------------------~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~ 109 (273)
T d1u46a_ 49 ------------------LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL 109 (273)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSC
T ss_pred ------------------cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCC
Confidence 11223445689999999999999999999999764 578999999999999877653 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus 110 ~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred HHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999999999999999999999999999999999999999998744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-31 Score=235.24 Aligned_cols=149 Identities=23% Similarity=0.386 Sum_probs=127.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++.+.. ++.||+|.+....
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~--~~~vAiK~l~~~~--------------------------------------- 53 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT--------------------------------------- 53 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS---------------------------------------
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECC--CCEEEEEEECccc---------------------------------------
Confidence 45789999999999999999998653 4579999985431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh--cCCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD--KGNFD 304 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~ 304 (362)
...+.+.+|+.+|+.++||||+++++++.+ +.+|+||||+++|+|..++.. .+.++
T Consensus 54 ---------------------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~ 111 (285)
T d1fmka3 54 ---------------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLR 111 (285)
T ss_dssp ---------------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCC
T ss_pred ---------------------CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccch
Confidence 122568899999999999999999999855 557999999999999988764 35699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 ~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 112 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred HHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999999999999999999999999999999999999999986643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6e-31 Score=239.23 Aligned_cols=158 Identities=30% Similarity=0.609 Sum_probs=139.2
Q ss_pred ccccCcEEEEEecccceecEEEEEecC--CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 146 LRLSDLRVITTLGVGGFGRVELVQIAG--DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 146 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
..+++|++++.||+|+||.||++.... .+++.||+|.+.+....
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~---------------------------------- 66 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV---------------------------------- 66 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE----------------------------------
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc----------------------------------
Confidence 357889999999999999999998643 35788999998764211
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCC
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.+....+.+.+|+.+|++++| |||+++++++.+...+|++|||+.+++|.+++...+.
T Consensus 67 ---------------------~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~ 125 (322)
T d1vzoa_ 67 ---------------------QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125 (322)
T ss_dssp ---------------------EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC
T ss_pred ---------------------cchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc
Confidence 112234567889999999976 8999999999999999999999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++..++.++.|++.||.|+|+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 126 ~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999999999999999999999999999999999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-30 Score=231.09 Aligned_cols=152 Identities=26% Similarity=0.402 Sum_probs=122.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCC--CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchH
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDP--SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 225 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~ 225 (362)
-++|++.+.||+|+||.||++.+.... +..+|+|.+...
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--------------------------------------- 46 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------------------------------------- 46 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---------------------------------------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---------------------------------------
Confidence 368999999999999999999876443 345777776432
Q ss_pred HhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-CCCC
Q psy14740 226 EIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-GNFD 304 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 304 (362)
........+.+|+.+|+.++||||+++++++. .+.+|+||||+++|+|.+++... ..++
T Consensus 47 -------------------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~ 106 (273)
T d1mp8a_ 47 -------------------TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLD 106 (273)
T ss_dssp -------------------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSC
T ss_pred -------------------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCC
Confidence 12234466889999999999999999999986 46789999999999999987654 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 305 DATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 305 ~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 107 ~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 107 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred HHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999999999999999999999999999999999999999987643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.1e-30 Score=235.65 Aligned_cols=152 Identities=27% Similarity=0.401 Sum_probs=133.2
Q ss_pred ccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
.++|++++.||+|+||.||+++..+ .+++.||+|.+...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~------------------------------------- 54 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------------------------------------- 54 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-------------------------------------
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-------------------------------------
Confidence 4689999999999999999998754 34568999987543
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC--
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-- 301 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 301 (362)
......+.+.+|+.+|+.++||||+++++++...+..+++||++++|+|.+++....
T Consensus 55 ---------------------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~ 113 (301)
T d1lufa_ 55 ---------------------ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113 (301)
T ss_dssp ---------------------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-
T ss_pred ---------------------cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcc
Confidence 112234668999999999999999999999999999999999999999999986422
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 302 ----------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 302 ----------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
.++...+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~ 191 (301)
T d1lufa_ 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191 (301)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred ccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheecc
Confidence 37888999999999999999999999999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=235.50 Aligned_cols=155 Identities=26% Similarity=0.447 Sum_probs=131.4
Q ss_pred hhccccCcEEEEEecccceecEEEEEecCCCC-CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 144 RSLRLSDLRVITTLGVGGFGRVELVQIAGDPS-RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 144 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
+...+++|++.+.||+|+||.||++.+.+... ..+|+|.+.+.
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~------------------------------------ 48 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------------------------------------ 48 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------------------------
T ss_pred CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc------------------------------------
Confidence 34567899999999999999999998764322 24677766432
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
......+.+.+|+.+|+.+ +||||+++++++.+++.+|+||||+++|+|.+++.+.
T Consensus 49 ----------------------~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~ 106 (309)
T d1fvra_ 49 ----------------------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 106 (309)
T ss_dssp ----------------------------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTC
T ss_pred ----------------------cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhcc
Confidence 1122345689999999998 7999999999999999999999999999999998643
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 301 ---------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 301 ---------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
..+++..+..++.|++.||.|+|+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 107 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~ 177 (309)
T d1fvra_ 107 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177 (309)
T ss_dssp HHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESS
T ss_pred ccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccc
Confidence 45899999999999999999999999999999999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-30 Score=233.60 Aligned_cols=152 Identities=22% Similarity=0.384 Sum_probs=125.8
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCC----ceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSR----SFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
+-++|++++.||+|+||.||++.+.. +++ .+|+|.+...
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~------------------------------------ 49 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREA------------------------------------ 49 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-------------------------------------
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccc------------------------------------
Confidence 34689999999999999999998654 344 3566655332
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc-C
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-G 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 301 (362)
......+.+.+|+.+++.++||||+++++++.++. .+++|+++.+++|.+.+... .
T Consensus 50 ----------------------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~ 106 (317)
T d1xkka_ 50 ----------------------TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD 106 (317)
T ss_dssp -------------------------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSS
T ss_pred ----------------------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCccccccccccc
Confidence 11223456899999999999999999999997654 67788888899999887764 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 107 ~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 107 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 699999999999999999999999999999999999999999999999999987643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.3e-30 Score=235.68 Aligned_cols=152 Identities=20% Similarity=0.383 Sum_probs=126.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++++.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~---------------------------------------- 55 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPF---------------------------------------- 55 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTT----------------------------------------
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhh----------------------------------------
Confidence 468999999999999999999855 568899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc------eEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK------YLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
......+.+.+|+.+|+.++||||++++++|...+ .+|+||||+ +.+|..+++. +
T Consensus 56 -----------------~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~ 116 (346)
T d1cm8a_ 56 -----------------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-E 116 (346)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-C
T ss_pred -----------------cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-c
Confidence 12234466889999999999999999999987654 579999999 7788887764 6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+|+.....
T Consensus 117 ~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 7999999999999999999999999999999999999999999999999999887543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.7e-30 Score=235.72 Aligned_cols=147 Identities=27% Similarity=0.393 Sum_probs=122.1
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|+..+.||+|+||+||++++. .+++.||+|.+.+..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~----------------------------------------- 57 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----------------------------------------- 57 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-----------------------------------------
T ss_pred CCcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccc-----------------------------------------
Confidence 36899999999999999999965 568899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHH---Hh
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTIL---RD 299 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l---~~ 299 (362)
....+|+.+|+.++||||+++++++.. ..++|+||||++++.+..+. ..
T Consensus 58 ----------------------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~ 115 (350)
T d1q5ka_ 58 ----------------------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115 (350)
T ss_dssp ----------------------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHT
T ss_pred ----------------------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhc
Confidence 112369999999999999999998843 34689999999655433332 23
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecCCC
Q psy14740 300 KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 300 ~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~~ 359 (362)
...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 116 ~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 45699999999999999999999999999999999999999775 8999999999887543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=5.9e-30 Score=233.64 Aligned_cols=147 Identities=23% Similarity=0.380 Sum_probs=127.5
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++++.||+|+||+||++.+. .+++.||+|++.+.
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~---------------------------------------- 71 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---------------------------------------- 71 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSS----------------------------------------
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHH----------------------------------------
Confidence 4578999999999999999999855 46889999998543
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcC-Ccceeeeeeeeec--cceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-CDFIVKLYKTFKD--KKYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
...++.+|+.+|+.+. ||||+++++++.. ...+|+||||+++++|..+. +.+
T Consensus 72 ----------------------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l 126 (328)
T d3bqca1 72 ----------------------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTL 126 (328)
T ss_dssp ----------------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSC
T ss_pred ----------------------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCC
Confidence 1245788999999995 9999999999874 45699999999999997754 469
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCC-cEEEEecccceecCCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSG-YVKLVDFGFAKKLIGP 359 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~-~~kl~DFG~a~~~~~~ 359 (362)
++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.+.
T Consensus 127 ~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999999999999999999999999999999998655 6999999999877543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=235.44 Aligned_cols=148 Identities=22% Similarity=0.412 Sum_probs=124.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.||+|.+.+..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~----------------------------------------- 45 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFE----------------------------------------- 45 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTT-----------------------------------------
T ss_pred CCeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhc-----------------------------------------
Confidence 57999999999999999999854 568899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccc-----eEEEEEeccCCcchHHHHHhcCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKK-----YLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
......++++|+.+|+.++||||+++++++.... .+|++|+ +.+++|.+++.. +++
T Consensus 46 -----------------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~~-~~l 106 (345)
T d1pmea_ 46 -----------------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKT-QHL 106 (345)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHHH-CCC
T ss_pred -----------------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe-ecCCchhhhhhc-CCC
Confidence 1223456889999999999999999999986543 3556555 559999999975 479
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 107 ~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 107 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 999999999999999999999999999999999999999999999999998664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=231.03 Aligned_cols=154 Identities=21% Similarity=0.338 Sum_probs=129.3
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
.+++|++++.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~--------------------------------------- 47 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMEN--------------------------------------- 47 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC-------------------------------------------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhh---------------------------------------
Confidence 4789999999999999999999965 568899999986531
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec--------cceEEEEEeccCCcchHHHHH
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD--------KKYLYMLMESCLGGELWTILR 298 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~ 298 (362)
.......++.+|+.+|+.++||||+++++++.. ++.+|++||++.++.+.....
T Consensus 48 ------------------~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~ 109 (318)
T d3blha1 48 ------------------EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 109 (318)
T ss_dssp ------------------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC
T ss_pred ------------------cchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh
Confidence 112234557899999999999999999998754 346899999997776666555
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 299 DKGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 299 ~~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 110 ~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 566799999999999999999999999999999999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=229.94 Aligned_cols=155 Identities=29% Similarity=0.408 Sum_probs=135.0
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.+.+ .+++.+|+|.+.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----------------------------------- 65 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------------------------- 65 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----------------------------------
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-----------------------------------
Confidence 34789999999999999999998643 456689999886531
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......+.+|+.+++.+ +||||+++++++.+++.+|++|||+++|+|.+++.+..
T Consensus 66 -----------------------~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~ 122 (311)
T d1t46a_ 66 -----------------------HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122 (311)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTT
T ss_pred -----------------------CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcc
Confidence 122345688999999998 79999999999999999999999999999999987532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 302 ------------------NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 302 ------------------~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||+++.....
T Consensus 123 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~ 198 (311)
T d1t46a_ 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198 (311)
T ss_dssp TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred ccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCC
Confidence 4889999999999999999999999999999999999999999999999999877543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.5e-30 Score=226.57 Aligned_cols=148 Identities=28% Similarity=0.464 Sum_probs=124.6
Q ss_pred cccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHH
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 226 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~ 226 (362)
..++|++.+.||+|+||.||++... +..+|+|.+.+..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~~--------------------------------------- 42 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--------------------------------------- 42 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC---------------------------------------
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcHH---------------------------------------
Confidence 4678999999999999999999864 5679999885431
Q ss_pred hhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeee-ccceEEEEEeccCCcchHHHHHhcC--CC
Q psy14740 227 IRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFK-DKKYLYMLMESCLGGELWTILRDKG--NF 303 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~l 303 (362)
..+.+.+|+.++++++||||+++++++. ..+.+|+||||+++|+|.+++.+.+ .+
T Consensus 43 ----------------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l 100 (262)
T d1byga_ 43 ----------------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 100 (262)
T ss_dssp ------------------------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred ----------------------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCC
Confidence 2245789999999999999999999874 4566899999999999999997543 48
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...+
T Consensus 101 ~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999999999999999999999999999999999999999987543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.4e-30 Score=229.29 Aligned_cols=152 Identities=30% Similarity=0.423 Sum_probs=119.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCC----CCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccc
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGD----PSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISS 223 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~ 223 (362)
-++|++.+.||+|+||.||++.+.+. +++.||+|.+....
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~------------------------------------ 55 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------------------------------ 55 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----------------------------------------
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc------------------------------------
Confidence 47899999999999999999986542 34578999875431
Q ss_pred hHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhc-
Q psy14740 224 LDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDK- 300 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~- 300 (362)
.......+.+|..++..+ +||||+.+++++.. +..+++||||+++|+|.+++...
T Consensus 56 ----------------------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~ 113 (299)
T d1ywna1 56 ----------------------THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113 (299)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTG
T ss_pred ----------------------CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhcc
Confidence 122334567788877776 68999999998654 45789999999999999999753
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 ---------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 ---------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 114 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 185 (299)
T d1ywna1 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185 (299)
T ss_dssp GGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CC
T ss_pred ccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcc
Confidence 237899999999999999999999999999999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-29 Score=226.35 Aligned_cols=154 Identities=25% Similarity=0.394 Sum_probs=127.1
Q ss_pred cccCcEEEEEecccceecEEEEEecCCC------CCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhh
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAGDP------SRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQL 220 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~ 220 (362)
..++|.+.+.||+|+||.||++...+.. +..||+|.+.+.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---------------------------------- 56 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---------------------------------- 56 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----------------------------------
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----------------------------------
Confidence 3478999999999999999999865422 236899987543
Q ss_pred ccchHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcchHHHHHh
Q psy14740 221 ISSLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|...+..+ +||||+++++++.+++.+|+||||+++|+|.+++..
T Consensus 57 ------------------------~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~ 112 (299)
T d1fgka_ 57 ------------------------ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 112 (299)
T ss_dssp ------------------------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHT
T ss_pred ------------------------cChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHh
Confidence 1123345678888888887 899999999999999999999999999999999974
Q ss_pred c----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 300 K----------------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 300 ~----------------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...+
T Consensus 113 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~ 187 (299)
T d1fgka_ 113 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187 (299)
T ss_dssp TSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGG
T ss_pred hcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccc
Confidence 3 2489999999999999999999999999999999999999999999999999987644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=228.70 Aligned_cols=153 Identities=23% Similarity=0.390 Sum_probs=132.8
Q ss_pred cccCcEEEEEecccceecEEEEEecC----CCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhcc
Q psy14740 147 RLSDLRVITTLGVGGFGRVELVQIAG----DPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLIS 222 (362)
Q Consensus 147 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~ 222 (362)
..++|++.+.||+|+||.||++.+.+ .++..||+|.+.+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~------------------------------------ 61 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------------------------------ 61 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT------------------------------------
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc------------------------------------
Confidence 45889999999999999999998643 23467999987543
Q ss_pred chHHhhhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhc--
Q psy14740 223 SLDEIRTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDK-- 300 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 300 (362)
........+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++...
T Consensus 62 ----------------------~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~ 119 (308)
T d1p4oa_ 62 ----------------------ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119 (308)
T ss_dssp ----------------------SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHH
T ss_pred ----------------------cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccc
Confidence 11223456889999999999999999999999999999999999999999988642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecC
Q psy14740 301 --------GNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLI 357 (362)
Q Consensus 301 --------~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~ 357 (362)
..++...+..++.|++.||.|||+++|+||||||+|||++.++++||+|||+|+.+.
T Consensus 120 ~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~ 184 (308)
T d1p4oa_ 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184 (308)
T ss_dssp HHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred ccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceecc
Confidence 236889999999999999999999999999999999999999999999999998664
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-29 Score=226.15 Aligned_cols=152 Identities=22% Similarity=0.357 Sum_probs=125.6
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
.++|++++.||+|+||.||++.+....++.||+|.+....
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~---------------------------------------- 45 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------------------------------------- 45 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB----------------------------------------
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhh----------------------------------------
Confidence 4789999999999999999999766657789999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhc---CCcceeeeeeeee-----ccceEEEEEeccCCcchHHHHHh
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEA---NCDFIVKLYKTFK-----DKKYLYMLMESCLGGELWTILRD 299 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~ 299 (362)
........+.+|+.+|+.+ +||||+++++++. ....+|++||+++++++......
T Consensus 46 -----------------~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~ 108 (305)
T d1blxa_ 46 -----------------GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV 108 (305)
T ss_dssp -----------------CTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS
T ss_pred -----------------ccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc
Confidence 1111223456788877765 7999999999874 34579999999988776554443
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceec
Q psy14740 300 -KGNFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKL 356 (362)
Q Consensus 300 -~~~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~ 356 (362)
...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 109 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 346999999999999999999999999999999999999999999999999998755
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=231.03 Aligned_cols=151 Identities=21% Similarity=0.374 Sum_probs=124.7
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++.+. .+++.||+|++.+..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~----------------------------------------- 55 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPF----------------------------------------- 55 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTT-----------------------------------------
T ss_pred CCeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchh-----------------------------------------
Confidence 57999999999999999999855 468899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeecc-----ceEEEEEeccCCcchHHHHHhcCCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDK-----KYLYMLMESCLGGELWTILRDKGNF 303 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l 303 (362)
.+.....++.+|+.+|+.++||||+++++++... ...+++|+++.+++|.+++.. +++
T Consensus 56 ----------------~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l 118 (348)
T d2gfsa1 56 ----------------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKL 118 (348)
T ss_dssp ----------------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCC
T ss_pred ----------------cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccc
Confidence 1223345678999999999999999999998533 234555666779999999865 579
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 304 DDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 304 ~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+|.....
T Consensus 119 ~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 9999999999999999999999999999999999999999999999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-28 Score=223.12 Aligned_cols=149 Identities=19% Similarity=0.284 Sum_probs=125.3
Q ss_pred EEEEecccceecEEEEEecCCCC--CceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 153 VITTLGVGGFGRVELVQIAGDPS--RSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 153 ~~~~lg~G~~g~v~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
..+.||+|+||+||++.+....+ ..+|+|.+.+.
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-------------------------------------------- 66 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------------------------------------------- 66 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--------------------------------------------
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--------------------------------------------
Confidence 35789999999999998755433 35788887532
Q ss_pred ccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec-cceEEEEEeccCCcchHHHHHhcC-CCCHHHH
Q psy14740 231 YVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD-KKYLYMLMESCLGGELWTILRDKG-NFDDATT 308 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~ 308 (362)
.......++.+|+++|++++||||+++++++.. ++..++||||+++++|.+++.... .++...+
T Consensus 67 --------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~ 132 (311)
T d1r0pa_ 67 --------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132 (311)
T ss_dssp --------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHH
T ss_pred --------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHH
Confidence 123345678999999999999999999998754 568999999999999999887543 4778889
Q ss_pred HHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCC
Q psy14740 309 RFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGP 359 (362)
Q Consensus 309 ~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~ 359 (362)
..++.|++.||.|+|+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 133 ~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred HHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999999999999999999999999999999999999999876543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3e-28 Score=224.54 Aligned_cols=150 Identities=24% Similarity=0.357 Sum_probs=122.4
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+++|++++.||+|+||+||++.+. .+++.||+|++.+..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~---------------------------------------- 54 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPF---------------------------------------- 54 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTT----------------------------------------
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhh----------------------------------------
Confidence 468999999999999999999865 468899999986531
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeec------cceEEEEEeccCCcchHHHHHhcC
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKD------KKYLYMLMESCLGGELWTILRDKG 301 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~ 301 (362)
.......++.+|+.+++.++||||++++++|.. ..++|+||||+.+ ++.+.+. .
T Consensus 55 -----------------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~--~ 114 (355)
T d2b1pa1 55 -----------------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--M 114 (355)
T ss_dssp -----------------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--S
T ss_pred -----------------cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh--c
Confidence 122334568899999999999999999999853 4689999999955 5555443 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 302 NFDDATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 302 ~l~~~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||+++....
T Consensus 115 ~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 115 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 699999999999999999999999999999999999999999999999999876543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-28 Score=218.74 Aligned_cols=144 Identities=18% Similarity=0.220 Sum_probs=121.4
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
.+|.+.+.||+|+||.||++... ++.||+|.+....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~~----------------------------------------- 38 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE----------------------------------------- 38 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET---TEEEEEEEECGGG-----------------------------------------
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc-----------------------------------------
Confidence 46788999999999999999853 6789999875321
Q ss_pred hhccchhhhhccccccccchhhhhhHH--HHHHHhhcCCcceeeeeeeeeccc----eEEEEEeccCCcchHHHHHhcCC
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMS--EKEIMGEANCDFIVKLYKTFKDKK----YLYMLMESCLGGELWTILRDKGN 302 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~ 302 (362)
.....+ |+..+..++||||+++++++.+.+ .+|+||||+++|+|.+++++ .+
T Consensus 39 ---------------------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~ 96 (303)
T d1vjya_ 39 ---------------------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YT 96 (303)
T ss_dssp ---------------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CC
T ss_pred ---------------------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CC
Confidence 122333 444556789999999999986543 68999999999999999986 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH--------CCcEeecCCCCcEEecCCCcEEEEecccceecCC
Q psy14740 303 FDDATTRFYTACVVEAFDYLHS--------RNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 303 l~~~~~~~~~~ql~~al~~lH~--------~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~ 358 (362)
+++.....++.|++.||.|+|+ +||+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 8999999999999999999996 5999999999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=1.1e-27 Score=215.01 Aligned_cols=147 Identities=20% Similarity=0.269 Sum_probs=127.8
Q ss_pred ccCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 148 LSDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 148 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
-++|++.+.||+|+||.||++.+. .+++.+|+|++....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~---------------------------------------- 42 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS---------------------------------------- 42 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT----------------------------------------
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc----------------------------------------
Confidence 357999999999999999999965 458899999874421
Q ss_pred hhhccchhhhhccccccccchhhhhhHHHHHHHhhcCC-cceeeeeeeeeccceEEEEEeccCCcchHHHHHhcC-CCCH
Q psy14740 228 RTKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANC-DFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKG-NFDD 305 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~ 305 (362)
....+.+|+++++.+.| ||++.+++++......|+||||+ +++|.+++...+ .++.
T Consensus 43 ---------------------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~ 100 (293)
T d1csna_ 43 ---------------------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV 100 (293)
T ss_dssp ---------------------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH
T ss_pred ---------------------CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhh
Confidence 12346788999999865 89999999999999999999999 889999887654 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC-----CCcEEEEecccceecC
Q psy14740 306 ATTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST-----SGYVKLVDFGFAKKLI 357 (362)
Q Consensus 306 ~~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~-----~~~~kl~DFG~a~~~~ 357 (362)
..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 101 ~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999999999999999999999999999999999964 5789999999998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2.3e-27 Score=213.51 Aligned_cols=147 Identities=25% Similarity=0.372 Sum_probs=122.0
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++.+.||+|+||.||++.+. .+++.||+|++....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~----------------------------------------- 44 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT----------------------------------------- 44 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT-----------------------------------------
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc-----------------------------------------
Confidence 46999999999999999999865 457899999875421
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcCCcc-eeeeeeeeeccceEEEEEeccCCcchHHHHH-hcCCCCHH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDF-IVKLYKTFKDKKYLYMLMESCLGGELWTILR-DKGNFDDA 306 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~ 306 (362)
....+..|+++++.++|+| |+.++.++..++..++||||+ ++++.+.+. ..+.+++.
T Consensus 45 --------------------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~ 103 (299)
T d1ckia_ 45 --------------------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLK 103 (299)
T ss_dssp --------------------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHH
T ss_pred --------------------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHH
Confidence 1234778999999997665 555666778888999999999 666666554 44579999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEecC---CCcEEEEecccceecCC
Q psy14740 307 TTRFYTACVVEAFDYLHSRNIIYRDLKPENLLLST---SGYVKLVDFGFAKKLIG 358 (362)
Q Consensus 307 ~~~~~~~ql~~al~~lH~~~iiHrDikp~NIl~~~---~~~~kl~DFG~a~~~~~ 358 (362)
.+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+.+..
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999999999999999999999999999999864 45799999999998754
|
| >d1ne6a2 b.82.3.2 (A:245-376) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.1e-24 Score=171.62 Aligned_cols=125 Identities=26% Similarity=0.406 Sum_probs=116.5
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|++| +++++..|++.++.+.|++|++|+++||+++.+|+|.+|.|+++..+.+|++...+..++||++|||.
T Consensus 3 ~L~~i~~f~~L-~~~~~~~l~~~~~~~~~~~g~~I~~~Gd~~~~~yii~~G~v~~~~~~~~~~~~~~~~~~~~g~~fG~~ 81 (132)
T d1ne6a2 3 FLSKVSILESL-DKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEI 81 (132)
T ss_dssp HHHTSGGGGGS-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEECCEEEEEESSSSCCEEEEEEECTTCEECHH
T ss_pred hHhCCHhhhCC-CHHHHHHHHHhCEEEEECCCCEEEEcCCcchHHHHHHhhhheeeccCCccccchhhhhccccceeeEe
Confidence 47899999999 99999999999999999999999999999999999999999999998886665668999999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDET 133 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~ 133 (362)
+++.+.||++|++|. ++|+++.|++++|.+++..+|++..+.++..
T Consensus 82 ~~~~~~~~~~t~~a~--~~~~~~~i~~~~~~~ll~~~p~~~~~~i~~~ 127 (132)
T d1ne6a2 82 ALLMNRPRAATVVAR--GPLKCVKLDRPRFERVLGPCSDILKRNIQQY 127 (132)
T ss_dssp HHHHTSSCSSEEEES--SCEEEEEEEHHHHHHHTGGGHHHHHHGGGGC
T ss_pred eecCCCceeEEEEEc--ccEEEEEEEHHHHHHHHHHCHHHHHHHHHHH
Confidence 999999999999999 5599999999999999999999987766543
|
| >d1cx4a1 b.82.3.2 (A:130-265) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=9.1e-24 Score=167.21 Aligned_cols=120 Identities=24% Similarity=0.336 Sum_probs=111.4
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|+++ +++++..|+..++.+.|++|++|+++||+++.+|+|.+|.|+++.... +.+..+..+++|++|||+
T Consensus 17 ~l~~~~~F~~l-~~~~~~~l~~~~~~~~~~~g~~I~~~G~~~~~~y~I~~G~v~v~~~~~--~~~~~~~~l~~g~~fg~~ 93 (136)
T d1cx4a1 17 ACKDILLFKNL-DPEQMSQVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCD--GVGRCVGNYDNRGSFGEL 93 (136)
T ss_dssp HHTTCGGGTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEECEEEEEEEET--TEEEEEEEEESSCEECHH
T ss_pred HHhCCHhhhcC-CHHHHHHHhcceEEEEECCCCEEEECCCcchhhhhhhhheeEEeeccc--cceeeeeccCCccccchH
Confidence 57899999999 999999999999999999999999999999999999999999976653 455778899999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~ 130 (362)
+++.+.|++++++|. ++|++|.|++++|.+++..++...++++
T Consensus 94 ~l~~~~~~~~s~~a~--~~~~~~~i~~~~f~~ll~~~~~~~r~~y 136 (136)
T d1cx4a1 94 ALMYNTPRAATITAT--SPGALWGLDRVTFRRIIVKNNAKKRKMY 136 (136)
T ss_dssp HHHHCCCCCSEEEES--SCEEEEEEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCcceEEEEEC--CCEEEEEEeHHHHHHHHHhCHHHHHhcC
Confidence 999999999999999 5599999999999999999999887653
|
| >d1ne6a1 b.82.3.2 (A:109-244) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=6.9e-24 Score=167.70 Aligned_cols=116 Identities=23% Similarity=0.398 Sum_probs=107.2
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++++|+++ +++++.+|+..++.+.|++|++||++||+++.+|+|.+|.|++.... ..+..++||++|||+
T Consensus 21 ~l~~~~lF~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~gd~~~~~yiI~~G~v~v~~~~------~~~~~l~~G~~fGe~ 93 (136)
T d1ne6a1 21 AIEKNVLFSHL-DDNERSDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNN------EWATSVGEGGSFGEL 93 (136)
T ss_dssp HHHHCGGGTSC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEEEETT------EEEEEECTTCEECCH
T ss_pred HHhCCHhhhhC-CHHHHHHHhcceEEEEECCCCEEEeCCCCcceeeeecCCceeeeccc------cccceeccccccccH
Confidence 47889999999 99999999999999999999999999999999999999999998532 457889999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhh
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~ 130 (362)
+++.+.||++||+|. ++|.++.|++++|..++..+|..+++++
T Consensus 94 ~ll~~~~~~~tv~a~--~~~~l~~i~~~~f~~ll~~~~~~~r~~y 136 (136)
T d1ne6a1 94 ALIYGTPRAATVKAK--TNVKLWGIDRDSYRRILMGSTLRKRKMY 136 (136)
T ss_dssp HHHHCCCCCSEEEES--SCEEEEEEEHHHHHHHTHHHHHHHHHHH
T ss_pred HHcCCCcceEEEEEc--cCEEEEEEEHHHHHHHHhhCHHHHHhhC
Confidence 999999999999999 5699999999999999999998876653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=9e-24 Score=177.19 Aligned_cols=154 Identities=16% Similarity=0.071 Sum_probs=109.0
Q ss_pred EEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhhc
Q psy14740 152 RVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKY 231 (362)
Q Consensus 152 ~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~~ 231 (362)
.+.+.||+|+||.||++.+. +++.+|+|+++.+...... .+.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~-~~~----------------------------------- 44 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKK-VKE----------------------------------- 44 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------C-CCC-----------------------------------
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhh-hhh-----------------------------------
Confidence 57789999999999999854 4778999987653210000 000
Q ss_pred cchhhhhccccccccchhhhhhHHHHHHHhhcCCcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHH
Q psy14740 232 VDETSERRRAPQIVETRQQQHIMSEKEIMGEANCDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFY 311 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~ 311 (362)
.+.................|...+..+.|++++..+++.. .+++||++++..+.+ ++...+..+
T Consensus 45 -----~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i 108 (191)
T d1zara2 45 -----KRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEV 108 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHH
T ss_pred -----hhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHH
Confidence 0000000011112234567888999999999998886642 379999998766533 455667789
Q ss_pred HHHHHHHHHHHHHCCcEeecCCCCcEEecCCCcEEEEecccceecCCCC
Q psy14740 312 TACVVEAFDYLHSRNIIYRDLKPENLLLSTSGYVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 312 ~~ql~~al~~lH~~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~~~~~~ 360 (362)
+.|++.++.|||++||+||||||+|||++.+ .++|+|||+|+....++
T Consensus 109 ~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~ 156 (191)
T d1zara2 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEG 156 (191)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTT
T ss_pred HHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCC
Confidence 9999999999999999999999999999865 58999999998876543
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=2.2e-23 Score=167.25 Aligned_cols=127 Identities=29% Similarity=0.494 Sum_probs=114.2
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCC-----CCcceEEEEecCCC
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPN-----STEEKYIRTLYKGD 80 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~-----~~~~~~~~~l~~G~ 80 (362)
-|+++|+|++| +++++.+|+.+++.+.|++|++|+++||+++.+|+|++|.|+++....+ .+....+..++||+
T Consensus 3 ~l~~~p~f~~l-~~~~l~~l~~~~~~~~~~~ge~i~~~G~~~~~~y~i~~G~v~v~~~~~~~~~~~~~~~~~i~~~~~g~ 81 (147)
T d1cx4a2 3 FIESLPFLKSL-EVSERLKVVDVIGTKVYNDGEQIIAQGDSADSFFIVESGEVRITMKRKGKSDIEENGAVEIARCLRGQ 81 (147)
T ss_dssp HHHTCGGGTTS-CHHHHHHHHHHCEEEEECTTCEEECTTCCCCEEEEEEEEEEEEEEEC--------CCEEEEEEECTTC
T ss_pred hHhcCHhhcCC-CHHHHHHHHHhCEEEEECCCCEEEeCCCCCceeEEEecceEEEEEecCCCccccccceeeeeeccCCc
Confidence 47899999999 9999999999999999999999999999999999999999999876542 13446789999999
Q ss_pred eeecccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 81 FFGEKALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 81 ~fGE~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
+|||.+++.+.|+++|++|. ++|+++.|++++|.+++..+|++..+.+.....
T Consensus 82 ~fGe~~~~~~~~~~~t~~a~--~~~~~~~i~~~~f~~ll~~~~~i~~~~~~~~~~ 134 (147)
T d1cx4a2 82 YFGELALVTNKPRAASAHAI--GTVKCLAMDVQAFERLLGPCMEIMKRNIATYEE 134 (147)
T ss_dssp EESCHHHHHTCCCSSEEEEE--EEEEEEEEEHHHHHHHCGGGHHHHHHHHHHHHH
T ss_pred EeeehhhcCCCCceEEEEEC--CCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHH
Confidence 99999999999999999999 569999999999999999999998777766554
|
| >d1zyba2 b.82.3.2 (A:1-147) Probable transcription regulator BT4300, N-terminal domain {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable transcription regulator BT4300, N-terminal domain species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=99.89 E-value=2e-22 Score=161.50 Aligned_cols=131 Identities=18% Similarity=0.184 Sum_probs=118.5
Q ss_pred ccccccccccccCCHHHHHHHHhhcc--eeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSS--QTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~--~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
+.|+++|+|+++ +++++..|+..+. .++|++|++|+++||+++.+|+|++|.|++...+.+ |++..+..+++|++|
T Consensus 6 d~L~~~~lF~~l-~~~~~~~ll~~~~~~~~~~~~g~~i~~~g~~~~~iy~i~~G~v~v~~~~~~-g~~~~~~~~~~g~~f 83 (147)
T d1zyba2 6 DTLLQLPLFQGL-CHEDFTSILDKVKLHFIKHKAGETIIKSGNPCTQLCFLLKGEISIVTNAKE-NIYTVIEQIEAPYLI 83 (147)
T ss_dssp TTGGGSGGGTTC-CHHHHHHHHHTSCCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECGG-GSCEEEEEEESSEEE
T ss_pred HHHhCCcccccC-CHHHHHHHHhhCceEEEEECCCCEEEeccCCccEEEEEecceEEEEEEcCC-CCEEEEEEcCCCCEe
Confidence 468999999999 9999999998765 678999999999999999999999999999999888 455889999999999
Q ss_pred ecccccCCCcc-eeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 83 GEKALQGDDLR-TANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 83 GE~~l~~~~~r-~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
||++++.+.++ +++++|. ++|+++.|+++.|.+++.++|.+..++++.++.+...
T Consensus 84 Ge~~~~~~~~~~~~~v~a~--~~~~vl~i~~~~~~~~~~~~p~~~~~~~~~ls~r~~~ 139 (147)
T d1zyba2 84 EPQSLFGMNTNYASSYVAH--TEVHTVCISKAFVLSDLFRYDIFRLNYMNIVSNRAQN 139 (147)
T ss_dssp CGGGGSSSCCBCSSEEEES--SCEEEEEEEHHHHHHTGGGSHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccccccceeeec--ceeeeeehhHHHHHHHHHHCHHHHHHHHHHHHHHHHH
Confidence 99999987765 7999999 5599999999999999999999999998877765443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=1.8e-22 Score=185.99 Aligned_cols=151 Identities=22% Similarity=0.311 Sum_probs=115.6
Q ss_pred cCcEEEEEecccceecEEEEEecCCCCCceeeeeeccccccccccccccceeeeCCCCceEEEeehhhHHhhccchHHhh
Q psy14740 149 SDLRVITTLGVGGFGRVELVQIAGDPSRSFALKQMKKSQVMNLDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIR 228 (362)
Q Consensus 149 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~ 228 (362)
++|++++.||+|+||.||++++. .+++.||+|++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~----------------------------------------- 50 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK----------------------------------------- 50 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-----------------------------------------
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-----------------------------------------
Confidence 46999999999999999999855 468899999986531
Q ss_pred hhccchhhhhccccccccchhhhhhHHHHHHHhhcC-----------Ccceeeeeeeeec--cceEEEEEeccCCcc-hH
Q psy14740 229 TKYVDETSERRRAPQIVETRQQQHIMSEKEIMGEAN-----------CDFIVKLYKTFKD--KKYLYMLMESCLGGE-LW 294 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~-L~ 294 (362)
...+...+|+.+++.++ ||||+++++++.. ....+++|.++.... ..
T Consensus 51 -------------------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (362)
T d1q8ya_ 51 -------------------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 111 (362)
T ss_dssp -------------------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHH
T ss_pred -------------------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccc
Confidence 11234566777776653 6889999988754 345666666654443 33
Q ss_pred HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEecCCC------cEEEEecccceecCCCC
Q psy14740 295 TILR--DKGNFDDATTRFYTACVVEAFDYLHS-RNIIYRDLKPENLLLSTSG------YVKLVDFGFAKKLIGPR 360 (362)
Q Consensus 295 ~~l~--~~~~l~~~~~~~~~~ql~~al~~lH~-~~iiHrDikp~NIl~~~~~------~~kl~DFG~a~~~~~~~ 360 (362)
.... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .++++|||.|+......
T Consensus 112 ~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~ 186 (362)
T d1q8ya_ 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186 (362)
T ss_dssp HHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC
T ss_pred cccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc
Confidence 3222 23468999999999999999999998 8999999999999998655 39999999998765443
|
| >d1wgpa_ b.82.3.2 (A:) Probable cyclic nucleotide-gated ion channel 6 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable cyclic nucleotide-gated ion channel 6 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.88 E-value=7.4e-23 Score=161.88 Aligned_cols=118 Identities=15% Similarity=0.262 Sum_probs=105.3
Q ss_pred CcccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 3 KNPELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 3 ~~~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
..+.|+++|+|+++ +++.+.+|+..++.+.|++|++|+++||+++.||+|.+|.|++.....++.....+..++||++|
T Consensus 4 ~~s~l~~vp~F~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~Gd~~~~ly~i~~G~v~~~~~~~~~~~~~~~~~l~~G~~f 82 (137)
T d1wgpa_ 4 GSSGVRRVPLFENM-DERLLDAICERLKPCLFTEKSYLVREGDPVNEMLFIIRGRLESVTTDGGRSGFYNRSLLKEGDFC 82 (137)
T ss_dssp CSCSCSSCSGGGSC-CHHHHHHHHHHCBCCCBCTTEEEECTTSBCSEEEEEEECCCEEECCSSCSSSSSCEEECCTTCBS
T ss_pred HHHHHHCCHhHhCC-CHHHHHHHHHhcEEEEECCCCEEEecccccceeehhccCceEEEEecCCCceeeeeeeccCCcEE
Confidence 35679999999999 99999999999999999999999999999999999999999998877765666778899999999
Q ss_pred ecccccC---------CCcceeeEEecCCCCeEEEEEehhhHHHHhhchH
Q psy14740 83 GEKALQG---------DDLRTANIVAADPEGVSCLVIDQETFNQLISSLD 123 (362)
Q Consensus 83 GE~~l~~---------~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p 123 (362)
||++++. ..+|++||+|+ ++|++|.|++++|+.++.+.+
T Consensus 83 GE~~ll~~~~~~~~~~~~~r~~tv~a~--t~~~l~~L~~~dl~~il~~~~ 130 (137)
T d1wgpa_ 83 GDELLTWALDPKSGSNLPSSTRTVKAL--TEVEAFALIADELKFVASQFR 130 (137)
T ss_dssp STHHHHHHHCSSCCSSSCBCSSEEEES--SCBEEEEEEHHHHHHHHHHHC
T ss_pred cchhHhccCCCcccccccccCcEEEEe--eeEEEEEEEHHHHHHHHHHhc
Confidence 9998862 24688999999 559999999999999886543
|
| >d1vp6a_ b.82.3.2 (A:) Putative ion channel CnbD {Mesorhizobium loti [TaxId: 381]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Putative ion channel CnbD species: Mesorhizobium loti [TaxId: 381]
Probab=99.87 E-value=1.4e-22 Score=159.53 Aligned_cols=121 Identities=31% Similarity=0.411 Sum_probs=110.5
Q ss_pred ccccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 5 PELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 5 ~~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.-|+++|+|+++ +++++..|+..++.+.|++|++|+++||+++.+|+|.+|.|+++..+ + ..++||++|||
T Consensus 11 ~~l~~~p~F~~l-~~~~l~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~I~~G~v~v~~~~---~-----~~l~~G~~~G~ 81 (133)
T d1vp6a_ 11 QLVAAVPLFQKL-GPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPN---P-----VELGPGAFFGE 81 (133)
T ss_dssp HHHTTCGGGGGC-CHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEECSSS---C-----EEECTTCEECH
T ss_pred HHHHCCCccccC-CHHHHHHHHHhCEEEEECCCCEEEeCCCCCccceeeeccccEEEEee---e-----eeeccCccccc
Confidence 357899999999 99999999999999999999999999999999999999999987432 1 25899999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSER 136 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~ 136 (362)
.+++.+.|+.++++|. ++|+++.|++++|.+++.++|.+...+++.+..+
T Consensus 82 ~~~l~~~~~~~~~~a~--~~~~i~~i~~~~~~~l~~~~p~~~~~~~~~~~~R 131 (133)
T d1vp6a_ 82 MALISGEPRSATVSAA--TTVSLLSLHSADFQMLCSSSPEIAEIFRKTALER 131 (133)
T ss_dssp HHHHHCCCCSSCEEES--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred ccccCCCcccceEEEC--CCEEEEEEeHHHHHHHHHhCHHHHHHHHHHHHHh
Confidence 9999999999999999 5599999999999999999999999888776654
|
| >d2gaua2 b.82.3.2 (A:10-151) Transcriptional regulator PG0396, N-terminal domain {Porphyromonas gingivalis [TaxId: 837]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Transcriptional regulator PG0396, N-terminal domain species: Porphyromonas gingivalis [TaxId: 837]
Probab=99.86 E-value=9.7e-22 Score=156.54 Aligned_cols=125 Identities=15% Similarity=0.210 Sum_probs=111.9
Q ss_pred ccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCC
Q psy14740 11 AYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD 90 (362)
Q Consensus 11 ~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~ 90 (362)
.+|+.+ +++++..+...++.+.|++|++|+.+|++++.+|+|.+|.|+++..+.+ |++.++..++||++|||.+++.+
T Consensus 7 elf~~l-~~~~~~~l~~~~~~~~~~~g~~l~~~g~~~~~ly~v~~G~v~~~~~~~~-g~~~~~~~~~~G~~~G~~~~~~~ 84 (142)
T d2gaua2 7 DVWSLL-NEEERELLDKEIQPFPCKKASTVFSEGDIPNNLFYLYEGKIKILREGVY-GRFHISRIVKPGQFFGMRPYFAE 84 (142)
T ss_dssp HHHTTC-CHHHHHHHHHHCEEEEECTTCEEECTTCCCCEEEEEEESCEEEEC------CCCEEEEECTTCEESHHHHHHT
T ss_pred HHHccC-CHHHHHHHHhcCEEEEECCCCEEEeCCCccceEEEEEecceeeEeeccc-cceeeeecccccchhhhhhhhcc
Confidence 479999 9999999999999999999999999999999999999999999998887 55588999999999999999999
Q ss_pred CcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 91 DLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 91 ~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
.|+.++++|+ ++|+++.|++++|.+++.++|.+...++..+..+...
T Consensus 85 ~~~~~~~~a~--~~s~v~~i~~~~~~~l~~~~~~~~~~~~~~l~~rl~~ 131 (142)
T d2gaua2 85 ETCSSTAIAV--ENSKVLAIPVEAIEALLKGNTSFCRYFLKALAKELGY 131 (142)
T ss_dssp SCCSSEEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHHHH
T ss_pred CCceeEEEec--CCEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHHHHH
Confidence 9999999999 5599999999999999999999999888877665443
|
| >d1o7fa2 b.82.3.2 (A:13-167) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=1.1e-21 Score=158.59 Aligned_cols=121 Identities=25% Similarity=0.351 Sum_probs=110.2
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCC-CcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNS-TEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~-~~~~~~~~l~~G~~fGE 84 (362)
.|++.++|+.+ +++.+.+|+..++.+.|++|++|+++||+++.+|+|.+|.|.|......+ +....+..++||++|||
T Consensus 25 ~L~~~~~F~~l-~~~~l~~l~~~~~~~~~~~ge~I~~~gd~~~~~y~I~~G~v~v~~~~~~~~~~~~~v~~l~~g~~fGe 103 (155)
T d1o7fa2 25 RLKGVKAFEKF-HPNLLRQICLCGYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE 103 (155)
T ss_dssp HHTTCTTTTTC-CHHHHHHHHHHCEEEEECTTCEEECTTSBCCEEEEEEESCEEEEECSSSCGGGCEEEEEECTTCEECG
T ss_pred HHhCCHhHhcC-CHHHHHHHHHhcEEEEECCCCEEEeCCCcceeeEEEeccchheeeecccccccccccccccccccchh
Confidence 47889999999 99999999999999999999999999999999999999999998765432 44677899999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhh
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYV 130 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~ 130 (362)
+++.+.||++||+|. ++|+++.|++++|.+++.++|++...++
T Consensus 104 -~~l~~~~~~~tv~a~--~~~~l~~i~~~~f~~il~~~~~~~~~ll 146 (155)
T d1o7fa2 104 -SILDNTPRHATIVTR--ESSELLRIEQEDFKALWEKYRQYMAGLL 146 (155)
T ss_dssp -GGGGTCBCSSEEEES--SSEEEEEEEHHHHHHHHHHHGGGTTTTS
T ss_pred -hhhcCCCceEEEEEC--CCEEEEEEeHHHHHHHHHHCHHHHHHHH
Confidence 899999999999999 5599999999999999999999876655
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=2.1e-21 Score=150.85 Aligned_cols=112 Identities=30% Similarity=0.425 Sum_probs=100.1
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEe-cCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeec
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFY-KEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGE 84 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~-~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE 84 (362)
.|+++|+|+++ +++.+++|+.++....+ ++|++|+++||+++.+|+|.+|.|++.... ...+..++||++|||
T Consensus 11 ~L~~~~~F~~l-~~~~l~~l~~~~~~~~~~~~ge~I~~~gd~~~~lyii~~G~v~~~~~~-----~~~~~~~~~G~~fGe 84 (124)
T d1o7fa3 11 ELLHIKALSHL-STTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYG-----KGVVCTLHEGDDFGK 84 (124)
T ss_dssp HHTTCGGGTTS-CHHHHHHHHHHCEEEEECSTTCEEECTTSCCCEEEEEEESEEEEEETT-----TEEEEEEETTCEECG
T ss_pred HHhCCHhhhcC-CHHHHHHHHhhCeEEEEcCCCCEEEECCCcCceEEEEEcceEEEEEee-----eeecccccCCcchhh
Confidence 58999999999 99999999999987665 679999999999999999999999987532 245788999999999
Q ss_pred ccccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHH
Q psy14740 85 KALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDE 124 (362)
Q Consensus 85 ~~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~ 124 (362)
++++.+.||++|++|.++ .|+++.|++++|.+++.+.|+
T Consensus 85 ~~ll~~~~r~~t~~a~~~-~~~l~~i~~~~f~~il~~~~~ 123 (124)
T d1o7fa3 85 LALVNDAPRAASIVLRED-NCHFLRVDKEDFNRILRDVEA 123 (124)
T ss_dssp GGGTCCSCCSSEEEESSS-SEEEEEEEHHHHHHHHHHTTC
T ss_pred hHhhCCCceeeEEEEEeC-cEEEEEEcHHHHHHHHhhccC
Confidence 999999999999999932 389999999999999987763
|
| >d2oz6a2 b.82.3.2 (A:9-142) Cyclic AMP receptor-like protein Vfr {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Cyclic AMP receptor-like protein Vfr species: Pseudomonas aeruginosa [TaxId: 287]
Probab=99.85 E-value=1e-20 Score=148.94 Aligned_cols=117 Identities=26% Similarity=0.335 Sum_probs=106.1
Q ss_pred HHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCC----Cccee
Q psy14740 20 GVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD----DLRTA 95 (362)
Q Consensus 20 ~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~----~~r~~ 95 (362)
+++++|+..++.++|++|++|+++||+++.+|+|++|.|+++..+.+ |++.++..++||++|||++++.+ .|+++
T Consensus 3 ~~le~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~v~~~~~~-g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~ 81 (134)
T d2oz6a2 3 KHLDKLLAHCHRRRYTAKSTIIYAGDRCETLFFIIKGSVTILIEDDD-GREMIIGYLNSGDFFGELGLFEKEGSEQERSA 81 (134)
T ss_dssp HHHHHHHHSSEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTT-SCEEEEEEEETTCEESCTTTCC-----CBCCS
T ss_pred HHHHHHHHhCEEEEECCCCEEEeCCCcCCEEEEEEEcccceeeeecc-cccceeeeccCCCccchHHHhcCcccccccee
Confidence 68999999999999999999999999999999999999999999988 55588999999999999999864 47899
Q ss_pred eEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 96 NIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 96 ~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
+++|. ++|+++.||++.|.+++..+|++...+++.+..+...
T Consensus 82 ~~~a~--~~~~vl~i~~~~~~~~~~~~~~~~~~~~~~~~~rl~~ 123 (134)
T d2oz6a2 82 WVRAK--VECEVAEISYAKFRELSQQDSEILYTLGSQMADRLRK 123 (134)
T ss_dssp EEEES--SCEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHHHH
T ss_pred EEEEC--CCEEEEEEeHHHHHHHHHHCHHHHHHHHHHHHHHHHH
Confidence 99999 5599999999999999999999999888877765443
|
| >d1i5za2 b.82.3.2 (A:6-137) Catabolite gene activator protein, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Catabolite gene activator protein, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=99.84 E-value=1.2e-20 Score=148.20 Aligned_cols=119 Identities=24% Similarity=0.353 Sum_probs=108.4
Q ss_pred CHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCC-Ccceee
Q psy14740 18 NQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGD-DLRTAN 96 (362)
Q Consensus 18 ~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~-~~r~~~ 96 (362)
++++++.++..++.+.|++|++|+++||+.+.+|+|++|.|+++..+.+ |++.++..+.||++||+.+++.+ .|+.++
T Consensus 2 sd~~le~l~~~~~~~~~~~g~~i~~~g~~~~~iy~i~~G~v~~~~~~~~-g~e~~l~~~~~G~~~G~~~~~~~~~~~~~~ 80 (132)
T d1i5za2 2 TDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEE-GKEMILSYLNQGDFIGELGLFEEGQERSAW 80 (132)
T ss_dssp CCHHHHHHHTTSEEEEECTTCEEECTTSBCCEEEEEEECCEEEEEECTT-CCEEEEEEECTTCEESCTTTTSSSCBCCSE
T ss_pred CHHHHHHHHHhCEEEEECcCCEEEcCCCCCCEEEEEEEccceeeecccc-chhhhhhhhCcccccchHHHhcCCccceEE
Confidence 5788999999999999999999999999999999999999999999988 55588999999999999999975 788999
Q ss_pred EEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 97 IVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 97 ~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
++|. ++|+++.|++++|.+++..+|.+..++++.+..+...
T Consensus 81 ~~a~--~~~~v~~i~~~~~~~~~~~~~~~~~~~~~~l~~rl~~ 121 (132)
T d1i5za2 81 VRAK--TACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQV 121 (132)
T ss_dssp EEES--SCEEEEEEEHHHHHHHHHHCTHHHHHHHHHHHHHHHH
T ss_pred EEEc--cceEEEEEcHHHHHHHHhhCHHHHHHHHHHHHHHHHH
Confidence 9999 5599999999999999999999999888877665443
|
| >d1q3ea_ b.82.3.2 (A:) HCN pacemaker channel {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: HCN pacemaker channel species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.82 E-value=1e-20 Score=158.62 Aligned_cols=121 Identities=22% Similarity=0.389 Sum_probs=109.3
Q ss_pred cccccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecc
Q psy14740 6 ELKLRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEK 85 (362)
Q Consensus 6 ~L~~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~ 85 (362)
.|+++|+|+++ ++..+..|+..++...|.+|++|+++||+++.+|+|.+|.|.|.... +. +..+++|++|||.
T Consensus 69 ~l~~~~~F~~~-~~~~l~~l~~~~~~~~~~~g~~I~~~g~~~~~ly~i~~G~v~v~~~~---~~---~~~l~~G~~fGe~ 141 (193)
T d1q3ea_ 69 LVASMPLFANA-DPNFVTAMLTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKG---NK---EMKLSDGSYFGEI 141 (193)
T ss_dssp HHHHCHHHHTS-CHHHHHHHHTTCEEEEECTTCEEECTTSBCCEEEEEEECCEEEEC-C---CC---EEEECTTCEECHH
T ss_pred HHhcchHHHhh-hHHHHHHHHHHHHHHhhccCceecccCCCCcceeEeeeeeEEeecCC---cc---eeeeccceeeeee
Confidence 47789999999 99999999999999999999999999999999999999999997432 22 5679999999999
Q ss_pred cccCCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhH
Q psy14740 86 ALQGDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSE 135 (362)
Q Consensus 86 ~l~~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~ 135 (362)
+++.+.+|++|++|. ++|+++.|++++|..++..+|.+...+......
T Consensus 142 ~~~~~~~~~~~~~a~--~~~~l~~l~~~~f~~ll~~~p~~~~~~~~~~~~ 189 (193)
T d1q3ea_ 142 CLLTRGRRTASVRAD--TYCRLYSLSVDNFNEVLEEYPMMRRAFETVAID 189 (193)
T ss_dssp HHHHCSBCSSEEEES--SCEEEEEEEHHHHHHHHHHSGGGHHHHHHHHHH
T ss_pred eccCCCcccccceec--CceEEEEEeHHHHHHHHHHCHHHHHHHHHHHHH
Confidence 999999999999999 559999999999999999999998877765543
|
| >d1o5la1 b.82.3.2 (A:1-129) CRP-like transcriptional regulator TM1171, N-terminal domain {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: CRP-like transcriptional regulator TM1171, N-terminal domain species: Thermotoga maritima [TaxId: 2336]
Probab=99.82 E-value=4.7e-20 Score=144.05 Aligned_cols=116 Identities=18% Similarity=0.262 Sum_probs=104.6
Q ss_pred HHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcc-eeeEEe
Q psy14740 21 VILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR-TANIVA 99 (362)
Q Consensus 21 ~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r-~~~~~A 99 (362)
+++.|+.+++.+.|++|++|+++||+++++|+|++|.|+++..+.+ |.+..+..++||++|||++++.+.++ +++++|
T Consensus 2 dl~~l~~~~~~~~~~kg~~l~~~g~~~~~~y~i~~G~v~~~~~~~~-g~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~~a 80 (129)
T d1o5la1 2 DLKKLLPCGKVIVFRKGEIVKHQDDPIEDVLILLEGTLKTEHVSEN-GKTLEIDEIKPVQIIASGFIFSSEPRFPVNVVA 80 (129)
T ss_dssp CGGGGGGGSEEEEECTTCEEECTTCBCCEEEEEEESCEEEEEECTT-SCEEEEEEECSSEESSGGGTTSSSCBCSSEEEE
T ss_pred cHHHHHhCCEEEEECCCCEEEECCCcCcEEEEEeccccEEEEeecc-cccchhhhcccccccchHHHhccCCCccEEEEe
Confidence 3677889999999999999999999999999999999999999888 55588999999999999999988764 699999
Q ss_pred cCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 100 ADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 100 ~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
. ++|+++.|+++.|.+++..+|.+...+++.++.+...
T Consensus 81 ~--~~~~vl~i~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 118 (129)
T d1o5la1 81 G--ENSKILSIPKEVFLDLLMKDRELLLFFLKDVSEHFRV 118 (129)
T ss_dssp S--SSEEEEEEEHHHHHHHHHHCHHHHHHHHHHHHHHHHH
T ss_pred e--cccEEEEEcHHHHHHHHHhCHHHHHHHHHHHHHHHHH
Confidence 9 5699999999999999999999999998887765443
|
| >d3e5ua2 b.82.3.2 (A:9-147) Chlorophenol reduction protein CprK {Desulfitobacterium hafniense [TaxId: 49338]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Chlorophenol reduction protein CprK species: Desulfitobacterium hafniense [TaxId: 49338]
Probab=99.81 E-value=1.6e-19 Score=142.86 Aligned_cols=120 Identities=9% Similarity=0.090 Sum_probs=108.3
Q ss_pred ccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCc
Q psy14740 13 FVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDL 92 (362)
Q Consensus 13 f~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~ 92 (362)
+.-+ +.++++.++..++.+.|++|++|+++||+.+++|+|++|.|+++..+.+ |++.++..++||++|||++. .+
T Consensus 9 ~~~~-p~e~l~~l~~~~~~~~y~kg~~i~~~g~~~~~~y~v~~G~v~~~~~~~~-g~~~~l~~~~~g~~~g~~~~---~~ 83 (139)
T d3e5ua2 9 DNFF-PIEKLRNYTQMGLIRDFAKGSAVIMPGEEITSMIFLVEGKIKLDIIFED-GSEKLLYYAGGNSLIGKLYP---TG 83 (139)
T ss_dssp BSCS-CCGGGGGGGGGSEEEEECTTCEEECTTCCCCSEEEEEESEEEEEEECTT-SCEEEEEEEETTCEECCCSC---CS
T ss_pred CCCC-CHHHHHHHHHhCEEEEECCCCEEEeCCCCCCEEEEEEeccceEEEeecc-ccccceeeccccceeehhhh---hc
Confidence 4555 8899999999999999999999999999999999999999999999988 56689999999999999653 46
Q ss_pred ceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHhhh
Q psy14740 93 RTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERRRL 139 (362)
Q Consensus 93 r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~~~ 139 (362)
++++++|. ++|+++.|+++.|..++..+|++...+++.+..+...
T Consensus 84 ~~~~~~a~--~~~~v~~i~~~~f~~l~~~~p~l~~~il~~~~~r~~~ 128 (139)
T d3e5ua2 84 NNIYATAM--EPTRTCWFSEKSLRTVFRTDEDMIFEIFKNYLTKVAY 128 (139)
T ss_dssp CEEEEEES--SCEEEEEECHHHHHHHHHHCTHHHHHHHHHHHHHHHH
T ss_pred cccccccc--ccceEEEeeHHHHHHHHhcCHHHHHHHHHHHHHHHHH
Confidence 88999999 6699999999999999999999999999888776443
|
| >d1ft9a2 b.82.3.1 (A:2-133) CO-sensing protein CooA, N-terminal domain {Rhodospirillum rubrum [TaxId: 1085]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: CO-sensing protein CooA, N-terminal domain domain: CO-sensing protein CooA, N-terminal domain species: Rhodospirillum rubrum [TaxId: 1085]
Probab=99.79 E-value=1.1e-19 Score=142.56 Aligned_cols=117 Identities=15% Similarity=0.099 Sum_probs=106.8
Q ss_pred ccccccccCCHHHHHHHHhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc
Q psy14740 9 LRAYFVHLVNQGVILTIVYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ 88 (362)
Q Consensus 9 ~~~lf~~l~~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~ 88 (362)
+.++|..| ++++++.++..++.++|++|++|+++|++++++|+|++|.|+++..+ + +++..+..++||++|||.
T Consensus 3 r~~~~~~L-~~~~~~~~~~~~~~~~~~kG~~i~~~g~~~~~ly~v~~G~v~~~~~~-~-g~e~~l~~~~~g~~f~~~--- 76 (132)
T d1ft9a2 3 RFNIANVL-LSPDGETFFRGFRSKIHAKGSLVCTGEGDENGVFVVVDGRLRVYLVG-E-EREISLFYLTSGDMFCMH--- 76 (132)
T ss_dssp CCCTHHHH-TSTTTTTTTTTCEEEEECTTCEEECTTCCCCCEEEEEESEEEEEEEE-T-TEEEEEEEEETTCEEESC---
T ss_pred CcChhHhC-CHHHHHHHHHhCEEEEecCCcEEECCCCCCCEEEEEEeCeEeeeccc-c-ccceeecccccccccccc---
Confidence 57899999 99999999999999999999999999999999999999999999776 4 456889999999999984
Q ss_pred CCCcceeeEEecCCCCeEEEEEehhhHHHHhhchHHHHHhhhhhhhHHh
Q psy14740 89 GDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTKYVDETSERR 137 (362)
Q Consensus 89 ~~~~r~~~~~A~~~~~~~~~~i~~~~f~~l~~~~p~~~~~~~~~~~~~~ 137 (362)
++++++|+ ++|+++.|+++.|.+++.++|.+...+++.+..+.
T Consensus 77 ----~~~~v~A~--~~s~v~~i~~~~~~~ll~~~p~~~~~l~~~l~~rl 119 (132)
T d1ft9a2 77 ----SGCLVEAT--ERTEVRFADIRTFEQKLQTCPSMAWGLIAILGRAL 119 (132)
T ss_dssp ----SSCEEEES--SCEEEEEECHHHHHHHHHHCGGGHHHHHHHHHHHH
T ss_pred ----ccccceec--cceeeeeehHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 47899999 66999999999999999999999998888877653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2.5e-07 Score=79.20 Aligned_cols=99 Identities=16% Similarity=0.132 Sum_probs=64.8
Q ss_pred hhHHHHHHHhhcC-CcceeeeeeeeeccceEEEEEeccCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------
Q psy14740 252 HIMSEKEIMGEAN-CDFIVKLYKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDATTRFYTACVVEAFDYLHS------ 324 (362)
Q Consensus 252 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~al~~lH~------ 324 (362)
.+.+|...+..+. +--+++++.+...++..|+||++++|.++.+..... .. ...+..++...+..||+
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~ 129 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTC
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCcccc
Confidence 4667888777663 333677778777888999999999988875533210 01 11122222222333331
Q ss_pred -----------------------------------------------------CCcEeecCCCCcEEecCCCcEEEEecc
Q psy14740 325 -----------------------------------------------------RNIIYRDLKPENLLLSTSGYVKLVDFG 351 (362)
Q Consensus 325 -----------------------------------------------------~~iiHrDikp~NIl~~~~~~~kl~DFG 351 (362)
..++|+|+.|.|||++.++.+.|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe 209 (263)
T d1j7la_ 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred ccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence 137999999999999877667799999
Q ss_pred ccee
Q psy14740 352 FAKK 355 (362)
Q Consensus 352 ~a~~ 355 (362)
.+..
T Consensus 210 ~a~~ 213 (263)
T d1j7la_ 210 RSGR 213 (263)
T ss_dssp TCEE
T ss_pred hccc
Confidence 8763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2e-05 Score=66.54 Aligned_cols=42 Identities=10% Similarity=0.096 Sum_probs=31.3
Q ss_pred hhHHHHHHHhhcC--CcceeeeeeeeeccceEEEEEeccCCcch
Q psy14740 252 HIMSEKEIMGEAN--CDFIVKLYKTFKDKKYLYMLMESCLGGEL 293 (362)
Q Consensus 252 ~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 293 (362)
.+..|...++.+. .-.+++++.+..+++..++||++++|.++
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3567777777663 22367778887888889999999988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.87 E-value=3.7e-05 Score=69.53 Aligned_cols=28 Identities=29% Similarity=0.389 Sum_probs=24.6
Q ss_pred CcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 326 NIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 326 ~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.++|+|+.|.|||++.++ ++++||-.|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998664 8999998875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.73 E-value=0.003 Score=54.89 Aligned_cols=29 Identities=24% Similarity=0.257 Sum_probs=23.6
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEeccccee
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAKK 355 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~~ 355 (362)
.++||+|+.|.|||++. + ..++||+-|+.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999964 3 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.36 E-value=0.014 Score=50.12 Aligned_cols=30 Identities=30% Similarity=0.417 Sum_probs=27.2
Q ss_pred CCcEeecCCCCcEEecCCCcEEEEecccce
Q psy14740 325 RNIIYRDLKPENLLLSTSGYVKLVDFGFAK 354 (362)
Q Consensus 325 ~~iiHrDikp~NIl~~~~~~~kl~DFG~a~ 354 (362)
.|+||+|+.++|++++.+...-++||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777999999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.10 E-value=0.012 Score=52.29 Aligned_cols=37 Identities=24% Similarity=0.187 Sum_probs=25.5
Q ss_pred hHHHHHHHhhc-CCcceeeeeeeeeccceEEEEEeccCCcch
Q psy14740 253 IMSEKEIMGEA-NCDFIVKLYKTFKDKKYLYMLMESCLGGEL 293 (362)
Q Consensus 253 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 293 (362)
..+|..+++.+ .+.-.+++++++.+ ++|++|++|.++
T Consensus 91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 35688888777 34445677777753 578999987554
|
| >d2bgca2 b.82.3.3 (A:7-137) Listeriolysin regulatory protein PrfA, N-terminal domain {Bacteria (Listeria monocytogenes) [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: Listeriolysin regulatory protein PrfA, N-terminal domain domain: Listeriolysin regulatory protein PrfA, N-terminal domain species: Bacteria (Listeria monocytogenes) [TaxId: 1639]
Probab=93.84 E-value=0.56 Score=31.59 Aligned_cols=92 Identities=17% Similarity=0.183 Sum_probs=68.6
Q ss_pred hcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcc--eeeEEecCCCCe
Q psy14740 28 FSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLR--TANIVAADPEGV 105 (362)
Q Consensus 28 ~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r--~~~~~A~~~~~~ 105 (362)
..++..|++-+.||.|=||.+...++-+|..+++..+.+ |. ..--....|.+.=--..++.... -++...++ +.+
T Consensus 10 gikpk~f~kke~ifnqwdp~eycifl~dgiakltsisen-g~-imnlqyykgafiimsg~idt~~~lgyynlevis-e~a 86 (131)
T d2bgca2 10 GIKPKQFHKKELIFNQWDPQEYCIFLYDGITKLTSISEN-GT-IMNLQYYKGAFVIMSGFIDTETSVGYYNLEVIS-EQA 86 (131)
T ss_dssp TCCCEEEETTCEEECTTCCCCEEEEEEESEEEEEEECTT-SC-EEEEEEEESSEEEESBCTTTCCBSCCCEEEECS-SEE
T ss_pred CCChhhhchhheeecccCcceeEEeeecchHHhcccccC-Cc-EEeeeeccccEEEEecccccCCccceeeeeeeh-hcc
Confidence 346889999999999999999999999999999999887 44 33445667777654445544322 23444444 458
Q ss_pred EEEEEehhhHHHHhhch
Q psy14740 106 SCLVIDQETFNQLISSL 122 (362)
Q Consensus 106 ~~~~i~~~~f~~l~~~~ 122 (362)
+.++|.-.++..++..+
T Consensus 87 tayvikisdlk~lvs~d 103 (131)
T d2bgca2 87 TAYVIKINELKELLSKN 103 (131)
T ss_dssp EEEEEEHHHHHHHHHHC
T ss_pred eeeeEEHHHHHHHHHHh
Confidence 88999999999988764
|
| >d1ne6a2 b.82.3.2 (A:245-376) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.24 E-value=0.25 Score=35.70 Aligned_cols=66 Identities=18% Similarity=0.411 Sum_probs=49.2
Q ss_pred ecEEEEEecCCCCCceeeeeecccccccc-----ccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 163 GRVELVQIAGDPSRSFALKQMKKSQVMNL-----DDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 163 g~v~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
|.|.......+..+.+.+..+.+++.++. +.++.+++.|..+ +.++.++++.|.+++...+++..+
T Consensus 52 G~v~~~~~~~~~~~~~~~~~~~~g~~fG~~~~~~~~~~~~t~~a~~~--~~~~~i~~~~~~~ll~~~p~~~~~ 122 (132)
T d1ne6a2 52 GSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGP--LKCVKLDRPRFERVLGPCSDILKR 122 (132)
T ss_dssp CCEEEEEESSSSCCEEEEEEECTTCEECHHHHHHTSSCSSEEEESSC--EEEEEEEHHHHHHHTGGGHHHHHH
T ss_pred hhheeeccCCccccchhhhhccccceeeEeeecCCCceeEEEEEccc--EEEEEEEHHHHHHHHHHCHHHHHH
Confidence 55554443434444556888889999983 4677888888755 999999999999999888877654
|
| >d1yhfa1 b.82.1.9 (A:1-112) Hypothetical protein SPy1581 {Streptococcus pyogenes [TaxId: 1314]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: TM1287-like domain: Hypothetical protein SPy1581 species: Streptococcus pyogenes [TaxId: 1314]
Probab=91.47 E-value=0.68 Score=32.37 Aligned_cols=67 Identities=18% Similarity=0.250 Sum_probs=45.6
Q ss_pred ceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEEE
Q psy14740 30 SQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCLV 109 (362)
Q Consensus 30 ~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~~ 109 (362)
....+++|+.+=..--+.+.+++|++|++.+... ++ ...+.+||++=- =.+.++ .++|.++ +.++.
T Consensus 40 ~~~~~~~G~~~~~H~h~~~~~~~vl~G~~~~~~~----~~---~~~l~~Gd~~~i---p~~~~H--~~~a~~~--~~~l~ 105 (112)
T d1yhfa1 40 TVFSLDKGQEIGRHSSPGDAMVTILSGLAEITID----QE---TYRVAEGQTIVM---PAGIPH--ALYAVEA--FQMLL 105 (112)
T ss_dssp EEEEECTTCEEEEECCSSEEEEEEEESEEEEEET----TE---EEEEETTCEEEE---CTTSCE--EEEESSC--EEEEE
T ss_pred EEEEECCCCCcceEECCCCEEEEEEeCEEEEEEc----cE---EEEecCCEEEEc---CCCCeE--EeEECCC--cEEEE
Confidence 3456789998887777788999999999998742 33 346799998631 133444 5566744 55544
Q ss_pred E
Q psy14740 110 I 110 (362)
Q Consensus 110 i 110 (362)
+
T Consensus 106 ~ 106 (112)
T d1yhfa1 106 V 106 (112)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >d2b8ma1 b.82.1.18 (A:1-108) Hypothetical protein MJ0764 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: MJ0764-like domain: Hypothetical protein MJ0764 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=90.36 E-value=0.44 Score=33.25 Aligned_cols=73 Identities=14% Similarity=0.201 Sum_probs=48.4
Q ss_pred cceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEE
Q psy14740 29 SSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCL 108 (362)
Q Consensus 29 ~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~ 108 (362)
+....+++|+.+-..=-+.+.+++|++|+..+...+ ++. ..+++||++=- =.+.+ ..+.+.+++++.++
T Consensus 28 v~~~~l~pG~~~p~H~H~~~e~~~Vl~G~~~~~v~~---~e~---~~v~~Gd~i~i---p~~~~--H~~~n~~~e~l~~l 96 (108)
T d2b8ma1 28 INHIVLPRGEQMPKHYSNSYVHLIIIKGEMTLTLED---QEP---HNYKEGNIVYV---PFNVK--MLIQNINSDILEFF 96 (108)
T ss_dssp EEEEEEETTCBCCCEECSSCEEEEEEESEEEEEETT---SCC---EEEETTCEEEE---CTTCE--EEEECCSSSEEEEE
T ss_pred EEEEEECCCCcChhhcccccEEEEEEeeeEEEEEec---ccE---EEeecceEeec---cCCce--EEEEcCCCCcEEEE
Confidence 346678888887665556778999999999997532 332 24689987631 23444 45566655778887
Q ss_pred EEeh
Q psy14740 109 VIDQ 112 (362)
Q Consensus 109 ~i~~ 112 (362)
.+..
T Consensus 97 ~v~~ 100 (108)
T d2b8ma1 97 VVKA 100 (108)
T ss_dssp EEEC
T ss_pred EEEC
Confidence 7754
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.75 E-value=0.63 Score=34.07 Aligned_cols=54 Identities=22% Similarity=0.394 Sum_probs=43.0
Q ss_pred CCceeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhccchHHhhhh
Q psy14740 175 SRSFALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEIRTK 230 (362)
Q Consensus 175 ~~~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~~~~ 230 (362)
+....+..+.+++++| .+.++..++.|..+ +.++.++++.|.+++....++..+
T Consensus 69 ~~~~~i~~~~~g~~fGe~~~~~~~~~~~t~~a~~~--~~~~~i~~~~f~~ll~~~~~i~~~ 127 (147)
T d1cx4a2 69 NGAVEIARCLRGQYFGELALVTNKPRAASAHAIGT--VKCLAMDVQAFERLLGPCMEIMKR 127 (147)
T ss_dssp CCEEEEEEECTTCEESCHHHHHTCCCSSEEEEEEE--EEEEEEEHHHHHHHCGGGHHHHHH
T ss_pred cceeeeeeccCCcEeeehhhcCCCCceEEEEECCC--EEEEEEEHHHHHHHHHHCHHHHHH
Confidence 3445677788899988 46788889999864 999999999999999887666543
|
| >d1o5ua_ b.82.1.8 (A:) Hypothetical protein TM1112 {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: Hypothetical protein TM1112 domain: Hypothetical protein TM1112 species: Thermotoga maritima [TaxId: 2336]
Probab=88.68 E-value=1.3 Score=29.46 Aligned_cols=57 Identities=18% Similarity=0.119 Sum_probs=38.9
Q ss_pred CHHHHHHH-HhhcceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 18 NQGVILTI-VYFSSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 18 ~~~~~~~l-~~~~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
+++.+.++ ....-.=.-.+|..=.. -+.+.+..|++|++.|.. .+ |+. ..++|||.|
T Consensus 8 ~~~~l~~lGv~~~gvW~~~pg~f~~~--y~~~E~~~ileG~v~i~~--~~-G~~---~~~~aGD~~ 65 (88)
T d1o5ua_ 8 TPEKLKELSVEKWPIWEKEVSEFDWY--YDTNETCYILEGKVEVTT--ED-GKK---YVIEKGDLV 65 (88)
T ss_dssp CHHHHHHHTGGGSCEEEECSEEEEEE--CSSCEEEEEEEEEEEEEE--TT-CCE---EEEETTCEE
T ss_pred CHHHHHhcCCcccceEeecCcEEEEE--cCccEEEEEEEeEEEEEc--CC-CCE---EEEeCCCEE
Confidence 77888777 33333445677775443 466899999999999963 33 442 358999987
|
| >d1v70a_ b.82.1.9 (A:) Hypothetical protein TTHA0104 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: TM1287-like domain: Hypothetical protein TTHA0104 species: Thermus thermophilus [TaxId: 274]
Probab=86.23 E-value=2.6 Score=28.48 Aligned_cols=70 Identities=14% Similarity=0.075 Sum_probs=46.2
Q ss_pred cceeEecCCCEEEecCCC-CCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeeccccc-CCCcceeeEEecCCCCeE
Q psy14740 29 SSQTFYKEGDYIIRQGAR-GDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQ-GDDLRTANIVAADPEGVS 106 (362)
Q Consensus 29 ~~~~~~~~g~~i~~~g~~-~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~-~~~~r~~~~~A~~~~~~~ 106 (362)
+....+++|+.+-..--+ .+.+|+|++|++.+... ++ ...+++||.+ .+ .+.++ .+++.++++++
T Consensus 30 ~~~~~~~PG~~~~~H~H~~~~e~~~vl~G~~~~~~~----~~---~~~l~~Gd~~----~~p~~~~H--~~~n~g~~~~~ 96 (105)
T d1v70a_ 30 YDLYALLPGQAQKVHVHEGSDKVYYALEGEVVVRVG----EE---EALLAPGMAA----FAPAGAPH--GVRNESASPAL 96 (105)
T ss_dssp EEEEEECTTCEEEEECCSSCEEEEEEEESCEEEEET----TE---EEEECTTCEE----EECTTSCE--EEECCSSSCEE
T ss_pred EEEEEECCCCCCcceECCCCeEEEEEEeeEEEEEEe----ee---EEEecceEEE----EeCCCCEE--EeEECCCCCEE
Confidence 346678899887766544 46899999999998742 22 2467999976 23 33444 45555446687
Q ss_pred EEEEe
Q psy14740 107 CLVID 111 (362)
Q Consensus 107 ~~~i~ 111 (362)
++.+.
T Consensus 97 ~l~v~ 101 (105)
T d1v70a_ 97 LLVVT 101 (105)
T ss_dssp EEEEE
T ss_pred EEEEE
Confidence 77664
|
| >d1fxza2 b.82.1.2 (A:297-470) Seed storage 7S protein {Soybean (Glycine max), proglycinin [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: Germin/Seed storage 7S protein domain: Seed storage 7S protein species: Soybean (Glycine max), proglycinin [TaxId: 3847]
Probab=85.62 E-value=1.5 Score=33.34 Aligned_cols=54 Identities=9% Similarity=0.175 Sum_probs=43.3
Q ss_pred hcceeEecCCCEEEec-CCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCee
Q psy14740 28 FSSQTFYKEGDYIIRQ-GARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFF 82 (362)
Q Consensus 28 ~~~~~~~~~g~~i~~~-g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~f 82 (362)
.+....+++|.+..-. --.++.+.+|++|+..+...+++ +....-..+++||+|
T Consensus 43 s~~~~~l~pga~~~PH~H~~A~ei~yV~~G~~~v~~v~~~-g~~~~~~~l~~Gdv~ 97 (174)
T d1fxza2 43 SAEFGSLRKNAMFVPHYNLNANSIIYALNGRALIQVVNCN-GERVFDGELQEGRVL 97 (174)
T ss_dssp CEEEEEECTTCEEEEEEETTCCEEEEEEESEEEEEEECTT-SCEEEEEEEETTCEE
T ss_pred eEEEeeecCCCEeCCccCCCCCEEEEEEecceEEEEecCC-CceeEEEEEcCCcEE
Confidence 3456778999888776 35688999999999999999876 444556679999998
|
| >d1od5a2 b.82.1.2 (A:321-493) Seed storage 7S protein {Soybean (Glycine max), glycinin A3B4 [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: Germin/Seed storage 7S protein domain: Seed storage 7S protein species: Soybean (Glycine max), glycinin A3B4 [TaxId: 3847]
Probab=85.20 E-value=1.8 Score=32.90 Aligned_cols=55 Identities=9% Similarity=0.161 Sum_probs=43.5
Q ss_pred hcceeEecCCCEEEec-CCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeee
Q psy14740 28 FSSQTFYKEGDYIIRQ-GARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFG 83 (362)
Q Consensus 28 ~~~~~~~~~g~~i~~~-g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fG 83 (362)
.+....+.+|.+..-. --.++.+.+|++|+..+...+++ +....-..+++||+|-
T Consensus 48 s~~~v~L~pga~~~PH~H~~A~ei~yV~~G~~~v~~v~~~-~~~~~~~~l~~Gdv~~ 103 (173)
T d1od5a2 48 SAQYVVLYRNGIYSPHWNLNANSVIYVTRGKGRVRVVNCQ-GNAVFDGELRRGQLLV 103 (173)
T ss_dssp EEEEEEECTTCEEEEEEESSCCEEEEEEEEEEEEEEECTT-SCEEEEEEEETTCEEE
T ss_pred eEEEEEEcCCcEecCccCCCCcEEEEEEecceEEEEEeCC-CceEEeEEecCCcEEE
Confidence 4567889999988776 34578999999999999998876 4434556799999984
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.86 E-value=1.4 Score=31.11 Aligned_cols=46 Identities=22% Similarity=0.353 Sum_probs=35.9
Q ss_pred eeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhccch
Q psy14740 178 FALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLISSL 224 (362)
Q Consensus 178 ~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~ 224 (362)
..+..+.+++.|| .+.+|.++++|..+ .|.++.++++.|.+++...
T Consensus 71 ~~~~~~~~G~~fGe~~ll~~~~r~~t~~a~~~-~~~l~~i~~~~f~~il~~~ 121 (124)
T d1o7fa3 71 GVVCTLHEGDDFGKLALVNDAPRAASIVLRED-NCHFLRVDKEDFNRILRDV 121 (124)
T ss_dssp EEEEEEETTCEECGGGGTCCSCCSSEEEESSS-SEEEEEEEHHHHHHHHHHT
T ss_pred eecccccCCcchhhhHhhCCCceeeEEEEEeC-cEEEEEEcHHHHHHHHhhc
Confidence 3456677788888 46888999998743 5899999999999987654
|
| >d1cx4a1 b.82.3.2 (A:130-265) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=83.99 E-value=0.98 Score=32.52 Aligned_cols=51 Identities=18% Similarity=0.233 Sum_probs=40.3
Q ss_pred CCceeeeeeccccccc-----cccccccceeeeCCCCceEEEeehhhHHhhccchHHh
Q psy14740 175 SRSFALKQMKKSQVMN-----LDDLRTANIVAADPEGVSCLVIDQETFNQLISSLDEI 227 (362)
Q Consensus 175 ~~~~aiK~~~~~~~~~-----~~~~~~a~~~a~~~~~v~~l~l~~~~f~~~~~~~~~~ 227 (362)
+....+..+.+++.++ .+.++.+++.|.++ +.++.++++.|.+++..-...
T Consensus 76 ~~~~~~~~l~~g~~fg~~~l~~~~~~~~s~~a~~~--~~~~~i~~~~f~~ll~~~~~~ 131 (136)
T d1cx4a1 76 GVGRCVGNYDNRGSFGELALMYNTPRAATITATSP--GALWGLDRVTFRRIIVKNNAK 131 (136)
T ss_dssp TEEEEEEEEESSCEECHHHHHHCCCCCSEEEESSC--EEEEEEEHHHHHHHHHHHHHH
T ss_pred cceeeeeccCCccccchHHHhCCCcceEEEEECCC--EEEEEEeHHHHHHHHHhCHHH
Confidence 4455667788888888 46788899888875 999999999999987655443
|
| >d1vj2a_ b.82.1.10 (A:) Hypothetical protein TM1459 {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: TM1459-like domain: Hypothetical protein TM1459 species: Thermotoga maritima [TaxId: 2336]
Probab=83.59 E-value=2.2 Score=29.55 Aligned_cols=72 Identities=17% Similarity=0.175 Sum_probs=45.0
Q ss_pred cceeEecCCCEEEecCCCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEE
Q psy14740 29 SSQTFYKEGDYIIRQGARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCL 108 (362)
Q Consensus 29 ~~~~~~~~g~~i~~~g~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~ 108 (362)
+...++++|..+=..--+.+.+++|++|++.+... ++ ...+.+||++=.- .+.++ .+.+.++++++++
T Consensus 38 ~~~~~i~pG~~~~~H~H~~~e~~~vl~G~~~~~~~----~~---~~~l~~Gd~~~ip---~~~~H--~~~n~~~~~~~~l 105 (114)
T d1vj2a_ 38 MRLFTVEPGGLIDRHSHPWEHEIFVLKGKLTVLKE----QG---EETVEEGFYIFVE---PNEIH--GFRNDTDSEVEFL 105 (114)
T ss_dssp EEEEEEEEEEEEEEECCSSCEEEEEEESEEEEECS----SC---EEEEETTEEEEEC---TTCCE--EEECCSSSCEEEE
T ss_pred EEEEEECCCCCCCceECCCcEEEEEEEceeEEEEe----ee---eeEEecCeEEEEc---CCCeE--EEEeCCCCCEEEE
Confidence 44567888888766555667778899999998732 33 3567999986321 23444 3455444557544
Q ss_pred -EEeh
Q psy14740 109 -VIDQ 112 (362)
Q Consensus 109 -~i~~ 112 (362)
.+++
T Consensus 106 ~iip~ 110 (114)
T d1vj2a_ 106 CLIPK 110 (114)
T ss_dssp EEEEG
T ss_pred EEECC
Confidence 4443
|
| >d1o4ta_ b.82.1.9 (A:) Hypothetical protein TM1287 {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: TM1287-like domain: Hypothetical protein TM1287 species: Thermotoga maritima [TaxId: 2336]
Probab=82.52 E-value=3.7 Score=28.41 Aligned_cols=69 Identities=10% Similarity=0.065 Sum_probs=43.7
Q ss_pred ceeEecCCCEEEecC-CCCCeEEEEeeeEEEEEEecCCCCcceEEEEecCCCeeecccccCCCcceeeEEecCCCCeEEE
Q psy14740 30 SQTFYKEGDYIIRQG-ARGDTFFIISKGKVKVTMKQPNSTEEKYIRTLYKGDFFGEKALQGDDLRTANIVAADPEGVSCL 108 (362)
Q Consensus 30 ~~~~~~~g~~i~~~g-~~~~~~yii~~G~v~v~~~~~~~~~~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~~~~~~~ 108 (362)
....++||..+=..= ...+.+|+|++|++.+... ++ ...+++||++= +=.+. ...+.+.++++++++
T Consensus 42 ~~~~~~PG~~~~~H~H~~~~E~~~vl~G~~~~~~~----~~---~~~l~~Gd~~~---ip~g~--~H~~~N~g~~~~~~l 109 (115)
T d1o4ta_ 42 ARMKLPPGSSVGLHKHEGEFEIYYILLGEGVFHDN----GK---DVPIKAGDVCF---TDSGE--SHSIENTGNTDLEFL 109 (115)
T ss_dssp EEEEECTTCEEEEEECCSEEEEEEEEESEEEEEET----TE---EEEEETTEEEE---ECTTC--EEEEECCSSSCEEEE
T ss_pred EEEEECCCCCcCCEECCCCcEEEEEEECcceEEEc----Ce---eEEeeccEEEE---ECCCC--eEEEEECCCCCEEEE
Confidence 355689999875443 3346799999999998742 23 34678998752 11233 344555555667776
Q ss_pred EE
Q psy14740 109 VI 110 (362)
Q Consensus 109 ~i 110 (362)
.|
T Consensus 110 ~I 111 (115)
T d1o4ta_ 110 AV 111 (115)
T ss_dssp EE
T ss_pred EE
Confidence 65
|
| >d2phla2 b.82.1.2 (A:220-381) Seed storage 7S protein {French bean (Phaseolus vulgaris), phaseolin [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: RmlC-like cupins family: Germin/Seed storage 7S protein domain: Seed storage 7S protein species: French bean (Phaseolus vulgaris), phaseolin [TaxId: 3885]
Probab=80.18 E-value=2.1 Score=32.04 Aligned_cols=75 Identities=20% Similarity=0.277 Sum_probs=51.2
Q ss_pred cceeEecCCCEEEec-CCCCCeEEEEeeeEEEEEEecCCCCc-----ceEEEEecCCCeeecccccCCCcceeeEEecCC
Q psy14740 29 SSQTFYKEGDYIIRQ-GARGDTFFIISKGKVKVTMKQPNSTE-----EKYIRTLYKGDFFGEKALQGDDLRTANIVAADP 102 (362)
Q Consensus 29 ~~~~~~~~g~~i~~~-g~~~~~~yii~~G~v~v~~~~~~~~~-----~~~~~~l~~G~~fGE~~l~~~~~r~~~~~A~~~ 102 (362)
+....+++|..+.-. -..++.+.+|.+|+..+....++|+. ...-..+++||+|-= . .-......+.
T Consensus 22 v~~~~l~p~~~~~PH~h~~A~~i~~V~~G~g~v~~v~~~g~~~~~~~~~~~~~l~~Gdv~vv----P-~G~~~~~~n~-- 94 (162)
T d2phla2 22 ISSIEMEEGALFVPHYYSKAIVILVVNEGEAHVELVGPKGNKETLEYESYRAELSKDDVFVI----P-AAYPVAIKAT-- 94 (162)
T ss_dssp EEEEEECTTEEEEEEEESSCEEEEEEEESEEEEEEEEECC--CCSCEEEEEEEEETTCEEEE----C-TTCCEEEEES--
T ss_pred EEEEEECCCcEeCCccCCCCCEEEEEEEeeeEEEEEecCCccccccceeeEeeecCCcEEEE----C-CCCEEEEEeC--
Confidence 356778999988876 46788999999999999998876543 245677999999742 1 1233455565
Q ss_pred CCeEEEEE
Q psy14740 103 EGVSCLVI 110 (362)
Q Consensus 103 ~~~~~~~i 110 (362)
.+..++.+
T Consensus 95 ~~~~~v~~ 102 (162)
T d2phla2 95 SNVNFTGF 102 (162)
T ss_dssp SSEEEEEE
T ss_pred CCceEEEE
Confidence 33555554
|